data_2mhn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mhn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 113.581 0.956 . . . . 64.11 113.581 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -57.31 143.11 41.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.809 1.244 . . . . 64.12 110.402 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.0 116.93 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.41 1.1 . . . . 72.33 108.166 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -68.63 124.64 24.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.685 -1.143 . . . . 63.44 108.209 170.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.74 105.29 13.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 105.324 -2.102 . . . . 73.25 105.324 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -113.03 174.24 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.057 -1.09 . . . . 74.53 108.057 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 74.99 17.35 2.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.005 2.522 . . . . 74.45 112.046 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.48 165.63 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.875 -0.515 . . . . 71.23 111.497 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.21 41.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.262 0.553 . . . . 75.13 111.463 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.04 -24.37 53.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.817 1.247 . . . . 61.41 113.736 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -123.25 19.4 9.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.366 1.867 . . . . 74.24 111.155 -167.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.0 tt -63.92 151.24 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.607 0.639 . . . . 73.14 109.961 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 160.9 35.77 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 125.089 1.356 . . . . 75.32 107.554 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.59 -42.15 57.31 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.233 1.289 . . . . 73.34 110.596 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -30.59 71.7 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.073 -0.965 . . . . 74.25 111.663 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.12 -30.72 62.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.549 1.068 . . . . 55.15 110.382 -169.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.91 -41.46 18.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.795 1.638 . . . . 74.24 110.527 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.87 -37.63 73.06 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.223 -0.658 . . . . 73.54 109.223 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.33 -55.47 28.13 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 126.722 2.009 . . . . 53.24 109.642 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -55.08 -29.78 58.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.85 1.26 . . . . 74.32 112.446 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.86 -35.65 13.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.188 0.81 . . . . 74.42 113.188 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.1 t -57.26 -23.11 46.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.641 1.176 . . . . 62.14 111.674 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.739 0.815 . . . . 71.14 112.735 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.86 6.28 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 64.13 111.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 -174.85 23.36 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 121.042 -1.036 . . . . 63.42 113.105 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -140.1 138.22 35.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.829 1.252 . . . . 74.25 109.334 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.54 138.68 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.628 1.571 . . . . 64.41 107.573 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -85.78 -57.71 2.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.852 1.661 . . . . 74.14 108.12 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -158.27 175.86 13.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.811 0.732 . . . . 63.41 109.701 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.2 113.61 26.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.109 1.764 . . . . 74.44 107.389 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.05 51.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.792 1.637 . . . . 75.11 108.578 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 ttt -66.57 128.96 38.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.906 1.282 . . . . 73.14 107.897 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 105.871 -1.9 . . . . 72.55 105.871 170.465 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 CA-C-O 118.916 -0.935 . . . . 74.32 113.987 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -139.11 148.7 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.601 1.2 . . . . 74.31 111.776 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.39 162.82 33.44 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.107 2.163 . . . . 74.24 109.842 170.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -130.09 114.56 15.91 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.662 1.585 . . . . 72.51 108.017 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.19 122.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.835 -1.172 . . . . 72.21 107.835 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -75.7 114.37 14.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.696 -1.224 . . . . 60.54 107.696 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.02 166.25 21.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.999 -0.371 . . . . 74.14 109.999 165.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.97 -9.36 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 118.68 -0.676 . . . . 71.33 111.358 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.55 135.0 40.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.342 1.883 . . . . 75.15 113.695 -168.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.443 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 7.1 p -60.21 -35.13 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.725 0.81 . . . . 71.31 111.981 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 m -80.68 -9.24 59.81 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 119.178 -1.009 . . . . 75.51 111.025 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.7 m -80.28 -11.81 59.68 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 117.548 -1.215 . . . . 72.55 113.659 172.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.34 -59.3 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 120.551 1.523 . . . . 63.42 108.765 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.48 -18.79 60.49 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.952 1.768 . . . . 54.31 113.667 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.52 -57.88 8.76 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 119.464 1.029 . . . . 73.42 108.75 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.01 69.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.704 1.202 . . . . 63.32 112.051 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.2 mt -54.85 -48.47 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.72 -0.845 . . . . 73.11 108.72 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.69 -6.21 21.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.727 1.156 . . . . 64.34 115.256 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.19 1.46 49.83 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.822 1.311 . . . . 73.33 112.168 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.68 -23.98 7.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.801 1.778 . . . . 74.34 115.801 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.15 1.65 37.91 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.143 0.878 . . . . 64.44 113.473 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.1 170.72 13.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.073 -1.084 . . . . 75.41 108.073 162.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -162.59 82.04 0.52 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.622 0.971 . . . . 74.32 113.622 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.78 117.24 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.608 -0.886 . . . . 63.31 108.608 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt 60.67 2.17 0.48 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.002 1.321 . . . . 73.21 114.157 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.79 11.96 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.799 -1.0 . . . . 61.24 113.132 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.7 t -112.37 86.12 7.78 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 118.945 1.373 . . . . 75.51 110.034 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.81 175.78 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.669 2.246 . . . . 65.12 111.369 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -134.92 140.42 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.302 1.041 . . . . 53.44 110.256 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mm -77.34 145.93 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.212 -0.93 . . . . 53.22 110.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.04 4.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 128.886 2.874 . . . . 72.15 115.806 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.8 -36.92 84.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.936 1.458 . . . . 71.31 114.936 -157.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.77 173.63 0.07 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.441 1.496 . . . . 63.42 110.091 -163.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 107.674 -1.232 . . . . 72.23 107.674 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 111.901 0.334 . . . . 74.22 111.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -85.35 144.3 28.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.198 -1.038 . . . . 73.13 108.198 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.65 122.14 66.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.355 1.062 . . . . 74.14 108.252 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -73.7 132.87 43.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.918 1.687 . . . . 71.52 110.107 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.7 m -117.64 130.3 56.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.541 1.936 . . . . 70.23 106.356 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.9 ttp -138.32 29.87 2.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.839 1.256 . . . . 61.53 110.69 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -153.86 15.31 0.49 Allowed 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.546 -1.346 . . . . 74.15 111.972 -165.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.29 156.59 36.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.825 0.45 . . . . 73.42 111.142 -167.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 152.23 44.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.052 0.454 . . . . 72.54 109.978 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.94 64.87 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.447 1.099 . . . . 74.43 113.744 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -121.59 58.48 1.0 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.752 1.221 . . . . 73.44 109.345 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 161.51 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.019 -1.051 . . . . 63.34 109.351 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -120.26 158.3 51.2 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 125.579 1.552 . . . . 62.53 108.099 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.86 -32.42 22.65 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.588 1.525 . . . . 74.44 111.319 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -70.82 -37.86 73.25 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.614 0.643 . . . . 74.55 111.322 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.83 -40.41 69.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.201 1.001 . . . . 73.12 110.74 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.3 -48.26 62.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.683 1.193 . . . . 74.44 110.88 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.2 -37.82 78.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.496 -0.764 . . . . 65.11 109.633 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.34 -25.86 66.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.068 0.849 . . . . 72.15 112.223 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.6 -36.63 83.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.744 0.702 . . . . 72.13 110.244 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -99.55 -33.88 10.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.501 -0.761 . . . . 71.24 112.417 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -66.02 -17.14 64.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.793 1.179 . . . . 74.52 111.501 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -80.95 -2.84 49.37 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.259 -0.901 . . . . 74.13 112.23 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.75 15.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.166 1.786 . . . . 73.12 111.481 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.06 -155.53 17.3 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.001 -1.639 . . . . 71.25 109.001 -161.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -157.81 147.74 20.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.853 1.327 . . . . 72.45 108.998 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -112.23 122.99 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.443 1.097 . . . . 65.53 110.024 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -76.07 -45.73 32.61 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.805 1.242 . . . . 73.55 110.501 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.9 163.64 37.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.443 1.097 . . . . 73.24 108.777 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.4 126.29 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.171 1.388 . . . . 74.35 107.296 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -132.6 103.97 6.42 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.698 -0.852 . . . . 74.22 108.698 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.42 137.11 35.98 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.448 1.099 . . . . 74.22 108.302 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 105.897 -1.89 . . . . 71.55 105.897 172.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 N-CA-C 109.726 -1.35 . . . . 53.43 109.726 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -120.57 128.31 76.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.034 1.334 . . . . 72.15 111.062 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.89 158.73 44.51 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.005 1.322 . . . . 72.23 110.176 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -124.34 135.69 53.53 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.979 -1.489 . . . . 72.35 106.979 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.375 1.5 p -138.54 109.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 65.55 110.56 -168.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -74.25 122.31 22.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.43 1.892 . . . . 72.24 110.357 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.76 153.92 38.59 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.16 0.981 . . . . 63.33 111.483 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -73.94 -21.76 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 115.229 -0.896 . . . . 73.22 110.868 166.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -137.85 128.22 26.31 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.243 1.417 . . . . 74.55 109.857 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.38 -30.66 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.216 1.406 . . . . 73.13 111.388 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -73.73 -21.11 60.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.243 -1.535 . . . . 72.11 112.855 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 m -81.71 -8.69 59.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.704 1.138 . . . . 74.13 112.553 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.15 -66.54 1.19 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 116.101 -1.904 . . . . 74.13 107.768 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.03 -17.87 58.46 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.433 2.089 . . . . 74.24 113.837 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.14 -42.45 76.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.554 1.142 . . . . 74.33 109.45 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.69 -36.55 69.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.017 0.747 . . . . 70.22 113.017 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.9 mt -59.41 -42.54 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.941 0.791 . . . . 72.23 109.769 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 -5.09 8.66 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.384 -0.676 . . . . 75.13 113.091 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.12 5.6 12.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.383 1.591 . . . . 74.13 112.456 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.7 t -48.07 -33.75 8.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.234 1.379 . . . . 62.52 113.094 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.85 12.86 41.8 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.891 1.71 . . . . 73.11 113.839 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.77 172.23 8.48 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 118.874 1.337 . . . . 74.51 108.069 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -155.93 99.46 1.98 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.388 0.675 . . . . 75.24 111.137 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.64 114.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.919 -1.141 . . . . 71.24 107.919 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt 54.53 21.35 3.3 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.873 1.064 . . . . 70.32 113.873 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.84 28.82 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.297 -0.724 . . . . 61.34 113.945 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.13 85.11 6.39 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.354 1.577 . . . . 71.15 109.719 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.83 177.76 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.862 2.375 . . . . 72.13 111.388 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.8 tt -136.48 169.09 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.871 0.693 . . . . 73.51 112.871 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.18 124.44 73.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.707 2.003 . . . . 74.31 108.798 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -53.38 -17.75 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.079 2.552 . . . . 71.21 115.831 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.87 -42.56 80.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.568 1.531 . . . . 73.41 111.646 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.0 41.83 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.836 1.654 . . . . 63.44 113.986 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.258 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 127.227 2.211 . . . . 74.32 111.449 -171.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.107 -0.473 . . . . 75.53 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.17 151.38 50.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.332 0.969 . . . . 74.32 112.237 -173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.84 122.92 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.1 1.76 . . . . 73.51 110.691 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.91 129.71 38.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.262 1.425 . . . . 73.51 109.647 169.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.6 m -122.15 105.06 9.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.994 -1.484 . . . . 64.52 106.994 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.8 ttm -88.01 174.57 8.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.712 0.805 . . . . 74.42 109.133 171.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.14 21.03 6.16 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.44 2.296 . . . . 74.23 113.185 164.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.7 mt -69.1 167.03 16.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.104 0.561 . . . . 73.24 111.77 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 147.73 47.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.976 -0.556 . . . . 64.14 110.332 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.99 -4.26 2.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.32 1.448 . . . . 70.33 113.675 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -139.36 13.57 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.77 1.628 . . . . 73.1 112.138 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tt -47.7 131.46 4.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.756 0.822 . . . . 75.54 112.275 -167.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -66.97 147.67 99.05 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 107.548 -1.279 . . . . 73.54 107.548 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.55 1.77 4.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.088 2.525 . . . . 61.32 113.36 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 -22.0 14.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.814 1.188 . . . . 75.45 113.019 167.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -30.43 71.52 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.811 1.187 . . . . 60.11 112.046 -165.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.3 mt -84.71 -24.13 29.03 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.989 0.516 . . . . 75.53 111.436 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -80.78 -52.01 7.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.33 -2.1 . . . . 71.14 105.33 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.12 -38.72 83.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.896 1.678 . . . . 74.23 110.668 -172.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -57.96 -49.26 77.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.237 0.926 . . . . 73.32 111.971 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -85.13 -15.23 44.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.1 0.407 . . . . 75.11 112.1 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -59.23 -20.13 51.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.617 1.567 . . . . 73.32 113.399 -171.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -65.38 -24.37 67.21 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.954 0.502 . . . . 73.21 110.466 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.87 47.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.009 -1.057 . . . . 75.34 110.75 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.17 153.5 9.37 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.005 1.764 . . . . 53.22 108.979 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 167.48 12.76 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.296 0.638 . . . . 72.31 110.71 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . 2.6 p -124.35 145.35 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.442 1.897 . . . . 62.35 107.78 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -74.11 -49.52 23.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.776 -1.107 . . . . 75.35 109.098 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -165.87 -179.69 5.41 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.405 1.002 . . . . 73.52 111.818 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.9 t -133.56 110.01 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 127.006 2.123 . . . . 75.11 107.623 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -104.34 85.33 2.34 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.377 1.071 . . . . 75.24 108.985 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.47 160.74 19.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.649 0.737 . . . . 75.3 110.086 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 106.841 -1.54 . . . . 74.11 106.841 -175.776 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.642 0 N-CA-C 110.349 -1.1 . . . . 72.4 110.349 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.54 156.11 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.86 1.264 . . . . 70.53 111.044 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.86 159.91 27.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.22 1.008 . . . . 74.44 113.43 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.35 105.41 10.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.777 2.431 . . . . 74.41 106.15 160.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -91.65 132.18 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.62 -1.622 . . . . 75.53 106.62 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -116.47 89.86 3.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.492 1.117 . . . . 73.44 110.276 -166.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.98 169.77 1.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.463 2.023 . . . . 74.12 116.463 -176.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.4 -23.71 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.539 -0.726 . . . . 73.43 112.216 167.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.15 144.66 38.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.436 1.471 . . . . 73.41 114.162 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -48.84 -43.76 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 129.704 3.201 . . . . 63.31 111.675 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.3 p -64.2 -20.65 66.17 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.065 1.302 . . . . 71.34 111.48 -171.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.8 -10.41 58.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.793 1.034 . . . . 73.12 113.793 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.97 -60.22 11.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.995 0.918 . . . . 72.11 109.591 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -11.57 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.537 1.491 . . . . 71.14 113.776 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.05 -49.16 68.64 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.946 0.794 . . . . 74.33 109.461 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.29 74.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.722 -0.611 . . . . 72.42 111.424 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.37 -44.76 89.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.38 0.672 . . . . 73.35 109.514 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.35 -35.85 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 118.624 0.647 . . . . 65.41 112.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.94 4.07 10.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.363 1.065 . . . . 74.42 113.554 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -46.44 -27.12 0.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.433 1.493 . . . . 74.43 114.419 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -3.91 63.22 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.868 -1.145 . . . . 70.05 113.677 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -77.08 176.5 8.63 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 119.217 1.509 . . . . 62.05 110.488 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 86.5 1.57 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.525 1.13 . . . . 73.03 109.019 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.46 93.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.584 1.554 . . . . 74.35 109.784 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt 46.24 43.3 11.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.658 1.218 . . . . 73.14 110.772 -167.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.43 21.0 46.23 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.314 -0.866 . . . . 71.33 113.347 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.7 85.87 28.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.85 1.66 . . . . 73.1 107.52 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.7 -179.44 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.299 1.999 . . . . 74.35 111.003 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.51 156.13 18.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.26 143.37 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.417 1.487 . . . . 72.1 108.797 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.52 3.75 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.16 1.784 . . . . 73.05 114.481 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.29 -53.15 6.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.445 1.898 . . . . 72.43 112.46 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.58 163.27 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.684 1.706 . . . . 64.34 112.872 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 104.208 -2.515 . . . . 74.23 104.208 168.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 116.187 1.921 . . . . 75.23 116.187 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -102.94 148.47 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.725 1.148 . . . . 72.22 109.734 -159.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -126.12 135.27 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.109 1.364 . . . . 72.43 109.635 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -100.25 106.61 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.499 1.12 . . . . 74.51 109.619 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -93.18 83.63 4.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.818 2.047 . . . . 55.31 109.221 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.7 ttp -91.21 41.37 1.06 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.3 0.852 . . . . 74.15 113.3 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -154.39 27.25 0.45 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.368 -1.458 . . . . 73.22 113.752 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.84 152.12 45.13 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.724 -0.61 . . . . 75.51 111.22 -173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.8 168.21 14.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.301 0.572 . . . . 71.12 111.531 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.67 66.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.026 1.121 . . . . 55.34 114.026 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -117.07 10.22 13.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.142 1.377 . . . . 75.34 111.434 -166.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -56.35 139.61 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.3 1.44 . . . . 73.52 111.659 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -87.82 161.46 44.39 Favored Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 124.32 1.048 . . . . 74.34 108.591 163.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.88 -44.61 38.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.044 1.829 . . . . 64.34 110.902 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -62.44 -23.28 66.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.135 -0.936 . . . . 75.52 112.724 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.53 -23.47 64.6 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.64 1.563 . . . . 75.14 111.719 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.44 -25.02 39.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.611 1.165 . . . . 74.51 112.893 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.0 -38.64 11.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.876 1.216 . . . . 75.53 109.606 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.52 -27.41 64.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.553 1.07 . . . . 75.54 112.683 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.02 -64.16 0.94 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.413 0.552 . . . . 72.55 109.77 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.0 -22.35 65.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.032 0.753 . . . . 75.14 113.032 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -64.29 -4.72 4.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.089 1.356 . . . . 71.13 111.094 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -53.33 -30.32 38.53 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.406 1.457 . . . . 72.23 110.66 161.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.5 m -144.68 65.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.492 1.517 . . . . 73.43 110.264 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.57 177.13 15.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 122.861 1.256 . . . . 75.31 115.003 149.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -91.74 53.91 2.34 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.814 1.413 . . . . 75.24 114.814 -151.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.308 1.5 p -44.6 130.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.528 1.131 . . . . 75.42 110.854 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -85.11 -48.25 9.36 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 112.72 -2.036 . . . . 73.24 109.843 -155.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -161.47 155.69 22.52 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 124.971 1.419 . . . . 75.45 110.302 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.02 148.6 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.67 1.588 . . . . 72.52 107.717 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -138.84 121.8 16.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.147 -1.797 . . . . 75.32 106.147 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.2 ptp -143.36 166.73 23.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.659 0.784 . . . . 74.43 111.284 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.235 0.311 0 CA-C-N 116.23 -0.441 . . . . 75.41 109.886 -168.72 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.831 -1.539 . . . . 75.54 110.983 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.3 118.91 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.356 1.078 . . . . 74.42 110.166 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.28 34.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.125 1.37 . . . . 75.55 108.222 163.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.62 83.52 2.08 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.037 2.135 . . . . 73.54 107.131 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.292 1.6 p -90.29 144.5 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.055 1.342 . . . . 72.44 111.104 -170.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.84 97.71 5.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.991 0.901 . . . . 63.13 109.131 -155.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.01 172.92 2.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.914 1.816 . . . . 75.31 112.005 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.87 -25.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 127.406 2.282 . . . . 74.22 112.075 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -138.42 142.81 39.52 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.154 1.782 . . . . 75.42 108.441 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.49 -22.38 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.857 0.863 . . . . 73.24 111.586 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 p -68.4 -20.33 64.66 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 120.671 -1.268 . . . . 62.31 111.868 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -74.65 -19.73 60.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.359 -0.838 . . . . 55.32 112.498 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.56 -57.27 28.15 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.086 -1.009 . . . . 75.53 110.622 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.42 -14.04 39.04 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.645 2.23 . . . . 72.45 113.075 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.72 -49.92 73.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.517 -0.92 . . . . 72.54 108.517 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.83 72.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.624 0.77 . . . . 64.42 111.894 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mt -55.83 -35.52 40.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.462 1.105 . . . . 74.02 110.216 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.69 -27.48 49.44 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.957 -0.913 . . . . 53.41 114.24 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mt -110.82 10.2 22.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.313 1.556 . . . . 74.22 112.455 -166.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 t -44.7 -36.49 3.17 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.242 1.383 . . . . 75.42 113.194 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 -26.52 58.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.833 1.206 . . . . 74.22 113.316 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.99 158.29 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.979 0.889 . . . . 74.51 108.683 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -158.06 115.93 3.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.812 0.845 . . . . 74.51 109.426 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -77.46 125.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 106.97 -1.493 . . . . 71.23 106.97 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt 48.34 37.76 9.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.174 1.39 . . . . 71.53 112.823 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.92 28.61 64.4 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.493 -1.171 . . . . 64.35 113.874 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.66 85.51 7.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.336 1.854 . . . . 75.31 108.872 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.16 -170.68 0.97 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.77 2.313 . . . . 72.11 111.226 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.65 159.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 121.404 -0.81 . . . . 63.54 111.48 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.28 141.19 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.145 -1.428 . . . . 72.41 107.145 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -52.48 -13.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.668 2.787 . . . . 74.03 116.036 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -44.5 -53.33 7.1 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.089 1.355 . . . . 74.24 113.859 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 38.45 29.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.722 1.209 . . . . 72.51 113.294 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 124.737 1.215 . . . . 75.25 111.261 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 116.767 2.136 . . . . 75.2 116.767 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -121.56 145.54 47.87 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.189 -1.411 . . . . 74.32 107.189 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.56 115.1 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.661 -1.978 . . . . 62.03 105.661 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -75.0 128.21 35.04 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.181 -1.785 . . . . 63.33 106.181 168.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -121.32 121.36 37.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 106.534 -1.654 . . . . 75.03 106.534 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.0 ttp -124.13 165.23 17.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.22 1.408 . . . . 75.41 107.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 75.31 12.17 3.31 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.028 2.131 . . . . 72.12 111.862 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.17 167.95 9.31 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.647 -0.658 . . . . 71.41 109.423 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.47 151.87 45.55 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.604 -0.685 . . . . 74.42 110.58 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.62 -4.19 25.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.155 0.982 . . . . 72.21 113.008 172.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.76 33.1 2.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.596 1.958 . . . . 74.05 110.374 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.97 138.58 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.049 -1.032 . . . . 74.42 108.768 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -77.91 153.48 80.36 Favored Pre-proline 0 N--CA 1.466 0.363 0 N-CA-C 108.218 -1.03 . . . . 74.02 108.218 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.37 0.9 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.395 2.73 . . . . 75.43 114.039 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -112.87 -5.25 13.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.941 1.246 . . . . 75.25 111.892 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.47 -30.44 64.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.6 -1.313 . . . . 63.44 108.729 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.48 -53.23 9.92 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.174 0.99 . . . . 72.21 110.195 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.54 -40.07 94.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.46 0.704 . . . . 61.1 110.524 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -67.87 -27.37 66.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.156 0.582 . . . . 75.41 112.067 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.26 -50.07 73.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.502 -0.285 . . . . 75.24 110.317 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -72.83 -28.26 62.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.88 0.764 . . . . 74.4 111.974 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 t -57.73 -20.36 34.04 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.632 1.973 . . . . 60.22 113.218 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -76.74 -15.85 59.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.149 -0.969 . . . . 75.12 111.268 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -136.98 11.54 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.031 0.932 . . . . 75.11 111.461 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.51 173.55 36.29 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 121.198 -0.939 . . . . 53.42 111.604 -160.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.76 137.12 29.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.532 -1.284 . . . . 75.12 107.532 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.24 131.8 65.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 125.92 1.688 . . . . 64.32 109.281 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -94.13 -42.54 8.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.048 -0.977 . . . . 75.0 110.879 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -167.41 158.45 11.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.783 2.033 . . . . 74.21 106.36 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.95 163.85 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.26 1.824 . . . . 74.44 109.684 -173.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 136.79 10.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.181 -0.95 . . . . 74.44 109.235 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.4 ptp -136.11 135.55 39.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.273 0.942 . . . . 75.13 110.18 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 45' ' ' ILE . 3.3 mp . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 116.07 -0.514 . . . . 75.12 112.352 -150.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 110.389 -1.084 . . . . 73.32 110.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.38 131.54 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.205 1.802 . . . . 75.32 109.903 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.15 165.6 35.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.737 1.615 . . . . 61.32 108.55 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -124.07 146.12 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.425 -1.694 . . . . 72.4 106.425 165.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.71 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.563 -1.643 . . . . 75.14 106.563 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -72.1 128.34 35.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.097 -1.446 . . . . 75.33 107.097 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.18 155.44 23.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 75.04 110.631 169.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.18 -26.99 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 117.996 -1.002 . . . . 73.31 110.187 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.13 150.43 50.52 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.191 1.36 . . . . 62.31 111.979 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.78 -34.54 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 117.986 -1.006 . . . . 75.14 111.806 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -69.99 -20.74 63.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.383 1.902 . . . . 74.34 112.411 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -89.94 -4.34 57.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.829 0.852 . . . . 75.13 112.443 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.29 -60.84 8.92 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 119.693 1.133 . . . . 75.0 109.787 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 -15.4 46.41 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 120.92 1.364 . . . . 62.31 113.381 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -55.22 35.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 120.547 -1.345 . . . . 74.44 110.145 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.82 -41.6 78.12 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.712 0.633 . . . . 74.02 111.253 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.01 -39.0 70.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.948 0.899 . . . . 72.43 110.36 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.58 -36.04 63.52 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.448 1.023 . . . . 74.31 112.905 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.6 12.75 1.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.574 1.15 . . . . 75.22 113.354 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -50.38 -28.23 7.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.298 1.439 . . . . 71.13 113.572 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.66 14.73 45.96 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.293 1.425 . . . . 75.22 112.914 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -93.71 170.4 9.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.261 1.03 . . . . 73.44 108.258 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -145.17 87.13 1.8 Allowed 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.635 -0.666 . . . . 75.05 109.978 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.94 110.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.708 -0.849 . . . . 63.25 108.708 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt 46.97 31.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.353 1.861 . . . . 62.45 112.979 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.42 19.43 27.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.781 0.705 . . . . 62.04 113.61 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.63 86.43 29.37 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.995 1.718 . . . . 72.41 109.165 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.23 173.79 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.456 2.104 . . . . 60.02 111.914 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.17 143.33 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.466 1.107 . . . . 71.4 109.453 -175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.9 mm -86.14 144.34 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.715 0.806 . . . . 72.33 109.442 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.15 10.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 129.298 3.039 . . . . 54.34 115.471 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -25.66 64.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 114.782 1.401 . . . . 75.24 114.782 -154.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.83 164.03 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.692 2.797 . . . . 61.22 111.766 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 106.135 -1.802 . . . . 55.24 106.135 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 116.943 2.201 . . . . 74.13 116.943 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -77.75 155.93 30.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.814 0.846 . . . . 72.52 111.47 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.09 179.29 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.499 1.52 . . . . 64.54 108.54 167.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -140.94 127.05 19.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.631 1.173 . . . . 72.24 110.048 -169.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.77 115.4 30.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.363 1.465 . . . . 72.5 107.451 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -128.87 32.59 4.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.623 1.569 . . . . 74.5 110.141 -174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -147.28 27.36 1.03 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.381 -1.449 . . . . 74.41 110.445 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.4 mt -68.03 155.19 40.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.949 1.3 . . . . 73.04 113.654 -172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.13 -174.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.812 1.645 . . . . 74.43 110.085 163.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.92 19.57 10.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.139 1.376 . . . . 73.0 111.879 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -140.26 8.82 2.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.648 1.179 . . . . 73.24 111.366 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.9 tt -76.0 148.82 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.317 1.447 . . . . 74.03 108.82 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.26 152.23 88.04 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.033 -1.042 . . . . 63.43 109.083 170.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.06 -48.94 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.687 1.591 . . . . 73.3 111.198 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttp85 -64.13 -21.27 66.48 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.124 -0.941 . . . . 74.33 112.767 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.19 -33.3 72.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.576 1.535 . . . . 74.12 110.492 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.28 -23.25 54.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.094 -0.955 . . . . 70.33 111.86 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.37 -33.48 15.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.19 0.904 . . . . 74.34 108.628 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.42 -36.56 76.11 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.272 1.829 . . . . 74.14 111.107 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -49.9 -62.45 1.56 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.126 0.97 . . . . 70.11 110.471 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.81 -17.61 64.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 71.43 111.833 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -2.33 6.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.727 1.01 . . . . 70.13 113.727 172.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -69.69 -34.58 74.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.416 1.462 . . . . 65.21 110.159 161.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -8.96 11.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 120.005 1.275 . . . . 64.51 113.806 -159.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.99 178.48 48.5 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.415 -0.674 . . . . 71.41 111.415 -160.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.64 135.75 54.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.892 1.346 . . . . 73.21 112.005 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 153.29 28.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 125.59 1.556 . . . . 53.21 109.614 -175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -97.35 -52.84 3.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.323 -1.762 . . . . 64.31 107.219 -166.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.13 -177.88 3.48 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.164 0.585 . . . . 72.22 110.267 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.05 149.52 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.199 1.0 . . . . 72.31 110.259 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -124.91 159.58 30.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.096 1.358 . . . . 70.43 109.735 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.1 ptp -138.6 132.0 30.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.771 1.228 . . . . 65.23 107.88 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 107.256 -1.387 . . . . 71.54 107.256 179.024 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.233 0 N-CA-C 109.452 -1.459 . . . . 71.3 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.96 141.15 27.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.926 1.29 . . . . 74.3 109.182 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.82 152.43 28.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.41 1.084 . . . . 70.23 108.927 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -124.95 146.1 49.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.553 1.541 . . . . 72.44 107.339 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.8 115.27 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.869 -1.16 . . . . 73.52 107.869 -161.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -85.9 96.57 9.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.884 0.873 . . . . 74.43 109.61 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 157.22 12.3 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 120.029 -1.67 . . . . 74.51 113.45 166.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.99 -29.19 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 109.702 -0.481 . . . . 74.32 109.702 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.44 144.83 42.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.97 1.308 . . . . 62.43 110.001 -171.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 p -72.91 -21.9 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.443 0.697 . . . . 73.23 112.527 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -59.26 -22.64 61.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.621 -1.3 . . . . 73.11 113.755 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m -93.27 -2.08 55.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.801 0.84 . . . . 72.23 113.094 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.42 -58.35 19.2 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 120.211 -1.556 . . . . 71.52 110.135 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.01 -14.63 44.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 CA-C-N 121.383 1.53 . . . . 74.33 112.683 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -41.34 94.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.336 -0.853 . . . . 74.51 108.762 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.79 -28.54 66.06 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.868 0.867 . . . . 62.41 112.966 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.5 mt -63.49 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 118.966 0.803 . . . . 70.51 109.076 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.39 -14.3 59.59 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.549 -0.72 . . . . 71.2 113.794 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.89 -0.79 41.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.508 1.154 . . . . 73.42 112.287 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -45.54 -45.62 13.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.872 1.269 . . . . 74.42 111.524 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.67 4.94 79.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.809 0.718 . . . . 71.21 114.245 -168.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -78.91 -171.14 2.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.505 1.152 . . . . 73.3 108.929 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.43 121.03 4.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.985 -1.487 . . . . 73.1 106.985 176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 97.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.287 -1.375 . . . . 72.42 107.287 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 mt 53.08 16.23 0.72 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.719 1.607 . . . . 70.42 113.439 -170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.99 7.29 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.132 0.872 . . . . 65.04 113.137 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.26 86.61 2.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.724 2.01 . . . . 61.3 111.222 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.76 175.84 1.58 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.157 1.904 . . . . 74.04 111.557 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.6 tt -127.19 163.96 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 O-C-N 121.53 -0.731 . . . . 73.12 110.278 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.528 HG21 ' H ' ' A' ' 86' ' ' GLN . 49.2 mm -99.87 140.25 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.743 -1.577 . . . . 70.2 106.743 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -44.92 -24.97 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.085 2.154 . . . . 74.21 114.83 170.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.528 ' H ' HG21 ' A' ' 84' ' ' ILE . 13.1 mt-30 -44.1 -51.7 7.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.123 1.769 . . . . 73.42 113.331 -162.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.33 48.75 18.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.798 1.239 . . . . 74.2 112.376 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 108.271 -1.011 . . . . 73.14 108.271 -174.332 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 114.562 1.319 . . . . 73.24 114.562 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.02 165.58 27.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.036 -1.468 . . . . 72.51 107.036 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.76 -178.5 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.936 0.895 . . . . 71.43 109.536 163.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.73 102.17 3.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.404 1.097 . . . . 75.43 110.573 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.5 m -87.66 94.94 9.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.384 1.874 . . . . 72.43 109.117 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.4 ttp -108.17 44.85 1.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.769 1.227 . . . . 63.52 110.207 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -164.8 68.3 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 74.43 110.36 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.39 166.1 10.92 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.364 -0.835 . . . . 74.34 111.367 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.9 171.55 7.58 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.627 1.171 . . . . 71.31 110.654 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.85 -30.94 65.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.266 0.839 . . . . 74.4 113.266 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.63 51.5 1.92 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.365 1.066 . . . . 64.21 108.959 -170.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 tt -80.47 154.13 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.772 -0.825 . . . . 71.2 108.772 170.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -111.76 160.59 29.1 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 107.802 -1.184 . . . . 74.1 107.802 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -59.96 -21.43 64.69 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.031 1.821 . . . . 73.32 112.436 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -34.5 73.0 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.963 -1.086 . . . . 74.22 112.297 173.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -34.31 74.74 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.874 1.216 . . . . 72.21 111.747 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.5 -41.8 96.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.558 0.743 . . . . 74.41 110.124 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.77 -35.12 29.94 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.221 -0.895 . . . . 72.5 109.99 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -63.92 -24.31 67.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.597 1.089 . . . . 72.13 111.253 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -65.46 -67.6 0.43 Allowed 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.874 -0.516 . . . . 73.51 110.388 168.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -71.4 -19.7 62.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.552 0.945 . . . . 65.3 113.552 -167.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 t -51.72 -28.64 15.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.96 1.304 . . . . 74.51 110.798 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -77.02 -14.94 59.77 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.146 -0.971 . . . . 73.14 110.987 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.36 -4.19 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.261 1.024 . . . . 72.23 113.358 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.15 -156.83 12.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.662 -1.375 . . . . 72.21 109.662 -174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -145.3 139.33 27.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.421 1.111 . . . . 73.52 110.985 166.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 t -71.17 143.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.925 1.69 . . . . 73.44 108.778 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -82.44 -50.6 8.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.013 -1.054 . . . . 74.5 109.606 163.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.58 124.06 11.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.275 0.488 . . . . 63.22 110.817 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.6 t -73.7 108.17 4.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 O-C-N 121.404 -0.81 . . . . 72.54 109.343 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -104.91 82.58 1.89 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.863 1.265 . . . . 71.52 108.129 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 153.57 23.4 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.613 0.765 . . . . 74.2 109.003 167.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 108.155 -1.054 . . . . 63.44 108.155 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 N-CA-C 109.606 -1.398 . . . . 64.32 109.606 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 pt -145.56 137.36 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.1 1.36 . . . . 74.12 110.152 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.61 135.19 29.76 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.601 -1.259 . . . . 75.3 107.601 163.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -122.11 70.77 0.98 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.625 -1.25 . . . . 75.2 107.625 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -67.35 135.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.539 0.685 . . . . 75.43 109.772 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.61 145.06 31.89 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.809 -1.182 . . . . 73.34 107.809 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.18 151.33 24.9 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 113.319 0.859 . . . . 73.44 113.319 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 -43.6 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.31 -0.859 . . . . 74.41 109.104 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.38 142.64 46.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.518 1.127 . . . . 73.52 109.71 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.97 -36.66 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 111.827 0.306 . . . . 72.51 111.827 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -62.6 -23.51 67.08 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.148 -0.97 . . . . 74.1 113.065 -166.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -77.07 -13.12 60.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.945 0.898 . . . . 71.51 113.07 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.98 -56.48 25.22 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.866 1.666 . . . . 62.31 111.723 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.63 -12.41 34.98 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 121.997 1.798 . . . . 64.23 113.635 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.26 -47.93 66.43 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.009 -1.057 . . . . 74.44 109.231 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.57 69.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.372 0.669 . . . . 62.33 112.395 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.9 mt -57.32 -41.4 78.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.754 0.822 . . . . 73.51 109.362 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.85 -18.46 56.92 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.56 -0.578 . . . . 74.54 112.865 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -101.34 9.44 41.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.708 1.203 . . . . 71.32 111.554 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -51.64 -30.02 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.69 1.132 . . . . 73.51 113.383 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.91 5.41 27.39 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.161 1.362 . . . . 63.1 112.796 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.95 174.95 8.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.779 1.29 . . . . 72.14 108.275 155.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 130.15 10.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.83 1.252 . . . . 73.34 108.642 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.19 115.52 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.819 -1.919 . . . . 74.53 105.819 162.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.65 3.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.737 2.125 . . . . 74.44 116.737 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.72 7.27 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.736 1.153 . . . . 65.33 113.923 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.39 86.99 2.97 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 128.323 2.649 . . . . 72.52 109.675 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.77 -176.67 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.791 2.327 . . . . 74.41 111.549 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.5 tt -136.77 167.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 121.19 -0.944 . . . . 73.4 109.715 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.509 HG21 ' H ' ' A' ' 86' ' ' GLN . 39.8 mm -111.95 144.72 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.671 -1.603 . . . . 72.11 106.671 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.34 -13.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.508 1.923 . . . . 73.1 112.832 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.509 ' H ' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -52.42 -26.68 13.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.001 2.52 . . . . 75.5 115.419 -171.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 43.32 89.92 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.352 1.461 . . . . 61.31 112.132 155.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 107.723 -1.214 . . . . 64.13 107.723 173.545 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.657 0.265 . . . . 73.55 111.164 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.63 150.67 49.7 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.909 -1.119 . . . . 74.35 109.664 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.71 171.7 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.357 1.463 . . . . 72.52 107.557 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.92 142.16 30.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.258 1.423 . . . . 75.21 108.238 -166.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.7 m -130.21 103.28 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.148 1.379 . . . . 64.52 109.858 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.1 ttm -92.83 -0.34 57.27 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.797 1.036 . . . . 75.25 113.797 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -128.18 29.08 5.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.278 1.214 . . . . 52.32 114.278 -163.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -73.34 151.53 41.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.355 1.062 . . . . 74.1 113.632 -171.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.21 165.72 17.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.549 1.14 . . . . 74.23 112.95 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.084 1.354 . . . . 74.14 113.542 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.98 47.09 1.96 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.26 1.024 . . . . 74.11 110.755 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.51 154.49 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 120.995 -1.065 . . . . 75.12 109.05 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -114.98 157.87 42.23 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 127.439 2.296 . . . . 72.31 107.738 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.21 -19.89 69.58 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.805 1.67 . . . . 74.42 112.182 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 1.5 ptp180 -76.71 -29.95 56.46 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.363 -0.827 . . . . 74.31 112.259 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -61.89 -25.19 67.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.491 1.041 . . . . 75.13 111.061 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -54.24 6.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.915 0.886 . . . . 75.34 109.07 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.57 -33.29 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 117.693 -1.146 . . . . 73.42 111.347 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.02 0.827 . . . . 74.51 109.53 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -52.79 -48.21 67.03 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 122.684 0.394 . . . . 74.22 110.718 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -80.04 -14.46 58.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.199 -1.0 . . . . 75.5 112.103 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 t -64.97 -17.25 64.25 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.362 1.437 . . . . 60.54 110.848 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 p -73.16 -21.77 60.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.779 1.172 . . . . 75.12 111.037 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.43 -7.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.641 1.576 . . . . 75.14 112.736 -166.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.37 18.46 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.114 1.34 . . . . 74.34 111.003 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -147.87 134.41 19.78 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.68 1.192 . . . . 73.42 110.573 -168.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.0 t -105.5 144.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.293 1.837 . . . . 73.43 108.395 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.71 -54.93 2.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.275 1.43 . . . . 75.13 108.378 172.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.56 165.04 27.91 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 124.162 0.914 . . . . 64.11 110.982 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.01 110.26 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.946 2.098 . . . . 74.43 106.502 -160.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -143.71 81.34 1.69 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.041 0.837 . . . . 71.43 110.047 -160.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.1 mtp -88.41 160.77 17.41 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 122.671 1.224 . . . . 75.4 110.429 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mm . . . . . 0 N--CA 1.433 -1.322 0 C-N-CA 124.823 1.249 . . . . 73.55 107.917 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.212 0 N-CA-C 110.416 -1.074 . . . . 74.31 110.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -145.65 153.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.288 1.044 . . . . 75.21 110.732 171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.8 40.78 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.976 1.31 . . . . 75.41 109.144 168.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -122.28 154.83 37.05 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 75.25 106.783 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 t -134.67 134.46 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.184 -2.154 . . . . 75.25 105.184 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.55 109.09 20.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.625 -1.991 . . . . 74.45 105.625 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -73.18 168.97 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.522 0.729 . . . . 74.41 109.296 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.43 -38.67 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 120.538 -0.465 . . . . 62.33 109.85 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.11 128.15 45.2 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.651 0.659 . . . . 71.22 110.447 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.82 -37.76 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 74.42 111.474 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -5.5 54.27 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.685 -1.259 . . . . 63.42 112.336 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.9 m -90.88 -12.06 37.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.232 -0.918 . . . . 74.34 111.824 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.5 t -54.58 -57.63 17.99 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.369 0.986 . . . . 75.22 110.089 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.86 -22.61 68.88 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.228 1.952 . . . . 73.53 113.872 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.21 -52.26 59.73 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.771 -0.826 . . . . 74.42 108.771 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.86 78.57 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.217 0.607 . . . . 74.5 111.328 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.87 -44.51 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.563 0.745 . . . . 75.11 109.385 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.92 -10.64 27.05 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.764 0.697 . . . . 43.02 114.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.41 5.84 50.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.555 1.178 . . . . 74.34 111.932 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -44.46 -45.75 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.996 1.718 . . . . 74.12 112.876 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.86 2.93 84.67 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.738 -1.034 . . . . 62.11 113.703 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.06 -176.59 2.16 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.508 1.654 . . . . 74.13 109.317 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -157.45 81.69 0.9 Allowed 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.829 0.851 . . . . 71.33 109.502 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.47 102.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.487 1.115 . . . . 75.24 108.541 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt 56.51 25.03 9.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.53 0.332 . . . . 73.11 111.677 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.73 -6.41 25.99 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.237 -1.313 . . . . 74.3 113.706 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.7 86.7 1.52 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.546 1.938 . . . . 74.43 111.915 -168.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.08 -179.58 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.76 2.307 . . . . 71.54 111.635 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -141.83 168.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.424 0.689 . . . . 75.51 109.278 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.8 mm -112.45 137.66 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.606 1.562 . . . . 74.55 106.968 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.31 -2.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 129.731 3.212 . . . . 75.41 117.058 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -62.03 -33.2 73.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.999 1.851 . . . . 73.42 115.999 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.65 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 123.515 1.626 . . . . 62.52 110.709 -162.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.893 0 CA-C-N 114.067 -1.424 . . . . 74.43 107.616 156.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 112.116 0.413 . . . . 61.34 112.116 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -66.7 126.98 30.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.857 -1.164 . . . . 73.51 107.857 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 174.2 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.528 -0.916 . . . . 74.53 108.528 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.7 98.39 3.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.624 1.202 . . . . 74.23 110.707 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.0 m -80.93 88.14 5.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.559 1.543 . . . . 72.44 108.541 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttp -90.94 13.12 17.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.988 0.915 . . . . 55.21 112.397 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -133.38 94.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.493 -1.38 . . . . 73.45 107.872 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.28 157.51 26.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.578 0.351 . . . . 55.25 111.577 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.43 160.56 32.13 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.011 0.91 . . . . 72.32 110.055 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.64 5.29 13.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.948 1.699 . . . . 73.53 114.103 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.71 64.12 1.0 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.012 1.278 . . . . 75.12 108.21 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 tt -109.83 136.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.712 1.205 . . . . 75.24 109.532 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -77.2 149.07 78.93 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 107.63 -1.248 . . . . 73.13 107.63 165.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.85 -32.82 93.13 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.238 1.292 . . . . 74.32 111.158 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttp85 -66.73 -20.8 66.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.074 -0.965 . . . . 63.43 112.507 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.5 -29.0 70.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.737 1.608 . . . . 73.13 109.679 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.67 -48.58 16.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.936 0.895 . . . . 75.51 109.754 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.14 -37.29 80.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.896 0.316 . . . . 74.32 110.996 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.823 0.849 . . . . 72.31 111.314 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -57.27 -46.13 83.38 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.498 0.59 . . . . 62.42 110.311 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -68.23 -26.62 65.79 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.612 -0.68 . . . . 73.14 112.667 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -15.33 34.99 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.655 1.182 . . . . 72.23 112.804 -173.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -61.81 -18.6 60.55 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.425 -0.797 . . . . 62.43 111.679 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.81 24.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.2 1.0 . . . . 62.2 110.401 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.3 -161.77 27.36 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.201 1.364 . . . . 72.04 115.371 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.57 146.37 28.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.34 1.856 . . . . 75.32 108.644 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.21 150.55 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 127.175 2.19 . . . . 73.1 107.963 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -82.04 -56.69 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.608 1.563 . . . . 73.32 109.282 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -159.43 134.64 8.25 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.132 -0.692 . . . . 72.23 109.132 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.43 162.27 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.397 1.879 . . . . 72.01 111.205 164.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.78 112.1 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.335 2.254 . . . . 75.03 107.81 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.0 ptp -116.76 147.8 41.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.874 1.216 . . . . 75.43 110.556 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp . . . . . 0 C--O 1.238 0.467 0 N-CA-C 107.886 -1.154 . . . . 72.22 107.886 -166.569 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 108.372 -1.891 . . . . 75.25 108.372 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.44 135.02 30.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.047 0.939 . . . . 74.34 108.941 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.78 147.78 21.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.329 1.852 . . . . 55.21 108.174 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -122.27 123.2 40.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.116 -1.809 . . . . 75.44 106.116 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.73 140.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 121.986 2.175 . . . . 75.14 108.057 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.05 115.57 12.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.9 -1.889 . . . . 72.31 105.9 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.21 160.57 22.98 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.307 0.958 . . . . 75.22 110.35 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.64 -27.94 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 118.629 -0.7 . . . . 74.21 110.759 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 64' ' ' VAL . 15.7 t70 -114.73 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.888 1.222 . . . . 63.14 110.217 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 5.8 p -102.68 -28.02 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.857 1.263 . . . . 75.34 110.587 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -68.99 -17.31 63.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.861 1.21 . . . . 73.11 110.56 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -70.47 -23.55 62.71 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.604 1.562 . . . . 75.54 113.923 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.07 -56.29 37.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.422 -0.799 . . . . 55.31 110.11 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.17 -13.26 39.05 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.611 1.541 . . . . 74.2 113.2 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.11 -48.01 69.43 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.798 1.181 . . . . 60.14 109.839 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.56 78.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.454 0.57 . . . . 62.12 111.446 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.77 -39.47 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.967 0.907 . . . . 72.12 110.016 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.92 -0.09 40.52 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.603 -1.109 . . . . 60.11 114.025 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.12 2.63 19.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.805 1.802 . . . . 74.44 111.794 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.1 t -50.45 -33.03 19.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.64 1.176 . . . . 74.13 113.54 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.78 21.9 26.92 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.725 1.155 . . . . 64.51 113.848 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.93 174.22 8.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.213 1.507 . . . . 73.34 108.176 153.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -159.87 85.74 0.76 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.384 0.993 . . . . 74.51 112.717 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.0 m -60.37 117.59 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.734 -0.469 . . . . 73.22 109.734 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.3 mt 51.31 31.03 6.52 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.589 1.156 . . . . 71.52 112.534 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.51 27.67 29.3 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.226 -0.763 . . . . 74.13 113.044 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 t -121.15 84.79 40.57 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.931 1.365 . . . . 75.23 109.619 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.32 177.54 5.17 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.285 2.657 . . . . 75.31 112.018 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.1 tt -132.69 144.4 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.477 -0.764 . . . . 75.44 109.695 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.491 HG21 ' H ' ' A' ' 86' ' ' GLN . 41.3 mm -86.52 142.54 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.507 -0.923 . . . . 75.45 108.507 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.53 -3.91 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 114.691 1.367 . . . . 74.55 114.691 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' H ' HG21 ' A' ' 84' ' ' ILE . 2.1 mm100 -46.45 -51.41 15.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.192 1.797 . . . . 75.13 113.887 -168.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.01 174.34 0.07 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.282 1.433 . . . . 73.51 110.281 -169.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 106.753 -1.573 . . . . 72.51 106.753 153.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.562 0.579 . . . . 73.03 112.562 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -70.84 149.17 47.09 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.878 0.847 . . . . 63.32 110.279 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.0 114.76 45.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 122.279 1.038 . . . . 74.44 108.45 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.93 104.75 14.27 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.471 -1.24 . . . . 73.21 108.829 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -92.27 121.11 33.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.151 -1.426 . . . . 62.45 107.151 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 ttm -125.53 18.79 8.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.267 1.027 . . . . 72.12 111.474 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.11 22.03 3.79 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.617 -1.302 . . . . 74.35 111.725 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.44 164.51 25.4 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.546 0.573 . . . . 73.02 112.546 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.4 26.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.735 1.214 . . . . 71.43 110.709 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 14.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.143 2.177 . . . . 73.03 114.929 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.91 16.69 2.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.95 1.25 . . . . 71.12 114.153 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.98 145.0 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.639 -1.288 . . . . 74.03 110.965 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -83.61 156.74 65.04 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-O 118.129 -0.939 . . . . 71.33 109.489 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.41 -37.12 74.13 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.138 1.892 . . . . 74.34 111.582 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.14 -28.48 68.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.684 -1.151 . . . . 71.1 111.982 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -33.47 69.72 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.866 1.666 . . . . 71.44 111.024 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.2 -29.75 69.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.458 1.103 . . . . 71.03 110.712 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -92.42 -30.87 15.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.937 0.895 . . . . 73.12 110.526 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.16 -44.68 92.14 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.486 1.514 . . . . 74.14 110.864 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.33 -63.75 1.04 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.487 1.515 . . . . 63.2 109.777 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.02 -22.5 61.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.266 0.469 . . . . 74.5 112.266 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -19.27 64.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.614 1.097 . . . . 74.31 111.443 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.8 p -61.24 -35.31 76.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.332 0.969 . . . . 74.4 111.077 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.0 8.42 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.934 2.494 . . . . 71.0 109.94 -167.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.19 -140.73 6.18 Favored Glycine 0 N--CA 1.442 -0.914 0 O-C-N 120.635 -1.29 . . . . 72.01 110.772 -162.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -152.83 -173.43 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.53 1.932 . . . . 73.11 106.808 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 t -143.99 149.35 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 129.712 3.205 . . . . 74.3 106.169 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -62.89 1.54 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.724 -1.213 . . . . 72.34 107.724 167.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -158.99 162.25 36.76 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.876 -0.787 . . . . 63.42 108.876 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.78 128.67 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.952 1.701 . . . . 74.03 106.457 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -123.35 74.26 1.23 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.417 1.087 . . . . 73.33 109.002 170.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 130.87 35.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.639 2.376 . . . . 51.32 109.665 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 106.31 -1.737 . . . . 74.24 106.31 174.232 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 111.413 -0.675 . . . . 71.45 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -135.09 130.32 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 74.14 111.177 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.56 151.4 25.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.747 1.219 . . . . 74.25 111.175 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -127.5 80.99 1.99 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.627 1.171 . . . . 74.25 109.748 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.395 1.5 p -81.8 121.68 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.452 -1.405 . . . . 74.11 110.585 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.66 137.58 33.17 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.637 1.575 . . . . 73.11 109.989 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.46 160.79 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.965 0.888 . . . . 74.04 111.836 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.53 -16.24 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 126.531 1.933 . . . . 73.22 111.209 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -128.56 170.22 13.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.028 1.731 . . . . 71.21 108.806 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.99 -28.35 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.542 1.537 . . . . 72.04 111.032 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -77.89 -14.57 59.51 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.459 -1.401 . . . . 72.42 112.122 -167.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -89.08 -0.49 57.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.139 0.975 . . . . 74.3 112.613 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.86 -56.73 27.09 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 120.83 1.65 . . . . 45.15 109.425 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -14.81 46.0 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.953 1.769 . . . . 73.24 114.166 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.57 -59.61 4.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.218 1.372 . . . . 70.51 108.488 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.95 59.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.379 1.072 . . . . 71.5 112.241 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.41 -54.61 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.964 0.906 . . . . 74.11 108.622 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.52 -0.4 11.82 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.916 -0.936 . . . . 71.41 113.818 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -100.61 1.79 41.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.119 1.959 . . . . 73.33 111.295 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -49.45 -30.6 8.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.12 1.327 . . . . 73.3 114.344 -173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.38 2.43 56.24 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.405 1.002 . . . . 63.12 114.181 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.96 175.57 8.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.234 1.517 . . . . 73.54 108.517 164.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -152.63 131.76 12.7 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.278 -0.889 . . . . 74.5 110.057 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -83.61 90.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.425 -1.695 . . . . 72.14 106.425 170.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mt 59.81 37.34 21.94 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.869 0.842 . . . . 73.41 110.406 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.72 3.32 58.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.997 1.284 . . . . 74.21 114.581 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.49 85.96 3.21 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.8 1.64 . . . . 74.34 109.801 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.07 -178.31 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.353 2.702 . . . . 73.13 112.608 168.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.33 148.75 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.063 0.945 . . . . 70.4 110.233 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 86' ' ' GLN . 46.0 mm -91.27 140.57 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.516 -1.29 . . . . 73.42 107.516 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -51.19 -18.75 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.917 2.087 . . . . 72.22 114.795 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.49 ' H ' HG22 ' A' ' 84' ' ' ILE . 7.6 mm100 -44.31 -47.41 9.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 125.662 1.585 . . . . 74.34 113.276 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.05 49.86 16.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.707 0.803 . . . . 73.42 112.118 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.307 24.2 p . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 125.26 1.424 . . . . 65.54 110.568 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 72.35 116.224 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.1 m -107.54 157.08 18.32 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 119.961 -1.712 . . . . 71.15 109.495 -161.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.78 174.83 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.475 -0.766 . . . . 65.41 109.52 170.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -138.73 133.83 32.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.686 1.594 . . . . 72.44 107.36 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.6 m -127.31 121.99 32.57 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.32 -2.104 . . . . 65.55 105.32 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.3 ttp -125.32 14.31 8.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.11 0.964 . . . . 65.14 111.635 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -139.75 33.77 2.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.045 1.338 . . . . 70.43 109.982 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 mt -64.95 145.04 56.86 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.751 -0.593 . . . . 63.44 110.771 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.6 162.63 20.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.071 0.939 . . . . 64.51 109.496 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.17 59.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.446 -1.252 . . . . 71.52 114.31 -166.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -145.87 65.35 1.22 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.489 1.04 . . . . 73.24 108.762 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.9 tt -96.97 163.57 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 122.818 0.447 . . . . 73.32 110.387 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -108.52 155.48 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 125.779 1.632 . . . . 75.33 108.72 168.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 -36.51 93.07 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.396 2.064 . . . . 74.12 111.979 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -60.99 -32.95 72.5 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.962 -1.018 . . . . 74.54 111.612 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -72.52 -11.73 60.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.232 1.378 . . . . 74.13 112.865 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.26 -44.99 9.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.666 -0.865 . . . . 73.44 108.666 169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.71 -38.22 88.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.508 0.594 . . . . 73.53 111.518 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.5 -25.8 63.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.112 1.365 . . . . 75.53 112.651 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.28 -64.13 1.02 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.35 -27.68 69.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.78 1.029 . . . . 75.21 113.78 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 p -67.27 -3.22 7.36 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.991 1.269 . . . . 63.22 113.523 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -55.14 -27.88 48.66 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.754 1.161 . . . . 73.43 111.005 165.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -139.83 43.59 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.383 1.073 . . . . 72.21 110.861 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.03 -141.5 8.86 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.014 -1.234 . . . . 72.54 110.014 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.0 157.55 43.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.164 -1.05 . . . . 72.35 108.164 174.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.98 163.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.518 -0.739 . . . . 73.13 109.194 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -122.31 -31.16 3.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.037 -1.459 . . . . 72.32 111.582 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -164.18 172.51 13.57 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.841 1.655 . . . . 54.25 109.196 159.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.55 126.0 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.515 1.926 . . . . 74.22 108.014 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.13 175.48 5.51 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.28 1.432 . . . . 74.53 109.929 169.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.3 ptp -166.29 154.93 10.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.898 1.679 . . . . 73.33 109.407 161.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.504 0.669 . . . . 72.34 109.923 -172.409 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.494 0 N-CA-C 108.786 -1.726 . . . . 74.42 108.786 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.71 122.73 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.363 1.465 . . . . 71.24 109.795 -168.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.89 150.87 37.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.258 1.023 . . . . 70.14 109.825 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.57 154.83 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.404 -2.073 . . . . 70.52 105.404 161.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.21 118.03 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.962 -2.236 . . . . 72.45 104.962 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -82.76 122.75 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.869 1.267 . . . . 72.44 108.638 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -96.42 176.22 6.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.801 0.81 . . . . 72.53 111.279 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.03 -24.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.358 1.863 . . . . 73.23 112.808 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -133.39 177.37 7.74 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.966 1.706 . . . . 51.44 111.4 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.46 -27.01 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.713 1.205 . . . . 74.11 111.59 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -67.73 -21.78 65.27 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.011 -1.055 . . . . 73.33 112.488 -166.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m -87.56 -9.58 54.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.523 -1.227 . . . . 71.44 113.146 172.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.7 -58.93 8.46 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 122.784 2.538 . . . . 74.35 109.895 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.03 -6.13 18.0 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.492 2.128 . . . . 73.22 114.783 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -70.59 -43.47 69.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.684 1.129 . . . . 72.01 109.395 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -25.61 47.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.999 0.92 . . . . 64.32 112.756 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.51 -46.03 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.976 0.911 . . . . 63.44 109.379 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.36 -1.52 43.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.205 -0.775 . . . . 64.02 113.985 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.26 4.2 33.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.934 1.367 . . . . 74.43 110.867 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -55.09 -20.3 9.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.944 1.298 . . . . 70.23 113.733 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.43 9.86 42.1 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.873 -0.959 . . . . 74.04 113.411 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -81.4 -179.98 7.6 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.754 1.277 . . . . 75.45 110.38 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -159.2 88.61 0.89 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.693 -0.629 . . . . 74.53 109.997 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.28 110.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.098 -1.445 . . . . 73.53 107.098 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.7 mt 55.02 21.5 3.81 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.649 -0.657 . . . . 75.55 112.0 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.98 1.22 27.0 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.398 -1.779 . . . . 70.42 115.047 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.15 85.95 2.97 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 120.723 2.261 . . . . 74.41 111.563 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.42 162.63 29.83 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.343 2.028 . . . . 65.44 112.007 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -117.04 159.74 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.428 1.091 . . . . 74.54 110.288 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.99 144.25 14.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 107.085 -1.45 . . . . 74.25 107.085 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.21 -0.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.063 2.545 . . . . 74.41 115.887 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -61.97 -36.74 82.37 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 114.911 1.448 . . . . 72.24 114.911 -166.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.09 177.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 120.482 1.492 . . . . 71.42 111.227 -169.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 53.21 108.891 174.459 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 117.941 -1.028 . . . . 74.34 111.407 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.7 m -50.84 138.61 18.45 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.276 1.83 . . . . 75.21 109.889 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 m -120.49 118.33 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.19 1.396 . . . . 73.54 109.43 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -68.83 155.67 39.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.894 1.278 . . . . 73.21 109.69 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -131.11 158.47 40.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.764 1.626 . . . . 61.52 107.947 162.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -143.29 11.14 1.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.502 0.927 . . . . 64.31 113.502 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -140.45 25.31 2.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.477 1.035 . . . . 73.44 112.391 -163.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.18 165.31 16.29 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.871 -0.518 . . . . 75.12 111.402 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.4 169.64 8.57 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.592 1.157 . . . . 73.22 109.857 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.28 -11.47 60.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.531 1.308 . . . . 60.11 114.531 -171.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 20.29 10.13 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.289 1.404 . . . . 75.54 113.489 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tp -64.48 163.58 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.258 1.023 . . . . 61.22 110.001 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -121.59 157.73 55.88 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.672 1.989 . . . . 74.01 107.528 162.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.84 -41.93 64.31 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 CA-C-N 121.374 1.526 . . . . 64.44 109.838 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.769 1.025 . . . . 73.3 113.769 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.47 -28.19 66.78 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.22 1.373 . . . . 61.24 110.443 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.82 -40.26 16.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.187 1.395 . . . . 72.23 110.615 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.49 -35.63 75.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.589 0.632 . . . . 63.13 110.394 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.47 -51.96 67.65 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.574 1.549 . . . . 72.34 108.242 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -51.45 -57.21 9.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.339 1.056 . . . . 75.33 110.533 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -72.14 -19.57 61.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.274 0.842 . . . . 72.32 113.274 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.0 p -66.05 -18.13 65.14 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.761 0.824 . . . . 61.4 111.37 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.0 p -66.24 -14.57 62.16 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.001 0.371 . . . . 71.52 112.001 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.55 5.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.974 0.909 . . . . 74.32 112.121 -167.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.22 25.82 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.269 -1.532 . . . . 72.24 109.269 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.31 131.9 21.1 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.716 1.246 . . . . 75.43 113.201 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.0 154.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 125.727 1.611 . . . . 64.32 110.303 165.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -96.2 -58.47 2.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.741 1.616 . . . . 74.03 107.963 164.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -158.83 155.02 27.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.633 1.106 . . . . 64.41 110.091 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.64 140.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.307 1.043 . . . . 75.35 109.03 -169.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -142.26 71.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.544 1.138 . . . . 74.44 109.876 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.9 ptp -66.13 158.28 29.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.661 -0.816 . . . . 73.55 108.97 163.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 107.022 -1.473 . . . . 72.42 107.022 173.618 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.826 0 N-CA-C 111.54 -0.624 . . . . 72.53 111.54 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.19 153.98 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.203 1.801 . . . . 73.23 111.102 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.75 166.0 32.7 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.466 1.907 . . . . 62.25 109.273 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -124.08 152.37 42.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 104.868 -2.271 . . . . 75.55 104.868 155.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.356 1.5 p -144.86 115.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.667 -1.27 . . . . 75.02 108.963 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -63.24 131.93 50.01 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.416 1.886 . . . . 74.11 106.651 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.68 156.22 20.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.542 0.687 . . . . 73.23 111.004 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.98 -24.74 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.746 -0.661 . . . . 75.11 109.46 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.13 131.88 44.42 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.976 -1.078 . . . . 75.32 110.355 -163.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.417 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 3.3 p -63.92 -31.72 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.922 1.689 . . . . 61.15 110.571 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -41.67 98.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.385 1.474 . . . . 75.43 110.913 -169.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -78.89 -5.47 53.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.394 0.886 . . . . 64.13 113.394 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.97 -56.43 35.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.809 1.64 . . . . 75.34 109.563 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.57 -15.5 45.04 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 CA-C-N 120.58 1.243 . . . . 55.04 112.717 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.6 tp -64.89 -43.93 91.27 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 121.031 1.741 . . . . 64.54 109.757 168.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.82 76.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.378 1.444 . . . . 62.51 111.565 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -58.83 -45.6 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.631 -0.668 . . . . 72.13 109.288 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.28 -8.1 22.56 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.177 1.37 . . . . 75.32 114.109 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -113.97 4.31 15.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.426 1.613 . . . . 73.23 112.358 -172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.62 -23.54 6.69 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.268 1.027 . . . . 61.51 113.645 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 19.26 35.29 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.86 1.219 . . . . 62.52 112.281 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -101.54 178.85 4.52 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.856 1.328 . . . . 73.12 109.428 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -152.48 95.31 2.01 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.426 1.091 . . . . 74.43 111.718 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.21 110.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.789 -1.189 . . . . 75.54 107.789 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt 50.85 35.22 11.77 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.746 1.218 . . . . 74.4 111.868 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.07 35.03 25.21 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.967 -0.907 . . . . 71.53 113.397 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.64 86.14 56.45 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.831 1.652 . . . . 75.3 108.008 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.83 171.91 12.62 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.505 2.136 . . . . 74.52 111.575 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.64 160.43 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.584 -0.698 . . . . 74.15 110.224 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 86' ' ' GLN . 49.4 mm -98.72 165.72 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.383 -1.34 . . . . 73.41 107.383 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.67 -21.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 117.829 -1.082 . . . . 73.14 113.16 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.439 ' H ' HG22 ' A' ' 84' ' ' ILE . 10.6 mt-30 -44.38 -42.94 7.26 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.585 1.698 . . . . 72.21 115.585 -150.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.05 41.53 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 63.25 112.334 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.286 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 127.085 2.154 . . . . 63.44 111.828 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 110.244 -0.28 . . . . 74.43 110.244 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.28 148.85 49.66 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 120.859 -1.15 . . . . 74.34 109.278 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.4 114.62 39.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.067 0.937 . . . . 74.1 111.436 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.08 93.31 8.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.414 1.086 . . . . 73.34 109.821 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.17 92.13 5.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.45 -1.25 . . . . 74.22 108.137 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.2 ttp -93.48 14.62 18.13 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.146 0.795 . . . . 72.12 113.146 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -137.79 36.14 2.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.308 -1.495 . . . . 74.12 112.19 -165.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 mt -78.22 145.4 35.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.029 0.932 . . . . 74.31 112.613 -171.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.08 147.85 46.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.377 1.871 . . . . 71.31 109.84 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.79 -0.97 6.06 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.321 1.971 . . . . 65.45 116.321 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -122.37 -0.38 9.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.56 1.527 . . . . 73.24 114.248 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.4 150.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.237 1.199 . . . . 74.21 114.237 -159.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -90.35 161.99 35.68 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.397 1.479 . . . . 71.25 109.901 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.79 -53.04 3.59 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.33 2.02 . . . . 73.23 111.795 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -66.15 -18.95 65.67 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.966 0.728 . . . . 72.41 112.966 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.39 -32.99 70.66 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.324 -0.86 . . . . 72.44 110.715 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.67 -52.65 16.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.01 -0.519 . . . . 74.43 109.872 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.69 -23.99 64.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.056 0.847 . . . . 74.43 110.916 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.76 -26.73 63.49 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.107 0.78 . . . . 71.21 113.107 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.34 -36.01 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 74.2 110.757 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.21 -25.74 19.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.513 0.931 . . . . 74.4 113.513 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -61.13 -20.71 62.99 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.417 1.887 . . . . 73.0 114.013 -169.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 t -58.08 -40.56 81.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.004 1.322 . . . . 71.22 108.969 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -148.31 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.18 0.992 . . . . 65.21 109.964 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.01 163.36 25.79 Favored Glycine 0 CA--C 1.521 0.448 0 O-C-N 120.673 -1.267 . . . . 71.03 112.032 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -116.46 124.64 50.46 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.026 0.93 . . . . 72.23 109.18 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -91.43 148.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.5 -1.296 . . . . 65.33 107.5 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -101.31 -46.79 4.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.029 1.731 . . . . 74.24 109.396 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -157.85 -176.99 6.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.012 0.824 . . . . 74.31 111.088 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.98 97.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.628 1.571 . . . . 74.43 108.411 -159.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -119.16 131.07 55.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.718 1.145 . . . . 73.42 110.161 -167.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.45 164.59 27.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.261 1.578 . . . . 70.02 115.261 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.237 0.447 0 N-CA-C 107.666 -1.235 . . . . 74.05 107.666 -179.09 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.416 0 CA-C-O 119.302 -0.721 . . . . 71.24 113.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.9 134.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.503 1.121 . . . . 73.24 110.094 -171.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.37 43.41 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.682 1.193 . . . . 74.01 111.819 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -120.98 108.6 14.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.229 1.812 . . . . 74.23 106.27 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.91 121.73 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.326 -1.361 . . . . 70.22 107.326 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -86.58 116.98 25.05 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.495 1.518 . . . . 74.02 109.072 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.71 162.47 18.74 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.485 1.514 . . . . 74.41 112.961 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 t -83.87 -20.34 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.046 1.339 . . . . 73.12 112.525 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.0 156.12 45.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.909 -1.145 . . . . 74.21 107.909 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.13 -26.27 36.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 123.456 0.473 . . . . 73.03 110.576 172.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -61.81 -36.86 82.38 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.045 -1.034 . . . . 65.04 113.626 -164.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 m -82.16 -5.45 58.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.617 1.099 . . . . 73.3 113.696 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.83 -57.97 18.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 119.997 1.272 . . . . 72.31 110.846 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.15 -15.86 52.26 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.966 1.778 . . . . 72.11 113.206 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.86 -45.54 81.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.351 0.978 . . . . 74.0 109.318 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.91 71.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.412 0.685 . . . . 73.11 111.14 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.51 -32.1 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.589 -0.694 . . . . 65.42 109.882 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.96 0.35 7.62 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.53 1.538 . . . . 71.1 114.23 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.82 11.74 3.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.038 1.735 . . . . 72.2 112.209 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -50.35 -29.55 10.21 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 121.123 1.783 . . . . 70.33 114.133 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.51 -16.02 55.89 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.826 -0.986 . . . . 71.11 112.894 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -70.7 170.88 11.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.646 1.223 . . . . 65.44 109.866 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -157.43 128.32 6.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.509 0.724 . . . . 73.21 109.219 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.3 t -84.71 94.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.262 -2.125 . . . . 73.1 105.262 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 mt 65.93 23.23 11.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.372 1.069 . . . . 65.03 112.93 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.07 11.8 29.01 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.82 -0.55 . . . . 63.05 113.16 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.5 t -113.05 83.59 6.27 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 126.078 1.751 . . . . 72.24 108.853 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 176.29 8.36 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.225 2.617 . . . . 73.34 111.796 166.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.97 177.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.724 1.21 . . . . 72.23 108.926 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 86' ' ' GLN . 34.1 mm -123.75 139.12 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.558 1.143 . . . . 72.15 108.908 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -44.73 -18.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 130.476 3.51 . . . . 72.32 115.968 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.472 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.3 mt-30 -53.22 -58.34 7.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.716 1.143 . . . . 73.12 110.937 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.06 50.15 18.52 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 125.264 1.603 . . . . 73.43 110.491 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 125.294 1.438 . . . . 72.22 111.138 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 114.708 1.373 . . . . 70.23 114.708 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -102.08 145.98 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.591 1.156 . . . . 74.31 108.75 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.26 118.34 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.779 -0.823 . . . . 74.45 108.779 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -72.82 113.06 9.44 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.335 1.054 . . . . 71.54 108.721 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.9 m -98.95 129.95 45.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.519 1.528 . . . . 70.2 107.469 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.6 ttp -127.44 175.85 7.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.09 1.756 . . . . 74.23 107.615 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 64.1 20.83 12.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.808 1.643 . . . . 74.44 113.525 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -72.6 168.73 18.03 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.744 0.817 . . . . 73.24 111.227 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.52 166.13 11.25 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.079 1.14 . . . . 72.13 114.079 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.62 23.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 64.32 112.231 169.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -135.68 76.78 1.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 106.688 -1.597 . . . . 71.22 106.688 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -140.77 165.38 20.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 124.071 0.948 . . . . 71.23 108.796 168.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -117.51 157.92 46.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 126.64 1.976 . . . . 75.5 107.408 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -55.32 2.56 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.235 1.957 . . . . 75.44 111.94 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -63.48 -21.74 66.49 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.595 -0.717 . . . . 63.33 112.274 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.3 -19.02 62.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.948 1.249 . . . . 74.41 110.35 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.887 1.221 . . . . 73.5 110.781 169.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -69.54 -37.83 77.24 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.864 -0.421 . . . . 73.23 109.864 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.47 -26.71 68.06 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.307 1.043 . . . . 72.53 112.339 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.73 -16.49 64.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.23 1.012 . . . . 74.52 113.37 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.66 -26.45 8.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.475 0.71 . . . . 72.51 111.22 173.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 t -53.78 -18.64 3.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.666 1.987 . . . . 71.22 111.949 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.465 ' HG1' HG23 ' A' ' 36' ' ' VAL . 34.4 p -46.31 -41.89 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.493 1.517 . . . . 74.42 111.12 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.465 HG23 ' HG1' ' A' ' 35' ' ' THR . 1.9 m -150.77 46.24 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.135 1.774 . . . . 74.42 108.269 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.46 178.03 48.32 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 124.274 0.94 . . . . 73.35 110.865 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -137.83 134.1 34.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.333 1.453 . . . . 74.11 107.796 169.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' PHE 0.276 1.8 p -118.28 143.25 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.048 1.339 . . . . 73.34 109.562 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -77.29 -50.28 13.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.4 1.88 . . . . 63.32 108.284 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -168.58 -178.49 3.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.096 0.558 . . . . 75.22 110.938 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.34 152.48 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.366 1.466 . . . . 75.12 109.024 174.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -125.93 101.34 6.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.513 1.925 . . . . 75.22 106.803 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.3 mtp -95.21 142.12 28.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.116 0.966 . . . . 74.54 110.819 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 72.4 113.36 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.131 0 N-CA-C 109.534 -1.427 . . . . 74.13 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 pt -139.8 146.6 24.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.838 1.255 . . . . 74.53 108.555 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.38 44.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.371 1.068 . . . . 63.2 108.907 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -123.85 127.91 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.661 -1.607 . . . . 71.4 106.661 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.05 112.18 39.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.8 -1.555 . . . . 74.42 106.8 -167.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -92.41 91.87 7.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.855 1.262 . . . . 72.13 108.01 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -56.08 177.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.043 1.337 . . . . 74.43 113.91 175.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.77 -31.12 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 O-C-N 120.448 -1.407 . . . . 73.33 110.917 168.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -117.18 175.66 5.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.475 1.489 . . . . 64.15 110.443 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.64 -27.04 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 118.836 0.744 . . . . 73.43 111.246 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -67.4 -22.18 65.55 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.558 -1.339 . . . . 72.32 112.038 -171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -5.2 57.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.945 1.091 . . . . 74.34 113.945 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.46 -55.53 39.07 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.32 1.418 . . . . 63.32 109.459 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.8 -10.32 28.41 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.849 . . . . 74.22 113.925 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.65 -59.38 3.65 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 120.082 1.31 . . . . 74.35 108.218 166.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -29.43 67.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.814 0.846 . . . . 71.21 113.007 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.68 -26.27 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.848 1.259 . . . . 70.33 110.568 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.61 80.9 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.559 1.552 . . . . 74.25 114.112 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.66 -4.06 58.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.157 1.479 . . . . 72.11 114.194 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.0 t -50.86 -21.35 1.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.364 1.987 . . . . 71.23 116.364 -160.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.4 -12.79 59.35 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.724 -1.235 . . . . 62.14 113.635 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -77.04 165.13 25.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.673 1.236 . . . . 74.52 110.451 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -140.76 88.35 2.18 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.137 1.775 . . . . 73.22 109.531 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.56 100.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.145 0.978 . . . . 74.23 109.002 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 mt 49.06 33.23 4.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.836 0.827 . . . . 73.24 111.275 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.74 5.94 62.59 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.536 -1.147 . . . . 64.14 114.157 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 t -105.5 86.46 1.75 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.702 2.001 . . . . 71.24 108.882 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.84 176.9 6.21 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.942 3.095 . . . . 65.43 112.404 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.58 151.06 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.496 0.665 . . . . 73.44 110.214 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.2 mm -106.28 156.13 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.295 1.438 . . . . 73.24 108.368 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 m -74.07 -0.78 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 114.904 1.446 . . . . 73.53 114.904 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -45.78 -60.33 2.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.033 1.123 . . . . 63.31 114.033 -165.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.79 157.37 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.999 1.319 . . . . 72.13 112.086 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 107.081 -1.452 . . . . 74.51 107.081 169.177 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 117.336 2.347 . . . . 74.5 117.336 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -110.62 153.73 24.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.751 1.16 . . . . 70.24 110.279 -164.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.604 1.562 . . . . 70.34 109.744 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.49 114.16 24.64 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.295 2.638 . . . . 74.01 110.876 -166.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.3 130.48 34.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.471 -0.566 . . . . 74.12 109.471 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -127.77 48.67 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.036 0.934 . . . . 75.42 111.695 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 11.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.129 -0.982 . . . . 74.22 113.128 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 168.6 8.78 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.809 -1.182 . . . . 73.01 113.264 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.87 170.57 9.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.226 -1.352 . . . . 70.42 113.194 -167.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.12 -12.43 61.49 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.634 1.574 . . . . 73.13 115.178 -161.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -134.47 31.01 3.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.369 0.986 . . . . 73.34 111.286 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.65 165.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.54 -0.541 . . . . 74.43 109.54 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -122.63 161.92 41.21 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.704 1.602 . . . . 74.42 109.038 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.86 -54.28 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.862 1.708 . . . . 74.12 109.535 165.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -38.73 69.01 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.53 -0.748 . . . . 74.14 111.985 -175.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.7 -34.14 72.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.591 1.087 . . . . 73.33 111.396 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.79 -10.27 59.76 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.442 0.697 . . . . 70.23 112.348 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -31.66 7.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.407 1.083 . . . . 74.12 109.777 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -70.24 -30.86 68.03 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.554 1.542 . . . . 65.43 112.494 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -62.41 -26.04 68.27 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.079 -1.013 . . . . 74.44 111.693 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.43 -12.05 16.75 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.439 -0.791 . . . . 73.01 112.641 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.5 p -62.8 -19.59 64.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.75 1.614 . . . . 73.23 112.117 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 p -64.81 -23.71 67.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.781 1.232 . . . . 73.43 110.926 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 8.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.593 1.557 . . . . 73.44 112.3 -166.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.61 45.74 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.658 -1.276 . . . . 54.33 111.708 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.88 141.96 50.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.686 1.594 . . . . 70.32 107.856 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.97 145.96 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.801 1.241 . . . . 72.14 109.295 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -87.58 -46.82 9.21 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.908 -1.496 . . . . 73.22 111.042 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -169.52 174.78 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.781 0.719 . . . . 73.13 109.798 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.87 145.46 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 73.15 109.694 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -117.38 98.1 6.24 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.108 1.763 . . . . 74.14 107.167 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.27 149.55 21.15 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.808 -1.182 . . . . 63.11 107.808 170.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 106.604 -1.628 . . . . 71.45 106.604 -176.719 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.215 0 N-CA-C 110.512 -1.035 . . . . 62.01 110.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -153.96 136.65 6.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 125.579 1.552 . . . . 73.14 109.128 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.57 151.19 30.36 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.544 1.137 . . . . 73.02 110.452 169.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -128.01 138.48 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.555 -1.646 . . . . 73.03 106.555 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.66 112.94 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.174 1.39 . . . . 73.1 108.258 -160.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.61 81.54 8.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.36 1.076 . . . . 71.4 109.987 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.19 150.17 4.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.858 1.263 . . . . 73.42 113.844 171.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.59 -24.04 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.657 . . . . 64.11 110.062 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -132.26 143.79 50.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.736 1.607 . . . . 70.33 113.15 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.2 -30.61 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.157 1.383 . . . . 64.5 111.344 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -66.28 -15.77 63.48 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.077 -1.014 . . . . 70.51 111.281 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 m -88.27 -6.67 57.65 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.476 1.287 . . . . 74.31 114.476 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -53.81 -56.7 22.65 Favored Pre-proline 0 N--CA 1.473 0.708 0 CA-C-N 121.85 2.113 . . . . 73.12 109.83 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -6.44 17.29 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 121.779 1.653 . . . . 74.2 114.335 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.33 -52.48 39.8 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.195 -1.565 . . . . 73.51 108.299 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.15 -23.65 65.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.645 0.778 . . . . 74.13 112.564 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.01 -45.62 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.921 1.289 . . . . 62.1 109.595 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.11 -2.6 48.38 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.951 -0.916 . . . . 64.21 113.247 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.99 2.82 55.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.323 1.562 . . . . 73.11 111.258 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -56.72 -20.87 24.12 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.541 1.064 . . . . 72.31 113.326 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.15 23.26 14.34 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.638 2.066 . . . . 51.24 112.045 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -118.35 175.58 5.64 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 128.699 2.8 . . . . 73.02 109.795 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -152.11 127.29 9.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.308 1.843 . . . . 74.15 108.602 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.5 101.0 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.889 -1.522 . . . . 73.01 106.889 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mt 64.22 -8.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.88 2.872 . . . . 73.44 116.662 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.24 -3.34 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.187 -1.006 . . . . 74.13 113.498 -160.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.12 85.25 12.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.872 2.069 . . . . 72.35 106.315 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.99 178.7 2.23 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.718 2.945 . . . . 73.43 111.92 175.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tt -137.38 161.47 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.27 1.028 . . . . 65.04 109.944 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.5 mm -101.62 158.08 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.283 -1.377 . . . . 74.05 107.283 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.92 -1.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.295 1.838 . . . . 75.24 114.877 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -46.1 67.03 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.128 -0.982 . . . . 74.0 113.278 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.96 29.79 2.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.618 1.71 . . . . 74.1 115.618 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.909 0 C-N-CA 126.787 2.035 . . . . 73.24 112.383 -173.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.454 HH11 ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.31 0.856 . . . . 74.1 113.31 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 152.73 43.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.885 1.274 . . . . 74.3 110.482 -171.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.26 170.1 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.626 -1.25 . . . . 72.44 107.626 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -138.31 104.26 5.13 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.292 1.437 . . . . 74.33 109.332 -171.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.73 75.29 8.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.615 1.966 . . . . 73.34 110.201 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -81.38 25.07 0.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.302 0.853 . . . . 75.31 113.302 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -148.78 48.46 1.01 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.131 -1.606 . . . . 75.3 112.627 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.6 mt -79.15 166.75 21.89 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.558 0.947 . . . . 74.0 113.558 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.76 -160.72 0.79 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.554 2.342 . . . . 55.32 110.859 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.45 -20.99 11.09 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.938 1.829 . . . . 74.2 115.938 -164.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -129.62 44.3 2.99 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.478 1.608 . . . . 74.34 108.33 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.38 140.71 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.251 -1.341 . . . . 74.4 107.914 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.81 161.8 32.79 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 124.251 1.02 . . . . 72.13 108.549 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.41 -37.48 89.66 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.055 1.17 . . . . 62.24 110.1 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -58.29 -31.82 67.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.56 -1.21 . . . . 75.01 113.294 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.11 -34.95 75.78 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 120.496 1.498 . . . . 73.24 110.121 -171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.14 -32.26 70.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.344 1.057 . . . . 75.14 111.833 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.85 -7.65 23.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 117.998 -1.001 . . . . 64.01 112.541 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -37.27 18.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.917 1.235 . . . . 74.0 108.566 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.54 -39.05 64.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.665 0.786 . . . . 73.1 112.377 -174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -106.73 2.2 25.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.426 -0.797 . . . . 75.43 112.278 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.7 p -74.62 -10.66 59.75 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 120.422 1.464 . . . . 73.31 112.076 170.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -44.93 -52.05 9.1 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.779 2.032 . . . . 71.24 109.765 165.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.18 57.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 64.31 108.299 -171.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.58 164.42 28.76 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.209 -0.932 . . . . 73.42 113.528 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -123.53 131.19 53.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.798 1.239 . . . . 75.2 109.456 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -88.52 138.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.313 1.445 . . . . 73.5 107.848 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -76.91 -51.78 10.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.489 -0.93 . . . . 55.44 108.489 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -162.47 -172.74 3.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.194 1.797 . . . . 55.04 107.564 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.25 93.98 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 119.823 1.192 . . . . 71.14 110.454 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.93 163.14 22.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.376 1.084 . . . . 74.11 110.684 163.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.59 136.19 11.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 127.914 2.486 . . . . 74.33 105.751 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.238 0.449 0 N-CA-C 105.777 -1.934 . . . . 60.23 105.777 170.383 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.319 0 CA-C-O 118.831 -0.983 . . . . 73.31 111.871 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.24 143.6 27.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.163 0.985 . . . . 72.24 110.099 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.0 156.64 41.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.7 2.0 . . . . 73.41 106.462 159.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -116.56 142.57 46.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 104.317 -2.475 . . . . 75.11 104.317 162.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.04 115.91 44.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.356 -2.091 . . . . 75.03 105.356 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -73.36 126.36 29.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.668 0.747 . . . . 64.2 109.507 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.75 166.67 10.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.658 1.183 . . . . 75.33 110.911 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.86 -14.37 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.513 0.725 . . . . 62.34 111.561 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -138.16 168.64 19.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.517 -1.364 . . . . 75.5 108.876 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 3.6 p -76.71 -43.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.173 -0.918 . . . . 61.4 108.608 167.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -64.99 -29.89 70.84 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.623 1.101 . . . . 75.2 113.681 -152.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -74.21 -8.14 55.15 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.536 0.939 . . . . 54.2 113.536 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -62.96 4.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 119.695 -1.878 . . . . 74.4 108.737 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.58 -10.83 29.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.948 1.374 . . . . 75.51 113.134 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.9 -54.32 13.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.531 1.06 . . . . 73.13 109.621 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.91 -30.18 63.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.942 1.297 . . . . 72.4 112.415 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.04 -49.14 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.487 1.115 . . . . 75.34 108.615 172.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.23 7.83 3.16 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.079 1.323 . . . . 73.41 114.484 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' CD2' HE21 ' A' ' 76' ' ' GLN . 70.2 mt -117.05 4.88 12.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.799 1.799 . . . . 72.22 111.001 170.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -49.91 -30.41 10.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.449 1.477 . . . . 72.0 111.932 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.57 18.64 54.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 125.115 1.34 . . . . 55.42 113.079 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.438 HE21 ' CD2' ' A' ' 73' ' ' LEU . 7.2 mt-30 -127.05 165.05 20.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.455 1.502 . . . . 74.14 107.674 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -149.17 130.51 14.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.29 0.636 . . . . 73.23 109.59 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.97 104.34 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 106.205 -1.776 . . . . 73.32 106.205 164.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt 59.91 19.28 8.27 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.625 1.57 . . . . 74.43 113.566 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.45 1.94 29.36 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.545 -0.586 . . . . 74.42 114.298 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -104.86 86.05 1.38 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.253 1.821 . . . . 73.44 107.209 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.14 179.07 3.07 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.672 2.248 . . . . 75.34 111.032 163.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 tt -121.34 175.86 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.708 1.203 . . . . 74.4 108.466 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 147.32 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.131 1.772 . . . . 75.34 106.848 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 t -55.55 -15.13 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.623 2.769 . . . . 71.2 115.646 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -44.61 -42.52 7.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.049 1.499 . . . . 73.1 115.049 -168.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.35 175.53 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.91 1.338 . . . . 63.54 109.294 -160.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 104.597 -2.372 . . . . 75.43 104.597 157.573 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HE ' ' N ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 115.404 1.631 . . . . 71.31 115.404 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.38 131.69 55.89 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.975 -1.078 . . . . 72.35 112.011 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.61 178.02 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.176 1.79 . . . . 73.15 109.496 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -145.76 117.75 8.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.917 1.287 . . . . 72.14 110.359 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -95.96 134.66 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.643 -1.243 . . . . 73.32 107.643 164.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.6 ttm -131.88 31.51 4.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 71.15 111.047 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -145.18 25.04 1.41 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.582 -1.323 . . . . 74.14 112.11 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.99 166.69 23.13 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.069 -1.02 . . . . 72.14 113.618 -164.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.96 169.59 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.573 1.149 . . . . 61.45 112.168 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -49.13 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.948 1.299 . . . . 73.14 111.925 162.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -92.46 19.83 6.83 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.103 0.961 . . . . 74.45 112.524 -167.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.23 163.23 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.441 0.696 . . . . 74.44 109.78 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -118.49 160.35 40.22 Favored Pre-proline 0 CA--C 1.519 -0.244 0 C-N-CA 125.11 1.364 . . . . 72.33 108.965 167.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.93 -29.85 87.82 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.605 1.537 . . . . 70.05 112.352 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -78.55 -18.78 54.17 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 117.662 -1.161 . . . . 74.01 113.309 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -33.61 73.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.339 1.427 . . . . 71.42 110.212 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.44 -44.97 61.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.238 1.015 . . . . 74.32 110.792 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.13 -41.62 85.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.448 -0.901 . . . . 65.11 108.727 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.02 -39.95 87.6 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.84 0.745 . . . . 73.14 112.571 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -55.76 -57.44 12.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.626 -0.879 . . . . 73.04 108.626 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.36 -25.14 60.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.144 0.794 . . . . 73.15 113.144 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -63.03 -11.45 19.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.96 1.304 . . . . 71.41 112.05 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 p -67.33 -21.46 65.65 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.846 1.657 . . . . 71.45 110.943 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.3 -0.57 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.819 0.848 . . . . 74.04 113.148 -165.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.78 146.08 6.43 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.906 -1.278 . . . . 70.32 109.906 165.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -63.95 148.87 48.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.916 0.358 . . . . 72.34 111.643 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.2 145.77 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 126.225 1.81 . . . . 65.15 108.14 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -84.68 -52.81 5.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.862 -1.066 . . . . 71.01 108.178 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -169.43 170.06 8.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.735 1.214 . . . . 64.01 110.63 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -100.52 165.64 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.014 1.726 . . . . 74.21 111.194 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -149.87 50.72 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.139 0.971 . . . . 74.42 109.859 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -66.78 120.65 13.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.242 2.217 . . . . 70.44 110.295 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 123.78 0.832 . . . . 74.03 109.051 -170.179 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.162 0 N-CA-C 110.711 -0.956 . . . . 51.25 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 pt -117.08 142.95 28.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.353 1.461 . . . . 74.24 109.835 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.84 150.12 36.57 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.083 1.353 . . . . 70.35 108.027 160.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -117.74 157.87 25.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.651 -1.981 . . . . 73.45 105.651 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.41 144.54 3.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.841 2.056 . . . . 74.43 106.327 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -111.72 119.73 39.64 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.748 1.619 . . . . 74.11 107.547 -165.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -80.47 173.92 12.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.66 0.743 . . . . 70.12 111.394 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.96 -32.12 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.467 -0.771 . . . . 74.25 108.974 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 4.8 m-20 -129.72 120.98 26.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.488 1.115 . . . . 74.01 108.462 -166.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 7.3 p -45.67 -34.59 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 129.06 2.944 . . . . 74.35 111.206 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 m -64.65 -18.87 65.34 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.929 -1.732 . . . . 74.01 112.83 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -1.77 24.09 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.6 -61.34 8.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 120.988 1.722 . . . . 74.24 109.273 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.44 -17.93 60.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.625 . . . . 73.44 113.703 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.37 -56.55 20.58 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.722 1.146 . . . . 72.01 110.343 172.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.57 80.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.39 0.676 . . . . 73.04 111.279 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.98 -47.67 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.654 1.182 . . . . 72.12 109.213 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.98 -22.25 34.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.999 0.809 . . . . 72.35 114.155 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -99.12 12.56 35.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.296 -1.12 . . . . 74.14 111.839 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.4 t -49.12 -26.39 2.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.434 1.094 . . . . 74.24 113.83 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -9.02 60.34 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.767 0.699 . . . . 73.44 114.502 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.38 163.49 26.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.505 1.153 . . . . 62.43 108.254 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -153.33 74.52 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.881 0.472 . . . . 71.15 110.633 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 t -53.16 103.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.925 1.69 . . . . 73.41 108.358 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt 54.72 29.57 11.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.762 0.825 . . . . 74.15 112.064 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 29.65 34.74 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.882 -0.511 . . . . 65.11 112.919 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.12 80.08 64.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.744 1.618 . . . . 61.55 108.922 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.96 -172.2 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.06 3.174 . . . . 72.42 112.06 171.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tt -137.49 146.56 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.72 1.208 . . . . 74.21 109.592 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.2 mm -87.65 141.58 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.084 -1.45 . . . . 74.13 107.084 171.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.91 0.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 128.697 2.799 . . . . 72.31 115.737 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -55.47 -51.13 67.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 126.296 1.838 . . . . 74.21 114.013 -169.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.8 169.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.278 1.031 . . . . 73.14 110.377 -162.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 105.206 -2.146 . . . . 65.04 105.206 162.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 118.764 2.876 . . . . 75.03 118.764 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.1 m -115.0 159.9 20.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 119.996 1.271 . . . . 75.04 109.51 -160.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.4 166.88 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.635 -1.616 . . . . 75.22 106.635 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -138.34 108.43 6.39 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.419 1.088 . . . . 75.34 110.721 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -79.79 125.27 29.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.726 1.61 . . . . 64.45 107.97 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -137.57 27.73 2.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.447 0.641 . . . . 64.54 112.542 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -141.99 46.5 1.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.644 -1.285 . . . . 74.22 110.095 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' H ' HD12 ' A' ' 20' ' ' LEU . 4.0 mp -90.27 -173.88 3.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.177 1.391 . . . . 74.44 112.74 -167.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.67 162.61 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.051 2.141 . . . . 72.12 109.681 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.49 -10.05 59.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.379 0.881 . . . . 64.12 113.379 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.67 56.78 1.83 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.311 1.044 . . . . 75.1 111.323 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 tt -112.81 133.13 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.496 1.119 . . . . 75.23 108.986 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -81.64 164.88 47.15 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 119.04 -0.505 . . . . 64.01 110.263 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.29 -46.21 22.93 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.568 1.512 . . . . 71.12 110.064 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -66.51 -16.82 64.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.369 0.878 . . . . 73.3 113.369 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -63.35 -34.97 78.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.801 1.182 . . . . 71.22 109.551 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 -43.38 18.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.728 -0.653 . . . . 62.31 110.157 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.66 -35.13 75.47 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.751 1.16 . . . . 75.03 110.013 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.71 -11.69 59.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.923 1.289 . . . . 74.02 113.654 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -72.52 -63.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 119.465 1.03 . . . . 74.44 108.408 170.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.21 -15.17 62.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 117.907 -1.044 . . . . 63.02 112.155 -175.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t -48.51 -25.38 1.66 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.63 1.572 . . . . 54.55 112.637 164.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -68.86 -19.72 64.25 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.713 -1.242 . . . . 70.53 111.094 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.38 -19.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.157 1.344 . . . . 74.11 114.525 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.55 -177.54 26.3 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 120.942 -1.099 . . . . 74.04 111.331 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -123.08 133.11 54.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.489 0.716 . . . . 75.43 109.373 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.23 133.14 41.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.256 -1.387 . . . . 74.44 107.256 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -74.29 -64.65 0.98 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.764 -1.569 . . . . 74.13 106.764 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -156.98 159.85 38.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.554 -1.646 . . . . 71.35 106.554 -157.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -134.03 145.36 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 73.04 109.374 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -132.55 136.4 46.57 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.55 1.94 . . . . 74.32 108.616 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.78 120.78 15.58 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.15 1.38 . . . . 74.12 109.441 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.747 0 CA-C-N 119.318 0.963 . . . . 72.35 110.827 -169.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.343 0 CA-C-O 119.735 -0.481 . . . . 74.33 111.899 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.83 121.85 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.622 0.769 . . . . 75.25 110.538 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.43 137.89 34.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.887 -0.782 . . . . 60.35 108.887 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -102.65 154.12 19.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.938 -1.875 . . . . 62.34 105.938 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.92 115.71 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.323 -2.102 . . . . 74.15 105.323 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -81.93 110.04 16.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 105.124 -2.176 . . . . 74.35 105.124 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.09 163.07 18.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.273 -0.892 . . . . 71.44 110.42 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.88 -15.32 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.5 0.32 . . . . 72.33 111.033 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.44 161.83 38.77 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.366 -1.459 . . . . 54.02 111.095 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.12 -22.87 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.089 1.355 . . . . 72.35 111.669 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -59.37 -27.18 65.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.089 -1.007 . . . . 64.33 111.403 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -86.06 -4.07 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.236 1.199 . . . . 75.33 114.236 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.05 -58.16 16.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.24 1.382 . . . . 72.52 109.263 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.81 -20.39 64.7 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.448 1.432 . . . . 74.31 113.326 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.09 -52.95 56.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.972 1.26 . . . . 74.31 110.408 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.33 73.66 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.267 0.355 . . . . 74.13 111.644 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.65 -42.49 88.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.888 0.875 . . . . 74.44 109.106 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.33 -31.14 59.32 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 117.994 0.361 . . . . 65.15 112.437 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.31 9.96 16.29 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.334 -1.098 . . . . 74.31 112.803 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 t -49.82 -29.85 8.69 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.384 1.447 . . . . 72.33 114.458 -172.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.08 6.46 40.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.476 1.036 . . . . 64.11 113.779 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -81.36 175.05 10.91 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.237 1.019 . . . . 74.12 108.792 165.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -149.58 135.16 18.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.925 -0.769 . . . . 74.31 108.925 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.95 119.57 35.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 74.51 105.847 162.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.9 mt 60.3 1.46 0.37 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.014 1.857 . . . . 64.34 116.014 171.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.44 2.21 15.36 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.718 -1.046 . . . . 70.24 113.902 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 68.9 t -104.57 86.39 1.4 Allowed Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 128.906 2.882 . . . . 71.31 109.151 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -65.3 177.49 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.23 1.953 . . . . 74.32 111.086 161.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 ' CG1' ' H ' ' A' ' 84' ' ' ILE 0.296 8.3 tt -122.19 176.45 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.951 0.9 . . . . 72.13 109.617 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.486 ' H ' ' CG1' ' A' ' 83' ' ' ILE . 47.8 mm -123.97 145.78 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.945 2.098 . . . . 72.41 106.077 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.52 -4.41 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.533 2.333 . . . . 73.31 114.819 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -53.85 -49.11 69.2 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.933 1.693 . . . . 72.34 113.717 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.4 179.36 0.15 Allowed 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.575 1.55 . . . . 70.24 111.498 -170.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 125.594 1.558 . . . . 74.31 106.963 178.096 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 114.336 1.236 . . . . 75.34 114.336 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 m -92.51 145.72 24.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.282 -1.006 . . . . 75.23 108.282 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -108.41 125.62 65.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 107.855 -1.165 . . . . 73.15 107.855 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.575 ' H ' ' HA ' ' A' ' 87' ' ' ALA . 7.3 t80 -89.55 124.29 34.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.869 1.668 . . . . 75.23 109.151 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -111.94 86.13 2.28 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.715 1.606 . . . . 71.22 108.941 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.0 ttp -92.03 27.54 2.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.711 0.804 . . . . 74.41 112.364 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -150.28 37.09 0.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.863 -1.773 . . . . 72.11 113.712 -173.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.67 153.27 42.17 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.476 -0.765 . . . . 72.32 112.916 -169.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.79 158.06 29.7 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.323 0.582 . . . . 72.23 111.154 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.88 -15.59 43.72 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.193 1.183 . . . . 70.12 114.193 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.69 30.65 5.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.101 1.318 . . . . 75.13 111.301 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.89 144.12 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 120.886 -1.134 . . . . 75.32 109.866 170.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -97.45 158.21 33.52 Favored Pre-proline 0 N--CA 1.464 0.27 0 C-N-CA 123.907 0.883 . . . . 73.42 109.724 160.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -57.85 -34.87 98.85 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 121.988 1.792 . . . . 63.45 112.364 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -67.44 -25.89 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.917 -0.489 . . . . 72.33 112.247 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.74 -32.8 74.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.01 1.277 . . . . 64.34 111.552 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -41.37 80.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.092 0.557 . . . . 72.04 110.586 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -76.54 -40.23 50.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.249 -0.278 . . . . 74.44 110.249 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.6 -44.08 76.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.84 1.256 . . . . 71.02 111.918 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -54.38 -42.43 70.36 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.098 -0.376 . . . . 73.44 111.232 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -88.08 -11.87 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.491 0.716 . . . . 73.41 112.529 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -65.66 -12.87 57.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.246 1.818 . . . . 74.45 111.783 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -59.08 -31.28 68.74 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.153 -0.967 . . . . 71.42 110.702 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.09 17.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.039 -1.038 . . . . 72.02 113.03 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 174.38 38.77 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 120.764 -1.21 . . . . 70.33 113.595 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 51.81 1.86 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.959 1.304 . . . . 74.45 111.673 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -43.73 126.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 127.904 2.482 . . . . 64.13 110.279 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -51.09 29.99 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.79 -1.55 . . . . 72.42 108.664 -158.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.54 179.12 7.46 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.193 1.558 . . . . 74.32 109.491 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.92 147.88 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.185 0.994 . . . . 64.31 109.221 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 102.53 11.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.56 2.344 . . . . 74.32 106.822 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.34 115.85 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.225 1.81 . . . . 75.15 107.07 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.535 0.398 0 C-N-CA 125.799 1.639 . . . . 74.23 108.677 -164.177 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.159 0 N-CA-C 109.892 -1.283 . . . . 74.01 109.892 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 pt -143.6 139.84 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.901 0.88 . . . . 71.21 111.384 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.36 157.27 43.52 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.289 1.836 . . . . 75.42 107.094 156.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.414 ' CE2' ' CD1' ' A' ' 16' ' ' PHE . 58.0 m-85 -124.99 128.38 48.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.884 -2.265 . . . . 75.23 104.884 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.04 112.93 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.291 -1.374 . . . . 75.35 107.291 -164.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.45 88.08 7.32 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.952 1.358 . . . . 73.13 110.578 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -49.92 156.91 0.67 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.402 1.572 . . . . 75.51 113.375 166.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.9 -35.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 128.276 2.63 . . . . 71.53 113.975 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -116.73 165.15 13.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.012 1.725 . . . . 73.12 108.438 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -88.42 -27.38 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.227 0.611 . . . . 74.42 110.075 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 t -60.64 -27.61 67.93 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.325 0.966 . . . . 71.44 112.066 -173.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 p -76.24 -19.67 58.14 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.829 -1.17 . . . . 70.53 114.147 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.5 t -52.22 -57.71 14.24 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.499 1.12 . . . . 75.22 109.668 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.82 -17.51 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.713 1.608 . . . . 74.32 113.652 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -51.97 50.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.022 1.283 . . . . 73.44 109.733 172.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.86 91.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.491 0.716 . . . . 74.05 110.576 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.54 -39.28 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.609 0.764 . . . . 74.43 109.393 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.76 -4.99 29.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.595 1.093 . . . . 71.23 114.492 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.9 mt -109.24 13.39 24.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.393 1.597 . . . . 72.05 111.735 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -54.3 -3.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.348 1.859 . . . . 73.35 115.22 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.61 7.88 24.19 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.13 1.347 . . . . 72.14 114.435 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -97.69 175.14 6.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.275 1.538 . . . . 72.04 110.311 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -155.57 89.07 1.16 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.265 -0.643 . . . . 72.23 109.265 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 m -60.31 113.45 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.151 -1.055 . . . . 72.34 108.151 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt 59.6 13.16 3.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.102 1.149 . . . . 73.05 114.102 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.07 13.3 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.638 -1.09 . . . . 74.05 113.425 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.01 85.02 1.12 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.481 1.513 . . . . 74.44 108.352 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.8 179.38 3.76 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.256 2.638 . . . . 70.02 111.164 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.7 tt -129.59 177.1 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.724 2.01 . . . . 74.43 108.37 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -126.73 147.24 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.304 1.841 . . . . 70.31 107.413 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.43 -10.25 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 116.39 1.996 . . . . 73.12 116.39 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -56.34 -41.92 76.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.975 1.261 . . . . 74.21 112.898 -166.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HA ' ' H ' ' A' ' 16' ' ' PHE . . . 58.97 174.94 0.07 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.279 1.038 . . . . 72.41 110.035 -165.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 105.494 -2.039 . . . . 75.41 105.494 171.361 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 111.105 0.039 . . . . 75.55 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.3 m -102.39 147.6 26.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.135 0.574 . . . . 64.44 109.628 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.41 129.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.462 1.105 . . . . 73.55 108.468 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -100.51 108.74 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.951 1.7 . . . . 73.41 109.143 -171.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 m -84.88 122.13 28.73 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.761 1.625 . . . . 53.13 106.871 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.2 ttp -139.04 52.27 1.78 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.029 0.919 . . . . 71.23 111.385 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.485 ' H ' HD11 ' A' ' 20' ' ' LEU . 5.7 tt0 -154.97 30.45 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.729 -1.232 . . . . 72.24 109.668 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.26 166.63 17.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.802 1.287 . . . . 74.22 110.923 -167.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -105.15 153.12 21.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.629 -2.078 . . . . 71.14 110.202 -171.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.46 13.66 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.76 2.024 . . . . 71.13 114.598 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 25.22 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.067 2.147 . . . . 75.2 111.035 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tp -72.34 155.3 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.456 -1.403 . . . . 75.21 109.42 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.31 161.55 25.56 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.997 1.719 . . . . 71.22 107.274 171.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.38 -42.02 44.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.888 1.725 . . . . 75.51 112.416 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.09 -30.47 71.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 75.52 111.904 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -24.5 66.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.568 0.622 . . . . 63.51 110.979 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.4 -41.45 12.1 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.305 -0.628 . . . . 75.35 109.305 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -66.83 -35.33 79.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.558 0.617 . . . . 63.21 111.261 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.93 -24.91 43.71 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.56 -0.712 . . . . 75.13 112.474 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.09 -36.3 70.44 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.126 -0.359 . . . . 73.02 111.111 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -96.96 -1.9 44.74 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.211 0.819 . . . . 71.42 113.211 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -60.11 -20.48 58.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.297 1.839 . . . . 73.43 111.026 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -13.41 61.52 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.036 -1.04 . . . . 74.24 112.902 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.55 2.53 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 120.493 -1.379 . . . . 72.54 113.67 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.34 -143.45 7.99 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.453 -1.859 . . . . 55.24 108.453 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -129.24 161.76 29.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.408 -0.96 . . . . 64.44 108.408 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.25 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.847 -0.797 . . . . 74.33 108.847 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -78.11 -59.95 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.09 -1.078 . . . . 74.51 108.09 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -142.78 137.47 29.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.222 1.009 . . . . 73.45 108.629 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.44 129.81 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.583 1.553 . . . . 74.41 107.726 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -153.46 112.25 3.71 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.828 0.74 . . . . 75.1 111.381 -172.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -136.78 157.48 46.66 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.065 -1.022 . . . . 73.23 112.504 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.648 -0.871 . . . . 74.42 108.648 -166.822 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 108.461 -1.855 . . . . 74.12 108.461 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.19 138.2 14.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.158 1.783 . . . . 73.54 109.925 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.29 151.48 33.0 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.198 1.399 . . . . 75.52 108.454 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -128.36 104.21 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.578 -2.008 . . . . 74.51 105.578 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.32 118.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.495 -1.669 . . . . 75.42 106.495 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -91.16 121.17 32.7 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.672 -1.603 . . . . 75.13 106.672 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.88 165.21 11.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.445 1.116 . . . . 75.14 112.181 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.6 m -76.56 -34.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.62 1.568 . . . . 73.12 112.761 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -134.13 152.4 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.358 1.063 . . . . 71.34 112.908 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.42 -27.72 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 73.31 112.054 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -60.02 -25.43 65.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.344 1.429 . . . . 71.25 113.95 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.4 p -77.64 -19.21 55.83 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.125 1.33 . . . . 72.51 114.254 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.47 -57.23 24.55 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.65 1.18 . . . . 71.15 111.404 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -63.59 -23.7 70.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.437 1.425 . . . . 73.32 111.462 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -50.97 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.967 0.907 . . . . 65.15 109.863 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.51 77.65 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.228 1.011 . . . . 65.14 111.418 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.0 mt -53.66 -43.62 55.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.18 0.992 . . . . 74.21 109.382 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.33 64.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.161 -0.8 . . . . 74.33 112.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -98.67 4.26 47.88 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.096 1.358 . . . . 70.13 111.279 -167.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.294 2.8 m -45.55 -26.79 0.64 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.565 0.95 . . . . 70.03 113.565 161.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 18.06 45.04 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.309 0.884 . . . . 61.31 115.309 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -125.68 163.17 23.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 119.328 1.564 . . . . 73.15 109.367 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -136.25 115.71 12.75 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.398 1.479 . . . . 70.35 110.335 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -79.96 98.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.868 -1.53 . . . . 74.03 106.868 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt 54.87 33.25 19.49 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.139 0.976 . . . . 73.24 112.082 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.81 57.17 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.71 -1.05 . . . . 70.34 113.917 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.06 85.32 9.96 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 118.891 1.345 . . . . 73.02 108.176 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.82 -177.63 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.734 2.29 . . . . 72.12 111.714 162.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -124.29 156.84 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.648 -0.871 . . . . 72.11 108.648 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' A' ' 86' ' ' GLN . 51.3 mm -100.92 146.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.423 -1.325 . . . . 65.13 107.423 171.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -74.12 16.32 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.688 1.995 . . . . 71.41 112.736 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' A' ' 84' ' ' ILE . 1.6 mm100 -70.21 -26.64 63.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.441 2.296 . . . . 73.22 112.889 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.46 36.24 22.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.288 1.835 . . . . 74.22 113.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 127.227 2.211 . . . . 74.33 114.918 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 N-CA-C 110.123 -1.191 . . . . 65.32 110.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -68.23 174.37 4.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.304 0.642 . . . . 72.13 110.541 166.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.4 mmm -123.97 -62.8 1.26 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.353 -1.721 . . . . 74.51 106.353 155.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -121.74 165.51 15.71 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.662 0.785 . . . . 72.24 109.48 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.19 168.75 19.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.028 1.731 . . . . 74.41 109.806 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.34 155.47 65.13 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.905 1.282 . . . . 63.11 110.62 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -55.36 -38.35 93.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.008 1.805 . . . . 71.45 112.228 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -76.02 -20.95 57.37 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.442 1.497 . . . . 63.35 110.798 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.26 -33.11 74.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.368 -0.833 . . . . 74.44 109.278 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -38.19 89.36 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.228 0.922 . . . . 71.22 110.383 177.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -55.33 -38.27 68.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.044 0.537 . . . . 73.42 110.67 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.17 2.16 25.34 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.017 1.858 . . . . 71.32 116.017 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -69.74 -9.7 55.5 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.01 -1.681 . . . . 64.11 113.581 178.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -57.31 143.11 41.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.809 1.244 . . . . 64.12 110.402 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.0 116.93 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.41 1.1 . . . . 72.33 108.166 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -68.63 124.64 24.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.685 -1.143 . . . . 63.44 108.209 170.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.74 105.29 13.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 105.324 -2.102 . . . . 73.25 105.324 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -113.03 174.24 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.057 -1.09 . . . . 74.53 108.057 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 74.99 17.35 2.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.005 2.522 . . . . 74.45 112.046 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.48 165.63 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.875 -0.515 . . . . 71.23 111.497 -171.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.21 41.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.262 0.553 . . . . 75.13 111.463 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.04 -24.37 53.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.817 1.247 . . . . 61.41 113.736 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -123.25 19.4 9.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.366 1.867 . . . . 74.24 111.155 -167.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.0 tt -63.92 151.24 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.607 0.639 . . . . 73.14 109.961 174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 160.9 35.77 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 125.089 1.356 . . . . 75.32 107.554 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.59 -42.15 57.31 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.233 1.289 . . . . 73.34 110.596 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -30.59 71.7 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.073 -0.965 . . . . 74.25 111.663 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.12 -30.72 62.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.549 1.068 . . . . 55.15 110.382 -169.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.91 -41.46 18.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.795 1.638 . . . . 74.24 110.527 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.87 -37.63 73.06 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.223 -0.658 . . . . 73.54 109.223 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.33 -55.47 28.13 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 126.722 2.009 . . . . 53.24 109.642 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -55.08 -29.78 58.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.85 1.26 . . . . 74.32 112.446 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.86 -35.65 13.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.188 0.81 . . . . 74.42 113.188 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.1 t -57.26 -23.11 46.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.641 1.176 . . . . 62.14 111.674 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.739 0.815 . . . . 71.14 112.735 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.86 6.28 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 64.13 111.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 -174.85 23.36 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 121.042 -1.036 . . . . 63.42 113.105 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -140.1 138.22 35.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.829 1.252 . . . . 74.25 109.334 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.54 138.68 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.628 1.571 . . . . 64.41 107.573 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -85.78 -57.71 2.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.852 1.661 . . . . 74.14 108.12 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -158.27 175.86 13.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.811 0.732 . . . . 63.41 109.701 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.2 113.61 26.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.109 1.764 . . . . 74.44 107.389 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.05 51.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.792 1.637 . . . . 75.11 108.578 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 ttt -66.57 128.96 38.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.906 1.282 . . . . 73.14 107.897 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.89 127.21 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.871 -1.9 . . . . 72.55 105.871 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -71.91 73.5 0.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.292 1.437 . . . . 62.35 111.281 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.3 68.92 5.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.808 2.043 . . . . 60.11 112.238 -159.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -116.25 -19.67 10.11 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.31 -1.494 . . . . 74.22 113.782 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -47.39 -24.79 0.86 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.999 2.119 . . . . 75.14 114.744 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.03 22.87 8.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.132 0.878 . . . . 53.11 112.154 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -149.52 -5.45 0.37 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.167 1.173 . . . . 72.34 114.167 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -99.87 -163.57 1.04 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.151 1.78 . . . . 74.54 109.206 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.07 -39.37 78.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 115.035 1.494 . . . . 63.45 115.035 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt 64.4 35.91 9.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.332 1.853 . . . . 61.21 112.221 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.2 46.69 0.32 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-O 118.916 -0.935 . . . . 74.32 113.987 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -139.11 148.7 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.601 1.2 . . . . 74.31 111.776 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.39 162.82 33.44 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.107 2.163 . . . . 74.24 109.842 170.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -130.09 114.56 15.91 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.662 1.585 . . . . 72.51 108.017 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.19 122.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.835 -1.172 . . . . 72.21 107.835 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -75.7 114.37 14.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.696 -1.224 . . . . 60.54 107.696 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.02 166.25 21.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.999 -0.371 . . . . 74.14 109.999 165.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.97 -9.36 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 118.68 -0.676 . . . . 71.33 111.358 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.55 135.0 40.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.342 1.883 . . . . 75.15 113.695 -168.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.443 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 7.1 p -60.21 -35.13 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.725 0.81 . . . . 71.31 111.981 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 m -80.68 -9.24 59.81 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 119.178 -1.009 . . . . 75.51 111.025 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.7 m -80.28 -11.81 59.68 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 117.548 -1.215 . . . . 72.55 113.659 172.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.34 -59.3 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 120.551 1.523 . . . . 63.42 108.765 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.48 -18.79 60.49 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.952 1.768 . . . . 54.31 113.667 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.52 -57.88 8.76 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 119.464 1.029 . . . . 73.42 108.75 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.01 69.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.704 1.202 . . . . 63.32 112.051 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.2 mt -54.85 -48.47 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.72 -0.845 . . . . 73.11 108.72 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.69 -6.21 21.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.727 1.156 . . . . 64.34 115.256 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.19 1.46 49.83 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.822 1.311 . . . . 73.33 112.168 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.68 -23.98 7.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.801 1.778 . . . . 74.34 115.801 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.15 1.65 37.91 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.143 0.878 . . . . 64.44 113.473 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.1 170.72 13.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.073 -1.084 . . . . 75.41 108.073 162.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -162.59 82.04 0.52 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.622 0.971 . . . . 74.32 113.622 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.78 117.24 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.608 -0.886 . . . . 63.31 108.608 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt 60.67 2.17 0.48 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.002 1.321 . . . . 73.21 114.157 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.79 11.96 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.799 -1.0 . . . . 61.24 113.132 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.7 t -112.37 86.12 7.78 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 118.945 1.373 . . . . 75.51 110.034 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.81 175.78 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.669 2.246 . . . . 65.12 111.369 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -134.92 140.42 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.302 1.041 . . . . 53.44 110.256 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mm -77.34 145.93 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.212 -0.93 . . . . 53.22 110.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.04 4.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 128.886 2.874 . . . . 72.15 115.806 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.8 -36.92 84.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.936 1.458 . . . . 71.31 114.936 -157.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.77 173.63 0.07 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.441 1.496 . . . . 63.42 110.091 -163.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.11 50.53 0.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.674 -1.232 . . . . 72.23 107.674 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -72.14 -179.32 2.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.313 1.445 . . . . 74.35 109.577 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.76 161.13 36.04 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.093 0.957 . . . . 72.11 110.264 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -81.57 49.2 1.28 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.467 1.907 . . . . 63.55 109.706 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -142.24 141.06 32.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.896 1.278 . . . . 73.43 108.061 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -154.59 105.47 2.63 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.32 -1.363 . . . . 61.13 107.32 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.17 2.188 . . . . 74.51 109.167 -167.183 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.835 0 N-CA-C 109.853 -1.299 . . . . 65.42 109.853 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 m80 64.58 15.06 9.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.696 1.598 . . . . 74.24 112.592 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.8 mtp 61.52 158.79 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.2 2.6 . . . . 72.15 112.819 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -73.3 159.63 33.09 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.924 -0.58 . . . . 72.52 109.986 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.0 tp -66.29 153.28 43.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.968 0.907 . . . . 74.33 110.566 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.6 145.34 35.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.931 1.293 . . . . 65.24 108.575 170.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.275 1.983 . . . . 72.52 111.369 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.48 -39.41 74.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.149 -0.685 . . . . 71.35 109.149 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.7 -20.17 59.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.066 0.946 . . . . 71.25 111.846 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -81.75 -31.04 32.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.544 -0.722 . . . . 74.35 110.931 169.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -40.15 87.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.845 0.748 . . . . 62.25 109.075 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.91 -3.83 1.33 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.586 2.354 . . . . 53.41 114.946 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -60.12 -28.64 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.593 1.088 . . . . 74.22 111.901 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -85.35 144.3 28.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.198 -1.038 . . . . 73.13 108.198 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.65 122.14 66.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.355 1.062 . . . . 74.14 108.252 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -73.7 132.87 43.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.918 1.687 . . . . 71.52 110.107 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.7 m -117.64 130.3 56.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.541 1.936 . . . . 70.23 106.356 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.9 ttp -138.32 29.87 2.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.839 1.256 . . . . 61.53 110.69 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -153.86 15.31 0.49 Allowed 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.546 -1.346 . . . . 74.15 111.972 -165.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.29 156.59 36.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.825 0.45 . . . . 73.42 111.142 -167.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 152.23 44.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.052 0.454 . . . . 72.54 109.978 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.94 64.87 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.447 1.099 . . . . 74.43 113.744 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -121.59 58.48 1.0 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.752 1.221 . . . . 73.44 109.345 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 161.51 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.019 -1.051 . . . . 63.34 109.351 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -120.26 158.3 51.2 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 125.579 1.552 . . . . 62.53 108.099 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.86 -32.42 22.65 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.588 1.525 . . . . 74.44 111.319 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -70.82 -37.86 73.25 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.614 0.643 . . . . 74.55 111.322 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.83 -40.41 69.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.201 1.001 . . . . 73.12 110.74 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.3 -48.26 62.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.683 1.193 . . . . 74.44 110.88 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.2 -37.82 78.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.496 -0.764 . . . . 65.11 109.633 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.34 -25.86 66.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.068 0.849 . . . . 72.15 112.223 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.6 -36.63 83.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.744 0.702 . . . . 72.13 110.244 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -99.55 -33.88 10.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.501 -0.761 . . . . 71.24 112.417 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -66.02 -17.14 64.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.793 1.179 . . . . 74.52 111.501 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -80.95 -2.84 49.37 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.259 -0.901 . . . . 74.13 112.23 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.75 15.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.166 1.786 . . . . 73.12 111.481 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.06 -155.53 17.3 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.001 -1.639 . . . . 71.25 109.001 -161.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -157.81 147.74 20.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.853 1.327 . . . . 72.45 108.998 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -112.23 122.99 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.443 1.097 . . . . 65.53 110.024 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -76.07 -45.73 32.61 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.805 1.242 . . . . 73.55 110.501 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.9 163.64 37.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.443 1.097 . . . . 73.24 108.777 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.4 126.29 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.171 1.388 . . . . 74.35 107.296 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -132.6 103.97 6.42 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.698 -0.852 . . . . 74.22 108.698 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.42 137.11 35.98 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.448 1.099 . . . . 74.22 108.302 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.77 82.05 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.897 -1.89 . . . . 71.55 105.897 172.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -103.55 4.77 36.15 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.766 0.826 . . . . 65.31 112.834 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.08 143.15 47.53 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.365 -1.717 . . . . 54.35 106.365 161.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 166.96 28.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.839 -0.8 . . . . 74.41 108.839 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -115.89 -7.01 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.415 0.686 . . . . 74.52 111.388 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -157.43 -70.87 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.944 -1.502 . . . . 74.21 106.944 161.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -138.01 165.51 26.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.809 -2.663 . . . . 52.23 103.809 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -163.97 -177.59 5.15 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.382 1.473 . . . . 73.41 107.196 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -28.49 58.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.809 1.186 . . . . 71.32 112.473 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 56.49 11.01 0.76 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 117.077 2.251 . . . . 74.54 117.077 171.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.13 55.34 0.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.726 -1.35 . . . . 53.43 109.726 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -120.57 128.31 76.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.034 1.334 . . . . 72.15 111.062 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.89 158.73 44.51 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.005 1.322 . . . . 72.23 110.176 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -124.34 135.69 53.53 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.979 -1.489 . . . . 72.35 106.979 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.375 1.5 p -138.54 109.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 65.55 110.56 -168.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -74.25 122.31 22.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.43 1.892 . . . . 72.24 110.357 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -74.76 153.92 38.59 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.16 0.981 . . . . 63.33 111.483 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -73.94 -21.76 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 115.229 -0.896 . . . . 73.22 110.868 166.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -137.85 128.22 26.31 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.243 1.417 . . . . 74.55 109.857 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.38 -30.66 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.216 1.406 . . . . 73.13 111.388 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -73.73 -21.11 60.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.243 -1.535 . . . . 72.11 112.855 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.2 m -81.71 -8.69 59.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.704 1.138 . . . . 74.13 112.553 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.15 -66.54 1.19 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 116.101 -1.904 . . . . 74.13 107.768 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.03 -17.87 58.46 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.433 2.089 . . . . 74.24 113.837 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.14 -42.45 76.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.554 1.142 . . . . 74.33 109.45 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.69 -36.55 69.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.017 0.747 . . . . 70.22 113.017 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.9 mt -59.41 -42.54 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.941 0.791 . . . . 72.23 109.769 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 -5.09 8.66 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.384 -0.676 . . . . 75.13 113.091 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.12 5.6 12.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.383 1.591 . . . . 74.13 112.456 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.7 t -48.07 -33.75 8.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.234 1.379 . . . . 62.52 113.094 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.85 12.86 41.8 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.891 1.71 . . . . 73.11 113.839 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.77 172.23 8.48 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 118.874 1.337 . . . . 74.51 108.069 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -155.93 99.46 1.98 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.388 0.675 . . . . 75.24 111.137 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.64 114.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.919 -1.141 . . . . 71.24 107.919 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt 54.53 21.35 3.3 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.873 1.064 . . . . 70.32 113.873 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.84 28.82 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.297 -0.724 . . . . 61.34 113.945 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.13 85.11 6.39 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.354 1.577 . . . . 71.15 109.719 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.83 177.76 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.862 2.375 . . . . 72.13 111.388 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.8 tt -136.48 169.09 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.871 0.693 . . . . 73.51 112.871 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.18 124.44 73.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.707 2.003 . . . . 74.31 108.798 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -53.38 -17.75 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.079 2.552 . . . . 71.21 115.831 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.87 -42.56 80.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.568 1.531 . . . . 73.41 111.646 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.0 41.83 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.836 1.654 . . . . 63.44 113.986 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.258 0.5 OUTLIER 43.65 74.98 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.227 2.211 . . . . 74.32 111.449 -171.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.58 155.94 0.14 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 74.25 113.546 169.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.21 55.06 2.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.985 0.514 . . . . 72.43 111.553 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 72.97 4.17 4.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.734 1.613 . . . . 73.34 113.001 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -92.28 -176.69 4.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.205 1.402 . . . . 52.12 111.472 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.7 t30 64.67 101.58 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 129.91 3.284 . . . . 72.11 110.62 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.839 0 C-N-CA 126.215 1.806 . . . . 71.32 109.409 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 111.502 -0.639 . . . . 72.44 111.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.42 -27.44 0.42 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.576 0.954 . . . . 73.43 113.576 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm -148.7 -62.05 0.24 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.25 0.932 . . . . 73.34 111.571 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.58 163.09 27.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.819 -0.808 . . . . 65.14 108.819 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.51 137.08 54.88 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.917 -1.512 . . . . 63.24 106.917 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.07 148.92 97.83 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 105.799 -1.926 . . . . 71.15 105.799 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.37 -15.44 45.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.672 1.582 . . . . 72.31 111.971 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -80.17 -33.39 38.38 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.304 1.042 . . . . 73.43 111.52 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.84 -43.46 85.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.596 1.089 . . . . 73.15 111.118 -168.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -68.13 -23.42 64.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 117.821 -1.085 . . . . 75.34 113.755 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.48 -17.5 28.55 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.504 1.121 . . . . 73.44 110.3 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.26 -61.99 1.84 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.02 1.328 . . . . 75.15 112.185 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 44.52 65.1 1.13 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.284 2.234 . . . . 75.53 110.843 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.17 151.38 50.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.332 0.969 . . . . 74.32 112.237 -173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.84 122.92 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.1 1.76 . . . . 73.51 110.691 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.91 129.71 38.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.262 1.425 . . . . 73.51 109.647 169.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.6 m -122.15 105.06 9.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.994 -1.484 . . . . 64.52 106.994 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.8 ttm -88.01 174.57 8.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.712 0.805 . . . . 74.42 109.133 171.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.14 21.03 6.16 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.44 2.296 . . . . 74.23 113.185 164.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.7 mt -69.1 167.03 16.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.104 0.561 . . . . 73.24 111.77 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.26 147.73 47.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.976 -0.556 . . . . 64.14 110.332 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.99 -4.26 2.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.32 1.448 . . . . 70.33 113.675 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -139.36 13.57 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.77 1.628 . . . . 73.1 112.138 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tt -47.7 131.46 4.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.756 0.822 . . . . 75.54 112.275 -167.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -66.97 147.67 99.05 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 107.548 -1.279 . . . . 73.54 107.548 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.55 1.77 4.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.088 2.525 . . . . 61.32 113.36 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 -22.0 14.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.814 1.188 . . . . 75.45 113.019 167.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -30.43 71.52 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.811 1.187 . . . . 60.11 112.046 -165.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.3 mt -84.71 -24.13 29.03 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.989 0.516 . . . . 75.53 111.436 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -80.78 -52.01 7.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.33 -2.1 . . . . 71.14 105.33 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.12 -38.72 83.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.896 1.678 . . . . 74.23 110.668 -172.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -57.96 -49.26 77.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.237 0.926 . . . . 73.32 111.971 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -85.13 -15.23 44.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.1 0.407 . . . . 75.11 112.1 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -59.23 -20.13 51.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.617 1.567 . . . . 73.32 113.399 -171.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -65.38 -24.37 67.21 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.954 0.502 . . . . 73.21 110.466 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.87 47.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.009 -1.057 . . . . 75.34 110.75 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.17 153.5 9.37 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.005 1.764 . . . . 53.22 108.979 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 167.48 12.76 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.296 0.638 . . . . 72.31 110.71 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . 2.6 p -124.35 145.35 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.442 1.897 . . . . 62.35 107.78 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -74.11 -49.52 23.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.776 -1.107 . . . . 75.35 109.098 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -165.87 -179.69 5.41 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.405 1.002 . . . . 73.52 111.818 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.9 t -133.56 110.01 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 127.006 2.123 . . . . 75.11 107.623 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -104.34 85.33 2.34 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.377 1.071 . . . . 75.24 108.985 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.47 160.74 19.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.649 0.737 . . . . 75.3 110.086 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.92 149.28 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.841 -1.54 . . . . 74.11 106.841 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -70.76 88.49 0.72 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.111 1.364 . . . . 73.22 107.903 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.25 129.93 42.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.664 0.786 . . . . 72.51 111.757 -171.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -137.15 -2.02 2.09 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.792 1.404 . . . . 70.43 114.792 -158.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 64.0 14.15 8.24 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.997 1.48 . . . . 73.44 114.997 157.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.5 t -139.69 -24.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.901 1.68 . . . . 74.1 111.326 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -159.68 52.33 0.35 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.649 -1.282 . . . . 73.33 110.021 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 153.19 45.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.505 -1.665 . . . . 74.32 106.505 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t -75.98 39.9 0.19 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.012 0.925 . . . . 72.11 112.645 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 52.23 25.77 3.55 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.412 1.634 . . . . 71.51 115.412 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.59 102.64 0.35 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.349 -1.1 . . . . 72.4 110.349 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.54 156.11 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.86 1.264 . . . . 70.53 111.044 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.86 159.91 27.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.22 1.008 . . . . 74.44 113.43 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.35 105.41 10.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.777 2.431 . . . . 74.41 106.15 160.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -91.65 132.18 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.62 -1.622 . . . . 75.53 106.62 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -116.47 89.86 3.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.492 1.117 . . . . 73.44 110.276 -166.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.98 169.77 1.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.463 2.023 . . . . 74.12 116.463 -176.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.1 t -87.4 -23.71 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.539 -0.726 . . . . 73.43 112.216 167.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.15 144.66 38.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.436 1.471 . . . . 73.41 114.162 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -48.84 -43.76 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 129.704 3.201 . . . . 63.31 111.675 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.3 p -64.2 -20.65 66.17 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.065 1.302 . . . . 71.34 111.48 -171.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.8 -10.41 58.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.793 1.034 . . . . 73.12 113.793 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.97 -60.22 11.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.995 0.918 . . . . 72.11 109.591 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -11.57 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.537 1.491 . . . . 71.14 113.776 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.05 -49.16 68.64 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.946 0.794 . . . . 74.33 109.461 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.29 74.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.722 -0.611 . . . . 72.42 111.424 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.7 mt -58.37 -44.76 89.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.38 0.672 . . . . 73.35 109.514 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.35 -35.85 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 118.624 0.647 . . . . 65.41 112.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.94 4.07 10.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.363 1.065 . . . . 74.42 113.554 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -46.44 -27.12 0.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.433 1.493 . . . . 74.43 114.419 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -3.91 63.22 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.868 -1.145 . . . . 70.05 113.677 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -77.08 176.5 8.63 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 119.217 1.509 . . . . 62.05 110.488 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 86.5 1.57 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.525 1.13 . . . . 73.03 109.019 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.46 93.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.584 1.554 . . . . 74.35 109.784 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt 46.24 43.3 11.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.658 1.218 . . . . 73.14 110.772 -167.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.43 21.0 46.23 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.314 -0.866 . . . . 71.33 113.347 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -118.7 85.87 28.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.85 1.66 . . . . 73.1 107.52 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.7 -179.44 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.299 1.999 . . . . 74.35 111.003 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.51 156.13 18.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.26 143.37 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.417 1.487 . . . . 72.1 108.797 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.52 3.75 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.16 1.784 . . . . 73.05 114.481 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.29 -53.15 6.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.445 1.898 . . . . 72.43 112.46 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.58 163.27 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.684 1.706 . . . . 64.34 112.872 -170.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -90.45 76.63 6.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 104.208 -2.515 . . . . 74.23 104.208 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -97.03 122.75 40.37 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.831 -1.168 . . . . 74.25 110.082 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.56 157.77 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.897 2.879 . . . . 54.54 112.422 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.33 32.86 0.19 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.859 1.664 . . . . 73.42 112.573 -170.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -111.62 -24.22 10.22 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.567 1.321 . . . . 73.21 114.567 -174.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -79.96 84.99 5.63 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.139 -1.43 . . . . 73.3 107.139 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 107.128 -1.434 . . . . 73.31 107.128 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.991 0 CA-C-O 116.894 -2.059 . . . . 72.33 111.403 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 43.65 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.46 2.704 . . . . 75.44 111.839 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.341 0.0 OUTLIER 54.45 -5.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 118.085 2.624 . . . . 61.32 118.085 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.3 t30 75.91 154.71 0.16 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 129.635 3.174 . . . . 75.11 110.428 -166.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.48 174.19 1.04 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.853 2.461 . . . . 74.43 111.224 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 153.08 47.0 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.34 -1.726 . . . . 74.45 106.34 159.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.22 -12.98 25.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.983 1.788 . . . . 74.42 113.458 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.9 -31.94 51.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.731 1.15 . . . . 75.23 112.255 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.75 -43.47 93.2 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.956 1.253 . . . . 64.32 110.561 -170.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.94 -17.18 55.97 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.93 1.085 . . . . 75.21 113.93 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.62 -43.08 8.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.843 1.657 . . . . 75.53 108.623 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.83 -65.09 0.64 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.815 2.046 . . . . 74.12 112.342 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 57.94 0.37 0.11 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 116.187 1.921 . . . . 75.23 116.187 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -102.94 148.47 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.725 1.148 . . . . 72.22 109.734 -159.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -126.12 135.27 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.109 1.364 . . . . 72.43 109.635 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -100.25 106.61 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.499 1.12 . . . . 74.51 109.619 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -93.18 83.63 4.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.818 2.047 . . . . 55.31 109.221 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.7 ttp -91.21 41.37 1.06 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.3 0.852 . . . . 74.15 113.3 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -154.39 27.25 0.45 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.368 -1.458 . . . . 73.22 113.752 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mt -65.84 152.12 45.13 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.724 -0.61 . . . . 75.51 111.22 -173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.8 168.21 14.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.301 0.572 . . . . 71.12 111.531 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.67 66.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.026 1.121 . . . . 55.34 114.026 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -117.07 10.22 13.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.142 1.377 . . . . 75.34 111.434 -166.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -56.35 139.61 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.3 1.44 . . . . 73.52 111.659 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -87.82 161.46 44.39 Favored Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 124.32 1.048 . . . . 74.34 108.591 163.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.88 -44.61 38.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.044 1.829 . . . . 64.34 110.902 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -62.44 -23.28 66.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.135 -0.936 . . . . 75.52 112.724 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.53 -23.47 64.6 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.64 1.563 . . . . 75.14 111.719 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -80.44 -25.02 39.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.611 1.165 . . . . 74.51 112.893 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.0 -38.64 11.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.876 1.216 . . . . 75.53 109.606 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.52 -27.41 64.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.553 1.07 . . . . 75.54 112.683 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.02 -64.16 0.94 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.413 0.552 . . . . 72.55 109.77 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.0 -22.35 65.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.032 0.753 . . . . 75.14 113.032 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -64.29 -4.72 4.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.089 1.356 . . . . 71.13 111.094 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -53.33 -30.32 38.53 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.406 1.457 . . . . 72.23 110.66 161.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.5 m -144.68 65.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.492 1.517 . . . . 73.43 110.264 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.57 177.13 15.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 122.861 1.256 . . . . 75.31 115.003 149.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -91.74 53.91 2.34 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.814 1.413 . . . . 75.24 114.814 -151.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.308 1.5 p -44.6 130.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.528 1.131 . . . . 75.42 110.854 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -85.11 -48.25 9.36 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 112.72 -2.036 . . . . 73.24 109.843 -155.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -161.47 155.69 22.52 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 124.971 1.419 . . . . 75.45 110.302 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.02 148.6 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.67 1.588 . . . . 72.52 107.717 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -138.84 121.8 16.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.147 -1.797 . . . . 75.32 106.147 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.2 ptp -143.36 166.73 23.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.659 0.784 . . . . 74.43 111.284 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.76 112.79 31.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.23 -0.441 . . . . 75.41 109.886 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.2 m -107.69 3.93 25.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 113.089 0.774 . . . . 61.43 113.089 160.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -77.53 80.71 4.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.01 2.124 . . . . 73.44 108.808 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -170.84 -45.68 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.079 0.952 . . . . 75.42 109.02 168.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.91 -71.08 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 129.489 3.116 . . . . 75.42 111.11 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 t -49.28 -36.26 20.24 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.585 2.354 . . . . 64.51 112.421 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.52 92.85 1.34 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.229 -1.026 . . . . 72.24 108.229 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.283 19.6 ptt180 -114.51 149.75 35.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 119.616 1.098 . . . . 73.53 110.68 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -67.36 -1.37 4.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.069 0.766 . . . . 62.52 113.069 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt 49.49 40.91 20.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.429 1.091 . . . . 75.33 111.52 168.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.36 47.07 0.04 OUTLIER Glycine 0 C--O 1.221 -0.712 0 CA-C-O 117.831 -1.539 . . . . 75.54 110.983 -159.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.3 118.91 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.356 1.078 . . . . 74.42 110.166 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.28 34.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.125 1.37 . . . . 75.55 108.222 163.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.62 83.52 2.08 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.037 2.135 . . . . 73.54 107.131 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.292 1.6 p -90.29 144.5 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.055 1.342 . . . . 72.44 111.104 -170.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.84 97.71 5.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.991 0.901 . . . . 63.13 109.131 -155.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.01 172.92 2.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.914 1.816 . . . . 75.31 112.005 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.87 -25.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 127.406 2.282 . . . . 74.22 112.075 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -138.42 142.81 39.52 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.154 1.782 . . . . 75.42 108.441 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.49 -22.38 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.857 0.863 . . . . 73.24 111.586 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 p -68.4 -20.33 64.66 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 120.671 -1.268 . . . . 62.31 111.868 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -74.65 -19.73 60.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.359 -0.838 . . . . 55.32 112.498 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.56 -57.27 28.15 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.086 -1.009 . . . . 75.53 110.622 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.42 -14.04 39.04 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.645 2.23 . . . . 72.45 113.075 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.72 -49.92 73.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.517 -0.92 . . . . 72.54 108.517 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.83 72.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.624 0.77 . . . . 64.42 111.894 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mt -55.83 -35.52 40.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.462 1.105 . . . . 74.02 110.216 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.69 -27.48 49.44 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.957 -0.913 . . . . 53.41 114.24 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mt -110.82 10.2 22.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.313 1.556 . . . . 74.22 112.455 -166.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.1 t -44.7 -36.49 3.17 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.242 1.383 . . . . 75.42 113.194 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 -26.52 58.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.833 1.206 . . . . 74.22 113.316 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.99 158.29 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.979 0.889 . . . . 74.51 108.683 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -158.06 115.93 3.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.812 0.845 . . . . 74.51 109.426 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -77.46 125.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 106.97 -1.493 . . . . 71.23 106.97 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt 48.34 37.76 9.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.174 1.39 . . . . 71.53 112.823 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.92 28.61 64.4 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.493 -1.171 . . . . 64.35 113.874 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.66 85.51 7.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.336 1.854 . . . . 75.31 108.872 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.16 -170.68 0.97 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.77 2.313 . . . . 72.11 111.226 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.3 tt -144.65 159.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 121.404 -0.81 . . . . 63.54 111.48 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.28 141.19 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.145 -1.428 . . . . 72.41 107.145 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -52.48 -13.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.668 2.787 . . . . 74.03 116.036 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -44.5 -53.33 7.1 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.089 1.355 . . . . 74.24 113.859 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 38.45 29.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.722 1.209 . . . . 72.51 113.294 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 53.55 -154.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.737 1.215 . . . . 75.25 111.261 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -61.53 140.44 58.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.416 -0.957 . . . . 72.24 108.416 163.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.89 148.85 12.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.236 1.014 . . . . 74.33 109.72 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.51 62.33 1.0 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 131.089 3.756 . . . . 74.03 107.549 172.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -130.2 164.7 23.93 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.644 1.578 . . . . 75.25 108.363 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -156.41 95.12 1.55 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.293 1.037 . . . . 61.24 109.809 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.984 1.714 . . . . 74.25 109.34 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.717 0 N-CA-C 110.014 -1.234 . . . . 55.52 110.014 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -71.84 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.271 2.229 . . . . 75.3 111.534 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.4 mtp 45.32 61.3 2.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.018 1.727 . . . . 71.43 111.956 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -166.2 -166.31 0.88 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.304 1.841 . . . . 73.03 107.937 168.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 106.4 2.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.721 2.008 . . . . 74.12 108.778 169.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -63.96 161.03 42.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.366 1.066 . . . . 75.4 111.845 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.9 -45.97 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.334 2.022 . . . . 55.53 112.116 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -62.52 -37.53 86.42 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 118.821 -0.609 . . . . 74.41 111.969 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.18 -32.97 72.64 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 124.109 0.964 . . . . 64.44 110.925 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -67.45 -41.79 84.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 121.778 -0.576 . . . . 74.2 109.683 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -80.29 -27.63 38.47 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.226 0.329 . . . . 73.24 111.294 -167.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.64 3.67 6.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.506 2.322 . . . . 62.42 114.501 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -61.28 1.42 0.19 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 127.974 2.51 . . . . 75.2 116.767 -167.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -121.56 145.54 47.87 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.189 -1.411 . . . . 74.32 107.189 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.56 115.1 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.661 -1.978 . . . . 62.03 105.661 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -75.0 128.21 35.04 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.181 -1.785 . . . . 63.33 106.181 168.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -121.32 121.36 37.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 106.534 -1.654 . . . . 75.03 106.534 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.0 ttp -124.13 165.23 17.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.22 1.408 . . . . 75.41 107.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 75.31 12.17 3.31 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.028 2.131 . . . . 72.12 111.862 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.17 167.95 9.31 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.647 -0.658 . . . . 71.41 109.423 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.47 151.87 45.55 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.604 -0.685 . . . . 74.42 110.58 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.62 -4.19 25.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.155 0.982 . . . . 72.21 113.008 172.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.76 33.1 2.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.596 1.958 . . . . 74.05 110.374 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.97 138.58 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.049 -1.032 . . . . 74.42 108.768 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -77.91 153.48 80.36 Favored Pre-proline 0 N--CA 1.466 0.363 0 N-CA-C 108.218 -1.03 . . . . 74.02 108.218 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.37 0.9 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.395 2.73 . . . . 75.43 114.039 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -112.87 -5.25 13.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.941 1.246 . . . . 75.25 111.892 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.47 -30.44 64.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.6 -1.313 . . . . 63.44 108.729 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.48 -53.23 9.92 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.174 0.99 . . . . 72.21 110.195 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.54 -40.07 94.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.46 0.704 . . . . 61.1 110.524 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -67.87 -27.37 66.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.156 0.582 . . . . 75.41 112.067 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.26 -50.07 73.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.502 -0.285 . . . . 75.24 110.317 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -72.83 -28.26 62.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.88 0.764 . . . . 74.4 111.974 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 t -57.73 -20.36 34.04 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.632 1.973 . . . . 60.22 113.218 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -76.74 -15.85 59.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.149 -0.969 . . . . 75.12 111.268 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -136.98 11.54 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.031 0.932 . . . . 75.11 111.461 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.51 173.55 36.29 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 121.198 -0.939 . . . . 53.42 111.604 -160.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.76 137.12 29.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.532 -1.284 . . . . 75.12 107.532 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.24 131.8 65.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 125.92 1.688 . . . . 64.32 109.281 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -94.13 -42.54 8.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.048 -0.977 . . . . 75.0 110.879 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -167.41 158.45 11.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.783 2.033 . . . . 74.21 106.36 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.95 163.85 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.26 1.824 . . . . 74.44 109.684 -173.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 136.79 10.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.181 -0.95 . . . . 74.44 109.235 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.4 ptp -136.11 135.55 39.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.273 0.942 . . . . 75.13 110.18 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 45' ' ' ILE . 3.3 mp -99.39 98.24 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.07 -0.514 . . . . 75.12 112.352 -150.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.3 m -89.95 4.83 48.85 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.846 1.258 . . . . 62.44 114.384 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.58 24.85 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 129.031 2.932 . . . . 73.02 115.566 -170.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.66 -73.07 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.591 1.956 . . . . 75.03 109.454 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 p30 47.27 18.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.885 2.074 . . . . 75.44 113.991 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.55 28.26 0.3 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.803 3.241 . . . . 72.34 114.167 -169.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.03 -39.18 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.875 1.67 . . . . 75.35 108.026 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 64.43 -173.51 0.17 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.104 1.761 . . . . 75.11 107.965 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -73.15 63.87 0.72 Allowed 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.25 -0.906 . . . . 72.02 109.238 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -12.76 61.68 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.348 1.059 . . . . 74.03 112.274 165.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.1 62.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 124.733 1.159 . . . . 73.32 110.389 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.38 131.54 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.205 1.802 . . . . 75.32 109.903 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.15 165.6 35.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.737 1.615 . . . . 61.32 108.55 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -124.07 146.12 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.425 -1.694 . . . . 72.4 106.425 165.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.6 t -130.71 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.563 -1.643 . . . . 75.14 106.563 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -72.1 128.34 35.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.097 -1.446 . . . . 75.33 107.097 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.18 155.44 23.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 75.04 110.631 169.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.18 -26.99 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 117.996 -1.002 . . . . 73.31 110.187 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.13 150.43 50.52 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.191 1.36 . . . . 62.31 111.979 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.78 -34.54 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 117.986 -1.006 . . . . 75.14 111.806 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -69.99 -20.74 63.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.383 1.902 . . . . 74.34 112.411 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -89.94 -4.34 57.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.829 0.852 . . . . 75.13 112.443 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.29 -60.84 8.92 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 119.693 1.133 . . . . 75.0 109.787 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 -15.4 46.41 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 120.92 1.364 . . . . 62.31 113.381 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -55.22 35.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 120.547 -1.345 . . . . 74.44 110.145 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.82 -41.6 78.12 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.712 0.633 . . . . 74.02 111.253 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.01 -39.0 70.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.948 0.899 . . . . 72.43 110.36 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.58 -36.04 63.52 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.448 1.023 . . . . 74.31 112.905 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.6 12.75 1.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.574 1.15 . . . . 75.22 113.354 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -50.38 -28.23 7.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.298 1.439 . . . . 71.13 113.572 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.66 14.73 45.96 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.293 1.425 . . . . 75.22 112.914 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -93.71 170.4 9.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.261 1.03 . . . . 73.44 108.258 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -145.17 87.13 1.8 Allowed 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.635 -0.666 . . . . 75.05 109.978 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.94 110.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.708 -0.849 . . . . 63.25 108.708 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt 46.97 31.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.353 1.861 . . . . 62.45 112.979 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.42 19.43 27.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.781 0.705 . . . . 62.04 113.61 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.63 86.43 29.37 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.995 1.718 . . . . 72.41 109.165 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.23 173.79 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.456 2.104 . . . . 60.02 111.914 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.1 tt -140.17 143.33 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.466 1.107 . . . . 71.4 109.453 -175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.9 mm -86.14 144.34 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.715 0.806 . . . . 72.33 109.442 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.15 10.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 129.298 3.039 . . . . 54.34 115.471 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -25.66 64.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 114.782 1.401 . . . . 75.24 114.782 -154.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.83 164.03 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.692 2.797 . . . . 61.22 111.766 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.82 93.11 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.135 -1.802 . . . . 55.24 106.135 167.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -105.02 148.44 26.75 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.882 -1.155 . . . . 75.02 107.882 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 48.8 -178.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.588 1.955 . . . . 72.33 112.693 -162.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.36 18.96 7.54 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.852 1.661 . . . . 75.22 109.611 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -95.15 -153.42 0.39 Allowed 'General case' 0 C--O 1.232 0.153 0 O-C-N 119.744 -1.847 . . . . 71.34 110.214 -165.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m120 43.98 75.77 0.09 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.376 2.271 . . . . 75.0 113.594 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.297 -1.371 . . . . 75.3 107.297 166.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.695 0 N-CA-C 108.969 -1.652 . . . . 71.41 108.969 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.03 10.75 4.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.69 1.196 . . . . 73.33 112.361 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -53.83 120.21 5.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.912 1.685 . . . . 72.14 110.586 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -120.5 14.66 11.96 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.469 0.914 . . . . 72.55 113.469 -171.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.08 105.29 10.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.251 1.82 . . . . 74.34 110.275 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.8 p -83.89 166.06 35.88 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.558 0.743 . . . . 72.22 109.989 -174.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -63.04 -40.88 31.38 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.59 1.246 . . . . 72.24 110.543 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -72.95 -29.2 62.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.955 0.798 . . . . 72.44 112.182 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.99 -47.33 81.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.78 -0.822 . . . . 52.13 108.78 166.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -73.76 -13.22 60.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.161 0.8 . . . . 74.5 113.161 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.87 -14.05 22.09 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.177 0.991 . . . . 62.5 111.659 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.71 -75.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.55 1.54 . . . . 73.52 110.944 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 58.68 -15.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 C-N-CA 131.15 3.78 . . . . 74.13 116.943 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -77.75 155.93 30.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.814 0.846 . . . . 72.52 111.47 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.09 179.29 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.499 1.52 . . . . 64.54 108.54 167.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -140.94 127.05 19.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.631 1.173 . . . . 72.24 110.048 -169.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.77 115.4 30.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.363 1.465 . . . . 72.5 107.451 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -128.87 32.59 4.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.623 1.569 . . . . 74.5 110.141 -174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -147.28 27.36 1.03 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.381 -1.449 . . . . 74.41 110.445 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.4 mt -68.03 155.19 40.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.949 1.3 . . . . 73.04 113.654 -172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.13 -174.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.812 1.645 . . . . 74.43 110.085 163.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.92 19.57 10.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.139 1.376 . . . . 73.0 111.879 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -140.26 8.82 2.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.648 1.179 . . . . 73.24 111.366 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.9 tt -76.0 148.82 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.317 1.447 . . . . 74.03 108.82 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.26 152.23 88.04 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.033 -1.042 . . . . 63.43 109.083 170.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.06 -48.94 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.687 1.591 . . . . 73.3 111.198 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttp85 -64.13 -21.27 66.48 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.124 -0.941 . . . . 74.33 112.767 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.19 -33.3 72.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.576 1.535 . . . . 74.12 110.492 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.28 -23.25 54.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.094 -0.955 . . . . 70.33 111.86 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.37 -33.48 15.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.19 0.904 . . . . 74.34 108.628 177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.42 -36.56 76.11 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.272 1.829 . . . . 74.14 111.107 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -49.9 -62.45 1.56 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.126 0.97 . . . . 70.11 110.471 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.81 -17.61 64.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 71.43 111.833 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -2.33 6.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.727 1.01 . . . . 70.13 113.727 172.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -69.69 -34.58 74.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.416 1.462 . . . . 65.21 110.159 161.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -8.96 11.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 120.005 1.275 . . . . 64.51 113.806 -159.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.99 178.48 48.5 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.415 -0.674 . . . . 71.41 111.415 -160.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.64 135.75 54.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.892 1.346 . . . . 73.21 112.005 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -123.21 153.29 28.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 125.59 1.556 . . . . 53.21 109.614 -175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -97.35 -52.84 3.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.323 -1.762 . . . . 64.31 107.219 -166.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.13 -177.88 3.48 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.164 0.585 . . . . 72.22 110.267 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.05 149.52 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.199 1.0 . . . . 72.31 110.259 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -124.91 159.58 30.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.096 1.358 . . . . 70.43 109.735 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.1 ptp -138.6 132.0 30.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.771 1.228 . . . . 65.23 107.88 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.04 80.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.256 -1.387 . . . . 71.54 107.256 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.3 m -80.29 96.59 6.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.959 1.704 . . . . 73.0 108.911 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.5 -171.11 2.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.396 1.878 . . . . 61.0 110.262 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -127.05 -68.72 0.79 Allowed 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.535 1.134 . . . . 73.31 110.699 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -129.43 74.12 1.56 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.894 1.33 . . . . 72.42 107.62 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.38 -68.0 0.32 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.691 -2.05 . . . . 63.04 109.786 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -158.25 42.38 0.28 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.487 -0.758 . . . . 75.2 109.667 -163.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -57.88 -32.33 67.59 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 118.735 -0.65 . . . . 74.13 109.951 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.3 m 45.27 35.87 1.99 Allowed 'General case' 0 C--N 1.34 0.154 0 C-N-CA 127.787 2.435 . . . . 72.01 112.706 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.36 0.0 OUTLIER 44.7 38.12 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.049 1.74 . . . . 73.4 113.581 -175.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.65 111.32 2.75 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.452 -1.459 . . . . 71.3 109.452 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -142.96 141.15 27.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.926 1.29 . . . . 74.3 109.182 -169.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.82 152.43 28.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.41 1.084 . . . . 70.23 108.927 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -124.95 146.1 49.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.553 1.541 . . . . 72.44 107.339 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.8 115.27 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.869 -1.16 . . . . 73.52 107.869 -161.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -85.9 96.57 9.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.884 0.873 . . . . 74.43 109.61 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.69 157.22 12.3 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 120.029 -1.67 . . . . 74.51 113.45 166.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.99 -29.19 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 109.702 -0.481 . . . . 74.32 109.702 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.44 144.83 42.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.97 1.308 . . . . 62.43 110.001 -171.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 p -72.91 -21.9 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.443 0.697 . . . . 73.23 112.527 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -59.26 -22.64 61.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.621 -1.3 . . . . 73.11 113.755 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m -93.27 -2.08 55.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.801 0.84 . . . . 72.23 113.094 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.42 -58.35 19.2 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 120.211 -1.556 . . . . 71.52 110.135 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.01 -14.63 44.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 CA-C-N 121.383 1.53 . . . . 74.33 112.683 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -41.34 94.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.336 -0.853 . . . . 74.51 108.762 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.79 -28.54 66.06 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.868 0.867 . . . . 62.41 112.966 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.5 mt -63.49 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 118.966 0.803 . . . . 70.51 109.076 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.39 -14.3 59.59 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.549 -0.72 . . . . 71.2 113.794 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.89 -0.79 41.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.508 1.154 . . . . 73.42 112.287 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -45.54 -45.62 13.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.872 1.269 . . . . 74.42 111.524 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.67 4.94 79.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.809 0.718 . . . . 71.21 114.245 -168.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -78.91 -171.14 2.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.505 1.152 . . . . 73.3 108.929 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.43 121.03 4.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.985 -1.487 . . . . 73.1 106.985 176.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 97.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.287 -1.375 . . . . 72.42 107.287 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 mt 53.08 16.23 0.72 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.719 1.607 . . . . 70.42 113.439 -170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.99 7.29 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.132 0.872 . . . . 65.04 113.137 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 82.4 t -107.26 86.61 2.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.724 2.01 . . . . 61.3 111.222 -174.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.76 175.84 1.58 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.157 1.904 . . . . 74.04 111.557 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.6 tt -127.19 163.96 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 O-C-N 121.53 -0.731 . . . . 73.12 110.278 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.528 HG21 ' H ' ' A' ' 86' ' ' GLN . 49.2 mm -99.87 140.25 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.743 -1.577 . . . . 70.2 106.743 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -44.92 -24.97 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.085 2.154 . . . . 74.21 114.83 170.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.528 ' H ' HG21 ' A' ' 84' ' ' ILE . 13.1 mt-30 -44.1 -51.7 7.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.123 1.769 . . . . 73.42 113.331 -162.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.33 48.75 18.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.798 1.239 . . . . 74.2 112.376 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 t 54.15 -152.98 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.271 -1.011 . . . . 73.14 108.271 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 50.67 76.98 0.13 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.49 1.516 . . . . 72.51 113.325 162.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.16 169.46 23.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.789 -1.194 . . . . 72.51 112.407 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.08 8.91 42.63 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.844 1.658 . . . . 73.54 110.73 158.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.1 mmtp -67.4 156.55 36.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.685 1.194 . . . . 73.24 109.742 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.36 147.87 28.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.226 -1.027 . . . . 72.13 108.226 159.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.77 2.028 . . . . 75.2 109.952 162.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 111.729 -0.548 . . . . 71.33 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -136.53 169.07 18.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.586 1.955 . . . . 73.11 107.774 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.6 ttm -140.87 49.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.095 -1.076 . . . . 73.21 108.095 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.57 150.17 29.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.689 1.196 . . . . 65.43 107.899 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.56 136.76 46.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.146 2.178 . . . . 74.25 106.793 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.7 p -76.08 165.52 52.44 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 118.874 0.761 . . . . 64.51 111.415 -174.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -60.37 -40.97 53.6 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.709 1.606 . . . . 75.45 110.073 172.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -58.14 -50.04 74.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.811 1.245 . . . . 75.15 110.188 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -52.03 -47.73 64.89 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.169 0.588 . . . . 75.15 110.422 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -70.81 -28.54 64.7 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.93 0.892 . . . . 71.25 112.726 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -44.14 52.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.672 1.589 . . . . 73.43 109.652 176.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.98 -66.02 0.6 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 71.23 111.838 -162.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 44.47 59.71 3.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.082 2.153 . . . . 73.24 114.562 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.02 165.58 27.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.036 -1.468 . . . . 72.51 107.036 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.76 -178.5 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.936 0.895 . . . . 71.43 109.536 163.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.73 102.17 3.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.404 1.097 . . . . 75.43 110.573 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.5 m -87.66 94.94 9.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.384 1.874 . . . . 72.43 109.117 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.4 ttp -108.17 44.85 1.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.769 1.227 . . . . 63.52 110.207 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -164.8 68.3 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 74.43 110.36 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.39 166.1 10.92 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.364 -0.835 . . . . 74.34 111.367 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.9 171.55 7.58 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.627 1.171 . . . . 71.31 110.654 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.85 -30.94 65.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.266 0.839 . . . . 74.4 113.266 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.63 51.5 1.92 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.365 1.066 . . . . 64.21 108.959 -170.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 tt -80.47 154.13 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.772 -0.825 . . . . 71.2 108.772 170.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -111.76 160.59 29.1 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 107.802 -1.184 . . . . 74.1 107.802 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -59.96 -21.43 64.69 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.031 1.821 . . . . 73.32 112.436 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -34.5 73.0 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.963 -1.086 . . . . 74.22 112.297 173.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -34.31 74.74 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.874 1.216 . . . . 72.21 111.747 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -64.5 -41.8 96.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.558 0.743 . . . . 74.41 110.124 -174.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.77 -35.12 29.94 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.221 -0.895 . . . . 72.5 109.99 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -63.92 -24.31 67.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.597 1.089 . . . . 72.13 111.253 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -65.46 -67.6 0.43 Allowed 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.874 -0.516 . . . . 73.51 110.388 168.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -71.4 -19.7 62.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.552 0.945 . . . . 65.3 113.552 -167.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 t -51.72 -28.64 15.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.96 1.304 . . . . 74.51 110.798 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -77.02 -14.94 59.77 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.146 -0.971 . . . . 73.14 110.987 -172.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.36 -4.19 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.261 1.024 . . . . 72.23 113.358 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.15 -156.83 12.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.662 -1.375 . . . . 72.21 109.662 -174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -145.3 139.33 27.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.421 1.111 . . . . 73.52 110.985 166.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 t -71.17 143.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.925 1.69 . . . . 73.44 108.778 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -82.44 -50.6 8.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.013 -1.054 . . . . 74.5 109.606 163.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.58 124.06 11.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.275 0.488 . . . . 63.22 110.817 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.6 t -73.7 108.17 4.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 O-C-N 121.404 -0.81 . . . . 72.54 109.343 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -104.91 82.58 1.89 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.863 1.265 . . . . 71.52 108.129 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 153.57 23.4 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.613 0.765 . . . . 74.2 109.003 167.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.39 161.73 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.155 -1.054 . . . . 63.44 108.155 -176.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 t 57.76 35.94 26.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.907 1.337 . . . . 64.32 111.025 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.98 4.25 10.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.719 2.007 . . . . 74.22 110.985 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 156.74 46.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 120.266 -1.522 . . . . 75.51 108.403 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.82 -24.96 64.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 118.708 -0.663 . . . . 72.12 112.579 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 t -74.88 41.51 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.125 1.784 . . . . 61.12 112.689 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -159.69 -49.74 0.05 Allowed 'General case' 0 C--N 1.344 0.348 0 O-C-N 120.137 -1.602 . . . . 63.42 112.062 157.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 54' ' ' LYS . 3.4 mpt_? 48.12 62.73 2.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.048 0.928 . . . . 75.33 110.268 -164.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -68.19 27.17 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 O-C-N 119.854 -1.778 . . . . 74.42 111.911 162.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.439 ' H ' ' C ' ' A' ' 52' ' ' ARG . 22.0 mtmt 61.12 5.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.438 1.644 . . . . 75.21 115.438 173.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.07 106.42 2.67 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 109.606 -1.398 . . . . 64.32 109.606 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 pt -145.56 137.36 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.1 1.36 . . . . 74.12 110.152 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.61 135.19 29.76 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.601 -1.259 . . . . 75.3 107.601 163.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -122.11 70.77 0.98 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.625 -1.25 . . . . 75.2 107.625 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -67.35 135.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.539 0.685 . . . . 75.43 109.772 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.61 145.06 31.89 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.809 -1.182 . . . . 73.34 107.809 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.18 151.33 24.9 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 113.319 0.859 . . . . 73.44 113.319 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 -43.6 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.31 -0.859 . . . . 74.41 109.104 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.38 142.64 46.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.518 1.127 . . . . 73.52 109.71 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.97 -36.66 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 111.827 0.306 . . . . 72.51 111.827 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -62.6 -23.51 67.08 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.148 -0.97 . . . . 74.1 113.065 -166.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -77.07 -13.12 60.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.945 0.898 . . . . 71.51 113.07 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.98 -56.48 25.22 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.866 1.666 . . . . 62.31 111.723 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.63 -12.41 34.98 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 121.997 1.798 . . . . 64.23 113.635 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.26 -47.93 66.43 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.009 -1.057 . . . . 74.44 109.231 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.57 69.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.372 0.669 . . . . 62.33 112.395 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 65.9 mt -57.32 -41.4 78.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.754 0.822 . . . . 73.51 109.362 176.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.85 -18.46 56.92 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.56 -0.578 . . . . 74.54 112.865 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -101.34 9.44 41.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.708 1.203 . . . . 71.32 111.554 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -51.64 -30.02 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.69 1.132 . . . . 73.51 113.383 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.91 5.41 27.39 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.161 1.362 . . . . 63.1 112.796 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.95 174.95 8.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.779 1.29 . . . . 72.14 108.275 155.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 130.15 10.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.83 1.252 . . . . 73.34 108.642 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.19 115.52 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.819 -1.919 . . . . 74.53 105.819 162.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.65 3.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.737 2.125 . . . . 74.44 116.737 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.72 7.27 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.736 1.153 . . . . 65.33 113.923 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.39 86.99 2.97 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 128.323 2.649 . . . . 72.52 109.675 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.77 -176.67 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.791 2.327 . . . . 74.41 111.549 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.5 tt -136.77 167.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 121.19 -0.944 . . . . 73.4 109.715 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.509 HG21 ' H ' ' A' ' 86' ' ' GLN . 39.8 mm -111.95 144.72 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.671 -1.603 . . . . 72.11 106.671 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.34 -13.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.508 1.923 . . . . 73.1 112.832 171.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.509 ' H ' HG21 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -52.42 -26.68 13.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.001 2.52 . . . . 75.5 115.419 -171.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 43.32 89.92 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.352 1.461 . . . . 61.31 112.132 155.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t -48.06 118.23 2.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.723 -1.214 . . . . 64.13 107.723 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -146.48 139.57 25.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.031 2.932 . . . . 75.21 105.856 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.19 161.72 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.457 2.303 . . . . 73.5 114.606 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.41 52.33 2.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.643 1.977 . . . . 72.53 108.425 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -143.36 149.81 38.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.583 2.353 . . . . 75.52 106.46 -170.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -154.21 104.62 2.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.073 -1.084 . . . . 75.44 108.073 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.593 0.757 . . . . 75.23 111.691 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.559 0 N-CA-C 110.191 -1.163 . . . . 73.12 110.191 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -99.89 144.06 29.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.09 0.956 . . . . 75.35 109.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mtm -166.41 167.18 16.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.4 2.28 . . . . 74.11 108.006 175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -66.68 129.79 41.01 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.306 -0.854 . . . . 73.12 110.075 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 mt 50.01 -173.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.53 1.932 . . . . 74.23 113.055 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -88.39 165.95 25.8 Favored Pre-proline 0 C--O 1.239 0.549 0 N-CA-C 107.383 -1.34 . . . . 73.33 107.383 158.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -23.97 51.77 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.143 1.087 . . . . 55.02 111.246 167.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.28 4.0 pt-20 -91.99 -33.63 14.77 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.188 0.995 . . . . 62.51 113.21 -165.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.76 -44.26 63.28 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.429 1.013 . . . . 75.44 111.288 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -63.0 -24.56 67.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.607 0.763 . . . . 74.11 112.556 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.57 -18.43 13.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.876 0.846 . . . . 63.25 111.028 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.49 -72.5 0.41 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.393 2.277 . . . . 75.24 109.957 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.27 73.2 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.655 1.582 . . . . 73.55 111.164 -164.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.63 150.67 49.7 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.909 -1.119 . . . . 74.35 109.664 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.71 171.7 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.357 1.463 . . . . 72.52 107.557 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.92 142.16 30.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.258 1.423 . . . . 75.21 108.238 -166.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.7 m -130.21 103.28 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.148 1.379 . . . . 64.52 109.858 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.1 ttm -92.83 -0.34 57.27 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.797 1.036 . . . . 75.25 113.797 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -128.18 29.08 5.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.278 1.214 . . . . 52.32 114.278 -163.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -73.34 151.53 41.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.355 1.062 . . . . 74.1 113.632 -171.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.21 165.72 17.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.549 1.14 . . . . 74.23 112.95 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.084 1.354 . . . . 74.14 113.542 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.98 47.09 1.96 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.26 1.024 . . . . 74.11 110.755 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.51 154.49 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 120.995 -1.065 . . . . 75.12 109.05 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -114.98 157.87 42.23 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 127.439 2.296 . . . . 72.31 107.738 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.21 -19.89 69.58 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.805 1.67 . . . . 74.42 112.182 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 1.5 ptp180 -76.71 -29.95 56.46 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.363 -0.827 . . . . 74.31 112.259 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -61.89 -25.19 67.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.491 1.041 . . . . 75.13 111.061 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.11 -54.24 6.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.915 0.886 . . . . 75.34 109.07 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.57 -33.29 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 117.693 -1.146 . . . . 73.42 111.347 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.02 0.827 . . . . 74.51 109.53 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -52.79 -48.21 67.03 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 122.684 0.394 . . . . 74.22 110.718 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -80.04 -14.46 58.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.199 -1.0 . . . . 75.5 112.103 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 t -64.97 -17.25 64.25 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.362 1.437 . . . . 60.54 110.848 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 p -73.16 -21.77 60.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.779 1.172 . . . . 75.12 111.037 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.43 -7.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.641 1.576 . . . . 75.14 112.736 -166.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.37 18.46 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.114 1.34 . . . . 74.34 111.003 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -147.87 134.41 19.78 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.68 1.192 . . . . 73.42 110.573 -168.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.0 t -105.5 144.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.293 1.837 . . . . 73.43 108.395 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.71 -54.93 2.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.275 1.43 . . . . 75.13 108.378 172.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.56 165.04 27.91 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 124.162 0.914 . . . . 64.11 110.982 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.01 110.26 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.946 2.098 . . . . 74.43 106.502 -160.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -143.71 81.34 1.69 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.041 0.837 . . . . 71.43 110.047 -160.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.1 mtp -88.41 160.77 17.41 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 122.671 1.224 . . . . 75.4 110.429 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.44 ' CG2' ' H ' ' A' ' 46' ' ' SER . 5.7 mm -88.14 -175.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 124.823 1.249 . . . . 73.55 107.917 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.44 ' H ' ' CG2' ' A' ' 45' ' ' ILE . 8.4 t 56.73 4.14 0.15 Allowed 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 127.331 2.252 . . . . 73.41 114.585 -169.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.15 -21.88 61.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.113 0.959 . . . . 74.53 111.114 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -107.68 4.54 25.89 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.209 1.804 . . . . 72.42 112.703 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 42.84 61.26 2.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.562 1.945 . . . . 75.21 113.209 167.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.9 p -150.62 -51.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.476 0.917 . . . . 62.31 113.476 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -124.36 104.04 8.55 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 106.856 -1.535 . . . . 73.54 106.856 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.5 155.09 42.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.942 1.297 . . . . 74.14 109.299 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 m -84.06 10.66 9.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 117.734 -1.126 . . . . 55.21 112.138 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.367 0.0 OUTLIER 44.95 68.27 0.58 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.643 1.577 . . . . 75.43 111.617 -163.241 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.63 77.26 0.28 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 124.766 1.174 . . . . 74.31 110.416 163.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -145.65 153.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.288 1.044 . . . . 75.21 110.732 171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.8 40.78 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.976 1.31 . . . . 75.41 109.144 168.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -122.28 154.83 37.05 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 75.25 106.783 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 t -134.67 134.46 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.184 -2.154 . . . . 75.25 105.184 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.55 109.09 20.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.625 -1.991 . . . . 74.45 105.625 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -73.18 168.97 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.522 0.729 . . . . 74.41 109.296 173.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.43 -38.67 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 120.538 -0.465 . . . . 62.33 109.85 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.11 128.15 45.2 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.651 0.659 . . . . 71.22 110.447 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.82 -37.76 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 74.42 111.474 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -5.5 54.27 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.685 -1.259 . . . . 63.42 112.336 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.9 m -90.88 -12.06 37.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.232 -0.918 . . . . 74.34 111.824 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.5 t -54.58 -57.63 17.99 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.369 0.986 . . . . 75.22 110.089 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.86 -22.61 68.88 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.228 1.952 . . . . 73.53 113.872 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.21 -52.26 59.73 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.771 -0.826 . . . . 74.42 108.771 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.86 78.57 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.217 0.607 . . . . 74.5 111.328 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.87 -44.51 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.563 0.745 . . . . 75.11 109.385 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.92 -10.64 27.05 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.764 0.697 . . . . 43.02 114.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.41 5.84 50.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.555 1.178 . . . . 74.34 111.932 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -44.46 -45.75 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.996 1.718 . . . . 74.12 112.876 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.86 2.93 84.67 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.738 -1.034 . . . . 62.11 113.703 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.06 -176.59 2.16 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.508 1.654 . . . . 74.13 109.317 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -157.45 81.69 0.9 Allowed 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.829 0.851 . . . . 71.33 109.502 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.47 102.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.487 1.115 . . . . 75.24 108.541 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt 56.51 25.03 9.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.53 0.332 . . . . 73.11 111.677 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.73 -6.41 25.99 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.237 -1.313 . . . . 74.3 113.706 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.7 86.7 1.52 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.546 1.938 . . . . 74.43 111.915 -168.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.08 -179.58 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.76 2.307 . . . . 71.54 111.635 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -141.83 168.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.424 0.689 . . . . 75.51 109.278 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.8 mm -112.45 137.66 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.606 1.562 . . . . 74.55 106.968 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.31 -2.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 129.731 3.212 . . . . 75.41 117.058 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -62.03 -33.2 73.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.999 1.851 . . . . 73.42 115.999 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.65 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 123.515 1.626 . . . . 62.52 110.709 -162.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.57 -164.59 1.19 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.067 -1.424 . . . . 74.43 107.616 156.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.77 53.75 10.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 127.306 2.242 . . . . 75.33 112.824 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.28 -161.74 0.78 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.125 0.57 . . . . 75.52 110.043 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.43 16.37 22.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.777 2.031 . . . . 74.45 110.709 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -121.73 151.3 40.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.296 -0.877 . . . . 73.43 111.015 -166.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.88 -7.29 0.07 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.267 1.427 . . . . 73.41 114.22 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--O 1.245 0.863 0 C-N-CA 125.491 1.517 . . . . 75.53 107.554 -177.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 111.31 -0.716 . . . . 72.4 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.2 m80 55.13 27.64 9.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.038 1.735 . . . . 74.03 112.204 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 31.3 ttm -140.76 167.18 22.79 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.803 2.441 . . . . 72.22 107.058 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 62.53 111.08 0.02 OUTLIER 'General case' 0 C--O 1.235 0.336 0 C-N-CA 128.114 2.566 . . . . 73.4 110.778 -171.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.96 134.5 52.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.356 1.863 . . . . 72.41 106.887 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.0 p -66.88 165.99 22.32 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 118.147 0.43 . . . . 75.31 111.46 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.02 -11.65 2.81 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.991 2.461 . . . . 74.32 114.432 163.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.7 -41.37 2.8 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.571 1.548 . . . . 73.03 110.663 -162.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.05 -36.3 70.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.945 1.248 . . . . 72.31 111.21 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -60.45 -28.98 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.724 0.81 . . . . 72.24 112.385 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -88.67 -43.43 11.32 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.608 1.563 . . . . 73.11 109.511 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.8 0.68 1.08 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.891 2.076 . . . . 75.5 114.199 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -63.44 -17.47 62.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.922 1.289 . . . . 61.34 112.116 163.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -66.7 126.98 30.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.857 -1.164 . . . . 73.51 107.857 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 174.2 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.528 -0.916 . . . . 74.53 108.528 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.7 98.39 3.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.624 1.202 . . . . 74.23 110.707 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.0 m -80.93 88.14 5.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.559 1.543 . . . . 72.44 108.541 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttp -90.94 13.12 17.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.988 0.915 . . . . 55.21 112.397 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -133.38 94.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.493 -1.38 . . . . 73.45 107.872 172.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.1 mt -118.28 157.51 26.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.578 0.351 . . . . 55.25 111.577 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.43 160.56 32.13 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.011 0.91 . . . . 72.32 110.055 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.64 5.29 13.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.948 1.699 . . . . 73.53 114.103 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.71 64.12 1.0 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.012 1.278 . . . . 75.12 108.21 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 tt -109.83 136.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.712 1.205 . . . . 75.24 109.532 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -77.2 149.07 78.93 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 107.63 -1.248 . . . . 73.13 107.63 165.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.85 -32.82 93.13 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.238 1.292 . . . . 74.32 111.158 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttp85 -66.73 -20.8 66.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.074 -0.965 . . . . 63.43 112.507 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.5 -29.0 70.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.737 1.608 . . . . 73.13 109.679 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -77.67 -48.58 16.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.936 0.895 . . . . 75.51 109.754 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.14 -37.29 80.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.896 0.316 . . . . 74.32 110.996 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.823 0.849 . . . . 72.31 111.314 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -57.27 -46.13 83.38 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.498 0.59 . . . . 62.42 110.311 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -68.23 -26.62 65.79 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.612 -0.68 . . . . 73.14 112.667 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -15.33 34.99 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.655 1.182 . . . . 72.23 112.804 -173.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -61.81 -18.6 60.55 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.425 -0.797 . . . . 62.43 111.679 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.81 24.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.2 1.0 . . . . 62.2 110.401 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.3 -161.77 27.36 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.201 1.364 . . . . 72.04 115.371 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.57 146.37 28.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.34 1.856 . . . . 75.32 108.644 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.21 150.55 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 127.175 2.19 . . . . 73.1 107.963 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -82.04 -56.69 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.608 1.563 . . . . 73.32 109.282 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -159.43 134.64 8.25 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.132 -0.692 . . . . 72.23 109.132 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.43 162.27 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.397 1.879 . . . . 72.01 111.205 164.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.78 112.1 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.335 2.254 . . . . 75.03 107.81 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.0 ptp -116.76 147.8 41.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.874 1.216 . . . . 75.43 110.556 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.3 mp -90.88 78.45 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.886 -1.154 . . . . 72.22 107.886 -166.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.8 m -94.24 9.68 37.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.039 1.126 . . . . 73.41 114.039 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.07 6.71 15.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.945 1.298 . . . . 71.14 112.767 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 58.54 -164.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.037 -1.039 . . . . 74.24 109.277 -151.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.8 p30 175.16 -1.73 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.642 1.977 . . . . 75.52 112.954 -165.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.65 16.16 9.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.043 1.337 . . . . 72.15 114.516 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 -57.35 0.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.369 -1.457 . . . . 74.52 108.417 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.33 72.77 0.51 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.922 2.489 . . . . 75.31 110.809 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -55.76 -2.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.945 2.098 . . . . 75.21 113.387 161.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 54.99 30.86 14.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.542 1.537 . . . . 75.12 113.459 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.75 90.16 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 108.372 -1.891 . . . . 75.25 108.372 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.44 135.02 30.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.047 0.939 . . . . 74.34 108.941 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.78 147.78 21.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.329 1.852 . . . . 55.21 108.174 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -122.27 123.2 40.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.116 -1.809 . . . . 75.44 106.116 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.73 140.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 121.986 2.175 . . . . 75.14 108.057 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.05 115.57 12.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.9 -1.889 . . . . 72.31 105.9 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.21 160.57 22.98 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.307 0.958 . . . . 75.22 110.35 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.64 -27.94 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 118.629 -0.7 . . . . 74.21 110.759 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.428 ' CG ' ' H ' ' A' ' 64' ' ' VAL . 15.7 t70 -114.73 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.888 1.222 . . . . 63.14 110.217 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 5.8 p -102.68 -28.02 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.857 1.263 . . . . 75.34 110.587 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -68.99 -17.31 63.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.861 1.21 . . . . 73.11 110.56 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -70.47 -23.55 62.71 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.604 1.562 . . . . 75.54 113.923 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.07 -56.29 37.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.422 -0.799 . . . . 55.31 110.11 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.17 -13.26 39.05 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.611 1.541 . . . . 74.2 113.2 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.11 -48.01 69.43 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.798 1.181 . . . . 60.14 109.839 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.56 78.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.454 0.57 . . . . 62.12 111.446 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.77 -39.47 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.967 0.907 . . . . 72.12 110.016 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.92 -0.09 40.52 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.603 -1.109 . . . . 60.11 114.025 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.12 2.63 19.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.805 1.802 . . . . 74.44 111.794 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.1 t -50.45 -33.03 19.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.64 1.176 . . . . 74.13 113.54 -171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.78 21.9 26.92 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.725 1.155 . . . . 64.51 113.848 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.93 174.22 8.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.213 1.507 . . . . 73.34 108.176 153.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -159.87 85.74 0.76 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.384 0.993 . . . . 74.51 112.717 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.0 m -60.37 117.59 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.734 -0.469 . . . . 73.22 109.734 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.3 mt 51.31 31.03 6.52 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.589 1.156 . . . . 71.52 112.534 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.51 27.67 29.3 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.226 -0.763 . . . . 74.13 113.044 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 t -121.15 84.79 40.57 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.931 1.365 . . . . 75.23 109.619 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.32 177.54 5.17 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.285 2.657 . . . . 75.31 112.018 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.1 tt -132.69 144.4 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.477 -0.764 . . . . 75.44 109.695 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.491 HG21 ' H ' ' A' ' 86' ' ' GLN . 41.3 mm -86.52 142.54 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.507 -0.923 . . . . 75.45 108.507 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.53 -3.91 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 114.691 1.367 . . . . 74.55 114.691 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' H ' HG21 ' A' ' 84' ' ' ILE . 2.1 mm100 -46.45 -51.41 15.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.192 1.797 . . . . 75.13 113.887 -168.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.01 174.34 0.07 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.282 1.433 . . . . 73.51 110.281 -169.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.36 156.2 20.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.753 -1.573 . . . . 72.51 106.753 153.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 168.57 19.64 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.485 1.914 . . . . 74.12 107.043 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.93 158.68 35.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.495 0.589 . . . . 71.12 110.551 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.97 11.62 35.23 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.294 1.438 . . . . 74.31 110.487 164.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.48 158.2 24.6 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.489 1.916 . . . . 72.41 110.638 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.43 19.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.762 1.225 . . . . 75.53 110.899 168.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 . . . . . 0 C--O 1.238 0.456 0 O-C-N 120.328 -1.482 . . . . 72.35 109.472 177.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 CA-C-O 119.24 -0.756 . . . . 73.1 111.519 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 58.66 71.01 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.256 2.222 . . . . 71.14 114.362 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpp -78.51 145.28 35.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.69 1.196 . . . . 63.54 110.661 167.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 55.74 -161.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.083 1.753 . . . . 74.13 113.489 163.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.49 156.71 44.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.06 1.744 . . . . 72.22 106.936 172.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.3 p -113.62 166.58 10.99 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 126.43 1.892 . . . . 73.45 109.514 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -59.8 -9.11 8.79 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 121.533 1.583 . . . . 73.15 113.142 168.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.03 -25.56 8.49 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.311 -1.493 . . . . 72.15 114.174 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -64.35 -21.47 66.63 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.284 1.402 . . . . 63.24 112.842 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -23.93 62.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.558 1.072 . . . . 70.22 112.015 171.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.1 -36.09 15.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.355 1.062 . . . . 72.21 110.097 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.28 59.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.723 1.209 . . . . 71.02 112.221 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -53.84 -33.46 56.3 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.035 0.934 . . . . 73.03 112.562 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -70.84 149.17 47.09 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.878 0.847 . . . . 63.32 110.279 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.0 114.76 45.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 122.279 1.038 . . . . 74.44 108.45 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.93 104.75 14.27 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.471 -1.24 . . . . 73.21 108.829 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -92.27 121.11 33.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.151 -1.426 . . . . 62.45 107.151 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 ttm -125.53 18.79 8.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.267 1.027 . . . . 72.12 111.474 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.11 22.03 3.79 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.617 -1.302 . . . . 74.35 111.725 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.7 mt -77.44 164.51 25.4 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.546 0.573 . . . . 73.02 112.546 -168.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.4 26.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.735 1.214 . . . . 71.43 110.709 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 14.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.143 2.177 . . . . 73.03 114.929 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.91 16.69 2.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.95 1.25 . . . . 71.12 114.153 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.98 145.0 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.639 -1.288 . . . . 74.03 110.965 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -83.61 156.74 65.04 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-O 118.129 -0.939 . . . . 71.33 109.489 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.41 -37.12 74.13 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.138 1.892 . . . . 74.34 111.582 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.14 -28.48 68.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.684 -1.151 . . . . 71.1 111.982 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -33.47 69.72 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.866 1.666 . . . . 71.44 111.024 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.2 -29.75 69.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.458 1.103 . . . . 71.03 110.712 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -92.42 -30.87 15.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.937 0.895 . . . . 73.12 110.526 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.16 -44.68 92.14 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.486 1.514 . . . . 74.14 110.864 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.33 -63.75 1.04 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.487 1.515 . . . . 63.2 109.777 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.02 -22.5 61.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.266 0.469 . . . . 74.5 112.266 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -19.27 64.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.614 1.097 . . . . 74.31 111.443 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.8 p -61.24 -35.31 76.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.332 0.969 . . . . 74.4 111.077 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.0 8.42 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.934 2.494 . . . . 71.0 109.94 -167.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.19 -140.73 6.18 Favored Glycine 0 N--CA 1.442 -0.914 0 O-C-N 120.635 -1.29 . . . . 72.01 110.772 -162.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -152.83 -173.43 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.53 1.932 . . . . 73.11 106.808 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.3 t -143.99 149.35 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 129.712 3.205 . . . . 74.3 106.169 174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -62.89 1.54 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.724 -1.213 . . . . 72.34 107.724 167.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -158.99 162.25 36.76 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.876 -0.787 . . . . 63.42 108.876 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.78 128.67 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.952 1.701 . . . . 74.03 106.457 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -123.35 74.26 1.23 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.417 1.087 . . . . 73.33 109.002 170.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 130.87 35.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.639 2.376 . . . . 51.32 109.665 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.71 74.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.31 -1.737 . . . . 74.24 106.31 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -71.74 91.35 1.13 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.529 -0.915 . . . . 73.01 108.529 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 50.57 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 130.005 3.322 . . . . 71.41 113.645 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 172.81 6.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 120.974 -1.079 . . . . 70.32 109.031 -168.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -44.85 1.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.673 1 C-N-CA 132.683 4.393 . . . . 73.43 120.593 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -142.58 -61.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.203 1.401 . . . . 72.45 109.321 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 174.36 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.508 2.723 . . . . 73.33 109.867 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? 58.08 -164.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.903 1.281 . . . . 74.24 109.174 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -14.31 58.81 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.386 -1.292 . . . . 54.14 113.261 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER 50.39 10.74 0.06 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 117.633 2.457 . . . . 73.21 117.633 -176.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.22 63.43 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 118.934 0.788 . . . . 71.45 111.413 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -135.09 130.32 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 74.14 111.177 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.56 151.4 25.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.747 1.219 . . . . 74.25 111.175 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -127.5 80.99 1.99 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.627 1.171 . . . . 74.25 109.748 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.395 1.5 p -81.8 121.68 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.452 -1.405 . . . . 74.11 110.585 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.66 137.58 33.17 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.637 1.575 . . . . 73.11 109.989 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.46 160.79 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.965 0.888 . . . . 74.04 111.836 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.53 -16.24 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 126.531 1.933 . . . . 73.22 111.209 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -128.56 170.22 13.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.028 1.731 . . . . 71.21 108.806 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.99 -28.35 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.542 1.537 . . . . 72.04 111.032 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -77.89 -14.57 59.51 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.459 -1.401 . . . . 72.42 112.122 -167.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -89.08 -0.49 57.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.139 0.975 . . . . 74.3 112.613 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.86 -56.73 27.09 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 120.83 1.65 . . . . 45.15 109.425 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -14.81 46.0 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.953 1.769 . . . . 73.24 114.166 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.57 -59.61 4.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.218 1.372 . . . . 70.51 108.488 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.95 59.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.379 1.072 . . . . 71.5 112.241 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.41 -54.61 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.964 0.906 . . . . 74.11 108.622 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.52 -0.4 11.82 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.916 -0.936 . . . . 71.41 113.818 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -100.61 1.79 41.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.119 1.959 . . . . 73.33 111.295 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.9 t -49.45 -30.6 8.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.12 1.327 . . . . 73.3 114.344 -173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.38 2.43 56.24 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.405 1.002 . . . . 63.12 114.181 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.96 175.57 8.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.234 1.517 . . . . 73.54 108.517 164.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -152.63 131.76 12.7 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.278 -0.889 . . . . 74.5 110.057 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -83.61 90.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.425 -1.695 . . . . 72.14 106.425 170.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mt 59.81 37.34 21.94 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.869 0.842 . . . . 73.41 110.406 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.72 3.32 58.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.997 1.284 . . . . 74.21 114.581 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.49 85.96 3.21 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.8 1.64 . . . . 74.34 109.801 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.07 -178.31 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.353 2.702 . . . . 73.13 112.608 168.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -134.33 148.75 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.063 0.945 . . . . 70.4 110.233 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 86' ' ' GLN . 46.0 mm -91.27 140.57 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.516 -1.29 . . . . 73.42 107.516 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.8 t -51.19 -18.75 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.917 2.087 . . . . 72.22 114.795 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.49 ' H ' HG22 ' A' ' 84' ' ' ILE . 7.6 mm100 -44.31 -47.41 9.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 125.662 1.585 . . . . 74.34 113.276 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.05 49.86 16.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.707 0.803 . . . . 73.42 112.118 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.307 24.2 p 60.66 -154.97 0.36 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.26 1.424 . . . . 65.54 110.568 -170.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 44.95 -164.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.62 2.768 . . . . 74.31 115.544 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 19.21 0.33 Allowed 'General case' 0 C--N 1.345 0.374 0 N-CA-C 114.226 1.195 . . . . 71.23 114.226 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.94 44.54 30.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.49 0.716 . . . . 74.42 111.837 -162.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -141.87 -63.65 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.796 1.238 . . . . 71.31 110.574 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 44.7 62.9 1.88 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 128.203 2.601 . . . . 74.14 111.785 -166.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 106.39 -1.707 . . . . 73.52 106.39 177.933 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.923 0 N-CA-C 109.903 -1.279 . . . . 73.24 109.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 44.06 45.1 6.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 74.22 112.795 159.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 mtm -80.32 86.2 5.72 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.077 0.941 . . . . 73.32 110.771 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 63.01 61.81 1.08 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 127.089 2.156 . . . . 70.11 110.206 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.91 106.66 0.09 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.779 2.032 . . . . 73.22 111.294 -172.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.0 151.68 73.77 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.352 1.861 . . . . 71.44 113.246 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.11 -16.42 31.98 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.919 2.413 . . . . 74.35 112.659 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.21 -49.75 10.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.252 0.933 . . . . 74.41 109.625 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -59.78 -43.11 94.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.842 0.857 . . . . 74.22 110.497 -175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -56.12 -27.46 54.06 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.625 0.77 . . . . 73.04 112.444 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.11 -16.23 14.32 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.337 1.455 . . . . 73.23 110.437 -167.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.35 -50.5 6.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.833 2.453 . . . . 74.23 111.403 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 61.1 6.12 1.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 72.35 116.224 167.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.1 m -107.54 157.08 18.32 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 119.961 -1.712 . . . . 71.15 109.495 -161.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.78 174.83 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.475 -0.766 . . . . 65.41 109.52 170.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -138.73 133.83 32.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.686 1.594 . . . . 72.44 107.36 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.6 m -127.31 121.99 32.57 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.32 -2.104 . . . . 65.55 105.32 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.3 ttp -125.32 14.31 8.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.11 0.964 . . . . 65.14 111.635 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -139.75 33.77 2.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.045 1.338 . . . . 70.43 109.982 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 mt -64.95 145.04 56.86 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.751 -0.593 . . . . 63.44 110.771 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.6 162.63 20.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.071 0.939 . . . . 64.51 109.496 174.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.17 59.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.446 -1.252 . . . . 71.52 114.31 -166.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -145.87 65.35 1.22 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.489 1.04 . . . . 73.24 108.762 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.9 tt -96.97 163.57 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 122.818 0.447 . . . . 73.32 110.387 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -108.52 155.48 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 125.779 1.632 . . . . 75.33 108.72 168.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 -36.51 93.07 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.396 2.064 . . . . 74.12 111.979 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -60.99 -32.95 72.5 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.962 -1.018 . . . . 74.54 111.612 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -72.52 -11.73 60.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.232 1.378 . . . . 74.13 112.865 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.26 -44.99 9.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.666 -0.865 . . . . 73.44 108.666 169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -65.71 -38.22 88.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.508 0.594 . . . . 73.53 111.518 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.5 -25.8 63.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.112 1.365 . . . . 75.53 112.651 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.28 -64.13 1.02 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.35 -27.68 69.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.78 1.029 . . . . 75.21 113.78 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 p -67.27 -3.22 7.36 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.991 1.269 . . . . 63.22 113.523 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -55.14 -27.88 48.66 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.754 1.161 . . . . 73.43 111.005 165.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -139.83 43.59 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.383 1.073 . . . . 72.21 110.861 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.03 -141.5 8.86 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.014 -1.234 . . . . 72.54 110.014 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.0 157.55 43.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.164 -1.05 . . . . 72.35 108.164 174.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 67.0 t -91.98 163.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.518 -0.739 . . . . 73.13 109.194 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -122.31 -31.16 3.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.037 -1.459 . . . . 72.32 111.582 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -164.18 172.51 13.57 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.841 1.655 . . . . 54.25 109.196 159.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.55 126.0 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.515 1.926 . . . . 74.22 108.014 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.13 175.48 5.51 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.28 1.432 . . . . 74.53 109.929 169.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.3 ptp -166.29 154.93 10.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.898 1.679 . . . . 73.33 109.407 161.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.14 95.48 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.504 0.669 . . . . 72.34 109.923 -172.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.59 61.46 6.28 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 123.336 1.541 . . . . 74.5 108.768 171.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 44.92 178.61 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 131.757 4.023 . . . . 71.51 112.897 -162.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -143.96 -37.75 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.637 1.175 . . . . 74.33 111.305 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -151.91 0.49 0.34 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.196 1.398 . . . . 73.22 111.457 -164.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.99 -171.59 2.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.793 2.437 . . . . 74.51 108.42 -172.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -133.18 83.57 2.07 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.047 -1.464 . . . . 70.12 107.047 161.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -136.14 -59.45 0.74 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.085 1.354 . . . . 73.42 107.779 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 p 43.88 42.79 4.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.548 1.939 . . . . 74.51 113.674 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -66.35 24.96 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.642 2.09 . . . . 61.44 116.642 -166.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 70.68 1.29 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 108.786 -1.726 . . . . 74.42 108.786 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.71 122.73 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.363 1.465 . . . . 71.24 109.795 -168.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.89 150.87 37.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.258 1.023 . . . . 70.14 109.825 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.57 154.83 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.404 -2.073 . . . . 70.52 105.404 161.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.21 118.03 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.962 -2.236 . . . . 72.45 104.962 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -82.76 122.75 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.869 1.267 . . . . 72.44 108.638 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -96.42 176.22 6.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.801 0.81 . . . . 72.53 111.279 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.03 -24.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.358 1.863 . . . . 73.23 112.808 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -133.39 177.37 7.74 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.966 1.706 . . . . 51.44 111.4 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.46 -27.01 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.713 1.205 . . . . 74.11 111.59 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -67.73 -21.78 65.27 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.011 -1.055 . . . . 73.33 112.488 -166.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m -87.56 -9.58 54.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.523 -1.227 . . . . 71.44 113.146 172.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.7 -58.93 8.46 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 122.784 2.538 . . . . 74.35 109.895 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.03 -6.13 18.0 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.492 2.128 . . . . 73.22 114.783 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -70.59 -43.47 69.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.684 1.129 . . . . 72.01 109.395 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -25.61 47.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.999 0.92 . . . . 64.32 112.756 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.51 -46.03 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.976 0.911 . . . . 63.44 109.379 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.36 -1.52 43.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.205 -0.775 . . . . 64.02 113.985 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.26 4.2 33.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.934 1.367 . . . . 74.43 110.867 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -55.09 -20.3 9.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.944 1.298 . . . . 70.23 113.733 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.43 9.86 42.1 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.873 -0.959 . . . . 74.04 113.411 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -81.4 -179.98 7.6 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.754 1.277 . . . . 75.45 110.38 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -159.2 88.61 0.89 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.693 -0.629 . . . . 74.53 109.997 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.28 110.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.098 -1.445 . . . . 73.53 107.098 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.7 mt 55.02 21.5 3.81 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.649 -0.657 . . . . 75.55 112.0 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.98 1.22 27.0 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.398 -1.779 . . . . 70.42 115.047 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.15 85.95 2.97 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 120.723 2.261 . . . . 74.41 111.563 -172.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.42 162.63 29.83 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.343 2.028 . . . . 65.44 112.007 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -117.04 159.74 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.428 1.091 . . . . 74.54 110.288 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.99 144.25 14.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 107.085 -1.45 . . . . 74.25 107.085 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.21 -0.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.063 2.545 . . . . 74.41 115.887 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -61.97 -36.74 82.37 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 114.911 1.448 . . . . 72.24 114.911 -166.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.09 177.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 120.482 1.492 . . . . 71.42 111.227 -169.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p -113.86 139.55 49.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 53.21 108.891 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 49.88 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 128.616 2.766 . . . . 73.12 112.616 -164.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.43 -172.3 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.111 2.164 . . . . 74.05 112.585 -167.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.8 76.74 1.7 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.406 -1.702 . . . . 74.0 106.406 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -130.53 150.62 51.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.524 -0.735 . . . . 73.11 109.537 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.51 63.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.014 -1.847 . . . . 74.2 106.014 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 . . . . . 0 C--O 1.247 0.926 0 N-CA-C 108.004 -1.11 . . . . 74.01 108.004 175.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 109.216 -1.554 . . . . 72.24 109.216 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -134.79 53.51 1.99 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.238 1.415 . . . . 71.02 107.582 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttm -108.8 80.61 1.35 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.212 1.005 . . . . 75.04 110.06 -161.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -67.4 156.28 36.93 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.888 1.675 . . . . 75.23 111.719 -163.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.47 146.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.354 3.062 . . . . 75.23 109.965 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -85.66 163.61 43.4 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.042 -1.661 . . . . 75.32 111.051 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.92 -55.09 1.48 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.012 2.475 . . . . 73.33 112.41 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -53.78 -39.9 65.82 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.132 0.573 . . . . 75.11 112.423 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.22 -47.96 69.29 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.704 -0.623 . . . . 74.31 109.813 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -62.45 -25.48 68.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.481 1.037 . . . . 74.22 111.644 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.24 -60.23 2.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.178 0.899 . . . . 71.45 109.154 166.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.44 -0.6 0.92 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.76 2.024 . . . . 61.52 116.138 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.417 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -57.83 -20.6 37.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.395 1.078 . . . . 74.34 111.407 161.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.7 m -50.84 138.61 18.45 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.276 1.83 . . . . 75.21 109.889 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 m -120.49 118.33 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.19 1.396 . . . . 73.54 109.43 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -68.83 155.67 39.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.894 1.278 . . . . 73.21 109.69 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 p -131.11 158.47 40.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.764 1.626 . . . . 61.52 107.947 162.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -143.29 11.14 1.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.502 0.927 . . . . 64.31 113.502 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -140.45 25.31 2.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.477 1.035 . . . . 73.44 112.391 -163.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.18 165.31 16.29 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.871 -0.518 . . . . 75.12 111.402 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.4 169.64 8.57 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.592 1.157 . . . . 73.22 109.857 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.28 -11.47 60.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.531 1.308 . . . . 60.11 114.531 -171.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 20.29 10.13 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.289 1.404 . . . . 75.54 113.489 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tp -64.48 163.58 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.258 1.023 . . . . 61.22 110.001 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -121.59 157.73 55.88 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.672 1.989 . . . . 74.01 107.528 162.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.84 -41.93 64.31 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 CA-C-N 121.374 1.526 . . . . 64.44 109.838 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.769 1.025 . . . . 73.3 113.769 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.47 -28.19 66.78 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.22 1.373 . . . . 61.24 110.443 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.82 -40.26 16.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.187 1.395 . . . . 72.23 110.615 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.49 -35.63 75.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.589 0.632 . . . . 63.13 110.394 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.47 -51.96 67.65 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.574 1.549 . . . . 72.34 108.242 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -51.45 -57.21 9.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.339 1.056 . . . . 75.33 110.533 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -72.14 -19.57 61.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.274 0.842 . . . . 72.32 113.274 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.0 p -66.05 -18.13 65.14 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.761 0.824 . . . . 61.4 111.37 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.0 p -66.24 -14.57 62.16 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.001 0.371 . . . . 71.52 112.001 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.55 5.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.974 0.909 . . . . 74.32 112.121 -167.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.22 25.82 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.269 -1.532 . . . . 72.24 109.269 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.31 131.9 21.1 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.716 1.246 . . . . 75.43 113.201 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.0 154.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 125.727 1.611 . . . . 64.32 110.303 165.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -96.2 -58.47 2.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.741 1.616 . . . . 74.03 107.963 164.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -158.83 155.02 27.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.633 1.106 . . . . 64.41 110.091 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.64 140.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.307 1.043 . . . . 75.35 109.03 -169.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -142.26 71.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.544 1.138 . . . . 74.44 109.876 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.9 ptp -66.13 158.28 29.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.661 -0.816 . . . . 73.55 108.97 163.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.66 137.04 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.022 -1.473 . . . . 72.42 107.022 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -71.44 87.29 0.87 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.434 -1.321 . . . . 75.05 107.434 168.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.62 156.27 39.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.31 1.444 . . . . 75.11 111.929 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 156.74 18.85 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.254 1.022 . . . . 75.44 113.111 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -44.51 -30.16 0.83 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 130.767 3.627 . . . . 64.43 114.156 172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -55.77 -6.55 0.22 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.626 1.57 . . . . 70.22 113.607 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -156.73 -36.68 0.08 Allowed 'General case' 0 C--N 1.344 0.327 0 O-C-N 119.98 -1.7 . . . . 73.25 111.028 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.477 ' C ' ' H ' ' A' ' 54' ' ' LYS . 9.1 mmm180 45.12 66.55 0.87 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.519 1.527 . . . . 75.42 107.96 -165.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 m -68.92 23.94 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.991 0.737 . . . . 71.34 112.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 52' ' ' ARG 0.404 18.3 ptpt 46.42 24.55 0.31 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.295 2.638 . . . . 75.54 117.314 175.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.33 92.58 0.58 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 120.246 1.384 . . . . 72.53 111.54 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.19 153.98 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.203 1.801 . . . . 73.23 111.102 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.75 166.0 32.7 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.466 1.907 . . . . 62.25 109.273 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -124.08 152.37 42.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 104.868 -2.271 . . . . 75.55 104.868 155.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.356 1.5 p -144.86 115.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.667 -1.27 . . . . 75.02 108.963 175.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -63.24 131.93 50.01 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.416 1.886 . . . . 74.11 106.651 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.68 156.22 20.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.542 0.687 . . . . 73.23 111.004 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.98 -24.74 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.746 -0.661 . . . . 75.11 109.46 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.13 131.88 44.42 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.976 -1.078 . . . . 75.32 110.355 -163.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.417 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 3.3 p -63.92 -31.72 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.922 1.689 . . . . 61.15 110.571 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -41.67 98.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.385 1.474 . . . . 75.43 110.913 -169.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -78.89 -5.47 53.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.394 0.886 . . . . 64.13 113.394 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.97 -56.43 35.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.809 1.64 . . . . 75.34 109.563 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.57 -15.5 45.04 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 CA-C-N 120.58 1.243 . . . . 55.04 112.717 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.6 tp -64.89 -43.93 91.27 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 121.031 1.741 . . . . 64.54 109.757 168.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.82 76.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.378 1.444 . . . . 62.51 111.565 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -58.83 -45.6 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.631 -0.668 . . . . 72.13 109.288 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.28 -8.1 22.56 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.177 1.37 . . . . 75.32 114.109 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -113.97 4.31 15.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.426 1.613 . . . . 73.23 112.358 -172.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.62 -23.54 6.69 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.268 1.027 . . . . 61.51 113.645 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 19.26 35.29 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.86 1.219 . . . . 62.52 112.281 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -101.54 178.85 4.52 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.856 1.328 . . . . 73.12 109.428 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -152.48 95.31 2.01 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.426 1.091 . . . . 74.43 111.718 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.21 110.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.789 -1.189 . . . . 75.54 107.789 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt 50.85 35.22 11.77 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.746 1.218 . . . . 74.4 111.868 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.07 35.03 25.21 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.967 -0.907 . . . . 71.53 113.397 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.64 86.14 56.45 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.831 1.652 . . . . 75.3 108.008 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.83 171.91 12.62 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.505 2.136 . . . . 74.52 111.575 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.64 160.43 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.584 -0.698 . . . . 74.15 110.224 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.439 HG22 ' H ' ' A' ' 86' ' ' GLN . 49.4 mm -98.72 165.72 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.383 -1.34 . . . . 73.41 107.383 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.67 -21.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 117.829 -1.082 . . . . 73.14 113.16 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' H ' HG22 ' A' ' 84' ' ' ILE . 10.6 mt-30 -44.38 -42.94 7.26 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.585 1.698 . . . . 72.21 115.585 -150.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.05 41.53 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 63.25 112.334 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.286 0.0 OUTLIER 47.18 -161.21 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.085 2.154 . . . . 63.44 111.828 -173.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -111.4 -164.78 0.94 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.473 -1.676 . . . . 75.31 106.473 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 157.57 44.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.682 0.674 . . . . 74.43 109.917 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.72 38.55 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.124 2.97 . . . . 62.02 111.463 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -129.77 142.43 50.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.295 1.438 . . . . 74.21 108.593 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.27 139.38 11.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.903 1.228 . . . . 74.53 109.003 172.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.965 0 C-N-CA 128.708 2.803 . . . . 74.52 114.994 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.766 0 N-CA-C 110.139 -1.184 . . . . 74.51 110.139 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -66.43 145.79 55.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 118.864 1.332 . . . . 74.2 107.917 157.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ptm -145.73 -1.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.654 0.613 . . . . 74.41 112.654 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -97.85 172.54 7.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 129.969 3.308 . . . . 72.24 109.529 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.36 156.93 29.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.722 1.209 . . . . 74.4 108.513 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.474 HG21 ' H ' ' A' ' 9' ' ' GLU . 1.7 t -80.53 158.5 71.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.174 1.352 . . . . 70.43 109.98 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.44 -37.28 97.48 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.208 2.605 . . . . 72.12 113.12 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.0 -31.37 58.91 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.739 1.154 . . . . 72.31 111.074 -167.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.474 ' H ' HG21 ' A' ' 6' ' ' THR . 19.7 tp10 -63.95 -41.02 97.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.292 1.437 . . . . 61.44 109.828 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -69.72 -19.99 63.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.431 -0.795 . . . . 74.14 112.237 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -37.46 16.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.377 1.071 . . . . 74.33 110.763 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.66 -58.76 6.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.526 1.53 . . . . 74.33 111.373 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 44.62 63.3 1.73 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.256 2.222 . . . . 74.43 110.244 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.28 148.85 49.66 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 120.859 -1.15 . . . . 74.34 109.278 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.4 114.62 39.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.067 0.937 . . . . 74.1 111.436 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.08 93.31 8.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.414 1.086 . . . . 73.34 109.821 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.17 92.13 5.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.45 -1.25 . . . . 74.22 108.137 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.2 ttp -93.48 14.62 18.13 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.146 0.795 . . . . 72.12 113.146 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -137.79 36.14 2.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.308 -1.495 . . . . 74.12 112.19 -165.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 mt -78.22 145.4 35.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.029 0.932 . . . . 74.31 112.613 -171.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.08 147.85 46.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.377 1.871 . . . . 71.31 109.84 164.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.79 -0.97 6.06 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.321 1.971 . . . . 65.45 116.321 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -122.37 -0.38 9.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.56 1.527 . . . . 73.24 114.248 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.4 150.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.237 1.199 . . . . 74.21 114.237 -159.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -90.35 161.99 35.68 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.397 1.479 . . . . 71.25 109.901 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.79 -53.04 3.59 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.33 2.02 . . . . 73.23 111.795 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -66.15 -18.95 65.67 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.966 0.728 . . . . 72.41 112.966 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.39 -32.99 70.66 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.324 -0.86 . . . . 72.44 110.715 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.67 -52.65 16.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.01 -0.519 . . . . 74.43 109.872 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.69 -23.99 64.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.056 0.847 . . . . 74.43 110.916 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.76 -26.73 63.49 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.107 0.78 . . . . 71.21 113.107 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.34 -36.01 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 74.2 110.757 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.21 -25.74 19.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.513 0.931 . . . . 74.4 113.513 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -61.13 -20.71 62.99 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.417 1.887 . . . . 73.0 114.013 -169.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 t -58.08 -40.56 81.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.004 1.322 . . . . 71.22 108.969 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -148.31 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.18 0.992 . . . . 65.21 109.964 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.01 163.36 25.79 Favored Glycine 0 CA--C 1.521 0.448 0 O-C-N 120.673 -1.267 . . . . 71.03 112.032 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -116.46 124.64 50.46 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.026 0.93 . . . . 72.23 109.18 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -91.43 148.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.5 -1.296 . . . . 65.33 107.5 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -101.31 -46.79 4.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.029 1.731 . . . . 74.24 109.396 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -157.85 -176.99 6.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.012 0.824 . . . . 74.31 111.088 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.98 97.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.628 1.571 . . . . 74.43 108.411 -159.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -119.16 131.07 55.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.718 1.145 . . . . 73.42 110.161 -167.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.45 164.59 27.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.261 1.578 . . . . 70.02 115.261 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.87 73.3 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.666 -1.235 . . . . 74.05 107.666 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.5 m -75.54 84.48 2.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.276 1.03 . . . . 62.42 108.738 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -177.05 3.24 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.1 -1.815 . . . . 63.02 106.1 156.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.0 mtp85 -58.71 -65.75 0.61 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.082 0.953 . . . . 73.35 109.268 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.78 -44.54 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.14 1.376 . . . . 73.14 109.376 -165.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.5 t 52.31 -85.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.896 1.678 . . . . 74.23 110.819 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -158.39 19.64 0.23 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.173 1.351 . . . . 73.11 110.834 159.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -171.5 2.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 74.44 113.514 -168.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -53.73 -12.02 0.46 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.488 1.915 . . . . 72.44 114.106 166.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 55.79 20.93 4.36 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.981 1.713 . . . . 73.33 114.216 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.89 91.27 0.09 OUTLIER Glycine 0 C--N 1.336 0.548 0 O-C-N 120.356 -1.465 . . . . 71.24 113.482 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.9 134.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.503 1.121 . . . . 73.24 110.094 -171.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.37 43.41 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.682 1.193 . . . . 74.01 111.819 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -120.98 108.6 14.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.229 1.812 . . . . 74.23 106.27 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.91 121.73 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.326 -1.361 . . . . 70.22 107.326 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -86.58 116.98 25.05 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.495 1.518 . . . . 74.02 109.072 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.71 162.47 18.74 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.485 1.514 . . . . 74.41 112.961 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 t -83.87 -20.34 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.046 1.339 . . . . 73.12 112.525 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.0 156.12 45.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.909 -1.145 . . . . 74.21 107.909 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.13 -26.27 36.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 123.456 0.473 . . . . 73.03 110.576 172.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -61.81 -36.86 82.38 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.045 -1.034 . . . . 65.04 113.626 -164.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 m -82.16 -5.45 58.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.617 1.099 . . . . 73.3 113.696 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.83 -57.97 18.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 119.997 1.272 . . . . 72.31 110.846 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.15 -15.86 52.26 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.966 1.778 . . . . 72.11 113.206 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.86 -45.54 81.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.351 0.978 . . . . 74.0 109.318 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.91 71.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.412 0.685 . . . . 73.11 111.14 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.51 -32.1 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.589 -0.694 . . . . 65.42 109.882 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.96 0.35 7.62 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.53 1.538 . . . . 71.1 114.23 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.82 11.74 3.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.038 1.735 . . . . 72.2 112.209 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -50.35 -29.55 10.21 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 121.123 1.783 . . . . 70.33 114.133 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.51 -16.02 55.89 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.826 -0.986 . . . . 71.11 112.894 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -70.7 170.88 11.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.646 1.223 . . . . 65.44 109.866 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -157.43 128.32 6.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.509 0.724 . . . . 73.21 109.219 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.3 t -84.71 94.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.262 -2.125 . . . . 73.1 105.262 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 mt 65.93 23.23 11.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.372 1.069 . . . . 65.03 112.93 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.07 11.8 29.01 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.82 -0.55 . . . . 63.05 113.16 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.5 t -113.05 83.59 6.27 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 126.078 1.751 . . . . 72.24 108.853 174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 176.29 8.36 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.225 2.617 . . . . 73.34 111.796 166.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.97 177.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.724 1.21 . . . . 72.23 108.926 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.472 HG22 ' H ' ' A' ' 86' ' ' GLN . 34.1 mm -123.75 139.12 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.558 1.143 . . . . 72.15 108.908 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -44.73 -18.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 130.476 3.51 . . . . 72.32 115.968 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.472 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.3 mt-30 -53.22 -58.34 7.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.716 1.143 . . . . 73.12 110.937 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.06 50.15 18.52 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 125.264 1.603 . . . . 73.43 110.491 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER 52.46 -154.16 0.21 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.294 1.438 . . . . 72.22 111.138 -174.221 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -55.44 131.05 45.01 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.989 -1.115 . . . . 72.3 107.989 159.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 24.6 1.47 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.871 1.669 . . . . 51.14 109.218 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 24.68 2.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 72.41 112.186 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 -176.07 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.73 1.212 . . . . 74.11 110.924 -166.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -137.07 61.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.607 1.963 . . . . 65.4 109.657 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.28 -1.343 . . . . 74.14 108.376 -171.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 108.922 -1.671 . . . . 74.43 108.922 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 44.12 66.02 0.92 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 72.04 112.397 168.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttp -148.15 166.63 27.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.446 -1.687 . . . . 70.44 106.446 171.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 57.88 -158.87 0.27 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.506 1.122 . . . . 73.04 109.723 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.24 143.22 50.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.188 2.195 . . . . 74.05 105.87 162.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.0 165.95 45.35 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 123.727 0.811 . . . . 63.34 111.555 -175.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -53.84 -40.28 81.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.446 1.431 . . . . 72.03 110.702 160.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.276 6.2 pt-20 -77.51 -40.96 40.99 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.906 1.682 . . . . 73.03 113.385 -165.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -50.83 -45.91 59.79 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.583 1.538 . . . . 70.33 111.844 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.4 -16.14 61.34 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.955 -1.091 . . . . 73.35 112.974 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -34.72 15.95 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.27 1.428 . . . . 65.24 110.579 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.98 2.98 18.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.415 2.686 . . . . 65.52 112.782 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -7.93 4.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.198 2.599 . . . . 70.23 114.708 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -102.08 145.98 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.591 1.156 . . . . 74.31 108.75 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.26 118.34 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.779 -0.823 . . . . 74.45 108.779 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -72.82 113.06 9.44 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.335 1.054 . . . . 71.54 108.721 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.9 m -98.95 129.95 45.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.519 1.528 . . . . 70.2 107.469 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.6 ttp -127.44 175.85 7.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.09 1.756 . . . . 74.23 107.615 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 64.1 20.83 12.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.808 1.643 . . . . 74.44 113.525 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -72.6 168.73 18.03 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.744 0.817 . . . . 73.24 111.227 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.52 166.13 11.25 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.079 1.14 . . . . 72.13 114.079 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.62 23.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 64.32 112.231 169.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -135.68 76.78 1.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 106.688 -1.597 . . . . 71.22 106.688 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -140.77 165.38 20.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 124.071 0.948 . . . . 71.23 108.796 168.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -117.51 157.92 46.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 126.64 1.976 . . . . 75.5 107.408 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -55.32 2.56 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.235 1.957 . . . . 75.44 111.94 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -63.48 -21.74 66.49 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.595 -0.717 . . . . 63.33 112.274 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.3 -19.02 62.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.948 1.249 . . . . 74.41 110.35 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.887 1.221 . . . . 73.5 110.781 169.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -69.54 -37.83 77.24 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.864 -0.421 . . . . 73.23 109.864 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.47 -26.71 68.06 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.307 1.043 . . . . 72.53 112.339 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.73 -16.49 64.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.23 1.012 . . . . 74.52 113.37 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.66 -26.45 8.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.475 0.71 . . . . 72.51 111.22 173.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.5 t -53.78 -18.64 3.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.666 1.987 . . . . 71.22 111.949 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.465 ' HG1' HG23 ' A' ' 36' ' ' VAL . 34.4 p -46.31 -41.89 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.493 1.517 . . . . 74.42 111.12 169.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.465 HG23 ' HG1' ' A' ' 35' ' ' THR . 1.9 m -150.77 46.24 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.135 1.774 . . . . 74.42 108.269 -170.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.46 178.03 48.32 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 124.274 0.94 . . . . 73.35 110.865 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -137.83 134.1 34.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.333 1.453 . . . . 74.11 107.796 169.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' PHE 0.276 1.8 p -118.28 143.25 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.048 1.339 . . . . 73.34 109.562 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -77.29 -50.28 13.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.4 1.88 . . . . 63.32 108.284 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -168.58 -178.49 3.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.096 0.558 . . . . 75.22 110.938 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.34 152.48 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.366 1.466 . . . . 75.12 109.024 174.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -125.93 101.34 6.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.513 1.925 . . . . 75.22 106.803 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.3 mtp -95.21 142.12 28.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.116 0.966 . . . . 74.54 110.819 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -143.29 54.82 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 72.4 113.36 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 t -94.91 4.8 53.39 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.711 -1.868 . . . . 70.13 111.562 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.74 36.88 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.798 1.639 . . . . 74.4 110.122 -170.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -116.39 160.71 20.15 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 120.657 -1.277 . . . . 72.14 108.368 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -122.83 58.36 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.636 1.975 . . . . 73.34 108.343 -171.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 52' ' ' ARG . 2.9 t -161.32 174.25 13.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.741 -1.118 . . . . 73.2 109.453 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -78.29 17.29 0.65 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.05 1.34 . . . . 71.44 111.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 50' ' ' SER . 10.6 mtt180 -44.8 -65.14 0.57 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.071 2.948 . . . . 72.2 109.762 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -169.45 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.573 0.953 . . . . 73.32 113.573 -172.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt 44.56 50.25 8.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.753 2.021 . . . . 72.24 113.941 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.28 66.06 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 109.534 -1.427 . . . . 74.13 109.534 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 pt -139.8 146.6 24.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.838 1.255 . . . . 74.53 108.555 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.38 44.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.371 1.068 . . . . 63.2 108.907 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -123.85 127.91 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.661 -1.607 . . . . 71.4 106.661 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.05 112.18 39.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.8 -1.555 . . . . 74.42 106.8 -167.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -92.41 91.87 7.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.855 1.262 . . . . 72.13 108.01 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -56.08 177.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.043 1.337 . . . . 74.43 113.91 175.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.77 -31.12 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 O-C-N 120.448 -1.407 . . . . 73.33 110.917 168.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -117.18 175.66 5.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.475 1.489 . . . . 64.15 110.443 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.64 -27.04 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 118.836 0.744 . . . . 73.43 111.246 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -67.4 -22.18 65.55 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.558 -1.339 . . . . 72.32 112.038 -171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -5.2 57.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.945 1.091 . . . . 74.34 113.945 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.46 -55.53 39.07 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.32 1.418 . . . . 63.32 109.459 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.8 -10.32 28.41 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.849 . . . . 74.22 113.925 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.65 -59.38 3.65 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 120.082 1.31 . . . . 74.35 108.218 166.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.34 -29.43 67.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.814 0.846 . . . . 71.21 113.007 -175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.68 -26.27 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.848 1.259 . . . . 70.33 110.568 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.61 80.9 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.559 1.552 . . . . 74.25 114.112 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -87.66 -4.06 58.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.157 1.479 . . . . 72.11 114.194 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.0 t -50.86 -21.35 1.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.364 1.987 . . . . 71.23 116.364 -160.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.4 -12.79 59.35 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.724 -1.235 . . . . 62.14 113.635 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -77.04 165.13 25.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.673 1.236 . . . . 74.52 110.451 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -140.76 88.35 2.18 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.137 1.775 . . . . 73.22 109.531 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.56 100.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.145 0.978 . . . . 74.23 109.002 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 mt 49.06 33.23 4.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.836 0.827 . . . . 73.24 111.275 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.74 5.94 62.59 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.536 -1.147 . . . . 64.14 114.157 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 t -105.5 86.46 1.75 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.702 2.001 . . . . 71.24 108.882 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.84 176.9 6.21 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.942 3.095 . . . . 65.43 112.404 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.58 151.06 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.496 0.665 . . . . 73.44 110.214 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.2 mm -106.28 156.13 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.295 1.438 . . . . 73.24 108.368 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 m -74.07 -0.78 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 114.904 1.446 . . . . 73.53 114.904 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -45.78 -60.33 2.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.033 1.123 . . . . 63.31 114.033 -165.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.79 157.37 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.999 1.319 . . . . 72.13 112.086 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -88.46 143.81 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.081 -1.452 . . . . 74.51 107.081 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 44.28 69.01 0.46 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.937 2.095 . . . . 71.42 112.874 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.81 159.2 44.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.564 0.745 . . . . 70.43 112.045 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -85.62 19.18 2.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.736 1.214 . . . . 70.05 110.748 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.02 -9.6 42.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 119.886 -1.759 . . . . 73.01 112.669 -173.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -84.19 71.66 10.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.972 1.309 . . . . 72.45 108.345 -171.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.135 1.774 . . . . 74.02 106.739 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 CA-C-O 119.255 -0.747 . . . . 73.41 111.413 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.65 60.89 3.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.612 1.165 . . . . 73.14 109.641 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.275 1.0 OUTLIER 45.07 11.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.446 3.499 . . . . 74.14 117.948 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -123.02 140.89 52.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.371 1.068 . . . . 72.13 108.927 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.0 134.97 46.22 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.089 1.356 . . . . 74.52 108.462 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.58 165.06 20.91 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 121.153 0.501 . . . . 73.12 110.346 171.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.0 -47.77 1.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.408 2.072 . . . . 53.4 110.315 167.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.17 -49.01 77.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.397 1.079 . . . . 73.42 111.149 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.98 -44.05 63.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.912 0.885 . . . . 74.31 111.378 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -63.99 -37.34 87.07 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.201 -0.937 . . . . 74.31 111.649 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -16.93 55.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 119.206 -0.426 . . . . 74.5 111.381 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.3 -48.51 5.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.884 2.074 . . . . 72.4 111.936 -174.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.2 mtt85 54.82 10.02 0.34 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.195 2.598 . . . . 74.5 117.336 166.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -110.62 153.73 24.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.751 1.16 . . . . 70.24 110.279 -164.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.604 1.562 . . . . 70.34 109.744 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.49 114.16 24.64 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.295 2.638 . . . . 74.01 110.876 -166.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.3 130.48 34.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.471 -0.566 . . . . 74.12 109.471 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -127.77 48.67 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.036 0.934 . . . . 75.42 111.695 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 11.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.129 -0.982 . . . . 74.22 113.128 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 168.6 8.78 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.809 -1.182 . . . . 73.01 113.264 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.87 170.57 9.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.226 -1.352 . . . . 70.42 113.194 -167.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.12 -12.43 61.49 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.634 1.574 . . . . 73.13 115.178 -161.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -134.47 31.01 3.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.369 0.986 . . . . 73.34 111.286 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.65 165.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.54 -0.541 . . . . 74.43 109.54 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -122.63 161.92 41.21 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.704 1.602 . . . . 74.42 109.038 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.86 -54.28 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.862 1.708 . . . . 74.12 109.535 165.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -38.73 69.01 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.53 -0.748 . . . . 74.14 111.985 -175.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.7 -34.14 72.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.591 1.087 . . . . 73.33 111.396 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.79 -10.27 59.76 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.442 0.697 . . . . 70.23 112.348 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.18 -31.66 7.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.407 1.083 . . . . 74.12 109.777 174.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -70.24 -30.86 68.03 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.554 1.542 . . . . 65.43 112.494 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -62.41 -26.04 68.27 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.079 -1.013 . . . . 74.44 111.693 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.43 -12.05 16.75 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.439 -0.791 . . . . 73.01 112.641 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.5 p -62.8 -19.59 64.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.75 1.614 . . . . 73.23 112.117 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 p -64.81 -23.71 67.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.781 1.232 . . . . 73.43 110.926 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 8.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.593 1.557 . . . . 73.44 112.3 -166.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.61 45.74 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.658 -1.276 . . . . 54.33 111.708 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.88 141.96 50.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.686 1.594 . . . . 70.32 107.856 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.97 145.96 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.801 1.241 . . . . 72.14 109.295 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -87.58 -46.82 9.21 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.908 -1.496 . . . . 73.22 111.042 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -169.52 174.78 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.781 0.719 . . . . 73.13 109.798 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -125.87 145.46 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 73.15 109.694 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -117.38 98.1 6.24 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.108 1.763 . . . . 74.14 107.167 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.27 149.55 21.15 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.808 -1.182 . . . . 63.11 107.808 170.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.94 97.22 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.604 -1.628 . . . . 71.45 106.604 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.0 m -152.26 99.41 2.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.706 -1.59 . . . . 71.42 106.706 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -160.67 12.28 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.126 1.37 . . . . 75.13 111.745 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -115.26 -83.18 0.62 Allowed 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.24 -0.912 . . . . 72.24 108.583 -160.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.34 -5.12 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.497 1.119 . . . . 73.45 112.582 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.06 40.93 10.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.978 1.473 . . . . 73.03 114.978 166.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -149.63 27.08 0.82 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.45 1.9 . . . . 75.41 109.671 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.53 -85.15 0.47 Allowed 'General case' 0 CA--C 1.523 -0.096 0 O-C-N 120.591 -1.318 . . . . 63.05 107.99 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.5 m -148.77 48.32 1.01 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.331 1.452 . . . . 74.02 109.972 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -7.09 5.13 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.147 1.536 . . . . 73.22 115.147 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.52 77.24 2.12 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 119.994 1.27 . . . . 62.01 110.512 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -153.96 136.65 6.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 125.579 1.552 . . . . 73.14 109.128 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.57 151.19 30.36 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.544 1.137 . . . . 73.02 110.452 169.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -128.01 138.48 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.555 -1.646 . . . . 73.03 106.555 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.66 112.94 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.174 1.39 . . . . 73.1 108.258 -160.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.61 81.54 8.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.36 1.076 . . . . 71.4 109.987 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.19 150.17 4.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.858 1.263 . . . . 73.42 113.844 171.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.59 -24.04 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.657 . . . . 64.11 110.062 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -132.26 143.79 50.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.736 1.607 . . . . 70.33 113.15 173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.2 -30.61 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.157 1.383 . . . . 64.5 111.344 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -66.28 -15.77 63.48 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.077 -1.014 . . . . 70.51 111.281 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 m -88.27 -6.67 57.65 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.476 1.287 . . . . 74.31 114.476 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -53.81 -56.7 22.65 Favored Pre-proline 0 N--CA 1.473 0.708 0 CA-C-N 121.85 2.113 . . . . 73.12 109.83 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -6.44 17.29 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 121.779 1.653 . . . . 74.2 114.335 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.33 -52.48 39.8 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.195 -1.565 . . . . 73.51 108.299 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.15 -23.65 65.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.645 0.778 . . . . 74.13 112.564 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.01 -45.62 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.921 1.289 . . . . 62.1 109.595 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.11 -2.6 48.38 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.951 -0.916 . . . . 64.21 113.247 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.99 2.82 55.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.323 1.562 . . . . 73.11 111.258 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -56.72 -20.87 24.12 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.541 1.064 . . . . 72.31 113.326 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.15 23.26 14.34 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.638 2.066 . . . . 51.24 112.045 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -118.35 175.58 5.64 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 128.699 2.8 . . . . 73.02 109.795 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -152.11 127.29 9.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.308 1.843 . . . . 74.15 108.602 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.5 101.0 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.889 -1.522 . . . . 73.01 106.889 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mt 64.22 -8.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.88 2.872 . . . . 73.44 116.662 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.24 -3.34 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.187 -1.006 . . . . 74.13 113.498 -160.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.12 85.25 12.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.872 2.069 . . . . 72.35 106.315 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.99 178.7 2.23 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.718 2.945 . . . . 73.43 111.92 175.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tt -137.38 161.47 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.27 1.028 . . . . 65.04 109.944 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.5 mm -101.62 158.08 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.283 -1.377 . . . . 74.05 107.283 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.92 -1.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.295 1.838 . . . . 75.24 114.877 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -46.1 67.03 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.128 -0.982 . . . . 74.0 113.278 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.96 29.79 2.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.618 1.71 . . . . 74.1 115.618 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.82 -168.49 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.787 2.035 . . . . 73.24 112.383 -173.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 47.04 47.51 15.95 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.298 2.239 . . . . 75.31 113.939 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.77 156.59 16.59 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.394 1.078 . . . . 52.04 110.98 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.84 8.86 2.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 128.639 2.776 . . . . 73.34 113.859 -169.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -66.18 -18.19 65.19 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.451 -1.406 . . . . 73.14 113.297 -170.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -79.0 71.06 5.44 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.727 2.011 . . . . 73.43 112.344 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 . . . . . 0 C--O 1.246 0.896 0 C-N-CA 124.528 1.131 . . . . 72.2 109.83 171.497 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 CA-C-O 118.568 -1.129 . . . . 73.33 111.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 47.09 80.5 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.243 1.817 . . . . 64.41 111.587 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.2 mtp -132.51 -59.71 0.9 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.001 0.92 . . . . 74.43 110.046 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -123.71 152.27 42.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.913 0.885 . . . . 75.5 109.499 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.35 127.64 32.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.402 1.481 . . . . 72.42 109.03 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.55 158.29 76.27 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.91 1.232 . . . . 75.33 108.903 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.76 -30.59 78.21 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.261 1.974 . . . . 74.51 111.858 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -71.09 -36.92 72.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.929 0.786 . . . . 73.14 109.858 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -55.99 -44.97 79.12 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.563 -0.71 . . . . 72.51 110.121 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -69.21 -15.02 63.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.089 -0.958 . . . . 75.13 112.838 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.57 -51.57 8.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.398 0.999 . . . . 74.52 109.329 160.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.57 40.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.674 2.39 . . . . 54.03 115.275 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.454 HH11 ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -86.27 3.01 45.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.377 1.871 . . . . 74.1 113.31 175.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 152.73 43.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.885 1.274 . . . . 74.3 110.482 -171.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.26 170.1 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.626 -1.25 . . . . 72.44 107.626 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -138.31 104.26 5.13 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.292 1.437 . . . . 74.33 109.332 -171.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.73 75.29 8.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.615 1.966 . . . . 73.34 110.201 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -81.38 25.07 0.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.302 0.853 . . . . 75.31 113.302 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -148.78 48.46 1.01 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.131 -1.606 . . . . 75.3 112.627 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.6 mt -79.15 166.75 21.89 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.558 0.947 . . . . 74.0 113.558 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.76 -160.72 0.79 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.554 2.342 . . . . 55.32 110.859 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.45 -20.99 11.09 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.938 1.829 . . . . 74.2 115.938 -164.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -129.62 44.3 2.99 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.478 1.608 . . . . 74.34 108.33 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.38 140.71 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.251 -1.341 . . . . 74.4 107.914 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.81 161.8 32.79 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 124.251 1.02 . . . . 72.13 108.549 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.41 -37.48 89.66 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.055 1.17 . . . . 62.24 110.1 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -58.29 -31.82 67.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.56 -1.21 . . . . 75.01 113.294 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.11 -34.95 75.78 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 120.496 1.498 . . . . 73.24 110.121 -171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.14 -32.26 70.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.344 1.057 . . . . 75.14 111.833 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.85 -7.65 23.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 117.998 -1.001 . . . . 64.01 112.541 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -37.27 18.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.917 1.235 . . . . 74.0 108.566 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.54 -39.05 64.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.665 0.786 . . . . 73.1 112.377 -174.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -106.73 2.2 25.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.426 -0.797 . . . . 75.43 112.278 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.7 p -74.62 -10.66 59.75 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 120.422 1.464 . . . . 73.31 112.076 170.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -44.93 -52.05 9.1 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.779 2.032 . . . . 71.24 109.765 165.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.18 57.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 64.31 108.299 -171.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.58 164.42 28.76 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.209 -0.932 . . . . 73.42 113.528 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -123.53 131.19 53.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.798 1.239 . . . . 75.2 109.456 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -88.52 138.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.313 1.445 . . . . 73.5 107.848 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -76.91 -51.78 10.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.489 -0.93 . . . . 55.44 108.489 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -162.47 -172.74 3.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.194 1.797 . . . . 55.04 107.564 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.25 93.98 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 119.823 1.192 . . . . 71.14 110.454 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.93 163.14 22.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.376 1.084 . . . . 74.11 110.684 163.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.59 136.19 11.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 127.914 2.486 . . . . 74.33 105.751 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.56 99.8 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.777 -1.934 . . . . 60.23 105.777 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 m -72.85 66.37 0.77 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.855 1.662 . . . . 74.0 111.317 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.251 0.4 OUTLIER 49.34 174.41 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 131.89 4.076 . . . . 73.11 115.64 -164.761 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -101.58 -75.18 0.6 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.742 -1.572 . . . . 72.13 107.45 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -141.93 -11.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.745 1.218 . . . . 51.33 112.34 -167.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.4 m -137.62 -86.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.568 -0.901 . . . . 71.41 108.568 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -172.98 33.68 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.205 3.002 . . . . 74.21 107.464 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.74 82.85 1.96 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.085 2.154 . . . . 74.44 110.241 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -22.69 56.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.72 -0.657 . . . . 74.4 111.83 167.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt 73.78 34.85 0.88 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.404 1.481 . . . . 73.32 111.846 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.19 65.17 2.53 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 125.846 1.688 . . . . 73.31 111.871 162.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.24 143.6 27.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.163 0.985 . . . . 72.24 110.099 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.0 156.64 41.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.7 2.0 . . . . 73.41 106.462 159.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -116.56 142.57 46.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 104.317 -2.475 . . . . 75.11 104.317 162.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.04 115.91 44.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.356 -2.091 . . . . 75.03 105.356 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -73.36 126.36 29.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.668 0.747 . . . . 64.2 109.507 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.75 166.67 10.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.658 1.183 . . . . 75.33 110.911 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.86 -14.37 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.513 0.725 . . . . 62.34 111.561 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -138.16 168.64 19.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.517 -1.364 . . . . 75.5 108.876 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 13' ' ' ARG . 3.6 p -76.71 -43.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.173 -0.918 . . . . 61.4 108.608 167.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -64.99 -29.89 70.84 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.623 1.101 . . . . 75.2 113.681 -152.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -74.21 -8.14 55.15 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.536 0.939 . . . . 54.2 113.536 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -62.96 4.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 119.695 -1.878 . . . . 74.4 108.737 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.58 -10.83 29.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.948 1.374 . . . . 75.51 113.134 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.9 -54.32 13.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.531 1.06 . . . . 73.13 109.621 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.91 -30.18 63.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.942 1.297 . . . . 72.4 112.415 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.04 -49.14 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.487 1.115 . . . . 75.34 108.615 172.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.23 7.83 3.16 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.079 1.323 . . . . 73.41 114.484 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' CD2' HE21 ' A' ' 76' ' ' GLN . 70.2 mt -117.05 4.88 12.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.799 1.799 . . . . 72.22 111.001 170.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -49.91 -30.41 10.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.449 1.477 . . . . 72.0 111.932 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.57 18.64 54.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 125.115 1.34 . . . . 55.42 113.079 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.438 HE21 ' CD2' ' A' ' 73' ' ' LEU . 7.2 mt-30 -127.05 165.05 20.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.455 1.502 . . . . 74.14 107.674 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -149.17 130.51 14.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.29 0.636 . . . . 73.23 109.59 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.97 104.34 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 106.205 -1.776 . . . . 73.32 106.205 164.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt 59.91 19.28 8.27 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.625 1.57 . . . . 74.43 113.566 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.45 1.94 29.36 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.545 -0.586 . . . . 74.42 114.298 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -104.86 86.05 1.38 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.253 1.821 . . . . 73.44 107.209 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.14 179.07 3.07 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.672 2.248 . . . . 75.34 111.032 163.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 tt -121.34 175.86 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.708 1.203 . . . . 74.4 108.466 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 147.32 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.131 1.772 . . . . 75.34 106.848 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 t -55.55 -15.13 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.623 2.769 . . . . 71.2 115.646 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -44.61 -42.52 7.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.049 1.499 . . . . 73.1 115.049 -168.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.35 175.53 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.91 1.338 . . . . 63.54 109.294 -160.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -91.09 124.4 35.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.597 -2.372 . . . . 75.43 104.597 157.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -122.49 147.28 46.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.805 -1.183 . . . . 72.13 107.805 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 92' ' ' LYS . . . -78.63 168.5 19.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.531 1.144 . . . . 74.2 111.722 -174.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.84 26.64 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.761 2.025 . . . . 64.5 111.848 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 90' ' ' ALA . 77.1 mttt -113.9 -3.47 13.4 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.439 1.896 . . . . 74.13 112.712 -170.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.2 -6.35 57.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.065 -0.493 . . . . 74.21 111.841 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.268 2.227 . . . . 72.22 109.875 -164.229 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 111.22 -0.752 . . . . 72.03 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.9 112.89 4.24 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.738 2.015 . . . . 74.31 105.703 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.6 mtp -139.51 -85.46 0.23 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.062 0.847 . . . . 54.55 108.748 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -64.38 148.42 50.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.446 -0.576 . . . . 71.23 109.446 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.8 tp -79.56 136.55 36.9 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.11 -1.071 . . . . 73.21 108.11 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -70.55 159.72 84.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 123.724 0.81 . . . . 74.03 110.254 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.36 -46.57 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.565 1.51 . . . . 73.13 110.179 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.2 -27.82 68.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.461 1.504 . . . . 74.32 112.064 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.22 -45.03 58.54 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.725 -0.609 . . . . 73.33 110.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -74.24 -33.6 63.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.453 0.569 . . . . 73.24 111.456 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.81 -33.9 77.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.497 0.719 . . . . 72.03 110.575 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.94 26.9 2.28 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.766 1.227 . . . . 73.03 112.698 -170.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.432 ' HE ' ' N ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -71.3 14.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.971 2.108 . . . . 71.31 115.404 -174.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.38 131.69 55.89 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.975 -1.078 . . . . 72.35 112.011 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.61 178.02 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.176 1.79 . . . . 73.15 109.496 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -145.76 117.75 8.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.917 1.287 . . . . 72.14 110.359 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -95.96 134.66 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.643 -1.243 . . . . 73.32 107.643 164.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.6 ttm -131.88 31.51 4.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 71.15 111.047 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -145.18 25.04 1.41 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.582 -1.323 . . . . 74.14 112.11 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.99 166.69 23.13 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.069 -1.02 . . . . 72.14 113.618 -164.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.96 169.59 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.573 1.149 . . . . 61.45 112.168 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -49.13 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.948 1.299 . . . . 73.14 111.925 162.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -92.46 19.83 6.83 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.103 0.961 . . . . 74.45 112.524 -167.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.6 tt -64.23 163.23 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.441 0.696 . . . . 74.44 109.78 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -118.49 160.35 40.22 Favored Pre-proline 0 CA--C 1.519 -0.244 0 C-N-CA 125.11 1.364 . . . . 72.33 108.965 167.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.93 -29.85 87.82 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.605 1.537 . . . . 70.05 112.352 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -78.55 -18.78 54.17 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 117.662 -1.161 . . . . 74.01 113.309 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -33.61 73.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.339 1.427 . . . . 71.42 110.212 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.44 -44.97 61.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.238 1.015 . . . . 74.32 110.792 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.13 -41.62 85.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.448 -0.901 . . . . 65.11 108.727 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.02 -39.95 87.6 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.84 0.745 . . . . 73.14 112.571 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -55.76 -57.44 12.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.626 -0.879 . . . . 73.04 108.626 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.36 -25.14 60.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.144 0.794 . . . . 73.15 113.144 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -63.03 -11.45 19.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.96 1.304 . . . . 71.41 112.05 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 p -67.33 -21.46 65.65 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.846 1.657 . . . . 71.45 110.943 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.3 -0.57 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.819 0.848 . . . . 74.04 113.148 -165.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.78 146.08 6.43 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.906 -1.278 . . . . 70.32 109.906 165.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -63.95 148.87 48.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.916 0.358 . . . . 72.34 111.643 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.2 145.77 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 126.225 1.81 . . . . 65.15 108.14 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -84.68 -52.81 5.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.862 -1.066 . . . . 71.01 108.178 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -169.43 170.06 8.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.735 1.214 . . . . 64.01 110.63 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -100.52 165.64 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.014 1.726 . . . . 74.21 111.194 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -149.87 50.72 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.139 0.971 . . . . 74.42 109.859 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -66.78 120.65 13.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.242 2.217 . . . . 70.44 110.295 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.69 122.14 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.78 0.832 . . . . 74.03 109.051 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -87.69 4.85 42.49 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.006 0.743 . . . . 73.14 113.006 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -89.99 125.65 35.46 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.729 -1.582 . . . . 74.35 106.729 177.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -130.51 -71.0 0.6 Allowed 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.53 -0.915 . . . . 73.51 108.53 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.3 21.62 0.84 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.072 1.749 . . . . 72.45 112.289 -171.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.52 4.13 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.253 2.621 . . . . 65.33 115.148 -170.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.8 37.32 0.72 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 119.889 -1.757 . . . . 74.52 112.989 -158.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -132.51 -24.93 1.97 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.5 0.72 . . . . 74.33 112.006 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.4 p -172.92 -58.35 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.873 0.469 . . . . 74.11 111.445 -159.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt 56.24 81.47 0.13 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.208 2.203 . . . . 65.13 112.746 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.33 59.82 0.71 Allowed Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.711 -0.956 . . . . 51.25 110.711 161.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 pt -117.08 142.95 28.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.353 1.461 . . . . 74.24 109.835 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.84 150.12 36.57 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.083 1.353 . . . . 70.35 108.027 160.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -117.74 157.87 25.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.651 -1.981 . . . . 73.45 105.651 158.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.41 144.54 3.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.841 2.056 . . . . 74.43 106.327 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -111.72 119.73 39.64 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.748 1.619 . . . . 74.11 107.547 -165.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -80.47 173.92 12.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.66 0.743 . . . . 70.12 111.394 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.96 -32.12 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.467 -0.771 . . . . 74.25 108.974 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 4.8 m-20 -129.72 120.98 26.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.488 1.115 . . . . 74.01 108.462 -166.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 7.3 p -45.67 -34.59 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 129.06 2.944 . . . . 74.35 111.206 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 m -64.65 -18.87 65.34 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.929 -1.732 . . . . 74.01 112.83 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -1.77 24.09 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.6 -61.34 8.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 120.988 1.722 . . . . 74.24 109.273 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.44 -17.93 60.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.625 . . . . 73.44 113.703 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.37 -56.55 20.58 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.722 1.146 . . . . 72.01 110.343 172.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.57 80.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.39 0.676 . . . . 73.04 111.279 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.98 -47.67 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.654 1.182 . . . . 72.12 109.213 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.98 -22.25 34.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.999 0.809 . . . . 72.35 114.155 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -99.12 12.56 35.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.296 -1.12 . . . . 74.14 111.839 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.4 t -49.12 -26.39 2.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.434 1.094 . . . . 74.24 113.83 177.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -9.02 60.34 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.767 0.699 . . . . 73.44 114.502 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.38 163.49 26.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.505 1.153 . . . . 62.43 108.254 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -153.33 74.52 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.881 0.472 . . . . 71.15 110.633 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 t -53.16 103.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.925 1.69 . . . . 73.41 108.358 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt 54.72 29.57 11.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.762 0.825 . . . . 74.15 112.064 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 29.65 34.74 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.882 -0.511 . . . . 65.11 112.919 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.4 t -125.12 80.08 64.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.744 1.618 . . . . 61.55 108.922 175.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.96 -172.2 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.06 3.174 . . . . 72.42 112.06 171.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.5 tt -137.49 146.56 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.72 1.208 . . . . 74.21 109.592 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.2 mm -87.65 141.58 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.084 -1.45 . . . . 74.13 107.084 171.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.91 0.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 128.697 2.799 . . . . 72.31 115.737 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -55.47 -51.13 67.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 126.296 1.838 . . . . 74.21 114.013 -169.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.8 169.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.278 1.031 . . . . 73.14 110.377 -162.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.23 119.24 38.84 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.206 -2.146 . . . . 65.04 105.206 162.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -106.82 141.74 37.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.857 -0.794 . . . . 72.21 108.857 -172.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 44.42 -153.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.875 1.67 . . . . 72.02 111.136 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -104.63 66.19 0.78 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.196 -1.409 . . . . 74.15 107.196 163.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -129.44 174.18 9.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.73 0.776 . . . . 71.01 112.711 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.9 t30 59.53 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.366 1 C-N-CA 132.55 4.34 . . . . 74.35 112.489 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 C-N-CA 127.513 2.325 . . . . 74.41 104.879 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 CA-C-O 117.903 -1.498 . . . . 72.34 114.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.65 104.08 1.95 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.984 -2.228 . . . . 70.35 104.984 166.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp -141.09 77.44 1.6 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.595 -2.002 . . . . 63.51 105.595 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.32 39.73 0.75 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.651 0.78 . . . . 71.31 112.805 -171.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.81 137.66 44.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 75.51 111.772 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.57 157.92 71.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.702 -1.221 . . . . 74.35 107.702 170.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.52 -27.67 70.12 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 120.535 1.227 . . . . 71.14 111.114 167.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -57.76 -49.16 77.51 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 124.54 1.136 . . . . 75.55 109.1 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -50.87 -42.66 59.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.164 1.386 . . . . 71.13 110.624 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -78.75 -20.85 48.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 117.662 -1.161 . . . . 75.35 113.493 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -87.75 -25.53 23.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.514 1.126 . . . . 73.53 110.582 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.31 18.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.62 1.568 . . . . 73.43 112.018 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 54.8 4.31 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.983 2.913 . . . . 75.03 118.764 163.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.1 m -115.0 159.9 20.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 119.996 1.271 . . . . 75.04 109.51 -160.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.4 166.88 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.635 -1.616 . . . . 75.22 106.635 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -138.34 108.43 6.39 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.419 1.088 . . . . 75.34 110.721 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -79.79 125.27 29.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.726 1.61 . . . . 64.45 107.97 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -137.57 27.73 2.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.447 0.641 . . . . 64.54 112.542 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -141.99 46.5 1.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.644 -1.285 . . . . 74.22 110.095 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' H ' HD12 ' A' ' 20' ' ' LEU . 4.0 mp -90.27 -173.88 3.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.177 1.391 . . . . 74.44 112.74 -167.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.67 162.61 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.051 2.141 . . . . 72.12 109.681 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.49 -10.05 59.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.379 0.881 . . . . 64.12 113.379 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.67 56.78 1.83 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.311 1.044 . . . . 75.1 111.323 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 tt -112.81 133.13 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.496 1.119 . . . . 75.23 108.986 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -81.64 164.88 47.15 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 119.04 -0.505 . . . . 64.01 110.263 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.29 -46.21 22.93 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.568 1.512 . . . . 71.12 110.064 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -66.51 -16.82 64.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.369 0.878 . . . . 73.3 113.369 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -63.35 -34.97 78.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.801 1.182 . . . . 71.22 109.551 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 -43.38 18.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.728 -0.653 . . . . 62.31 110.157 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.66 -35.13 75.47 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.751 1.16 . . . . 75.03 110.013 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.71 -11.69 59.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.923 1.289 . . . . 74.02 113.654 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -72.52 -63.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 119.465 1.03 . . . . 74.44 108.408 170.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.21 -15.17 62.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 117.907 -1.044 . . . . 63.02 112.155 -175.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t -48.51 -25.38 1.66 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.63 1.572 . . . . 54.55 112.637 164.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -68.86 -19.72 64.25 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.713 -1.242 . . . . 70.53 111.094 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.38 -19.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.157 1.344 . . . . 74.11 114.525 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.55 -177.54 26.3 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 120.942 -1.099 . . . . 74.04 111.331 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -123.08 133.11 54.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.489 0.716 . . . . 75.43 109.373 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.23 133.14 41.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.256 -1.387 . . . . 74.44 107.256 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -74.29 -64.65 0.98 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.764 -1.569 . . . . 74.13 106.764 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -156.98 159.85 38.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.554 -1.646 . . . . 71.35 106.554 -157.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -134.03 145.36 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 73.04 109.374 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -132.55 136.4 46.57 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.55 1.94 . . . . 74.32 108.616 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.78 120.78 15.58 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.15 1.38 . . . . 74.12 109.441 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.14 154.95 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.318 0.963 . . . . 72.35 110.827 -169.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.2 m -137.74 9.88 2.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 116.506 2.039 . . . . 73.01 116.506 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 71.79 -66.78 0.29 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.219 3.007 . . . . 71.05 107.835 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 -30.41 0.07 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.83 1.652 . . . . 75.14 109.51 157.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' C ' ' H ' ' A' ' 51' ' ' ARG . 1.3 m-80 -44.82 -31.06 1.1 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 126.8 2.04 . . . . 73.14 113.743 -168.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.43 -11.67 0.17 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.728 1.611 . . . . 75.02 113.933 172.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' A' ' 49' ' ' ASN . 1.1 ttp-105 -131.44 31.45 4.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.902 2.481 . . . . 74.24 109.188 -164.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -156.43 -54.01 0.08 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.046 2.139 . . . . 71.23 109.871 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . 0.259 19.4 p 44.67 -21.63 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 130.432 3.493 . . . . 71.31 118.58 -154.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.438 10.4 ptpp? 48.63 22.16 0.48 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.926 1.694 . . . . 74.52 112.939 -148.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.69 86.9 0.02 OUTLIER Glycine 0 C--N 1.344 0.979 0 C-N-CA 125.577 1.561 . . . . 74.33 111.899 176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.83 121.85 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.622 0.769 . . . . 75.25 110.538 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.43 137.89 34.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.887 -0.782 . . . . 60.35 108.887 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -102.65 154.12 19.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.938 -1.875 . . . . 62.34 105.938 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.92 115.71 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.323 -2.102 . . . . 74.15 105.323 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -81.93 110.04 16.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 105.124 -2.176 . . . . 74.35 105.124 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.09 163.07 18.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.273 -0.892 . . . . 71.44 110.42 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.88 -15.32 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.5 0.32 . . . . 72.33 111.033 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.44 161.83 38.77 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.366 -1.459 . . . . 54.02 111.095 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.12 -22.87 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.089 1.355 . . . . 72.35 111.669 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -59.37 -27.18 65.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.089 -1.007 . . . . 64.33 111.403 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -86.06 -4.07 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.236 1.199 . . . . 75.33 114.236 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.05 -58.16 16.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.24 1.382 . . . . 72.52 109.263 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.81 -20.39 64.7 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.448 1.432 . . . . 74.31 113.326 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.09 -52.95 56.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.972 1.26 . . . . 74.31 110.408 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.33 73.66 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.267 0.355 . . . . 74.13 111.644 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.65 -42.49 88.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.888 0.875 . . . . 74.44 109.106 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.33 -31.14 59.32 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 117.994 0.361 . . . . 65.15 112.437 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.31 9.96 16.29 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.334 -1.098 . . . . 74.31 112.803 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 t -49.82 -29.85 8.69 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.384 1.447 . . . . 72.33 114.458 -172.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.08 6.46 40.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.476 1.036 . . . . 64.11 113.779 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -81.36 175.05 10.91 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.237 1.019 . . . . 74.12 108.792 165.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -149.58 135.16 18.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.925 -0.769 . . . . 74.31 108.925 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.95 119.57 35.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 74.51 105.847 162.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.9 mt 60.3 1.46 0.37 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.014 1.857 . . . . 64.34 116.014 171.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.44 2.21 15.36 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.718 -1.046 . . . . 70.24 113.902 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 68.9 t -104.57 86.39 1.4 Allowed Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 128.906 2.882 . . . . 71.31 109.151 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -65.3 177.49 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.23 1.953 . . . . 74.32 111.086 161.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 ' CG1' ' H ' ' A' ' 84' ' ' ILE 0.296 8.3 tt -122.19 176.45 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.951 0.9 . . . . 72.13 109.617 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.486 ' H ' ' CG1' ' A' ' 83' ' ' ILE . 47.8 mm -123.97 145.78 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.945 2.098 . . . . 72.41 106.077 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.52 -4.41 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.533 2.333 . . . . 73.31 114.819 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -53.85 -49.11 69.2 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.933 1.693 . . . . 72.34 113.717 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.4 179.36 0.15 Allowed 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.575 1.55 . . . . 70.24 111.498 -170.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -99.23 112.0 24.25 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.594 1.558 . . . . 74.31 106.963 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 63.41 -172.23 0.17 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.255 1.422 . . . . 71.53 111.733 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.25 174.2 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.885 1.674 . . . . 73.31 108.857 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.45 14.9 0.4 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.846 1.259 . . . . 71.51 113.568 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -115.46 -73.77 0.64 Allowed 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 121.455 -0.778 . . . . 72.21 110.507 -160.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 50.02 64.05 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.75 2.02 . . . . 75.24 111.668 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 . . . . . 0 C--O 1.252 1.219 0 O-C-N 121.847 -0.533 . . . . 75.54 111.618 -174.138 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 N-CA-C 110.146 -1.181 . . . . 75.32 110.146 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.53 68.87 0.25 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.246 1.418 . . . . 70.54 111.975 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.0 tpp -170.44 -46.75 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.413 1.885 . . . . 74.45 109.638 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -106.05 167.39 9.84 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.707 0.803 . . . . 75.51 111.018 -162.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 130.33 35.48 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.618 0.767 . . . . 73.32 109.039 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.539 HG23 ' H ' ' A' ' 9' ' ' GLU . 3.0 t -65.54 147.61 98.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.757 -0.831 . . . . 73.41 108.757 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 -11.01 27.05 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.472 2.115 . . . . 75.21 112.971 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.91 -49.91 11.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.876 1.27 . . . . 75.31 110.723 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.539 ' H ' HG23 ' A' ' 6' ' ' THR . 75.7 tt0 -58.02 -47.27 83.58 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.475 1.51 . . . . 74.53 110.861 -177.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -62.99 -32.13 73.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.578 0.585 . . . . 62.15 112.578 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -32.72 72.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.884 1.274 . . . . 74.13 108.314 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.88 27.2 1.86 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.596 2.759 . . . . 73.44 112.219 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.9 62.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.336 1.236 . . . . 75.34 114.336 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 m -92.51 145.72 24.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.282 -1.006 . . . . 75.23 108.282 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -108.41 125.62 65.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 107.855 -1.165 . . . . 73.15 107.855 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.575 ' H ' ' HA ' ' A' ' 87' ' ' ALA . 7.3 t80 -89.55 124.29 34.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.869 1.668 . . . . 75.23 109.151 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -111.94 86.13 2.28 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.715 1.606 . . . . 71.22 108.941 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.0 ttp -92.03 27.54 2.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.711 0.804 . . . . 74.41 112.364 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -150.28 37.09 0.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.863 -1.773 . . . . 72.11 113.712 -173.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.67 153.27 42.17 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.476 -0.765 . . . . 72.32 112.916 -169.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.79 158.06 29.7 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.323 0.582 . . . . 72.23 111.154 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.88 -15.59 43.72 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.193 1.183 . . . . 70.12 114.193 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.69 30.65 5.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.101 1.318 . . . . 75.13 111.301 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.89 144.12 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 120.886 -1.134 . . . . 75.32 109.866 170.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -97.45 158.21 33.52 Favored Pre-proline 0 N--CA 1.464 0.27 0 C-N-CA 123.907 0.883 . . . . 73.42 109.724 160.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -57.85 -34.87 98.85 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 121.988 1.792 . . . . 63.45 112.364 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -67.44 -25.89 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.917 -0.489 . . . . 72.33 112.247 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.74 -32.8 74.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.01 1.277 . . . . 64.34 111.552 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -41.37 80.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.092 0.557 . . . . 72.04 110.586 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -76.54 -40.23 50.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.249 -0.278 . . . . 74.44 110.249 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.6 -44.08 76.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.84 1.256 . . . . 71.02 111.918 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -54.38 -42.43 70.36 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.098 -0.376 . . . . 73.44 111.232 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -88.08 -11.87 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.491 0.716 . . . . 73.41 112.529 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -65.66 -12.87 57.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.246 1.818 . . . . 74.45 111.783 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -59.08 -31.28 68.74 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.153 -0.967 . . . . 71.42 110.702 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.09 17.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.039 -1.038 . . . . 72.02 113.03 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 174.38 38.77 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 120.764 -1.21 . . . . 70.33 113.595 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.26 51.81 1.86 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.959 1.304 . . . . 74.45 111.673 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 p -43.73 126.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 127.904 2.482 . . . . 64.13 110.279 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -51.09 29.99 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.79 -1.55 . . . . 72.42 108.664 -158.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.54 179.12 7.46 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.193 1.558 . . . . 74.32 109.491 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.6 t -136.92 147.88 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.185 0.994 . . . . 64.31 109.221 -174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 102.53 11.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.56 2.344 . . . . 74.32 106.822 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.34 115.85 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.225 1.81 . . . . 75.15 107.07 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.81 75.97 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.799 1.639 . . . . 74.23 108.677 -164.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -80.01 64.1 4.74 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.499 1.142 . . . . 73.41 111.61 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -77.14 19.01 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.969 2.108 . . . . 64.13 112.85 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.268 11.1 ptt180 47.92 -170.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.99 2.916 . . . . 74.32 114.098 -172.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -86.82 84.59 7.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.022 -1.473 . . . . 73.22 107.022 172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.4 t -150.42 -83.45 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.22 -1.4 . . . . 63.42 107.22 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -124.25 109.17 13.05 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.042 -2.207 . . . . 72.21 105.042 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.41 155.78 34.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.396 0.998 . . . . 73.35 112.698 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -71.2 2.16 5.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.537 1.535 . . . . 74.42 112.808 166.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? 53.52 -1.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.446 3.098 . . . . 75.04 118.614 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.39 76.09 0.16 Allowed Glycine 0 CA--C 1.517 0.159 0 CA-C-N 120.91 1.686 . . . . 74.01 109.892 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 pt -143.6 139.84 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.901 0.88 . . . . 71.21 111.384 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.36 157.27 43.52 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.289 1.836 . . . . 75.42 107.094 156.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.414 ' CE2' ' CD1' ' A' ' 16' ' ' PHE . 58.0 m-85 -124.99 128.38 48.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.884 -2.265 . . . . 75.23 104.884 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.04 112.93 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.291 -1.374 . . . . 75.35 107.291 -164.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.45 88.08 7.32 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.952 1.358 . . . . 73.13 110.578 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -49.92 156.91 0.67 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.402 1.572 . . . . 75.51 113.375 166.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 m -79.9 -35.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 128.276 2.63 . . . . 71.53 113.975 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -116.73 165.15 13.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.012 1.725 . . . . 73.12 108.438 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -88.42 -27.38 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.227 0.611 . . . . 74.42 110.075 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 t -60.64 -27.61 67.93 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.325 0.966 . . . . 71.44 112.066 -173.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 p -76.24 -19.67 58.14 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.829 -1.17 . . . . 70.53 114.147 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.5 t -52.22 -57.71 14.24 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.499 1.12 . . . . 75.22 109.668 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.82 -17.51 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.713 1.608 . . . . 74.32 113.652 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -51.97 50.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.022 1.283 . . . . 73.44 109.733 172.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.86 91.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.491 0.716 . . . . 74.05 110.576 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.54 -39.28 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.609 0.764 . . . . 74.43 109.393 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.76 -4.99 29.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.595 1.093 . . . . 71.23 114.492 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.9 mt -109.24 13.39 24.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.393 1.597 . . . . 72.05 111.735 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -54.3 -3.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.348 1.859 . . . . 73.35 115.22 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.61 7.88 24.19 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.13 1.347 . . . . 72.14 114.435 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -97.69 175.14 6.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.275 1.538 . . . . 72.04 110.311 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -155.57 89.07 1.16 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.265 -0.643 . . . . 72.23 109.265 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 m -60.31 113.45 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.151 -1.055 . . . . 72.34 108.151 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt 59.6 13.16 3.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.102 1.149 . . . . 73.05 114.102 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.07 13.3 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.638 -1.09 . . . . 74.05 113.425 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.01 85.02 1.12 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.481 1.513 . . . . 74.44 108.352 172.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.8 179.38 3.76 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.256 2.638 . . . . 70.02 111.164 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.7 tt -129.59 177.1 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.724 2.01 . . . . 74.43 108.37 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -126.73 147.24 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.304 1.841 . . . . 70.31 107.413 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.43 -10.25 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 116.39 1.996 . . . . 73.12 116.39 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -56.34 -41.92 76.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.975 1.261 . . . . 74.21 112.898 -166.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.575 ' HA ' ' H ' ' A' ' 16' ' ' PHE . . . 58.97 174.94 0.07 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.279 1.038 . . . . 72.41 110.035 -165.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 t -88.57 102.79 15.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.494 -2.039 . . . . 75.41 105.494 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 166.89 12.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.504 1.122 . . . . 73.33 108.927 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.5 122.69 18.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.504 -1.295 . . . . 61.11 107.504 167.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.2 60.13 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.99 -1.855 . . . . 74.03 105.99 170.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -143.23 165.8 26.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.967 1.707 . . . . 71.44 108.424 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -157.93 139.49 13.73 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 103.427 -2.805 . . . . 64.34 103.427 162.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 . . . . . 0 C--O 1.258 1.518 0 CA-C-N 120.22 1.373 . . . . 73.12 107.597 175.833 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 111.304 -0.718 . . . . 74.35 111.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.45 107.07 4.81 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.585 -1.635 . . . . 74.31 106.585 164.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.8 mtm -144.3 -80.2 0.18 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.067 -1.086 . . . . 74.22 108.067 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.24 142.04 30.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.013 0.369 . . . . 72.35 110.701 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 111.55 5.74 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.46 1.504 . . . . 74.32 109.985 -172.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 p -78.04 164.93 54.18 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.266 -0.896 . . . . 74.23 110.678 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.53 -51.54 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.256 1.97 . . . . 73.44 111.503 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.17 -24.32 63.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.822 0.737 . . . . 62.11 111.279 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -57.16 -56.0 27.48 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.85 0.75 . . . . 62.32 109.06 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -57.42 -30.68 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.275 0.488 . . . . 75.23 111.576 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -84.18 -17.79 38.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.495 1.518 . . . . 72.54 111.808 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.4 -85.57 0.05 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.466 0.706 . . . . 74.35 109.578 164.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.7 37.78 24.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.782 0.833 . . . . 75.55 111.105 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.3 m -102.39 147.6 26.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.135 0.574 . . . . 64.44 109.628 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.41 129.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.462 1.105 . . . . 73.55 108.468 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -100.51 108.74 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.951 1.7 . . . . 73.41 109.143 -171.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.1 m -84.88 122.13 28.73 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.761 1.625 . . . . 53.13 106.871 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.2 ttp -139.04 52.27 1.78 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.029 0.919 . . . . 71.23 111.385 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.485 ' H ' HD11 ' A' ' 20' ' ' LEU . 5.7 tt0 -154.97 30.45 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.729 -1.232 . . . . 72.24 109.668 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 19' ' ' GLN . 0.3 OUTLIER -84.26 166.63 17.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.802 1.287 . . . . 74.22 110.923 -167.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -105.15 153.12 21.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.629 -2.078 . . . . 71.14 110.202 -171.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.46 13.66 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.76 2.024 . . . . 71.13 114.598 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 25.22 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.067 2.147 . . . . 75.2 111.035 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.6 tp -72.34 155.3 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.456 -1.403 . . . . 75.21 109.42 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.31 161.55 25.56 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.997 1.719 . . . . 71.22 107.274 171.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.38 -42.02 44.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.888 1.725 . . . . 75.51 112.416 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.09 -30.47 71.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 75.52 111.904 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -24.5 66.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.568 0.622 . . . . 63.51 110.979 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.4 -41.45 12.1 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.305 -0.628 . . . . 75.35 109.305 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -66.83 -35.33 79.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.558 0.617 . . . . 63.21 111.261 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.93 -24.91 43.71 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.56 -0.712 . . . . 75.13 112.474 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.09 -36.3 70.44 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.126 -0.359 . . . . 73.02 111.111 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -96.96 -1.9 44.74 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.211 0.819 . . . . 71.42 113.211 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -60.11 -20.48 58.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.297 1.839 . . . . 73.43 111.026 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -13.41 61.52 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.036 -1.04 . . . . 74.24 112.902 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.55 2.53 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 120.493 -1.379 . . . . 72.54 113.67 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.34 -143.45 7.99 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.453 -1.859 . . . . 55.24 108.453 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.7 ptmm? -129.24 161.76 29.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.408 -0.96 . . . . 64.44 108.408 174.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.25 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.847 -0.797 . . . . 74.33 108.847 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -78.11 -59.95 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.09 -1.078 . . . . 74.51 108.09 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -142.78 137.47 29.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.222 1.009 . . . . 73.45 108.629 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.44 129.81 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.583 1.553 . . . . 74.41 107.726 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -153.46 112.25 3.71 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.828 0.74 . . . . 75.1 111.381 -172.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -136.78 157.48 46.66 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.065 -1.022 . . . . 73.23 112.504 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.18 65.34 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.648 -0.871 . . . . 74.42 108.648 -166.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.0 t -104.34 12.92 32.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.851 0.86 . . . . 75.33 112.123 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.53 124.49 16.23 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.282 1.433 . . . . 71.23 107.332 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.67 -69.33 0.72 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 117.764 -1.112 . . . . 75.54 110.163 160.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 p30 173.43 -2.9 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.946 2.499 . . . . 72.32 112.301 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.2 -176.1 4.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.977 1.711 . . . . 74.31 111.981 -158.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -107.12 90.24 3.24 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 105.968 -1.864 . . . . 75.03 105.968 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -135.55 -175.35 3.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.214 -1.773 . . . . 72.22 106.214 -164.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -66.65 78.46 0.11 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.391 -0.523 . . . . 75.1 109.864 162.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.274 6.7 ptmt -83.02 -12.07 57.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.32 1.848 . . . . 75.4 112.519 165.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.97 72.84 2.38 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 108.461 -1.855 . . . . 74.12 108.461 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.19 138.2 14.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.158 1.783 . . . . 73.54 109.925 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.29 151.48 33.0 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.198 1.399 . . . . 75.52 108.454 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -128.36 104.21 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.578 -2.008 . . . . 74.51 105.578 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.32 118.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.495 -1.669 . . . . 75.42 106.495 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -91.16 121.17 32.7 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.672 -1.603 . . . . 75.13 106.672 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.88 165.21 11.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.445 1.116 . . . . 75.14 112.181 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.6 m -76.56 -34.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.62 1.568 . . . . 73.12 112.761 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -134.13 152.4 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.358 1.063 . . . . 71.34 112.908 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.42 -27.72 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 73.31 112.054 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -60.02 -25.43 65.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.344 1.429 . . . . 71.25 113.95 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.4 p -77.64 -19.21 55.83 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.125 1.33 . . . . 72.51 114.254 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.47 -57.23 24.55 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.65 1.18 . . . . 71.15 111.404 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -63.59 -23.7 70.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.437 1.425 . . . . 73.32 111.462 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -50.97 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.967 0.907 . . . . 65.15 109.863 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.51 77.65 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.228 1.011 . . . . 65.14 111.418 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.0 mt -53.66 -43.62 55.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.18 0.992 . . . . 74.21 109.382 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.33 64.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.161 -0.8 . . . . 74.33 112.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -98.67 4.26 47.88 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.096 1.358 . . . . 70.13 111.279 -167.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.294 2.8 m -45.55 -26.79 0.64 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.565 0.95 . . . . 70.03 113.565 161.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 18.06 45.04 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.309 0.884 . . . . 61.31 115.309 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -125.68 163.17 23.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 119.328 1.564 . . . . 73.15 109.367 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -136.25 115.71 12.75 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.398 1.479 . . . . 70.35 110.335 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -79.96 98.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.868 -1.53 . . . . 74.03 106.868 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt 54.87 33.25 19.49 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.139 0.976 . . . . 73.24 112.082 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.81 57.17 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.71 -1.05 . . . . 70.34 113.917 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.06 85.32 9.96 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 118.891 1.345 . . . . 73.02 108.176 168.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.82 -177.63 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.734 2.29 . . . . 72.12 111.714 162.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -124.29 156.84 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.648 -0.871 . . . . 72.11 108.648 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.409 ' C ' ' H ' ' A' ' 86' ' ' GLN . 51.3 mm -100.92 146.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.423 -1.325 . . . . 65.13 107.423 171.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -74.12 16.32 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.688 1.995 . . . . 71.41 112.736 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.409 ' H ' ' C ' ' A' ' 84' ' ' ILE . 1.6 mm100 -70.21 -26.64 63.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.441 2.296 . . . . 73.22 112.889 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.46 36.24 22.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.288 1.835 . . . . 74.22 113.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 50.71 23.26 1.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.227 2.211 . . . . 74.33 114.918 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -78.73 132.95 37.16 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.371 -0.831 . . . . 64.24 109.651 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.8 142.08 11.94 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.305 1.442 . . . . 73.21 107.148 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -83.29 57.65 4.09 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.912 1.685 . . . . 73.43 107.736 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -128.97 -172.07 2.63 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.168 1.387 . . . . 74.11 110.758 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.306 68.3 m-20 74.61 21.7 2.18 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.708 2.803 . . . . 60.12 112.252 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? . . . . . 0 C--O 1.255 1.349 0 C-N-CA 130.266 3.426 . . . . 73.22 111.853 174.43 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 113.581 0.956 . . . . 64.11 113.581 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -57.31 143.11 41.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.809 1.244 . . . . 63.52 110.402 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.0 116.93 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.41 1.1 . . . . 72.33 108.166 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -68.63 124.64 24.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.685 -1.143 . . . . 63.34 108.209 170.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.74 105.29 13.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 105.324 -2.102 . . . . 73.25 105.324 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -113.03 174.24 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.057 -1.09 . . . . 61.22 108.057 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 74.99 17.35 2.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.005 2.522 . . . . 74.44 112.046 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.698 ' HA ' HG13 ' A' ' 81' ' ' VAL . 20.7 mt -77.48 165.63 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.875 -0.515 . . . . 71.23 111.497 -171.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.21 41.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.262 0.553 . . . . 75.13 111.463 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.04 -24.37 53.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.817 1.247 . . . . 33.34 113.736 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -123.25 19.4 9.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.366 1.867 . . . . 74.24 111.155 -167.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.623 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.0 tt -63.92 151.24 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.607 0.639 . . . . 64.12 109.961 174.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 160.9 35.77 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 125.089 1.356 . . . . 75.32 107.554 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.59 -42.15 57.31 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.233 1.289 . . . . 73.34 110.596 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -30.59 71.7 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.073 -0.965 . . . . 74.25 111.663 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.12 -30.72 62.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.549 1.068 . . . . 55.15 110.382 -169.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.91 -41.46 18.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.795 1.638 . . . . 74.24 110.527 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.87 -37.63 73.06 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.223 -0.658 . . . . 65.34 109.223 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.33 -55.47 28.13 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 126.722 2.009 . . . . 43.42 109.642 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -55.08 -29.78 58.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.85 1.26 . . . . 73.23 112.446 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.86 -35.65 13.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.188 0.81 . . . . 63.34 113.188 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.1 t -57.26 -23.11 46.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.641 1.176 . . . . 62.14 111.674 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.739 0.815 . . . . 64.23 112.735 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.86 6.28 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 64.13 111.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 -174.85 23.36 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 121.042 -1.036 . . . . 61.34 113.105 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -140.1 138.22 35.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.829 1.252 . . . . 72.44 109.334 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.54 138.68 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.628 1.571 . . . . 61.41 107.573 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -85.78 -57.71 2.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.852 1.661 . . . . 42.02 108.12 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -158.27 175.86 13.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.811 0.732 . . . . 63.41 109.701 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.2 113.61 26.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.109 1.764 . . . . 71.31 107.389 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.05 51.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.792 1.637 . . . . 55.44 108.578 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 ttt -66.57 128.96 38.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.906 1.282 . . . . 73.14 107.897 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.73 ' H ' HD12 ' A' ' 45' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 105.871 -1.9 . . . . 62.21 105.871 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 CA-C-O 118.916 -0.935 . . . . 74.32 113.987 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -139.11 148.7 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.601 1.2 . . . . 74.31 111.776 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.39 162.82 33.44 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.107 2.163 . . . . 62.31 109.842 170.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.641 ' CE2' HD11 ' A' ' 45' ' ' ILE . 85.8 m-85 -130.09 114.56 15.91 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.662 1.585 . . . . 63.31 108.017 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.19 122.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.835 -1.172 . . . . 72.21 107.835 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -75.7 114.37 14.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.696 -1.224 . . . . 52.32 107.696 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 2.9 m-85 -80.02 166.25 21.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.999 -0.371 . . . . 74.14 109.999 165.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.97 -9.36 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 118.68 -0.676 . . . . 63.55 111.358 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.55 135.0 40.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.342 1.883 . . . . 75.15 113.695 -168.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.21 -35.13 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.725 0.81 . . . . 71.31 111.981 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 m -80.68 -9.24 59.81 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 119.178 -1.009 . . . . 75.51 111.025 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.7 m -80.28 -11.81 59.68 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 117.548 -1.215 . . . . 55.12 113.659 172.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.34 -59.3 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 120.551 1.523 . . . . 52.44 108.765 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.48 -18.79 60.49 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.952 1.768 . . . . 54.31 113.667 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.52 -57.88 8.76 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 119.464 1.029 . . . . 73.14 108.75 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.01 69.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.704 1.202 . . . . 63.32 112.051 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.2 mt -54.85 -48.47 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.72 -0.845 . . . . 73.11 108.72 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.69 -6.21 21.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.727 1.156 . . . . 64.34 115.256 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.19 1.46 49.83 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.822 1.311 . . . . 73.33 112.168 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.68 -23.98 7.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.801 1.778 . . . . 71.42 115.801 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.15 1.65 37.91 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.143 0.878 . . . . 31.15 113.473 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -72.1 170.72 13.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.073 -1.084 . . . . 60.23 108.073 162.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -162.59 82.04 0.52 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.622 0.971 . . . . 71.21 113.622 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.78 117.24 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.608 -0.886 . . . . 63.22 108.608 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt 60.67 2.17 0.48 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.002 1.321 . . . . 65.12 114.157 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.79 11.96 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.799 -1.0 . . . . 52.35 113.132 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 20' ' ' LEU . 65.7 t -112.37 86.12 7.78 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 118.945 1.373 . . . . 72.13 110.034 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.81 175.78 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.669 2.246 . . . . 44.54 111.369 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -134.92 140.42 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.302 1.041 . . . . 52.15 110.256 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mm -77.34 145.93 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.212 -0.93 . . . . 53.22 110.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.04 4.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 128.886 2.874 . . . . 54.34 115.806 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.8 -36.92 84.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.936 1.458 . . . . 61.13 114.936 -157.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.77 173.63 0.07 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.441 1.496 . . . . 63.42 110.091 -163.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 107.674 -1.232 . . . . 52.42 107.674 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 111.901 0.334 . . . . 73.34 111.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -85.35 144.3 28.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.198 -1.038 . . . . 70.25 108.198 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.65 122.14 66.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.355 1.062 . . . . 74.14 108.252 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -73.7 132.87 43.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.918 1.687 . . . . 71.52 110.107 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.7 m -117.64 130.3 56.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.541 1.936 . . . . 70.23 106.356 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.9 ttp -138.32 29.87 2.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.839 1.256 . . . . 31.2 110.69 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -153.86 15.31 0.49 Allowed 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.546 -1.346 . . . . 74.15 111.972 -165.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.29 156.59 36.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.825 0.45 . . . . 73.42 111.142 -167.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 152.23 44.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.052 0.454 . . . . 72.54 109.978 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.94 64.87 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.447 1.099 . . . . 74.43 113.744 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -121.59 58.48 1.0 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.752 1.221 . . . . 73.44 109.345 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 161.51 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.019 -1.051 . . . . 42.11 109.351 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -120.26 158.3 51.2 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 125.579 1.552 . . . . 62.53 108.099 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.86 -32.42 22.65 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.588 1.525 . . . . 72.22 111.319 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -70.82 -37.86 73.25 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.614 0.643 . . . . 74.55 111.322 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.83 -40.41 69.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.201 1.001 . . . . 71.32 110.74 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.3 -48.26 62.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.683 1.193 . . . . 74.44 110.88 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 39' ' ' VAL . 10.7 pt-20 -69.2 -37.82 78.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.496 -0.764 . . . . 65.11 109.633 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.34 -25.86 66.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.068 0.849 . . . . 72.15 112.223 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.6 -36.63 83.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.744 0.702 . . . . 72.13 110.244 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -99.55 -33.88 10.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.501 -0.761 . . . . 71.24 112.417 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -66.02 -17.14 64.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.793 1.179 . . . . 62.33 111.501 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -80.95 -2.84 49.37 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.259 -0.901 . . . . 74.13 112.23 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.75 15.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.166 1.786 . . . . 52.43 111.481 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.06 -155.53 17.3 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.001 -1.639 . . . . 61.54 109.001 -161.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -157.81 147.74 20.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.853 1.327 . . . . 65.11 108.998 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 30' ' ' GLU . 53.4 t -112.23 122.99 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.443 1.097 . . . . 65.53 110.024 -173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -76.07 -45.73 32.61 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.805 1.242 . . . . 73.55 110.501 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.9 163.64 37.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.443 1.097 . . . . 73.24 108.777 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.4 126.29 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.171 1.388 . . . . 63.53 107.296 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -132.6 103.97 6.42 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.698 -0.852 . . . . 61.51 108.698 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.42 137.11 35.98 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.448 1.099 . . . . 74.22 108.302 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 105.897 -1.89 . . . . 70.55 105.897 172.844 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 N-CA-C 109.726 -1.35 . . . . 32.53 109.726 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -120.57 128.31 76.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.034 1.334 . . . . 72.15 111.062 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.89 158.73 44.51 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.005 1.322 . . . . 72.23 110.176 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -124.34 135.69 53.53 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.979 -1.489 . . . . 70.34 106.979 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.375 1.5 p -138.54 109.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 65.55 110.56 -168.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -74.25 122.31 22.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.43 1.892 . . . . 72.24 110.357 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 66' ' ' SER . 3.2 m-85 -74.76 153.92 38.59 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.16 0.981 . . . . 63.33 111.483 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -73.94 -21.76 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 115.229 -0.896 . . . . 73.22 110.868 166.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -137.85 128.22 26.31 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.243 1.417 . . . . 74.55 109.857 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.38 -30.66 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.216 1.406 . . . . 61.53 111.388 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -73.73 -21.11 60.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.243 -1.535 . . . . 72.11 112.855 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 7.2 m -81.71 -8.69 59.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.704 1.138 . . . . 74.13 112.553 172.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.15 -66.54 1.19 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 116.101 -1.904 . . . . 71.45 107.768 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.03 -17.87 58.46 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.433 2.089 . . . . 74.24 113.837 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.14 -42.45 76.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.554 1.142 . . . . 74.33 109.45 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.69 -36.55 69.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.017 0.747 . . . . 63.11 113.017 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.9 mt -59.41 -42.54 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.941 0.791 . . . . 72.22 109.769 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 -5.09 8.66 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.384 -0.676 . . . . 75.13 113.091 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.12 5.6 12.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.383 1.591 . . . . 74.13 112.456 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.7 t -48.07 -33.75 8.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.234 1.379 . . . . 62.52 113.094 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.85 12.86 41.8 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.891 1.71 . . . . 73.11 113.839 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.77 172.23 8.48 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 118.874 1.337 . . . . 74.51 108.069 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -155.93 99.46 1.98 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.388 0.675 . . . . 75.24 111.137 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.64 114.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.919 -1.141 . . . . 70.34 107.919 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt 54.53 21.35 3.3 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.873 1.064 . . . . 70.32 113.873 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.84 28.82 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.297 -0.724 . . . . 61.34 113.945 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.13 85.11 6.39 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.354 1.577 . . . . 71.12 109.719 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.83 177.76 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.862 2.375 . . . . 72.13 111.388 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.8 tt -136.48 169.09 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.871 0.693 . . . . 73.35 112.871 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.18 124.44 73.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.707 2.003 . . . . 61.55 108.798 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -53.38 -17.75 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.079 2.552 . . . . 70.15 115.831 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.87 -42.56 80.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.568 1.531 . . . . 65.24 111.646 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.0 41.83 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.836 1.654 . . . . 63.34 113.986 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.258 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 127.227 2.211 . . . . 74.32 111.449 -171.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.107 -0.473 . . . . 60.34 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.17 151.38 50.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.332 0.969 . . . . 72.43 112.237 -173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.84 122.92 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.1 1.76 . . . . 62.42 110.691 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.91 129.71 38.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.262 1.425 . . . . 73.51 109.647 169.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.6 m -122.15 105.06 9.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.994 -1.484 . . . . 64.52 106.994 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.8 ttm -88.01 174.57 8.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.712 0.805 . . . . 72.43 109.133 171.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 70.14 21.03 6.16 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.44 2.296 . . . . 73.44 113.185 164.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.7 mt -69.1 167.03 16.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.104 0.561 . . . . 65.2 111.77 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -62.26 147.73 47.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.976 -0.556 . . . . 64.14 110.332 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.99 -4.26 2.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.32 1.448 . . . . 51.24 113.675 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -139.36 13.57 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.77 1.628 . . . . 73.1 112.138 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tt -47.7 131.46 4.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.756 0.822 . . . . 71.54 112.275 -167.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -66.97 147.67 99.05 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 107.548 -1.279 . . . . 71.43 107.548 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.55 1.77 4.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.088 2.525 . . . . 55.04 113.36 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 -22.0 14.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.814 1.188 . . . . 72.35 113.019 167.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -30.43 71.52 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.811 1.187 . . . . 52.12 112.046 -165.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.3 mt -84.71 -24.13 29.03 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.989 0.516 . . . . 72.44 111.436 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 42' ' ' VAL . 1.4 mt-10 -80.78 -52.01 7.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.33 -2.1 . . . . 71.14 105.33 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.12 -38.72 83.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.896 1.678 . . . . 74.23 110.668 -172.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -57.96 -49.26 77.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.237 0.926 . . . . 73.32 111.971 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -85.13 -15.23 44.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.1 0.407 . . . . 74.34 112.1 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -59.23 -20.13 51.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.617 1.567 . . . . 72.11 113.399 -171.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -65.38 -24.37 67.21 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.954 0.502 . . . . 64.51 110.466 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.87 47.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.009 -1.057 . . . . 74.43 110.75 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.17 153.5 9.37 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.005 1.764 . . . . 53.22 108.979 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.694 ' HG2' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -89.97 167.48 12.76 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.296 0.638 . . . . 51.22 110.71 -178.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . 2.6 p -124.35 145.35 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.442 1.897 . . . . 55.03 107.78 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -74.11 -49.52 23.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.776 -1.107 . . . . 64.55 109.098 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -165.87 -179.69 5.41 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.405 1.002 . . . . 73.35 111.818 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.44 HG21 ' HG2' ' A' ' 30' ' ' GLU . 51.9 t -133.56 110.01 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 127.006 2.123 . . . . 75.11 107.623 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -104.34 85.33 2.34 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.377 1.071 . . . . 75.24 108.985 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.47 160.74 19.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.649 0.737 . . . . 65.24 110.086 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 106.841 -1.54 . . . . 74.11 106.841 -175.776 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.642 0 N-CA-C 110.349 -1.1 . . . . 72.4 110.349 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.54 156.11 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.86 1.264 . . . . 51.34 111.044 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.86 159.91 27.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.22 1.008 . . . . 73.14 113.43 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.35 105.41 10.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.777 2.431 . . . . 74.21 106.15 160.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -91.65 132.18 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.62 -1.622 . . . . 75.33 106.62 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -116.47 89.86 3.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.492 1.117 . . . . 73.44 110.276 -166.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.98 169.77 1.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.463 2.023 . . . . 72.43 116.463 -176.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.694 HG21 ' HG2' ' A' ' 38' ' ' LYS . 31.1 t -87.4 -23.71 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.539 -0.726 . . . . 53.24 112.216 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.15 144.66 38.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.436 1.471 . . . . 73.41 114.162 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -48.84 -43.76 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 129.704 3.201 . . . . 63.31 111.675 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.3 p -64.2 -20.65 66.17 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.065 1.302 . . . . 61.22 111.48 -171.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.408 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -83.8 -10.41 58.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.793 1.034 . . . . 64.31 113.793 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.97 -60.22 11.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.995 0.918 . . . . 72.11 109.591 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -11.57 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.537 1.491 . . . . 71.14 113.776 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.05 -49.16 68.64 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.946 0.794 . . . . 72.24 109.461 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.29 74.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.722 -0.611 . . . . 61.45 111.424 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 87' ' ' ALA . 88.7 mt -58.37 -44.76 89.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.38 0.672 . . . . 73.35 109.514 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.35 -35.85 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 118.624 0.647 . . . . 54.45 112.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.94 4.07 10.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.363 1.065 . . . . 65.21 113.554 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.0 t -46.44 -27.12 0.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.433 1.493 . . . . 74.21 114.419 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -3.91 63.22 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.868 -1.145 . . . . 70.05 113.677 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -77.08 176.5 8.63 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 119.217 1.509 . . . . 60.43 110.488 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 86.5 1.57 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.525 1.13 . . . . 73.03 109.019 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.46 93.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.584 1.554 . . . . 55.32 109.784 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt 46.24 43.3 11.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.658 1.218 . . . . 64.23 110.772 -167.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.43 21.0 46.23 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.314 -0.866 . . . . 71.33 113.347 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 21' ' ' ALA . 21.5 t -118.7 85.87 28.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.85 1.66 . . . . 72.14 107.52 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.7 -179.44 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.299 1.999 . . . . 74.35 111.003 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.599 HG23 ' HA ' ' A' ' 74' ' ' THR . 14.9 tt -142.51 156.13 18.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.26 143.37 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.417 1.487 . . . . 71.24 108.797 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.52 3.75 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.16 1.784 . . . . 62.14 114.481 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.29 -53.15 6.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.445 1.898 . . . . 72.22 112.46 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . 58.58 163.27 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.684 1.706 . . . . 61.12 112.872 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 104.208 -2.515 . . . . 70.01 104.208 168.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 116.187 1.921 . . . . 72.12 116.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -102.94 148.47 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.725 1.148 . . . . 64.33 109.734 -159.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -126.12 135.27 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.109 1.364 . . . . 72.43 109.635 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -100.25 106.61 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.499 1.12 . . . . 72.43 109.619 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -93.18 83.63 4.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.818 2.047 . . . . 55.31 109.221 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.7 ttp -91.21 41.37 1.06 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.3 0.852 . . . . 74.15 113.3 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -154.39 27.25 0.45 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.368 -1.458 . . . . 73.22 113.752 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 29' ' ' LEU . 10.6 mt -65.84 152.12 45.13 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.724 -0.61 . . . . 64.54 111.22 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.8 168.21 14.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.301 0.572 . . . . 71.12 111.531 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.67 66.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.026 1.121 . . . . 44.01 114.026 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -117.07 10.22 13.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.142 1.377 . . . . 73.53 111.434 -166.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -56.35 139.61 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.3 1.44 . . . . 73.52 111.659 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -87.82 161.46 44.39 Favored Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 124.32 1.048 . . . . 74.34 108.591 163.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.88 -44.61 38.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.044 1.829 . . . . 64.23 110.902 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -62.44 -23.28 66.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.135 -0.936 . . . . 73.23 112.724 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.53 -23.47 64.6 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.64 1.563 . . . . 53.15 111.719 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD11 HD22 ' A' ' 20' ' ' LEU . 2.3 mm? -80.44 -25.02 39.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.611 1.165 . . . . 53.23 112.893 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.0 -38.64 11.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.876 1.216 . . . . 75.53 109.606 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.52 -27.41 64.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.553 1.07 . . . . 75.54 112.683 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.02 -64.16 0.94 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.413 0.552 . . . . 72.55 109.77 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.0 -22.35 65.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.032 0.753 . . . . 75.14 113.032 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -64.29 -4.72 4.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.089 1.356 . . . . 71.13 111.094 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -53.33 -30.32 38.53 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.406 1.457 . . . . 64.45 110.66 161.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.5 m -144.68 65.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.492 1.517 . . . . 63.22 110.264 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.57 177.13 15.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 122.861 1.256 . . . . 75.31 115.003 149.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.741 ' HG3' HG21 ' A' ' 62' ' ' VAL . 1.3 ptpt -91.74 53.91 2.34 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.814 1.413 . . . . 74.42 114.814 -151.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.308 1.5 p -44.6 130.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.528 1.131 . . . . 73.42 110.854 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -85.11 -48.25 9.36 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 112.72 -2.036 . . . . 64.54 109.843 -155.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -161.47 155.69 22.52 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 124.971 1.419 . . . . 75.45 110.302 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.02 148.6 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.67 1.588 . . . . 52.42 107.717 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -138.84 121.8 16.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.147 -1.797 . . . . 75.32 106.147 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.2 ptp -143.36 166.73 23.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.659 0.784 . . . . 74.24 111.284 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.235 0.311 0 CA-C-N 116.23 -0.441 . . . . 74.31 109.886 -168.72 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.831 -1.539 . . . . 75.54 110.983 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.3 118.91 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.356 1.078 . . . . 71.23 110.166 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.28 34.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.125 1.37 . . . . 75.55 108.222 163.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.62 83.52 2.08 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.037 2.135 . . . . 73.54 107.131 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.292 1.6 p -90.29 144.5 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.055 1.342 . . . . 64.24 111.104 -170.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.84 97.71 5.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.991 0.901 . . . . 60.33 109.131 -155.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.01 172.92 2.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.914 1.816 . . . . 61.23 112.005 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 38' ' ' LYS . 4.0 m -89.87 -25.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 127.406 2.282 . . . . 61.52 112.075 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -138.42 142.81 39.52 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.154 1.782 . . . . 75.42 108.441 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.49 -22.38 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.857 0.863 . . . . 63.51 111.586 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 p -68.4 -20.33 64.66 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 120.671 -1.268 . . . . 52.25 111.868 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -74.65 -19.73 60.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.359 -0.838 . . . . 43.34 112.498 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.56 -57.27 28.15 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.086 -1.009 . . . . 75.53 110.622 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.42 -14.04 39.04 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.645 2.23 . . . . 72.33 113.075 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.72 -49.92 73.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.517 -0.92 . . . . 63.34 108.517 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.83 72.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.624 0.77 . . . . 42.03 111.894 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mt -55.83 -35.52 40.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.462 1.105 . . . . 72.23 110.216 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.69 -27.48 49.44 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.957 -0.913 . . . . 23.34 114.24 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mt -110.82 10.2 22.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.313 1.556 . . . . 74.22 112.455 -166.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 83' ' ' ILE . 10.1 t -44.7 -36.49 3.17 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.242 1.383 . . . . 63.32 113.194 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 -26.52 58.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.833 1.206 . . . . 63.34 113.316 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.99 158.29 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.979 0.889 . . . . 55.02 108.683 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -158.06 115.93 3.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.812 0.845 . . . . 74.51 109.426 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -77.46 125.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 106.97 -1.493 . . . . 71.23 106.97 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt 48.34 37.76 9.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.174 1.39 . . . . 62.31 112.823 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.92 28.61 64.4 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.493 -1.171 . . . . 53.14 113.874 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.66 85.51 7.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.336 1.854 . . . . 71.32 108.872 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.16 -170.68 0.97 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.77 2.313 . . . . 61.22 111.226 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.3 tt -144.65 159.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 121.404 -0.81 . . . . 61.24 111.48 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.28 141.19 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.145 -1.428 . . . . 64.12 107.145 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -52.48 -13.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.668 2.787 . . . . 61.44 116.036 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -44.5 -53.33 7.1 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.089 1.355 . . . . 74.24 113.859 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 38.45 29.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.722 1.209 . . . . 62.11 113.294 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 124.737 1.215 . . . . 75.25 111.261 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 116.767 2.136 . . . . 75.2 116.767 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -121.56 145.54 47.87 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.189 -1.411 . . . . 71.41 107.189 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.56 115.1 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.661 -1.978 . . . . 62.03 105.661 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -75.0 128.21 35.04 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.181 -1.785 . . . . 63.33 106.181 168.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -121.32 121.36 37.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 106.534 -1.654 . . . . 60.44 106.534 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.0 ttp -124.13 165.23 17.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.22 1.408 . . . . 75.41 107.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 75.31 12.17 3.31 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.028 2.131 . . . . 72.12 111.862 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.17 167.95 9.31 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.647 -0.658 . . . . 71.41 109.423 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.47 151.87 45.55 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.604 -0.685 . . . . 55.21 110.58 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.62 -4.19 25.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.155 0.982 . . . . 72.21 113.008 172.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.76 33.1 2.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.596 1.958 . . . . 74.05 110.374 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.97 138.58 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.049 -1.032 . . . . 74.42 108.768 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -77.91 153.48 80.36 Favored Pre-proline 0 N--CA 1.466 0.363 0 N-CA-C 108.218 -1.03 . . . . 74.02 108.218 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.37 0.9 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.395 2.73 . . . . 75.43 114.039 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -112.87 -5.25 13.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.941 1.246 . . . . 72.41 111.892 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.47 -30.44 64.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.6 -1.313 . . . . 63.44 108.729 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.48 -53.23 9.92 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.174 0.99 . . . . 55.41 110.195 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.54 -40.07 94.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.46 0.704 . . . . 61.1 110.524 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -67.87 -27.37 66.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.156 0.582 . . . . 75.41 112.067 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.26 -50.07 73.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.502 -0.285 . . . . 60.21 110.317 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -72.83 -28.26 62.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.88 0.764 . . . . 74.4 111.974 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 t -57.73 -20.36 34.04 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.632 1.973 . . . . 60.22 113.218 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -76.74 -15.85 59.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.149 -0.969 . . . . 63.3 111.268 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -136.98 11.54 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.031 0.932 . . . . 73.02 111.461 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.51 173.55 36.29 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 121.198 -0.939 . . . . 23.35 111.604 -160.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.76 137.12 29.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.532 -1.284 . . . . 64.24 107.532 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.24 131.8 65.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 125.92 1.688 . . . . 64.32 109.281 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -94.13 -42.54 8.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.048 -0.977 . . . . 72.2 110.879 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -167.41 158.45 11.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.783 2.033 . . . . 72.02 106.36 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 59' ' ' VAL . 29.5 m -133.95 163.85 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.26 1.824 . . . . 62.22 109.684 -173.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 136.79 10.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.181 -0.95 . . . . 73.44 109.235 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.4 ptp -136.11 135.55 39.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.273 0.942 . . . . 75.03 110.18 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 116.07 -0.514 . . . . 71.33 112.352 -150.134 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 110.389 -1.084 . . . . 73.32 110.389 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.38 131.54 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.205 1.802 . . . . 75.32 109.903 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.15 165.6 35.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.737 1.615 . . . . 61.32 108.55 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -124.07 146.12 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.425 -1.694 . . . . 72.4 106.425 165.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 42' ' ' VAL . 25.6 t -130.71 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.563 -1.643 . . . . 75.14 106.563 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -72.1 128.34 35.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.097 -1.446 . . . . 74.23 107.097 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.18 155.44 23.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 64.11 110.631 169.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.18 -26.99 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 117.996 -1.002 . . . . 72.33 110.187 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.13 150.43 50.52 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.191 1.36 . . . . 60.13 111.979 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.78 -34.54 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 117.986 -1.006 . . . . 75.14 111.806 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -69.99 -20.74 63.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.383 1.902 . . . . 74.34 112.411 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -89.94 -4.34 57.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.829 0.852 . . . . 75.13 112.443 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.29 -60.84 8.92 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 119.693 1.133 . . . . 71.3 109.787 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 -15.4 46.41 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 120.92 1.364 . . . . 52.54 113.381 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -55.22 35.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 120.547 -1.345 . . . . 74.44 110.145 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.82 -41.6 78.12 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.712 0.633 . . . . 71.31 111.253 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.01 -39.0 70.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.948 0.899 . . . . 72.31 110.36 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.58 -36.04 63.52 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.448 1.023 . . . . 74.31 112.905 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.6 12.75 1.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.574 1.15 . . . . 72.12 113.354 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.567 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -50.38 -28.23 7.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.298 1.439 . . . . 71.13 113.572 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.66 14.73 45.96 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.293 1.425 . . . . 75.22 112.914 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -93.71 170.4 9.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.261 1.03 . . . . 73.44 108.258 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -145.17 87.13 1.8 Allowed 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.635 -0.666 . . . . 73.14 109.978 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.94 110.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.708 -0.849 . . . . 61.25 108.708 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt 46.97 31.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.353 1.861 . . . . 62.45 112.979 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.42 19.43 27.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.781 0.705 . . . . 62.04 113.61 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.63 86.43 29.37 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.995 1.718 . . . . 60.45 109.165 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.23 173.79 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.456 2.104 . . . . 60.02 111.914 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.1 tt -140.17 143.33 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.466 1.107 . . . . 71.13 109.453 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.9 mm -86.14 144.34 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.715 0.806 . . . . 72.33 109.442 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.15 10.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 129.298 3.039 . . . . 51.22 115.471 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -25.66 64.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 114.782 1.401 . . . . 71.04 114.782 -154.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.83 164.03 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.692 2.797 . . . . 61.22 111.766 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 106.135 -1.802 . . . . 55.24 106.135 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 116.943 2.201 . . . . 73.41 116.943 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -77.75 155.93 30.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.814 0.846 . . . . 64.33 111.47 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.09 179.29 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.499 1.52 . . . . 63.14 108.54 167.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -140.94 127.05 19.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.631 1.173 . . . . 70.2 110.048 -169.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.77 115.4 30.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.363 1.465 . . . . 72.5 107.451 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -128.87 32.59 4.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.623 1.569 . . . . 74.22 110.141 -174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -147.28 27.36 1.03 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.381 -1.449 . . . . 73.3 110.445 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 59.4 mt -68.03 155.19 40.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.949 1.3 . . . . 72.21 113.654 -172.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.13 -174.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.812 1.645 . . . . 44.1 110.085 163.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.92 19.57 10.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.139 1.376 . . . . 73.0 111.879 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -140.26 8.82 2.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.648 1.179 . . . . 73.24 111.366 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.9 tt -76.0 148.82 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.317 1.447 . . . . 74.03 108.82 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.26 152.23 88.04 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.033 -1.042 . . . . 62.1 109.083 170.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.06 -48.94 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.687 1.591 . . . . 73.3 111.198 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttp85 -64.13 -21.27 66.48 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.124 -0.941 . . . . 74.33 112.767 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.19 -33.3 72.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.576 1.535 . . . . 62.41 110.492 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.28 -23.25 54.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.094 -0.955 . . . . 65.41 111.86 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HB2' HG11 ' A' ' 39' ' ' VAL . 2.9 pt-20 -91.37 -33.48 15.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.19 0.904 . . . . 74.34 108.628 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.42 -36.56 76.11 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.272 1.829 . . . . 74.14 111.107 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -49.9 -62.45 1.56 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.126 0.97 . . . . 63.51 110.471 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.81 -17.61 64.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 65.51 111.833 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -2.33 6.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.727 1.01 . . . . 70.13 113.727 172.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -69.69 -34.58 74.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.416 1.462 . . . . 64.24 110.159 161.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -8.96 11.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 120.005 1.275 . . . . 64.51 113.806 -159.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.99 178.48 48.5 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.415 -0.674 . . . . 45.04 111.415 -160.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.64 135.75 54.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.892 1.346 . . . . 62.32 112.005 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 HG12 ' A' ' 59' ' ' VAL . 9.9 p -123.21 153.29 28.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 125.59 1.556 . . . . 51.32 109.614 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -97.35 -52.84 3.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.323 -1.762 . . . . 64.31 107.219 -166.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.13 -177.88 3.48 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.164 0.585 . . . . 72.22 110.267 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.05 149.52 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.199 1.0 . . . . 72.31 110.259 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -124.91 159.58 30.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.096 1.358 . . . . 70.43 109.735 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.1 ptp -138.6 132.0 30.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.771 1.228 . . . . 54.3 107.88 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HB ' HD13 ' A' ' 56' ' ' ILE . 3.6 mp . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 107.256 -1.387 . . . . 54.4 107.256 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.233 0 N-CA-C 109.452 -1.459 . . . . 71.3 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.592 HD13 ' HB ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -142.96 141.15 27.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.926 1.29 . . . . 61.4 109.182 -169.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.82 152.43 28.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.41 1.084 . . . . 70.23 108.927 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -124.95 146.1 49.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.553 1.541 . . . . 72.44 107.339 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 39' ' ' VAL . 1.8 t -130.8 115.27 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.869 -1.16 . . . . 73.52 107.869 -161.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -85.9 96.57 9.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.884 0.873 . . . . 74.43 109.61 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -59.69 157.22 12.3 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 120.029 -1.67 . . . . 74.51 113.45 166.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.99 -29.19 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 109.702 -0.481 . . . . 74.32 109.702 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.44 144.83 42.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.97 1.308 . . . . 62.11 110.001 -171.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 p -72.91 -21.9 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.443 0.697 . . . . 73.23 112.527 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -59.26 -22.64 61.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.621 -1.3 . . . . 73.11 113.755 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m -93.27 -2.08 55.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.801 0.84 . . . . 72.23 113.094 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.42 -58.35 19.2 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 120.211 -1.556 . . . . 65.5 110.135 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.01 -14.63 44.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 CA-C-N 121.383 1.53 . . . . 74.33 112.683 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -41.34 94.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.336 -0.853 . . . . 74.51 108.762 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.79 -28.54 66.06 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.868 0.867 . . . . 62.41 112.966 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.5 mt -63.49 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 118.966 0.803 . . . . 70.51 109.076 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.39 -14.3 59.59 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.549 -0.72 . . . . 30.45 113.794 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.89 -0.79 41.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.508 1.154 . . . . 73.42 112.287 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -45.54 -45.62 13.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.872 1.269 . . . . 74.42 111.524 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.67 4.94 79.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.809 0.718 . . . . 71.21 114.245 -168.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -78.91 -171.14 2.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.505 1.152 . . . . 73.3 108.929 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.43 121.03 4.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.985 -1.487 . . . . 73.1 106.985 176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 97.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.287 -1.375 . . . . 72.42 107.287 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 mt 53.08 16.23 0.72 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.719 1.607 . . . . 70.42 113.439 -170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.99 7.29 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.132 0.872 . . . . 53.32 113.137 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 20' ' ' LEU . 82.4 t -107.26 86.61 2.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.724 2.01 . . . . 61.3 111.222 -174.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.76 175.84 1.58 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.157 1.904 . . . . 51.34 111.557 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.6 tt -127.19 163.96 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 O-C-N 121.53 -0.731 . . . . 62.41 110.278 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 86' ' ' GLN . 49.2 mm -99.87 140.25 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.743 -1.577 . . . . 62.23 106.743 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -44.92 -24.97 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.085 2.154 . . . . 74.21 114.83 170.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.516 ' H ' HG22 ' A' ' 84' ' ' ILE . 13.1 mt-30 -44.1 -51.7 7.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.123 1.769 . . . . 73.42 113.331 -162.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.33 48.75 18.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.798 1.239 . . . . 74.2 112.376 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 108.271 -1.011 . . . . 73.14 108.271 -174.332 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 114.562 1.319 . . . . 73.24 114.562 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.02 165.58 27.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.036 -1.468 . . . . 72.51 107.036 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.76 -178.5 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.936 0.895 . . . . 71.43 109.536 163.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.73 102.17 3.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.404 1.097 . . . . 75.43 110.573 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.5 m -87.66 94.94 9.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.384 1.874 . . . . 70.51 109.117 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.4 ttp -108.17 44.85 1.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.769 1.227 . . . . 63.52 110.207 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -164.8 68.3 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 72.2 110.36 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.39 166.1 10.92 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.364 -0.835 . . . . 74.34 111.367 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.9 171.55 7.58 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.627 1.171 . . . . 45.2 110.654 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.85 -30.94 65.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.266 0.839 . . . . 74.4 113.266 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.63 51.5 1.92 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.365 1.066 . . . . 62.44 108.959 -170.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 tt -80.47 154.13 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.772 -0.825 . . . . 71.2 108.772 170.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -111.76 160.59 29.1 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 107.802 -1.184 . . . . 72.54 107.802 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -59.96 -21.43 64.69 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.031 1.821 . . . . 73.32 112.436 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -34.5 73.0 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.963 -1.086 . . . . 71.11 112.297 173.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -34.31 74.74 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.874 1.216 . . . . 63.31 111.747 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' HG11 ' A' ' 59' ' ' VAL . 2.2 mm? -64.5 -41.8 96.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.558 0.743 . . . . 74.41 110.124 -174.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.77 -35.12 29.94 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.221 -0.895 . . . . 62.44 109.99 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -63.92 -24.31 67.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.597 1.089 . . . . 72.13 111.253 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -65.46 -67.6 0.43 Allowed 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.874 -0.516 . . . . 73.51 110.388 168.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -71.4 -19.7 62.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.552 0.945 . . . . 65.3 113.552 -167.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 t -51.72 -28.64 15.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.96 1.304 . . . . 74.51 110.798 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.418 HG23 HG13 ' A' ' 36' ' ' VAL . 1.3 t -77.02 -14.94 59.77 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.146 -0.971 . . . . 62.11 110.987 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 35' ' ' THR . 31.2 m -131.36 -4.19 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.261 1.024 . . . . 72.23 113.358 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.15 -156.83 12.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.662 -1.375 . . . . 72.21 109.662 -174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -145.3 139.33 27.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.421 1.111 . . . . 73.52 110.985 166.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 t -71.17 143.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.925 1.69 . . . . 73.44 108.778 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -82.44 -50.6 8.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.013 -1.054 . . . . 54.12 109.606 163.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.58 124.06 11.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.275 0.488 . . . . 63.22 110.817 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.6 t -73.7 108.17 4.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 O-C-N 121.404 -0.81 . . . . 62.41 109.343 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -104.91 82.58 1.89 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.863 1.265 . . . . 71.2 108.129 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 153.57 23.4 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.613 0.765 . . . . 74.2 109.003 167.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 108.155 -1.054 . . . . 63.44 108.155 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 N-CA-C 109.606 -1.398 . . . . 62.22 109.606 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 pt -145.56 137.36 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.1 1.36 . . . . 74.12 110.152 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.61 135.19 29.76 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.601 -1.259 . . . . 64.4 107.601 163.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -122.11 70.77 0.98 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.625 -1.25 . . . . 75.2 107.625 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 29' ' ' LEU . 3.1 m -67.35 135.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.539 0.685 . . . . 61.1 109.772 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.61 145.06 31.89 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.809 -1.182 . . . . 73.34 107.809 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.18 151.33 24.9 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 113.319 0.859 . . . . 73.44 113.319 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 -43.6 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.31 -0.859 . . . . 70.3 109.104 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.38 142.64 46.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.518 1.127 . . . . 73.52 109.71 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.97 -36.66 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 111.827 0.306 . . . . 50.3 111.827 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -62.6 -23.51 67.08 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.148 -0.97 . . . . 74.1 113.065 -166.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -77.07 -13.12 60.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.945 0.898 . . . . 54.14 113.07 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.98 -56.48 25.22 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.866 1.666 . . . . 62.31 111.723 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.63 -12.41 34.98 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 121.997 1.798 . . . . 64.23 113.635 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.26 -47.93 66.43 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.009 -1.057 . . . . 52.44 109.231 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.57 69.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.372 0.669 . . . . 62.33 112.395 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 85' ' ' VAL . 65.9 mt -57.32 -41.4 78.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.754 0.822 . . . . 73.51 109.362 176.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.85 -18.46 56.92 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.56 -0.578 . . . . 74.54 112.865 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -101.34 9.44 41.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.708 1.203 . . . . 71.32 111.554 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -51.64 -30.02 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.69 1.132 . . . . 61.1 113.383 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.91 5.41 27.39 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.161 1.362 . . . . 63.1 112.796 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.95 174.95 8.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.779 1.29 . . . . 62.41 108.275 155.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 130.15 10.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.83 1.252 . . . . 73.34 108.642 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.19 115.52 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.819 -1.919 . . . . 65.2 105.819 162.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.65 3.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.737 2.125 . . . . 63.52 116.737 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.72 7.27 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.736 1.153 . . . . 42.24 113.923 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.39 86.99 2.97 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 128.323 2.649 . . . . 72.22 109.675 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.77 -176.67 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.791 2.327 . . . . 74.41 111.549 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.5 tt -136.77 167.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 121.19 -0.944 . . . . 71.24 109.715 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 86' ' ' GLN . 39.8 mm -111.95 144.72 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.671 -1.603 . . . . 72.11 106.671 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 71' ' ' ILE . 28.2 t -57.34 -13.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.508 1.923 . . . . 73.1 112.832 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' H ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -52.42 -26.68 13.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.001 2.52 . . . . 75.5 115.419 -171.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 43.32 89.92 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.352 1.461 . . . . 54.04 112.132 155.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 107.723 -1.214 . . . . 62.51 107.723 173.545 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.657 0.265 . . . . 73.55 111.164 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.63 150.67 49.7 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.909 -1.119 . . . . 74.35 109.664 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 61' ' ' PHE . 28.1 m -133.71 171.7 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.357 1.463 . . . . 72.52 107.557 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.92 142.16 30.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.258 1.423 . . . . 75.21 108.238 -166.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.7 m -130.21 103.28 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.148 1.379 . . . . 64.52 109.858 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.1 ttm -92.83 -0.34 57.27 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.797 1.036 . . . . 72.12 113.797 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -128.18 29.08 5.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.278 1.214 . . . . 52.32 114.278 -163.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.401 ' HA ' HG13 ' A' ' 81' ' ' VAL . 87.0 mt -73.34 151.53 41.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.355 1.062 . . . . 74.1 113.632 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.21 165.72 17.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.549 1.14 . . . . 72.1 112.95 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.084 1.354 . . . . 74.14 113.542 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.98 47.09 1.96 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.26 1.024 . . . . 74.11 110.755 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.51 154.49 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 120.995 -1.065 . . . . 74.22 109.05 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -114.98 157.87 42.23 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 127.439 2.296 . . . . 72.31 107.738 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.21 -19.89 69.58 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.805 1.67 . . . . 74.42 112.182 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 1.5 ptp180 -76.71 -29.95 56.46 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.363 -0.827 . . . . 73.34 112.259 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -61.89 -25.19 67.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.491 1.041 . . . . 75.13 111.061 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' H ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -78.11 -54.24 6.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.915 0.886 . . . . 75.34 109.07 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.57 -33.29 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 117.693 -1.146 . . . . 73.42 111.347 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.02 0.827 . . . . 74.5 109.53 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CG ' HG21 ' A' ' 78' ' ' VAL . 9.0 t80 -52.79 -48.21 67.03 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 122.684 0.394 . . . . 61.14 110.718 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -80.04 -14.46 58.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.199 -1.0 . . . . 75.5 112.103 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 t -64.97 -17.25 64.25 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.362 1.437 . . . . 55.01 110.848 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 p -73.16 -21.77 60.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.779 1.172 . . . . 71.43 111.037 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.43 -7.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.641 1.576 . . . . 71.42 112.736 -166.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.37 18.46 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.114 1.34 . . . . 22.42 111.003 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -147.87 134.41 19.78 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.68 1.192 . . . . 73.42 110.573 -168.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.0 t -105.5 144.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.293 1.837 . . . . 71.3 108.395 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.71 -54.93 2.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.275 1.43 . . . . 72.43 108.378 172.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.56 165.04 27.91 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 124.162 0.914 . . . . 64.11 110.982 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.01 110.26 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.946 2.098 . . . . 71.21 106.502 -160.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -143.71 81.34 1.69 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.041 0.837 . . . . 64.14 110.047 -160.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.1 mtp -88.41 160.77 17.41 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 122.671 1.224 . . . . 64.33 110.429 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mm . . . . . 0 N--CA 1.433 -1.322 0 C-N-CA 124.823 1.249 . . . . 60.12 107.917 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.212 0 N-CA-C 110.416 -1.074 . . . . 74.31 110.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -145.65 153.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.288 1.044 . . . . 73.52 110.732 171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.8 40.78 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.976 1.31 . . . . 63.33 109.144 168.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -122.28 154.83 37.05 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 75.25 106.783 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 t -134.67 134.46 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.184 -2.154 . . . . 75.25 105.184 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.55 109.09 20.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.625 -1.991 . . . . 72.21 105.625 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' A' ' 15' ' ' VAL . 3.5 m-30 -73.18 168.97 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.522 0.729 . . . . 71.53 109.296 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.43 -38.67 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 120.538 -0.465 . . . . 62.33 109.85 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.11 128.15 45.2 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.651 0.659 . . . . 71.22 110.447 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.82 -37.76 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 72.35 111.474 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -5.5 54.27 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.685 -1.259 . . . . 63.42 112.336 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.9 m -90.88 -12.06 37.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.232 -0.918 . . . . 74.34 111.824 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.5 t -54.58 -57.63 17.99 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.369 0.986 . . . . 75.22 110.089 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.86 -22.61 68.88 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.228 1.952 . . . . 73.53 113.872 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.21 -52.26 59.73 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.771 -0.826 . . . . 72.24 108.771 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.86 78.57 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.217 0.607 . . . . 74.5 111.328 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.87 -44.51 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.563 0.745 . . . . 75.11 109.385 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.92 -10.64 27.05 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.764 0.697 . . . . 40.3 114.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.41 5.84 50.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.555 1.178 . . . . 72.13 111.932 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.679 ' HA ' HG23 ' A' ' 83' ' ' ILE . 8.9 t -44.46 -45.75 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.996 1.718 . . . . 74.12 112.876 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.86 2.93 84.67 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.738 -1.034 . . . . 62.11 113.703 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.06 -176.59 2.16 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.508 1.654 . . . . 74.13 109.317 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -157.45 81.69 0.9 Allowed 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.829 0.851 . . . . 71.22 109.502 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 32' ' ' PHE . 60.7 t -58.47 102.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.487 1.115 . . . . 51.31 108.541 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt 56.51 25.03 9.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.53 0.332 . . . . 71.11 111.677 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.73 -6.41 25.99 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.237 -1.313 . . . . 54.13 113.706 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 20' ' ' LEU . 59.1 t -104.7 86.7 1.52 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.546 1.938 . . . . 64.3 111.915 -168.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.08 -179.58 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.76 2.307 . . . . 71.44 111.635 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -141.83 168.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.424 0.689 . . . . 53.02 109.278 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.8 mm -112.45 137.66 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.606 1.562 . . . . 63.44 106.968 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.31 -2.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 129.731 3.212 . . . . 74.23 117.058 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -62.03 -33.2 73.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.999 1.851 . . . . 72.12 115.999 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.65 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 123.515 1.626 . . . . 51.03 110.709 -162.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.893 0 CA-C-N 114.067 -1.424 . . . . 71.41 107.616 156.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 112.116 0.413 . . . . 61.34 112.116 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -66.7 126.98 30.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.857 -1.164 . . . . 64.31 107.857 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 174.2 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.528 -0.916 . . . . 73.24 108.528 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.7 98.39 3.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.624 1.202 . . . . 74.23 110.707 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' HB3' HD21 ' A' ' 20' ' ' LEU . 62.0 m -80.93 88.14 5.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.559 1.543 . . . . 52.03 108.541 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttp -90.94 13.12 17.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.988 0.915 . . . . 55.21 112.397 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.4 mt-30 -133.38 94.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.493 -1.38 . . . . 53.03 107.872 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 29' ' ' LEU . 12.1 mt -118.28 157.51 26.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.578 0.351 . . . . 55.25 111.577 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.43 160.56 32.13 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.011 0.91 . . . . 72.32 110.055 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.64 5.29 13.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.948 1.699 . . . . 71.14 114.103 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.71 64.12 1.0 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.012 1.278 . . . . 75.12 108.21 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 tt -109.83 136.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.712 1.205 . . . . 73.44 109.532 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -77.2 149.07 78.93 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 107.63 -1.248 . . . . 73.05 107.63 165.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.85 -32.82 93.13 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.238 1.292 . . . . 72.32 111.158 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttp85 -66.73 -20.8 66.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.074 -0.965 . . . . 63.33 112.507 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.5 -29.0 70.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.737 1.608 . . . . 73.13 109.679 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 2.4 mm? -77.67 -48.58 16.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.936 0.895 . . . . 75.13 109.754 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.14 -37.29 80.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.896 0.316 . . . . 74.32 110.996 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.823 0.849 . . . . 72.02 111.314 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -57.27 -46.13 83.38 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.498 0.59 . . . . 55.24 110.311 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -68.23 -26.62 65.79 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.612 -0.68 . . . . 73.14 112.667 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -15.33 34.99 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.655 1.182 . . . . 72.23 112.804 -173.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -61.81 -18.6 60.55 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.425 -0.797 . . . . 62.43 111.679 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.81 24.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.2 1.0 . . . . 62.2 110.401 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.3 -161.77 27.36 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.201 1.364 . . . . 72.04 115.371 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.57 146.37 28.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.34 1.856 . . . . 75.32 108.644 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.21 150.55 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 127.175 2.19 . . . . 73.03 107.963 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -82.04 -56.69 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.608 1.563 . . . . 73.32 109.282 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -159.43 134.64 8.25 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.132 -0.692 . . . . 72.23 109.132 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.43 162.27 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.397 1.879 . . . . 72.01 111.205 164.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.78 112.1 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.335 2.254 . . . . 75.03 107.81 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.0 ptp -116.76 147.8 41.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.874 1.216 . . . . 75.43 110.556 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.3 mp . . . . . 0 C--O 1.238 0.467 0 N-CA-C 107.886 -1.154 . . . . 52.01 107.886 -166.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 108.372 -1.891 . . . . 75.25 108.372 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.44 135.02 30.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.047 0.939 . . . . 74.31 108.941 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.78 147.78 21.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.329 1.852 . . . . 55.21 108.174 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -122.27 123.2 40.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.116 -1.809 . . . . 75.44 106.116 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.73 140.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 121.986 2.175 . . . . 75.14 108.057 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.05 115.57 12.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.9 -1.889 . . . . 71.32 105.9 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.21 160.57 22.98 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.307 0.958 . . . . 75.22 110.35 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.64 -27.94 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 118.629 -0.7 . . . . 74.21 110.759 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -114.73 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.888 1.222 . . . . 63.14 110.217 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.68 -28.02 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.857 1.263 . . . . 71.23 110.587 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -68.99 -17.31 63.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.861 1.21 . . . . 73.11 110.56 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -70.47 -23.55 62.71 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.604 1.562 . . . . 72.51 113.923 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.07 -56.29 37.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.422 -0.799 . . . . 44.43 110.11 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.17 -13.26 39.05 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.611 1.541 . . . . 74.2 113.2 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.11 -48.01 69.43 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.798 1.181 . . . . 60.14 109.839 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.56 78.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.454 0.57 . . . . 44.2 111.446 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.77 -39.47 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.967 0.907 . . . . 64.14 110.016 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.92 -0.09 40.52 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.603 -1.109 . . . . 60.11 114.025 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.12 2.63 19.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.805 1.802 . . . . 74.44 111.794 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 83' ' ' ILE . 15.1 t -50.45 -33.03 19.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.64 1.176 . . . . 74.13 113.54 -171.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.78 21.9 26.92 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.725 1.155 . . . . 64.51 113.848 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.93 174.22 8.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.213 1.507 . . . . 73.34 108.176 153.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -159.87 85.74 0.76 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.384 0.993 . . . . 74.51 112.717 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.0 m -60.37 117.59 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.734 -0.469 . . . . 71.2 109.734 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.3 mt 51.31 31.03 6.52 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.589 1.156 . . . . 63.14 112.534 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.51 27.67 29.3 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.226 -0.763 . . . . 54.25 113.044 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 t -121.15 84.79 40.57 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.931 1.365 . . . . 75.23 109.619 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.32 177.54 5.17 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.285 2.657 . . . . 75.31 112.018 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.1 tt -132.69 144.4 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.477 -0.764 . . . . 75.44 109.695 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 86' ' ' GLN . 41.3 mm -86.52 142.54 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.507 -0.923 . . . . 71.33 108.507 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.53 -3.91 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 114.691 1.367 . . . . 72.21 114.691 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 84' ' ' ILE . 2.1 mm100 -46.45 -51.41 15.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.192 1.797 . . . . 72.41 113.887 -168.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.01 174.34 0.07 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.282 1.433 . . . . 73.51 110.281 -169.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 106.753 -1.573 . . . . 72.51 106.753 153.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.562 0.579 . . . . 73.03 112.562 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -70.84 149.17 47.09 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.878 0.847 . . . . 53.41 110.279 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.0 114.76 45.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 122.279 1.038 . . . . 65.01 108.45 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.93 104.75 14.27 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.471 -1.24 . . . . 73.21 108.829 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -92.27 121.11 33.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.151 -1.426 . . . . 51.13 107.151 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 ttm -125.53 18.79 8.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.267 1.027 . . . . 72.12 111.474 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.11 22.03 3.79 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.617 -1.302 . . . . 74.35 111.725 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.777 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.7 mt -77.44 164.51 25.4 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.546 0.573 . . . . 64.41 112.546 -168.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.4 26.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.735 1.214 . . . . 71.43 110.709 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 14.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.143 2.177 . . . . 73.03 114.929 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.91 16.69 2.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.95 1.25 . . . . 63.4 114.153 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.98 145.0 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.639 -1.288 . . . . 73.12 110.965 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -83.61 156.74 65.04 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-O 118.129 -0.939 . . . . 70.13 109.489 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.41 -37.12 74.13 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.138 1.892 . . . . 74.34 111.582 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.14 -28.48 68.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.684 -1.151 . . . . 65.13 111.982 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -33.47 69.72 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.866 1.666 . . . . 71.44 111.024 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.2 -29.75 69.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.458 1.103 . . . . 71.03 110.712 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.6 pt-20 -92.42 -30.87 15.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.937 0.895 . . . . 73.12 110.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.16 -44.68 92.14 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.486 1.514 . . . . 64.21 110.864 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.33 -63.75 1.04 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.487 1.515 . . . . 63.2 109.777 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.02 -22.5 61.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.266 0.469 . . . . 74.5 112.266 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -19.27 64.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.614 1.097 . . . . 74.31 111.443 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.8 p -61.24 -35.31 76.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.332 0.969 . . . . 61.14 111.077 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.0 8.42 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.934 2.494 . . . . 70.22 109.94 -167.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.19 -140.73 6.18 Favored Glycine 0 N--CA 1.442 -0.914 0 O-C-N 120.635 -1.29 . . . . 63.44 110.772 -162.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -152.83 -173.43 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.53 1.932 . . . . 73.11 106.808 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 30' ' ' GLU . 24.3 t -143.99 149.35 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 129.712 3.205 . . . . 71.02 106.169 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -62.89 1.54 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.724 -1.213 . . . . 65.42 107.724 167.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -158.99 162.25 36.76 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.876 -0.787 . . . . 63.0 108.876 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.78 128.67 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.952 1.701 . . . . 74.03 106.457 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -123.35 74.26 1.23 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.417 1.087 . . . . 73.33 109.002 170.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 130.87 35.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.639 2.376 . . . . 51.32 109.665 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 106.31 -1.737 . . . . 71.42 106.31 174.232 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 111.413 -0.675 . . . . 71.45 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -135.09 130.32 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 74.14 111.177 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.56 151.4 25.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.747 1.219 . . . . 65.01 111.175 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -127.5 80.99 1.99 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.627 1.171 . . . . 72.13 109.748 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.395 1.5 p -81.8 121.68 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.452 -1.405 . . . . 72.41 110.585 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.66 137.58 33.17 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.637 1.575 . . . . 73.11 109.989 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.46 160.79 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.965 0.888 . . . . 71.22 111.836 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.53 -16.24 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 126.531 1.933 . . . . 70.41 111.209 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -128.56 170.22 13.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.028 1.731 . . . . 71.21 108.806 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.99 -28.35 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.542 1.537 . . . . 72.04 111.032 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -77.89 -14.57 59.51 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.459 -1.401 . . . . 72.42 112.122 -167.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -89.08 -0.49 57.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.139 0.975 . . . . 74.3 112.613 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.86 -56.73 27.09 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 120.83 1.65 . . . . 44.13 109.425 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -14.81 46.0 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.953 1.769 . . . . 73.24 114.166 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.57 -59.61 4.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.218 1.372 . . . . 70.51 108.488 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.95 59.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.379 1.072 . . . . 71.5 112.241 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' VAL . 56.7 mt -57.41 -54.61 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.964 0.906 . . . . 70.53 108.622 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.52 -0.4 11.82 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.916 -0.936 . . . . 70.44 113.818 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -100.61 1.79 41.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.119 1.959 . . . . 73.24 111.295 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -49.45 -30.6 8.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.12 1.327 . . . . 73.3 114.344 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.38 2.43 56.24 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.405 1.002 . . . . 63.12 114.181 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.96 175.57 8.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.234 1.517 . . . . 72.31 108.517 164.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -152.63 131.76 12.7 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.278 -0.889 . . . . 74.5 110.057 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -83.61 90.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.425 -1.695 . . . . 62.4 106.425 170.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mt 59.81 37.34 21.94 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.869 0.842 . . . . 73.13 110.406 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.72 3.32 58.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.997 1.284 . . . . 74.21 114.581 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 20' ' ' LEU . 96.8 t -108.49 85.96 3.21 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.8 1.64 . . . . 74.34 109.801 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.07 -178.31 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.353 2.702 . . . . 73.13 112.608 168.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.438 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -134.33 148.75 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.063 0.945 . . . . 70.4 110.233 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 86' ' ' GLN . 46.0 mm -91.27 140.57 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.516 -1.29 . . . . 73.42 107.516 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 71' ' ' ILE . 24.8 t -51.19 -18.75 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.917 2.087 . . . . 70.31 114.795 171.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 84' ' ' ILE . 7.6 mm100 -44.31 -47.41 9.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 125.662 1.585 . . . . 70.11 113.276 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.05 49.86 16.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.707 0.803 . . . . 63.44 112.118 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.307 24.2 p . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 125.26 1.424 . . . . 65.54 110.568 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 72.35 116.224 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.1 m -107.54 157.08 18.32 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 119.961 -1.712 . . . . 54.44 109.495 -161.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.78 174.83 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.475 -0.766 . . . . 45.15 109.52 170.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -138.73 133.83 32.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.686 1.594 . . . . 72.44 107.36 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.6 m -127.31 121.99 32.57 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.32 -2.104 . . . . 65.55 105.32 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.3 ttp -125.32 14.31 8.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.11 0.964 . . . . 65.14 111.635 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -139.75 33.77 2.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.045 1.338 . . . . 63.14 109.982 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 mt -64.95 145.04 56.86 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.751 -0.593 . . . . 62.21 110.771 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -66.6 162.63 20.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.071 0.939 . . . . 64.51 109.496 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.17 59.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.446 -1.252 . . . . 70.14 114.31 -166.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -145.87 65.35 1.22 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.489 1.04 . . . . 73.24 108.762 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.9 tt -96.97 163.57 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 122.818 0.447 . . . . 73.32 110.387 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -108.52 155.48 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 125.779 1.632 . . . . 72.55 108.72 168.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 -36.51 93.07 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.396 2.064 . . . . 74.12 111.979 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -60.99 -32.95 72.5 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.962 -1.018 . . . . 61.41 111.612 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -72.52 -11.73 60.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.232 1.378 . . . . 74.13 112.865 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.26 -44.99 9.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.666 -0.865 . . . . 55.43 108.666 169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.8 pt-20 -65.71 -38.22 88.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.508 0.594 . . . . 73.53 111.518 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.5 -25.8 63.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.112 1.365 . . . . 75.53 112.651 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.28 -64.13 1.02 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.35 -27.68 69.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.78 1.029 . . . . 75.21 113.78 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 p -67.27 -3.22 7.36 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.991 1.269 . . . . 63.22 113.523 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -55.14 -27.88 48.66 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.754 1.161 . . . . 73.43 111.005 165.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -139.83 43.59 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.383 1.073 . . . . 72.21 110.861 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.03 -141.5 8.86 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.014 -1.234 . . . . 72.54 110.014 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -148.0 157.55 43.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.164 -1.05 . . . . 64.42 108.164 174.543 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 30' ' ' GLU . 67.0 t -91.98 163.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.518 -0.739 . . . . 53.01 109.194 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -122.31 -31.16 3.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.037 -1.459 . . . . 72.32 111.582 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -164.18 172.51 13.57 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.841 1.655 . . . . 54.25 109.196 159.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.55 126.0 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.515 1.926 . . . . 70.24 108.014 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.13 175.48 5.51 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.28 1.432 . . . . 74.53 109.929 169.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.3 ptp -166.29 154.93 10.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.898 1.679 . . . . 73.33 109.407 161.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.504 0.669 . . . . 64.21 109.923 -172.409 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.494 0 N-CA-C 108.786 -1.726 . . . . 33.53 108.786 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.71 122.73 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.363 1.465 . . . . 54.42 109.795 -168.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.89 150.87 37.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.258 1.023 . . . . 70.14 109.825 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.57 154.83 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.404 -2.073 . . . . 70.52 105.404 161.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.21 118.03 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.962 -2.236 . . . . 70.51 104.962 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -82.76 122.75 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.869 1.267 . . . . 72.44 108.638 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -96.42 176.22 6.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.801 0.81 . . . . 72.53 111.279 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG21 ' HG3' ' A' ' 38' ' ' LYS . 19.5 m -86.03 -24.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.358 1.863 . . . . 72.43 112.808 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -133.39 177.37 7.74 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.966 1.706 . . . . 51.44 111.4 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.46 -27.01 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.713 1.205 . . . . 72.21 111.59 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -67.73 -21.78 65.27 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.011 -1.055 . . . . 73.33 112.488 -166.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m -87.56 -9.58 54.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.523 -1.227 . . . . 71.44 113.146 172.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.7 -58.93 8.46 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 122.784 2.538 . . . . 74.34 109.895 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.03 -6.13 18.0 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.492 2.128 . . . . 73.22 114.783 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -70.59 -43.47 69.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.684 1.129 . . . . 72.01 109.395 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -25.61 47.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.999 0.92 . . . . 32.14 112.756 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.51 -46.03 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.976 0.911 . . . . 63.44 109.379 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.36 -1.52 43.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.205 -0.775 . . . . 61.05 113.985 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.26 4.2 33.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.934 1.367 . . . . 73.33 110.867 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -55.09 -20.3 9.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.944 1.298 . . . . 70.23 113.733 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.43 9.86 42.1 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.873 -0.959 . . . . 74.04 113.411 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -81.4 -179.98 7.6 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.754 1.277 . . . . 74.42 110.38 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -159.2 88.61 0.89 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.693 -0.629 . . . . 64.31 109.997 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.728 ' O ' HG12 ' A' ' 81' ' ' VAL . 57.3 t -68.28 110.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.098 -1.445 . . . . 73.53 107.098 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.7 mt 55.02 21.5 3.81 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.649 -0.657 . . . . 44.22 112.0 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.98 1.22 27.0 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.398 -1.779 . . . . 70.42 115.047 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 78' ' ' VAL . 7.1 p -108.15 85.95 2.97 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 120.723 2.261 . . . . 74.41 111.563 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.42 162.63 29.83 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.343 2.028 . . . . 52.11 112.007 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -117.04 159.74 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.428 1.091 . . . . 74.54 110.288 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.99 144.25 14.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 107.085 -1.45 . . . . 74.25 107.085 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.21 -0.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.063 2.545 . . . . 74.41 115.887 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -61.97 -36.74 82.37 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 114.911 1.448 . . . . 70.23 114.911 -166.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.09 177.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 120.482 1.492 . . . . 71.42 111.227 -169.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 53.21 108.891 174.459 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 117.941 -1.028 . . . . 74.34 111.407 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.7 m -50.84 138.61 18.45 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.276 1.83 . . . . 55.25 109.889 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 59' ' ' VAL . 7.1 m -120.49 118.33 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.19 1.396 . . . . 55.15 109.43 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -68.83 155.67 39.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.894 1.278 . . . . 73.21 109.69 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 57' ' ' ALA . 1.8 p -131.11 158.47 40.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.764 1.626 . . . . 61.52 107.947 162.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -143.29 11.14 1.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.502 0.927 . . . . 33.1 113.502 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -140.45 25.31 2.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.477 1.035 . . . . 64.54 112.391 -163.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.18 165.31 16.29 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.871 -0.518 . . . . 55.04 111.402 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.4 169.64 8.57 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.592 1.157 . . . . 72.53 109.857 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.28 -11.47 60.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.531 1.308 . . . . 23.5 114.531 -171.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 20.29 10.13 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.289 1.404 . . . . 75.54 113.489 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tp -64.48 163.58 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.258 1.023 . . . . 60.34 110.001 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -121.59 157.73 55.88 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.672 1.989 . . . . 74.01 107.528 162.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.84 -41.93 64.31 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 CA-C-N 121.374 1.526 . . . . 51.25 109.838 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.769 1.025 . . . . 73.3 113.769 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.47 -28.19 66.78 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.22 1.373 . . . . 61.24 110.443 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.82 -40.26 16.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.187 1.395 . . . . 63.3 110.615 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.49 -35.63 75.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.589 0.632 . . . . 63.13 110.394 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.47 -51.96 67.65 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.574 1.549 . . . . 54.1 108.242 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -51.45 -57.21 9.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.339 1.056 . . . . 75.33 110.533 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -72.14 -19.57 61.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.274 0.842 . . . . 72.13 113.274 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.0 p -66.05 -18.13 65.14 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.761 0.824 . . . . 43.3 111.37 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.0 p -66.24 -14.57 62.16 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.001 0.371 . . . . 71.31 112.001 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.55 5.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.974 0.909 . . . . 61.1 112.121 -167.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.22 25.82 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.269 -1.532 . . . . 72.24 109.269 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.31 131.9 21.1 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.716 1.246 . . . . 75.04 113.201 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.0 154.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 125.727 1.611 . . . . 34.23 110.303 165.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -96.2 -58.47 2.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.741 1.616 . . . . 74.03 107.963 164.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -158.83 155.02 27.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.633 1.106 . . . . 52.14 110.091 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.64 140.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.307 1.043 . . . . 63.32 109.03 -169.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -142.26 71.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.544 1.138 . . . . 63.34 109.876 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.9 ptp -66.13 158.28 29.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.661 -0.816 . . . . 60.52 108.97 163.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 107.022 -1.473 . . . . 62.13 107.022 173.618 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.826 0 N-CA-C 111.54 -0.624 . . . . 60.53 111.54 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.19 153.98 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.203 1.801 . . . . 73.23 111.102 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -151.75 166.0 32.7 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.466 1.907 . . . . 42.14 109.273 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -124.08 152.37 42.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 104.868 -2.271 . . . . 75.41 104.868 155.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 15' ' ' VAL 0.356 1.5 p -144.86 115.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.667 -1.27 . . . . 55.14 108.963 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -63.24 131.93 50.01 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.416 1.886 . . . . 74.11 106.651 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.68 156.22 20.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.542 0.687 . . . . 73.23 111.004 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.98 -24.74 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.746 -0.661 . . . . 63.31 109.46 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.13 131.88 44.42 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.976 -1.078 . . . . 73.13 110.355 -163.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.403 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 3.3 p -63.92 -31.72 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.922 1.689 . . . . 60.35 110.571 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -41.67 98.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.385 1.474 . . . . 63.54 110.913 -169.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -78.89 -5.47 53.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.394 0.886 . . . . 60.33 113.394 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.97 -56.43 35.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.809 1.64 . . . . 73.24 109.563 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.57 -15.5 45.04 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 CA-C-N 120.58 1.243 . . . . 52.43 112.717 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.6 tp -64.89 -43.93 91.27 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 121.031 1.741 . . . . 64.54 109.757 168.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.82 76.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.378 1.444 . . . . 62.51 111.565 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -58.83 -45.6 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.631 -0.668 . . . . 72.13 109.288 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.28 -8.1 22.56 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.177 1.37 . . . . 73.52 114.109 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -113.97 4.31 15.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.426 1.613 . . . . 71.3 112.358 -172.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.62 -23.54 6.69 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.268 1.027 . . . . 61.51 113.645 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 19.26 35.29 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.86 1.219 . . . . 62.52 112.281 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -101.54 178.85 4.52 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.856 1.328 . . . . 64.53 109.428 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -152.48 95.31 2.01 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.426 1.091 . . . . 74.43 111.718 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.21 110.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.789 -1.189 . . . . 75.54 107.789 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt 50.85 35.22 11.77 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.746 1.218 . . . . 74.4 111.868 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.07 35.03 25.21 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.967 -0.907 . . . . 71.53 113.397 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.64 86.14 56.45 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.831 1.652 . . . . 75.24 108.008 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.83 171.91 12.62 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.505 2.136 . . . . 63.22 111.575 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.64 160.43 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.584 -0.698 . . . . 53.04 110.224 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.72 165.72 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.383 -1.34 . . . . 44.42 107.383 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.67 -21.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 117.829 -1.082 . . . . 72.34 113.16 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -44.38 -42.94 7.26 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.585 1.698 . . . . 55.04 115.585 -150.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.05 41.53 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 61.45 112.334 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.286 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 127.085 2.154 . . . . 63.44 111.828 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 110.244 -0.28 . . . . 72.0 110.244 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.28 148.85 49.66 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 120.859 -1.15 . . . . 74.34 109.278 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.4 114.62 39.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.067 0.937 . . . . 63.1 111.436 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.08 93.31 8.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.414 1.086 . . . . 73.34 109.821 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.17 92.13 5.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.45 -1.25 . . . . 72.33 108.137 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.2 ttp -93.48 14.62 18.13 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.146 0.795 . . . . 71.41 113.146 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -137.79 36.14 2.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.308 -1.495 . . . . 74.12 112.19 -165.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 mt -78.22 145.4 35.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.029 0.932 . . . . 74.31 112.613 -171.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' VAL . . . -72.08 147.85 46.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.377 1.871 . . . . 71.13 109.84 164.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.79 -0.97 6.06 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.321 1.971 . . . . 64.15 116.321 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -122.37 -0.38 9.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.56 1.527 . . . . 73.24 114.248 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.4 150.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.237 1.199 . . . . 54.22 114.237 -159.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -90.35 161.99 35.68 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.397 1.479 . . . . 71.25 109.901 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.79 -53.04 3.59 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.33 2.02 . . . . 73.23 111.795 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -66.15 -18.95 65.67 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.966 0.728 . . . . 71.11 112.966 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.39 -32.99 70.66 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.324 -0.86 . . . . 72.44 110.715 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.67 -52.65 16.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.01 -0.519 . . . . 74.43 109.872 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.69 -23.99 64.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.056 0.847 . . . . 70.42 110.916 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.76 -26.73 63.49 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.107 0.78 . . . . 71.21 113.107 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.34 -36.01 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 70.32 110.757 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.21 -25.74 19.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.513 0.931 . . . . 73.41 113.513 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -61.13 -20.71 62.99 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.417 1.887 . . . . 73.0 114.013 -169.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 t -58.08 -40.56 81.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.004 1.322 . . . . 71.22 108.969 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -148.31 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.18 0.992 . . . . 63.1 109.964 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.01 163.36 25.79 Favored Glycine 0 CA--C 1.521 0.448 0 O-C-N 120.673 -1.267 . . . . 71.03 112.032 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -116.46 124.64 50.46 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.026 0.93 . . . . 72.21 109.18 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -91.43 148.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.5 -1.296 . . . . 52.21 107.5 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -101.31 -46.79 4.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.029 1.731 . . . . 73.31 109.396 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -157.85 -176.99 6.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.012 0.824 . . . . 74.31 111.088 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.98 97.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.628 1.571 . . . . 73.44 108.411 -159.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -119.16 131.07 55.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.718 1.145 . . . . 73.42 110.161 -167.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.45 164.59 27.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.261 1.578 . . . . 70.02 115.261 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.237 0.447 0 N-CA-C 107.666 -1.235 . . . . 74.05 107.666 -179.09 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.416 0 CA-C-O 119.302 -0.721 . . . . 71.24 113.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.9 134.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.503 1.121 . . . . 62.41 110.094 -171.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.37 43.41 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.682 1.193 . . . . 74.01 111.819 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -120.98 108.6 14.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.229 1.812 . . . . 74.23 106.27 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.91 121.73 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.326 -1.361 . . . . 70.22 107.326 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -86.58 116.98 25.05 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.495 1.518 . . . . 74.02 109.072 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.71 162.47 18.74 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.485 1.514 . . . . 61.14 112.961 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 t -83.87 -20.34 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.046 1.339 . . . . 73.12 112.525 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.0 156.12 45.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.909 -1.145 . . . . 65.4 107.909 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.13 -26.27 36.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 123.456 0.473 . . . . 72.24 110.576 172.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -61.81 -36.86 82.38 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.045 -1.034 . . . . 65.04 113.626 -164.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 m -82.16 -5.45 58.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.617 1.099 . . . . 73.03 113.696 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.83 -57.97 18.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 119.997 1.272 . . . . 72.31 110.846 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.15 -15.86 52.26 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.966 1.778 . . . . 53.44 113.206 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.86 -45.54 81.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.351 0.978 . . . . 72.03 109.318 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.91 71.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.412 0.685 . . . . 45.3 111.14 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.51 -32.1 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.589 -0.694 . . . . 62.22 109.882 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.96 0.35 7.62 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.53 1.538 . . . . 71.1 114.23 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.82 11.74 3.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.038 1.735 . . . . 72.2 112.209 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -50.35 -29.55 10.21 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 121.123 1.783 . . . . 70.33 114.133 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.51 -16.02 55.89 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.826 -0.986 . . . . 71.11 112.894 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -70.7 170.88 11.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.646 1.223 . . . . 65.44 109.866 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -157.43 128.32 6.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.509 0.724 . . . . 64.42 109.219 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.3 t -84.71 94.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.262 -2.125 . . . . 65.41 105.262 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 mt 65.93 23.23 11.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.372 1.069 . . . . 64.33 112.93 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.07 11.8 29.01 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.82 -0.55 . . . . 63.05 113.16 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' ALA . 57.5 t -113.05 83.59 6.27 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 126.078 1.751 . . . . 72.24 108.853 174.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 176.29 8.36 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.225 2.617 . . . . 64.1 111.796 166.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.97 177.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.724 1.21 . . . . 72.23 108.926 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.646 HG22 ' H ' ' A' ' 86' ' ' GLN . 34.1 mm -123.75 139.12 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.558 1.143 . . . . 71.04 108.908 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -44.73 -18.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 130.476 3.51 . . . . 72.32 115.968 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.646 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.3 mt-30 -53.22 -58.34 7.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.716 1.143 . . . . 72.32 110.937 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.06 50.15 18.52 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 125.264 1.603 . . . . 65.33 110.491 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 125.294 1.438 . . . . 62.44 111.138 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 114.708 1.373 . . . . 63.32 114.708 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -102.08 145.98 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.591 1.156 . . . . 73.22 108.75 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.26 118.34 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.779 -0.823 . . . . 74.45 108.779 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -72.82 113.06 9.44 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.335 1.054 . . . . 71.22 108.721 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.9 m -98.95 129.95 45.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.519 1.528 . . . . 53.33 107.469 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.6 ttp -127.44 175.85 7.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.09 1.756 . . . . 73.53 107.615 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 64.1 20.83 12.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.808 1.643 . . . . 73.44 113.525 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -72.6 168.73 18.03 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.744 0.817 . . . . 70.21 111.227 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.52 166.13 11.25 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.079 1.14 . . . . 52.14 114.079 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.62 23.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 64.32 112.231 169.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -135.68 76.78 1.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 106.688 -1.597 . . . . 71.22 106.688 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -140.77 165.38 20.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 124.071 0.948 . . . . 65.43 108.796 168.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -117.51 157.92 46.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 126.64 1.976 . . . . 74.52 107.408 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -55.32 2.56 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.235 1.957 . . . . 75.44 111.94 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -63.48 -21.74 66.49 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.595 -0.717 . . . . 61.33 112.274 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.3 -19.02 62.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.948 1.249 . . . . 74.41 110.35 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.887 1.221 . . . . 73.5 110.781 169.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -69.54 -37.83 77.24 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.864 -0.421 . . . . 71.11 109.864 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 34' ' ' SER . 6.2 mm-40 -65.47 -26.71 68.06 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.307 1.043 . . . . 72.53 112.339 -176.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.73 -16.49 64.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.23 1.012 . . . . 62.55 113.37 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.66 -26.45 8.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.475 0.71 . . . . 72.41 111.22 173.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 6.5 t -53.78 -18.64 3.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.666 1.987 . . . . 62.14 111.949 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.4 p -46.31 -41.89 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.493 1.517 . . . . 74.42 111.12 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.77 46.24 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.135 1.774 . . . . 60.11 108.269 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.46 178.03 48.32 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 124.274 0.94 . . . . 63.32 110.865 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -137.83 134.1 34.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.333 1.453 . . . . 74.11 107.796 169.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 61' ' ' PHE 0.276 1.8 p -118.28 143.25 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.048 1.339 . . . . 61.43 109.562 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -77.29 -50.28 13.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.4 1.88 . . . . 62.44 108.284 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -168.58 -178.49 3.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.096 0.558 . . . . 75.22 110.938 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.34 152.48 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.366 1.466 . . . . 75.12 109.024 174.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -125.93 101.34 6.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.513 1.925 . . . . 71.41 106.803 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.3 mtp -95.21 142.12 28.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.116 0.966 . . . . 74.54 110.819 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 72.4 113.36 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.131 0 N-CA-C 109.534 -1.427 . . . . 74.13 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 pt -139.8 146.6 24.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.838 1.255 . . . . 73.21 108.555 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.38 44.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.371 1.068 . . . . 44.04 108.907 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -123.85 127.91 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.661 -1.607 . . . . 70.32 106.661 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.05 112.18 39.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.8 -1.555 . . . . 50.22 106.8 -167.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -92.41 91.87 7.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.855 1.262 . . . . 72.13 108.01 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -56.08 177.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.043 1.337 . . . . 73.11 113.91 175.404 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.77 -31.12 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 O-C-N 120.448 -1.407 . . . . 72.31 110.917 168.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -117.18 175.66 5.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.475 1.489 . . . . 64.15 110.443 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.64 -27.04 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 118.836 0.744 . . . . 60.33 111.246 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -67.4 -22.18 65.55 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.558 -1.339 . . . . 72.32 112.038 -171.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -5.2 57.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.945 1.091 . . . . 74.34 113.945 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.46 -55.53 39.07 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.32 1.418 . . . . 62.42 109.459 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.8 -10.32 28.41 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.849 . . . . 72.05 113.925 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.65 -59.38 3.65 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 120.082 1.31 . . . . 74.35 108.218 166.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HA ' HD23 ' A' ' 73' ' ' LEU . . . -59.34 -29.43 67.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.814 0.846 . . . . 71.21 113.007 -175.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.68 -26.27 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.848 1.259 . . . . 64.33 110.568 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.61 80.9 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.559 1.552 . . . . 74.25 114.112 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 70' ' ' ALA . 3.2 mm? -87.66 -4.06 58.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.157 1.479 . . . . 72.11 114.194 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.0 t -50.86 -21.35 1.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.364 1.987 . . . . 71.21 116.364 -160.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.4 -12.79 59.35 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.724 -1.235 . . . . 62.14 113.635 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.04 165.13 25.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.673 1.236 . . . . 71.32 110.451 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -140.76 88.35 2.18 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.137 1.775 . . . . 63.32 109.531 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.56 100.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.145 0.978 . . . . 74.23 109.002 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 mt 49.06 33.23 4.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.836 0.827 . . . . 73.24 111.275 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.74 5.94 62.59 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.536 -1.147 . . . . 64.14 114.157 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 t -105.5 86.46 1.75 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.702 2.001 . . . . 44.03 108.882 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.84 176.9 6.21 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.942 3.095 . . . . 65.43 112.404 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.58 151.06 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.496 0.665 . . . . 73.44 110.214 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.2 mm -106.28 156.13 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.295 1.438 . . . . 73.24 108.368 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 m -74.07 -0.78 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 114.904 1.446 . . . . 73.23 114.904 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -45.78 -60.33 2.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.033 1.123 . . . . 63.31 114.033 -165.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.79 157.37 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.999 1.319 . . . . 65.42 112.086 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 107.081 -1.452 . . . . 74.51 107.081 169.177 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HE ' ' HA ' ' A' ' 63' ' ' ASP . 11.2 mtt85 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 117.336 2.347 . . . . 74.5 117.336 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -110.62 153.73 24.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.751 1.16 . . . . 70.24 110.279 -164.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.604 1.562 . . . . 44.2 109.744 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.49 114.16 24.64 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.295 2.638 . . . . 74.01 110.876 -166.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.3 130.48 34.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.471 -0.566 . . . . 74.12 109.471 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -127.77 48.67 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.036 0.934 . . . . 75.42 111.695 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -157.71 11.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.129 -0.982 . . . . 73.02 113.128 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 168.6 8.78 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.809 -1.182 . . . . 73.01 113.264 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.87 170.57 9.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.226 -1.352 . . . . 70.42 113.194 -167.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.12 -12.43 61.49 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.634 1.574 . . . . 61.12 115.178 -161.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -134.47 31.01 3.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.369 0.986 . . . . 71.44 111.286 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.65 165.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.54 -0.541 . . . . 43.45 109.54 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -122.63 161.92 41.21 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.704 1.602 . . . . 72.24 109.038 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.86 -54.28 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.862 1.708 . . . . 74.01 109.535 165.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -38.73 69.01 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.53 -0.748 . . . . 74.14 111.985 -175.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.7 -34.14 72.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.591 1.087 . . . . 54.54 111.396 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.79 -10.27 59.76 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.442 0.697 . . . . 53.22 112.348 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' CB ' HG11 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -109.18 -31.66 7.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.407 1.083 . . . . 74.12 109.777 174.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -70.24 -30.86 68.03 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.554 1.542 . . . . 54.55 112.494 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -62.41 -26.04 68.27 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.079 -1.013 . . . . 71.15 111.693 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.43 -12.05 16.75 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.439 -0.791 . . . . 73.01 112.641 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.5 p -62.8 -19.59 64.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.75 1.614 . . . . 73.23 112.117 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 p -64.81 -23.71 67.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.781 1.232 . . . . 72.13 110.926 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 8.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.593 1.557 . . . . 73.44 112.3 -166.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.61 45.74 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.658 -1.276 . . . . 54.33 111.708 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.88 141.96 50.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.686 1.594 . . . . 52.32 107.856 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.463 HG21 ' CG1' ' A' ' 59' ' ' VAL . 11.3 p -135.97 145.96 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.801 1.241 . . . . 71.41 109.295 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -87.58 -46.82 9.21 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.908 -1.496 . . . . 73.22 111.042 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -169.52 174.78 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.781 0.719 . . . . 73.13 109.798 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 59' ' ' VAL . 49.1 t -125.87 145.46 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 73.15 109.694 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -117.38 98.1 6.24 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.108 1.763 . . . . 70.31 107.167 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.27 149.55 21.15 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.808 -1.182 . . . . 54.44 107.808 170.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 106.604 -1.628 . . . . 71.45 106.604 -176.719 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.215 0 N-CA-C 110.512 -1.035 . . . . 60.33 110.512 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -153.96 136.65 6.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 125.579 1.552 . . . . 72.01 109.128 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.57 151.19 30.36 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.544 1.137 . . . . 73.02 110.452 169.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -128.01 138.48 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.555 -1.646 . . . . 73.03 106.555 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' CG1' HG21 ' A' ' 39' ' ' VAL . 93.4 t -128.66 112.94 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.174 1.39 . . . . 64.03 108.258 -160.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.61 81.54 8.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.36 1.076 . . . . 61.3 109.987 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.19 150.17 4.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.858 1.263 . . . . 73.42 113.844 171.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.59 -24.04 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.657 . . . . 61.3 110.062 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 21.9 t0 -132.26 143.79 50.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.736 1.607 . . . . 70.33 113.15 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.2 -30.61 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.157 1.383 . . . . 62.3 111.344 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -66.28 -15.77 63.48 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.077 -1.014 . . . . 70.51 111.281 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 m -88.27 -6.67 57.65 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.476 1.287 . . . . 74.31 114.476 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -53.81 -56.7 22.65 Favored Pre-proline 0 N--CA 1.473 0.708 0 CA-C-N 121.85 2.113 . . . . 71.53 109.83 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -6.44 17.29 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 121.779 1.653 . . . . 63.51 114.335 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.33 -52.48 39.8 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.195 -1.565 . . . . 73.51 108.299 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.15 -23.65 65.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.645 0.778 . . . . 74.13 112.564 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.01 -45.62 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.921 1.289 . . . . 62.1 109.595 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.11 -2.6 48.38 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.951 -0.916 . . . . 13.25 113.247 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.99 2.82 55.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.323 1.562 . . . . 71.42 111.258 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -56.72 -20.87 24.12 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.541 1.064 . . . . 62.35 113.326 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.15 23.26 14.34 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.638 2.066 . . . . 51.24 112.045 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.35 175.58 5.64 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 128.699 2.8 . . . . 73.02 109.795 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -152.11 127.29 9.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.308 1.843 . . . . 74.15 108.602 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.5 101.0 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.889 -1.522 . . . . 71.45 106.889 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mt 64.22 -8.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.88 2.872 . . . . 70.33 116.662 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.24 -3.34 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.187 -1.006 . . . . 74.13 113.498 -160.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.12 85.25 12.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.872 2.069 . . . . 72.32 106.315 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.99 178.7 2.23 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.718 2.945 . . . . 73.43 111.92 175.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tt -137.38 161.47 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.27 1.028 . . . . 54.14 109.944 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.5 mm -101.62 158.08 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.283 -1.377 . . . . 74.05 107.283 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.92 -1.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.295 1.838 . . . . 75.24 114.877 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -46.1 67.03 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.128 -0.982 . . . . 74.0 113.278 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.96 29.79 2.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.618 1.71 . . . . 74.1 115.618 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.909 0 C-N-CA 126.787 2.035 . . . . 63.32 112.383 -173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.584 HH11 ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.31 0.856 . . . . 63.14 113.31 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 152.73 43.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.885 1.274 . . . . 74.3 110.482 -171.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.26 170.1 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.626 -1.25 . . . . 72.11 107.626 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -138.31 104.26 5.13 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.292 1.437 . . . . 74.33 109.332 -171.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.73 75.29 8.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.615 1.966 . . . . 73.34 110.201 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -81.38 25.07 0.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.302 0.853 . . . . 53.2 113.302 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -148.78 48.46 1.01 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.131 -1.606 . . . . 75.3 112.627 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.6 mt -79.15 166.75 21.89 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.558 0.947 . . . . 74.0 113.558 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.76 -160.72 0.79 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.554 2.342 . . . . 43.42 110.859 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.45 -20.99 11.09 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.938 1.829 . . . . 74.2 115.938 -164.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -129.62 44.3 2.99 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.478 1.608 . . . . 74.34 108.33 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.38 140.71 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.251 -1.341 . . . . 55.23 107.914 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.81 161.8 32.79 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 124.251 1.02 . . . . 72.13 108.549 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.41 -37.48 89.66 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.055 1.17 . . . . 62.24 110.1 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -58.29 -31.82 67.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.56 -1.21 . . . . 75.01 113.294 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.11 -34.95 75.78 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 120.496 1.498 . . . . 72.34 110.121 -171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.14 -32.26 70.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.344 1.057 . . . . 72.42 111.833 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.85 -7.65 23.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 117.998 -1.001 . . . . 64.01 112.541 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -37.27 18.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.917 1.235 . . . . 74.0 108.566 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.54 -39.05 64.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.665 0.786 . . . . 73.1 112.377 -174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -106.73 2.2 25.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.426 -0.797 . . . . 75.43 112.278 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.7 p -74.62 -10.66 59.75 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 120.422 1.464 . . . . 73.31 112.076 170.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -44.93 -52.05 9.1 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.779 2.032 . . . . 71.24 109.765 165.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.18 57.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 54.03 108.299 -171.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.58 164.42 28.76 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.209 -0.932 . . . . 73.42 113.528 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -123.53 131.19 53.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.798 1.239 . . . . 75.2 109.456 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -88.52 138.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.313 1.445 . . . . 73.42 107.848 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -76.91 -51.78 10.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.489 -0.93 . . . . 55.44 108.489 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 7.3 t0 -162.47 -172.74 3.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.194 1.797 . . . . 55.04 107.564 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.25 93.98 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 119.823 1.192 . . . . 71.14 110.454 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.93 163.14 22.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.376 1.084 . . . . 73.41 110.684 163.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.59 136.19 11.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 127.914 2.486 . . . . 74.33 105.751 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.238 0.449 0 N-CA-C 105.777 -1.934 . . . . 53.4 105.777 170.383 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.319 0 CA-C-O 118.831 -0.983 . . . . 73.31 111.871 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.24 143.6 27.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.163 0.985 . . . . 71.04 110.099 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.0 156.64 41.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.7 2.0 . . . . 73.41 106.462 159.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -116.56 142.57 46.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 104.317 -2.475 . . . . 75.11 104.317 162.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.04 115.91 44.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.356 -2.091 . . . . 61.54 105.356 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 41' ' ' ASP . 2.6 pm0 -73.36 126.36 29.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.668 0.747 . . . . 64.2 109.507 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.75 166.67 10.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.658 1.183 . . . . 75.33 110.911 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.86 -14.37 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.513 0.725 . . . . 35.34 111.561 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -138.16 168.64 19.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.517 -1.364 . . . . 64.52 108.876 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.71 -43.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.173 -0.918 . . . . 61.4 108.608 167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -64.99 -29.89 70.84 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.623 1.101 . . . . 60.24 113.681 -152.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -74.21 -8.14 55.15 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.536 0.939 . . . . 52.01 113.536 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -62.96 4.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 119.695 -1.878 . . . . 74.4 108.737 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.58 -10.83 29.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.948 1.374 . . . . 75.51 113.134 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.9 -54.32 13.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.531 1.06 . . . . 63.34 109.621 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.91 -30.18 63.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.942 1.297 . . . . 72.4 112.415 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.04 -49.14 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.487 1.115 . . . . 73.41 108.615 172.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.23 7.83 3.16 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.079 1.323 . . . . 73.41 114.484 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.2 mt -117.05 4.88 12.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.799 1.799 . . . . 53.32 111.001 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -49.91 -30.41 10.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.449 1.477 . . . . 72.0 111.932 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.57 18.64 54.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 125.115 1.34 . . . . 53.5 113.079 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.05 165.05 20.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.455 1.502 . . . . 72.3 107.674 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -149.17 130.51 14.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.29 0.636 . . . . 60.12 109.59 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.97 104.34 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 106.205 -1.776 . . . . 71.22 106.205 164.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt 59.91 19.28 8.27 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.625 1.57 . . . . 74.43 113.566 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.45 1.94 29.36 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.545 -0.586 . . . . 74.42 114.298 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -104.86 86.05 1.38 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.253 1.821 . . . . 55.53 107.209 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.14 179.07 3.07 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.672 2.248 . . . . 61.21 111.032 163.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 tt -121.34 175.86 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.708 1.203 . . . . 74.4 108.466 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 147.32 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.131 1.772 . . . . 75.21 106.848 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 t -55.55 -15.13 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.623 2.769 . . . . 71.2 115.646 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -44.61 -42.52 7.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.049 1.499 . . . . 73.1 115.049 -168.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.35 175.53 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.91 1.338 . . . . 63.54 109.294 -160.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 104.597 -2.372 . . . . 73.52 104.597 157.573 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.481 ' HE ' ' C ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 115.404 1.631 . . . . 61.23 115.404 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.38 131.69 55.89 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.975 -1.078 . . . . 72.35 112.011 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.61 178.02 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.176 1.79 . . . . 73.12 109.496 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -145.76 117.75 8.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.917 1.287 . . . . 64.35 110.359 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -95.96 134.66 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.643 -1.243 . . . . 70.45 107.643 164.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.6 ttm -131.88 31.51 4.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 65.11 111.047 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -145.18 25.04 1.41 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.582 -1.323 . . . . 74.14 112.11 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.99 166.69 23.13 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.069 -1.02 . . . . 64.11 113.618 -164.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.96 169.59 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.573 1.149 . . . . 43.25 112.168 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -49.13 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.948 1.299 . . . . 65.43 111.925 162.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -92.46 19.83 6.83 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.103 0.961 . . . . 74.45 112.524 -167.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.548 HD12 HG11 ' A' ' 81' ' ' VAL . 11.6 tt -64.23 163.23 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.441 0.696 . . . . 72.53 109.78 168.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -118.49 160.35 40.22 Favored Pre-proline 0 CA--C 1.519 -0.244 0 C-N-CA 125.11 1.364 . . . . 72.14 108.965 167.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.93 -29.85 87.82 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.605 1.537 . . . . 43.45 112.352 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -78.55 -18.78 54.17 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 117.662 -1.161 . . . . 74.01 113.309 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -33.61 73.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.339 1.427 . . . . 71.42 110.212 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.44 -44.97 61.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.238 1.015 . . . . 74.32 110.792 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.13 -41.62 85.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.448 -0.901 . . . . 63.24 108.727 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.02 -39.95 87.6 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.84 0.745 . . . . 73.14 112.571 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -55.76 -57.44 12.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.626 -0.879 . . . . 73.04 108.626 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.36 -25.14 60.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.144 0.794 . . . . 72.25 113.144 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -63.03 -11.45 19.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.96 1.304 . . . . 71.41 112.05 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 p -67.33 -21.46 65.65 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.846 1.657 . . . . 71.15 110.943 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.3 -0.57 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.819 0.848 . . . . 71.21 113.148 -165.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.78 146.08 6.43 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.906 -1.278 . . . . 70.32 109.906 165.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -63.95 148.87 48.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.916 0.358 . . . . 72.34 111.643 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.2 145.77 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 126.225 1.81 . . . . 62.21 108.14 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -84.68 -52.81 5.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.862 -1.066 . . . . 71.01 108.178 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -169.43 170.06 8.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.735 1.214 . . . . 54.24 110.63 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -100.52 165.64 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.014 1.726 . . . . 51.54 111.194 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -149.87 50.72 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.139 0.971 . . . . 73.45 109.859 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -66.78 120.65 13.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.242 2.217 . . . . 70.44 110.295 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 45' ' ' ILE . 3.8 mp . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 123.78 0.832 . . . . 74.03 109.051 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.162 0 N-CA-C 110.711 -0.956 . . . . 45.14 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 pt -117.08 142.95 28.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.353 1.461 . . . . 72.43 109.835 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.84 150.12 36.57 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.083 1.353 . . . . 62.02 108.027 160.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 45' ' ' ILE . 62.0 m-85 -117.74 157.87 25.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.651 -1.981 . . . . 70.14 105.651 158.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.41 144.54 3.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.841 2.056 . . . . 73.35 106.327 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -111.72 119.73 39.64 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.748 1.619 . . . . 74.11 107.547 -165.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -80.47 173.92 12.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.66 0.743 . . . . 64.22 111.394 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.96 -32.12 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.467 -0.771 . . . . 65.01 108.974 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 4.8 m-20 -129.72 120.98 26.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.488 1.115 . . . . 73.05 108.462 -166.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.405 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 7.3 p -45.67 -34.59 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 129.06 2.944 . . . . 74.35 111.206 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 m -64.65 -18.87 65.34 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.929 -1.732 . . . . 74.01 112.83 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -1.77 24.09 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG23 ' NH2' ' A' ' 13' ' ' ARG . 92.4 t -61.6 -61.34 8.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 120.988 1.722 . . . . 74.24 109.273 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.44 -17.93 60.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.625 . . . . 73.44 113.703 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.37 -56.55 20.58 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.722 1.146 . . . . 65.32 110.343 172.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.57 80.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.39 0.676 . . . . 73.04 111.279 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.98 -47.67 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.654 1.182 . . . . 71.33 109.213 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.98 -22.25 34.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.999 0.809 . . . . 72.35 114.155 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -99.12 12.56 35.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.296 -1.12 . . . . 72.32 111.839 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.4 t -49.12 -26.39 2.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.434 1.094 . . . . 74.24 113.83 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -9.02 60.34 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.767 0.699 . . . . 73.44 114.502 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.38 163.49 26.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.505 1.153 . . . . 62.43 108.254 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -153.33 74.52 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.881 0.472 . . . . 52.24 110.633 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 t -53.16 103.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.925 1.69 . . . . 73.22 108.358 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt 54.72 29.57 11.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.762 0.825 . . . . 74.15 112.064 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 29.65 34.74 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.882 -0.511 . . . . 65.11 112.919 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 24' ' ' ILE . 38.4 t -125.12 80.08 64.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.744 1.618 . . . . 61.32 108.922 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.96 -172.2 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.06 3.174 . . . . 72.42 112.06 171.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.5 tt -137.49 146.56 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.72 1.208 . . . . 74.21 109.592 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.2 mm -87.65 141.58 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.084 -1.45 . . . . 71.03 107.084 171.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.91 0.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 128.697 2.799 . . . . 72.31 115.737 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -55.47 -51.13 67.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 126.296 1.838 . . . . 74.21 114.013 -169.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.8 169.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.278 1.031 . . . . 73.14 110.377 -162.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 105.206 -2.146 . . . . 53.42 105.206 162.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 118.764 2.876 . . . . 75.03 118.764 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.1 m -115.0 159.9 20.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 119.996 1.271 . . . . 54.14 109.51 -160.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.4 166.88 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.635 -1.616 . . . . 75.22 106.635 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -138.34 108.43 6.39 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.419 1.088 . . . . 75.34 110.721 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -79.79 125.27 29.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.726 1.61 . . . . 43.15 107.97 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -137.57 27.73 2.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.447 0.641 . . . . 51.05 112.542 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -141.99 46.5 1.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.644 -1.285 . . . . 70.45 110.095 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HG13 ' A' ' 81' ' ' VAL . 4.0 mp -90.27 -173.88 3.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.177 1.391 . . . . 62.31 112.74 -167.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.67 162.61 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.051 2.141 . . . . 61.11 109.681 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.49 -10.05 59.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.379 0.881 . . . . 64.12 113.379 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.67 56.78 1.83 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.311 1.044 . . . . 75.1 111.323 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 tt -112.81 133.13 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.496 1.119 . . . . 75.23 108.986 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -81.64 164.88 47.15 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 119.04 -0.505 . . . . 64.01 110.263 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.29 -46.21 22.93 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.568 1.512 . . . . 60.32 110.064 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -66.51 -16.82 64.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.369 0.878 . . . . 73.3 113.369 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -63.35 -34.97 78.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.801 1.182 . . . . 71.22 109.551 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 -43.38 18.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.728 -0.653 . . . . 62.31 110.157 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.66 -35.13 75.47 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.751 1.16 . . . . 75.03 110.013 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.71 -11.69 59.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.923 1.289 . . . . 72.32 113.654 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -72.52 -63.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 119.465 1.03 . . . . 74.44 108.408 170.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.21 -15.17 62.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 117.907 -1.044 . . . . 63.02 112.155 -175.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t -48.51 -25.38 1.66 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.63 1.572 . . . . 54.53 112.637 164.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -68.86 -19.72 64.25 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.713 -1.242 . . . . 61.33 111.094 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.38 -19.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.157 1.344 . . . . 74.11 114.525 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.55 -177.54 26.3 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 120.942 -1.099 . . . . 74.04 111.331 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -123.08 133.11 54.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.489 0.716 . . . . 75.43 109.373 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.23 133.14 41.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.256 -1.387 . . . . 74.44 107.256 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -74.29 -64.65 0.98 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.764 -1.569 . . . . 72.23 106.764 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -156.98 159.85 38.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.554 -1.646 . . . . 71.35 106.554 -157.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -134.03 145.36 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 60.44 109.374 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -132.55 136.4 46.57 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.55 1.94 . . . . 64.41 108.616 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.78 120.78 15.58 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.15 1.38 . . . . 40.25 109.441 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.747 0 CA-C-N 119.318 0.963 . . . . 71.41 110.827 -169.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' HD13 ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.519 0.343 0 CA-C-O 119.735 -0.481 . . . . 74.33 111.899 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.83 121.85 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.622 0.769 . . . . 62.32 110.538 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.43 137.89 34.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.887 -0.782 . . . . 55.23 108.887 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -102.65 154.12 19.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.938 -1.875 . . . . 62.34 105.938 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.92 115.71 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.323 -2.102 . . . . 72.41 105.323 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -81.93 110.04 16.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 105.124 -2.176 . . . . 74.35 105.124 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.09 163.07 18.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.273 -0.892 . . . . 71.44 110.42 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.88 -15.32 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.5 0.32 . . . . 72.33 111.033 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.44 161.83 38.77 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.366 -1.459 . . . . 53.31 111.095 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.12 -22.87 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.089 1.355 . . . . 64.35 111.669 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -59.37 -27.18 65.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.089 -1.007 . . . . 64.33 111.403 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -86.06 -4.07 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.236 1.199 . . . . 75.33 114.236 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.05 -58.16 16.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.24 1.382 . . . . 72.52 109.263 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.81 -20.39 64.7 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.448 1.432 . . . . 74.31 113.326 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.09 -52.95 56.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.972 1.26 . . . . 65.54 110.408 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.33 73.66 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.267 0.355 . . . . 74.13 111.644 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.65 -42.49 88.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.888 0.875 . . . . 74.44 109.106 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.33 -31.14 59.32 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 117.994 0.361 . . . . 41.13 112.437 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.31 9.96 16.29 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.334 -1.098 . . . . 74.31 112.803 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 83' ' ' ILE . 1.4 t -49.82 -29.85 8.69 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.384 1.447 . . . . 71.45 114.458 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.08 6.46 40.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.476 1.036 . . . . 64.11 113.779 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -81.36 175.05 10.91 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.237 1.019 . . . . 70.23 108.792 165.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -149.58 135.16 18.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.925 -0.769 . . . . 74.31 108.925 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.95 119.57 35.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 63.02 105.847 162.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.9 mt 60.3 1.46 0.37 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.014 1.857 . . . . 63.4 116.014 171.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.44 2.21 15.36 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.718 -1.046 . . . . 70.24 113.902 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 20' ' ' LEU . 68.9 t -104.57 86.39 1.4 Allowed Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 128.906 2.882 . . . . 70.51 109.151 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -65.3 177.49 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.23 1.953 . . . . 45.2 111.086 161.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.584 HG23 ' HA ' ' A' ' 74' ' ' THR 0.296 8.3 tt -122.19 176.45 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.951 0.9 . . . . 71.22 109.617 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 83' ' ' ILE . 47.8 mm -123.97 145.78 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.945 2.098 . . . . 70.24 106.077 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.52 -4.41 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.533 2.333 . . . . 71.33 114.819 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -53.85 -49.11 69.2 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.933 1.693 . . . . 72.34 113.717 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.4 179.36 0.15 Allowed 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.575 1.55 . . . . 64.54 111.498 -170.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 125.594 1.558 . . . . 74.31 106.963 178.096 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 114.336 1.236 . . . . 75.34 114.336 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 m -92.51 145.72 24.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.282 -1.006 . . . . 74.05 108.282 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -108.41 125.62 65.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 107.855 -1.165 . . . . 53.51 107.855 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.637 ' H ' ' HA ' ' A' ' 87' ' ' ALA . 7.3 t80 -89.55 124.29 34.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.869 1.668 . . . . 75.23 109.151 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -111.94 86.13 2.28 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.715 1.606 . . . . 71.22 108.941 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.0 ttp -92.03 27.54 2.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.711 0.804 . . . . 73.25 112.364 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -150.28 37.09 0.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.863 -1.773 . . . . 70.23 113.712 -173.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.67 153.27 42.17 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.476 -0.765 . . . . 72.32 112.916 -169.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.79 158.06 29.7 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.323 0.582 . . . . 72.23 111.154 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.88 -15.59 43.72 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.193 1.183 . . . . 61.12 114.193 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.69 30.65 5.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.101 1.318 . . . . 64.15 111.301 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -60.89 144.12 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 120.886 -1.134 . . . . 55.55 109.866 170.164 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -97.45 158.21 33.52 Favored Pre-proline 0 N--CA 1.464 0.27 0 C-N-CA 123.907 0.883 . . . . 72.34 109.724 160.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -57.85 -34.87 98.85 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 121.988 1.792 . . . . 62.34 112.364 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -67.44 -25.89 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.917 -0.489 . . . . 72.33 112.247 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.74 -32.8 74.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.01 1.277 . . . . 64.34 111.552 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -41.37 80.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.092 0.557 . . . . 62.41 110.586 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -76.54 -40.23 50.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.249 -0.278 . . . . 74.44 110.249 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.6 -44.08 76.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.84 1.256 . . . . 62.02 111.918 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -54.38 -42.43 70.36 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.098 -0.376 . . . . 72.15 111.232 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -88.08 -11.87 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.491 0.716 . . . . 73.41 112.529 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -65.66 -12.87 57.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.246 1.818 . . . . 74.45 111.783 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -59.08 -31.28 68.74 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.153 -0.967 . . . . 71.42 110.702 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.09 17.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.039 -1.038 . . . . 70.15 113.03 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 174.38 38.77 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 120.764 -1.21 . . . . 70.33 113.595 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.761 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -127.26 51.81 1.86 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.959 1.304 . . . . 71.53 111.673 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 HG12 ' A' ' 59' ' ' VAL . 2.2 p -43.73 126.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 127.904 2.482 . . . . 63.25 110.279 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -51.09 29.99 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.79 -1.55 . . . . 63.41 108.664 -158.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.54 179.12 7.46 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.193 1.558 . . . . 74.32 109.491 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 59' ' ' VAL . 20.6 t -136.92 147.88 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.185 0.994 . . . . 64.13 109.221 -174.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 102.53 11.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.56 2.344 . . . . 74.12 106.822 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.34 115.85 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.225 1.81 . . . . 74.34 107.07 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.535 0.398 0 C-N-CA 125.799 1.639 . . . . 55.34 108.677 -164.177 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.159 0 N-CA-C 109.892 -1.283 . . . . 74.01 109.892 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 pt -143.6 139.84 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.901 0.88 . . . . 64.35 111.384 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.36 157.27 43.52 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.289 1.836 . . . . 75.42 107.094 156.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.414 ' CE2' ' CD1' ' A' ' 16' ' ' PHE . 58.0 m-85 -124.99 128.38 48.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.884 -2.265 . . . . 75.05 104.884 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 42' ' ' VAL . 2.7 t -116.04 112.93 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.291 -1.374 . . . . 73.41 107.291 -164.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.45 88.08 7.32 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.952 1.358 . . . . 73.13 110.578 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -49.92 156.91 0.67 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.402 1.572 . . . . 75.51 113.375 166.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.761 HG21 ' HG3' ' A' ' 38' ' ' LYS . 3.5 m -79.9 -35.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 128.276 2.63 . . . . 61.32 113.975 176.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -116.73 165.15 13.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.012 1.725 . . . . 73.12 108.438 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -88.42 -27.38 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.227 0.611 . . . . 54.41 110.075 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 t -60.64 -27.61 67.93 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.325 0.966 . . . . 71.44 112.066 -173.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 p -76.24 -19.67 58.14 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.829 -1.17 . . . . 61.35 114.147 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.5 t -52.22 -57.71 14.24 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.499 1.12 . . . . 72.04 109.668 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.82 -17.51 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.713 1.608 . . . . 74.32 113.652 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -51.97 50.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.022 1.283 . . . . 73.44 109.733 172.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.86 91.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.491 0.716 . . . . 74.05 110.576 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.54 -39.28 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.609 0.764 . . . . 74.43 109.393 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.76 -4.99 29.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.595 1.093 . . . . 24.31 114.492 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.9 mt -109.24 13.39 24.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.393 1.597 . . . . 70.04 111.735 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 83' ' ' ILE . 3.3 t -54.3 -3.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.348 1.859 . . . . 73.35 115.22 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.61 7.88 24.19 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.13 1.347 . . . . 44.51 114.435 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -97.69 175.14 6.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.275 1.538 . . . . 72.04 110.311 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -155.57 89.07 1.16 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.265 -0.643 . . . . 72.23 109.265 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 m -60.31 113.45 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.151 -1.055 . . . . 72.21 108.151 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt 59.6 13.16 3.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.102 1.149 . . . . 72.33 114.102 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.07 13.3 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.638 -1.09 . . . . 65.25 113.425 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 24' ' ' ILE . 46.3 t -105.01 85.02 1.12 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.481 1.513 . . . . 63.02 108.352 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.8 179.38 3.76 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.256 2.638 . . . . 51.35 111.164 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 74' ' ' THR . 11.7 tt -129.59 177.1 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.724 2.01 . . . . 74.43 108.37 176.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -126.73 147.24 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.304 1.841 . . . . 70.31 107.413 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.43 -10.25 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 116.39 1.996 . . . . 65.02 116.39 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -56.34 -41.92 76.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.975 1.261 . . . . 74.21 112.898 -166.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.637 ' HA ' ' H ' ' A' ' 16' ' ' PHE . . . 58.97 174.94 0.07 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.279 1.038 . . . . 72.41 110.035 -165.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 105.494 -2.039 . . . . 75.41 105.494 171.361 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 111.105 0.039 . . . . 75.55 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.3 m -102.39 147.6 26.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.135 0.574 . . . . 64.44 109.628 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.41 129.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.462 1.105 . . . . 73.55 108.468 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -100.51 108.74 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.951 1.7 . . . . 71.21 109.143 -171.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' HD11 ' A' ' 20' ' ' LEU . 13.1 m -84.88 122.13 28.73 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.761 1.625 . . . . 53.13 106.871 175.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.2 ttp -139.04 52.27 1.78 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.029 0.919 . . . . 71.23 111.385 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.443 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 tt0 -154.97 30.45 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.729 -1.232 . . . . 64.14 109.668 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.675 ' H ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -84.26 166.63 17.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.802 1.287 . . . . 74.22 110.923 -167.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -105.15 153.12 21.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.629 -2.078 . . . . 34.35 110.202 -171.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.46 13.66 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.76 2.024 . . . . 71.13 114.598 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 25.22 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.067 2.147 . . . . 75.2 111.035 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 81' ' ' VAL . 10.6 tp -72.34 155.3 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.456 -1.403 . . . . 74.1 109.42 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.31 161.55 25.56 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.997 1.719 . . . . 71.22 107.274 171.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.38 -42.02 44.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.888 1.725 . . . . 75.51 112.416 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.09 -30.47 71.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 75.52 111.904 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -24.5 66.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.568 0.622 . . . . 63.51 110.979 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.4 -41.45 12.1 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.305 -0.628 . . . . 60.35 109.305 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -66.83 -35.33 79.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.558 0.617 . . . . 63.21 111.261 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.93 -24.91 43.71 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.56 -0.712 . . . . 75.13 112.474 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.09 -36.3 70.44 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.126 -0.359 . . . . 65.32 111.111 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -96.96 -1.9 44.74 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.211 0.819 . . . . 65.12 113.211 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -60.11 -20.48 58.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.297 1.839 . . . . 73.43 111.026 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -13.41 61.52 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.036 -1.04 . . . . 74.24 112.902 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.55 2.53 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 120.493 -1.379 . . . . 72.54 113.67 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.34 -143.45 7.99 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.453 -1.859 . . . . 51.23 108.453 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.701 ' HG2' HG11 ' A' ' 62' ' ' VAL . 3.7 ptmm? -129.24 161.76 29.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.408 -0.96 . . . . 64.44 108.408 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.25 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.847 -0.797 . . . . 72.25 108.847 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -78.11 -59.95 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.09 -1.078 . . . . 72.25 108.09 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -142.78 137.47 29.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.222 1.009 . . . . 73.45 108.629 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.44 129.81 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.583 1.553 . . . . 72.42 107.726 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -153.46 112.25 3.71 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.828 0.74 . . . . 75.1 111.381 -172.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -136.78 157.48 46.66 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.065 -1.022 . . . . 64.12 112.504 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.648 -0.871 . . . . 74.42 108.648 -166.822 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 20' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 108.461 -1.855 . . . . 50.5 108.461 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.19 138.2 14.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.158 1.783 . . . . 73.53 109.925 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.29 151.48 33.0 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.198 1.399 . . . . 75.52 108.454 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -128.36 104.21 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.578 -2.008 . . . . 74.43 105.578 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.32 118.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.495 -1.669 . . . . 64.21 106.495 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -91.16 121.17 32.7 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.672 -1.603 . . . . 75.13 106.672 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.88 165.21 11.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.445 1.116 . . . . 75.14 112.181 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.701 HG11 ' HG2' ' A' ' 38' ' ' LYS . 15.6 m -76.56 -34.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.62 1.568 . . . . 61.41 112.761 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -134.13 152.4 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.358 1.063 . . . . 55.32 112.908 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.42 -27.72 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 71.14 112.054 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -60.02 -25.43 65.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.344 1.429 . . . . 65.21 113.95 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.4 p -77.64 -19.21 55.83 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.125 1.33 . . . . 64.14 114.254 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.47 -57.23 24.55 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.65 1.18 . . . . 71.15 111.404 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -63.59 -23.7 70.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.437 1.425 . . . . 73.15 111.462 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -50.97 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.967 0.907 . . . . 62.43 109.863 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.51 77.65 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.228 1.011 . . . . 65.14 111.418 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.0 mt -53.66 -43.62 55.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.18 0.992 . . . . 74.21 109.382 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.33 64.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.161 -0.8 . . . . 74.33 112.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -98.67 4.26 47.88 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.096 1.358 . . . . 65.13 111.279 -167.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.294 2.8 m -45.55 -26.79 0.64 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.565 0.95 . . . . 70.03 113.565 161.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 18.06 45.04 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.309 0.884 . . . . 61.15 115.309 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -125.68 163.17 23.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 119.328 1.564 . . . . 73.15 109.367 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -136.25 115.71 12.75 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.398 1.479 . . . . 63.23 110.335 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -79.96 98.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.868 -1.53 . . . . 74.03 106.868 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt 54.87 33.25 19.49 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.139 0.976 . . . . 73.24 112.082 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.81 57.17 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.71 -1.05 . . . . 52.33 113.917 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 20' ' ' LEU . 99.3 t -114.06 85.32 9.96 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 118.891 1.345 . . . . 65.23 108.176 168.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.82 -177.63 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.734 2.29 . . . . 51.51 111.714 162.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -124.29 156.84 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.648 -0.871 . . . . 70.22 108.648 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.92 146.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.423 -1.325 . . . . 65.13 107.423 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -74.12 16.32 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.688 1.995 . . . . 61.31 112.736 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.21 -26.64 63.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.441 2.296 . . . . 72.31 112.889 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.46 36.24 22.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.288 1.835 . . . . 64.01 113.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 127.227 2.211 . . . . 62.52 114.918 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 N-CA-C 110.123 -1.191 . . . . 64.43 110.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -68.23 174.37 4.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.304 0.642 . . . . 61.42 110.541 166.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.4 mmm -123.97 -62.8 1.26 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.353 -1.721 . . . . 72.11 106.353 155.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -121.74 165.51 15.71 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.662 0.785 . . . . 72.24 109.48 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.19 168.75 19.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.028 1.731 . . . . 62.11 109.806 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.34 155.47 65.13 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.905 1.282 . . . . 63.11 110.62 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -55.36 -38.35 93.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.008 1.805 . . . . 41.32 112.228 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -76.02 -20.95 57.37 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.442 1.497 . . . . 63.35 110.798 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.26 -33.11 74.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.368 -0.833 . . . . 53.53 109.278 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -38.19 89.36 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.228 0.922 . . . . 71.22 110.383 177.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -55.33 -38.27 68.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.044 0.537 . . . . 73.42 110.67 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.17 2.16 25.34 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.017 1.858 . . . . 71.32 116.017 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -9.7 55.5 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.01 -1.681 . . . . 64.11 113.581 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -57.31 143.11 41.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.809 1.244 . . . . 63.52 110.402 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.0 116.93 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.41 1.1 . . . . 72.33 108.166 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -68.63 124.64 24.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.685 -1.143 . . . . 63.34 108.209 170.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.74 105.29 13.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 105.324 -2.102 . . . . 73.25 105.324 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -113.03 174.24 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.057 -1.09 . . . . 61.22 108.057 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 74.99 17.35 2.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.005 2.522 . . . . 74.44 112.046 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.698 ' HA ' HG13 ' A' ' 81' ' ' VAL . 20.7 mt -77.48 165.63 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.875 -0.515 . . . . 71.23 111.497 -171.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.21 41.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.262 0.553 . . . . 75.13 111.463 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.04 -24.37 53.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.817 1.247 . . . . 33.34 113.736 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -123.25 19.4 9.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.366 1.867 . . . . 74.24 111.155 -167.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.623 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.0 tt -63.92 151.24 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.607 0.639 . . . . 64.12 109.961 174.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 160.9 35.77 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 125.089 1.356 . . . . 75.32 107.554 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.59 -42.15 57.31 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.233 1.289 . . . . 73.34 110.596 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -30.59 71.7 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.073 -0.965 . . . . 74.25 111.663 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.12 -30.72 62.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.549 1.068 . . . . 55.15 110.382 -169.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.91 -41.46 18.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.795 1.638 . . . . 74.24 110.527 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.87 -37.63 73.06 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.223 -0.658 . . . . 65.34 109.223 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.33 -55.47 28.13 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 126.722 2.009 . . . . 43.42 109.642 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -55.08 -29.78 58.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.85 1.26 . . . . 73.23 112.446 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.86 -35.65 13.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.188 0.81 . . . . 63.34 113.188 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.1 t -57.26 -23.11 46.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.641 1.176 . . . . 62.14 111.674 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.739 0.815 . . . . 64.23 112.735 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.86 6.28 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 64.13 111.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 -174.85 23.36 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 121.042 -1.036 . . . . 61.34 113.105 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -140.1 138.22 35.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.829 1.252 . . . . 72.44 109.334 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.54 138.68 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.628 1.571 . . . . 61.41 107.573 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -85.78 -57.71 2.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.852 1.661 . . . . 42.02 108.12 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -158.27 175.86 13.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.811 0.732 . . . . 63.41 109.701 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.2 113.61 26.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.109 1.764 . . . . 71.31 107.389 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.05 51.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.792 1.637 . . . . 55.44 108.578 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 ttt -66.57 128.96 38.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.906 1.282 . . . . 73.14 107.897 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.73 ' H ' HD12 ' A' ' 45' ' ' ILE . 2.8 mp -65.89 127.21 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.871 -1.9 . . . . 62.21 105.871 170.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -71.91 73.5 0.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.292 1.437 . . . . 44.11 111.281 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.3 68.92 5.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.808 2.043 . . . . 60.11 112.238 -159.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -116.25 -19.67 10.11 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.31 -1.494 . . . . 61.23 113.782 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -47.39 -24.79 0.86 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.999 2.119 . . . . 75.14 114.744 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.03 22.87 8.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.132 0.878 . . . . 53.11 112.154 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -149.52 -5.45 0.37 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.167 1.173 . . . . 72.34 114.167 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -99.87 -163.57 1.04 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.151 1.78 . . . . 74.54 109.206 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.07 -39.37 78.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 115.035 1.494 . . . . 63.45 115.035 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt 64.4 35.91 9.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.332 1.853 . . . . 61.21 112.221 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.2 46.69 0.32 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-O 118.916 -0.935 . . . . 74.32 113.987 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -139.11 148.7 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.601 1.2 . . . . 74.31 111.776 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.39 162.82 33.44 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.107 2.163 . . . . 62.31 109.842 170.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.641 ' CE2' HD11 ' A' ' 45' ' ' ILE . 85.8 m-85 -130.09 114.56 15.91 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.662 1.585 . . . . 63.31 108.017 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.19 122.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.835 -1.172 . . . . 72.21 107.835 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -75.7 114.37 14.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.696 -1.224 . . . . 52.32 107.696 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 2.9 m-85 -80.02 166.25 21.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.999 -0.371 . . . . 74.14 109.999 165.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.97 -9.36 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 118.68 -0.676 . . . . 63.55 111.358 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.55 135.0 40.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.342 1.883 . . . . 75.15 113.695 -168.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.21 -35.13 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.725 0.81 . . . . 71.31 111.981 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 m -80.68 -9.24 59.81 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 119.178 -1.009 . . . . 75.51 111.025 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.7 m -80.28 -11.81 59.68 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 117.548 -1.215 . . . . 55.12 113.659 172.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.34 -59.3 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 120.551 1.523 . . . . 52.44 108.765 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.48 -18.79 60.49 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.952 1.768 . . . . 54.31 113.667 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.52 -57.88 8.76 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 119.464 1.029 . . . . 73.14 108.75 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.01 69.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.704 1.202 . . . . 63.32 112.051 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.2 mt -54.85 -48.47 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.72 -0.845 . . . . 73.11 108.72 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.69 -6.21 21.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.727 1.156 . . . . 64.34 115.256 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -97.19 1.46 49.83 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.822 1.311 . . . . 73.33 112.168 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.68 -23.98 7.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.801 1.778 . . . . 71.42 115.801 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.15 1.65 37.91 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.143 0.878 . . . . 31.15 113.473 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -72.1 170.72 13.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.073 -1.084 . . . . 60.23 108.073 162.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -162.59 82.04 0.52 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.622 0.971 . . . . 71.21 113.622 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.78 117.24 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.608 -0.886 . . . . 63.22 108.608 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt 60.67 2.17 0.48 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.002 1.321 . . . . 65.12 114.157 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.79 11.96 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.799 -1.0 . . . . 52.35 113.132 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 20' ' ' LEU . 65.7 t -112.37 86.12 7.78 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 118.945 1.373 . . . . 72.13 110.034 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.81 175.78 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.669 2.246 . . . . 44.54 111.369 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -134.92 140.42 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.302 1.041 . . . . 52.15 110.256 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mm -77.34 145.93 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.212 -0.93 . . . . 53.22 110.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.04 4.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 128.886 2.874 . . . . 54.34 115.806 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.8 -36.92 84.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.936 1.458 . . . . 61.13 114.936 -157.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.77 173.63 0.07 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.441 1.496 . . . . 63.42 110.091 -163.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.11 50.53 0.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.674 -1.232 . . . . 52.42 107.674 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -72.14 -179.32 2.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.313 1.445 . . . . 74.35 109.577 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.76 161.13 36.04 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.093 0.957 . . . . 65.33 110.264 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -81.57 49.2 1.28 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.467 1.907 . . . . 63.55 109.706 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -142.24 141.06 32.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.896 1.278 . . . . 64.31 108.061 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -154.59 105.47 2.63 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.32 -1.363 . . . . 61.13 107.32 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.17 2.188 . . . . 60.22 109.167 -167.183 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.835 0 N-CA-C 109.853 -1.299 . . . . 52.14 109.853 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 m80 64.58 15.06 9.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.696 1.598 . . . . 62.33 112.592 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.8 mtp 61.52 158.79 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.2 2.6 . . . . 72.15 112.819 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -73.3 159.63 33.09 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.924 -0.58 . . . . 72.52 109.986 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.0 tp -66.29 153.28 43.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.968 0.907 . . . . 74.33 110.566 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.6 145.34 35.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.931 1.293 . . . . 62.23 108.575 170.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.275 1.983 . . . . 72.43 111.369 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.48 -39.41 74.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.149 -0.685 . . . . 71.32 109.149 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.7 -20.17 59.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.066 0.946 . . . . 71.25 111.846 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -81.75 -31.04 32.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.544 -0.722 . . . . 74.35 110.931 169.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -40.15 87.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.845 0.748 . . . . 50.35 109.075 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.91 -3.83 1.33 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.586 2.354 . . . . 50.35 114.946 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -60.12 -28.64 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.593 1.088 . . . . 73.34 111.901 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -85.35 144.3 28.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.198 -1.038 . . . . 70.25 108.198 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.65 122.14 66.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.355 1.062 . . . . 74.14 108.252 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -73.7 132.87 43.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.918 1.687 . . . . 71.52 110.107 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.7 m -117.64 130.3 56.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.541 1.936 . . . . 70.23 106.356 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.9 ttp -138.32 29.87 2.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.839 1.256 . . . . 31.2 110.69 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -153.86 15.31 0.49 Allowed 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.546 -1.346 . . . . 74.15 111.972 -165.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.29 156.59 36.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.825 0.45 . . . . 73.42 111.142 -167.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 152.23 44.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.052 0.454 . . . . 72.54 109.978 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.94 64.87 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.447 1.099 . . . . 74.43 113.744 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -121.59 58.48 1.0 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.752 1.221 . . . . 73.44 109.345 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 161.51 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.019 -1.051 . . . . 42.11 109.351 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -120.26 158.3 51.2 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 125.579 1.552 . . . . 62.53 108.099 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.86 -32.42 22.65 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.588 1.525 . . . . 72.22 111.319 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -70.82 -37.86 73.25 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.614 0.643 . . . . 74.55 111.322 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.83 -40.41 69.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.201 1.001 . . . . 71.32 110.74 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.3 -48.26 62.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.683 1.193 . . . . 74.44 110.88 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 39' ' ' VAL . 10.7 pt-20 -69.2 -37.82 78.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.496 -0.764 . . . . 65.11 109.633 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.34 -25.86 66.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.068 0.849 . . . . 72.15 112.223 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.6 -36.63 83.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.744 0.702 . . . . 72.13 110.244 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -99.55 -33.88 10.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.501 -0.761 . . . . 71.24 112.417 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -66.02 -17.14 64.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.793 1.179 . . . . 62.33 111.501 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -80.95 -2.84 49.37 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.259 -0.901 . . . . 74.13 112.23 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.75 15.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.166 1.786 . . . . 52.43 111.481 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.06 -155.53 17.3 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.001 -1.639 . . . . 61.54 109.001 -161.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -157.81 147.74 20.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.853 1.327 . . . . 65.11 108.998 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 30' ' ' GLU . 53.4 t -112.23 122.99 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.443 1.097 . . . . 65.53 110.024 -173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -76.07 -45.73 32.61 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.805 1.242 . . . . 73.55 110.501 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.9 163.64 37.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.443 1.097 . . . . 73.24 108.777 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.4 126.29 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.171 1.388 . . . . 63.53 107.296 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -132.6 103.97 6.42 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.698 -0.852 . . . . 61.51 108.698 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.42 137.11 35.98 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.448 1.099 . . . . 74.22 108.302 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.77 82.05 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.897 -1.89 . . . . 70.55 105.897 172.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -103.55 4.77 36.15 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.766 0.826 . . . . 61.34 112.834 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.08 143.15 47.53 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.365 -1.717 . . . . 54.35 106.365 161.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 166.96 28.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.839 -0.8 . . . . 74.12 108.839 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -115.89 -7.01 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.415 0.686 . . . . 73.12 111.388 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -157.43 -70.87 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.944 -1.502 . . . . 73.23 106.944 161.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -138.01 165.51 26.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.809 -2.663 . . . . 52.23 103.809 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -163.97 -177.59 5.15 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.382 1.473 . . . . 71.34 107.196 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -28.49 58.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.809 1.186 . . . . 70.22 112.473 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 56.49 11.01 0.76 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 117.077 2.251 . . . . 74.54 117.077 171.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.13 55.34 0.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.726 -1.35 . . . . 32.53 109.726 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -120.57 128.31 76.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.034 1.334 . . . . 72.15 111.062 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.89 158.73 44.51 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.005 1.322 . . . . 72.23 110.176 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -124.34 135.69 53.53 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.979 -1.489 . . . . 70.34 106.979 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.375 1.5 p -138.54 109.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 65.55 110.56 -168.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -74.25 122.31 22.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.43 1.892 . . . . 72.24 110.357 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 66' ' ' SER . 3.2 m-85 -74.76 153.92 38.59 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.16 0.981 . . . . 63.33 111.483 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -73.94 -21.76 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 115.229 -0.896 . . . . 73.22 110.868 166.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -137.85 128.22 26.31 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.243 1.417 . . . . 74.55 109.857 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.38 -30.66 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.216 1.406 . . . . 61.53 111.388 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -73.73 -21.11 60.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.243 -1.535 . . . . 72.11 112.855 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 7.2 m -81.71 -8.69 59.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.704 1.138 . . . . 74.13 112.553 172.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.15 -66.54 1.19 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 116.101 -1.904 . . . . 71.45 107.768 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.03 -17.87 58.46 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.433 2.089 . . . . 74.24 113.837 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.14 -42.45 76.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.554 1.142 . . . . 74.33 109.45 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.69 -36.55 69.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.017 0.747 . . . . 63.11 113.017 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.9 mt -59.41 -42.54 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.941 0.791 . . . . 72.22 109.769 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 -5.09 8.66 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.384 -0.676 . . . . 75.13 113.091 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.12 5.6 12.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.383 1.591 . . . . 74.13 112.456 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.7 t -48.07 -33.75 8.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.234 1.379 . . . . 62.52 113.094 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.85 12.86 41.8 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.891 1.71 . . . . 73.11 113.839 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.77 172.23 8.48 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 118.874 1.337 . . . . 74.51 108.069 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -155.93 99.46 1.98 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.388 0.675 . . . . 75.24 111.137 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.64 114.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.919 -1.141 . . . . 70.34 107.919 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt 54.53 21.35 3.3 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.873 1.064 . . . . 70.32 113.873 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.84 28.82 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.297 -0.724 . . . . 61.34 113.945 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.13 85.11 6.39 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.354 1.577 . . . . 71.12 109.719 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.83 177.76 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.862 2.375 . . . . 72.13 111.388 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.8 tt -136.48 169.09 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.871 0.693 . . . . 73.35 112.871 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.18 124.44 73.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.707 2.003 . . . . 61.55 108.798 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -53.38 -17.75 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.079 2.552 . . . . 70.15 115.831 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.87 -42.56 80.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.568 1.531 . . . . 65.24 111.646 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.0 41.83 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.836 1.654 . . . . 63.34 113.986 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.258 0.5 OUTLIER 43.65 74.98 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.227 2.211 . . . . 74.32 111.449 -171.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.58 155.94 0.14 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 70.31 113.546 169.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.21 55.06 2.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.985 0.514 . . . . 72.12 111.553 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 72.97 4.17 4.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.734 1.613 . . . . 43.32 113.001 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -92.28 -176.69 4.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.205 1.402 . . . . 51.43 111.472 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.7 t30 64.67 101.58 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 129.91 3.284 . . . . 72.11 110.62 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.839 0 C-N-CA 126.215 1.806 . . . . 71.32 109.409 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 111.502 -0.639 . . . . 72.44 111.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.42 -27.44 0.42 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.576 0.954 . . . . 73.43 113.576 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm -148.7 -62.05 0.24 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.25 0.932 . . . . 70.01 111.571 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.58 163.09 27.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.819 -0.808 . . . . 65.14 108.819 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.51 137.08 54.88 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.917 -1.512 . . . . 63.24 106.917 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.07 148.92 97.83 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 105.799 -1.926 . . . . 65.24 105.799 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.37 -15.44 45.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.672 1.582 . . . . 72.31 111.971 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -80.17 -33.39 38.38 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.304 1.042 . . . . 73.43 111.52 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.84 -43.46 85.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.596 1.089 . . . . 73.15 111.118 -168.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -68.13 -23.42 64.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 117.821 -1.085 . . . . 75.34 113.755 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.48 -17.5 28.55 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.504 1.121 . . . . 73.44 110.3 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.26 -61.99 1.84 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.02 1.328 . . . . 52.05 112.185 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 44.52 65.1 1.13 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.284 2.234 . . . . 60.34 110.843 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.17 151.38 50.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.332 0.969 . . . . 72.43 112.237 -173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.84 122.92 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.1 1.76 . . . . 62.42 110.691 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.91 129.71 38.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.262 1.425 . . . . 73.51 109.647 169.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.6 m -122.15 105.06 9.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.994 -1.484 . . . . 64.52 106.994 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.8 ttm -88.01 174.57 8.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.712 0.805 . . . . 72.43 109.133 171.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 70.14 21.03 6.16 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.44 2.296 . . . . 73.44 113.185 164.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.7 mt -69.1 167.03 16.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.104 0.561 . . . . 65.2 111.77 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -62.26 147.73 47.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.976 -0.556 . . . . 64.14 110.332 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.99 -4.26 2.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.32 1.448 . . . . 51.24 113.675 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -139.36 13.57 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.77 1.628 . . . . 73.1 112.138 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tt -47.7 131.46 4.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.756 0.822 . . . . 71.54 112.275 -167.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -66.97 147.67 99.05 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 107.548 -1.279 . . . . 71.43 107.548 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.55 1.77 4.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.088 2.525 . . . . 55.04 113.36 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 -22.0 14.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.814 1.188 . . . . 72.35 113.019 167.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -30.43 71.52 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.811 1.187 . . . . 52.12 112.046 -165.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.3 mt -84.71 -24.13 29.03 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.989 0.516 . . . . 72.44 111.436 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 42' ' ' VAL . 1.4 mt-10 -80.78 -52.01 7.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.33 -2.1 . . . . 71.14 105.33 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.12 -38.72 83.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.896 1.678 . . . . 74.23 110.668 -172.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -57.96 -49.26 77.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.237 0.926 . . . . 73.32 111.971 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -85.13 -15.23 44.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.1 0.407 . . . . 74.34 112.1 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -59.23 -20.13 51.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.617 1.567 . . . . 72.11 113.399 -171.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -65.38 -24.37 67.21 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.954 0.502 . . . . 64.51 110.466 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.87 47.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.009 -1.057 . . . . 74.43 110.75 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.17 153.5 9.37 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.005 1.764 . . . . 53.22 108.979 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.694 ' HG2' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -89.97 167.48 12.76 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.296 0.638 . . . . 51.22 110.71 -178.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . 2.6 p -124.35 145.35 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.442 1.897 . . . . 55.03 107.78 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -74.11 -49.52 23.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.776 -1.107 . . . . 64.55 109.098 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -165.87 -179.69 5.41 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.405 1.002 . . . . 73.35 111.818 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.44 HG21 ' HG2' ' A' ' 30' ' ' GLU . 51.9 t -133.56 110.01 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 127.006 2.123 . . . . 75.11 107.623 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -104.34 85.33 2.34 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.377 1.071 . . . . 75.24 108.985 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.47 160.74 19.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.649 0.737 . . . . 65.24 110.086 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.92 149.28 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.841 -1.54 . . . . 74.11 106.841 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -70.76 88.49 0.72 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.111 1.364 . . . . 72.12 107.903 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.25 129.93 42.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.664 0.786 . . . . 72.51 111.757 -171.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -137.15 -2.02 2.09 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.792 1.404 . . . . 65.41 114.792 -158.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 64.0 14.15 8.24 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.997 1.48 . . . . 73.23 114.997 157.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.5 t -139.69 -24.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.901 1.68 . . . . 65.44 111.326 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -159.68 52.33 0.35 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.649 -1.282 . . . . 73.33 110.021 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 153.19 45.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.505 -1.665 . . . . 74.32 106.505 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t -75.98 39.9 0.19 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.012 0.925 . . . . 71.03 112.645 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 52.23 25.77 3.55 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.412 1.634 . . . . 70.3 115.412 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.59 102.64 0.35 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.349 -1.1 . . . . 72.4 110.349 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.54 156.11 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.86 1.264 . . . . 51.34 111.044 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.86 159.91 27.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.22 1.008 . . . . 73.14 113.43 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.35 105.41 10.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.777 2.431 . . . . 74.21 106.15 160.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -91.65 132.18 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.62 -1.622 . . . . 75.33 106.62 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -116.47 89.86 3.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.492 1.117 . . . . 73.44 110.276 -166.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.98 169.77 1.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.463 2.023 . . . . 72.43 116.463 -176.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.694 HG21 ' HG2' ' A' ' 38' ' ' LYS . 31.1 t -87.4 -23.71 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.539 -0.726 . . . . 53.24 112.216 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.15 144.66 38.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.436 1.471 . . . . 73.41 114.162 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -48.84 -43.76 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 129.704 3.201 . . . . 63.31 111.675 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.3 p -64.2 -20.65 66.17 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.065 1.302 . . . . 61.22 111.48 -171.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.408 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -83.8 -10.41 58.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.793 1.034 . . . . 64.31 113.793 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.97 -60.22 11.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.995 0.918 . . . . 72.11 109.591 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -11.57 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.537 1.491 . . . . 71.14 113.776 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.05 -49.16 68.64 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.946 0.794 . . . . 72.24 109.461 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.29 74.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.722 -0.611 . . . . 61.45 111.424 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 87' ' ' ALA . 88.7 mt -58.37 -44.76 89.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.38 0.672 . . . . 73.35 109.514 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.35 -35.85 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 118.624 0.647 . . . . 54.45 112.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.94 4.07 10.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.363 1.065 . . . . 65.21 113.554 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.0 t -46.44 -27.12 0.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.433 1.493 . . . . 74.21 114.419 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -3.91 63.22 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.868 -1.145 . . . . 70.05 113.677 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -77.08 176.5 8.63 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 119.217 1.509 . . . . 60.43 110.488 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 86.5 1.57 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.525 1.13 . . . . 73.03 109.019 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.46 93.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.584 1.554 . . . . 55.32 109.784 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt 46.24 43.3 11.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.658 1.218 . . . . 64.23 110.772 -167.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.43 21.0 46.23 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.314 -0.866 . . . . 71.33 113.347 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 21' ' ' ALA . 21.5 t -118.7 85.87 28.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.85 1.66 . . . . 72.14 107.52 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.7 -179.44 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.299 1.999 . . . . 74.35 111.003 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.599 HG23 ' HA ' ' A' ' 74' ' ' THR . 14.9 tt -142.51 156.13 18.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.535 -0.913 . . . . 72.45 108.535 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.26 143.37 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.417 1.487 . . . . 71.24 108.797 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.52 3.75 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.16 1.784 . . . . 62.14 114.481 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.29 -53.15 6.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.445 1.898 . . . . 72.22 112.46 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . 58.58 163.27 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.684 1.706 . . . . 61.12 112.872 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -90.45 76.63 6.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 104.208 -2.515 . . . . 70.01 104.208 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -97.03 122.75 40.37 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.831 -1.168 . . . . 74.25 110.082 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.56 157.77 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.897 2.879 . . . . 54.54 112.422 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.33 32.86 0.19 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.859 1.664 . . . . 73.42 112.573 -170.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -111.62 -24.22 10.22 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.567 1.321 . . . . 73.21 114.567 -174.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -79.96 84.99 5.63 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.139 -1.43 . . . . 72.11 107.139 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 107.128 -1.434 . . . . 72.21 107.128 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.991 0 CA-C-O 116.894 -2.059 . . . . 64.03 111.403 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 43.65 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.46 2.704 . . . . 75.44 111.839 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.341 0.0 OUTLIER 54.45 -5.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 118.085 2.624 . . . . 55.44 118.085 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.3 t30 75.91 154.71 0.16 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 129.635 3.174 . . . . 75.11 110.428 -166.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.48 174.19 1.04 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.853 2.461 . . . . 72.15 111.224 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 153.08 47.0 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.34 -1.726 . . . . 74.45 106.34 159.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.22 -12.98 25.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.983 1.788 . . . . 74.42 113.458 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.9 -31.94 51.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.731 1.15 . . . . 75.23 112.255 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.75 -43.47 93.2 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.956 1.253 . . . . 62.21 110.561 -170.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.94 -17.18 55.97 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.93 1.085 . . . . 63.53 113.93 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.62 -43.08 8.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.843 1.657 . . . . 72.51 108.623 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.83 -65.09 0.64 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.815 2.046 . . . . 63.53 112.342 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 57.94 0.37 0.11 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 116.187 1.921 . . . . 72.12 116.187 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -102.94 148.47 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.725 1.148 . . . . 64.33 109.734 -159.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -126.12 135.27 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.109 1.364 . . . . 72.43 109.635 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -100.25 106.61 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.499 1.12 . . . . 72.43 109.619 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -93.18 83.63 4.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.818 2.047 . . . . 55.31 109.221 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.7 ttp -91.21 41.37 1.06 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.3 0.852 . . . . 74.15 113.3 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -154.39 27.25 0.45 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.368 -1.458 . . . . 73.22 113.752 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 29' ' ' LEU . 10.6 mt -65.84 152.12 45.13 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.724 -0.61 . . . . 64.54 111.22 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.8 168.21 14.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.301 0.572 . . . . 71.12 111.531 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.67 66.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.026 1.121 . . . . 44.01 114.026 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -117.07 10.22 13.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.142 1.377 . . . . 73.53 111.434 -166.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -56.35 139.61 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.3 1.44 . . . . 73.52 111.659 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -87.82 161.46 44.39 Favored Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 124.32 1.048 . . . . 74.34 108.591 163.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.88 -44.61 38.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.044 1.829 . . . . 64.23 110.902 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -62.44 -23.28 66.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.135 -0.936 . . . . 73.23 112.724 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.53 -23.47 64.6 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.64 1.563 . . . . 53.15 111.719 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD11 HD22 ' A' ' 20' ' ' LEU . 2.3 mm? -80.44 -25.02 39.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.611 1.165 . . . . 53.23 112.893 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.0 -38.64 11.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.876 1.216 . . . . 75.53 109.606 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.52 -27.41 64.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.553 1.07 . . . . 75.54 112.683 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.02 -64.16 0.94 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.413 0.552 . . . . 72.55 109.77 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.0 -22.35 65.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.032 0.753 . . . . 75.14 113.032 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -64.29 -4.72 4.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.089 1.356 . . . . 71.13 111.094 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -53.33 -30.32 38.53 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.406 1.457 . . . . 64.45 110.66 161.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.5 m -144.68 65.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.492 1.517 . . . . 63.22 110.264 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.57 177.13 15.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 122.861 1.256 . . . . 75.31 115.003 149.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.741 ' HG3' HG21 ' A' ' 62' ' ' VAL . 1.3 ptpt -91.74 53.91 2.34 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.814 1.413 . . . . 74.42 114.814 -151.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.308 1.5 p -44.6 130.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.528 1.131 . . . . 73.42 110.854 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -85.11 -48.25 9.36 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 112.72 -2.036 . . . . 64.54 109.843 -155.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -161.47 155.69 22.52 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 124.971 1.419 . . . . 75.45 110.302 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.02 148.6 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.67 1.588 . . . . 52.42 107.717 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -138.84 121.8 16.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.147 -1.797 . . . . 75.32 106.147 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.2 ptp -143.36 166.73 23.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.659 0.784 . . . . 74.24 111.284 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.76 112.79 31.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.23 -0.441 . . . . 74.31 109.886 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.2 m -107.69 3.93 25.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 113.089 0.774 . . . . 61.43 113.089 160.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -77.53 80.71 4.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.01 2.124 . . . . 73.33 108.808 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -170.84 -45.68 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.079 0.952 . . . . 51.22 109.02 168.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.91 -71.08 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 129.489 3.116 . . . . 75.42 111.11 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 t -49.28 -36.26 20.24 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.585 2.354 . . . . 64.51 112.421 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.52 92.85 1.34 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.229 -1.026 . . . . 53.31 108.229 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.283 19.6 ptt180 -114.51 149.75 35.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 119.616 1.098 . . . . 72.5 110.68 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -67.36 -1.37 4.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.069 0.766 . . . . 62.52 113.069 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt 49.49 40.91 20.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.429 1.091 . . . . 75.2 111.52 168.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.36 47.07 0.04 OUTLIER Glycine 0 C--O 1.221 -0.712 0 CA-C-O 117.831 -1.539 . . . . 75.54 110.983 -159.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.3 118.91 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.356 1.078 . . . . 71.23 110.166 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.28 34.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.125 1.37 . . . . 75.55 108.222 163.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.62 83.52 2.08 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.037 2.135 . . . . 73.54 107.131 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.292 1.6 p -90.29 144.5 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.055 1.342 . . . . 64.24 111.104 -170.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.84 97.71 5.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.991 0.901 . . . . 60.33 109.131 -155.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.01 172.92 2.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.914 1.816 . . . . 61.23 112.005 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 38' ' ' LYS . 4.0 m -89.87 -25.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 127.406 2.282 . . . . 61.52 112.075 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -138.42 142.81 39.52 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.154 1.782 . . . . 75.42 108.441 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.49 -22.38 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.857 0.863 . . . . 63.51 111.586 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 p -68.4 -20.33 64.66 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 120.671 -1.268 . . . . 52.25 111.868 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -74.65 -19.73 60.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.359 -0.838 . . . . 43.34 112.498 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.56 -57.27 28.15 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.086 -1.009 . . . . 75.53 110.622 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.42 -14.04 39.04 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.645 2.23 . . . . 72.33 113.075 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.72 -49.92 73.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.517 -0.92 . . . . 63.34 108.517 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.83 72.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.624 0.77 . . . . 42.03 111.894 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mt -55.83 -35.52 40.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.462 1.105 . . . . 72.23 110.216 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.69 -27.48 49.44 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.957 -0.913 . . . . 23.34 114.24 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mt -110.82 10.2 22.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.313 1.556 . . . . 74.22 112.455 -166.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 83' ' ' ILE . 10.1 t -44.7 -36.49 3.17 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.242 1.383 . . . . 63.32 113.194 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 -26.52 58.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.833 1.206 . . . . 63.34 113.316 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.99 158.29 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.979 0.889 . . . . 55.02 108.683 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -158.06 115.93 3.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.812 0.845 . . . . 74.51 109.426 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -77.46 125.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 106.97 -1.493 . . . . 71.23 106.97 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt 48.34 37.76 9.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.174 1.39 . . . . 62.31 112.823 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.92 28.61 64.4 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.493 -1.171 . . . . 53.14 113.874 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.66 85.51 7.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.336 1.854 . . . . 71.32 108.872 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.16 -170.68 0.97 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.77 2.313 . . . . 61.22 111.226 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.3 tt -144.65 159.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 121.404 -0.81 . . . . 61.24 111.48 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.28 141.19 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.145 -1.428 . . . . 64.12 107.145 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -52.48 -13.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.668 2.787 . . . . 61.44 116.036 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -44.5 -53.33 7.1 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.089 1.355 . . . . 74.24 113.859 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 38.45 29.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.722 1.209 . . . . 62.11 113.294 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 53.55 -154.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.737 1.215 . . . . 75.25 111.261 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -61.53 140.44 58.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.416 -0.957 . . . . 72.24 108.416 163.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.89 148.85 12.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.236 1.014 . . . . 55.14 109.72 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.51 62.33 1.0 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 131.089 3.756 . . . . 74.03 107.549 172.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -130.2 164.7 23.93 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.644 1.578 . . . . 73.32 108.363 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -156.41 95.12 1.55 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.293 1.037 . . . . 61.24 109.809 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.984 1.714 . . . . 73.25 109.34 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.717 0 N-CA-C 110.014 -1.234 . . . . 55.52 110.014 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -71.84 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.271 2.229 . . . . 75.3 111.534 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.4 mtp 45.32 61.3 2.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.018 1.727 . . . . 71.43 111.956 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -166.2 -166.31 0.88 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.304 1.841 . . . . 73.03 107.937 168.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 106.4 2.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.721 2.008 . . . . 74.12 108.778 169.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -63.96 161.03 42.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.366 1.066 . . . . 73.41 111.845 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.9 -45.97 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.334 2.022 . . . . 55.53 112.116 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -62.52 -37.53 86.42 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 118.821 -0.609 . . . . 74.41 111.969 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.18 -32.97 72.64 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 124.109 0.964 . . . . 64.44 110.925 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -67.45 -41.79 84.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 121.778 -0.576 . . . . 73.21 109.683 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -80.29 -27.63 38.47 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.226 0.329 . . . . 73.24 111.294 -167.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.64 3.67 6.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.506 2.322 . . . . 60.44 114.501 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -61.28 1.42 0.19 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 127.974 2.51 . . . . 75.2 116.767 -167.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -121.56 145.54 47.87 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.189 -1.411 . . . . 71.41 107.189 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.56 115.1 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.661 -1.978 . . . . 62.03 105.661 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -75.0 128.21 35.04 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.181 -1.785 . . . . 63.33 106.181 168.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -121.32 121.36 37.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 106.534 -1.654 . . . . 60.44 106.534 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.0 ttp -124.13 165.23 17.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.22 1.408 . . . . 75.41 107.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 75.31 12.17 3.31 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.028 2.131 . . . . 72.12 111.862 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.17 167.95 9.31 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.647 -0.658 . . . . 71.41 109.423 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.47 151.87 45.55 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.604 -0.685 . . . . 55.21 110.58 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.62 -4.19 25.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.155 0.982 . . . . 72.21 113.008 172.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.76 33.1 2.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.596 1.958 . . . . 74.05 110.374 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.97 138.58 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.049 -1.032 . . . . 74.42 108.768 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -77.91 153.48 80.36 Favored Pre-proline 0 N--CA 1.466 0.363 0 N-CA-C 108.218 -1.03 . . . . 74.02 108.218 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.37 0.9 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.395 2.73 . . . . 75.43 114.039 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -112.87 -5.25 13.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.941 1.246 . . . . 72.41 111.892 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.47 -30.44 64.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.6 -1.313 . . . . 63.44 108.729 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.48 -53.23 9.92 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.174 0.99 . . . . 55.41 110.195 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.54 -40.07 94.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.46 0.704 . . . . 61.1 110.524 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -67.87 -27.37 66.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.156 0.582 . . . . 75.41 112.067 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.26 -50.07 73.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.502 -0.285 . . . . 60.21 110.317 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -72.83 -28.26 62.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.88 0.764 . . . . 74.4 111.974 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 t -57.73 -20.36 34.04 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.632 1.973 . . . . 60.22 113.218 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -76.74 -15.85 59.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.149 -0.969 . . . . 63.3 111.268 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -136.98 11.54 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.031 0.932 . . . . 73.02 111.461 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.51 173.55 36.29 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 121.198 -0.939 . . . . 23.35 111.604 -160.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.76 137.12 29.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.532 -1.284 . . . . 64.24 107.532 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.24 131.8 65.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 125.92 1.688 . . . . 64.32 109.281 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -94.13 -42.54 8.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.048 -0.977 . . . . 72.2 110.879 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -167.41 158.45 11.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.783 2.033 . . . . 72.02 106.36 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 59' ' ' VAL . 29.5 m -133.95 163.85 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.26 1.824 . . . . 62.22 109.684 -173.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 136.79 10.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.181 -0.95 . . . . 73.44 109.235 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.4 ptp -136.11 135.55 39.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.273 0.942 . . . . 75.03 110.18 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.39 98.24 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.07 -0.514 . . . . 71.33 112.352 -150.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.3 m -89.95 4.83 48.85 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.846 1.258 . . . . 62.44 114.384 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.58 24.85 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 129.031 2.932 . . . . 73.02 115.566 -170.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.66 -73.07 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.591 1.956 . . . . 62.44 109.454 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 p30 47.27 18.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.885 2.074 . . . . 75.44 113.991 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.55 28.26 0.3 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.803 3.241 . . . . 72.34 114.167 -169.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.03 -39.18 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.875 1.67 . . . . 74.33 108.026 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 64.43 -173.51 0.17 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.104 1.761 . . . . 75.11 107.965 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -73.15 63.87 0.72 Allowed 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.25 -0.906 . . . . 54.21 109.238 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -12.76 61.68 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.348 1.059 . . . . 61.34 112.274 165.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.1 62.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 124.733 1.159 . . . . 73.32 110.389 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.38 131.54 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.205 1.802 . . . . 75.32 109.903 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.15 165.6 35.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.737 1.615 . . . . 61.32 108.55 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -124.07 146.12 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.425 -1.694 . . . . 72.4 106.425 165.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 42' ' ' VAL . 25.6 t -130.71 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.563 -1.643 . . . . 75.14 106.563 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -72.1 128.34 35.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.097 -1.446 . . . . 74.23 107.097 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.18 155.44 23.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 64.11 110.631 169.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.18 -26.99 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 117.996 -1.002 . . . . 72.33 110.187 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.13 150.43 50.52 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.191 1.36 . . . . 60.13 111.979 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.78 -34.54 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 117.986 -1.006 . . . . 75.14 111.806 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -69.99 -20.74 63.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.383 1.902 . . . . 74.34 112.411 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -89.94 -4.34 57.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.829 0.852 . . . . 75.13 112.443 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.29 -60.84 8.92 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 119.693 1.133 . . . . 71.3 109.787 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 -15.4 46.41 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 120.92 1.364 . . . . 52.54 113.381 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -55.22 35.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 120.547 -1.345 . . . . 74.44 110.145 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.82 -41.6 78.12 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.712 0.633 . . . . 71.31 111.253 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.01 -39.0 70.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.948 0.899 . . . . 72.31 110.36 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.58 -36.04 63.52 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.448 1.023 . . . . 74.31 112.905 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.6 12.75 1.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.574 1.15 . . . . 72.12 113.354 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.567 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -50.38 -28.23 7.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.298 1.439 . . . . 71.13 113.572 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.66 14.73 45.96 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.293 1.425 . . . . 75.22 112.914 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -93.71 170.4 9.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.261 1.03 . . . . 73.44 108.258 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -145.17 87.13 1.8 Allowed 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.635 -0.666 . . . . 73.14 109.978 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.94 110.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.708 -0.849 . . . . 61.25 108.708 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt 46.97 31.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.353 1.861 . . . . 62.45 112.979 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.42 19.43 27.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.781 0.705 . . . . 62.04 113.61 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.63 86.43 29.37 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.995 1.718 . . . . 60.45 109.165 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.23 173.79 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.456 2.104 . . . . 60.02 111.914 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.1 tt -140.17 143.33 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.466 1.107 . . . . 71.13 109.453 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.9 mm -86.14 144.34 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.715 0.806 . . . . 72.33 109.442 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.15 10.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 129.298 3.039 . . . . 51.22 115.471 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -25.66 64.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 114.782 1.401 . . . . 71.04 114.782 -154.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.83 164.03 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.692 2.797 . . . . 61.22 111.766 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.82 93.11 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.135 -1.802 . . . . 55.24 106.135 167.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -105.02 148.44 26.75 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.882 -1.155 . . . . 75.02 107.882 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 48.8 -178.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.588 1.955 . . . . 61.21 112.693 -162.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.36 18.96 7.54 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.852 1.661 . . . . 75.22 109.611 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -95.15 -153.42 0.39 Allowed 'General case' 0 C--O 1.232 0.153 0 O-C-N 119.744 -1.847 . . . . 63.34 110.214 -165.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m120 43.98 75.77 0.09 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.376 2.271 . . . . 63.42 113.594 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.297 -1.371 . . . . 75.3 107.297 166.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.695 0 N-CA-C 108.969 -1.652 . . . . 52.32 108.969 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.03 10.75 4.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.69 1.196 . . . . 65.44 112.361 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -53.83 120.21 5.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.912 1.685 . . . . 70.23 110.586 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -120.5 14.66 11.96 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.469 0.914 . . . . 72.55 113.469 -171.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.08 105.29 10.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.251 1.82 . . . . 74.14 110.275 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 7' ' ' PRO . 14.8 p -83.89 166.06 35.88 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.558 0.743 . . . . 72.22 109.989 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 55.7 Cg_endo -63.04 -40.88 31.38 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.59 1.246 . . . . 72.24 110.543 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -72.95 -29.2 62.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.955 0.798 . . . . 72.44 112.182 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.99 -47.33 81.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.78 -0.822 . . . . 52.13 108.78 166.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -73.76 -13.22 60.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.161 0.8 . . . . 70.11 113.161 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.87 -14.05 22.09 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.177 0.991 . . . . 62.5 111.659 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.71 -75.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.55 1.54 . . . . 73.52 110.944 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 58.68 -15.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 C-N-CA 131.15 3.78 . . . . 73.41 116.943 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -77.75 155.93 30.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.814 0.846 . . . . 64.33 111.47 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.09 179.29 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.499 1.52 . . . . 63.14 108.54 167.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -140.94 127.05 19.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.631 1.173 . . . . 70.2 110.048 -169.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.77 115.4 30.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.363 1.465 . . . . 72.5 107.451 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -128.87 32.59 4.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.623 1.569 . . . . 74.22 110.141 -174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -147.28 27.36 1.03 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.381 -1.449 . . . . 73.3 110.445 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 59.4 mt -68.03 155.19 40.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.949 1.3 . . . . 72.21 113.654 -172.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.13 -174.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.812 1.645 . . . . 44.1 110.085 163.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.92 19.57 10.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.139 1.376 . . . . 73.0 111.879 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -140.26 8.82 2.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.648 1.179 . . . . 73.24 111.366 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.9 tt -76.0 148.82 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.317 1.447 . . . . 74.03 108.82 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.26 152.23 88.04 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.033 -1.042 . . . . 62.1 109.083 170.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.06 -48.94 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.687 1.591 . . . . 73.3 111.198 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttp85 -64.13 -21.27 66.48 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.124 -0.941 . . . . 74.33 112.767 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.19 -33.3 72.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.576 1.535 . . . . 62.41 110.492 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.28 -23.25 54.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.094 -0.955 . . . . 65.41 111.86 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HB2' HG11 ' A' ' 39' ' ' VAL . 2.9 pt-20 -91.37 -33.48 15.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.19 0.904 . . . . 74.34 108.628 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.42 -36.56 76.11 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.272 1.829 . . . . 74.14 111.107 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -49.9 -62.45 1.56 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.126 0.97 . . . . 63.51 110.471 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.81 -17.61 64.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 65.51 111.833 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -2.33 6.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.727 1.01 . . . . 70.13 113.727 172.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -69.69 -34.58 74.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.416 1.462 . . . . 64.24 110.159 161.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -8.96 11.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 120.005 1.275 . . . . 64.51 113.806 -159.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.99 178.48 48.5 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.415 -0.674 . . . . 45.04 111.415 -160.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.64 135.75 54.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.892 1.346 . . . . 62.32 112.005 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 HG12 ' A' ' 59' ' ' VAL . 9.9 p -123.21 153.29 28.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 125.59 1.556 . . . . 51.32 109.614 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -97.35 -52.84 3.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.323 -1.762 . . . . 64.31 107.219 -166.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.13 -177.88 3.48 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.164 0.585 . . . . 72.22 110.267 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.05 149.52 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.199 1.0 . . . . 72.31 110.259 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -124.91 159.58 30.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.096 1.358 . . . . 70.43 109.735 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.1 ptp -138.6 132.0 30.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.771 1.228 . . . . 54.3 107.88 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HB ' HD13 ' A' ' 56' ' ' ILE . 3.6 mp -84.04 80.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.256 -1.387 . . . . 54.4 107.256 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.3 m -80.29 96.59 6.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.959 1.704 . . . . 73.0 108.911 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.5 -171.11 2.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.396 1.878 . . . . 55.13 110.262 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -127.05 -68.72 0.79 Allowed 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.535 1.134 . . . . 73.0 110.699 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -129.43 74.12 1.56 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.894 1.33 . . . . 53.4 107.62 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.38 -68.0 0.32 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.691 -2.05 . . . . 63.04 109.786 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -158.25 42.38 0.28 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.487 -0.758 . . . . 62.21 109.667 -163.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -57.88 -32.33 67.59 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 118.735 -0.65 . . . . 74.13 109.951 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.3 m 45.27 35.87 1.99 Allowed 'General case' 0 C--N 1.34 0.154 0 C-N-CA 127.787 2.435 . . . . 72.01 112.706 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.36 0.0 OUTLIER 44.7 38.12 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.049 1.74 . . . . 73.4 113.581 -175.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.65 111.32 2.75 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.452 -1.459 . . . . 71.3 109.452 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD13 ' HB ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -142.96 141.15 27.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.926 1.29 . . . . 61.4 109.182 -169.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.82 152.43 28.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.41 1.084 . . . . 70.23 108.927 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -124.95 146.1 49.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.553 1.541 . . . . 72.44 107.339 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 39' ' ' VAL . 1.8 t -130.8 115.27 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.869 -1.16 . . . . 73.52 107.869 -161.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -85.9 96.57 9.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.884 0.873 . . . . 74.43 109.61 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -59.69 157.22 12.3 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 120.029 -1.67 . . . . 74.51 113.45 166.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.99 -29.19 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 109.702 -0.481 . . . . 74.32 109.702 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.44 144.83 42.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.97 1.308 . . . . 62.11 110.001 -171.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 p -72.91 -21.9 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.443 0.697 . . . . 73.23 112.527 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -59.26 -22.64 61.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.621 -1.3 . . . . 73.11 113.755 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m -93.27 -2.08 55.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.801 0.84 . . . . 72.23 113.094 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.42 -58.35 19.2 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 120.211 -1.556 . . . . 65.5 110.135 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.01 -14.63 44.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 CA-C-N 121.383 1.53 . . . . 74.33 112.683 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -41.34 94.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.336 -0.853 . . . . 74.51 108.762 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.79 -28.54 66.06 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.868 0.867 . . . . 62.41 112.966 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.5 mt -63.49 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 118.966 0.803 . . . . 70.51 109.076 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.39 -14.3 59.59 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.549 -0.72 . . . . 30.45 113.794 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.89 -0.79 41.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.508 1.154 . . . . 73.42 112.287 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -45.54 -45.62 13.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.872 1.269 . . . . 74.42 111.524 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.67 4.94 79.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.809 0.718 . . . . 71.21 114.245 -168.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -78.91 -171.14 2.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.505 1.152 . . . . 73.3 108.929 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.43 121.03 4.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.985 -1.487 . . . . 73.1 106.985 176.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 97.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.287 -1.375 . . . . 72.42 107.287 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 mt 53.08 16.23 0.72 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.719 1.607 . . . . 70.42 113.439 -170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.99 7.29 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.132 0.872 . . . . 53.32 113.137 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 20' ' ' LEU . 82.4 t -107.26 86.61 2.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.724 2.01 . . . . 61.3 111.222 -174.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.76 175.84 1.58 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.157 1.904 . . . . 51.34 111.557 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.6 tt -127.19 163.96 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 O-C-N 121.53 -0.731 . . . . 62.41 110.278 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 86' ' ' GLN . 49.2 mm -99.87 140.25 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.743 -1.577 . . . . 62.23 106.743 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -44.92 -24.97 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.085 2.154 . . . . 74.21 114.83 170.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.516 ' H ' HG22 ' A' ' 84' ' ' ILE . 13.1 mt-30 -44.1 -51.7 7.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.123 1.769 . . . . 73.42 113.331 -162.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.33 48.75 18.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.798 1.239 . . . . 74.2 112.376 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 t 54.15 -152.98 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.271 -1.011 . . . . 73.14 108.271 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 50.67 76.98 0.13 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.49 1.516 . . . . 52.2 113.325 162.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' HB1' ' H ' ' A' ' 92' ' ' LYS . . . -154.16 169.46 23.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.789 -1.194 . . . . 72.51 112.407 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.08 8.91 42.63 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.844 1.658 . . . . 73.54 110.73 158.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' H ' ' HB1' ' A' ' 90' ' ' ALA . 23.1 mmtp -67.4 156.55 36.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.685 1.194 . . . . 64.54 109.742 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -150.36 147.87 28.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.226 -1.027 . . . . 71.42 108.226 159.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.77 2.028 . . . . 75.2 109.952 162.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 111.729 -0.548 . . . . 65.15 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -136.53 169.07 18.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.586 1.955 . . . . 73.11 107.774 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.6 ttm -140.87 49.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.095 -1.076 . . . . 72.13 108.095 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.57 150.17 29.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.689 1.196 . . . . 65.43 107.899 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.56 136.76 46.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.146 2.178 . . . . 73.22 106.793 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 7' ' ' PRO . 30.7 p -76.08 165.52 52.44 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 118.874 0.761 . . . . 61.24 111.415 -174.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 23.1 Cg_endo -60.37 -40.97 53.6 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.709 1.606 . . . . 74.54 110.073 172.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -58.14 -50.04 74.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.811 1.245 . . . . 75.15 110.188 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -52.03 -47.73 64.89 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.169 0.588 . . . . 75.15 110.422 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -70.81 -28.54 64.7 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.93 0.892 . . . . 71.25 112.726 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -44.14 52.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.672 1.589 . . . . 73.43 109.652 176.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.98 -66.02 0.6 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 54.42 111.838 -162.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 44.47 59.71 3.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.082 2.153 . . . . 73.24 114.562 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.02 165.58 27.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.036 -1.468 . . . . 72.51 107.036 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.76 -178.5 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.936 0.895 . . . . 71.43 109.536 163.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.73 102.17 3.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.404 1.097 . . . . 75.43 110.573 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.5 m -87.66 94.94 9.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.384 1.874 . . . . 70.51 109.117 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.4 ttp -108.17 44.85 1.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.769 1.227 . . . . 63.52 110.207 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -164.8 68.3 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 72.2 110.36 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.39 166.1 10.92 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.364 -0.835 . . . . 74.34 111.367 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.9 171.55 7.58 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.627 1.171 . . . . 45.2 110.654 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.85 -30.94 65.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.266 0.839 . . . . 74.4 113.266 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.63 51.5 1.92 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.365 1.066 . . . . 62.44 108.959 -170.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 tt -80.47 154.13 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.772 -0.825 . . . . 71.2 108.772 170.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -111.76 160.59 29.1 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 107.802 -1.184 . . . . 72.54 107.802 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -59.96 -21.43 64.69 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.031 1.821 . . . . 73.32 112.436 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -34.5 73.0 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.963 -1.086 . . . . 71.11 112.297 173.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -34.31 74.74 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.874 1.216 . . . . 63.31 111.747 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' HG11 ' A' ' 59' ' ' VAL . 2.2 mm? -64.5 -41.8 96.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.558 0.743 . . . . 74.41 110.124 -174.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.77 -35.12 29.94 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.221 -0.895 . . . . 62.44 109.99 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -63.92 -24.31 67.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.597 1.089 . . . . 72.13 111.253 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -65.46 -67.6 0.43 Allowed 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.874 -0.516 . . . . 73.51 110.388 168.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -71.4 -19.7 62.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.552 0.945 . . . . 65.3 113.552 -167.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 t -51.72 -28.64 15.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.96 1.304 . . . . 74.51 110.798 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.418 HG23 HG13 ' A' ' 36' ' ' VAL . 1.3 t -77.02 -14.94 59.77 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.146 -0.971 . . . . 62.11 110.987 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 35' ' ' THR . 31.2 m -131.36 -4.19 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.261 1.024 . . . . 72.23 113.358 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.15 -156.83 12.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.662 -1.375 . . . . 72.21 109.662 -174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -145.3 139.33 27.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.421 1.111 . . . . 73.52 110.985 166.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 t -71.17 143.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.925 1.69 . . . . 73.44 108.778 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -82.44 -50.6 8.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.013 -1.054 . . . . 54.12 109.606 163.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.58 124.06 11.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.275 0.488 . . . . 63.22 110.817 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.6 t -73.7 108.17 4.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 O-C-N 121.404 -0.81 . . . . 62.41 109.343 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -104.91 82.58 1.89 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.863 1.265 . . . . 71.2 108.129 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 153.57 23.4 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.613 0.765 . . . . 74.2 109.003 167.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.39 161.73 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.155 -1.054 . . . . 63.44 108.155 -176.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 t 57.76 35.94 26.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.907 1.337 . . . . 64.32 111.025 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.98 4.25 10.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.719 2.007 . . . . 74.22 110.985 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 156.74 46.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 120.266 -1.522 . . . . 75.51 108.403 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.82 -24.96 64.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 118.708 -0.663 . . . . 72.12 112.579 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 t -74.88 41.51 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.125 1.784 . . . . 35.33 112.689 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -159.69 -49.74 0.05 Allowed 'General case' 0 C--N 1.344 0.348 0 O-C-N 120.137 -1.602 . . . . 63.42 112.062 157.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 48.12 62.73 2.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.048 0.928 . . . . 75.33 110.268 -164.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -68.19 27.17 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 O-C-N 119.854 -1.778 . . . . 73.42 111.911 162.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 61.12 5.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.438 1.644 . . . . 75.21 115.438 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.07 106.42 2.67 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 109.606 -1.398 . . . . 62.22 109.606 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 pt -145.56 137.36 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.1 1.36 . . . . 74.12 110.152 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.61 135.19 29.76 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.601 -1.259 . . . . 64.4 107.601 163.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -122.11 70.77 0.98 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.625 -1.25 . . . . 75.2 107.625 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 29' ' ' LEU . 3.1 m -67.35 135.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.539 0.685 . . . . 61.1 109.772 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.61 145.06 31.89 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.809 -1.182 . . . . 73.34 107.809 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.18 151.33 24.9 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 113.319 0.859 . . . . 73.44 113.319 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 -43.6 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.31 -0.859 . . . . 70.3 109.104 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.38 142.64 46.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.518 1.127 . . . . 73.52 109.71 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.97 -36.66 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 111.827 0.306 . . . . 50.3 111.827 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -62.6 -23.51 67.08 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.148 -0.97 . . . . 74.1 113.065 -166.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -77.07 -13.12 60.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.945 0.898 . . . . 54.14 113.07 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.98 -56.48 25.22 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.866 1.666 . . . . 62.31 111.723 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.63 -12.41 34.98 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 121.997 1.798 . . . . 64.23 113.635 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.26 -47.93 66.43 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.009 -1.057 . . . . 52.44 109.231 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.57 69.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.372 0.669 . . . . 62.33 112.395 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 85' ' ' VAL . 65.9 mt -57.32 -41.4 78.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.754 0.822 . . . . 73.51 109.362 176.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.85 -18.46 56.92 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.56 -0.578 . . . . 74.54 112.865 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -101.34 9.44 41.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.708 1.203 . . . . 71.32 111.554 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -51.64 -30.02 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.69 1.132 . . . . 61.1 113.383 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.91 5.41 27.39 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.161 1.362 . . . . 63.1 112.796 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.95 174.95 8.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.779 1.29 . . . . 62.41 108.275 155.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 130.15 10.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.83 1.252 . . . . 73.34 108.642 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.19 115.52 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.819 -1.919 . . . . 65.2 105.819 162.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.65 3.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.737 2.125 . . . . 63.52 116.737 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.72 7.27 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.736 1.153 . . . . 42.24 113.923 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.39 86.99 2.97 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 128.323 2.649 . . . . 72.22 109.675 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.77 -176.67 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.791 2.327 . . . . 74.41 111.549 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.5 tt -136.77 167.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 121.19 -0.944 . . . . 71.24 109.715 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 86' ' ' GLN . 39.8 mm -111.95 144.72 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.671 -1.603 . . . . 72.11 106.671 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 71' ' ' ILE . 28.2 t -57.34 -13.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.508 1.923 . . . . 73.1 112.832 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' H ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -52.42 -26.68 13.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.001 2.52 . . . . 75.5 115.419 -171.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 43.32 89.92 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.352 1.461 . . . . 54.04 112.132 155.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t -48.06 118.23 2.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.723 -1.214 . . . . 62.51 107.723 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -146.48 139.57 25.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.031 2.932 . . . . 73.5 105.856 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.19 161.72 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.457 2.303 . . . . 55.4 114.606 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.41 52.33 2.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.643 1.977 . . . . 72.53 108.425 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -143.36 149.81 38.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.583 2.353 . . . . 75.52 106.46 -170.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -154.21 104.62 2.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.073 -1.084 . . . . 75.44 108.073 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.593 0.757 . . . . 75.23 111.691 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.559 0 N-CA-C 110.191 -1.163 . . . . 62.33 110.191 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -99.89 144.06 29.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.09 0.956 . . . . 75.35 109.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mtm -166.41 167.18 16.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.4 2.28 . . . . 71.25 108.006 175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -66.68 129.79 41.01 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.306 -0.854 . . . . 73.12 110.075 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 mt 50.01 -173.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.53 1.932 . . . . 74.23 113.055 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -88.39 165.95 25.8 Favored Pre-proline 0 C--O 1.239 0.549 0 N-CA-C 107.383 -1.34 . . . . 73.33 107.383 158.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -23.97 51.77 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.143 1.087 . . . . 55.02 111.246 167.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.28 4.0 pt-20 -91.99 -33.63 14.77 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.188 0.995 . . . . 62.51 113.21 -165.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.76 -44.26 63.28 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.429 1.013 . . . . 63.31 111.288 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -63.0 -24.56 67.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.607 0.763 . . . . 60.41 112.556 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.57 -18.43 13.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.876 0.846 . . . . 55.45 111.028 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.49 -72.5 0.41 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.393 2.277 . . . . 43.15 109.957 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.27 73.2 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.655 1.582 . . . . 73.55 111.164 -164.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.63 150.67 49.7 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.909 -1.119 . . . . 74.35 109.664 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 61' ' ' PHE . 28.1 m -133.71 171.7 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.357 1.463 . . . . 72.52 107.557 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.92 142.16 30.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.258 1.423 . . . . 75.21 108.238 -166.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.7 m -130.21 103.28 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.148 1.379 . . . . 64.52 109.858 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.1 ttm -92.83 -0.34 57.27 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.797 1.036 . . . . 72.12 113.797 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -128.18 29.08 5.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.278 1.214 . . . . 52.32 114.278 -163.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.401 ' HA ' HG13 ' A' ' 81' ' ' VAL . 87.0 mt -73.34 151.53 41.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.355 1.062 . . . . 74.1 113.632 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.21 165.72 17.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.549 1.14 . . . . 72.1 112.95 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.084 1.354 . . . . 74.14 113.542 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.98 47.09 1.96 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.26 1.024 . . . . 74.11 110.755 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.51 154.49 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 120.995 -1.065 . . . . 74.22 109.05 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -114.98 157.87 42.23 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 127.439 2.296 . . . . 72.31 107.738 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.21 -19.89 69.58 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.805 1.67 . . . . 74.42 112.182 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 1.5 ptp180 -76.71 -29.95 56.46 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.363 -0.827 . . . . 73.34 112.259 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -61.89 -25.19 67.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.491 1.041 . . . . 75.13 111.061 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' H ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -78.11 -54.24 6.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.915 0.886 . . . . 75.34 109.07 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.57 -33.29 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 117.693 -1.146 . . . . 73.42 111.347 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.02 0.827 . . . . 74.5 109.53 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CG ' HG21 ' A' ' 78' ' ' VAL . 9.0 t80 -52.79 -48.21 67.03 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 122.684 0.394 . . . . 61.14 110.718 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -80.04 -14.46 58.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.199 -1.0 . . . . 75.5 112.103 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 t -64.97 -17.25 64.25 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.362 1.437 . . . . 55.01 110.848 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 p -73.16 -21.77 60.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.779 1.172 . . . . 71.43 111.037 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.43 -7.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.641 1.576 . . . . 71.42 112.736 -166.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.37 18.46 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.114 1.34 . . . . 22.42 111.003 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -147.87 134.41 19.78 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.68 1.192 . . . . 73.42 110.573 -168.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.0 t -105.5 144.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.293 1.837 . . . . 71.3 108.395 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.71 -54.93 2.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.275 1.43 . . . . 72.43 108.378 172.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.56 165.04 27.91 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 124.162 0.914 . . . . 64.11 110.982 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.01 110.26 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.946 2.098 . . . . 71.21 106.502 -160.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -143.71 81.34 1.69 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.041 0.837 . . . . 64.14 110.047 -160.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.1 mtp -88.41 160.77 17.41 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 122.671 1.224 . . . . 64.33 110.429 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 46' ' ' SER . 5.7 mm -88.14 -175.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 124.823 1.249 . . . . 60.12 107.917 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.738 ' H ' HG22 ' A' ' 45' ' ' ILE . 8.4 t 56.73 4.14 0.15 Allowed 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 127.331 2.252 . . . . 40.15 114.585 -169.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.15 -21.88 61.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.113 0.959 . . . . 72.23 111.114 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -107.68 4.54 25.89 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.209 1.804 . . . . 72.42 112.703 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 42.84 61.26 2.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.562 1.945 . . . . 75.21 113.209 167.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.9 p -150.62 -51.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.476 0.917 . . . . 62.31 113.476 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -124.36 104.04 8.55 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 106.856 -1.535 . . . . 53.04 106.856 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.5 155.09 42.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.942 1.297 . . . . 74.12 109.299 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 m -84.06 10.66 9.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 117.734 -1.126 . . . . 55.21 112.138 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.367 0.0 OUTLIER 44.95 68.27 0.58 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.643 1.577 . . . . 75.43 111.617 -163.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.63 77.26 0.28 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 124.766 1.174 . . . . 74.31 110.416 163.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -145.65 153.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.288 1.044 . . . . 73.52 110.732 171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.8 40.78 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.976 1.31 . . . . 63.33 109.144 168.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -122.28 154.83 37.05 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 75.25 106.783 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 t -134.67 134.46 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.184 -2.154 . . . . 75.25 105.184 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.55 109.09 20.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.625 -1.991 . . . . 72.21 105.625 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' A' ' 15' ' ' VAL . 3.5 m-30 -73.18 168.97 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.522 0.729 . . . . 71.53 109.296 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.43 -38.67 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 120.538 -0.465 . . . . 62.33 109.85 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.11 128.15 45.2 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.651 0.659 . . . . 71.22 110.447 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.82 -37.76 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 72.35 111.474 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -5.5 54.27 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.685 -1.259 . . . . 63.42 112.336 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.9 m -90.88 -12.06 37.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.232 -0.918 . . . . 74.34 111.824 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.5 t -54.58 -57.63 17.99 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.369 0.986 . . . . 75.22 110.089 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.86 -22.61 68.88 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.228 1.952 . . . . 73.53 113.872 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.21 -52.26 59.73 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.771 -0.826 . . . . 72.24 108.771 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.86 78.57 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.217 0.607 . . . . 74.5 111.328 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.87 -44.51 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.563 0.745 . . . . 75.11 109.385 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.92 -10.64 27.05 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.764 0.697 . . . . 40.3 114.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.41 5.84 50.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.555 1.178 . . . . 72.13 111.932 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.679 ' HA ' HG23 ' A' ' 83' ' ' ILE . 8.9 t -44.46 -45.75 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.996 1.718 . . . . 74.12 112.876 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.86 2.93 84.67 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.738 -1.034 . . . . 62.11 113.703 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.06 -176.59 2.16 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.508 1.654 . . . . 74.13 109.317 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -157.45 81.69 0.9 Allowed 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.829 0.851 . . . . 71.22 109.502 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 32' ' ' PHE . 60.7 t -58.47 102.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.487 1.115 . . . . 51.31 108.541 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt 56.51 25.03 9.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.53 0.332 . . . . 71.11 111.677 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.73 -6.41 25.99 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.237 -1.313 . . . . 54.13 113.706 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 20' ' ' LEU . 59.1 t -104.7 86.7 1.52 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.546 1.938 . . . . 64.3 111.915 -168.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.08 -179.58 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.76 2.307 . . . . 71.44 111.635 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -141.83 168.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.424 0.689 . . . . 53.02 109.278 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.8 mm -112.45 137.66 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.606 1.562 . . . . 63.44 106.968 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.31 -2.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 129.731 3.212 . . . . 74.23 117.058 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -62.03 -33.2 73.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.999 1.851 . . . . 72.12 115.999 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.65 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 123.515 1.626 . . . . 51.03 110.709 -162.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.57 -164.59 1.19 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.067 -1.424 . . . . 71.41 107.616 156.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.77 53.75 10.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 127.306 2.242 . . . . 75.33 112.824 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.28 -161.74 0.78 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.125 0.57 . . . . 62.13 110.043 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.43 16.37 22.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.777 2.031 . . . . 74.45 110.709 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -121.73 151.3 40.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.296 -0.877 . . . . 73.43 111.015 -166.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.88 -7.29 0.07 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.267 1.427 . . . . 73.41 114.22 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--O 1.245 0.863 0 C-N-CA 125.491 1.517 . . . . 75.53 107.554 -177.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 111.31 -0.716 . . . . 72.4 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.2 m80 55.13 27.64 9.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.038 1.735 . . . . 72.21 112.204 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.418 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 31.3 ttm -140.76 167.18 22.79 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.803 2.441 . . . . 72.22 107.058 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.418 ' H ' ' HG2' ' A' ' 3' ' ' MET . 39.2 t-20 62.53 111.08 0.02 OUTLIER 'General case' 0 C--O 1.235 0.336 0 C-N-CA 128.114 2.566 . . . . 73.4 110.778 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.96 134.5 52.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.356 1.863 . . . . 72.41 106.887 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.0 p -66.88 165.99 22.32 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 118.147 0.43 . . . . 75.31 111.46 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.02 -11.65 2.81 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.991 2.461 . . . . 74.32 114.432 163.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.7 -41.37 2.8 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.571 1.548 . . . . 71.32 110.663 -162.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.05 -36.3 70.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.945 1.248 . . . . 64.32 111.21 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -60.45 -28.98 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.724 0.81 . . . . 72.24 112.385 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -88.67 -43.43 11.32 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.608 1.563 . . . . 61.12 109.511 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.8 0.68 1.08 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.891 2.076 . . . . 75.5 114.199 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -63.44 -17.47 62.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.922 1.289 . . . . 61.34 112.116 163.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -66.7 126.98 30.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.857 -1.164 . . . . 64.31 107.857 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 174.2 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.528 -0.916 . . . . 73.24 108.528 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.7 98.39 3.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.624 1.202 . . . . 74.23 110.707 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' HB3' HD21 ' A' ' 20' ' ' LEU . 62.0 m -80.93 88.14 5.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.559 1.543 . . . . 52.03 108.541 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttp -90.94 13.12 17.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.988 0.915 . . . . 55.21 112.397 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.4 mt-30 -133.38 94.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.493 -1.38 . . . . 53.03 107.872 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 29' ' ' LEU . 12.1 mt -118.28 157.51 26.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.578 0.351 . . . . 55.25 111.577 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.43 160.56 32.13 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.011 0.91 . . . . 72.32 110.055 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.64 5.29 13.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.948 1.699 . . . . 71.14 114.103 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.71 64.12 1.0 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.012 1.278 . . . . 75.12 108.21 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 tt -109.83 136.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.712 1.205 . . . . 73.44 109.532 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -77.2 149.07 78.93 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 107.63 -1.248 . . . . 73.05 107.63 165.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.85 -32.82 93.13 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.238 1.292 . . . . 72.32 111.158 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttp85 -66.73 -20.8 66.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.074 -0.965 . . . . 63.33 112.507 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.5 -29.0 70.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.737 1.608 . . . . 73.13 109.679 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 2.4 mm? -77.67 -48.58 16.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.936 0.895 . . . . 75.13 109.754 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.14 -37.29 80.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.896 0.316 . . . . 74.32 110.996 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.823 0.849 . . . . 72.02 111.314 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -57.27 -46.13 83.38 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.498 0.59 . . . . 55.24 110.311 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -68.23 -26.62 65.79 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.612 -0.68 . . . . 73.14 112.667 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -15.33 34.99 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.655 1.182 . . . . 72.23 112.804 -173.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -61.81 -18.6 60.55 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.425 -0.797 . . . . 62.43 111.679 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.81 24.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.2 1.0 . . . . 62.2 110.401 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.3 -161.77 27.36 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.201 1.364 . . . . 72.04 115.371 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.57 146.37 28.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.34 1.856 . . . . 75.32 108.644 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.21 150.55 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 127.175 2.19 . . . . 73.03 107.963 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -82.04 -56.69 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.608 1.563 . . . . 73.32 109.282 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -159.43 134.64 8.25 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.132 -0.692 . . . . 72.23 109.132 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.43 162.27 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.397 1.879 . . . . 72.01 111.205 164.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.78 112.1 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.335 2.254 . . . . 75.03 107.81 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.0 ptp -116.76 147.8 41.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.874 1.216 . . . . 75.43 110.556 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 45' ' ' ILE . 2.3 mp -90.88 78.45 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.886 -1.154 . . . . 52.01 107.886 -166.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.8 m -94.24 9.68 37.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.039 1.126 . . . . 73.41 114.039 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.07 6.71 15.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.945 1.298 . . . . 71.14 112.767 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 58.54 -164.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.037 -1.039 . . . . 74.24 109.277 -151.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.8 p30 175.16 -1.73 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.642 1.977 . . . . 72.23 112.954 -165.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.65 16.16 9.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.043 1.337 . . . . 64.14 114.516 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 -57.35 0.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.369 -1.457 . . . . 73.34 108.417 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.33 72.77 0.51 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.922 2.489 . . . . 75.31 110.809 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -55.76 -2.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.945 2.098 . . . . 75.21 113.387 161.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 54.99 30.86 14.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.542 1.537 . . . . 74.12 113.459 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.75 90.16 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 108.372 -1.891 . . . . 75.25 108.372 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.44 135.02 30.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.047 0.939 . . . . 74.31 108.941 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.78 147.78 21.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.329 1.852 . . . . 55.21 108.174 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -122.27 123.2 40.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.116 -1.809 . . . . 75.44 106.116 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.73 140.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 121.986 2.175 . . . . 75.14 108.057 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.05 115.57 12.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.9 -1.889 . . . . 71.32 105.9 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.21 160.57 22.98 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.307 0.958 . . . . 75.22 110.35 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.64 -27.94 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 118.629 -0.7 . . . . 74.21 110.759 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -114.73 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.888 1.222 . . . . 63.14 110.217 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.68 -28.02 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.857 1.263 . . . . 71.23 110.587 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -68.99 -17.31 63.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.861 1.21 . . . . 73.11 110.56 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -70.47 -23.55 62.71 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.604 1.562 . . . . 72.51 113.923 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.07 -56.29 37.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.422 -0.799 . . . . 44.43 110.11 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.17 -13.26 39.05 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.611 1.541 . . . . 74.2 113.2 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.11 -48.01 69.43 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.798 1.181 . . . . 60.14 109.839 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.56 78.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.454 0.57 . . . . 44.2 111.446 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.77 -39.47 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.967 0.907 . . . . 64.14 110.016 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.92 -0.09 40.52 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.603 -1.109 . . . . 60.11 114.025 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.12 2.63 19.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.805 1.802 . . . . 74.44 111.794 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 83' ' ' ILE . 15.1 t -50.45 -33.03 19.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.64 1.176 . . . . 74.13 113.54 -171.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.78 21.9 26.92 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.725 1.155 . . . . 64.51 113.848 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.93 174.22 8.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.213 1.507 . . . . 73.34 108.176 153.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -159.87 85.74 0.76 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.384 0.993 . . . . 74.51 112.717 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.0 m -60.37 117.59 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.734 -0.469 . . . . 71.2 109.734 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.3 mt 51.31 31.03 6.52 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.589 1.156 . . . . 63.14 112.534 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.51 27.67 29.3 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.226 -0.763 . . . . 54.25 113.044 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 t -121.15 84.79 40.57 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.931 1.365 . . . . 75.23 109.619 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.32 177.54 5.17 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.285 2.657 . . . . 75.31 112.018 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.1 tt -132.69 144.4 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.477 -0.764 . . . . 75.44 109.695 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 86' ' ' GLN . 41.3 mm -86.52 142.54 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.507 -0.923 . . . . 71.33 108.507 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.53 -3.91 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 114.691 1.367 . . . . 72.21 114.691 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 84' ' ' ILE . 2.1 mm100 -46.45 -51.41 15.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.192 1.797 . . . . 72.41 113.887 -168.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.01 174.34 0.07 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.282 1.433 . . . . 73.51 110.281 -169.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.36 156.2 20.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.753 -1.573 . . . . 72.51 106.753 153.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 168.57 19.64 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.485 1.914 . . . . 64.41 107.043 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.93 158.68 35.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.495 0.589 . . . . 71.12 110.551 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.97 11.62 35.23 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.294 1.438 . . . . 72.31 110.487 164.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.48 158.2 24.6 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.489 1.916 . . . . 63.35 110.638 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.43 19.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.762 1.225 . . . . 71.21 110.899 168.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 . . . . . 0 C--O 1.238 0.456 0 O-C-N 120.328 -1.482 . . . . 72.23 109.472 177.897 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 CA-C-O 119.24 -0.756 . . . . 65.32 111.519 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 58.66 71.01 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.256 2.222 . . . . 71.14 114.362 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpp -78.51 145.28 35.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.69 1.196 . . . . 63.54 110.661 167.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 55.74 -161.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.083 1.753 . . . . 74.03 113.489 163.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.49 156.71 44.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.06 1.744 . . . . 62.21 106.936 172.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.3 p -113.62 166.58 10.99 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 126.43 1.892 . . . . 73.45 109.514 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -59.8 -9.11 8.79 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 121.533 1.583 . . . . 71.24 113.142 168.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.03 -25.56 8.49 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.311 -1.493 . . . . 72.15 114.174 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -64.35 -21.47 66.63 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.284 1.402 . . . . 63.24 112.842 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -23.93 62.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.558 1.072 . . . . 70.22 112.015 171.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.1 -36.09 15.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.355 1.062 . . . . 72.21 110.097 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.28 59.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.723 1.209 . . . . 71.02 112.221 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -53.84 -33.46 56.3 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.035 0.934 . . . . 73.03 112.562 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -70.84 149.17 47.09 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.878 0.847 . . . . 53.41 110.279 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.0 114.76 45.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 122.279 1.038 . . . . 65.01 108.45 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.93 104.75 14.27 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.471 -1.24 . . . . 73.21 108.829 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -92.27 121.11 33.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.151 -1.426 . . . . 51.13 107.151 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 ttm -125.53 18.79 8.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.267 1.027 . . . . 72.12 111.474 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -134.11 22.03 3.79 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.617 -1.302 . . . . 74.35 111.725 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.777 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.7 mt -77.44 164.51 25.4 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.546 0.573 . . . . 64.41 112.546 -168.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.4 26.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.735 1.214 . . . . 71.43 110.709 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 14.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.143 2.177 . . . . 73.03 114.929 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.91 16.69 2.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.95 1.25 . . . . 63.4 114.153 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.98 145.0 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.639 -1.288 . . . . 73.12 110.965 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -83.61 156.74 65.04 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-O 118.129 -0.939 . . . . 70.13 109.489 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.41 -37.12 74.13 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.138 1.892 . . . . 74.34 111.582 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.14 -28.48 68.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.684 -1.151 . . . . 65.13 111.982 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -33.47 69.72 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.866 1.666 . . . . 71.44 111.024 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.2 -29.75 69.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.458 1.103 . . . . 71.03 110.712 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.6 pt-20 -92.42 -30.87 15.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.937 0.895 . . . . 73.12 110.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.16 -44.68 92.14 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.486 1.514 . . . . 64.21 110.864 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.33 -63.75 1.04 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.487 1.515 . . . . 63.2 109.777 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.02 -22.5 61.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.266 0.469 . . . . 74.5 112.266 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -19.27 64.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.614 1.097 . . . . 74.31 111.443 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.8 p -61.24 -35.31 76.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.332 0.969 . . . . 61.14 111.077 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.0 8.42 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.934 2.494 . . . . 70.22 109.94 -167.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.19 -140.73 6.18 Favored Glycine 0 N--CA 1.442 -0.914 0 O-C-N 120.635 -1.29 . . . . 63.44 110.772 -162.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -152.83 -173.43 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.53 1.932 . . . . 73.11 106.808 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 30' ' ' GLU . 24.3 t -143.99 149.35 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 129.712 3.205 . . . . 71.02 106.169 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -62.89 1.54 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.724 -1.213 . . . . 65.42 107.724 167.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -158.99 162.25 36.76 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.876 -0.787 . . . . 63.0 108.876 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.78 128.67 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.952 1.701 . . . . 74.03 106.457 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -123.35 74.26 1.23 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.417 1.087 . . . . 73.33 109.002 170.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 130.87 35.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.639 2.376 . . . . 51.32 109.665 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.71 74.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.31 -1.737 . . . . 71.42 106.31 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -71.74 91.35 1.13 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.529 -0.915 . . . . 73.01 108.529 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 50.57 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 130.005 3.322 . . . . 65.32 113.645 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 172.81 6.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 120.974 -1.079 . . . . 63.05 109.031 -168.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -44.85 1.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.673 1 C-N-CA 132.683 4.393 . . . . 70.34 120.593 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -142.58 -61.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.203 1.401 . . . . 72.34 109.321 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 174.36 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.508 2.723 . . . . 65.25 109.867 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? 58.08 -164.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.903 1.281 . . . . 70.14 109.174 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -14.31 58.81 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.386 -1.292 . . . . 54.14 113.261 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER 50.39 10.74 0.06 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 117.633 2.457 . . . . 70.51 117.633 -176.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.22 63.43 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 118.934 0.788 . . . . 71.45 111.413 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -135.09 130.32 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 74.14 111.177 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.56 151.4 25.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.747 1.219 . . . . 65.01 111.175 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -127.5 80.99 1.99 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.627 1.171 . . . . 72.13 109.748 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.395 1.5 p -81.8 121.68 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.452 -1.405 . . . . 72.41 110.585 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.66 137.58 33.17 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.637 1.575 . . . . 73.11 109.989 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.46 160.79 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.965 0.888 . . . . 71.22 111.836 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.53 -16.24 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 126.531 1.933 . . . . 70.41 111.209 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -128.56 170.22 13.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.028 1.731 . . . . 71.21 108.806 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.99 -28.35 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.542 1.537 . . . . 72.04 111.032 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -77.89 -14.57 59.51 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.459 -1.401 . . . . 72.42 112.122 -167.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -89.08 -0.49 57.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.139 0.975 . . . . 74.3 112.613 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.86 -56.73 27.09 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 120.83 1.65 . . . . 44.13 109.425 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -14.81 46.0 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.953 1.769 . . . . 73.24 114.166 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.57 -59.61 4.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.218 1.372 . . . . 70.51 108.488 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.95 59.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.379 1.072 . . . . 71.5 112.241 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' VAL . 56.7 mt -57.41 -54.61 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.964 0.906 . . . . 70.53 108.622 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.52 -0.4 11.82 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.916 -0.936 . . . . 70.44 113.818 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -100.61 1.79 41.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.119 1.959 . . . . 73.24 111.295 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -49.45 -30.6 8.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.12 1.327 . . . . 73.3 114.344 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.38 2.43 56.24 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.405 1.002 . . . . 63.12 114.181 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.96 175.57 8.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.234 1.517 . . . . 72.31 108.517 164.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -152.63 131.76 12.7 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.278 -0.889 . . . . 74.5 110.057 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -83.61 90.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.425 -1.695 . . . . 62.4 106.425 170.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mt 59.81 37.34 21.94 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.869 0.842 . . . . 73.13 110.406 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.72 3.32 58.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.997 1.284 . . . . 74.21 114.581 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 20' ' ' LEU . 96.8 t -108.49 85.96 3.21 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.8 1.64 . . . . 74.34 109.801 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.07 -178.31 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.353 2.702 . . . . 73.13 112.608 168.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.438 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -134.33 148.75 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.063 0.945 . . . . 70.4 110.233 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 86' ' ' GLN . 46.0 mm -91.27 140.57 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.516 -1.29 . . . . 73.42 107.516 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 71' ' ' ILE . 24.8 t -51.19 -18.75 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.917 2.087 . . . . 70.31 114.795 171.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 84' ' ' ILE . 7.6 mm100 -44.31 -47.41 9.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 125.662 1.585 . . . . 70.11 113.276 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.05 49.86 16.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.707 0.803 . . . . 63.44 112.118 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.307 24.2 p 60.66 -154.97 0.36 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.26 1.424 . . . . 65.54 110.568 -170.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 44.95 -164.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.62 2.768 . . . . 74.31 115.544 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 19.21 0.33 Allowed 'General case' 0 C--N 1.345 0.374 0 N-CA-C 114.226 1.195 . . . . 70.54 114.226 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.94 44.54 30.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.49 0.716 . . . . 74.32 111.837 -162.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -141.87 -63.65 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.796 1.238 . . . . 70.14 110.574 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 44.7 62.9 1.88 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 128.203 2.601 . . . . 74.14 111.785 -166.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 106.39 -1.707 . . . . 73.52 106.39 177.933 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.923 0 N-CA-C 109.903 -1.279 . . . . 73.24 109.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.5 p80 44.06 45.1 6.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 63.41 112.795 159.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 mtm -80.32 86.2 5.72 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.077 0.941 . . . . 73.32 110.771 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 63.01 61.81 1.08 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 127.089 2.156 . . . . 70.11 110.206 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.91 106.66 0.09 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.779 2.032 . . . . 73.22 111.294 -172.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.712 HG23 ' HB2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.0 151.68 73.77 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.352 1.861 . . . . 71.44 113.246 174.785 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.11 -16.42 31.98 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.919 2.413 . . . . 74.35 112.659 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.21 -49.75 10.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.252 0.933 . . . . 74.41 109.625 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.712 ' HB2' HG23 ' A' ' 6' ' ' THR . 9.4 tt0 -59.78 -43.11 94.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.842 0.857 . . . . 74.22 110.497 -175.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -56.12 -27.46 54.06 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.625 0.77 . . . . 73.04 112.444 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.11 -16.23 14.32 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.337 1.455 . . . . 64.33 110.437 -167.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.35 -50.5 6.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.833 2.453 . . . . 74.23 111.403 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 61.1 6.12 1.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 72.35 116.224 167.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.1 m -107.54 157.08 18.32 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 119.961 -1.712 . . . . 54.44 109.495 -161.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.78 174.83 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.475 -0.766 . . . . 45.15 109.52 170.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -138.73 133.83 32.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.686 1.594 . . . . 72.44 107.36 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.6 m -127.31 121.99 32.57 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.32 -2.104 . . . . 65.55 105.32 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.3 ttp -125.32 14.31 8.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.11 0.964 . . . . 65.14 111.635 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -139.75 33.77 2.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.045 1.338 . . . . 63.14 109.982 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 mt -64.95 145.04 56.86 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.751 -0.593 . . . . 62.21 110.771 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -66.6 162.63 20.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.071 0.939 . . . . 64.51 109.496 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.17 59.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.446 -1.252 . . . . 70.14 114.31 -166.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -145.87 65.35 1.22 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.489 1.04 . . . . 73.24 108.762 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.9 tt -96.97 163.57 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 122.818 0.447 . . . . 73.32 110.387 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -108.52 155.48 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 125.779 1.632 . . . . 72.55 108.72 168.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 -36.51 93.07 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.396 2.064 . . . . 74.12 111.979 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -60.99 -32.95 72.5 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.962 -1.018 . . . . 61.41 111.612 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -72.52 -11.73 60.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.232 1.378 . . . . 74.13 112.865 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.26 -44.99 9.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.666 -0.865 . . . . 55.43 108.666 169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.8 pt-20 -65.71 -38.22 88.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.508 0.594 . . . . 73.53 111.518 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.5 -25.8 63.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.112 1.365 . . . . 75.53 112.651 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.28 -64.13 1.02 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.689 -1.226 . . . . 73.51 107.689 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.35 -27.68 69.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.78 1.029 . . . . 75.21 113.78 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 p -67.27 -3.22 7.36 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.991 1.269 . . . . 63.22 113.523 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -55.14 -27.88 48.66 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.754 1.161 . . . . 73.43 111.005 165.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -139.83 43.59 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.383 1.073 . . . . 72.21 110.861 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.03 -141.5 8.86 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.014 -1.234 . . . . 72.54 110.014 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -148.0 157.55 43.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.164 -1.05 . . . . 64.42 108.164 174.543 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 30' ' ' GLU . 67.0 t -91.98 163.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.518 -0.739 . . . . 53.01 109.194 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -122.31 -31.16 3.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.037 -1.459 . . . . 72.32 111.582 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -164.18 172.51 13.57 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.841 1.655 . . . . 54.25 109.196 159.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.55 126.0 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.515 1.926 . . . . 70.24 108.014 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.13 175.48 5.51 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.28 1.432 . . . . 74.53 109.929 169.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.3 ptp -166.29 154.93 10.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.898 1.679 . . . . 73.33 109.407 161.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.14 95.48 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.504 0.669 . . . . 64.21 109.923 -172.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.59 61.46 6.28 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 123.336 1.541 . . . . 63.44 108.768 171.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 44.92 178.61 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 131.757 4.023 . . . . 71.51 112.897 -162.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -143.96 -37.75 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.637 1.175 . . . . 74.33 111.305 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -151.91 0.49 0.34 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.196 1.398 . . . . 70.23 111.457 -164.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.99 -171.59 2.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.793 2.437 . . . . 63.53 108.42 -172.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -133.18 83.57 2.07 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.047 -1.464 . . . . 70.12 107.047 161.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -136.14 -59.45 0.74 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.085 1.354 . . . . 73.42 107.779 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 p 43.88 42.79 4.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.548 1.939 . . . . 65.33 113.674 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -66.35 24.96 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.642 2.09 . . . . 61.44 116.642 -166.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 70.68 1.29 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 108.786 -1.726 . . . . 33.53 108.786 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.71 122.73 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.363 1.465 . . . . 54.42 109.795 -168.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.89 150.87 37.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.258 1.023 . . . . 70.14 109.825 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.57 154.83 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.404 -2.073 . . . . 70.52 105.404 161.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.21 118.03 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.962 -2.236 . . . . 70.51 104.962 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -82.76 122.75 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.869 1.267 . . . . 72.44 108.638 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -96.42 176.22 6.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.801 0.81 . . . . 72.53 111.279 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG21 ' HG3' ' A' ' 38' ' ' LYS . 19.5 m -86.03 -24.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.358 1.863 . . . . 72.43 112.808 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -133.39 177.37 7.74 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.966 1.706 . . . . 51.44 111.4 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.46 -27.01 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.713 1.205 . . . . 72.21 111.59 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -67.73 -21.78 65.27 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.011 -1.055 . . . . 73.33 112.488 -166.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m -87.56 -9.58 54.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.523 -1.227 . . . . 71.44 113.146 172.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.7 -58.93 8.46 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 122.784 2.538 . . . . 74.34 109.895 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.03 -6.13 18.0 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.492 2.128 . . . . 73.22 114.783 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -70.59 -43.47 69.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.684 1.129 . . . . 72.01 109.395 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -25.61 47.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.999 0.92 . . . . 32.14 112.756 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.51 -46.03 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.976 0.911 . . . . 63.44 109.379 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.36 -1.52 43.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.205 -0.775 . . . . 61.05 113.985 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.26 4.2 33.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.934 1.367 . . . . 73.33 110.867 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -55.09 -20.3 9.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.944 1.298 . . . . 70.23 113.733 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.43 9.86 42.1 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.873 -0.959 . . . . 74.04 113.411 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -81.4 -179.98 7.6 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.754 1.277 . . . . 74.42 110.38 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -159.2 88.61 0.89 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.693 -0.629 . . . . 64.31 109.997 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.728 ' O ' HG12 ' A' ' 81' ' ' VAL . 57.3 t -68.28 110.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.098 -1.445 . . . . 73.53 107.098 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.7 mt 55.02 21.5 3.81 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.649 -0.657 . . . . 44.22 112.0 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.98 1.22 27.0 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.398 -1.779 . . . . 70.42 115.047 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 78' ' ' VAL . 7.1 p -108.15 85.95 2.97 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 120.723 2.261 . . . . 74.41 111.563 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.42 162.63 29.83 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.343 2.028 . . . . 52.11 112.007 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -117.04 159.74 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.428 1.091 . . . . 74.54 110.288 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.99 144.25 14.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 107.085 -1.45 . . . . 74.25 107.085 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.21 -0.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.063 2.545 . . . . 74.41 115.887 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -61.97 -36.74 82.37 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 114.911 1.448 . . . . 70.23 114.911 -166.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.09 177.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 120.482 1.492 . . . . 71.42 111.227 -169.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p -113.86 139.55 49.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 53.21 108.891 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 49.88 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 128.616 2.766 . . . . 73.12 112.616 -164.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.43 -172.3 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.111 2.164 . . . . 70.0 112.585 -167.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.8 76.74 1.7 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.406 -1.702 . . . . 74.0 106.406 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -130.53 150.62 51.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.524 -0.735 . . . . 70.35 109.537 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.51 63.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.014 -1.847 . . . . 74.2 106.014 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 . . . . . 0 C--O 1.247 0.926 0 N-CA-C 108.004 -1.11 . . . . 74.01 108.004 175.224 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 109.216 -1.554 . . . . 72.24 109.216 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -134.79 53.51 1.99 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.238 1.415 . . . . 63.24 107.582 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttm -108.8 80.61 1.35 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.212 1.005 . . . . 73.22 110.06 -161.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -67.4 156.28 36.93 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.888 1.675 . . . . 71.34 111.719 -163.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.47 146.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.354 3.062 . . . . 75.23 109.965 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -85.66 163.61 43.4 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.042 -1.661 . . . . 75.32 111.051 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.92 -55.09 1.48 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.012 2.475 . . . . 73.33 112.41 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -53.78 -39.9 65.82 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.132 0.573 . . . . 75.11 112.423 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.22 -47.96 69.29 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.704 -0.623 . . . . 63.51 109.813 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -62.45 -25.48 68.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.481 1.037 . . . . 62.45 111.644 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.24 -60.23 2.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.178 0.899 . . . . 55.41 109.154 166.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.44 -0.6 0.92 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.76 2.024 . . . . 53.31 116.138 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -57.83 -20.6 37.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.395 1.078 . . . . 74.34 111.407 161.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.7 m -50.84 138.61 18.45 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.276 1.83 . . . . 55.25 109.889 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 59' ' ' VAL . 7.1 m -120.49 118.33 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.19 1.396 . . . . 55.15 109.43 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -68.83 155.67 39.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.894 1.278 . . . . 73.21 109.69 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 57' ' ' ALA . 1.8 p -131.11 158.47 40.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.764 1.626 . . . . 61.52 107.947 162.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -143.29 11.14 1.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.502 0.927 . . . . 33.1 113.502 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -140.45 25.31 2.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.477 1.035 . . . . 64.54 112.391 -163.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.18 165.31 16.29 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.871 -0.518 . . . . 55.04 111.402 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.4 169.64 8.57 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.592 1.157 . . . . 72.53 109.857 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.28 -11.47 60.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.531 1.308 . . . . 23.5 114.531 -171.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 20.29 10.13 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.289 1.404 . . . . 75.54 113.489 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tp -64.48 163.58 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.258 1.023 . . . . 60.34 110.001 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -121.59 157.73 55.88 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.672 1.989 . . . . 74.01 107.528 162.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.84 -41.93 64.31 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 CA-C-N 121.374 1.526 . . . . 51.25 109.838 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.769 1.025 . . . . 73.3 113.769 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.47 -28.19 66.78 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.22 1.373 . . . . 61.24 110.443 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.82 -40.26 16.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.187 1.395 . . . . 63.3 110.615 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.49 -35.63 75.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.589 0.632 . . . . 63.13 110.394 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.47 -51.96 67.65 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.574 1.549 . . . . 54.1 108.242 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -51.45 -57.21 9.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.339 1.056 . . . . 75.33 110.533 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -72.14 -19.57 61.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.274 0.842 . . . . 72.13 113.274 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.0 p -66.05 -18.13 65.14 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.761 0.824 . . . . 43.3 111.37 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.0 p -66.24 -14.57 62.16 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.001 0.371 . . . . 71.31 112.001 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.55 5.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.974 0.909 . . . . 61.1 112.121 -167.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.22 25.82 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.269 -1.532 . . . . 72.24 109.269 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.31 131.9 21.1 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.716 1.246 . . . . 75.04 113.201 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.0 154.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 125.727 1.611 . . . . 34.23 110.303 165.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -96.2 -58.47 2.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.741 1.616 . . . . 74.03 107.963 164.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -158.83 155.02 27.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.633 1.106 . . . . 52.14 110.091 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.64 140.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.307 1.043 . . . . 63.32 109.03 -169.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -142.26 71.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.544 1.138 . . . . 63.34 109.876 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.9 ptp -66.13 158.28 29.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.661 -0.816 . . . . 60.52 108.97 163.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.66 137.04 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.022 -1.473 . . . . 62.13 107.022 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -71.44 87.29 0.87 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.434 -1.321 . . . . 73.04 107.434 168.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.62 156.27 39.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.31 1.444 . . . . 75.11 111.929 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 156.74 18.85 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.254 1.022 . . . . 75.44 113.111 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -44.51 -30.16 0.83 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 130.767 3.627 . . . . 64.43 114.156 172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -55.77 -6.55 0.22 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.626 1.57 . . . . 70.22 113.607 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -156.73 -36.68 0.08 Allowed 'General case' 0 C--N 1.344 0.327 0 O-C-N 119.98 -1.7 . . . . 51.14 111.028 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 45.12 66.55 0.87 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.519 1.527 . . . . 73.21 107.96 -165.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 m -68.92 23.94 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.991 0.737 . . . . 71.34 112.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.404 18.3 ptpt 46.42 24.55 0.31 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.295 2.638 . . . . 75.54 117.314 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.33 92.58 0.58 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 120.246 1.384 . . . . 60.53 111.54 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.19 153.98 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.203 1.801 . . . . 73.23 111.102 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -151.75 166.0 32.7 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.466 1.907 . . . . 42.14 109.273 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -124.08 152.37 42.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 104.868 -2.271 . . . . 75.41 104.868 155.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 15' ' ' VAL 0.356 1.5 p -144.86 115.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.667 -1.27 . . . . 55.14 108.963 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -63.24 131.93 50.01 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.416 1.886 . . . . 74.11 106.651 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.68 156.22 20.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.542 0.687 . . . . 73.23 111.004 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.98 -24.74 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.746 -0.661 . . . . 63.31 109.46 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.13 131.88 44.42 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.976 -1.078 . . . . 73.13 110.355 -163.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.403 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 3.3 p -63.92 -31.72 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.922 1.689 . . . . 60.35 110.571 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -41.67 98.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.385 1.474 . . . . 63.54 110.913 -169.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -78.89 -5.47 53.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.394 0.886 . . . . 60.33 113.394 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.97 -56.43 35.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.809 1.64 . . . . 73.24 109.563 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.57 -15.5 45.04 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 CA-C-N 120.58 1.243 . . . . 52.43 112.717 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.6 tp -64.89 -43.93 91.27 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 121.031 1.741 . . . . 64.54 109.757 168.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.82 76.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.378 1.444 . . . . 62.51 111.565 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -58.83 -45.6 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.631 -0.668 . . . . 72.13 109.288 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.28 -8.1 22.56 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.177 1.37 . . . . 73.52 114.109 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -113.97 4.31 15.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.426 1.613 . . . . 71.3 112.358 -172.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.62 -23.54 6.69 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.268 1.027 . . . . 61.51 113.645 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 19.26 35.29 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.86 1.219 . . . . 62.52 112.281 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -101.54 178.85 4.52 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.856 1.328 . . . . 64.53 109.428 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -152.48 95.31 2.01 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.426 1.091 . . . . 74.43 111.718 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.21 110.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.789 -1.189 . . . . 75.54 107.789 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt 50.85 35.22 11.77 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.746 1.218 . . . . 74.4 111.868 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.07 35.03 25.21 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.967 -0.907 . . . . 71.53 113.397 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.64 86.14 56.45 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.831 1.652 . . . . 75.24 108.008 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.83 171.91 12.62 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.505 2.136 . . . . 63.22 111.575 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.64 160.43 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.584 -0.698 . . . . 53.04 110.224 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.72 165.72 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.383 -1.34 . . . . 44.42 107.383 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.67 -21.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 117.829 -1.082 . . . . 72.34 113.16 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -44.38 -42.94 7.26 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.585 1.698 . . . . 55.04 115.585 -150.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.05 41.53 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 61.45 112.334 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.286 0.0 OUTLIER 47.18 -161.21 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.085 2.154 . . . . 63.44 111.828 -173.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -111.4 -164.78 0.94 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.473 -1.676 . . . . 71.21 106.473 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 157.57 44.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.682 0.674 . . . . 74.43 109.917 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.72 38.55 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.124 2.97 . . . . 62.02 111.463 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -129.77 142.43 50.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.295 1.438 . . . . 64.42 108.593 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.27 139.38 11.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.903 1.228 . . . . 74.53 109.003 172.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.965 0 C-N-CA 128.708 2.803 . . . . 74.52 114.994 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.766 0 N-CA-C 110.139 -1.184 . . . . 65.21 110.139 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -66.43 145.79 55.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 118.864 1.332 . . . . 74.2 107.917 157.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ptm -145.73 -1.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.654 0.613 . . . . 73.44 112.654 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -97.85 172.54 7.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 129.969 3.308 . . . . 64.31 109.529 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.36 156.93 29.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.722 1.209 . . . . 74.22 108.513 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 9' ' ' GLU . 1.7 t -80.53 158.5 71.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.174 1.352 . . . . 63.22 109.98 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.44 -37.28 97.48 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.208 2.605 . . . . 44.3 113.12 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.0 -31.37 58.91 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.739 1.154 . . . . 72.31 111.074 -167.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' H ' HG23 ' A' ' 6' ' ' THR . 19.7 tp10 -63.95 -41.02 97.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.292 1.437 . . . . 61.44 109.828 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -69.72 -19.99 63.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.431 -0.795 . . . . 74.14 112.237 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -37.46 16.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.377 1.071 . . . . 65.1 110.763 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.66 -58.76 6.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.526 1.53 . . . . 74.33 111.373 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 44.62 63.3 1.73 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.256 2.222 . . . . 72.0 110.244 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.28 148.85 49.66 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 120.859 -1.15 . . . . 74.34 109.278 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.4 114.62 39.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.067 0.937 . . . . 63.1 111.436 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.08 93.31 8.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.414 1.086 . . . . 73.34 109.821 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.17 92.13 5.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.45 -1.25 . . . . 72.33 108.137 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.2 ttp -93.48 14.62 18.13 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.146 0.795 . . . . 71.41 113.146 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -137.79 36.14 2.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.308 -1.495 . . . . 74.12 112.19 -165.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 mt -78.22 145.4 35.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.029 0.932 . . . . 74.31 112.613 -171.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' VAL . . . -72.08 147.85 46.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.377 1.871 . . . . 71.13 109.84 164.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.79 -0.97 6.06 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.321 1.971 . . . . 64.15 116.321 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -122.37 -0.38 9.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.56 1.527 . . . . 73.24 114.248 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.4 150.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.237 1.199 . . . . 54.22 114.237 -159.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -90.35 161.99 35.68 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.397 1.479 . . . . 71.25 109.901 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.79 -53.04 3.59 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.33 2.02 . . . . 73.23 111.795 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -66.15 -18.95 65.67 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.966 0.728 . . . . 71.11 112.966 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.39 -32.99 70.66 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.324 -0.86 . . . . 72.44 110.715 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.67 -52.65 16.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.01 -0.519 . . . . 74.43 109.872 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.69 -23.99 64.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.056 0.847 . . . . 70.42 110.916 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.76 -26.73 63.49 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.107 0.78 . . . . 71.21 113.107 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.34 -36.01 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 70.32 110.757 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.21 -25.74 19.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.513 0.931 . . . . 73.41 113.513 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -61.13 -20.71 62.99 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.417 1.887 . . . . 73.0 114.013 -169.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 t -58.08 -40.56 81.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.004 1.322 . . . . 71.22 108.969 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -148.31 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.18 0.992 . . . . 63.1 109.964 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.01 163.36 25.79 Favored Glycine 0 CA--C 1.521 0.448 0 O-C-N 120.673 -1.267 . . . . 71.03 112.032 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -116.46 124.64 50.46 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.026 0.93 . . . . 72.21 109.18 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -91.43 148.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.5 -1.296 . . . . 52.21 107.5 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -101.31 -46.79 4.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.029 1.731 . . . . 73.31 109.396 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -157.85 -176.99 6.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.012 0.824 . . . . 74.31 111.088 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.98 97.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.628 1.571 . . . . 73.44 108.411 -159.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -119.16 131.07 55.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.718 1.145 . . . . 73.42 110.161 -167.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.45 164.59 27.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.261 1.578 . . . . 70.02 115.261 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.87 73.3 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.666 -1.235 . . . . 74.05 107.666 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.5 m -75.54 84.48 2.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.276 1.03 . . . . 62.01 108.738 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -177.05 3.24 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.1 -1.815 . . . . 63.02 106.1 156.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.0 mtp85 -58.71 -65.75 0.61 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.082 0.953 . . . . 71.43 109.268 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.78 -44.54 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.14 1.376 . . . . 73.14 109.376 -165.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.5 t 52.31 -85.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.896 1.678 . . . . 74.23 110.819 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -158.39 19.64 0.23 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.173 1.351 . . . . 70.42 110.834 159.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -171.5 2.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 74.44 113.514 -168.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -53.73 -12.02 0.46 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.488 1.915 . . . . 72.44 114.106 166.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 55.79 20.93 4.36 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.981 1.713 . . . . 64.41 114.216 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.89 91.27 0.09 OUTLIER Glycine 0 C--N 1.336 0.548 0 O-C-N 120.356 -1.465 . . . . 71.24 113.482 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.9 134.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.503 1.121 . . . . 62.41 110.094 -171.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.37 43.41 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.682 1.193 . . . . 74.01 111.819 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -120.98 108.6 14.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.229 1.812 . . . . 74.23 106.27 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.91 121.73 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.326 -1.361 . . . . 70.22 107.326 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -86.58 116.98 25.05 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.495 1.518 . . . . 74.02 109.072 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.71 162.47 18.74 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.485 1.514 . . . . 61.14 112.961 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 t -83.87 -20.34 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.046 1.339 . . . . 73.12 112.525 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.0 156.12 45.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.909 -1.145 . . . . 65.4 107.909 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.13 -26.27 36.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 123.456 0.473 . . . . 72.24 110.576 172.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -61.81 -36.86 82.38 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.045 -1.034 . . . . 65.04 113.626 -164.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 m -82.16 -5.45 58.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.617 1.099 . . . . 73.03 113.696 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.83 -57.97 18.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 119.997 1.272 . . . . 72.31 110.846 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.15 -15.86 52.26 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.966 1.778 . . . . 53.44 113.206 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.86 -45.54 81.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.351 0.978 . . . . 72.03 109.318 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.91 71.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.412 0.685 . . . . 45.3 111.14 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.51 -32.1 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.589 -0.694 . . . . 62.22 109.882 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.96 0.35 7.62 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.53 1.538 . . . . 71.1 114.23 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.82 11.74 3.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.038 1.735 . . . . 72.2 112.209 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -50.35 -29.55 10.21 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 121.123 1.783 . . . . 70.33 114.133 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.51 -16.02 55.89 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.826 -0.986 . . . . 71.11 112.894 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -70.7 170.88 11.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.646 1.223 . . . . 65.44 109.866 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -157.43 128.32 6.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.509 0.724 . . . . 64.42 109.219 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.3 t -84.71 94.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.262 -2.125 . . . . 65.41 105.262 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 mt 65.93 23.23 11.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.372 1.069 . . . . 64.33 112.93 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.07 11.8 29.01 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.82 -0.55 . . . . 63.05 113.16 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' ALA . 57.5 t -113.05 83.59 6.27 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 126.078 1.751 . . . . 72.24 108.853 174.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 176.29 8.36 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.225 2.617 . . . . 64.1 111.796 166.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.97 177.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.724 1.21 . . . . 72.23 108.926 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.646 HG22 ' H ' ' A' ' 86' ' ' GLN . 34.1 mm -123.75 139.12 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.558 1.143 . . . . 71.04 108.908 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -44.73 -18.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 130.476 3.51 . . . . 72.32 115.968 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.646 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.3 mt-30 -53.22 -58.34 7.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.716 1.143 . . . . 72.32 110.937 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.06 50.15 18.52 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 125.264 1.603 . . . . 65.33 110.491 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER 52.46 -154.16 0.21 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.294 1.438 . . . . 62.44 111.138 -174.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -55.44 131.05 45.01 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.989 -1.115 . . . . 72.3 107.989 159.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 24.6 1.47 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.871 1.669 . . . . 44.31 109.218 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 24.68 2.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 72.41 112.186 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 -176.07 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.73 1.212 . . . . 74.11 110.924 -166.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -137.07 61.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.607 1.963 . . . . 65.4 109.657 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.28 -1.343 . . . . 74.14 108.376 -171.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 108.922 -1.671 . . . . 65.22 108.922 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 44.12 66.02 0.92 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 72.04 112.397 168.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttp -148.15 166.63 27.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.446 -1.687 . . . . 51.54 106.446 171.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 57.88 -158.87 0.27 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.506 1.122 . . . . 73.04 109.723 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.24 143.22 50.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.188 2.195 . . . . 74.05 105.87 162.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.0 165.95 45.35 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 123.727 0.811 . . . . 54.34 111.555 -175.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -53.84 -40.28 81.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.446 1.431 . . . . 72.03 110.702 160.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.276 6.2 pt-20 -77.51 -40.96 40.99 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.906 1.682 . . . . 73.03 113.385 -165.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -50.83 -45.91 59.79 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.583 1.538 . . . . 70.33 111.844 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.4 -16.14 61.34 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.955 -1.091 . . . . 73.35 112.974 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -34.72 15.95 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.27 1.428 . . . . 65.24 110.579 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.98 2.98 18.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.415 2.686 . . . . 44.02 112.782 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -7.93 4.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.198 2.599 . . . . 63.32 114.708 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -102.08 145.98 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.591 1.156 . . . . 73.22 108.75 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.26 118.34 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.779 -0.823 . . . . 74.45 108.779 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -72.82 113.06 9.44 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.335 1.054 . . . . 71.22 108.721 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.9 m -98.95 129.95 45.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.519 1.528 . . . . 53.33 107.469 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.6 ttp -127.44 175.85 7.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.09 1.756 . . . . 73.53 107.615 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 64.1 20.83 12.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.808 1.643 . . . . 73.44 113.525 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -72.6 168.73 18.03 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.744 0.817 . . . . 70.21 111.227 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.52 166.13 11.25 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.079 1.14 . . . . 52.14 114.079 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.62 23.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 64.32 112.231 169.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -135.68 76.78 1.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 106.688 -1.597 . . . . 71.22 106.688 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -140.77 165.38 20.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 124.071 0.948 . . . . 65.43 108.796 168.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -117.51 157.92 46.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 126.64 1.976 . . . . 74.52 107.408 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -55.32 2.56 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.235 1.957 . . . . 75.44 111.94 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -63.48 -21.74 66.49 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.595 -0.717 . . . . 61.33 112.274 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.3 -19.02 62.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.948 1.249 . . . . 74.41 110.35 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.887 1.221 . . . . 73.5 110.781 169.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -69.54 -37.83 77.24 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.864 -0.421 . . . . 71.11 109.864 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 34' ' ' SER . 6.2 mm-40 -65.47 -26.71 68.06 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.307 1.043 . . . . 72.53 112.339 -176.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.73 -16.49 64.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.23 1.012 . . . . 62.55 113.37 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.66 -26.45 8.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.475 0.71 . . . . 72.41 111.22 173.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 6.5 t -53.78 -18.64 3.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.666 1.987 . . . . 62.14 111.949 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.4 p -46.31 -41.89 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.493 1.517 . . . . 74.42 111.12 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.77 46.24 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.135 1.774 . . . . 60.11 108.269 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.46 178.03 48.32 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 124.274 0.94 . . . . 63.32 110.865 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -137.83 134.1 34.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.333 1.453 . . . . 74.11 107.796 169.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 61' ' ' PHE 0.276 1.8 p -118.28 143.25 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.048 1.339 . . . . 61.43 109.562 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -77.29 -50.28 13.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.4 1.88 . . . . 62.44 108.284 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -168.58 -178.49 3.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.096 0.558 . . . . 75.22 110.938 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.34 152.48 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.366 1.466 . . . . 75.12 109.024 174.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -125.93 101.34 6.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.513 1.925 . . . . 71.41 106.803 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.3 mtp -95.21 142.12 28.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.116 0.966 . . . . 74.54 110.819 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -143.29 54.82 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 72.4 113.36 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 t -94.91 4.8 53.39 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.711 -1.868 . . . . 70.13 111.562 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.74 36.88 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.798 1.639 . . . . 74.4 110.122 -170.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -116.39 160.71 20.15 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 120.657 -1.277 . . . . 72.11 108.368 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -122.83 58.36 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.636 1.975 . . . . 71.54 108.343 -171.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -161.32 174.25 13.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.741 -1.118 . . . . 54.14 109.453 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -78.29 17.29 0.65 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.05 1.34 . . . . 65.32 111.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -44.8 -65.14 0.57 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.071 2.948 . . . . 72.2 109.762 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -169.45 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.573 0.953 . . . . 73.32 113.573 -172.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt 44.56 50.25 8.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.753 2.021 . . . . 72.24 113.941 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.28 66.06 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 109.534 -1.427 . . . . 74.13 109.534 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 pt -139.8 146.6 24.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.838 1.255 . . . . 73.21 108.555 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.38 44.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.371 1.068 . . . . 44.04 108.907 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -123.85 127.91 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.661 -1.607 . . . . 70.32 106.661 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.05 112.18 39.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.8 -1.555 . . . . 50.22 106.8 -167.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -92.41 91.87 7.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.855 1.262 . . . . 72.13 108.01 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -56.08 177.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.043 1.337 . . . . 73.11 113.91 175.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.77 -31.12 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 O-C-N 120.448 -1.407 . . . . 72.31 110.917 168.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -117.18 175.66 5.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.475 1.489 . . . . 64.15 110.443 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.64 -27.04 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 118.836 0.744 . . . . 60.33 111.246 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -67.4 -22.18 65.55 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.558 -1.339 . . . . 72.32 112.038 -171.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -5.2 57.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.945 1.091 . . . . 74.34 113.945 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.46 -55.53 39.07 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.32 1.418 . . . . 62.42 109.459 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.8 -10.32 28.41 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.849 . . . . 72.05 113.925 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.65 -59.38 3.65 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 120.082 1.31 . . . . 74.35 108.218 166.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HA ' HD23 ' A' ' 73' ' ' LEU . . . -59.34 -29.43 67.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.814 0.846 . . . . 71.21 113.007 -175.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.68 -26.27 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.848 1.259 . . . . 64.33 110.568 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.61 80.9 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.559 1.552 . . . . 74.25 114.112 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 70' ' ' ALA . 3.2 mm? -87.66 -4.06 58.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.157 1.479 . . . . 72.11 114.194 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.0 t -50.86 -21.35 1.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.364 1.987 . . . . 71.21 116.364 -160.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.4 -12.79 59.35 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.724 -1.235 . . . . 62.14 113.635 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -77.04 165.13 25.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.673 1.236 . . . . 71.32 110.451 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -140.76 88.35 2.18 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.137 1.775 . . . . 63.32 109.531 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.56 100.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.145 0.978 . . . . 74.23 109.002 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 mt 49.06 33.23 4.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.836 0.827 . . . . 73.24 111.275 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.74 5.94 62.59 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.536 -1.147 . . . . 64.14 114.157 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 t -105.5 86.46 1.75 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.702 2.001 . . . . 44.03 108.882 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.84 176.9 6.21 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.942 3.095 . . . . 65.43 112.404 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.58 151.06 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.496 0.665 . . . . 73.44 110.214 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.2 mm -106.28 156.13 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.295 1.438 . . . . 73.24 108.368 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 m -74.07 -0.78 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 114.904 1.446 . . . . 73.23 114.904 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -45.78 -60.33 2.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.033 1.123 . . . . 63.31 114.033 -165.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.79 157.37 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.999 1.319 . . . . 65.42 112.086 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -88.46 143.81 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.081 -1.452 . . . . 74.51 107.081 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 44.28 69.01 0.46 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.937 2.095 . . . . 71.42 112.874 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.81 159.2 44.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.564 0.745 . . . . 70.43 112.045 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -85.62 19.18 2.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.736 1.214 . . . . 65.04 110.748 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.02 -9.6 42.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 119.886 -1.759 . . . . 71.33 112.669 -173.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -84.19 71.66 10.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.972 1.309 . . . . 72.45 108.345 -171.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.135 1.774 . . . . 72.13 106.739 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 CA-C-O 119.255 -0.747 . . . . 73.41 111.413 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.65 60.89 3.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.612 1.165 . . . . 73.14 109.641 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.275 1.0 OUTLIER 45.07 11.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.446 3.499 . . . . 71.11 117.948 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -123.02 140.89 52.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.371 1.068 . . . . 70.52 108.927 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.0 134.97 46.22 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.089 1.356 . . . . 74.52 108.462 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.58 165.06 20.91 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 121.153 0.501 . . . . 63.51 110.346 171.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.0 -47.77 1.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.408 2.072 . . . . 53.4 110.315 167.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.17 -49.01 77.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.397 1.079 . . . . 73.42 111.149 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.98 -44.05 63.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.912 0.885 . . . . 74.31 111.378 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -63.99 -37.34 87.07 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.201 -0.937 . . . . 74.31 111.649 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -16.93 55.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 119.206 -0.426 . . . . 74.21 111.381 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.3 -48.51 5.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.884 2.074 . . . . 52.01 111.936 -174.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HE ' ' HA ' ' A' ' 63' ' ' ASP . 11.2 mtt85 54.82 10.02 0.34 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.195 2.598 . . . . 74.5 117.336 166.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -110.62 153.73 24.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.751 1.16 . . . . 70.24 110.279 -164.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.604 1.562 . . . . 44.2 109.744 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.49 114.16 24.64 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.295 2.638 . . . . 74.01 110.876 -166.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.3 130.48 34.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.471 -0.566 . . . . 74.12 109.471 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -127.77 48.67 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.036 0.934 . . . . 75.42 111.695 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -157.71 11.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.129 -0.982 . . . . 73.02 113.128 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 168.6 8.78 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.809 -1.182 . . . . 73.01 113.264 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.87 170.57 9.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.226 -1.352 . . . . 70.42 113.194 -167.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.12 -12.43 61.49 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.634 1.574 . . . . 61.12 115.178 -161.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -134.47 31.01 3.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.369 0.986 . . . . 71.44 111.286 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.65 165.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.54 -0.541 . . . . 43.45 109.54 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -122.63 161.92 41.21 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.704 1.602 . . . . 72.24 109.038 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.86 -54.28 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.862 1.708 . . . . 74.01 109.535 165.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -38.73 69.01 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.53 -0.748 . . . . 74.14 111.985 -175.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.7 -34.14 72.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.591 1.087 . . . . 54.54 111.396 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.79 -10.27 59.76 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.442 0.697 . . . . 53.22 112.348 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' CB ' HG11 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -109.18 -31.66 7.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.407 1.083 . . . . 74.12 109.777 174.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -70.24 -30.86 68.03 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.554 1.542 . . . . 54.55 112.494 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -62.41 -26.04 68.27 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.079 -1.013 . . . . 71.15 111.693 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.43 -12.05 16.75 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.439 -0.791 . . . . 73.01 112.641 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.5 p -62.8 -19.59 64.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.75 1.614 . . . . 73.23 112.117 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 p -64.81 -23.71 67.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.781 1.232 . . . . 72.13 110.926 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 8.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.593 1.557 . . . . 73.44 112.3 -166.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.61 45.74 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.658 -1.276 . . . . 54.33 111.708 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.88 141.96 50.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.686 1.594 . . . . 52.32 107.856 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.463 HG21 ' CG1' ' A' ' 59' ' ' VAL . 11.3 p -135.97 145.96 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.801 1.241 . . . . 71.41 109.295 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -87.58 -46.82 9.21 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.908 -1.496 . . . . 73.22 111.042 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -169.52 174.78 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.781 0.719 . . . . 73.13 109.798 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 59' ' ' VAL . 49.1 t -125.87 145.46 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 73.15 109.694 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -117.38 98.1 6.24 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.108 1.763 . . . . 70.31 107.167 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.27 149.55 21.15 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.808 -1.182 . . . . 54.44 107.808 170.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.94 97.22 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.604 -1.628 . . . . 71.45 106.604 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.0 m -152.26 99.41 2.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.706 -1.59 . . . . 53.13 106.706 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -160.67 12.28 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.126 1.37 . . . . 75.13 111.745 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -115.26 -83.18 0.62 Allowed 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.24 -0.912 . . . . 72.24 108.583 -160.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.34 -5.12 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.497 1.119 . . . . 72.03 112.582 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.06 40.93 10.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.978 1.473 . . . . 73.03 114.978 166.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -149.63 27.08 0.82 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.45 1.9 . . . . 75.41 109.671 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.53 -85.15 0.47 Allowed 'General case' 0 CA--C 1.523 -0.096 0 O-C-N 120.591 -1.318 . . . . 63.05 107.99 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.5 m -148.77 48.32 1.01 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.331 1.452 . . . . 74.02 109.972 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -7.09 5.13 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.147 1.536 . . . . 73.22 115.147 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.52 77.24 2.12 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 119.994 1.27 . . . . 60.33 110.512 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -153.96 136.65 6.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 125.579 1.552 . . . . 72.01 109.128 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.57 151.19 30.36 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.544 1.137 . . . . 73.02 110.452 169.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -128.01 138.48 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.555 -1.646 . . . . 73.03 106.555 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' CG1' HG21 ' A' ' 39' ' ' VAL . 93.4 t -128.66 112.94 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.174 1.39 . . . . 64.03 108.258 -160.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.61 81.54 8.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.36 1.076 . . . . 61.3 109.987 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.19 150.17 4.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.858 1.263 . . . . 73.42 113.844 171.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.59 -24.04 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.657 . . . . 61.3 110.062 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 21.9 t0 -132.26 143.79 50.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.736 1.607 . . . . 70.33 113.15 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.2 -30.61 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.157 1.383 . . . . 62.3 111.344 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -66.28 -15.77 63.48 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.077 -1.014 . . . . 70.51 111.281 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 m -88.27 -6.67 57.65 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.476 1.287 . . . . 74.31 114.476 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -53.81 -56.7 22.65 Favored Pre-proline 0 N--CA 1.473 0.708 0 CA-C-N 121.85 2.113 . . . . 71.53 109.83 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -6.44 17.29 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 121.779 1.653 . . . . 63.51 114.335 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.33 -52.48 39.8 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.195 -1.565 . . . . 73.51 108.299 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.15 -23.65 65.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.645 0.778 . . . . 74.13 112.564 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.01 -45.62 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.921 1.289 . . . . 62.1 109.595 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.11 -2.6 48.38 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.951 -0.916 . . . . 13.25 113.247 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.99 2.82 55.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.323 1.562 . . . . 71.42 111.258 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -56.72 -20.87 24.12 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.541 1.064 . . . . 62.35 113.326 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.15 23.26 14.34 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.638 2.066 . . . . 51.24 112.045 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.35 175.58 5.64 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 128.699 2.8 . . . . 73.02 109.795 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -152.11 127.29 9.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.308 1.843 . . . . 74.15 108.602 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.5 101.0 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.889 -1.522 . . . . 71.45 106.889 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mt 64.22 -8.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.88 2.872 . . . . 70.33 116.662 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.24 -3.34 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.187 -1.006 . . . . 74.13 113.498 -160.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.12 85.25 12.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.872 2.069 . . . . 72.32 106.315 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.99 178.7 2.23 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.718 2.945 . . . . 73.43 111.92 175.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tt -137.38 161.47 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.27 1.028 . . . . 54.14 109.944 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.5 mm -101.62 158.08 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.283 -1.377 . . . . 74.05 107.283 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.92 -1.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.295 1.838 . . . . 75.24 114.877 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -46.1 67.03 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.128 -0.982 . . . . 74.0 113.278 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.96 29.79 2.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.618 1.71 . . . . 74.1 115.618 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.82 -168.49 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.787 2.035 . . . . 63.32 112.383 -173.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 47.04 47.51 15.95 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.298 2.239 . . . . 73.1 113.939 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.77 156.59 16.59 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.394 1.078 . . . . 52.04 110.98 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.84 8.86 2.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 128.639 2.776 . . . . 73.34 113.859 -169.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -66.18 -18.19 65.19 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.451 -1.406 . . . . 61.32 113.297 -170.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -79.0 71.06 5.44 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.727 2.011 . . . . 73.43 112.344 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 . . . . . 0 C--O 1.246 0.896 0 C-N-CA 124.528 1.131 . . . . 72.2 109.83 171.497 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 CA-C-O 118.568 -1.129 . . . . 63.11 111.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 47.09 80.5 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.243 1.817 . . . . 63.51 111.587 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.2 mtp -132.51 -59.71 0.9 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.001 0.92 . . . . 64.11 110.046 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -123.71 152.27 42.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.913 0.885 . . . . 71.33 109.499 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.35 127.64 32.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.402 1.481 . . . . 60.5 109.03 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.55 158.29 76.27 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.91 1.232 . . . . 73.22 108.903 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.76 -30.59 78.21 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.261 1.974 . . . . 74.51 111.858 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -71.09 -36.92 72.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.929 0.786 . . . . 73.14 109.858 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -55.99 -44.97 79.12 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.563 -0.71 . . . . 72.51 110.121 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -69.21 -15.02 63.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.089 -0.958 . . . . 75.13 112.838 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.57 -51.57 8.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.398 0.999 . . . . 74.52 109.329 160.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.57 40.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.674 2.39 . . . . 54.03 115.275 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.584 HH11 ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -86.27 3.01 45.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.377 1.871 . . . . 63.14 113.31 175.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 152.73 43.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.885 1.274 . . . . 74.3 110.482 -171.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.26 170.1 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.626 -1.25 . . . . 72.11 107.626 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -138.31 104.26 5.13 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.292 1.437 . . . . 74.33 109.332 -171.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.73 75.29 8.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.615 1.966 . . . . 73.34 110.201 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -81.38 25.07 0.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.302 0.853 . . . . 53.2 113.302 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -148.78 48.46 1.01 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.131 -1.606 . . . . 75.3 112.627 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.6 mt -79.15 166.75 21.89 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.558 0.947 . . . . 74.0 113.558 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.76 -160.72 0.79 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.554 2.342 . . . . 43.42 110.859 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.45 -20.99 11.09 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.938 1.829 . . . . 74.2 115.938 -164.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -129.62 44.3 2.99 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.478 1.608 . . . . 74.34 108.33 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.38 140.71 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.251 -1.341 . . . . 55.23 107.914 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.81 161.8 32.79 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 124.251 1.02 . . . . 72.13 108.549 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.41 -37.48 89.66 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.055 1.17 . . . . 62.24 110.1 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -58.29 -31.82 67.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.56 -1.21 . . . . 75.01 113.294 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.11 -34.95 75.78 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 120.496 1.498 . . . . 72.34 110.121 -171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.14 -32.26 70.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.344 1.057 . . . . 72.42 111.833 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.85 -7.65 23.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 117.998 -1.001 . . . . 64.01 112.541 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -37.27 18.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.917 1.235 . . . . 74.0 108.566 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.54 -39.05 64.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.665 0.786 . . . . 73.1 112.377 -174.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -106.73 2.2 25.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.426 -0.797 . . . . 75.43 112.278 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.7 p -74.62 -10.66 59.75 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 120.422 1.464 . . . . 73.31 112.076 170.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -44.93 -52.05 9.1 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.779 2.032 . . . . 71.24 109.765 165.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.18 57.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 54.03 108.299 -171.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.58 164.42 28.76 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.209 -0.932 . . . . 73.42 113.528 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -123.53 131.19 53.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.798 1.239 . . . . 75.2 109.456 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -88.52 138.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.313 1.445 . . . . 73.42 107.848 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -76.91 -51.78 10.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.489 -0.93 . . . . 55.44 108.489 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 7.3 t0 -162.47 -172.74 3.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.194 1.797 . . . . 55.04 107.564 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.25 93.98 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 119.823 1.192 . . . . 71.14 110.454 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.93 163.14 22.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.376 1.084 . . . . 73.41 110.684 163.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.59 136.19 11.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 127.914 2.486 . . . . 74.33 105.751 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.56 99.8 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.777 -1.934 . . . . 53.4 105.777 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 m -72.85 66.37 0.77 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.855 1.662 . . . . 71.4 111.317 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.251 0.4 OUTLIER 49.34 174.41 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 131.89 4.076 . . . . 73.11 115.64 -164.761 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -101.58 -75.18 0.6 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.742 -1.572 . . . . 72.13 107.45 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -141.93 -11.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.745 1.218 . . . . 51.33 112.34 -167.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.4 m -137.62 -86.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.568 -0.901 . . . . 71.41 108.568 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -172.98 33.68 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.205 3.002 . . . . 72.41 107.464 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.74 82.85 1.96 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.085 2.154 . . . . 74.44 110.241 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -22.69 56.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.72 -0.657 . . . . 73.11 111.83 167.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt 73.78 34.85 0.88 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.404 1.481 . . . . 64.44 111.846 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.19 65.17 2.53 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 125.846 1.688 . . . . 73.31 111.871 162.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.24 143.6 27.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.163 0.985 . . . . 71.04 110.099 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.0 156.64 41.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.7 2.0 . . . . 73.41 106.462 159.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -116.56 142.57 46.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 104.317 -2.475 . . . . 75.11 104.317 162.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.04 115.91 44.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.356 -2.091 . . . . 61.54 105.356 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 41' ' ' ASP . 2.6 pm0 -73.36 126.36 29.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.668 0.747 . . . . 64.2 109.507 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.75 166.67 10.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.658 1.183 . . . . 75.33 110.911 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.86 -14.37 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.513 0.725 . . . . 35.34 111.561 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -138.16 168.64 19.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.517 -1.364 . . . . 64.52 108.876 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.71 -43.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.173 -0.918 . . . . 61.4 108.608 167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -64.99 -29.89 70.84 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.623 1.101 . . . . 60.24 113.681 -152.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -74.21 -8.14 55.15 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.536 0.939 . . . . 52.01 113.536 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -62.96 4.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 119.695 -1.878 . . . . 74.4 108.737 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.58 -10.83 29.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.948 1.374 . . . . 75.51 113.134 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.9 -54.32 13.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.531 1.06 . . . . 63.34 109.621 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.91 -30.18 63.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.942 1.297 . . . . 72.4 112.415 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.04 -49.14 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.487 1.115 . . . . 73.41 108.615 172.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.23 7.83 3.16 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.079 1.323 . . . . 73.41 114.484 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.2 mt -117.05 4.88 12.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.799 1.799 . . . . 53.32 111.001 170.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -49.91 -30.41 10.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.449 1.477 . . . . 72.0 111.932 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.57 18.64 54.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 125.115 1.34 . . . . 53.5 113.079 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -127.05 165.05 20.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.455 1.502 . . . . 72.3 107.674 174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -149.17 130.51 14.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.29 0.636 . . . . 60.12 109.59 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.97 104.34 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 106.205 -1.776 . . . . 71.22 106.205 164.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt 59.91 19.28 8.27 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.625 1.57 . . . . 74.43 113.566 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.45 1.94 29.36 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.545 -0.586 . . . . 74.42 114.298 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -104.86 86.05 1.38 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.253 1.821 . . . . 55.53 107.209 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.14 179.07 3.07 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.672 2.248 . . . . 61.21 111.032 163.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 tt -121.34 175.86 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.708 1.203 . . . . 74.4 108.466 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 147.32 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.131 1.772 . . . . 75.21 106.848 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 t -55.55 -15.13 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.623 2.769 . . . . 71.2 115.646 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -44.61 -42.52 7.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.049 1.499 . . . . 73.1 115.049 -168.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.35 175.53 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.91 1.338 . . . . 63.54 109.294 -160.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -91.09 124.4 35.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.597 -2.372 . . . . 73.52 104.597 157.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -122.49 147.28 46.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.805 -1.183 . . . . 62.53 107.805 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.63 168.5 19.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.531 1.144 . . . . 61.54 111.722 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.84 26.64 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.761 2.025 . . . . 64.5 111.848 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -113.9 -3.47 13.4 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.439 1.896 . . . . 73.54 112.712 -170.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.2 -6.35 57.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.065 -0.493 . . . . 64.44 111.841 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.268 2.227 . . . . 63.33 109.875 -164.229 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 111.22 -0.752 . . . . 50.32 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.9 112.89 4.24 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.738 2.015 . . . . 63.02 105.703 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.6 mtp -139.51 -85.46 0.23 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.062 0.847 . . . . 54.51 108.748 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -64.38 148.42 50.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.446 -0.576 . . . . 65.43 109.446 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.8 tp -79.56 136.55 36.9 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.11 -1.071 . . . . 73.12 108.11 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -70.55 159.72 84.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 123.724 0.81 . . . . 74.03 110.254 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.36 -46.57 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.565 1.51 . . . . 73.13 110.179 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.2 -27.82 68.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.461 1.504 . . . . 74.03 112.064 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.22 -45.03 58.54 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.725 -0.609 . . . . 73.33 110.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -74.24 -33.6 63.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.453 0.569 . . . . 64.12 111.456 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.81 -33.9 77.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.497 0.719 . . . . 62.34 110.575 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.94 26.9 2.28 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.766 1.227 . . . . 73.03 112.698 -170.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.481 ' HE ' ' C ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.3 14.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.971 2.108 . . . . 61.23 115.404 -174.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.38 131.69 55.89 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.975 -1.078 . . . . 72.35 112.011 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.61 178.02 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.176 1.79 . . . . 73.12 109.496 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -145.76 117.75 8.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.917 1.287 . . . . 64.35 110.359 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -95.96 134.66 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.643 -1.243 . . . . 70.45 107.643 164.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.6 ttm -131.88 31.51 4.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 65.11 111.047 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -145.18 25.04 1.41 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.582 -1.323 . . . . 74.14 112.11 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.99 166.69 23.13 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.069 -1.02 . . . . 64.11 113.618 -164.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.96 169.59 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.573 1.149 . . . . 43.25 112.168 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -49.13 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.948 1.299 . . . . 65.43 111.925 162.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -92.46 19.83 6.83 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.103 0.961 . . . . 74.45 112.524 -167.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.548 HD12 HG11 ' A' ' 81' ' ' VAL . 11.6 tt -64.23 163.23 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.441 0.696 . . . . 72.53 109.78 168.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -118.49 160.35 40.22 Favored Pre-proline 0 CA--C 1.519 -0.244 0 C-N-CA 125.11 1.364 . . . . 72.14 108.965 167.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.93 -29.85 87.82 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.605 1.537 . . . . 43.45 112.352 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -78.55 -18.78 54.17 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 117.662 -1.161 . . . . 74.01 113.309 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -33.61 73.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.339 1.427 . . . . 71.42 110.212 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.44 -44.97 61.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.238 1.015 . . . . 74.32 110.792 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.13 -41.62 85.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.448 -0.901 . . . . 63.24 108.727 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.02 -39.95 87.6 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.84 0.745 . . . . 73.14 112.571 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -55.76 -57.44 12.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.626 -0.879 . . . . 73.04 108.626 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.36 -25.14 60.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.144 0.794 . . . . 72.25 113.144 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -63.03 -11.45 19.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.96 1.304 . . . . 71.41 112.05 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 p -67.33 -21.46 65.65 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.846 1.657 . . . . 71.15 110.943 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.3 -0.57 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.819 0.848 . . . . 71.21 113.148 -165.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.78 146.08 6.43 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.906 -1.278 . . . . 70.32 109.906 165.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -63.95 148.87 48.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.916 0.358 . . . . 72.34 111.643 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.2 145.77 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 126.225 1.81 . . . . 62.21 108.14 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -84.68 -52.81 5.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.862 -1.066 . . . . 71.01 108.178 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -169.43 170.06 8.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.735 1.214 . . . . 54.24 110.63 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -100.52 165.64 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.014 1.726 . . . . 51.54 111.194 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -149.87 50.72 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.139 0.971 . . . . 73.45 109.859 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -66.78 120.65 13.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.242 2.217 . . . . 70.44 110.295 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 45' ' ' ILE . 3.8 mp -79.69 122.14 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.78 0.832 . . . . 74.03 109.051 -170.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -87.69 4.85 42.49 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.006 0.743 . . . . 73.14 113.006 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' H ' HG22 ' A' ' 45' ' ' ILE . 7.1 m-20 -89.99 125.65 35.46 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.729 -1.582 . . . . 72.24 106.729 177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -130.51 -71.0 0.6 Allowed 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.53 -0.915 . . . . 71.43 108.53 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.3 21.62 0.84 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.072 1.749 . . . . 72.45 112.289 -171.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.52 4.13 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.253 2.621 . . . . 64.11 115.148 -170.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.8 37.32 0.72 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 119.889 -1.757 . . . . 73.45 112.989 -158.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -132.51 -24.93 1.97 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.5 0.72 . . . . 74.33 112.006 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.4 p -172.92 -58.35 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.873 0.469 . . . . 74.11 111.445 -159.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt 56.24 81.47 0.13 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.208 2.203 . . . . 65.13 112.746 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.33 59.82 0.71 Allowed Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.711 -0.956 . . . . 45.14 110.711 161.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 pt -117.08 142.95 28.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.353 1.461 . . . . 72.43 109.835 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.84 150.12 36.57 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.083 1.353 . . . . 62.02 108.027 160.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 45' ' ' ILE . 62.0 m-85 -117.74 157.87 25.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.651 -1.981 . . . . 70.14 105.651 158.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.41 144.54 3.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.841 2.056 . . . . 73.35 106.327 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -111.72 119.73 39.64 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.748 1.619 . . . . 74.11 107.547 -165.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -80.47 173.92 12.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.66 0.743 . . . . 64.22 111.394 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.96 -32.12 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.467 -0.771 . . . . 65.01 108.974 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 4.8 m-20 -129.72 120.98 26.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.488 1.115 . . . . 73.05 108.462 -166.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.405 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 7.3 p -45.67 -34.59 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 129.06 2.944 . . . . 74.35 111.206 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 m -64.65 -18.87 65.34 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.929 -1.732 . . . . 74.01 112.83 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -1.77 24.09 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG23 ' NH2' ' A' ' 13' ' ' ARG . 92.4 t -61.6 -61.34 8.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 120.988 1.722 . . . . 74.24 109.273 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.44 -17.93 60.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.625 . . . . 73.44 113.703 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.37 -56.55 20.58 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.722 1.146 . . . . 65.32 110.343 172.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.57 80.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.39 0.676 . . . . 73.04 111.279 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.98 -47.67 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.654 1.182 . . . . 71.33 109.213 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.98 -22.25 34.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.999 0.809 . . . . 72.35 114.155 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -99.12 12.56 35.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.296 -1.12 . . . . 72.32 111.839 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.4 t -49.12 -26.39 2.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.434 1.094 . . . . 74.24 113.83 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -9.02 60.34 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.767 0.699 . . . . 73.44 114.502 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.38 163.49 26.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.505 1.153 . . . . 62.43 108.254 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -153.33 74.52 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.881 0.472 . . . . 52.24 110.633 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 t -53.16 103.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.925 1.69 . . . . 73.22 108.358 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt 54.72 29.57 11.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.762 0.825 . . . . 74.15 112.064 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 29.65 34.74 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.882 -0.511 . . . . 65.11 112.919 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 24' ' ' ILE . 38.4 t -125.12 80.08 64.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.744 1.618 . . . . 61.32 108.922 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.96 -172.2 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.06 3.174 . . . . 72.42 112.06 171.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.5 tt -137.49 146.56 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.72 1.208 . . . . 74.21 109.592 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.2 mm -87.65 141.58 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.084 -1.45 . . . . 71.03 107.084 171.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.91 0.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 128.697 2.799 . . . . 72.31 115.737 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -55.47 -51.13 67.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 126.296 1.838 . . . . 74.21 114.013 -169.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.8 169.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.278 1.031 . . . . 73.14 110.377 -162.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.23 119.24 38.84 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.206 -2.146 . . . . 53.42 105.206 162.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -106.82 141.74 37.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.857 -0.794 . . . . 72.21 108.857 -172.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 44.42 -153.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.875 1.67 . . . . 72.02 111.136 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -104.63 66.19 0.78 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.196 -1.409 . . . . 71.21 107.196 163.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -129.44 174.18 9.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.73 0.776 . . . . 71.01 112.711 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.9 t30 59.53 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.366 1 C-N-CA 132.55 4.34 . . . . 64.13 112.489 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 C-N-CA 127.513 2.325 . . . . 74.41 104.879 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 CA-C-O 117.903 -1.498 . . . . 64.54 114.119 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.65 104.08 1.95 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.984 -2.228 . . . . 70.35 104.984 166.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp -141.09 77.44 1.6 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.595 -2.002 . . . . 63.51 105.595 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.32 39.73 0.75 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.651 0.78 . . . . 71.21 112.805 -171.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.81 137.66 44.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 75.51 111.772 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.57 157.92 71.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.702 -1.221 . . . . 71.35 107.702 170.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.52 -27.67 70.12 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 120.535 1.227 . . . . 71.14 111.114 167.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -57.76 -49.16 77.51 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 124.54 1.136 . . . . 64.44 109.1 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -50.87 -42.66 59.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.164 1.386 . . . . 71.13 110.624 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -78.75 -20.85 48.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 117.662 -1.161 . . . . 75.35 113.493 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -87.75 -25.53 23.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.514 1.126 . . . . 73.53 110.582 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.31 18.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.62 1.568 . . . . 63.34 112.018 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 54.8 4.31 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.983 2.913 . . . . 75.03 118.764 163.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.1 m -115.0 159.9 20.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 119.996 1.271 . . . . 54.14 109.51 -160.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.4 166.88 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.635 -1.616 . . . . 75.22 106.635 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -138.34 108.43 6.39 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.419 1.088 . . . . 75.34 110.721 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -79.79 125.27 29.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.726 1.61 . . . . 43.15 107.97 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -137.57 27.73 2.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.447 0.641 . . . . 51.05 112.542 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -141.99 46.5 1.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.644 -1.285 . . . . 70.45 110.095 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HG13 ' A' ' 81' ' ' VAL . 4.0 mp -90.27 -173.88 3.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.177 1.391 . . . . 62.31 112.74 -167.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.67 162.61 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.051 2.141 . . . . 61.11 109.681 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.49 -10.05 59.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.379 0.881 . . . . 64.12 113.379 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.67 56.78 1.83 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.311 1.044 . . . . 75.1 111.323 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 tt -112.81 133.13 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.496 1.119 . . . . 75.23 108.986 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -81.64 164.88 47.15 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 119.04 -0.505 . . . . 64.01 110.263 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.29 -46.21 22.93 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.568 1.512 . . . . 60.32 110.064 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -66.51 -16.82 64.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.369 0.878 . . . . 73.3 113.369 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -63.35 -34.97 78.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.801 1.182 . . . . 71.22 109.551 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 -43.38 18.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.728 -0.653 . . . . 62.31 110.157 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.66 -35.13 75.47 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.751 1.16 . . . . 75.03 110.013 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.71 -11.69 59.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.923 1.289 . . . . 72.32 113.654 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -72.52 -63.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 119.465 1.03 . . . . 74.44 108.408 170.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.21 -15.17 62.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 117.907 -1.044 . . . . 63.02 112.155 -175.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t -48.51 -25.38 1.66 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.63 1.572 . . . . 54.53 112.637 164.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -68.86 -19.72 64.25 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.713 -1.242 . . . . 61.33 111.094 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.38 -19.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.157 1.344 . . . . 74.11 114.525 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.55 -177.54 26.3 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 120.942 -1.099 . . . . 74.04 111.331 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -123.08 133.11 54.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.489 0.716 . . . . 75.43 109.373 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.23 133.14 41.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.256 -1.387 . . . . 74.44 107.256 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -74.29 -64.65 0.98 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.764 -1.569 . . . . 72.23 106.764 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -156.98 159.85 38.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.554 -1.646 . . . . 71.35 106.554 -157.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -134.03 145.36 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 60.44 109.374 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -132.55 136.4 46.57 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.55 1.94 . . . . 64.41 108.616 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.78 120.78 15.58 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.15 1.38 . . . . 40.25 109.441 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.14 154.95 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.318 0.963 . . . . 71.41 110.827 -169.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 50' ' ' SER . 70.2 m -137.74 9.88 2.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 116.506 2.039 . . . . 72.24 116.506 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 71.79 -66.78 0.29 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.219 3.007 . . . . 63.42 107.835 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 -30.41 0.07 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.83 1.652 . . . . 75.14 109.51 157.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.82 -31.06 1.1 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 126.8 2.04 . . . . 73.14 113.743 -168.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER 65.43 -11.67 0.17 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.728 1.611 . . . . 75.02 113.933 172.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -131.44 31.45 4.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.902 2.481 . . . . 55.44 109.188 -164.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -156.43 -54.01 0.08 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.046 2.139 . . . . 64.4 109.871 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . 0.259 19.4 p 44.67 -21.63 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 130.432 3.493 . . . . 55.33 118.58 -154.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.438 10.4 ptpp? 48.63 22.16 0.48 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.926 1.694 . . . . 74.52 112.939 -148.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' HD13 ' A' ' 20' ' ' LEU . . . 57.69 86.9 0.02 OUTLIER Glycine 0 C--N 1.344 0.979 0 C-N-CA 125.577 1.561 . . . . 74.33 111.899 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.83 121.85 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.622 0.769 . . . . 62.32 110.538 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.43 137.89 34.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.887 -0.782 . . . . 55.23 108.887 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -102.65 154.12 19.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.938 -1.875 . . . . 62.34 105.938 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.92 115.71 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.323 -2.102 . . . . 72.41 105.323 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -81.93 110.04 16.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 105.124 -2.176 . . . . 74.35 105.124 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.09 163.07 18.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.273 -0.892 . . . . 71.44 110.42 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.88 -15.32 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.5 0.32 . . . . 72.33 111.033 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.44 161.83 38.77 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.366 -1.459 . . . . 53.31 111.095 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.12 -22.87 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.089 1.355 . . . . 64.35 111.669 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -59.37 -27.18 65.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.089 -1.007 . . . . 64.33 111.403 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -86.06 -4.07 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.236 1.199 . . . . 75.33 114.236 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.05 -58.16 16.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.24 1.382 . . . . 72.52 109.263 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.81 -20.39 64.7 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.448 1.432 . . . . 74.31 113.326 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.09 -52.95 56.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.972 1.26 . . . . 65.54 110.408 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.33 73.66 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.267 0.355 . . . . 74.13 111.644 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.65 -42.49 88.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.888 0.875 . . . . 74.44 109.106 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.33 -31.14 59.32 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 117.994 0.361 . . . . 41.13 112.437 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.31 9.96 16.29 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.334 -1.098 . . . . 74.31 112.803 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 83' ' ' ILE . 1.4 t -49.82 -29.85 8.69 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.384 1.447 . . . . 71.45 114.458 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.08 6.46 40.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.476 1.036 . . . . 64.11 113.779 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -81.36 175.05 10.91 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.237 1.019 . . . . 70.23 108.792 165.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -149.58 135.16 18.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.925 -0.769 . . . . 74.31 108.925 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.95 119.57 35.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 63.02 105.847 162.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.9 mt 60.3 1.46 0.37 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.014 1.857 . . . . 63.4 116.014 171.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.44 2.21 15.36 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.718 -1.046 . . . . 70.24 113.902 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 20' ' ' LEU . 68.9 t -104.57 86.39 1.4 Allowed Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 128.906 2.882 . . . . 70.51 109.151 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -65.3 177.49 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.23 1.953 . . . . 45.2 111.086 161.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.584 HG23 ' HA ' ' A' ' 74' ' ' THR 0.296 8.3 tt -122.19 176.45 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.951 0.9 . . . . 71.22 109.617 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 83' ' ' ILE . 47.8 mm -123.97 145.78 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.945 2.098 . . . . 70.24 106.077 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.52 -4.41 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.533 2.333 . . . . 71.33 114.819 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -53.85 -49.11 69.2 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.933 1.693 . . . . 72.34 113.717 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.4 179.36 0.15 Allowed 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.575 1.55 . . . . 64.54 111.498 -170.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -99.23 112.0 24.25 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.594 1.558 . . . . 74.31 106.963 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 63.41 -172.23 0.17 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.255 1.422 . . . . 64.25 111.733 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.25 174.2 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.885 1.674 . . . . 73.31 108.857 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.45 14.9 0.4 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.846 1.259 . . . . 71.51 113.568 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -115.46 -73.77 0.64 Allowed 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 121.455 -0.778 . . . . 72.21 110.507 -160.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 50.02 64.05 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.75 2.02 . . . . 74.54 111.668 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 . . . . . 0 C--O 1.252 1.219 0 O-C-N 121.847 -0.533 . . . . 75.54 111.618 -174.138 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 N-CA-C 110.146 -1.181 . . . . 74.53 110.146 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.53 68.87 0.25 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.246 1.418 . . . . 70.54 111.975 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.0 tpp -170.44 -46.75 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.413 1.885 . . . . 74.45 109.638 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -106.05 167.39 9.84 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.707 0.803 . . . . 75.51 111.018 -162.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 130.33 35.48 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.618 0.767 . . . . 61.35 109.039 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.66 HG23 ' H ' ' A' ' 9' ' ' GLU . 3.0 t -65.54 147.61 98.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.757 -0.831 . . . . 73.41 108.757 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 -11.01 27.05 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.472 2.115 . . . . 75.21 112.971 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.91 -49.91 11.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.876 1.27 . . . . 75.31 110.723 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.66 ' H ' HG23 ' A' ' 6' ' ' THR . 75.7 tt0 -58.02 -47.27 83.58 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.475 1.51 . . . . 74.53 110.861 -177.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -62.99 -32.13 73.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.578 0.585 . . . . 61.14 112.578 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -32.72 72.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.884 1.274 . . . . 74.13 108.314 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.88 27.2 1.86 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.596 2.759 . . . . 72.42 112.219 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.9 62.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.336 1.236 . . . . 75.34 114.336 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 m -92.51 145.72 24.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.282 -1.006 . . . . 74.05 108.282 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -108.41 125.62 65.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 107.855 -1.165 . . . . 53.51 107.855 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.637 ' H ' ' HA ' ' A' ' 87' ' ' ALA . 7.3 t80 -89.55 124.29 34.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.869 1.668 . . . . 75.23 109.151 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -111.94 86.13 2.28 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.715 1.606 . . . . 71.22 108.941 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.0 ttp -92.03 27.54 2.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.711 0.804 . . . . 73.25 112.364 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -150.28 37.09 0.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.863 -1.773 . . . . 70.23 113.712 -173.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.67 153.27 42.17 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.476 -0.765 . . . . 72.32 112.916 -169.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.79 158.06 29.7 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.323 0.582 . . . . 72.23 111.154 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.88 -15.59 43.72 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.193 1.183 . . . . 61.12 114.193 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.69 30.65 5.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.101 1.318 . . . . 64.15 111.301 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -60.89 144.12 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 120.886 -1.134 . . . . 55.55 109.866 170.164 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -97.45 158.21 33.52 Favored Pre-proline 0 N--CA 1.464 0.27 0 C-N-CA 123.907 0.883 . . . . 72.34 109.724 160.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -57.85 -34.87 98.85 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 121.988 1.792 . . . . 62.34 112.364 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -67.44 -25.89 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.917 -0.489 . . . . 72.33 112.247 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.74 -32.8 74.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.01 1.277 . . . . 64.34 111.552 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -41.37 80.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.092 0.557 . . . . 62.41 110.586 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -76.54 -40.23 50.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.249 -0.278 . . . . 74.44 110.249 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.6 -44.08 76.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.84 1.256 . . . . 62.02 111.918 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -54.38 -42.43 70.36 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.098 -0.376 . . . . 72.15 111.232 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -88.08 -11.87 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.491 0.716 . . . . 73.41 112.529 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -65.66 -12.87 57.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.246 1.818 . . . . 74.45 111.783 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -59.08 -31.28 68.74 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.153 -0.967 . . . . 71.42 110.702 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.09 17.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.039 -1.038 . . . . 70.15 113.03 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 174.38 38.77 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 120.764 -1.21 . . . . 70.33 113.595 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.761 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -127.26 51.81 1.86 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.959 1.304 . . . . 71.53 111.673 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 HG12 ' A' ' 59' ' ' VAL . 2.2 p -43.73 126.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 127.904 2.482 . . . . 63.25 110.279 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -51.09 29.99 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.79 -1.55 . . . . 63.41 108.664 -158.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.54 179.12 7.46 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.193 1.558 . . . . 74.32 109.491 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 59' ' ' VAL . 20.6 t -136.92 147.88 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.185 0.994 . . . . 64.13 109.221 -174.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 102.53 11.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.56 2.344 . . . . 74.12 106.822 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.34 115.85 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.225 1.81 . . . . 74.34 107.07 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.81 75.97 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.799 1.639 . . . . 55.34 108.677 -164.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -80.01 64.1 4.74 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.499 1.142 . . . . 54.32 111.61 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -77.14 19.01 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.969 2.108 . . . . 44.11 112.85 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.268 11.1 ptt180 47.92 -170.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.99 2.916 . . . . 53.3 114.098 -172.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -86.82 84.59 7.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.022 -1.473 . . . . 73.22 107.022 172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.4 t -150.42 -83.45 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.22 -1.4 . . . . 60.31 107.22 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -124.25 109.17 13.05 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.042 -2.207 . . . . 62.1 105.042 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.41 155.78 34.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.396 0.998 . . . . 60.14 112.698 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -71.2 2.16 5.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.537 1.535 . . . . 62.45 112.808 166.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? 53.52 -1.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.446 3.098 . . . . 74.22 118.614 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.39 76.09 0.16 Allowed Glycine 0 CA--C 1.517 0.159 0 CA-C-N 120.91 1.686 . . . . 74.01 109.892 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 pt -143.6 139.84 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.901 0.88 . . . . 64.35 111.384 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.36 157.27 43.52 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.289 1.836 . . . . 75.42 107.094 156.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.414 ' CE2' ' CD1' ' A' ' 16' ' ' PHE . 58.0 m-85 -124.99 128.38 48.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.884 -2.265 . . . . 75.05 104.884 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 42' ' ' VAL . 2.7 t -116.04 112.93 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.291 -1.374 . . . . 73.41 107.291 -164.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.45 88.08 7.32 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.952 1.358 . . . . 73.13 110.578 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -49.92 156.91 0.67 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.402 1.572 . . . . 75.51 113.375 166.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.761 HG21 ' HG3' ' A' ' 38' ' ' LYS . 3.5 m -79.9 -35.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 128.276 2.63 . . . . 61.32 113.975 176.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -116.73 165.15 13.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.012 1.725 . . . . 73.12 108.438 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -88.42 -27.38 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.227 0.611 . . . . 54.41 110.075 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 t -60.64 -27.61 67.93 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.325 0.966 . . . . 71.44 112.066 -173.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 p -76.24 -19.67 58.14 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.829 -1.17 . . . . 61.35 114.147 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.5 t -52.22 -57.71 14.24 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.499 1.12 . . . . 72.04 109.668 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.82 -17.51 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.713 1.608 . . . . 74.32 113.652 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -51.97 50.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.022 1.283 . . . . 73.44 109.733 172.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.86 91.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.491 0.716 . . . . 74.05 110.576 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.54 -39.28 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.609 0.764 . . . . 74.43 109.393 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.76 -4.99 29.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.595 1.093 . . . . 24.31 114.492 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.9 mt -109.24 13.39 24.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.393 1.597 . . . . 70.04 111.735 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 83' ' ' ILE . 3.3 t -54.3 -3.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.348 1.859 . . . . 73.35 115.22 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.61 7.88 24.19 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.13 1.347 . . . . 44.51 114.435 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -97.69 175.14 6.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.275 1.538 . . . . 72.04 110.311 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -155.57 89.07 1.16 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.265 -0.643 . . . . 72.23 109.265 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 m -60.31 113.45 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.151 -1.055 . . . . 72.21 108.151 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt 59.6 13.16 3.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.102 1.149 . . . . 72.33 114.102 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.07 13.3 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.638 -1.09 . . . . 65.25 113.425 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 24' ' ' ILE . 46.3 t -105.01 85.02 1.12 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.481 1.513 . . . . 63.02 108.352 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.8 179.38 3.76 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.256 2.638 . . . . 51.35 111.164 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 74' ' ' THR . 11.7 tt -129.59 177.1 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.724 2.01 . . . . 74.43 108.37 176.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -126.73 147.24 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.304 1.841 . . . . 70.31 107.413 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.43 -10.25 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 116.39 1.996 . . . . 65.02 116.39 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -56.34 -41.92 76.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.975 1.261 . . . . 74.21 112.898 -166.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.637 ' HA ' ' H ' ' A' ' 16' ' ' PHE . . . 58.97 174.94 0.07 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.279 1.038 . . . . 72.41 110.035 -165.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 t -88.57 102.79 15.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.494 -2.039 . . . . 75.41 105.494 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 166.89 12.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.504 1.122 . . . . 73.33 108.927 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.5 122.69 18.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.504 -1.295 . . . . 61.11 107.504 167.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.2 60.13 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.99 -1.855 . . . . 61.33 105.99 170.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -143.23 165.8 26.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.967 1.707 . . . . 71.14 108.424 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -157.93 139.49 13.73 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 103.427 -2.805 . . . . 55.14 103.427 162.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 . . . . . 0 C--O 1.258 1.518 0 CA-C-N 120.22 1.373 . . . . 71.22 107.597 175.833 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 111.304 -0.718 . . . . 74.35 111.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.45 107.07 4.81 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.585 -1.635 . . . . 74.31 106.585 164.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.8 mtm -144.3 -80.2 0.18 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.067 -1.086 . . . . 72.41 108.067 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.24 142.04 30.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.013 0.369 . . . . 72.35 110.701 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 111.55 5.74 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.46 1.504 . . . . 72.34 109.985 -172.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 p -78.04 164.93 54.18 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.266 -0.896 . . . . 74.23 110.678 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.53 -51.54 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.256 1.97 . . . . 72.13 111.503 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.17 -24.32 63.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.822 0.737 . . . . 60.33 111.279 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -57.16 -56.0 27.48 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.85 0.75 . . . . 62.32 109.06 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -57.42 -30.68 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.275 0.488 . . . . 63.12 111.576 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -84.18 -17.79 38.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.495 1.518 . . . . 72.54 111.808 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.4 -85.57 0.05 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.466 0.706 . . . . 64.44 109.578 164.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.7 37.78 24.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.782 0.833 . . . . 75.55 111.105 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.3 m -102.39 147.6 26.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.135 0.574 . . . . 64.44 109.628 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.41 129.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.462 1.105 . . . . 73.55 108.468 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -100.51 108.74 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.951 1.7 . . . . 71.21 109.143 -171.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' HD11 ' A' ' 20' ' ' LEU . 13.1 m -84.88 122.13 28.73 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.761 1.625 . . . . 53.13 106.871 175.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.2 ttp -139.04 52.27 1.78 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.029 0.919 . . . . 71.23 111.385 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.443 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 tt0 -154.97 30.45 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.729 -1.232 . . . . 64.14 109.668 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.675 ' H ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -84.26 166.63 17.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.802 1.287 . . . . 74.22 110.923 -167.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -105.15 153.12 21.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.629 -2.078 . . . . 34.35 110.202 -171.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.46 13.66 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.76 2.024 . . . . 71.13 114.598 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 25.22 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.067 2.147 . . . . 75.2 111.035 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 81' ' ' VAL . 10.6 tp -72.34 155.3 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.456 -1.403 . . . . 74.1 109.42 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.31 161.55 25.56 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.997 1.719 . . . . 71.22 107.274 171.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.38 -42.02 44.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.888 1.725 . . . . 75.51 112.416 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.09 -30.47 71.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 75.52 111.904 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -24.5 66.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.568 0.622 . . . . 63.51 110.979 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.4 -41.45 12.1 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.305 -0.628 . . . . 60.35 109.305 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -66.83 -35.33 79.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.558 0.617 . . . . 63.21 111.261 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.93 -24.91 43.71 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.56 -0.712 . . . . 75.13 112.474 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.09 -36.3 70.44 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.126 -0.359 . . . . 65.32 111.111 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -96.96 -1.9 44.74 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.211 0.819 . . . . 65.12 113.211 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -60.11 -20.48 58.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.297 1.839 . . . . 73.43 111.026 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -13.41 61.52 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.036 -1.04 . . . . 74.24 112.902 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.55 2.53 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 120.493 -1.379 . . . . 72.54 113.67 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.34 -143.45 7.99 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.453 -1.859 . . . . 51.23 108.453 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.701 ' HG2' HG11 ' A' ' 62' ' ' VAL . 3.7 ptmm? -129.24 161.76 29.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.408 -0.96 . . . . 64.44 108.408 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.25 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.847 -0.797 . . . . 72.25 108.847 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -78.11 -59.95 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.09 -1.078 . . . . 72.25 108.09 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -142.78 137.47 29.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.222 1.009 . . . . 73.45 108.629 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.44 129.81 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.583 1.553 . . . . 72.42 107.726 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -153.46 112.25 3.71 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.828 0.74 . . . . 75.1 111.381 -172.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -136.78 157.48 46.66 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.065 -1.022 . . . . 64.12 112.504 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.18 65.34 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.648 -0.871 . . . . 74.42 108.648 -166.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.0 t -104.34 12.92 32.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.851 0.86 . . . . 75.33 112.123 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.53 124.49 16.23 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.282 1.433 . . . . 71.23 107.332 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.67 -69.33 0.72 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 117.764 -1.112 . . . . 74.44 110.163 160.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.406 ' H ' ' H ' ' A' ' 50' ' ' SER . 8.5 p30 173.43 -2.9 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.946 2.499 . . . . 62.43 112.301 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -143.2 -176.1 4.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.977 1.711 . . . . 63.51 111.981 -158.091 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -107.12 90.24 3.24 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 105.968 -1.864 . . . . 63.03 105.968 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -135.55 -175.35 3.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.214 -1.773 . . . . 72.22 106.214 -164.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -66.65 78.46 0.11 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.391 -0.523 . . . . 75.1 109.864 162.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.274 6.7 ptmt -83.02 -12.07 57.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.32 1.848 . . . . 75.13 112.519 165.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 20' ' ' LEU . . . -87.97 72.84 2.38 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 108.461 -1.855 . . . . 50.5 108.461 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.19 138.2 14.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.158 1.783 . . . . 73.53 109.925 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.29 151.48 33.0 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.198 1.399 . . . . 75.52 108.454 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -128.36 104.21 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.578 -2.008 . . . . 74.43 105.578 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.32 118.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.495 -1.669 . . . . 64.21 106.495 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -91.16 121.17 32.7 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.672 -1.603 . . . . 75.13 106.672 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.88 165.21 11.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.445 1.116 . . . . 75.14 112.181 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.701 HG11 ' HG2' ' A' ' 38' ' ' LYS . 15.6 m -76.56 -34.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.62 1.568 . . . . 61.41 112.761 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -134.13 152.4 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.358 1.063 . . . . 55.32 112.908 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.42 -27.72 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 71.14 112.054 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -60.02 -25.43 65.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.344 1.429 . . . . 65.21 113.95 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.4 p -77.64 -19.21 55.83 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.125 1.33 . . . . 64.14 114.254 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.47 -57.23 24.55 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.65 1.18 . . . . 71.15 111.404 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -63.59 -23.7 70.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.437 1.425 . . . . 73.15 111.462 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -50.97 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.967 0.907 . . . . 62.43 109.863 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.51 77.65 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.228 1.011 . . . . 65.14 111.418 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.0 mt -53.66 -43.62 55.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.18 0.992 . . . . 74.21 109.382 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.33 64.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.161 -0.8 . . . . 74.33 112.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -98.67 4.26 47.88 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.096 1.358 . . . . 65.13 111.279 -167.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.294 2.8 m -45.55 -26.79 0.64 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.565 0.95 . . . . 70.03 113.565 161.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 18.06 45.04 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.309 0.884 . . . . 61.15 115.309 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -125.68 163.17 23.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 119.328 1.564 . . . . 73.15 109.367 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -136.25 115.71 12.75 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.398 1.479 . . . . 63.23 110.335 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -79.96 98.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.868 -1.53 . . . . 74.03 106.868 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt 54.87 33.25 19.49 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.139 0.976 . . . . 73.24 112.082 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.81 57.17 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.71 -1.05 . . . . 52.33 113.917 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 20' ' ' LEU . 99.3 t -114.06 85.32 9.96 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 118.891 1.345 . . . . 65.23 108.176 168.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.82 -177.63 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.734 2.29 . . . . 51.51 111.714 162.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -124.29 156.84 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.648 -0.871 . . . . 70.22 108.648 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.92 146.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.423 -1.325 . . . . 65.13 107.423 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -74.12 16.32 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.688 1.995 . . . . 61.31 112.736 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.21 -26.64 63.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.441 2.296 . . . . 72.31 112.889 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.46 36.24 22.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.288 1.835 . . . . 64.01 113.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 50.71 23.26 1.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.227 2.211 . . . . 62.52 114.918 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -78.73 132.95 37.16 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.371 -0.831 . . . . 61.12 109.651 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.8 142.08 11.94 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.305 1.442 . . . . 73.21 107.148 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -83.29 57.65 4.09 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.912 1.685 . . . . 73.43 107.736 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -128.97 -172.07 2.63 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.168 1.387 . . . . 74.11 110.758 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.306 68.3 m-20 74.61 21.7 2.18 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.708 2.803 . . . . 60.12 112.252 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? . . . . . 0 C--O 1.255 1.349 0 C-N-CA 130.266 3.426 . . . . 73.1 111.853 174.43 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 113.581 0.956 . . . . 64.109999999999999 113.581 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -57.31 143.11 41.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.809 1.244 . . . . 63.520000000000003 110.402 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.0 116.93 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.41 1.1 . . . . 72.329999999999998 108.166 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -68.63 124.64 24.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.685 -1.143 . . . . 63.340000000000003 108.209 170.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.74 105.29 13.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 105.324 -2.102 . . . . 73.25 105.324 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -113.03 174.24 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.057 -1.09 . . . . 61.219999999999999 108.057 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 74.99 17.35 2.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.005 2.522 . . . . 74.439999999999998 112.046 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.698 ' HA ' HG13 ' A' ' 81' ' ' VAL . 20.7 mt -77.48 165.63 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.875 -0.515 . . . . 71.230000000000004 111.497 -171.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.21 41.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.262 0.553 . . . . 75.129999999999995 111.463 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.04 -24.37 53.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.817 1.247 . . . . 33.340000000000003 113.736 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -123.25 19.4 9.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.366 1.867 . . . . 74.239999999999995 111.155 -167.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.623 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.0 tt -63.92 151.24 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.607 0.639 . . . . 64.120000000000005 109.961 174.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 160.9 35.77 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 125.089 1.356 . . . . 75.319999999999993 107.554 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.59 -42.15 57.31 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.233 1.289 . . . . 73.340000000000003 110.596 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -30.59 71.7 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.073 -0.965 . . . . 74.25 111.663 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.12 -30.72 62.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.549 1.068 . . . . 55.149999999999999 110.382 -169.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.91 -41.46 18.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.795 1.638 . . . . 74.239999999999995 110.527 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.87 -37.63 73.06 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.223 -0.658 . . . . 65.340000000000003 109.223 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.33 -55.47 28.13 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 126.722 2.009 . . . . 43.420000000000002 109.642 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -55.08 -29.78 58.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.85 1.26 . . . . 73.230000000000004 112.446 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.86 -35.65 13.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.188 0.81 . . . . 63.340000000000003 113.188 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.1 t -57.26 -23.11 46.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.641 1.176 . . . . 62.140000000000001 111.674 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.739 0.815 . . . . 64.230000000000004 112.735 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.86 6.28 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 64.129999999999995 111.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 -174.85 23.36 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 121.042 -1.036 . . . . 61.340000000000003 113.105 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -140.1 138.22 35.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.829 1.252 . . . . 72.439999999999998 109.334 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.54 138.68 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.628 1.571 . . . . 61.409999999999997 107.573 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -85.78 -57.71 2.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.852 1.661 . . . . 42.020000000000003 108.12 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -158.27 175.86 13.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.811 0.732 . . . . 63.409999999999997 109.701 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.2 113.61 26.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.109 1.764 . . . . 71.310000000000002 107.389 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.05 51.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.792 1.637 . . . . 55.439999999999998 108.578 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 ttt -66.57 128.96 38.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.906 1.282 . . . . 73.140000000000001 107.897 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.73 HD12 ' H ' ' A' ' 45' ' ' ILE . 2.8 mp . . . . . 0 CA--C 1.534 0.363 0 N-CA-C 105.871 -1.9 . . . . 62.210000000000001 105.871 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.52 0 CA-C-O 118.916 -0.935 . . . . 74.319999999999993 113.987 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -139.11 148.7 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.601 1.2 . . . . 74.310000000000002 111.776 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.39 162.82 33.44 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.107 2.163 . . . . 62.310000000000002 109.842 170.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.641 ' CE2' HD11 ' A' ' 45' ' ' ILE . 85.8 m-85 -130.09 114.56 15.91 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.662 1.585 . . . . 63.310000000000002 108.017 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.19 122.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.835 -1.172 . . . . 72.209999999999994 107.835 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -75.7 114.37 14.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.696 -1.224 . . . . 52.32 107.696 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 2.9 m-85 -80.02 166.25 21.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.999 -0.371 . . . . 74.140000000000001 109.999 165.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.97 -9.36 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 118.68 -0.676 . . . . 63.549999999999997 111.358 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.55 135.0 40.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.342 1.883 . . . . 75.150000000000006 113.695 -168.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.21 -35.13 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.725 0.81 . . . . 71.310000000000002 111.981 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 m -80.68 -9.24 59.81 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 119.178 -1.009 . . . . 75.510000000000005 111.025 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.7 m -80.28 -11.81 59.68 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 117.548 -1.215 . . . . 55.119999999999997 113.659 172.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.34 -59.3 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 120.551 1.523 . . . . 52.439999999999998 108.765 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.48 -18.79 60.49 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.952 1.768 . . . . 54.310000000000002 113.667 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.52 -57.88 8.76 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 119.464 1.029 . . . . 73.140000000000001 108.75 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.01 69.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.704 1.202 . . . . 63.32 112.051 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.2 mt -54.85 -48.47 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.72 -0.845 . . . . 73.109999999999999 108.72 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.69 -6.21 21.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.727 1.156 . . . . 64.340000000000003 115.256 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.433 HD22 HE21 ' A' ' 76' ' ' GLN . 91.5 mt -97.19 1.46 49.83 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.822 1.311 . . . . 73.329999999999998 112.168 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.68 -23.98 7.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.801 1.778 . . . . 71.420000000000002 115.801 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.15 1.65 37.91 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.143 0.878 . . . . 31.149999999999999 113.473 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.433 HE21 HD22 ' A' ' 73' ' ' LEU . 26.5 mt-30 -72.1 170.72 13.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.073 -1.084 . . . . 60.229999999999997 108.073 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -162.59 82.04 0.52 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.622 0.971 . . . . 71.209999999999994 113.622 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.78 117.24 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.608 -0.886 . . . . 63.219999999999999 108.608 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt 60.67 2.17 0.48 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.002 1.321 . . . . 65.120000000000005 114.157 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.79 11.96 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.799 -1.0 . . . . 52.350000000000001 113.132 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 20' ' ' LEU . 65.7 t -112.37 86.12 7.78 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 118.945 1.373 . . . . 72.129999999999995 110.034 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.81 175.78 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.669 2.246 . . . . 44.539999999999999 111.369 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -134.92 140.42 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.302 1.041 . . . . 52.149999999999999 110.256 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mm -77.34 145.93 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.212 -0.93 . . . . 53.219999999999999 110.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.04 4.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 128.886 2.874 . . . . 54.340000000000003 115.806 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.8 -36.92 84.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.936 1.458 . . . . 61.130000000000003 114.936 -157.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.77 173.63 0.07 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.441 1.496 . . . . 63.420000000000002 110.091 -163.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.657 0 N-CA-C 107.674 -1.232 . . . . 52.420000000000002 107.674 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 111.901 0.334 . . . . 73.340000000000003 111.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -85.35 144.3 28.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.198 -1.038 . . . . 70.25 108.198 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.65 122.14 66.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.355 1.062 . . . . 74.140000000000001 108.252 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -73.7 132.87 43.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.918 1.687 . . . . 71.519999999999996 110.107 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.7 m -117.64 130.3 56.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.541 1.936 . . . . 70.230000000000004 106.356 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.9 ttp -138.32 29.87 2.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.839 1.256 . . . . 31.199999999999999 110.69 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -153.86 15.31 0.49 Allowed 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.546 -1.346 . . . . 74.150000000000006 111.972 -165.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.29 156.59 36.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.825 0.45 . . . . 73.420000000000002 111.142 -167.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 152.23 44.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.052 0.454 . . . . 72.540000000000006 109.978 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.94 64.87 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.447 1.099 . . . . 74.430000000000007 113.744 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -121.59 58.48 1.0 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.752 1.221 . . . . 73.439999999999998 109.345 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 161.51 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.019 -1.051 . . . . 42.109999999999999 109.351 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -120.26 158.3 51.2 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 125.579 1.552 . . . . 62.530000000000001 108.099 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.86 -32.42 22.65 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.588 1.525 . . . . 72.219999999999999 111.319 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -70.82 -37.86 73.25 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.614 0.643 . . . . 74.549999999999997 111.322 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.83 -40.41 69.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.201 1.001 . . . . 71.319999999999993 110.74 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.3 -48.26 62.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.683 1.193 . . . . 74.439999999999998 110.88 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 39' ' ' VAL . 10.7 pt-20 -69.2 -37.82 78.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.496 -0.764 . . . . 65.109999999999999 109.633 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.34 -25.86 66.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.068 0.849 . . . . 72.150000000000006 112.223 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.6 -36.63 83.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.744 0.702 . . . . 72.129999999999995 110.244 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -99.55 -33.88 10.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.501 -0.761 . . . . 71.239999999999995 112.417 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -66.02 -17.14 64.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.793 1.179 . . . . 62.329999999999998 111.501 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -80.95 -2.84 49.37 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.259 -0.901 . . . . 74.129999999999995 112.23 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.75 15.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.166 1.786 . . . . 52.43 111.481 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.06 -155.53 17.3 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.001 -1.639 . . . . 61.539999999999999 109.001 -161.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -157.81 147.74 20.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.853 1.327 . . . . 65.109999999999999 108.998 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 30' ' ' GLU . 53.4 t -112.23 122.99 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.443 1.097 . . . . 65.530000000000001 110.024 -173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -76.07 -45.73 32.61 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.805 1.242 . . . . 73.549999999999997 110.501 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.9 163.64 37.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.443 1.097 . . . . 73.239999999999995 108.777 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.4 126.29 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.171 1.388 . . . . 63.530000000000001 107.296 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -132.6 103.97 6.42 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.698 -0.852 . . . . 61.509999999999998 108.698 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.42 137.11 35.98 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.448 1.099 . . . . 74.219999999999999 108.302 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.326 -0.438 0 N-CA-C 105.897 -1.89 . . . . 70.549999999999997 105.897 172.844 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.482 0 N-CA-C 109.726 -1.35 . . . . 32.530000000000001 109.726 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -120.57 128.31 76.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.034 1.334 . . . . 72.150000000000006 111.062 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.89 158.73 44.51 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.005 1.322 . . . . 72.230000000000004 110.176 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -124.34 135.69 53.53 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.979 -1.489 . . . . 70.340000000000003 106.979 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.375 1.5 p -138.54 109.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 65.549999999999997 110.56 -168.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -74.25 122.31 22.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.43 1.892 . . . . 72.239999999999995 110.357 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 66' ' ' SER . 3.2 m-85 -74.76 153.92 38.59 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.16 0.981 . . . . 63.329999999999998 111.483 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -73.94 -21.76 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 115.229 -0.896 . . . . 73.219999999999999 110.868 166.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -137.85 128.22 26.31 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.243 1.417 . . . . 74.549999999999997 109.857 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.38 -30.66 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.216 1.406 . . . . 61.530000000000001 111.388 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -73.73 -21.11 60.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.243 -1.535 . . . . 72.109999999999999 112.855 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 7.2 m -81.71 -8.69 59.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.704 1.138 . . . . 74.129999999999995 112.553 172.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.15 -66.54 1.19 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 116.101 -1.904 . . . . 71.450000000000003 107.768 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.03 -17.87 58.46 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.433 2.089 . . . . 74.239999999999995 113.837 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.14 -42.45 76.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.554 1.142 . . . . 74.329999999999998 109.45 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.69 -36.55 69.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.017 0.747 . . . . 63.109999999999999 113.017 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.9 mt -59.41 -42.54 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.941 0.791 . . . . 72.219999999999999 109.769 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 -5.09 8.66 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.384 -0.676 . . . . 75.129999999999995 113.091 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.12 5.6 12.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.383 1.591 . . . . 74.129999999999995 112.456 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.7 t -48.07 -33.75 8.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.234 1.379 . . . . 62.520000000000003 113.094 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.85 12.86 41.8 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.891 1.71 . . . . 73.109999999999999 113.839 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.77 172.23 8.48 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 118.874 1.337 . . . . 74.510000000000005 108.069 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -155.93 99.46 1.98 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.388 0.675 . . . . 75.239999999999995 111.137 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.64 114.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.919 -1.141 . . . . 70.340000000000003 107.919 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt 54.53 21.35 3.3 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.873 1.064 . . . . 70.319999999999993 113.873 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.84 28.82 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.297 -0.724 . . . . 61.340000000000003 113.945 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.13 85.11 6.39 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.354 1.577 . . . . 71.120000000000005 109.719 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.83 177.76 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.862 2.375 . . . . 72.129999999999995 111.388 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.8 tt -136.48 169.09 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.871 0.693 . . . . 73.349999999999994 112.871 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.18 124.44 73.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.707 2.003 . . . . 61.549999999999997 108.798 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -53.38 -17.75 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.079 2.552 . . . . 70.150000000000006 115.831 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.87 -42.56 80.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.568 1.531 . . . . 65.239999999999995 111.646 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.0 41.83 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.836 1.654 . . . . 63.340000000000003 113.986 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.258 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 127.227 2.211 . . . . 74.319999999999993 111.449 -171.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.107 -0.473 . . . . 60.340000000000003 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.17 151.38 50.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.332 0.969 . . . . 72.430000000000007 112.237 -173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.84 122.92 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.1 1.76 . . . . 62.420000000000002 110.691 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.91 129.71 38.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.262 1.425 . . . . 73.510000000000005 109.647 169.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.6 m -122.15 105.06 9.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.994 -1.484 . . . . 64.519999999999996 106.994 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.8 ttm -88.01 174.57 8.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.712 0.805 . . . . 72.430000000000007 109.133 171.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.43 HE21 HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER 70.14 21.03 6.16 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.44 2.296 . . . . 73.439999999999998 113.185 164.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.7 mt -69.1 167.03 16.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.104 0.561 . . . . 65.200000000000003 111.77 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -62.26 147.73 47.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.976 -0.556 . . . . 64.140000000000001 110.332 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.99 -4.26 2.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.32 1.448 . . . . 51.240000000000002 113.675 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -139.36 13.57 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.77 1.628 . . . . 73.099999999999994 112.138 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tt -47.7 131.46 4.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.756 0.822 . . . . 71.540000000000006 112.275 -167.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -66.97 147.67 99.05 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 107.548 -1.279 . . . . 71.430000000000007 107.548 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.55 1.77 4.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.088 2.525 . . . . 55.039999999999999 113.36 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 -22.0 14.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.814 1.188 . . . . 72.349999999999994 113.019 167.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -30.43 71.52 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.811 1.187 . . . . 52.119999999999997 112.046 -165.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.3 mt -84.71 -24.13 29.03 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.989 0.516 . . . . 72.439999999999998 111.436 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 42' ' ' VAL . 1.4 mt-10 -80.78 -52.01 7.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.33 -2.1 . . . . 71.140000000000001 105.33 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.12 -38.72 83.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.896 1.678 . . . . 74.230000000000004 110.668 -172.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -57.96 -49.26 77.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.237 0.926 . . . . 73.319999999999993 111.971 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -85.13 -15.23 44.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.1 0.407 . . . . 74.340000000000003 112.1 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -59.23 -20.13 51.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.617 1.567 . . . . 72.109999999999999 113.399 -171.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -65.38 -24.37 67.21 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.954 0.502 . . . . 64.510000000000005 110.466 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.87 47.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.009 -1.057 . . . . 74.430000000000007 110.75 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.17 153.5 9.37 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.005 1.764 . . . . 53.219999999999999 108.979 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.694 ' HG2' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -89.97 167.48 12.76 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.296 0.638 . . . . 51.219999999999999 110.71 -178.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . 2.6 p -124.35 145.35 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.442 1.897 . . . . 55.030000000000001 107.78 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -74.11 -49.52 23.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.776 -1.107 . . . . 64.549999999999997 109.098 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -165.87 -179.69 5.41 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.405 1.002 . . . . 73.349999999999994 111.818 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.44 HG21 ' HG2' ' A' ' 30' ' ' GLU . 51.9 t -133.56 110.01 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 127.006 2.123 . . . . 75.109999999999999 107.623 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -104.34 85.33 2.34 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.377 1.071 . . . . 75.239999999999995 108.985 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.47 160.74 19.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.649 0.737 . . . . 65.239999999999995 110.086 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 106.841 -1.54 . . . . 74.109999999999999 106.841 -175.776 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.642 0 N-CA-C 110.349 -1.1 . . . . 72.400000000000006 110.349 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.54 156.11 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.86 1.264 . . . . 51.340000000000003 111.044 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.86 159.91 27.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.22 1.008 . . . . 73.140000000000001 113.43 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.35 105.41 10.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.777 2.431 . . . . 74.209999999999994 106.15 160.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -91.65 132.18 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.62 -1.622 . . . . 75.329999999999998 106.62 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -116.47 89.86 3.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.492 1.117 . . . . 73.439999999999998 110.276 -166.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.98 169.77 1.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.463 2.023 . . . . 72.430000000000007 116.463 -176.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.694 HG21 ' HG2' ' A' ' 38' ' ' LYS . 31.1 t -87.4 -23.71 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.539 -0.726 . . . . 53.240000000000002 112.216 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.15 144.66 38.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.436 1.471 . . . . 73.409999999999997 114.162 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -48.84 -43.76 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 129.704 3.201 . . . . 63.310000000000002 111.675 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.3 p -64.2 -20.65 66.17 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.065 1.302 . . . . 61.219999999999999 111.48 -171.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.408 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -83.8 -10.41 58.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.793 1.034 . . . . 64.310000000000002 113.793 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.97 -60.22 11.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.995 0.918 . . . . 72.109999999999999 109.591 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -11.57 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.537 1.491 . . . . 71.140000000000001 113.776 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.05 -49.16 68.64 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.946 0.794 . . . . 72.239999999999995 109.461 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.29 74.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.722 -0.611 . . . . 61.450000000000003 111.424 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 87' ' ' ALA . 88.7 mt -58.37 -44.76 89.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.38 0.672 . . . . 73.349999999999994 109.514 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.35 -35.85 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 118.624 0.647 . . . . 54.450000000000003 112.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.94 4.07 10.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.363 1.065 . . . . 65.209999999999994 113.554 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.0 t -46.44 -27.12 0.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.433 1.493 . . . . 74.209999999999994 114.419 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -3.91 63.22 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.868 -1.145 . . . . 70.049999999999997 113.677 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -77.08 176.5 8.63 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 119.217 1.509 . . . . 60.43 110.488 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 86.5 1.57 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.525 1.13 . . . . 73.030000000000001 109.019 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.46 93.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.584 1.554 . . . . 55.32 109.784 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt 46.24 43.3 11.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.658 1.218 . . . . 64.230000000000004 110.772 -167.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.43 21.0 46.23 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.314 -0.866 . . . . 71.329999999999998 113.347 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 21' ' ' ALA . 21.5 t -118.7 85.87 28.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.85 1.66 . . . . 72.140000000000001 107.52 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.7 -179.44 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.299 1.999 . . . . 74.349999999999994 111.003 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.599 HG23 ' HA ' ' A' ' 74' ' ' THR . 14.9 tt -142.51 156.13 18.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.535 -0.913 . . . . 72.450000000000003 108.535 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.43 HD11 HE21 ' A' ' 19' ' ' GLN . 46.1 mm -108.26 143.37 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.417 1.487 . . . . 71.239999999999995 108.797 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.52 3.75 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.16 1.784 . . . . 62.140000000000001 114.481 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.29 -53.15 6.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.445 1.898 . . . . 72.219999999999999 112.46 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . 58.58 163.27 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.684 1.706 . . . . 61.119999999999997 112.872 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 104.208 -2.515 . . . . 70.010000000000005 104.208 168.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 116.187 1.921 . . . . 72.120000000000005 116.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -102.94 148.47 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.725 1.148 . . . . 64.329999999999998 109.734 -159.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -126.12 135.27 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.109 1.364 . . . . 72.430000000000007 109.635 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -100.25 106.61 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.499 1.12 . . . . 72.430000000000007 109.619 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -93.18 83.63 4.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.818 2.047 . . . . 55.310000000000002 109.221 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.7 ttp -91.21 41.37 1.06 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.3 0.852 . . . . 74.150000000000006 113.3 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -154.39 27.25 0.45 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.368 -1.458 . . . . 73.219999999999999 113.752 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 29' ' ' LEU . 10.6 mt -65.84 152.12 45.13 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.724 -0.61 . . . . 64.540000000000006 111.22 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.8 168.21 14.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.301 0.572 . . . . 71.120000000000005 111.531 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.67 66.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.026 1.121 . . . . 44.009999999999998 114.026 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -117.07 10.22 13.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.142 1.377 . . . . 73.530000000000001 111.434 -166.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -56.35 139.61 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.3 1.44 . . . . 73.519999999999996 111.659 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -87.82 161.46 44.39 Favored Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 124.32 1.048 . . . . 74.340000000000003 108.591 163.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.88 -44.61 38.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.044 1.829 . . . . 64.230000000000004 110.902 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -62.44 -23.28 66.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.135 -0.936 . . . . 73.230000000000004 112.724 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.53 -23.47 64.6 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.64 1.563 . . . . 53.149999999999999 111.719 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD11 HD22 ' A' ' 20' ' ' LEU . 2.3 mm? -80.44 -25.02 39.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.611 1.165 . . . . 53.229999999999997 112.893 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.0 -38.64 11.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.876 1.216 . . . . 75.530000000000001 109.606 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.52 -27.41 64.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.553 1.07 . . . . 75.540000000000006 112.683 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.02 -64.16 0.94 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.413 0.552 . . . . 72.549999999999997 109.77 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.0 -22.35 65.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.032 0.753 . . . . 75.140000000000001 113.032 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -64.29 -4.72 4.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.089 1.356 . . . . 71.129999999999995 111.094 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -53.33 -30.32 38.53 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.406 1.457 . . . . 64.450000000000003 110.66 161.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.5 m -144.68 65.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.492 1.517 . . . . 63.219999999999999 110.264 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.57 177.13 15.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 122.861 1.256 . . . . 75.310000000000002 115.003 149.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.741 ' HG3' HG21 ' A' ' 62' ' ' VAL . 1.3 ptpt -91.74 53.91 2.34 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.814 1.413 . . . . 74.420000000000002 114.814 -151.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.308 1.5 p -44.6 130.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.528 1.131 . . . . 73.420000000000002 110.854 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -85.11 -48.25 9.36 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 112.72 -2.036 . . . . 64.540000000000006 109.843 -155.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -161.47 155.69 22.52 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 124.971 1.419 . . . . 75.450000000000003 110.302 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.02 148.6 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.67 1.588 . . . . 52.420000000000002 107.717 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -138.84 121.8 16.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.147 -1.797 . . . . 75.319999999999993 106.147 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.2 ptp -143.36 166.73 23.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.659 0.784 . . . . 74.239999999999995 111.284 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.235 0.311 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 109.886 -168.72 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.712 0 CA-C-O 117.831 -1.539 . . . . 75.540000000000006 110.983 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.3 118.91 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.356 1.078 . . . . 71.230000000000004 110.166 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.28 34.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.125 1.37 . . . . 75.549999999999997 108.222 163.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.62 83.52 2.08 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.037 2.135 . . . . 73.540000000000006 107.131 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.292 1.6 p -90.29 144.5 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.055 1.342 . . . . 64.239999999999995 111.104 -170.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.84 97.71 5.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.991 0.901 . . . . 60.329999999999998 109.131 -155.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.01 172.92 2.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.914 1.816 . . . . 61.229999999999997 112.005 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 38' ' ' LYS . 4.0 m -89.87 -25.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 127.406 2.282 . . . . 61.520000000000003 112.075 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -138.42 142.81 39.52 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.154 1.782 . . . . 75.420000000000002 108.441 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.49 -22.38 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.857 0.863 . . . . 63.509999999999998 111.586 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 p -68.4 -20.33 64.66 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 120.671 -1.268 . . . . 52.25 111.868 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -74.65 -19.73 60.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.359 -0.838 . . . . 43.340000000000003 112.498 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.56 -57.27 28.15 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.086 -1.009 . . . . 75.530000000000001 110.622 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.42 -14.04 39.04 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.645 2.23 . . . . 72.329999999999998 113.075 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.72 -49.92 73.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.517 -0.92 . . . . 63.340000000000003 108.517 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.83 72.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.624 0.77 . . . . 42.030000000000001 111.894 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mt -55.83 -35.52 40.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.462 1.105 . . . . 72.230000000000004 110.216 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.69 -27.48 49.44 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.957 -0.913 . . . . 23.34 114.24 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mt -110.82 10.2 22.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.313 1.556 . . . . 74.219999999999999 112.455 -166.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 83' ' ' ILE . 10.1 t -44.7 -36.49 3.17 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.242 1.383 . . . . 63.32 113.194 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 -26.52 58.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.833 1.206 . . . . 63.340000000000003 113.316 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.99 158.29 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.979 0.889 . . . . 55.020000000000003 108.683 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -158.06 115.93 3.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.812 0.845 . . . . 74.510000000000005 109.426 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -77.46 125.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 106.97 -1.493 . . . . 71.230000000000004 106.97 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt 48.34 37.76 9.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.174 1.39 . . . . 62.310000000000002 112.823 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.92 28.61 64.4 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.493 -1.171 . . . . 53.140000000000001 113.874 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.66 85.51 7.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.336 1.854 . . . . 71.319999999999993 108.872 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.16 -170.68 0.97 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.77 2.313 . . . . 61.219999999999999 111.226 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.3 tt -144.65 159.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 121.404 -0.81 . . . . 61.240000000000002 111.48 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.28 141.19 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.145 -1.428 . . . . 64.120000000000005 107.145 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -52.48 -13.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.668 2.787 . . . . 61.439999999999998 116.036 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -44.5 -53.33 7.1 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.089 1.355 . . . . 74.239999999999995 113.859 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 38.45 29.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.722 1.209 . . . . 62.109999999999999 113.294 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.537 0.47 0 C-N-CA 124.737 1.215 . . . . 75.25 111.261 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 . . . . . 0 N--CA 1.453 -0.275 0 N-CA-C 116.767 2.136 . . . . 75.200000000000003 116.767 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -121.56 145.54 47.87 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.189 -1.411 . . . . 71.409999999999997 107.189 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.56 115.1 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.661 -1.978 . . . . 62.030000000000001 105.661 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -75.0 128.21 35.04 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.181 -1.785 . . . . 63.329999999999998 106.181 168.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -121.32 121.36 37.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 106.534 -1.654 . . . . 60.439999999999998 106.534 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.0 ttp -124.13 165.23 17.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.22 1.408 . . . . 75.409999999999997 107.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 75.31 12.17 3.31 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.028 2.131 . . . . 72.120000000000005 111.862 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.17 167.95 9.31 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.647 -0.658 . . . . 71.409999999999997 109.423 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.47 151.87 45.55 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.604 -0.685 . . . . 55.210000000000001 110.58 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.62 -4.19 25.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.155 0.982 . . . . 72.209999999999994 113.008 172.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.76 33.1 2.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.596 1.958 . . . . 74.049999999999997 110.374 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.97 138.58 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.049 -1.032 . . . . 74.420000000000002 108.768 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -77.91 153.48 80.36 Favored Pre-proline 0 N--CA 1.466 0.363 0 N-CA-C 108.218 -1.03 . . . . 74.019999999999996 108.218 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.37 0.9 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.395 2.73 . . . . 75.430000000000007 114.039 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -112.87 -5.25 13.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.941 1.246 . . . . 72.409999999999997 111.892 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.47 -30.44 64.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.6 -1.313 . . . . 63.439999999999998 108.729 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.48 -53.23 9.92 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.174 0.99 . . . . 55.409999999999997 110.195 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.54 -40.07 94.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.46 0.704 . . . . 61.100000000000001 110.524 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -67.87 -27.37 66.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.156 0.582 . . . . 75.409999999999997 112.067 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.26 -50.07 73.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.502 -0.285 . . . . 60.210000000000001 110.317 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -72.83 -28.26 62.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.88 0.764 . . . . 74.400000000000006 111.974 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 t -57.73 -20.36 34.04 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.632 1.973 . . . . 60.219999999999999 113.218 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -76.74 -15.85 59.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.149 -0.969 . . . . 63.299999999999997 111.268 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -136.98 11.54 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.031 0.932 . . . . 73.019999999999996 111.461 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.51 173.55 36.29 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 121.198 -0.939 . . . . 23.350000000000001 111.604 -160.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.76 137.12 29.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.532 -1.284 . . . . 64.239999999999995 107.532 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.24 131.8 65.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 125.92 1.688 . . . . 64.319999999999993 109.281 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -94.13 -42.54 8.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.048 -0.977 . . . . 72.200000000000003 110.879 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -167.41 158.45 11.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.783 2.033 . . . . 72.019999999999996 106.36 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 59' ' ' VAL . 29.5 m -133.95 163.85 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.26 1.824 . . . . 62.219999999999999 109.684 -173.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 136.79 10.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.181 -0.95 . . . . 73.439999999999998 109.235 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.4 ptp -136.11 135.55 39.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.273 0.942 . . . . 75.030000000000001 110.18 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.537 0.477 0 CA-C-N 116.07 -0.514 . . . . 71.329999999999998 112.352 -150.134 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 N-CA-C 110.389 -1.084 . . . . 73.319999999999993 110.389 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.38 131.54 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.205 1.802 . . . . 75.319999999999993 109.903 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.15 165.6 35.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.737 1.615 . . . . 61.32 108.55 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -124.07 146.12 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.425 -1.694 . . . . 72.400000000000006 106.425 165.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 42' ' ' VAL . 25.6 t -130.71 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.563 -1.643 . . . . 75.140000000000001 106.563 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -72.1 128.34 35.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.097 -1.446 . . . . 74.230000000000004 107.097 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.18 155.44 23.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 64.109999999999999 110.631 169.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.18 -26.99 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 117.996 -1.002 . . . . 72.329999999999998 110.187 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.13 150.43 50.52 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.191 1.36 . . . . 60.130000000000003 111.979 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.78 -34.54 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 117.986 -1.006 . . . . 75.140000000000001 111.806 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -69.99 -20.74 63.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.383 1.902 . . . . 74.340000000000003 112.411 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -89.94 -4.34 57.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.829 0.852 . . . . 75.129999999999995 112.443 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.29 -60.84 8.92 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 119.693 1.133 . . . . 71.299999999999997 109.787 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 -15.4 46.41 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 120.92 1.364 . . . . 52.539999999999999 113.381 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -55.22 35.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 120.547 -1.345 . . . . 74.439999999999998 110.145 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.82 -41.6 78.12 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.712 0.633 . . . . 71.310000000000002 111.253 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.01 -39.0 70.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.948 0.899 . . . . 72.310000000000002 110.36 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.58 -36.04 63.52 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.448 1.023 . . . . 74.310000000000002 112.905 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.6 12.75 1.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.574 1.15 . . . . 72.120000000000005 113.354 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.567 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -50.38 -28.23 7.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.298 1.439 . . . . 71.129999999999995 113.572 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.66 14.73 45.96 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.293 1.425 . . . . 75.219999999999999 112.914 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -93.71 170.4 9.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.261 1.03 . . . . 73.439999999999998 108.258 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -145.17 87.13 1.8 Allowed 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.635 -0.666 . . . . 73.140000000000001 109.978 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.94 110.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.708 -0.849 . . . . 61.25 108.708 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt 46.97 31.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.353 1.861 . . . . 62.450000000000003 112.979 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.42 19.43 27.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.781 0.705 . . . . 62.039999999999999 113.61 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.63 86.43 29.37 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.995 1.718 . . . . 60.450000000000003 109.165 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.23 173.79 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.456 2.104 . . . . 60.020000000000003 111.914 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.1 tt -140.17 143.33 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.466 1.107 . . . . 71.129999999999995 109.453 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.9 mm -86.14 144.34 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.715 0.806 . . . . 72.329999999999998 109.442 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.15 10.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 129.298 3.039 . . . . 51.219999999999999 115.471 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -25.66 64.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 114.782 1.401 . . . . 71.040000000000006 114.782 -154.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.83 164.03 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.692 2.797 . . . . 61.219999999999999 111.766 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 N-CA-C 106.135 -1.802 . . . . 55.240000000000002 106.135 167.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 116.943 2.201 . . . . 73.409999999999997 116.943 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -77.75 155.93 30.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.814 0.846 . . . . 64.329999999999998 111.47 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.09 179.29 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.499 1.52 . . . . 63.140000000000001 108.54 167.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -140.94 127.05 19.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.631 1.173 . . . . 70.200000000000003 110.048 -169.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.77 115.4 30.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.363 1.465 . . . . 72.5 107.451 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -128.87 32.59 4.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.623 1.569 . . . . 74.219999999999999 110.141 -174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -147.28 27.36 1.03 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.381 -1.449 . . . . 73.299999999999997 110.445 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 59.4 mt -68.03 155.19 40.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.949 1.3 . . . . 72.209999999999994 113.654 -172.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.13 -174.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.812 1.645 . . . . 44.100000000000001 110.085 163.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.92 19.57 10.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.139 1.376 . . . . 73.0 111.879 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -140.26 8.82 2.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.648 1.179 . . . . 73.239999999999995 111.366 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.9 tt -76.0 148.82 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.317 1.447 . . . . 74.030000000000001 108.82 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.26 152.23 88.04 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.033 -1.042 . . . . 62.100000000000001 109.083 170.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.06 -48.94 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.687 1.591 . . . . 73.299999999999997 111.198 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttp85 -64.13 -21.27 66.48 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.124 -0.941 . . . . 74.329999999999998 112.767 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.19 -33.3 72.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.576 1.535 . . . . 62.409999999999997 110.492 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.28 -23.25 54.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.094 -0.955 . . . . 65.409999999999997 111.86 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HB2' HG11 ' A' ' 39' ' ' VAL . 2.9 pt-20 -91.37 -33.48 15.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.19 0.904 . . . . 74.340000000000003 108.628 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.42 -36.56 76.11 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.272 1.829 . . . . 74.140000000000001 111.107 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -49.9 -62.45 1.56 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.126 0.97 . . . . 63.509999999999998 110.471 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.81 -17.61 64.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 65.510000000000005 111.833 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -2.33 6.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.727 1.01 . . . . 70.129999999999995 113.727 172.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -69.69 -34.58 74.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.416 1.462 . . . . 64.239999999999995 110.159 161.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -8.96 11.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 120.005 1.275 . . . . 64.510000000000005 113.806 -159.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.99 178.48 48.5 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.415 -0.674 . . . . 45.039999999999999 111.415 -160.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.64 135.75 54.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.892 1.346 . . . . 62.32 112.005 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 HG12 ' A' ' 59' ' ' VAL . 9.9 p -123.21 153.29 28.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 125.59 1.556 . . . . 51.32 109.614 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -97.35 -52.84 3.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.323 -1.762 . . . . 64.310000000000002 107.219 -166.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.13 -177.88 3.48 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.164 0.585 . . . . 72.219999999999999 110.267 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.05 149.52 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.199 1.0 . . . . 72.310000000000002 110.259 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -124.91 159.58 30.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.096 1.358 . . . . 70.430000000000007 109.735 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.1 ptp -138.6 132.0 30.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.771 1.228 . . . . 54.299999999999997 107.88 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HB ' HD13 ' A' ' 56' ' ' ILE . 3.6 mp . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 107.256 -1.387 . . . . 54.399999999999999 107.256 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.233 0 N-CA-C 109.452 -1.459 . . . . 71.299999999999997 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.592 HD13 ' HB ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -142.96 141.15 27.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.926 1.29 . . . . 61.399999999999999 109.182 -169.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.82 152.43 28.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.41 1.084 . . . . 70.230000000000004 108.927 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -124.95 146.1 49.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.553 1.541 . . . . 72.439999999999998 107.339 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 39' ' ' VAL . 1.8 t -130.8 115.27 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.869 -1.16 . . . . 73.519999999999996 107.869 -161.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -85.9 96.57 9.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.884 0.873 . . . . 74.430000000000007 109.61 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -59.69 157.22 12.3 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 120.029 -1.67 . . . . 74.510000000000005 113.45 166.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.99 -29.19 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 109.702 -0.481 . . . . 74.319999999999993 109.702 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.44 144.83 42.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.97 1.308 . . . . 62.109999999999999 110.001 -171.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 p -72.91 -21.9 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 112.527 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -59.26 -22.64 61.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.621 -1.3 . . . . 73.109999999999999 113.755 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m -93.27 -2.08 55.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.801 0.84 . . . . 72.230000000000004 113.094 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.42 -58.35 19.2 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 120.211 -1.556 . . . . 65.5 110.135 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.01 -14.63 44.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 CA-C-N 121.383 1.53 . . . . 74.329999999999998 112.683 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -41.34 94.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.336 -0.853 . . . . 74.510000000000005 108.762 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.79 -28.54 66.06 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.868 0.867 . . . . 62.409999999999997 112.966 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.5 mt -63.49 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 118.966 0.803 . . . . 70.510000000000005 109.076 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.39 -14.3 59.59 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.549 -0.72 . . . . 30.449999999999999 113.794 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.89 -0.79 41.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.508 1.154 . . . . 73.420000000000002 112.287 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -45.54 -45.62 13.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.872 1.269 . . . . 74.420000000000002 111.524 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.67 4.94 79.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.809 0.718 . . . . 71.209999999999994 114.245 -168.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -78.91 -171.14 2.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.505 1.152 . . . . 73.299999999999997 108.929 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.43 121.03 4.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.985 -1.487 . . . . 73.099999999999994 106.985 176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 97.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.287 -1.375 . . . . 72.420000000000002 107.287 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 mt 53.08 16.23 0.72 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.719 1.607 . . . . 70.420000000000002 113.439 -170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.99 7.29 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.132 0.872 . . . . 53.32 113.137 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 20' ' ' LEU . 82.4 t -107.26 86.61 2.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.724 2.01 . . . . 61.299999999999997 111.222 -174.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.76 175.84 1.58 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.157 1.904 . . . . 51.340000000000003 111.557 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.6 tt -127.19 163.96 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 O-C-N 121.53 -0.731 . . . . 62.409999999999997 110.278 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 86' ' ' GLN . 49.2 mm -99.87 140.25 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.743 -1.577 . . . . 62.229999999999997 106.743 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -44.92 -24.97 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.085 2.154 . . . . 74.209999999999994 114.83 170.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.516 ' H ' HG22 ' A' ' 84' ' ' ILE . 13.1 mt-30 -44.1 -51.7 7.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.123 1.769 . . . . 73.420000000000002 113.331 -162.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.33 48.75 18.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.798 1.239 . . . . 74.200000000000003 112.376 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 108.271 -1.011 . . . . 73.140000000000001 108.271 -174.332 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 114.562 1.319 . . . . 73.239999999999995 114.562 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.02 165.58 27.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.036 -1.468 . . . . 72.510000000000005 107.036 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.76 -178.5 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.936 0.895 . . . . 71.430000000000007 109.536 163.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.73 102.17 3.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.404 1.097 . . . . 75.430000000000007 110.573 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.5 m -87.66 94.94 9.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.384 1.874 . . . . 70.510000000000005 109.117 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.4 ttp -108.17 44.85 1.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.769 1.227 . . . . 63.520000000000003 110.207 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -164.8 68.3 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 72.200000000000003 110.36 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.39 166.1 10.92 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.364 -0.835 . . . . 74.340000000000003 111.367 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.9 171.55 7.58 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.627 1.171 . . . . 45.200000000000003 110.654 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.85 -30.94 65.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.266 0.839 . . . . 74.400000000000006 113.266 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.63 51.5 1.92 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.365 1.066 . . . . 62.439999999999998 108.959 -170.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 tt -80.47 154.13 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.772 -0.825 . . . . 71.200000000000003 108.772 170.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -111.76 160.59 29.1 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 107.802 -1.184 . . . . 72.540000000000006 107.802 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -59.96 -21.43 64.69 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.031 1.821 . . . . 73.319999999999993 112.436 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -34.5 73.0 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.963 -1.086 . . . . 71.109999999999999 112.297 173.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -34.31 74.74 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.874 1.216 . . . . 63.310000000000002 111.747 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' HG11 ' A' ' 59' ' ' VAL . 2.2 mm? -64.5 -41.8 96.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.558 0.743 . . . . 74.409999999999997 110.124 -174.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.77 -35.12 29.94 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.221 -0.895 . . . . 62.439999999999998 109.99 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -63.92 -24.31 67.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.597 1.089 . . . . 72.129999999999995 111.253 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -65.46 -67.6 0.43 Allowed 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.874 -0.516 . . . . 73.510000000000005 110.388 168.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -71.4 -19.7 62.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.552 0.945 . . . . 65.299999999999997 113.552 -167.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 t -51.72 -28.64 15.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.96 1.304 . . . . 74.510000000000005 110.798 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.418 HG23 HG13 ' A' ' 36' ' ' VAL . 1.3 t -77.02 -14.94 59.77 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.146 -0.971 . . . . 62.109999999999999 110.987 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 35' ' ' THR . 31.2 m -131.36 -4.19 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.261 1.024 . . . . 72.230000000000004 113.358 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.15 -156.83 12.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.662 -1.375 . . . . 72.209999999999994 109.662 -174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -145.3 139.33 27.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.421 1.111 . . . . 73.519999999999996 110.985 166.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 t -71.17 143.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.925 1.69 . . . . 73.439999999999998 108.778 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -82.44 -50.6 8.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.013 -1.054 . . . . 54.119999999999997 109.606 163.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.58 124.06 11.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.275 0.488 . . . . 63.219999999999999 110.817 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.6 t -73.7 108.17 4.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 O-C-N 121.404 -0.81 . . . . 62.409999999999997 109.343 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -104.91 82.58 1.89 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.863 1.265 . . . . 71.200000000000003 108.129 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 153.57 23.4 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.613 0.765 . . . . 74.200000000000003 109.003 167.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 108.155 -1.054 . . . . 63.439999999999998 108.155 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 N-CA-C 109.606 -1.398 . . . . 62.219999999999999 109.606 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 pt -145.56 137.36 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.1 1.36 . . . . 74.120000000000005 110.152 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.61 135.19 29.76 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.601 -1.259 . . . . 64.400000000000006 107.601 163.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -122.11 70.77 0.98 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.625 -1.25 . . . . 75.200000000000003 107.625 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 29' ' ' LEU . 3.1 m -67.35 135.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.539 0.685 . . . . 61.100000000000001 109.772 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.61 145.06 31.89 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.809 -1.182 . . . . 73.340000000000003 107.809 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.18 151.33 24.9 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 113.319 0.859 . . . . 73.439999999999998 113.319 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 -43.6 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.31 -0.859 . . . . 70.299999999999997 109.104 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.38 142.64 46.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.518 1.127 . . . . 73.519999999999996 109.71 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.97 -36.66 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 111.827 0.306 . . . . 50.299999999999997 111.827 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -62.6 -23.51 67.08 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.148 -0.97 . . . . 74.099999999999994 113.065 -166.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -77.07 -13.12 60.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.945 0.898 . . . . 54.140000000000001 113.07 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.98 -56.48 25.22 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.866 1.666 . . . . 62.310000000000002 111.723 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.63 -12.41 34.98 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 121.997 1.798 . . . . 64.230000000000004 113.635 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.26 -47.93 66.43 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.009 -1.057 . . . . 52.439999999999998 109.231 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.57 69.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.372 0.669 . . . . 62.329999999999998 112.395 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 85' ' ' VAL . 65.9 mt -57.32 -41.4 78.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.754 0.822 . . . . 73.510000000000005 109.362 176.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.85 -18.46 56.92 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.56 -0.578 . . . . 74.540000000000006 112.865 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -101.34 9.44 41.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.708 1.203 . . . . 71.319999999999993 111.554 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -51.64 -30.02 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.69 1.132 . . . . 61.100000000000001 113.383 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.91 5.41 27.39 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.161 1.362 . . . . 63.100000000000001 112.796 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.95 174.95 8.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.779 1.29 . . . . 62.409999999999997 108.275 155.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 130.15 10.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.83 1.252 . . . . 73.340000000000003 108.642 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.19 115.52 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.819 -1.919 . . . . 65.200000000000003 105.819 162.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.65 3.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.737 2.125 . . . . 63.520000000000003 116.737 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.72 7.27 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.736 1.153 . . . . 42.240000000000002 113.923 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.39 86.99 2.97 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 128.323 2.649 . . . . 72.219999999999999 109.675 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.77 -176.67 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.791 2.327 . . . . 74.409999999999997 111.549 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.5 tt -136.77 167.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 121.19 -0.944 . . . . 71.239999999999995 109.715 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 86' ' ' GLN . 39.8 mm -111.95 144.72 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.671 -1.603 . . . . 72.109999999999999 106.671 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 71' ' ' ILE . 28.2 t -57.34 -13.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.508 1.923 . . . . 73.099999999999994 112.832 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.491 ' H ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -52.42 -26.68 13.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.001 2.52 . . . . 75.5 115.419 -171.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 43.32 89.92 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.352 1.461 . . . . 54.039999999999999 112.132 155.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 107.723 -1.214 . . . . 62.509999999999998 107.723 173.545 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.657 0.265 . . . . 73.549999999999997 111.164 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.63 150.67 49.7 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.909 -1.119 . . . . 74.349999999999994 109.664 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 61' ' ' PHE . 28.1 m -133.71 171.7 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.357 1.463 . . . . 72.519999999999996 107.557 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.92 142.16 30.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.258 1.423 . . . . 75.209999999999994 108.238 -166.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.7 m -130.21 103.28 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.148 1.379 . . . . 64.519999999999996 109.858 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.1 ttm -92.83 -0.34 57.27 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.797 1.036 . . . . 72.120000000000005 113.797 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -128.18 29.08 5.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.278 1.214 . . . . 52.32 114.278 -163.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.401 ' HA ' HG13 ' A' ' 81' ' ' VAL . 87.0 mt -73.34 151.53 41.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.355 1.062 . . . . 74.099999999999994 113.632 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.21 165.72 17.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.549 1.14 . . . . 72.099999999999994 112.95 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.084 1.354 . . . . 74.140000000000001 113.542 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.98 47.09 1.96 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.26 1.024 . . . . 74.109999999999999 110.755 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.51 154.49 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 120.995 -1.065 . . . . 74.219999999999999 109.05 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -114.98 157.87 42.23 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 127.439 2.296 . . . . 72.310000000000002 107.738 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.21 -19.89 69.58 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.805 1.67 . . . . 74.420000000000002 112.182 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 1.5 ptp180 -76.71 -29.95 56.46 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.363 -0.827 . . . . 73.340000000000003 112.259 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -61.89 -25.19 67.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.491 1.041 . . . . 75.129999999999995 111.061 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' H ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -78.11 -54.24 6.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.915 0.886 . . . . 75.340000000000003 109.07 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.57 -33.29 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 117.693 -1.146 . . . . 73.420000000000002 111.347 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.02 0.827 . . . . 74.5 109.53 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CG ' HG21 ' A' ' 78' ' ' VAL . 9.0 t80 -52.79 -48.21 67.03 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 122.684 0.394 . . . . 61.140000000000001 110.718 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -80.04 -14.46 58.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.199 -1.0 . . . . 75.5 112.103 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 t -64.97 -17.25 64.25 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.362 1.437 . . . . 55.009999999999998 110.848 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 p -73.16 -21.77 60.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.779 1.172 . . . . 71.430000000000007 111.037 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.43 -7.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.641 1.576 . . . . 71.420000000000002 112.736 -166.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.37 18.46 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.114 1.34 . . . . 22.420000000000002 111.003 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -147.87 134.41 19.78 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.68 1.192 . . . . 73.420000000000002 110.573 -168.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.0 t -105.5 144.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.293 1.837 . . . . 71.299999999999997 108.395 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.71 -54.93 2.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.275 1.43 . . . . 72.430000000000007 108.378 172.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.56 165.04 27.91 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 124.162 0.914 . . . . 64.109999999999999 110.982 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.01 110.26 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.946 2.098 . . . . 71.209999999999994 106.502 -160.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -143.71 81.34 1.69 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.041 0.837 . . . . 64.140000000000001 110.047 -160.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.1 mtp -88.41 160.77 17.41 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 122.671 1.224 . . . . 64.329999999999998 110.429 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.7 mm . . . . . 0 N--CA 1.433 -1.322 0 C-N-CA 124.823 1.249 . . . . 60.119999999999997 107.917 179.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.212 0 N-CA-C 110.416 -1.074 . . . . 74.310000000000002 110.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -145.65 153.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.288 1.044 . . . . 73.519999999999996 110.732 171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.8 40.78 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.976 1.31 . . . . 63.329999999999998 109.144 168.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -122.28 154.83 37.05 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 75.25 106.783 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 t -134.67 134.46 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.184 -2.154 . . . . 75.25 105.184 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.55 109.09 20.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.625 -1.991 . . . . 72.209999999999994 105.625 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' A' ' 15' ' ' VAL . 3.5 m-30 -73.18 168.97 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.522 0.729 . . . . 71.530000000000001 109.296 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.43 -38.67 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 120.538 -0.465 . . . . 62.329999999999998 109.85 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.11 128.15 45.2 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.651 0.659 . . . . 71.219999999999999 110.447 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.82 -37.76 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 72.349999999999994 111.474 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -5.5 54.27 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.685 -1.259 . . . . 63.420000000000002 112.336 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.9 m -90.88 -12.06 37.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.232 -0.918 . . . . 74.340000000000003 111.824 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.5 t -54.58 -57.63 17.99 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.369 0.986 . . . . 75.219999999999999 110.089 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.86 -22.61 68.88 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.228 1.952 . . . . 73.530000000000001 113.872 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.21 -52.26 59.73 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.771 -0.826 . . . . 72.239999999999995 108.771 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.86 78.57 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.217 0.607 . . . . 74.5 111.328 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.87 -44.51 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.563 0.745 . . . . 75.109999999999999 109.385 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.92 -10.64 27.05 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.764 0.697 . . . . 40.299999999999997 114.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.41 5.84 50.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.555 1.178 . . . . 72.129999999999995 111.932 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.679 ' HA ' HG23 ' A' ' 83' ' ' ILE . 8.9 t -44.46 -45.75 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.996 1.718 . . . . 74.120000000000005 112.876 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.86 2.93 84.67 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.738 -1.034 . . . . 62.109999999999999 113.703 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.06 -176.59 2.16 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.508 1.654 . . . . 74.129999999999995 109.317 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -157.45 81.69 0.9 Allowed 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.829 0.851 . . . . 71.219999999999999 109.502 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 32' ' ' PHE . 60.7 t -58.47 102.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.487 1.115 . . . . 51.310000000000002 108.541 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt 56.51 25.03 9.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.53 0.332 . . . . 71.109999999999999 111.677 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.73 -6.41 25.99 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.237 -1.313 . . . . 54.130000000000003 113.706 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 20' ' ' LEU . 59.1 t -104.7 86.7 1.52 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.546 1.938 . . . . 64.299999999999997 111.915 -168.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.08 -179.58 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.76 2.307 . . . . 71.439999999999998 111.635 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -141.83 168.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.424 0.689 . . . . 53.020000000000003 109.278 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.8 mm -112.45 137.66 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.606 1.562 . . . . 63.439999999999998 106.968 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.31 -2.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 129.731 3.212 . . . . 74.230000000000004 117.058 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -62.03 -33.2 73.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.999 1.851 . . . . 72.120000000000005 115.999 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.65 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 123.515 1.626 . . . . 51.030000000000001 110.709 -162.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.893 0 CA-C-N 114.067 -1.424 . . . . 71.409999999999997 107.616 156.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 . . . . . 0 N--CA 1.465 0.308 0 N-CA-C 112.116 0.413 . . . . 61.340000000000003 112.116 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -66.7 126.98 30.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.857 -1.164 . . . . 64.310000000000002 107.857 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 174.2 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.528 -0.916 . . . . 73.239999999999995 108.528 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.7 98.39 3.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.624 1.202 . . . . 74.230000000000004 110.707 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' HB3' HD21 ' A' ' 20' ' ' LEU . 62.0 m -80.93 88.14 5.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.559 1.543 . . . . 52.030000000000001 108.541 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttp -90.94 13.12 17.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.988 0.915 . . . . 55.210000000000001 112.397 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 20' ' ' LEU . 6.0 mt-30 -133.38 94.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.493 -1.38 . . . . 53.030000000000001 107.872 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 29' ' ' LEU . 12.1 mt -118.28 157.51 26.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.578 0.351 . . . . 55.25 111.577 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.43 160.56 32.13 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.011 0.91 . . . . 72.319999999999993 110.055 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.64 5.29 13.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.948 1.699 . . . . 71.140000000000001 114.103 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.71 64.12 1.0 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.012 1.278 . . . . 75.120000000000005 108.21 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 tt -109.83 136.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.712 1.205 . . . . 73.439999999999998 109.532 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -77.2 149.07 78.93 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 107.63 -1.248 . . . . 73.049999999999997 107.63 165.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.85 -32.82 93.13 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.238 1.292 . . . . 72.319999999999993 111.158 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttp85 -66.73 -20.8 66.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.074 -0.965 . . . . 63.329999999999998 112.507 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.5 -29.0 70.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.737 1.608 . . . . 73.129999999999995 109.679 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 2.4 mm? -77.67 -48.58 16.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.936 0.895 . . . . 75.129999999999995 109.754 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.14 -37.29 80.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.896 0.316 . . . . 74.319999999999993 110.996 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.823 0.849 . . . . 72.019999999999996 111.314 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -57.27 -46.13 83.38 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.498 0.59 . . . . 55.240000000000002 110.311 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -68.23 -26.62 65.79 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.612 -0.68 . . . . 73.140000000000001 112.667 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -15.33 34.99 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.655 1.182 . . . . 72.230000000000004 112.804 -173.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -61.81 -18.6 60.55 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.425 -0.797 . . . . 62.43 111.679 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.81 24.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.2 1.0 . . . . 62.200000000000003 110.401 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.3 -161.77 27.36 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.201 1.364 . . . . 72.040000000000006 115.371 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.57 146.37 28.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.34 1.856 . . . . 75.319999999999993 108.644 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.21 150.55 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 127.175 2.19 . . . . 73.030000000000001 107.963 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -82.04 -56.69 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.608 1.563 . . . . 73.319999999999993 109.282 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -159.43 134.64 8.25 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.132 -0.692 . . . . 72.230000000000004 109.132 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.43 162.27 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.397 1.879 . . . . 72.010000000000005 111.205 164.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.78 112.1 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.335 2.254 . . . . 75.030000000000001 107.81 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.0 ptp -116.76 147.8 41.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.874 1.216 . . . . 75.430000000000007 110.556 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.3 mp . . . . . 0 C--O 1.238 0.467 0 N-CA-C 107.886 -1.154 . . . . 52.009999999999998 107.886 -166.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 108.372 -1.891 . . . . 75.25 108.372 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.44 135.02 30.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.047 0.939 . . . . 74.310000000000002 108.941 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.78 147.78 21.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.329 1.852 . . . . 55.210000000000001 108.174 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -122.27 123.2 40.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.116 -1.809 . . . . 75.439999999999998 106.116 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.73 140.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 121.986 2.175 . . . . 75.140000000000001 108.057 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.05 115.57 12.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.9 -1.889 . . . . 71.319999999999993 105.9 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.21 160.57 22.98 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.307 0.958 . . . . 75.219999999999999 110.35 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.64 -27.94 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 118.629 -0.7 . . . . 74.209999999999994 110.759 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -114.73 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.888 1.222 . . . . 63.140000000000001 110.217 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.68 -28.02 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.857 1.263 . . . . 71.230000000000004 110.587 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -68.99 -17.31 63.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.861 1.21 . . . . 73.109999999999999 110.56 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -70.47 -23.55 62.71 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.604 1.562 . . . . 72.510000000000005 113.923 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.07 -56.29 37.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.422 -0.799 . . . . 44.43 110.11 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.17 -13.26 39.05 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.611 1.541 . . . . 74.200000000000003 113.2 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.11 -48.01 69.43 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.798 1.181 . . . . 60.140000000000001 109.839 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.56 78.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.454 0.57 . . . . 44.200000000000003 111.446 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.77 -39.47 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.967 0.907 . . . . 64.140000000000001 110.016 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.92 -0.09 40.52 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.603 -1.109 . . . . 60.109999999999999 114.025 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.12 2.63 19.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.805 1.802 . . . . 74.439999999999998 111.794 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 83' ' ' ILE . 15.1 t -50.45 -33.03 19.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.64 1.176 . . . . 74.129999999999995 113.54 -171.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.78 21.9 26.92 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.725 1.155 . . . . 64.510000000000005 113.848 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.93 174.22 8.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.213 1.507 . . . . 73.340000000000003 108.176 153.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -159.87 85.74 0.76 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.384 0.993 . . . . 74.510000000000005 112.717 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.0 m -60.37 117.59 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.734 -0.469 . . . . 71.200000000000003 109.734 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.3 mt 51.31 31.03 6.52 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.589 1.156 . . . . 63.140000000000001 112.534 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.51 27.67 29.3 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.226 -0.763 . . . . 54.25 113.044 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 t -121.15 84.79 40.57 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.931 1.365 . . . . 75.230000000000004 109.619 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.32 177.54 5.17 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.285 2.657 . . . . 75.310000000000002 112.018 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.1 tt -132.69 144.4 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.477 -0.764 . . . . 75.439999999999998 109.695 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 86' ' ' GLN . 41.3 mm -86.52 142.54 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.507 -0.923 . . . . 71.329999999999998 108.507 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.53 -3.91 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 114.691 1.367 . . . . 72.209999999999994 114.691 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 84' ' ' ILE . 2.1 mm100 -46.45 -51.41 15.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.192 1.797 . . . . 72.409999999999997 113.887 -168.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.01 174.34 0.07 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.282 1.433 . . . . 73.510000000000005 110.281 -169.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 106.753 -1.573 . . . . 72.510000000000005 106.753 153.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.562 0.579 . . . . 73.030000000000001 112.562 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -70.84 149.17 47.09 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.878 0.847 . . . . 53.409999999999997 110.279 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.0 114.76 45.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 122.279 1.038 . . . . 65.010000000000005 108.45 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.93 104.75 14.27 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.471 -1.24 . . . . 73.209999999999994 108.829 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -92.27 121.11 33.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.151 -1.426 . . . . 51.130000000000003 107.151 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 ttm -125.53 18.79 8.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.267 1.027 . . . . 72.120000000000005 111.474 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.11 22.03 3.79 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.617 -1.302 . . . . 74.349999999999994 111.725 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.777 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.7 mt -77.44 164.51 25.4 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.546 0.573 . . . . 64.409999999999997 112.546 -168.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.4 26.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.735 1.214 . . . . 71.430000000000007 110.709 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 14.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.143 2.177 . . . . 73.030000000000001 114.929 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.91 16.69 2.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.95 1.25 . . . . 63.399999999999999 114.153 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.98 145.0 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.639 -1.288 . . . . 73.120000000000005 110.965 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -83.61 156.74 65.04 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-O 118.129 -0.939 . . . . 70.129999999999995 109.489 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.41 -37.12 74.13 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.138 1.892 . . . . 74.340000000000003 111.582 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.14 -28.48 68.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.684 -1.151 . . . . 65.129999999999995 111.982 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -33.47 69.72 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.866 1.666 . . . . 71.439999999999998 111.024 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.2 -29.75 69.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.458 1.103 . . . . 71.030000000000001 110.712 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.6 pt-20 -92.42 -30.87 15.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.937 0.895 . . . . 73.120000000000005 110.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.16 -44.68 92.14 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.486 1.514 . . . . 64.209999999999994 110.864 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.33 -63.75 1.04 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.487 1.515 . . . . 63.200000000000003 109.777 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.02 -22.5 61.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.266 0.469 . . . . 74.5 112.266 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -19.27 64.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.614 1.097 . . . . 74.310000000000002 111.443 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.8 p -61.24 -35.31 76.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.332 0.969 . . . . 61.140000000000001 111.077 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.0 8.42 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.934 2.494 . . . . 70.219999999999999 109.94 -167.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.19 -140.73 6.18 Favored Glycine 0 N--CA 1.442 -0.914 0 O-C-N 120.635 -1.29 . . . . 63.439999999999998 110.772 -162.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -152.83 -173.43 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.53 1.932 . . . . 73.109999999999999 106.808 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 30' ' ' GLU . 24.3 t -143.99 149.35 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 129.712 3.205 . . . . 71.019999999999996 106.169 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -62.89 1.54 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.724 -1.213 . . . . 65.420000000000002 107.724 167.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -158.99 162.25 36.76 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.876 -0.787 . . . . 63.0 108.876 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.78 128.67 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.952 1.701 . . . . 74.030000000000001 106.457 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -123.35 74.26 1.23 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.417 1.087 . . . . 73.329999999999998 109.002 170.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 130.87 35.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.639 2.376 . . . . 51.32 109.665 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.455 -0.207 0 N-CA-C 106.31 -1.737 . . . . 71.420000000000002 106.31 174.232 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 111.413 -0.675 . . . . 71.450000000000003 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -135.09 130.32 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 74.140000000000001 111.177 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.56 151.4 25.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.747 1.219 . . . . 65.010000000000005 111.175 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -127.5 80.99 1.99 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.627 1.171 . . . . 72.129999999999995 109.748 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.395 1.5 p -81.8 121.68 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.452 -1.405 . . . . 72.409999999999997 110.585 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.66 137.58 33.17 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.637 1.575 . . . . 73.109999999999999 109.989 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.46 160.79 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.965 0.888 . . . . 71.219999999999999 111.836 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.53 -16.24 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 126.531 1.933 . . . . 70.409999999999997 111.209 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -128.56 170.22 13.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.028 1.731 . . . . 71.209999999999994 108.806 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.99 -28.35 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.542 1.537 . . . . 72.040000000000006 111.032 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -77.89 -14.57 59.51 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.459 -1.401 . . . . 72.420000000000002 112.122 -167.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -89.08 -0.49 57.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.139 0.975 . . . . 74.299999999999997 112.613 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.86 -56.73 27.09 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 120.83 1.65 . . . . 44.130000000000003 109.425 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -14.81 46.0 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.953 1.769 . . . . 73.239999999999995 114.166 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.57 -59.61 4.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.218 1.372 . . . . 70.510000000000005 108.488 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.95 59.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.379 1.072 . . . . 71.5 112.241 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' VAL . 56.7 mt -57.41 -54.61 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.964 0.906 . . . . 70.530000000000001 108.622 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.52 -0.4 11.82 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.916 -0.936 . . . . 70.439999999999998 113.818 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -100.61 1.79 41.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.119 1.959 . . . . 73.239999999999995 111.295 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -49.45 -30.6 8.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.12 1.327 . . . . 73.299999999999997 114.344 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.38 2.43 56.24 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.405 1.002 . . . . 63.119999999999997 114.181 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.96 175.57 8.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.234 1.517 . . . . 72.310000000000002 108.517 164.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -152.63 131.76 12.7 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.278 -0.889 . . . . 74.5 110.057 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -83.61 90.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.425 -1.695 . . . . 62.399999999999999 106.425 170.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mt 59.81 37.34 21.94 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.869 0.842 . . . . 73.129999999999995 110.406 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.72 3.32 58.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.997 1.284 . . . . 74.209999999999994 114.581 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 20' ' ' LEU . 96.8 t -108.49 85.96 3.21 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.8 1.64 . . . . 74.340000000000003 109.801 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.07 -178.31 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.353 2.702 . . . . 73.129999999999995 112.608 168.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.438 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -134.33 148.75 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.063 0.945 . . . . 70.400000000000006 110.233 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 86' ' ' GLN . 46.0 mm -91.27 140.57 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.516 -1.29 . . . . 73.420000000000002 107.516 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 71' ' ' ILE . 24.8 t -51.19 -18.75 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.917 2.087 . . . . 70.310000000000002 114.795 171.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 84' ' ' ILE . 7.6 mm100 -44.31 -47.41 9.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 125.662 1.585 . . . . 70.109999999999999 113.276 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.05 49.86 16.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.707 0.803 . . . . 63.439999999999998 112.118 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.307 24.2 p . . . . . 0 CA--C 1.537 0.451 0 C-N-CA 125.26 1.424 . . . . 65.540000000000006 110.568 -170.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 72.349999999999994 116.224 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.1 m -107.54 157.08 18.32 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 119.961 -1.712 . . . . 54.439999999999998 109.495 -161.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.78 174.83 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.475 -0.766 . . . . 45.149999999999999 109.52 170.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -138.73 133.83 32.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.686 1.594 . . . . 72.439999999999998 107.36 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.6 m -127.31 121.99 32.57 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.32 -2.104 . . . . 65.549999999999997 105.32 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.3 ttp -125.32 14.31 8.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.11 0.964 . . . . 65.140000000000001 111.635 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -139.75 33.77 2.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.045 1.338 . . . . 63.140000000000001 109.982 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 mt -64.95 145.04 56.86 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.751 -0.593 . . . . 62.210000000000001 110.771 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -66.6 162.63 20.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.071 0.939 . . . . 64.510000000000005 109.496 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.17 59.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.446 -1.252 . . . . 70.140000000000001 114.31 -166.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -145.87 65.35 1.22 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.489 1.04 . . . . 73.239999999999995 108.762 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.9 tt -96.97 163.57 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 122.818 0.447 . . . . 73.319999999999993 110.387 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -108.52 155.48 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 125.779 1.632 . . . . 72.549999999999997 108.72 168.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 -36.51 93.07 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.396 2.064 . . . . 74.120000000000005 111.979 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -60.99 -32.95 72.5 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.962 -1.018 . . . . 61.409999999999997 111.612 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -72.52 -11.73 60.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.232 1.378 . . . . 74.129999999999995 112.865 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.26 -44.99 9.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.666 -0.865 . . . . 55.43 108.666 169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.8 pt-20 -65.71 -38.22 88.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.508 0.594 . . . . 73.530000000000001 111.518 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.5 -25.8 63.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.112 1.365 . . . . 75.530000000000001 112.651 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.28 -64.13 1.02 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.689 -1.226 . . . . 73.510000000000005 107.689 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.35 -27.68 69.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.78 1.029 . . . . 75.209999999999994 113.78 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 p -67.27 -3.22 7.36 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.991 1.269 . . . . 63.219999999999999 113.523 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -55.14 -27.88 48.66 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.754 1.161 . . . . 73.430000000000007 111.005 165.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -139.83 43.59 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.383 1.073 . . . . 72.209999999999994 110.861 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.03 -141.5 8.86 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.014 -1.234 . . . . 72.540000000000006 110.014 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -148.0 157.55 43.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.164 -1.05 . . . . 64.420000000000002 108.164 174.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 30' ' ' GLU . 67.0 t -91.98 163.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.518 -0.739 . . . . 53.009999999999998 109.194 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -122.31 -31.16 3.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.037 -1.459 . . . . 72.319999999999993 111.582 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -164.18 172.51 13.57 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.841 1.655 . . . . 54.25 109.196 159.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.55 126.0 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.515 1.926 . . . . 70.239999999999995 108.014 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.13 175.48 5.51 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.28 1.432 . . . . 74.530000000000001 109.929 169.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.3 ptp -166.29 154.93 10.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.898 1.679 . . . . 73.329999999999998 109.407 161.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.504 0.669 . . . . 64.209999999999994 109.923 -172.409 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.494 0 N-CA-C 108.786 -1.726 . . . . 33.530000000000001 108.786 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.71 122.73 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.363 1.465 . . . . 54.420000000000002 109.795 -168.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.89 150.87 37.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.258 1.023 . . . . 70.140000000000001 109.825 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.57 154.83 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.404 -2.073 . . . . 70.519999999999996 105.404 161.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.21 118.03 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.962 -2.236 . . . . 70.510000000000005 104.962 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -82.76 122.75 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.869 1.267 . . . . 72.439999999999998 108.638 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -96.42 176.22 6.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.801 0.81 . . . . 72.530000000000001 111.279 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.536 HG21 ' HG3' ' A' ' 38' ' ' LYS . 19.5 m -86.03 -24.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.358 1.863 . . . . 72.430000000000007 112.808 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -133.39 177.37 7.74 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.966 1.706 . . . . 51.439999999999998 111.4 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.46 -27.01 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.713 1.205 . . . . 72.209999999999994 111.59 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -67.73 -21.78 65.27 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.011 -1.055 . . . . 73.329999999999998 112.488 -166.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m -87.56 -9.58 54.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.523 -1.227 . . . . 71.439999999999998 113.146 172.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.7 -58.93 8.46 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 122.784 2.538 . . . . 74.340000000000003 109.895 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.03 -6.13 18.0 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.492 2.128 . . . . 73.219999999999999 114.783 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -70.59 -43.47 69.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.684 1.129 . . . . 72.010000000000005 109.395 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -25.61 47.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.999 0.92 . . . . 32.140000000000001 112.756 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.51 -46.03 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.976 0.911 . . . . 63.439999999999998 109.379 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.36 -1.52 43.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.205 -0.775 . . . . 61.049999999999997 113.985 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.26 4.2 33.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.934 1.367 . . . . 73.329999999999998 110.867 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -55.09 -20.3 9.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.944 1.298 . . . . 70.230000000000004 113.733 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.43 9.86 42.1 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.873 -0.959 . . . . 74.040000000000006 113.411 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -81.4 -179.98 7.6 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.754 1.277 . . . . 74.420000000000002 110.38 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -159.2 88.61 0.89 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.693 -0.629 . . . . 64.310000000000002 109.997 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.728 ' O ' HG12 ' A' ' 81' ' ' VAL . 57.3 t -68.28 110.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.098 -1.445 . . . . 73.530000000000001 107.098 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.7 mt 55.02 21.5 3.81 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.649 -0.657 . . . . 44.219999999999999 112.0 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.98 1.22 27.0 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.398 -1.779 . . . . 70.420000000000002 115.047 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 78' ' ' VAL . 7.1 p -108.15 85.95 2.97 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 120.723 2.261 . . . . 74.409999999999997 111.563 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.42 162.63 29.83 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.343 2.028 . . . . 52.109999999999999 112.007 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -117.04 159.74 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.428 1.091 . . . . 74.540000000000006 110.288 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.99 144.25 14.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 107.085 -1.45 . . . . 74.25 107.085 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.21 -0.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.063 2.545 . . . . 74.409999999999997 115.887 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -61.97 -36.74 82.37 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 114.911 1.448 . . . . 70.230000000000004 114.911 -166.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.09 177.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 120.482 1.492 . . . . 71.420000000000002 111.227 -169.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 53.210000000000001 108.891 174.459 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.328 0 CA-C-O 117.941 -1.028 . . . . 74.340000000000003 111.407 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.7 m -50.84 138.61 18.45 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.276 1.83 . . . . 55.25 109.889 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 59' ' ' VAL . 7.1 m -120.49 118.33 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.19 1.396 . . . . 55.149999999999999 109.43 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -68.83 155.67 39.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.894 1.278 . . . . 73.209999999999994 109.69 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 57' ' ' ALA . 1.8 p -131.11 158.47 40.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.764 1.626 . . . . 61.520000000000003 107.947 162.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -143.29 11.14 1.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.502 0.927 . . . . 33.100000000000001 113.502 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -140.45 25.31 2.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.477 1.035 . . . . 64.540000000000006 112.391 -163.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.18 165.31 16.29 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.871 -0.518 . . . . 55.039999999999999 111.402 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.4 169.64 8.57 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.592 1.157 . . . . 72.530000000000001 109.857 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.28 -11.47 60.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.531 1.308 . . . . 23.5 114.531 -171.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 20.29 10.13 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.289 1.404 . . . . 75.540000000000006 113.489 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tp -64.48 163.58 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.258 1.023 . . . . 60.340000000000003 110.001 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -121.59 157.73 55.88 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.672 1.989 . . . . 74.010000000000005 107.528 162.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.84 -41.93 64.31 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 CA-C-N 121.374 1.526 . . . . 51.25 109.838 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.769 1.025 . . . . 73.299999999999997 113.769 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.47 -28.19 66.78 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.22 1.373 . . . . 61.240000000000002 110.443 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.82 -40.26 16.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.187 1.395 . . . . 63.299999999999997 110.615 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.49 -35.63 75.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.589 0.632 . . . . 63.130000000000003 110.394 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.47 -51.96 67.65 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.574 1.549 . . . . 54.100000000000001 108.242 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -51.45 -57.21 9.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.339 1.056 . . . . 75.329999999999998 110.533 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -72.14 -19.57 61.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.274 0.842 . . . . 72.129999999999995 113.274 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.0 p -66.05 -18.13 65.14 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.761 0.824 . . . . 43.299999999999997 111.37 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.0 p -66.24 -14.57 62.16 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.001 0.371 . . . . 71.310000000000002 112.001 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.55 5.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.974 0.909 . . . . 61.100000000000001 112.121 -167.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.22 25.82 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.269 -1.532 . . . . 72.239999999999995 109.269 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.31 131.9 21.1 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.716 1.246 . . . . 75.040000000000006 113.201 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.0 154.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 125.727 1.611 . . . . 34.229999999999997 110.303 165.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -96.2 -58.47 2.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.741 1.616 . . . . 74.030000000000001 107.963 164.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -158.83 155.02 27.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.633 1.106 . . . . 52.140000000000001 110.091 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.64 140.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.307 1.043 . . . . 63.32 109.03 -169.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -142.26 71.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.544 1.138 . . . . 63.340000000000003 109.876 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.9 ptp -66.13 158.28 29.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.661 -0.816 . . . . 60.520000000000003 108.97 163.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 107.022 -1.473 . . . . 62.130000000000003 107.022 173.618 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.826 0 N-CA-C 111.54 -0.624 . . . . 60.530000000000001 111.54 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.19 153.98 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.203 1.801 . . . . 73.230000000000004 111.102 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -151.75 166.0 32.7 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.466 1.907 . . . . 42.140000000000001 109.273 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -124.08 152.37 42.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 104.868 -2.271 . . . . 75.409999999999997 104.868 155.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 15' ' ' VAL 0.356 1.5 p -144.86 115.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.667 -1.27 . . . . 55.140000000000001 108.963 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -63.24 131.93 50.01 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.416 1.886 . . . . 74.109999999999999 106.651 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.68 156.22 20.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.542 0.687 . . . . 73.230000000000004 111.004 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.98 -24.74 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.746 -0.661 . . . . 63.310000000000002 109.46 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.13 131.88 44.42 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.976 -1.078 . . . . 73.129999999999995 110.355 -163.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.403 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 3.3 p -63.92 -31.72 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.922 1.689 . . . . 60.350000000000001 110.571 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -41.67 98.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.385 1.474 . . . . 63.539999999999999 110.913 -169.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -78.89 -5.47 53.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.394 0.886 . . . . 60.329999999999998 113.394 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.97 -56.43 35.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.809 1.64 . . . . 73.239999999999995 109.563 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.57 -15.5 45.04 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 CA-C-N 120.58 1.243 . . . . 52.43 112.717 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.6 tp -64.89 -43.93 91.27 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 121.031 1.741 . . . . 64.540000000000006 109.757 168.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.82 76.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.378 1.444 . . . . 62.509999999999998 111.565 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -58.83 -45.6 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.631 -0.668 . . . . 72.129999999999995 109.288 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.28 -8.1 22.56 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.177 1.37 . . . . 73.519999999999996 114.109 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -113.97 4.31 15.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.426 1.613 . . . . 71.299999999999997 112.358 -172.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.62 -23.54 6.69 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.268 1.027 . . . . 61.509999999999998 113.645 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 19.26 35.29 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.86 1.219 . . . . 62.520000000000003 112.281 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -101.54 178.85 4.52 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.856 1.328 . . . . 64.530000000000001 109.428 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -152.48 95.31 2.01 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.426 1.091 . . . . 74.430000000000007 111.718 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.21 110.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.789 -1.189 . . . . 75.540000000000006 107.789 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt 50.85 35.22 11.77 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.746 1.218 . . . . 74.400000000000006 111.868 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.07 35.03 25.21 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.967 -0.907 . . . . 71.530000000000001 113.397 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.64 86.14 56.45 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.831 1.652 . . . . 75.239999999999995 108.008 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.83 171.91 12.62 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.505 2.136 . . . . 63.219999999999999 111.575 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.64 160.43 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.584 -0.698 . . . . 53.039999999999999 110.224 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.72 165.72 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.383 -1.34 . . . . 44.420000000000002 107.383 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.67 -21.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 117.829 -1.082 . . . . 72.340000000000003 113.16 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -44.38 -42.94 7.26 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.585 1.698 . . . . 55.039999999999999 115.585 -150.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.05 41.53 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 61.450000000000003 112.334 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.286 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 127.085 2.154 . . . . 63.439999999999998 111.828 -173.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 . . . . . 0 CA--C 1.518 -0.277 0 N-CA-C 110.244 -0.28 . . . . 72.0 110.244 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.28 148.85 49.66 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 120.859 -1.15 . . . . 74.340000000000003 109.278 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.4 114.62 39.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.067 0.937 . . . . 63.100000000000001 111.436 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.08 93.31 8.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.414 1.086 . . . . 73.340000000000003 109.821 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.17 92.13 5.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.45 -1.25 . . . . 72.329999999999998 108.137 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.2 ttp -93.48 14.62 18.13 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.146 0.795 . . . . 71.409999999999997 113.146 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -137.79 36.14 2.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.308 -1.495 . . . . 74.120000000000005 112.19 -165.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 mt -78.22 145.4 35.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.029 0.932 . . . . 74.310000000000002 112.613 -171.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' VAL . . . -72.08 147.85 46.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.377 1.871 . . . . 71.129999999999995 109.84 164.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.79 -0.97 6.06 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.321 1.971 . . . . 64.150000000000006 116.321 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -122.37 -0.38 9.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.56 1.527 . . . . 73.239999999999995 114.248 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.4 150.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.237 1.199 . . . . 54.219999999999999 114.237 -159.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -90.35 161.99 35.68 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.397 1.479 . . . . 71.25 109.901 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.79 -53.04 3.59 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.33 2.02 . . . . 73.230000000000004 111.795 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -66.15 -18.95 65.67 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.966 0.728 . . . . 71.109999999999999 112.966 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.39 -32.99 70.66 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.324 -0.86 . . . . 72.439999999999998 110.715 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.67 -52.65 16.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.01 -0.519 . . . . 74.430000000000007 109.872 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.69 -23.99 64.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.056 0.847 . . . . 70.420000000000002 110.916 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.76 -26.73 63.49 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.107 0.78 . . . . 71.209999999999994 113.107 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.34 -36.01 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 70.319999999999993 110.757 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.21 -25.74 19.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.513 0.931 . . . . 73.409999999999997 113.513 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -61.13 -20.71 62.99 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.417 1.887 . . . . 73.0 114.013 -169.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 t -58.08 -40.56 81.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.004 1.322 . . . . 71.219999999999999 108.969 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -148.31 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.18 0.992 . . . . 63.100000000000001 109.964 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.01 163.36 25.79 Favored Glycine 0 CA--C 1.521 0.448 0 O-C-N 120.673 -1.267 . . . . 71.030000000000001 112.032 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -116.46 124.64 50.46 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.026 0.93 . . . . 72.209999999999994 109.18 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -91.43 148.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.5 -1.296 . . . . 52.210000000000001 107.5 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -101.31 -46.79 4.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.029 1.731 . . . . 73.310000000000002 109.396 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -157.85 -176.99 6.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.012 0.824 . . . . 74.310000000000002 111.088 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.98 97.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.628 1.571 . . . . 73.439999999999998 108.411 -159.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -119.16 131.07 55.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.718 1.145 . . . . 73.420000000000002 110.161 -167.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.45 164.59 27.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.261 1.578 . . . . 70.019999999999996 115.261 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 C--O 1.237 0.447 0 N-CA-C 107.666 -1.235 . . . . 74.049999999999997 107.666 -179.09 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.416 0 CA-C-O 119.302 -0.721 . . . . 71.239999999999995 113.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.9 134.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.503 1.121 . . . . 62.409999999999997 110.094 -171.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.37 43.41 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.682 1.193 . . . . 74.010000000000005 111.819 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -120.98 108.6 14.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.229 1.812 . . . . 74.230000000000004 106.27 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.91 121.73 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.326 -1.361 . . . . 70.219999999999999 107.326 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -86.58 116.98 25.05 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.495 1.518 . . . . 74.019999999999996 109.072 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.71 162.47 18.74 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.485 1.514 . . . . 61.140000000000001 112.961 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 t -83.87 -20.34 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.046 1.339 . . . . 73.120000000000005 112.525 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.0 156.12 45.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.909 -1.145 . . . . 65.400000000000006 107.909 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.13 -26.27 36.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 123.456 0.473 . . . . 72.239999999999995 110.576 172.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -61.81 -36.86 82.38 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.045 -1.034 . . . . 65.040000000000006 113.626 -164.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 m -82.16 -5.45 58.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.617 1.099 . . . . 73.030000000000001 113.696 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.83 -57.97 18.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 119.997 1.272 . . . . 72.310000000000002 110.846 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.15 -15.86 52.26 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.966 1.778 . . . . 53.439999999999998 113.206 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.86 -45.54 81.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.351 0.978 . . . . 72.030000000000001 109.318 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.91 71.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.412 0.685 . . . . 45.299999999999997 111.14 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.51 -32.1 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.589 -0.694 . . . . 62.219999999999999 109.882 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.96 0.35 7.62 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.53 1.538 . . . . 71.099999999999994 114.23 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.82 11.74 3.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.038 1.735 . . . . 72.200000000000003 112.209 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -50.35 -29.55 10.21 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 121.123 1.783 . . . . 70.329999999999998 114.133 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.51 -16.02 55.89 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.826 -0.986 . . . . 71.109999999999999 112.894 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -70.7 170.88 11.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.646 1.223 . . . . 65.439999999999998 109.866 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -157.43 128.32 6.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.509 0.724 . . . . 64.420000000000002 109.219 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.3 t -84.71 94.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.262 -2.125 . . . . 65.409999999999997 105.262 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 mt 65.93 23.23 11.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.372 1.069 . . . . 64.329999999999998 112.93 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.07 11.8 29.01 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.82 -0.55 . . . . 63.049999999999997 113.16 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' ALA . 57.5 t -113.05 83.59 6.27 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 126.078 1.751 . . . . 72.239999999999995 108.853 174.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 176.29 8.36 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.225 2.617 . . . . 64.099999999999994 111.796 166.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.97 177.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.724 1.21 . . . . 72.230000000000004 108.926 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.646 HG22 ' H ' ' A' ' 86' ' ' GLN . 34.1 mm -123.75 139.12 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.558 1.143 . . . . 71.040000000000006 108.908 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -44.73 -18.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 130.476 3.51 . . . . 72.319999999999993 115.968 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.646 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.3 mt-30 -53.22 -58.34 7.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.716 1.143 . . . . 72.319999999999993 110.937 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.06 50.15 18.52 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 125.264 1.603 . . . . 65.329999999999998 110.491 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.429 0 C-N-CA 125.294 1.438 . . . . 62.439999999999998 111.138 -174.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 114.708 1.373 . . . . 63.32 114.708 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -102.08 145.98 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.591 1.156 . . . . 73.219999999999999 108.75 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.26 118.34 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.779 -0.823 . . . . 74.450000000000003 108.779 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -72.82 113.06 9.44 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.335 1.054 . . . . 71.219999999999999 108.721 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.9 m -98.95 129.95 45.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.519 1.528 . . . . 53.329999999999998 107.469 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.6 ttp -127.44 175.85 7.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.09 1.756 . . . . 73.530000000000001 107.615 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 64.1 20.83 12.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.808 1.643 . . . . 73.439999999999998 113.525 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -72.6 168.73 18.03 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.744 0.817 . . . . 70.209999999999994 111.227 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.52 166.13 11.25 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.079 1.14 . . . . 52.140000000000001 114.079 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.62 23.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 64.319999999999993 112.231 169.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -135.68 76.78 1.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 106.688 -1.597 . . . . 71.219999999999999 106.688 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -140.77 165.38 20.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 124.071 0.948 . . . . 65.430000000000007 108.796 168.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -117.51 157.92 46.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 126.64 1.976 . . . . 74.519999999999996 107.408 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -55.32 2.56 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.235 1.957 . . . . 75.439999999999998 111.94 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -63.48 -21.74 66.49 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.595 -0.717 . . . . 61.329999999999998 112.274 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.3 -19.02 62.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.948 1.249 . . . . 74.409999999999997 110.35 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.887 1.221 . . . . 73.5 110.781 169.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -69.54 -37.83 77.24 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.864 -0.421 . . . . 71.109999999999999 109.864 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 34' ' ' SER . 6.2 mm-40 -65.47 -26.71 68.06 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.307 1.043 . . . . 72.530000000000001 112.339 -176.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.73 -16.49 64.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.23 1.012 . . . . 62.549999999999997 113.37 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.66 -26.45 8.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.475 0.71 . . . . 72.409999999999997 111.22 173.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 6.5 t -53.78 -18.64 3.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.666 1.987 . . . . 62.140000000000001 111.949 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.4 p -46.31 -41.89 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.493 1.517 . . . . 74.420000000000002 111.12 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.77 46.24 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.135 1.774 . . . . 60.109999999999999 108.269 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.46 178.03 48.32 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 124.274 0.94 . . . . 63.32 110.865 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -137.83 134.1 34.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.333 1.453 . . . . 74.109999999999999 107.796 169.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 61' ' ' PHE 0.276 1.8 p -118.28 143.25 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.048 1.339 . . . . 61.43 109.562 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -77.29 -50.28 13.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.4 1.88 . . . . 62.439999999999998 108.284 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -168.58 -178.49 3.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.096 0.558 . . . . 75.219999999999999 110.938 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.34 152.48 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.366 1.466 . . . . 75.120000000000005 109.024 174.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -125.93 101.34 6.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.513 1.925 . . . . 71.409999999999997 106.803 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.3 mtp -95.21 142.12 28.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.116 0.966 . . . . 74.540000000000006 110.819 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 72.400000000000006 113.36 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.131 0 N-CA-C 109.534 -1.427 . . . . 74.129999999999995 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 pt -139.8 146.6 24.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.838 1.255 . . . . 73.209999999999994 108.555 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.38 44.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.371 1.068 . . . . 44.039999999999999 108.907 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -123.85 127.91 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.661 -1.607 . . . . 70.319999999999993 106.661 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.05 112.18 39.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.8 -1.555 . . . . 50.219999999999999 106.8 -167.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -92.41 91.87 7.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.855 1.262 . . . . 72.129999999999995 108.01 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -56.08 177.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.043 1.337 . . . . 73.109999999999999 113.91 175.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.77 -31.12 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 O-C-N 120.448 -1.407 . . . . 72.310000000000002 110.917 168.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -117.18 175.66 5.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.475 1.489 . . . . 64.150000000000006 110.443 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.64 -27.04 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 118.836 0.744 . . . . 60.329999999999998 111.246 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -67.4 -22.18 65.55 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.558 -1.339 . . . . 72.319999999999993 112.038 -171.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -5.2 57.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.945 1.091 . . . . 74.340000000000003 113.945 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.46 -55.53 39.07 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.32 1.418 . . . . 62.420000000000002 109.459 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.8 -10.32 28.41 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.849 . . . . 72.049999999999997 113.925 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.65 -59.38 3.65 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 120.082 1.31 . . . . 74.349999999999994 108.218 166.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HA ' HD23 ' A' ' 73' ' ' LEU . . . -59.34 -29.43 67.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.814 0.846 . . . . 71.209999999999994 113.007 -175.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.68 -26.27 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.848 1.259 . . . . 64.329999999999998 110.568 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.61 80.9 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.559 1.552 . . . . 74.25 114.112 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 70' ' ' ALA . 3.2 mm? -87.66 -4.06 58.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.157 1.479 . . . . 72.109999999999999 114.194 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.0 t -50.86 -21.35 1.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.364 1.987 . . . . 71.209999999999994 116.364 -160.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.4 -12.79 59.35 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.724 -1.235 . . . . 62.140000000000001 113.635 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -77.04 165.13 25.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.673 1.236 . . . . 71.319999999999993 110.451 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -140.76 88.35 2.18 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.137 1.775 . . . . 63.32 109.531 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.56 100.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.145 0.978 . . . . 74.230000000000004 109.002 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 mt 49.06 33.23 4.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.836 0.827 . . . . 73.239999999999995 111.275 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.74 5.94 62.59 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.536 -1.147 . . . . 64.140000000000001 114.157 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 t -105.5 86.46 1.75 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.702 2.001 . . . . 44.030000000000001 108.882 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.84 176.9 6.21 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.942 3.095 . . . . 65.430000000000007 112.404 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.58 151.06 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.496 0.665 . . . . 73.439999999999998 110.214 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.2 mm -106.28 156.13 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.295 1.438 . . . . 73.239999999999995 108.368 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 m -74.07 -0.78 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 114.904 1.446 . . . . 73.230000000000004 114.904 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -45.78 -60.33 2.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.033 1.123 . . . . 63.310000000000002 114.033 -165.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.79 157.37 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.999 1.319 . . . . 65.420000000000002 112.086 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.328 -0.33 0 N-CA-C 107.081 -1.452 . . . . 74.510000000000005 107.081 169.177 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HE ' ' HA ' ' A' ' 63' ' ' ASP . 11.2 mtt85 . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 117.336 2.347 . . . . 74.5 117.336 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -110.62 153.73 24.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.751 1.16 . . . . 70.239999999999995 110.279 -164.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.604 1.562 . . . . 44.200000000000003 109.744 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.49 114.16 24.64 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.295 2.638 . . . . 74.010000000000005 110.876 -166.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.3 130.48 34.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.471 -0.566 . . . . 74.120000000000005 109.471 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -127.77 48.67 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.036 0.934 . . . . 75.420000000000002 111.695 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 11.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.129 -0.982 . . . . 73.019999999999996 113.128 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 168.6 8.78 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.809 -1.182 . . . . 73.010000000000005 113.264 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.87 170.57 9.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.226 -1.352 . . . . 70.420000000000002 113.194 -167.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.12 -12.43 61.49 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.634 1.574 . . . . 61.119999999999997 115.178 -161.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -134.47 31.01 3.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.369 0.986 . . . . 71.439999999999998 111.286 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.65 165.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.54 -0.541 . . . . 43.450000000000003 109.54 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -122.63 161.92 41.21 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.704 1.602 . . . . 72.239999999999995 109.038 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.86 -54.28 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.862 1.708 . . . . 74.010000000000005 109.535 165.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -38.73 69.01 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.53 -0.748 . . . . 74.140000000000001 111.985 -175.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.7 -34.14 72.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.591 1.087 . . . . 54.539999999999999 111.396 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.79 -10.27 59.76 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.442 0.697 . . . . 53.219999999999999 112.348 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' CB ' HG11 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -109.18 -31.66 7.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.407 1.083 . . . . 74.120000000000005 109.777 174.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -70.24 -30.86 68.03 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.554 1.542 . . . . 54.549999999999997 112.494 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -62.41 -26.04 68.27 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.079 -1.013 . . . . 71.150000000000006 111.693 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.43 -12.05 16.75 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.439 -0.791 . . . . 73.010000000000005 112.641 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.5 p -62.8 -19.59 64.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.75 1.614 . . . . 73.230000000000004 112.117 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 p -64.81 -23.71 67.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.781 1.232 . . . . 72.129999999999995 110.926 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 8.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.593 1.557 . . . . 73.439999999999998 112.3 -166.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.61 45.74 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.658 -1.276 . . . . 54.329999999999998 111.708 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.88 141.96 50.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.686 1.594 . . . . 52.32 107.856 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.463 HG21 ' CG1' ' A' ' 59' ' ' VAL . 11.3 p -135.97 145.96 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.801 1.241 . . . . 71.409999999999997 109.295 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -87.58 -46.82 9.21 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.908 -1.496 . . . . 73.219999999999999 111.042 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -169.52 174.78 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.781 0.719 . . . . 73.129999999999995 109.798 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 59' ' ' VAL . 49.1 t -125.87 145.46 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 73.150000000000006 109.694 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -117.38 98.1 6.24 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.108 1.763 . . . . 70.310000000000002 107.167 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.27 149.55 21.15 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.808 -1.182 . . . . 54.439999999999998 107.808 170.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 C--N 1.33 -0.281 0 N-CA-C 106.604 -1.628 . . . . 71.450000000000003 106.604 -176.719 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.215 0 N-CA-C 110.512 -1.035 . . . . 60.329999999999998 110.512 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -153.96 136.65 6.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 125.579 1.552 . . . . 72.010000000000005 109.128 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.57 151.19 30.36 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.544 1.137 . . . . 73.019999999999996 110.452 169.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -128.01 138.48 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.555 -1.646 . . . . 73.030000000000001 106.555 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' CG1' HG21 ' A' ' 39' ' ' VAL . 93.4 t -128.66 112.94 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.174 1.39 . . . . 64.030000000000001 108.258 -160.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.61 81.54 8.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.36 1.076 . . . . 61.299999999999997 109.987 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.19 150.17 4.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.858 1.263 . . . . 73.420000000000002 113.844 171.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.59 -24.04 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.657 . . . . 61.299999999999997 110.062 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 21.9 t0 -132.26 143.79 50.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.736 1.607 . . . . 70.329999999999998 113.15 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.2 -30.61 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.157 1.383 . . . . 62.299999999999997 111.344 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -66.28 -15.77 63.48 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.077 -1.014 . . . . 70.510000000000005 111.281 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 m -88.27 -6.67 57.65 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.476 1.287 . . . . 74.310000000000002 114.476 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -53.81 -56.7 22.65 Favored Pre-proline 0 N--CA 1.473 0.708 0 CA-C-N 121.85 2.113 . . . . 71.530000000000001 109.83 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -6.44 17.29 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 121.779 1.653 . . . . 63.509999999999998 114.335 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.33 -52.48 39.8 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.195 -1.565 . . . . 73.510000000000005 108.299 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.15 -23.65 65.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.645 0.778 . . . . 74.129999999999995 112.564 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.01 -45.62 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.921 1.289 . . . . 62.100000000000001 109.595 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.11 -2.6 48.38 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.951 -0.916 . . . . 13.25 113.247 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.99 2.82 55.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.323 1.562 . . . . 71.420000000000002 111.258 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -56.72 -20.87 24.12 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.541 1.064 . . . . 62.350000000000001 113.326 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.15 23.26 14.34 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.638 2.066 . . . . 51.240000000000002 112.045 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -118.35 175.58 5.64 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 128.699 2.8 . . . . 73.019999999999996 109.795 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -152.11 127.29 9.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.308 1.843 . . . . 74.150000000000006 108.602 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.5 101.0 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.889 -1.522 . . . . 71.450000000000003 106.889 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mt 64.22 -8.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.88 2.872 . . . . 70.329999999999998 116.662 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.24 -3.34 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.187 -1.006 . . . . 74.129999999999995 113.498 -160.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.12 85.25 12.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.872 2.069 . . . . 72.319999999999993 106.315 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.99 178.7 2.23 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.718 2.945 . . . . 73.430000000000007 111.92 175.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tt -137.38 161.47 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.27 1.028 . . . . 54.140000000000001 109.944 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.5 mm -101.62 158.08 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.283 -1.377 . . . . 74.049999999999997 107.283 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.92 -1.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.295 1.838 . . . . 75.239999999999995 114.877 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -46.1 67.03 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.128 -0.982 . . . . 74.0 113.278 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.96 29.79 2.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.618 1.71 . . . . 74.099999999999994 115.618 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.549 0.909 0 C-N-CA 126.787 2.035 . . . . 63.32 112.383 -173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.584 HH11 ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.31 0.856 . . . . 63.140000000000001 113.31 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 152.73 43.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.885 1.274 . . . . 74.299999999999997 110.482 -171.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.26 170.1 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.626 -1.25 . . . . 72.109999999999999 107.626 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -138.31 104.26 5.13 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.292 1.437 . . . . 74.329999999999998 109.332 -171.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.73 75.29 8.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.615 1.966 . . . . 73.340000000000003 110.201 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -81.38 25.07 0.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.302 0.853 . . . . 53.200000000000003 113.302 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -148.78 48.46 1.01 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.131 -1.606 . . . . 75.299999999999997 112.627 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.6 mt -79.15 166.75 21.89 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.558 0.947 . . . . 74.0 113.558 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.76 -160.72 0.79 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.554 2.342 . . . . 43.420000000000002 110.859 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.45 -20.99 11.09 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.938 1.829 . . . . 74.200000000000003 115.938 -164.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -129.62 44.3 2.99 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.478 1.608 . . . . 74.340000000000003 108.33 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.38 140.71 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.251 -1.341 . . . . 55.229999999999997 107.914 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.81 161.8 32.79 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 124.251 1.02 . . . . 72.129999999999995 108.549 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.41 -37.48 89.66 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.055 1.17 . . . . 62.240000000000002 110.1 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -58.29 -31.82 67.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.56 -1.21 . . . . 75.010000000000005 113.294 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.11 -34.95 75.78 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 120.496 1.498 . . . . 72.340000000000003 110.121 -171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.14 -32.26 70.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.344 1.057 . . . . 72.420000000000002 111.833 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.85 -7.65 23.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 117.998 -1.001 . . . . 64.010000000000005 112.541 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -37.27 18.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.917 1.235 . . . . 74.0 108.566 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.54 -39.05 64.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.665 0.786 . . . . 73.099999999999994 112.377 -174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -106.73 2.2 25.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.426 -0.797 . . . . 75.430000000000007 112.278 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.7 p -74.62 -10.66 59.75 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 120.422 1.464 . . . . 73.310000000000002 112.076 170.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -44.93 -52.05 9.1 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.779 2.032 . . . . 71.239999999999995 109.765 165.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.18 57.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 54.030000000000001 108.299 -171.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.58 164.42 28.76 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.209 -0.932 . . . . 73.420000000000002 113.528 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -123.53 131.19 53.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.798 1.239 . . . . 75.200000000000003 109.456 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -88.52 138.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.313 1.445 . . . . 73.420000000000002 107.848 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -76.91 -51.78 10.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.489 -0.93 . . . . 55.439999999999998 108.489 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 7.3 t0 -162.47 -172.74 3.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.194 1.797 . . . . 55.039999999999999 107.564 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.25 93.98 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 119.823 1.192 . . . . 71.140000000000001 110.454 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.93 163.14 22.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.376 1.084 . . . . 73.409999999999997 110.684 163.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.59 136.19 11.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 127.914 2.486 . . . . 74.329999999999998 105.751 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.238 0.449 0 N-CA-C 105.777 -1.934 . . . . 53.399999999999999 105.777 170.383 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.319 0 CA-C-O 118.831 -0.983 . . . . 73.310000000000002 111.871 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.24 143.6 27.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.163 0.985 . . . . 71.040000000000006 110.099 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.0 156.64 41.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.7 2.0 . . . . 73.409999999999997 106.462 159.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -116.56 142.57 46.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 104.317 -2.475 . . . . 75.109999999999999 104.317 162.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.04 115.91 44.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.356 -2.091 . . . . 61.539999999999999 105.356 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 41' ' ' ASP . 2.6 pm0 -73.36 126.36 29.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.668 0.747 . . . . 64.200000000000003 109.507 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.75 166.67 10.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.658 1.183 . . . . 75.329999999999998 110.911 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.86 -14.37 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.513 0.725 . . . . 35.340000000000003 111.561 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -138.16 168.64 19.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.517 -1.364 . . . . 64.519999999999996 108.876 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.71 -43.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.173 -0.918 . . . . 61.399999999999999 108.608 167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -64.99 -29.89 70.84 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.623 1.101 . . . . 60.240000000000002 113.681 -152.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -74.21 -8.14 55.15 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.536 0.939 . . . . 52.009999999999998 113.536 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -62.96 4.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 119.695 -1.878 . . . . 74.400000000000006 108.737 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.58 -10.83 29.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.948 1.374 . . . . 75.510000000000005 113.134 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.9 -54.32 13.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.531 1.06 . . . . 63.340000000000003 109.621 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.91 -30.18 63.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.942 1.297 . . . . 72.400000000000006 112.415 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.04 -49.14 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.487 1.115 . . . . 73.409999999999997 108.615 172.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.23 7.83 3.16 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.079 1.323 . . . . 73.409999999999997 114.484 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD2' HE21 ' A' ' 76' ' ' GLN . 70.2 mt -117.05 4.88 12.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.799 1.799 . . . . 53.32 111.001 170.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -49.91 -30.41 10.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.449 1.477 . . . . 72.0 111.932 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.57 18.64 54.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 125.115 1.34 . . . . 53.5 113.079 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.428 HE21 ' CD2' ' A' ' 73' ' ' LEU . 7.2 mt-30 -127.05 165.05 20.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.455 1.502 . . . . 72.299999999999997 107.674 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -149.17 130.51 14.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.29 0.636 . . . . 60.119999999999997 109.59 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.97 104.34 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 106.205 -1.776 . . . . 71.219999999999999 106.205 164.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt 59.91 19.28 8.27 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.625 1.57 . . . . 74.430000000000007 113.566 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.45 1.94 29.36 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.545 -0.586 . . . . 74.420000000000002 114.298 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -104.86 86.05 1.38 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.253 1.821 . . . . 55.530000000000001 107.209 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.14 179.07 3.07 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.672 2.248 . . . . 61.210000000000001 111.032 163.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 tt -121.34 175.86 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.708 1.203 . . . . 74.400000000000006 108.466 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 147.32 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.131 1.772 . . . . 75.209999999999994 106.848 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 t -55.55 -15.13 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.623 2.769 . . . . 71.200000000000003 115.646 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -44.61 -42.52 7.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.049 1.499 . . . . 73.099999999999994 115.049 -168.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.35 175.53 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.91 1.338 . . . . 63.539999999999999 109.294 -160.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 104.597 -2.372 . . . . 73.519999999999996 104.597 157.573 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.481 ' HE ' ' C ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 115.404 1.631 . . . . 61.229999999999997 115.404 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.38 131.69 55.89 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.975 -1.078 . . . . 72.349999999999994 112.011 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.61 178.02 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.176 1.79 . . . . 73.120000000000005 109.496 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -145.76 117.75 8.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.917 1.287 . . . . 64.349999999999994 110.359 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -95.96 134.66 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.643 -1.243 . . . . 70.450000000000003 107.643 164.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.6 ttm -131.88 31.51 4.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 65.109999999999999 111.047 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -145.18 25.04 1.41 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.582 -1.323 . . . . 74.140000000000001 112.11 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.99 166.69 23.13 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.069 -1.02 . . . . 64.109999999999999 113.618 -164.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.96 169.59 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.573 1.149 . . . . 43.25 112.168 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -49.13 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.948 1.299 . . . . 65.430000000000007 111.925 162.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -92.46 19.83 6.83 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.103 0.961 . . . . 74.450000000000003 112.524 -167.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.548 HD12 HG11 ' A' ' 81' ' ' VAL . 11.6 tt -64.23 163.23 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.441 0.696 . . . . 72.530000000000001 109.78 168.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -118.49 160.35 40.22 Favored Pre-proline 0 CA--C 1.519 -0.244 0 C-N-CA 125.11 1.364 . . . . 72.140000000000001 108.965 167.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.93 -29.85 87.82 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.605 1.537 . . . . 43.450000000000003 112.352 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -78.55 -18.78 54.17 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 117.662 -1.161 . . . . 74.010000000000005 113.309 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -33.61 73.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.339 1.427 . . . . 71.420000000000002 110.212 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.44 -44.97 61.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.238 1.015 . . . . 74.319999999999993 110.792 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.13 -41.62 85.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.448 -0.901 . . . . 63.240000000000002 108.727 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.02 -39.95 87.6 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.84 0.745 . . . . 73.140000000000001 112.571 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -55.76 -57.44 12.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.626 -0.879 . . . . 73.040000000000006 108.626 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.36 -25.14 60.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.144 0.794 . . . . 72.25 113.144 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -63.03 -11.45 19.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.96 1.304 . . . . 71.409999999999997 112.05 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 p -67.33 -21.46 65.65 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.846 1.657 . . . . 71.150000000000006 110.943 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.3 -0.57 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.819 0.848 . . . . 71.209999999999994 113.148 -165.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.78 146.08 6.43 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.906 -1.278 . . . . 70.319999999999993 109.906 165.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -63.95 148.87 48.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.916 0.358 . . . . 72.340000000000003 111.643 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.2 145.77 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 126.225 1.81 . . . . 62.210000000000001 108.14 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -84.68 -52.81 5.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.862 -1.066 . . . . 71.010000000000005 108.178 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -169.43 170.06 8.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.735 1.214 . . . . 54.240000000000002 110.63 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -100.52 165.64 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.014 1.726 . . . . 51.539999999999999 111.194 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -149.87 50.72 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.139 0.971 . . . . 73.450000000000003 109.859 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -66.78 120.65 13.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.242 2.217 . . . . 70.439999999999998 110.295 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 45' ' ' ILE . 3.8 mp . . . . . 0 N--CA 1.465 0.307 0 C-N-CA 123.78 0.832 . . . . 74.030000000000001 109.051 -170.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.162 0 N-CA-C 110.711 -0.956 . . . . 45.140000000000001 110.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 pt -117.08 142.95 28.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.353 1.461 . . . . 72.430000000000007 109.835 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.84 150.12 36.57 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.083 1.353 . . . . 62.020000000000003 108.027 160.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 45' ' ' ILE . 62.0 m-85 -117.74 157.87 25.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.651 -1.981 . . . . 70.140000000000001 105.651 158.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.41 144.54 3.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.841 2.056 . . . . 73.349999999999994 106.327 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -111.72 119.73 39.64 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.748 1.619 . . . . 74.109999999999999 107.547 -165.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -80.47 173.92 12.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.66 0.743 . . . . 64.219999999999999 111.394 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.96 -32.12 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.467 -0.771 . . . . 65.010000000000005 108.974 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 4.8 m-20 -129.72 120.98 26.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.488 1.115 . . . . 73.049999999999997 108.462 -166.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.405 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 7.3 p -45.67 -34.59 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 129.06 2.944 . . . . 74.349999999999994 111.206 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 m -64.65 -18.87 65.34 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.929 -1.732 . . . . 74.010000000000005 112.83 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -1.77 24.09 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG23 ' NH2' ' A' ' 13' ' ' ARG . 92.4 t -61.6 -61.34 8.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 120.988 1.722 . . . . 74.239999999999995 109.273 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.44 -17.93 60.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.625 . . . . 73.439999999999998 113.703 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.37 -56.55 20.58 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.722 1.146 . . . . 65.319999999999993 110.343 172.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.57 80.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.39 0.676 . . . . 73.040000000000006 111.279 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.98 -47.67 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.654 1.182 . . . . 71.329999999999998 109.213 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.98 -22.25 34.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.999 0.809 . . . . 72.349999999999994 114.155 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -99.12 12.56 35.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.296 -1.12 . . . . 72.319999999999993 111.839 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.4 t -49.12 -26.39 2.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.434 1.094 . . . . 74.239999999999995 113.83 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -9.02 60.34 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.767 0.699 . . . . 73.439999999999998 114.502 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.38 163.49 26.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.505 1.153 . . . . 62.43 108.254 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -153.33 74.52 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.881 0.472 . . . . 52.240000000000002 110.633 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 t -53.16 103.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.925 1.69 . . . . 73.219999999999999 108.358 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt 54.72 29.57 11.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.762 0.825 . . . . 74.150000000000006 112.064 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 29.65 34.74 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.882 -0.511 . . . . 65.109999999999999 112.919 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 24' ' ' ILE . 38.4 t -125.12 80.08 64.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.744 1.618 . . . . 61.32 108.922 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.96 -172.2 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.06 3.174 . . . . 72.420000000000002 112.06 171.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.5 tt -137.49 146.56 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.72 1.208 . . . . 74.209999999999994 109.592 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.2 mm -87.65 141.58 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.084 -1.45 . . . . 71.030000000000001 107.084 171.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.91 0.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 128.697 2.799 . . . . 72.310000000000002 115.737 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -55.47 -51.13 67.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 126.296 1.838 . . . . 74.209999999999994 114.013 -169.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.8 169.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.278 1.031 . . . . 73.140000000000001 110.377 -162.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.235 0.336 0 N-CA-C 105.206 -2.146 . . . . 53.420000000000002 105.206 162.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 118.764 2.876 . . . . 75.030000000000001 118.764 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.1 m -115.0 159.9 20.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 119.996 1.271 . . . . 54.140000000000001 109.51 -160.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.4 166.88 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.635 -1.616 . . . . 75.219999999999999 106.635 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -138.34 108.43 6.39 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.419 1.088 . . . . 75.340000000000003 110.721 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -79.79 125.27 29.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.726 1.61 . . . . 43.149999999999999 107.97 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -137.57 27.73 2.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.447 0.641 . . . . 51.049999999999997 112.542 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -141.99 46.5 1.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.644 -1.285 . . . . 70.450000000000003 110.095 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HG13 ' A' ' 81' ' ' VAL . 4.0 mp -90.27 -173.88 3.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.177 1.391 . . . . 62.310000000000002 112.74 -167.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.67 162.61 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.051 2.141 . . . . 61.109999999999999 109.681 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.49 -10.05 59.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.379 0.881 . . . . 64.120000000000005 113.379 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.67 56.78 1.83 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.311 1.044 . . . . 75.099999999999994 111.323 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 tt -112.81 133.13 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.496 1.119 . . . . 75.230000000000004 108.986 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -81.64 164.88 47.15 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 119.04 -0.505 . . . . 64.010000000000005 110.263 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.29 -46.21 22.93 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.568 1.512 . . . . 60.32 110.064 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -66.51 -16.82 64.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.369 0.878 . . . . 73.299999999999997 113.369 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -63.35 -34.97 78.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.801 1.182 . . . . 71.219999999999999 109.551 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 -43.38 18.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.728 -0.653 . . . . 62.310000000000002 110.157 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.66 -35.13 75.47 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.751 1.16 . . . . 75.030000000000001 110.013 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.71 -11.69 59.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.923 1.289 . . . . 72.319999999999993 113.654 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -72.52 -63.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 119.465 1.03 . . . . 74.439999999999998 108.408 170.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.21 -15.17 62.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 117.907 -1.044 . . . . 63.020000000000003 112.155 -175.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t -48.51 -25.38 1.66 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.63 1.572 . . . . 54.530000000000001 112.637 164.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -68.86 -19.72 64.25 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.713 -1.242 . . . . 61.329999999999998 111.094 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.38 -19.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.157 1.344 . . . . 74.109999999999999 114.525 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.55 -177.54 26.3 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 120.942 -1.099 . . . . 74.040000000000006 111.331 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -123.08 133.11 54.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.489 0.716 . . . . 75.430000000000007 109.373 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.23 133.14 41.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.256 -1.387 . . . . 74.439999999999998 107.256 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -74.29 -64.65 0.98 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.764 -1.569 . . . . 72.230000000000004 106.764 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -156.98 159.85 38.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.554 -1.646 . . . . 71.349999999999994 106.554 -157.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -134.03 145.36 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 60.439999999999998 109.374 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -132.55 136.4 46.57 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.55 1.94 . . . . 64.409999999999997 108.616 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.78 120.78 15.58 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.15 1.38 . . . . 40.25 109.441 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.747 0 CA-C-N 119.318 0.963 . . . . 71.409999999999997 110.827 -169.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' HD13 ' A' ' 20' ' ' LEU . . . . . . . . 0 CA--C 1.519 0.343 0 CA-C-O 119.735 -0.481 . . . . 74.329999999999998 111.899 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.83 121.85 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.622 0.769 . . . . 62.32 110.538 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.43 137.89 34.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.887 -0.782 . . . . 55.229999999999997 108.887 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -102.65 154.12 19.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.938 -1.875 . . . . 62.340000000000003 105.938 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.92 115.71 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.323 -2.102 . . . . 72.409999999999997 105.323 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -81.93 110.04 16.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 105.124 -2.176 . . . . 74.349999999999994 105.124 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.09 163.07 18.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.273 -0.892 . . . . 71.439999999999998 110.42 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.88 -15.32 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.5 0.32 . . . . 72.329999999999998 111.033 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.44 161.83 38.77 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.366 -1.459 . . . . 53.310000000000002 111.095 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.12 -22.87 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.089 1.355 . . . . 64.349999999999994 111.669 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -59.37 -27.18 65.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.089 -1.007 . . . . 64.329999999999998 111.403 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -86.06 -4.07 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.236 1.199 . . . . 75.329999999999998 114.236 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.05 -58.16 16.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.24 1.382 . . . . 72.519999999999996 109.263 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.81 -20.39 64.7 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.448 1.432 . . . . 74.310000000000002 113.326 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.09 -52.95 56.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.972 1.26 . . . . 65.540000000000006 110.408 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.33 73.66 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.267 0.355 . . . . 74.129999999999995 111.644 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.65 -42.49 88.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.888 0.875 . . . . 74.439999999999998 109.106 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.33 -31.14 59.32 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 117.994 0.361 . . . . 41.130000000000003 112.437 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.31 9.96 16.29 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.334 -1.098 . . . . 74.310000000000002 112.803 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 83' ' ' ILE . 1.4 t -49.82 -29.85 8.69 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.384 1.447 . . . . 71.450000000000003 114.458 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.08 6.46 40.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.476 1.036 . . . . 64.109999999999999 113.779 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -81.36 175.05 10.91 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.237 1.019 . . . . 70.230000000000004 108.792 165.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -149.58 135.16 18.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.925 -0.769 . . . . 74.310000000000002 108.925 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.95 119.57 35.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 63.020000000000003 105.847 162.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.9 mt 60.3 1.46 0.37 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.014 1.857 . . . . 63.399999999999999 116.014 171.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.44 2.21 15.36 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.718 -1.046 . . . . 70.239999999999995 113.902 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 20' ' ' LEU . 68.9 t -104.57 86.39 1.4 Allowed Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 128.906 2.882 . . . . 70.510000000000005 109.151 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -65.3 177.49 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.23 1.953 . . . . 45.200000000000003 111.086 161.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.584 HG23 ' HA ' ' A' ' 74' ' ' THR 0.296 8.3 tt -122.19 176.45 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.951 0.9 . . . . 71.219999999999999 109.617 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 83' ' ' ILE . 47.8 mm -123.97 145.78 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.945 2.098 . . . . 70.239999999999995 106.077 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.52 -4.41 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.533 2.333 . . . . 71.329999999999998 114.819 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -53.85 -49.11 69.2 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.933 1.693 . . . . 72.340000000000003 113.717 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.4 179.36 0.15 Allowed 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.575 1.55 . . . . 64.540000000000006 111.498 -170.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 125.594 1.558 . . . . 74.310000000000002 106.963 178.096 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 114.336 1.236 . . . . 75.340000000000003 114.336 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 m -92.51 145.72 24.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.282 -1.006 . . . . 74.049999999999997 108.282 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -108.41 125.62 65.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 107.855 -1.165 . . . . 53.509999999999998 107.855 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.637 ' H ' ' HA ' ' A' ' 87' ' ' ALA . 7.3 t80 -89.55 124.29 34.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.869 1.668 . . . . 75.230000000000004 109.151 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -111.94 86.13 2.28 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.715 1.606 . . . . 71.219999999999999 108.941 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.0 ttp -92.03 27.54 2.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.711 0.804 . . . . 73.25 112.364 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -150.28 37.09 0.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.863 -1.773 . . . . 70.230000000000004 113.712 -173.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.67 153.27 42.17 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.476 -0.765 . . . . 72.319999999999993 112.916 -169.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.79 158.06 29.7 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.323 0.582 . . . . 72.230000000000004 111.154 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.88 -15.59 43.72 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.193 1.183 . . . . 61.119999999999997 114.193 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.69 30.65 5.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.101 1.318 . . . . 64.150000000000006 111.301 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -60.89 144.12 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 120.886 -1.134 . . . . 55.549999999999997 109.866 170.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -97.45 158.21 33.52 Favored Pre-proline 0 N--CA 1.464 0.27 0 C-N-CA 123.907 0.883 . . . . 72.340000000000003 109.724 160.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -57.85 -34.87 98.85 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 121.988 1.792 . . . . 62.340000000000003 112.364 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -67.44 -25.89 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.917 -0.489 . . . . 72.329999999999998 112.247 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.74 -32.8 74.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.01 1.277 . . . . 64.340000000000003 111.552 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -41.37 80.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.092 0.557 . . . . 62.409999999999997 110.586 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -76.54 -40.23 50.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.249 -0.278 . . . . 74.439999999999998 110.249 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.6 -44.08 76.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.84 1.256 . . . . 62.020000000000003 111.918 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -54.38 -42.43 70.36 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.098 -0.376 . . . . 72.150000000000006 111.232 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -88.08 -11.87 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.491 0.716 . . . . 73.409999999999997 112.529 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -65.66 -12.87 57.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.246 1.818 . . . . 74.450000000000003 111.783 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -59.08 -31.28 68.74 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.153 -0.967 . . . . 71.420000000000002 110.702 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.09 17.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.039 -1.038 . . . . 70.150000000000006 113.03 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 174.38 38.77 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 120.764 -1.21 . . . . 70.329999999999998 113.595 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.761 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -127.26 51.81 1.86 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.959 1.304 . . . . 71.530000000000001 111.673 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 HG12 ' A' ' 59' ' ' VAL . 2.2 p -43.73 126.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 127.904 2.482 . . . . 63.25 110.279 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -51.09 29.99 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.79 -1.55 . . . . 63.409999999999997 108.664 -158.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.54 179.12 7.46 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.193 1.558 . . . . 74.319999999999993 109.491 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 59' ' ' VAL . 20.6 t -136.92 147.88 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.185 0.994 . . . . 64.129999999999995 109.221 -174.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 102.53 11.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.56 2.344 . . . . 74.120000000000005 106.822 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.34 115.85 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.225 1.81 . . . . 74.340000000000003 107.07 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.535 0.398 0 C-N-CA 125.799 1.639 . . . . 55.340000000000003 108.677 -164.177 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.159 0 N-CA-C 109.892 -1.283 . . . . 74.010000000000005 109.892 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 pt -143.6 139.84 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.901 0.88 . . . . 64.349999999999994 111.384 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.36 157.27 43.52 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.289 1.836 . . . . 75.420000000000002 107.094 156.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.414 ' CE2' ' CD1' ' A' ' 16' ' ' PHE . 58.0 m-85 -124.99 128.38 48.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.884 -2.265 . . . . 75.049999999999997 104.884 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 42' ' ' VAL . 2.7 t -116.04 112.93 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.291 -1.374 . . . . 73.409999999999997 107.291 -164.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.45 88.08 7.32 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.952 1.358 . . . . 73.129999999999995 110.578 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -49.92 156.91 0.67 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.402 1.572 . . . . 75.510000000000005 113.375 166.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.761 HG21 ' HG3' ' A' ' 38' ' ' LYS . 3.5 m -79.9 -35.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 128.276 2.63 . . . . 61.32 113.975 176.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -116.73 165.15 13.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.012 1.725 . . . . 73.120000000000005 108.438 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -88.42 -27.38 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.227 0.611 . . . . 54.409999999999997 110.075 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 t -60.64 -27.61 67.93 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.325 0.966 . . . . 71.439999999999998 112.066 -173.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 p -76.24 -19.67 58.14 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.829 -1.17 . . . . 61.350000000000001 114.147 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.5 t -52.22 -57.71 14.24 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.499 1.12 . . . . 72.040000000000006 109.668 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.82 -17.51 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.713 1.608 . . . . 74.319999999999993 113.652 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -51.97 50.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.022 1.283 . . . . 73.439999999999998 109.733 172.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.86 91.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.491 0.716 . . . . 74.049999999999997 110.576 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.54 -39.28 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.609 0.764 . . . . 74.430000000000007 109.393 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.76 -4.99 29.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.595 1.093 . . . . 24.309999999999999 114.492 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.9 mt -109.24 13.39 24.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.393 1.597 . . . . 70.040000000000006 111.735 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 83' ' ' ILE . 3.3 t -54.3 -3.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.348 1.859 . . . . 73.349999999999994 115.22 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.61 7.88 24.19 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.13 1.347 . . . . 44.509999999999998 114.435 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -97.69 175.14 6.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.275 1.538 . . . . 72.040000000000006 110.311 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -155.57 89.07 1.16 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.265 -0.643 . . . . 72.230000000000004 109.265 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 m -60.31 113.45 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.151 -1.055 . . . . 72.209999999999994 108.151 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt 59.6 13.16 3.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.102 1.149 . . . . 72.329999999999998 114.102 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.07 13.3 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.638 -1.09 . . . . 65.25 113.425 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 24' ' ' ILE . 46.3 t -105.01 85.02 1.12 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.481 1.513 . . . . 63.020000000000003 108.352 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.8 179.38 3.76 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.256 2.638 . . . . 51.350000000000001 111.164 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 74' ' ' THR . 11.7 tt -129.59 177.1 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.724 2.01 . . . . 74.430000000000007 108.37 176.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -126.73 147.24 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.304 1.841 . . . . 70.310000000000002 107.413 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.43 -10.25 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 116.39 1.996 . . . . 65.019999999999996 116.39 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -56.34 -41.92 76.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.975 1.261 . . . . 74.209999999999994 112.898 -166.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.637 ' HA ' ' H ' ' A' ' 16' ' ' PHE . . . 58.97 174.94 0.07 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.279 1.038 . . . . 72.409999999999997 110.035 -165.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 105.494 -2.039 . . . . 75.409999999999997 105.494 171.361 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 111.105 0.039 . . . . 75.549999999999997 111.105 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.3 m -102.39 147.6 26.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.135 0.574 . . . . 64.439999999999998 109.628 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.41 129.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.462 1.105 . . . . 73.549999999999997 108.468 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -100.51 108.74 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.951 1.7 . . . . 71.209999999999994 109.143 -171.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' HD11 ' A' ' 20' ' ' LEU . 13.1 m -84.88 122.13 28.73 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.761 1.625 . . . . 53.130000000000003 106.871 175.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.2 ttp -139.04 52.27 1.78 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.029 0.919 . . . . 71.230000000000004 111.385 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.443 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 tt0 -154.97 30.45 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.729 -1.232 . . . . 64.140000000000001 109.668 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.675 ' H ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -84.26 166.63 17.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.802 1.287 . . . . 74.219999999999999 110.923 -167.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -105.15 153.12 21.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.629 -2.078 . . . . 34.350000000000001 110.202 -171.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.46 13.66 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.76 2.024 . . . . 71.129999999999995 114.598 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 25.22 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.067 2.147 . . . . 75.200000000000003 111.035 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 81' ' ' VAL . 10.6 tp -72.34 155.3 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.456 -1.403 . . . . 74.099999999999994 109.42 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.31 161.55 25.56 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.997 1.719 . . . . 71.219999999999999 107.274 171.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.38 -42.02 44.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.888 1.725 . . . . 75.510000000000005 112.416 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.09 -30.47 71.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 75.519999999999996 111.904 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -24.5 66.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.568 0.622 . . . . 63.509999999999998 110.979 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.4 -41.45 12.1 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.305 -0.628 . . . . 60.350000000000001 109.305 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -66.83 -35.33 79.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.558 0.617 . . . . 63.210000000000001 111.261 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.93 -24.91 43.71 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.56 -0.712 . . . . 75.129999999999995 112.474 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.09 -36.3 70.44 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.126 -0.359 . . . . 65.319999999999993 111.111 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -96.96 -1.9 44.74 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.211 0.819 . . . . 65.120000000000005 113.211 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -60.11 -20.48 58.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.297 1.839 . . . . 73.430000000000007 111.026 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -13.41 61.52 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.036 -1.04 . . . . 74.239999999999995 112.902 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.55 2.53 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 120.493 -1.379 . . . . 72.540000000000006 113.67 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.34 -143.45 7.99 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.453 -1.859 . . . . 51.229999999999997 108.453 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.701 ' HG2' HG11 ' A' ' 62' ' ' VAL . 3.7 ptmm? -129.24 161.76 29.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.408 -0.96 . . . . 64.439999999999998 108.408 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.25 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.847 -0.797 . . . . 72.25 108.847 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -78.11 -59.95 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.09 -1.078 . . . . 72.25 108.09 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -142.78 137.47 29.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.222 1.009 . . . . 73.450000000000003 108.629 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.44 129.81 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.583 1.553 . . . . 72.420000000000002 107.726 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -153.46 112.25 3.71 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.828 0.74 . . . . 75.099999999999994 111.381 -172.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -136.78 157.48 46.66 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.065 -1.022 . . . . 64.120000000000005 112.504 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 108.648 -0.871 . . . . 74.420000000000002 108.648 -166.822 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 20' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 108.461 -1.855 . . . . 50.5 108.461 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.19 138.2 14.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.158 1.783 . . . . 73.530000000000001 109.925 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.29 151.48 33.0 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.198 1.399 . . . . 75.519999999999996 108.454 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -128.36 104.21 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.578 -2.008 . . . . 74.430000000000007 105.578 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.32 118.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.495 -1.669 . . . . 64.209999999999994 106.495 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -91.16 121.17 32.7 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.672 -1.603 . . . . 75.129999999999995 106.672 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.88 165.21 11.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.445 1.116 . . . . 75.140000000000001 112.181 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.701 HG11 ' HG2' ' A' ' 38' ' ' LYS . 15.6 m -76.56 -34.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.62 1.568 . . . . 61.409999999999997 112.761 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -134.13 152.4 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.358 1.063 . . . . 55.32 112.908 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.42 -27.72 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 71.140000000000001 112.054 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -60.02 -25.43 65.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.344 1.429 . . . . 65.209999999999994 113.95 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.4 p -77.64 -19.21 55.83 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.125 1.33 . . . . 64.140000000000001 114.254 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.47 -57.23 24.55 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.65 1.18 . . . . 71.150000000000006 111.404 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -63.59 -23.7 70.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.437 1.425 . . . . 73.150000000000006 111.462 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -50.97 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.967 0.907 . . . . 62.43 109.863 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.51 77.65 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.228 1.011 . . . . 65.140000000000001 111.418 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.0 mt -53.66 -43.62 55.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.18 0.992 . . . . 74.209999999999994 109.382 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.33 64.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.161 -0.8 . . . . 74.329999999999998 112.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -98.67 4.26 47.88 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.096 1.358 . . . . 65.129999999999995 111.279 -167.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.294 2.8 m -45.55 -26.79 0.64 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.565 0.95 . . . . 70.030000000000001 113.565 161.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 18.06 45.04 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.309 0.884 . . . . 61.149999999999999 115.309 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -125.68 163.17 23.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 119.328 1.564 . . . . 73.150000000000006 109.367 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -136.25 115.71 12.75 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.398 1.479 . . . . 63.229999999999997 110.335 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -79.96 98.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.868 -1.53 . . . . 74.030000000000001 106.868 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt 54.87 33.25 19.49 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.139 0.976 . . . . 73.239999999999995 112.082 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.81 57.17 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.71 -1.05 . . . . 52.329999999999998 113.917 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 20' ' ' LEU . 99.3 t -114.06 85.32 9.96 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 118.891 1.345 . . . . 65.230000000000004 108.176 168.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.82 -177.63 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.734 2.29 . . . . 51.509999999999998 111.714 162.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -124.29 156.84 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.648 -0.871 . . . . 70.219999999999999 108.648 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.92 146.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.423 -1.325 . . . . 65.129999999999995 107.423 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -74.12 16.32 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.688 1.995 . . . . 61.310000000000002 112.736 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.21 -26.64 63.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.441 2.296 . . . . 72.310000000000002 112.889 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.46 36.24 22.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.288 1.835 . . . . 64.010000000000005 113.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 C-N-CA 127.227 2.211 . . . . 62.520000000000003 114.918 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 N-CA-C 110.123 -1.191 . . . . 64.430000000000007 110.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -68.23 174.37 4.0 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.304 0.642 . . . . 61.420000000000002 110.541 166.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.4 mmm -123.97 -62.8 1.26 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.353 -1.721 . . . . 72.109999999999999 106.353 155.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -121.74 165.51 15.71 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.662 0.785 . . . . 72.239999999999995 109.48 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.19 168.75 19.53 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.028 1.731 . . . . 62.109999999999999 109.806 178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.34 155.47 65.13 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.905 1.282 . . . . 63.109999999999999 110.62 166.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -55.36 -38.35 93.91 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.008 1.805 . . . . 41.32 112.228 167.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -76.02 -20.95 57.37 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.442 1.497 . . . . 63.350000000000001 110.798 -174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.26 -33.11 74.62 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 121.368 -0.833 . . . . 53.530000000000001 109.278 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -38.19 89.36 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 119.228 0.922 . . . . 71.219999999999999 110.383 177.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -55.33 -38.27 68.5 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.044 0.537 . . . . 73.420000000000002 110.67 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.17 2.16 25.34 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 116.017 1.858 . . . . 71.319999999999993 116.017 -174.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.74 -9.7 55.5 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.01 -1.681 . . . . 64.109999999999999 113.581 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.3 m -57.31 143.11 41.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.809 1.244 . . . . 63.520000000000003 110.402 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.0 116.93 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-O 122.41 1.1 . . . . 72.329999999999998 108.166 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -68.63 124.64 24.17 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.685 -1.143 . . . . 63.340000000000003 108.209 170.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.1 m -113.74 105.29 13.12 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 105.324 -2.102 . . . . 73.25 105.324 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.3 tmm? -113.03 174.24 6.0 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.057 -1.09 . . . . 61.219999999999999 108.057 175.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 74.99 17.35 2.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 128.005 2.522 . . . . 74.439999999999998 112.046 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.698 ' HA ' HG13 ' A' ' 81' ' ' VAL . 20.7 mt -77.48 165.63 24.12 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.875 -0.515 . . . . 71.230000000000004 111.497 -171.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.5 153.21 41.47 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.262 0.553 . . . . 75.129999999999995 111.463 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.04 -24.37 53.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.817 1.247 . . . . 33.340000000000003 113.736 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -123.25 19.4 9.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.366 1.867 . . . . 74.239999999999995 111.155 -167.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.623 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.0 tt -63.92 151.24 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 118.607 0.639 . . . . 64.120000000000005 109.961 174.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 160.9 35.77 Favored Pre-proline 0 N--CA 1.464 0.266 0 C-N-CA 125.089 1.356 . . . . 75.319999999999993 107.554 170.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -58.59 -42.15 57.31 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.233 1.289 . . . . 73.340000000000003 110.596 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -30.59 71.7 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-O 118.073 -0.965 . . . . 74.25 111.663 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -56.12 -30.72 62.49 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.549 1.068 . . . . 55.149999999999999 110.382 -169.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -82.91 -41.46 18.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.795 1.638 . . . . 74.239999999999995 110.527 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.87 -37.63 73.06 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 109.223 -0.658 . . . . 65.340000000000003 109.223 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -54.33 -55.47 28.13 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 126.722 2.009 . . . . 43.420000000000002 109.642 170.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -55.08 -29.78 58.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.85 1.26 . . . . 73.230000000000004 112.446 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.86 -35.65 13.25 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 113.188 0.81 . . . . 63.340000000000003 113.188 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.1 t -57.26 -23.11 46.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.641 1.176 . . . . 62.140000000000001 111.674 -174.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 t -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.739 0.815 . . . . 64.230000000000004 112.735 177.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -136.86 6.28 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.171 1.388 . . . . 64.129999999999995 111.315 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.39 -174.85 23.36 Favored Glycine 0 C--N 1.336 0.552 0 O-C-N 121.042 -1.036 . . . . 61.340000000000003 113.105 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -140.1 138.22 35.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.829 1.252 . . . . 72.439999999999998 109.334 172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.3 t -103.54 138.68 26.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 125.628 1.571 . . . . 61.409999999999997 107.573 -176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 ttt180 -85.78 -57.71 2.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.852 1.661 . . . . 42.020000000000003 108.12 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -158.27 175.86 13.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.811 0.732 . . . . 63.409999999999997 109.701 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.2 t -130.2 113.61 26.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 126.109 1.764 . . . . 71.310000000000002 107.389 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -115.05 51.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.792 1.637 . . . . 55.439999999999998 108.578 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.1 ttt -66.57 128.96 38.25 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.906 1.282 . . . . 73.140000000000001 107.897 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.73 HD12 ' H ' ' A' ' 45' ' ' ILE . 2.8 mp -65.89 127.21 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.871 -1.9 . . . . 62.210000000000001 105.871 170.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -71.91 73.5 0.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.292 1.437 . . . . 44.109999999999999 111.281 -172.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.3 68.92 5.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.808 2.043 . . . . 60.109999999999999 112.238 -159.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mtt-85 -116.25 -19.67 10.11 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.31 -1.494 . . . . 61.229999999999997 113.782 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -47.39 -24.79 0.86 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.999 2.119 . . . . 75.140000000000001 114.744 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 68.03 22.87 8.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.132 0.878 . . . . 53.109999999999999 112.154 171.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -149.52 -5.45 0.37 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.167 1.173 . . . . 72.340000000000003 114.167 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -99.87 -163.57 1.04 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.151 1.78 . . . . 74.540000000000006 109.206 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 m -58.07 -39.37 78.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 115.035 1.494 . . . . 63.450000000000003 115.035 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt 64.4 35.91 9.31 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 126.332 1.853 . . . . 61.210000000000001 112.221 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.2 46.69 0.32 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-O 118.916 -0.935 . . . . 74.319999999999993 113.987 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.4 pt -139.11 148.7 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 118.601 1.2 . . . . 74.310000000000002 111.776 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.39 162.82 33.44 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.107 2.163 . . . . 62.310000000000002 109.842 170.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.641 ' CE2' HD11 ' A' ' 45' ' ' ILE . 85.8 m-85 -130.09 114.56 15.91 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.662 1.585 . . . . 63.310000000000002 108.017 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.5 t -99.19 122.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 107.835 -1.172 . . . . 72.209999999999994 107.835 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -75.7 114.37 14.21 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.696 -1.224 . . . . 52.32 107.696 170.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 66' ' ' SER . 2.9 m-85 -80.02 166.25 21.75 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.999 -0.371 . . . . 74.140000000000001 109.999 165.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.9 t -91.97 -9.36 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 CA-C-O 118.68 -0.676 . . . . 63.549999999999997 111.358 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -135.55 135.0 40.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 121.342 1.883 . . . . 75.150000000000006 113.695 -168.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.1 p -60.21 -35.13 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 123.725 0.81 . . . . 71.310000000000002 111.981 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.1 m -80.68 -9.24 59.81 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 119.178 -1.009 . . . . 75.510000000000005 111.025 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.478 ' HB3' ' CE2' ' A' ' 61' ' ' PHE . 12.7 m -80.28 -11.81 59.68 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 117.548 -1.215 . . . . 55.119999999999997 113.659 172.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.5 t -61.34 -59.3 14.04 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 120.551 1.523 . . . . 52.439999999999998 108.765 172.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.48 -18.79 60.49 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 121.952 1.768 . . . . 54.310000000000002 113.667 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 tt -63.52 -57.88 8.76 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 119.464 1.029 . . . . 73.140000000000001 108.75 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.01 69.28 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.704 1.202 . . . . 63.32 112.051 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 71.2 mt -54.85 -48.47 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 108.72 -0.845 . . . . 73.109999999999999 108.72 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -64.69 -6.21 21.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.727 1.156 . . . . 64.340000000000003 115.256 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.433 HD22 HE21 ' A' ' 76' ' ' GLN . 91.5 mt -97.19 1.46 49.83 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.822 1.311 . . . . 73.329999999999998 112.168 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.68 -23.98 7.69 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.801 1.778 . . . . 71.420000000000002 115.801 -170.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.15 1.65 37.91 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.143 0.878 . . . . 31.149999999999999 113.473 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.433 HE21 HD22 ' A' ' 73' ' ' LEU . 26.5 mt-30 -72.1 170.72 13.33 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.073 -1.084 . . . . 60.229999999999997 108.073 162.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -162.59 82.04 0.52 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 113.622 0.971 . . . . 71.209999999999994 113.622 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 m -61.78 117.24 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.608 -0.886 . . . . 63.219999999999999 108.608 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt 60.67 2.17 0.48 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.002 1.321 . . . . 65.120000000000005 114.157 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.79 11.96 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-O 118.799 -1.0 . . . . 52.350000000000001 113.132 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 20' ' ' LEU . 65.7 t -112.37 86.12 7.78 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 118.945 1.373 . . . . 72.129999999999995 110.034 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -69.81 175.78 7.69 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.669 2.246 . . . . 44.539999999999999 111.369 166.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.4 tt -134.92 140.42 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 124.302 1.041 . . . . 52.149999999999999 110.256 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.8 mm -77.34 145.93 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.212 -0.93 . . . . 53.219999999999999 110.047 174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.04 4.99 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 128.886 2.874 . . . . 54.340000000000003 115.806 171.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.8 -36.92 84.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.936 1.458 . . . . 61.130000000000003 114.936 -157.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.77 173.63 0.07 Allowed 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.441 1.496 . . . . 63.420000000000002 110.091 -163.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.11 50.53 0.97 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.674 -1.232 . . . . 52.420000000000002 107.674 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -72.14 -179.32 2.78 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.313 1.445 . . . . 74.349999999999994 109.577 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.76 161.13 36.04 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.093 0.957 . . . . 65.329999999999998 110.264 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -81.57 49.2 1.28 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.467 1.907 . . . . 63.549999999999997 109.706 174.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -142.24 141.06 32.46 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.896 1.278 . . . . 64.310000000000002 108.061 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -154.59 105.47 2.63 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 107.32 -1.363 . . . . 61.130000000000003 107.32 171.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.17 2.188 . . . . 60.219999999999999 109.167 -167.183 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.835 0 N-CA-C 109.853 -1.299 . . . . 52.140000000000001 109.853 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 m80 64.58 15.06 9.42 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.696 1.598 . . . . 62.329999999999998 112.592 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.8 mtp 61.52 158.79 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 128.2 2.6 . . . . 72.150000000000006 112.819 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -73.3 159.63 33.09 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.924 -0.58 . . . . 72.519999999999996 109.986 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 24.0 tp -66.29 153.28 43.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.968 0.907 . . . . 74.329999999999998 110.566 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.6 145.34 35.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 124.931 1.293 . . . . 62.229999999999997 108.575 170.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -62.64 -25.21 75.19 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.275 1.983 . . . . 72.430000000000007 111.369 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -70.48 -39.41 74.23 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.149 -0.685 . . . . 71.319999999999993 109.149 -173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -74.7 -20.17 59.96 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.066 0.946 . . . . 71.25 111.846 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -81.75 -31.04 32.17 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 121.544 -0.722 . . . . 74.349999999999994 110.931 169.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -40.15 87.66 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.845 0.748 . . . . 50.350000000000001 109.075 173.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.91 -3.83 1.33 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.586 2.354 . . . . 50.350000000000001 114.946 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -60.12 -28.64 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.593 1.088 . . . . 73.340000000000003 111.901 173.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.2 m -85.35 144.3 28.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.198 -1.038 . . . . 70.25 108.198 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.65 122.14 66.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 124.355 1.062 . . . . 74.140000000000001 108.252 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -73.7 132.87 43.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.918 1.687 . . . . 71.519999999999996 110.107 176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.7 m -117.64 130.3 56.28 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.541 1.936 . . . . 70.230000000000004 106.356 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.9 ttp -138.32 29.87 2.44 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.839 1.256 . . . . 31.199999999999999 110.69 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -153.86 15.31 0.49 Allowed 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.546 -1.346 . . . . 74.150000000000006 111.972 -165.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 58.3 mt -67.29 156.59 36.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.825 0.45 . . . . 73.420000000000002 111.142 -167.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.45 152.23 44.45 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.052 0.454 . . . . 72.540000000000006 109.978 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.94 64.87 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.447 1.099 . . . . 74.430000000000007 113.744 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -121.59 58.48 1.0 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.752 1.221 . . . . 73.439999999999998 109.345 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.2 tp -58.73 161.51 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.019 -1.051 . . . . 42.109999999999999 109.351 172.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -120.26 158.3 51.2 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 125.579 1.552 . . . . 62.530000000000001 108.099 175.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -68.86 -32.42 22.65 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 121.588 1.525 . . . . 72.219999999999999 111.319 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -70.82 -37.86 73.25 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 118.614 0.643 . . . . 74.549999999999997 111.322 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.83 -40.41 69.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.201 1.001 . . . . 71.319999999999993 110.74 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.3 -48.26 62.1 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.683 1.193 . . . . 74.439999999999998 110.88 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 39' ' ' VAL . 10.7 pt-20 -69.2 -37.82 78.3 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 118.496 -0.764 . . . . 65.109999999999999 109.633 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.34 -25.86 66.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.068 0.849 . . . . 72.150000000000006 112.223 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.6 -36.63 83.35 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.744 0.702 . . . . 72.129999999999995 110.244 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -99.55 -33.88 10.46 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.501 -0.761 . . . . 71.239999999999995 112.417 -174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.1 t -66.02 -17.14 64.49 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.793 1.179 . . . . 62.329999999999998 111.501 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -80.95 -2.84 49.37 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.259 -0.901 . . . . 74.129999999999995 112.23 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.0 m -142.75 15.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 126.166 1.786 . . . . 52.43 111.481 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.06 -155.53 17.3 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.001 -1.639 . . . . 61.539999999999999 109.001 -161.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -157.81 147.74 20.29 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.853 1.327 . . . . 65.109999999999999 108.998 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 30' ' ' GLU . 53.4 t -112.23 122.99 67.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 124.443 1.097 . . . . 65.530000000000001 110.024 -173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -76.07 -45.73 32.61 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.805 1.242 . . . . 73.549999999999997 110.501 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.9 163.64 37.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.443 1.097 . . . . 73.239999999999995 108.777 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 p -142.4 126.29 15.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.171 1.388 . . . . 63.530000000000001 107.296 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -132.6 103.97 6.42 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.698 -0.852 . . . . 61.509999999999998 108.698 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -96.42 137.11 35.98 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.448 1.099 . . . . 74.219999999999999 108.302 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -91.77 82.05 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.897 -1.89 . . . . 70.549999999999997 105.897 172.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.3 m -103.55 4.77 36.15 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.766 0.826 . . . . 61.340000000000003 112.834 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.08 143.15 47.53 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.365 -1.717 . . . . 54.350000000000001 106.365 161.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 166.96 28.31 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.839 -0.8 . . . . 74.120000000000005 108.839 164.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -115.89 -7.01 12.04 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.415 0.686 . . . . 73.120000000000005 111.388 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -157.43 -70.87 0.1 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.944 -1.502 . . . . 73.230000000000004 106.944 161.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -138.01 165.51 26.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 103.809 -2.663 . . . . 52.229999999999997 103.809 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -163.97 -177.59 5.15 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.382 1.473 . . . . 71.340000000000003 107.196 174.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -28.49 58.07 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 119.809 1.186 . . . . 70.219999999999999 112.473 172.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.366 0.0 OUTLIER 56.49 11.01 0.76 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 117.077 2.251 . . . . 74.540000000000006 117.077 171.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.13 55.34 0.71 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 109.726 -1.35 . . . . 32.530000000000001 109.726 164.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -120.57 128.31 76.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.034 1.334 . . . . 72.150000000000006 111.062 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.89 158.73 44.51 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.005 1.322 . . . . 72.230000000000004 110.176 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -124.34 135.69 53.53 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.979 -1.489 . . . . 70.340000000000003 106.979 164.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.375 1.5 p -138.54 109.93 5.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.088 0.955 . . . . 65.549999999999997 110.56 -168.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -74.25 122.31 22.63 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.43 1.892 . . . . 72.239999999999995 110.357 -171.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 66' ' ' SER . 3.2 m-85 -74.76 153.92 38.59 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 122.16 0.981 . . . . 63.329999999999998 111.483 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -73.94 -21.76 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 115.229 -0.896 . . . . 73.219999999999999 110.868 166.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -137.85 128.22 26.31 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.243 1.417 . . . . 74.549999999999997 109.857 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.0 p -54.38 -30.66 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.216 1.406 . . . . 61.530000000000001 111.388 172.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -73.73 -21.11 60.32 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.243 -1.535 . . . . 72.109999999999999 112.855 -175.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' HB2' ' CD1' ' A' ' 61' ' ' PHE . 7.2 m -81.71 -8.69 59.73 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 119.704 1.138 . . . . 74.129999999999995 112.553 172.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.15 -66.54 1.19 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 116.101 -1.904 . . . . 71.450000000000003 107.768 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -62.03 -17.87 58.46 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.433 2.089 . . . . 74.239999999999995 113.837 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.14 -42.45 76.98 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.554 1.142 . . . . 74.329999999999998 109.45 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.69 -36.55 69.75 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.017 0.747 . . . . 63.109999999999999 113.017 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.9 mt -59.41 -42.54 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 118.941 0.791 . . . . 72.219999999999999 109.769 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.02 -5.09 8.66 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.384 -0.676 . . . . 75.129999999999995 113.091 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 mt -118.12 5.6 12.01 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.383 1.591 . . . . 74.129999999999995 112.456 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.7 t -48.07 -33.75 8.59 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.234 1.379 . . . . 62.520000000000003 113.094 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.85 12.86 41.8 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 125.891 1.71 . . . . 73.109999999999999 113.839 -174.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -92.77 172.23 8.48 Favored 'General case' 0 C--O 1.227 -0.107 0 CA-C-N 118.874 1.337 . . . . 74.510000000000005 108.069 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -155.93 99.46 1.98 Allowed 'General case' 0 C--O 1.231 0.114 0 C-N-CA 123.388 0.675 . . . . 75.239999999999995 111.137 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.64 114.11 5.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 107.919 -1.141 . . . . 70.340000000000003 107.919 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 mt 54.53 21.35 3.3 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.873 1.064 . . . . 70.319999999999993 113.873 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 102.72 13.84 28.82 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 119.297 -0.724 . . . . 61.340000000000003 113.945 -176.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -112.13 85.11 6.39 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 119.354 1.577 . . . . 71.120000000000005 109.719 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.83 177.76 8.09 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.862 2.375 . . . . 72.129999999999995 111.388 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.8 tt -136.48 169.09 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.871 0.693 . . . . 73.349999999999994 112.871 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.8 mm -117.18 124.44 73.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.707 2.003 . . . . 61.549999999999997 108.798 -169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.7 t -53.38 -17.75 1.47 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 128.079 2.552 . . . . 70.150000000000006 115.831 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.87 -42.56 80.01 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.568 1.531 . . . . 65.239999999999995 111.646 176.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.0 41.83 15.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.836 1.654 . . . . 63.340000000000003 113.986 170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.258 0.5 OUTLIER 43.65 74.98 0.1 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 127.227 2.211 . . . . 74.319999999999993 111.449 -171.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.58 155.94 0.14 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.571 1.148 . . . . 70.310000000000002 113.546 169.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -83.21 55.06 2.99 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.985 0.514 . . . . 72.120000000000005 111.553 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 72.97 4.17 4.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.734 1.613 . . . . 43.32 113.001 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -92.28 -176.69 4.42 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.205 1.402 . . . . 51.43 111.472 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 41.7 t30 64.67 101.58 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 129.91 3.284 . . . . 72.109999999999999 110.62 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.839 0 C-N-CA 126.215 1.806 . . . . 71.319999999999993 109.409 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 111.502 -0.639 . . . . 72.439999999999998 111.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -146.42 -27.44 0.42 Allowed 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 113.576 0.954 . . . . 73.430000000000007 113.576 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm -148.7 -62.05 0.24 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.25 0.932 . . . . 70.010000000000005 111.571 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.58 163.09 27.71 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.819 -0.808 . . . . 65.140000000000001 108.819 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.0 tp -121.51 137.08 54.88 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.917 -1.512 . . . . 63.240000000000002 106.917 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.07 148.92 97.83 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 105.799 -1.926 . . . . 65.239999999999995 105.799 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.37 -15.44 45.09 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.672 1.582 . . . . 72.310000000000002 111.971 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -80.17 -33.39 38.38 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 124.304 1.042 . . . . 73.430000000000007 111.52 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.84 -43.46 85.85 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.596 1.089 . . . . 73.150000000000006 111.118 -168.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 44.2 ttt85 -68.13 -23.42 64.89 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 117.821 -1.085 . . . . 75.340000000000003 113.755 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.48 -17.5 28.55 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.504 1.121 . . . . 73.439999999999998 110.3 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.26 -61.99 1.84 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.02 1.328 . . . . 52.049999999999997 112.185 -176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 44.52 65.1 1.13 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 127.284 2.234 . . . . 60.340000000000003 110.843 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.17 151.38 50.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.332 0.969 . . . . 72.430000000000007 112.237 -173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.84 122.92 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.1 1.76 . . . . 62.420000000000002 110.691 169.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -72.91 129.71 38.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.262 1.425 . . . . 73.510000000000005 109.647 169.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.6 m -122.15 105.06 9.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.994 -1.484 . . . . 64.519999999999996 106.994 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.8 ttm -88.01 174.57 8.21 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.712 0.805 . . . . 72.430000000000007 109.133 171.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.43 HE21 HD11 ' A' ' 84' ' ' ILE . 0.9 OUTLIER 70.14 21.03 6.16 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 127.44 2.296 . . . . 73.439999999999998 113.185 164.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.7 mt -69.1 167.03 16.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.104 0.561 . . . . 65.200000000000003 111.77 -174.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' HB2' HG21 ' A' ' 81' ' ' VAL . . . -62.26 147.73 47.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.976 -0.556 . . . . 64.140000000000001 110.332 175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.99 -4.26 2.11 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.32 1.448 . . . . 51.240000000000002 113.675 173.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -139.36 13.57 2.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.77 1.628 . . . . 73.099999999999994 112.138 -175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.2 tt -47.7 131.46 4.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.756 0.822 . . . . 71.540000000000006 112.275 -167.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -66.97 147.67 99.05 Favored Pre-proline 0 N--CA 1.454 -0.237 0 N-CA-C 107.548 -1.279 . . . . 71.430000000000007 107.548 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.55 1.77 4.63 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.088 2.525 . . . . 55.039999999999999 113.36 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.67 -22.0 14.02 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.814 1.188 . . . . 72.349999999999994 113.019 167.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -30.43 71.52 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 119.811 1.187 . . . . 52.119999999999997 112.046 -165.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.3 mt -84.71 -24.13 29.03 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 122.989 0.516 . . . . 72.439999999999998 111.436 -176.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.44 ' HG2' HG21 ' A' ' 42' ' ' VAL . 1.4 mt-10 -80.78 -52.01 7.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.33 -2.1 . . . . 71.140000000000001 105.33 177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.12 -38.72 83.9 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.896 1.678 . . . . 74.230000000000004 110.668 -172.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -57.96 -49.26 77.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.237 0.926 . . . . 73.319999999999993 111.971 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -85.13 -15.23 44.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.1 0.407 . . . . 74.340000000000003 112.1 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.7 p -59.23 -20.13 51.5 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 125.617 1.567 . . . . 72.109999999999999 113.399 -171.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.9 t -65.38 -24.37 67.21 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 122.954 0.502 . . . . 64.510000000000005 110.466 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.87 47.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 O-C-N 121.009 -1.057 . . . . 74.430000000000007 110.75 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.17 153.5 9.37 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 126.005 1.764 . . . . 53.219999999999999 108.979 175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.694 ' HG2' HG21 ' A' ' 62' ' ' VAL . 0.0 OUTLIER -89.97 167.48 12.76 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.296 0.638 . . . . 51.219999999999999 110.71 -178.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 61' ' ' PHE . 2.6 p -124.35 145.35 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.442 1.897 . . . . 55.030000000000001 107.78 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ttt180 -74.11 -49.52 23.51 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.776 -1.107 . . . . 64.549999999999997 109.098 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -165.87 -179.69 5.41 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.405 1.002 . . . . 73.349999999999994 111.818 176.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.44 HG21 ' HG2' ' A' ' 30' ' ' GLU . 51.9 t -133.56 110.01 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 127.006 2.123 . . . . 75.109999999999999 107.623 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -104.34 85.33 2.34 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.377 1.071 . . . . 75.239999999999995 108.985 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.47 160.74 19.64 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.649 0.737 . . . . 65.239999999999995 110.086 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 mp -83.92 149.28 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.841 -1.54 . . . . 74.109999999999999 106.841 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 m -70.76 88.49 0.72 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.111 1.364 . . . . 72.120000000000005 107.903 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.25 129.93 42.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.664 0.786 . . . . 72.510000000000005 111.757 -171.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -137.15 -2.02 2.09 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.792 1.404 . . . . 65.409999999999997 114.792 -158.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 64.0 14.15 8.24 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.997 1.48 . . . . 73.230000000000004 114.997 157.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.5 t -139.69 -24.37 0.85 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.901 1.68 . . . . 65.439999999999998 111.326 -171.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -159.68 52.33 0.35 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.649 -1.282 . . . . 73.329999999999998 110.021 170.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 153.19 45.86 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 106.505 -1.665 . . . . 74.319999999999993 106.505 176.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t -75.98 39.9 0.19 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.012 0.925 . . . . 71.030000000000001 112.645 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt 52.23 25.77 3.55 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 115.412 1.634 . . . . 70.299999999999997 115.412 171.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.59 102.64 0.35 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.349 -1.1 . . . . 72.400000000000006 110.349 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.54 156.11 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.86 1.264 . . . . 51.340000000000003 111.044 -172.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -161.86 159.91 27.44 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.22 1.008 . . . . 73.140000000000001 113.43 -172.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -122.35 105.41 10.16 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.777 2.431 . . . . 74.209999999999994 106.15 160.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 78.7 t -91.65 132.18 36.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.62 -1.622 . . . . 75.329999999999998 106.62 175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -116.47 89.86 3.2 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.492 1.117 . . . . 73.439999999999998 110.276 -166.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.3 OUTLIER -60.98 169.77 1.83 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.463 2.023 . . . . 72.430000000000007 116.463 -176.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.694 HG21 ' HG2' ' A' ' 38' ' ' LYS . 31.1 t -87.4 -23.71 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 O-C-N 121.539 -0.726 . . . . 53.240000000000002 112.216 167.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -139.15 144.66 38.7 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 120.436 1.471 . . . . 73.409999999999997 114.162 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.2 t -48.84 -43.76 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 129.704 3.201 . . . . 63.310000000000002 111.675 173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.3 p -64.2 -20.65 66.17 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 120.065 1.302 . . . . 61.219999999999999 111.48 -171.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.408 ' HB2' ' CD2' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -83.8 -10.41 58.09 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.793 1.034 . . . . 64.310000000000002 113.793 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.2 t -60.97 -60.22 11.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.995 0.918 . . . . 72.109999999999999 109.591 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -11.57 32.73 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 121.537 1.491 . . . . 71.140000000000001 113.776 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tt -66.05 -49.16 68.64 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.946 0.794 . . . . 72.239999999999995 109.461 173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.57 -38.29 74.58 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.722 -0.611 . . . . 61.450000000000003 111.424 175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD11 ' HB2' ' A' ' 87' ' ' ALA . 88.7 mt -58.37 -44.76 89.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.38 0.672 . . . . 73.349999999999994 109.514 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.35 -35.85 61.76 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 118.624 0.647 . . . . 54.450000000000003 112.894 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.5 mt -76.94 4.07 10.74 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.363 1.065 . . . . 65.209999999999994 113.554 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.0 t -46.44 -27.12 0.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.433 1.493 . . . . 74.209999999999994 114.419 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.17 -3.91 63.22 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.868 -1.145 . . . . 70.049999999999997 113.677 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -77.08 176.5 8.63 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 119.217 1.509 . . . . 60.43 110.488 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.03 86.5 1.57 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.525 1.13 . . . . 73.030000000000001 109.019 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.46 93.99 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.584 1.554 . . . . 55.32 109.784 -173.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt 46.24 43.3 11.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 122.658 1.218 . . . . 64.230000000000004 110.772 -167.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.43 21.0 46.23 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 121.314 -0.866 . . . . 71.329999999999998 113.347 178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 21' ' ' ALA . 21.5 t -118.7 85.87 28.46 Favored Pre-proline 0 C--O 1.236 0.382 0 C-N-CA 125.85 1.66 . . . . 72.140000000000001 107.52 178.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -67.7 -179.44 2.03 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.299 1.999 . . . . 74.349999999999994 111.003 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.599 HG23 ' HA ' ' A' ' 74' ' ' THR . 14.9 tt -142.51 156.13 18.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 108.535 -0.913 . . . . 72.450000000000003 108.535 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.43 HD11 HE21 ' A' ' 19' ' ' GLN . 46.1 mm -108.26 143.37 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.417 1.487 . . . . 71.239999999999995 108.797 -174.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -66.52 3.75 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.16 1.784 . . . . 62.140000000000001 114.481 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -44.29 -53.15 6.95 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.445 1.898 . . . . 72.219999999999999 112.46 -172.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.469 ' HB2' HD11 ' A' ' 71' ' ' ILE . . . 58.58 163.27 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 123.684 1.706 . . . . 61.119999999999997 112.872 -170.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 40.4 t -90.45 76.63 6.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 104.208 -2.515 . . . . 70.010000000000005 104.208 168.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -97.03 122.75 40.37 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.831 -1.168 . . . . 74.25 110.082 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 69.56 157.77 0.16 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 128.897 2.879 . . . . 54.539999999999999 112.422 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.33 32.86 0.19 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.859 1.664 . . . . 73.420000000000002 112.573 -170.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -111.62 -24.22 10.22 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.567 1.321 . . . . 73.209999999999994 114.567 -174.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -79.96 84.99 5.63 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.139 -1.43 . . . . 72.109999999999999 107.139 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.169 0 N-CA-C 107.128 -1.434 . . . . 72.209999999999994 107.128 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.991 0 CA-C-O 116.894 -2.059 . . . . 64.030000000000001 111.403 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 43.65 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.46 2.704 . . . . 75.439999999999998 111.839 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.341 0.0 OUTLIER 54.45 -5.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 118.085 2.624 . . . . 55.439999999999998 118.085 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.3 t30 75.91 154.71 0.16 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 129.635 3.174 . . . . 75.109999999999999 110.428 -166.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.48 174.19 1.04 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.853 2.461 . . . . 72.150000000000006 111.224 -174.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.88 153.08 47.0 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.34 -1.726 . . . . 74.450000000000003 106.34 159.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -61.22 -12.98 25.74 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.983 1.788 . . . . 74.420000000000002 113.458 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.9 -31.94 51.52 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.731 1.15 . . . . 75.230000000000004 112.255 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -64.75 -43.47 93.2 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.956 1.253 . . . . 62.210000000000001 110.561 -170.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.94 -17.18 55.97 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.93 1.085 . . . . 63.530000000000001 113.93 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.62 -43.08 8.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.843 1.657 . . . . 72.510000000000005 108.623 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.83 -65.09 0.64 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.815 2.046 . . . . 63.530000000000001 112.342 -173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 21.0 mtt85 57.94 0.37 0.11 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 116.187 1.921 . . . . 72.120000000000005 116.187 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -102.94 148.47 25.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.725 1.148 . . . . 64.329999999999998 109.734 -159.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.9 m -126.12 135.27 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 C-N-CA 125.109 1.364 . . . . 72.430000000000007 109.635 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -100.25 106.61 18.29 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.499 1.12 . . . . 72.430000000000007 109.619 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -93.18 83.63 4.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.818 2.047 . . . . 55.310000000000002 109.221 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.7 ttp -91.21 41.37 1.06 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.3 0.852 . . . . 74.150000000000006 113.3 -171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -154.39 27.25 0.45 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.368 -1.458 . . . . 73.219999999999999 113.752 -172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 29' ' ' LEU . 10.6 mt -65.84 152.12 45.13 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.724 -0.61 . . . . 64.540000000000006 111.22 -173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.8 168.21 14.5 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.301 0.572 . . . . 71.120000000000005 111.531 175.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.67 66.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.026 1.121 . . . . 44.009999999999998 114.026 -169.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -117.07 10.22 13.85 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.142 1.377 . . . . 73.530000000000001 111.434 -166.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.1 tt -56.35 139.61 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.3 1.44 . . . . 73.519999999999996 111.659 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -87.82 161.46 44.39 Favored Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 124.32 1.048 . . . . 74.340000000000003 108.591 163.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -57.88 -44.61 38.84 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.044 1.829 . . . . 64.230000000000004 110.902 171.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -62.44 -23.28 66.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.135 -0.936 . . . . 73.230000000000004 112.724 -175.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -60.53 -23.47 64.6 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 120.64 1.563 . . . . 53.149999999999999 111.719 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD11 HD22 ' A' ' 20' ' ' LEU . 2.3 mm? -80.44 -25.02 39.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.611 1.165 . . . . 53.229999999999997 112.893 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.0 -38.64 11.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.876 1.216 . . . . 75.530000000000001 109.606 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.52 -27.41 64.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.553 1.07 . . . . 75.540000000000006 112.683 -177.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -70.02 -64.16 0.94 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.413 0.552 . . . . 72.549999999999997 109.77 172.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -67.0 -22.35 65.91 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.032 0.753 . . . . 75.140000000000001 113.032 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -64.29 -4.72 4.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.089 1.356 . . . . 71.129999999999995 111.094 175.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -53.33 -30.32 38.53 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.406 1.457 . . . . 64.450000000000003 110.66 161.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.5 m -144.68 65.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.492 1.517 . . . . 63.219999999999999 110.264 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 120.57 177.13 15.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 122.861 1.256 . . . . 75.310000000000002 115.003 149.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.741 ' HG3' HG21 ' A' ' 62' ' ' VAL . 1.3 ptpt -91.74 53.91 2.34 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.814 1.413 . . . . 74.420000000000002 114.814 -151.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . 0.308 1.5 p -44.6 130.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.528 1.131 . . . . 73.420000000000002 110.854 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.2 ttt-85 -85.11 -48.25 9.36 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 112.72 -2.036 . . . . 64.540000000000006 109.843 -155.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -161.47 155.69 22.52 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 124.971 1.419 . . . . 75.450000000000003 110.302 171.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.02 148.6 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.67 1.588 . . . . 52.420000000000002 107.717 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -138.84 121.8 16.68 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.147 -1.797 . . . . 75.319999999999993 106.147 170.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.2 ptp -143.36 166.73 23.95 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.659 0.784 . . . . 74.239999999999995 111.284 -169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.76 112.79 31.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 109.886 -168.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 74.2 m -107.69 3.93 25.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 113.089 0.774 . . . . 61.43 113.089 160.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -77.53 80.71 4.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.01 2.124 . . . . 73.329999999999998 108.808 -171.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -170.84 -45.68 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.079 0.952 . . . . 51.219999999999999 109.02 168.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 59.91 -71.08 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 C-N-CA 129.489 3.116 . . . . 75.420000000000002 111.11 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 t -49.28 -36.26 20.24 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 127.585 2.354 . . . . 64.510000000000005 112.421 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.52 92.85 1.34 Allowed 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 108.229 -1.026 . . . . 53.310000000000002 108.229 175.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.283 19.6 ptt180 -114.51 149.75 35.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 119.616 1.098 . . . . 72.5 110.68 172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -67.36 -1.37 4.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 113.069 0.766 . . . . 62.520000000000003 113.069 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt 49.49 40.91 20.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.429 1.091 . . . . 75.200000000000003 111.52 168.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.36 47.07 0.04 OUTLIER Glycine 0 C--O 1.221 -0.712 0 CA-C-O 117.831 -1.539 . . . . 75.540000000000006 110.983 -159.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.7 pt -149.3 118.91 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.356 1.078 . . . . 71.230000000000004 110.166 -172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -145.44 149.28 34.41 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.125 1.37 . . . . 75.549999999999997 108.222 163.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -120.62 83.52 2.08 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 127.037 2.135 . . . . 73.540000000000006 107.131 173.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.292 1.6 p -90.29 144.5 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.055 1.342 . . . . 64.239999999999995 111.104 -170.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -118.84 97.71 5.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.991 0.901 . . . . 60.329999999999998 109.131 -155.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.01 172.92 2.09 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.914 1.816 . . . . 61.229999999999997 112.005 171.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.741 HG21 ' HG3' ' A' ' 38' ' ' LYS . 4.0 m -89.87 -25.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 127.406 2.282 . . . . 61.520000000000003 112.075 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -138.42 142.81 39.52 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 126.154 1.782 . . . . 75.420000000000002 108.441 -168.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.49 -22.38 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.857 0.863 . . . . 63.509999999999998 111.586 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 p -68.4 -20.33 64.66 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 120.671 -1.268 . . . . 52.25 111.868 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 m -74.65 -19.73 60.16 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.359 -0.838 . . . . 43.340000000000003 112.498 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.7 t -59.56 -57.27 28.15 Favored Pre-proline 0 CA--C 1.546 0.817 0 O-C-N 121.086 -1.009 . . . . 75.530000000000001 110.622 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.42 -14.04 39.04 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.645 2.23 . . . . 72.329999999999998 113.075 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.72 -49.92 73.16 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.517 -0.92 . . . . 63.340000000000003 108.517 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.26 -34.83 72.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.624 0.77 . . . . 42.030000000000001 111.894 -175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 21.7 mt -55.83 -35.52 40.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 124.462 1.105 . . . . 72.230000000000004 110.216 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.69 -27.48 49.44 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 118.957 -0.913 . . . . 23.34 114.24 176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.7 mt -110.82 10.2 22.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.313 1.556 . . . . 74.219999999999999 112.455 -166.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' HG23 ' A' ' 83' ' ' ILE . 10.1 t -44.7 -36.49 3.17 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 120.242 1.383 . . . . 63.32 113.194 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.82 -26.52 58.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.833 1.206 . . . . 63.340000000000003 113.316 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -75.99 158.29 32.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.979 0.889 . . . . 55.020000000000003 108.683 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -158.06 115.93 3.01 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.812 0.845 . . . . 74.510000000000005 109.426 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -77.46 125.72 37.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 106.97 -1.493 . . . . 71.230000000000004 106.97 171.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt 48.34 37.76 9.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.174 1.39 . . . . 62.310000000000002 112.823 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.92 28.61 64.4 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.493 -1.171 . . . . 53.140000000000001 113.874 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 t -112.66 85.51 7.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.336 1.854 . . . . 71.319999999999993 108.872 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.16 -170.68 0.97 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.77 2.313 . . . . 61.219999999999999 111.226 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.3 tt -144.65 159.4 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 O-C-N 121.404 -0.81 . . . . 61.240000000000002 111.48 177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mt -105.28 141.19 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 107.145 -1.428 . . . . 64.120000000000005 107.145 177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -52.48 -13.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 128.668 2.787 . . . . 61.439999999999998 116.036 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -44.5 -53.33 7.1 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.089 1.355 . . . . 74.239999999999995 113.859 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 57.06 38.45 29.21 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.722 1.209 . . . . 62.109999999999999 113.294 170.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 53.55 -154.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.737 1.215 . . . . 75.25 111.261 -174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -61.53 140.44 58.1 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 108.416 -0.957 . . . . 72.239999999999995 108.416 163.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -162.89 148.85 12.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.236 1.014 . . . . 55.140000000000001 109.72 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.51 62.33 1.0 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 131.089 3.756 . . . . 74.030000000000001 107.549 172.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -130.2 164.7 23.93 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 125.644 1.578 . . . . 73.319999999999993 108.363 176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -156.41 95.12 1.55 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.293 1.037 . . . . 61.240000000000002 109.809 170.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 . . . . . 0 C--O 1.252 1.198 0 C-N-CA 125.984 1.714 . . . . 73.25 109.34 -179.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.717 0 N-CA-C 110.014 -1.234 . . . . 55.520000000000003 110.014 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -71.84 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.271 2.229 . . . . 75.299999999999997 111.534 -177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.4 mtp 45.32 61.3 2.63 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 126.018 1.727 . . . . 71.430000000000007 111.956 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -166.2 -166.31 0.88 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.304 1.841 . . . . 73.030000000000001 107.937 168.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.86 106.4 2.69 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.721 2.008 . . . . 74.120000000000005 108.778 169.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -63.96 161.03 42.11 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.366 1.066 . . . . 73.409999999999997 111.845 -177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.9 -45.97 21.9 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.334 2.022 . . . . 55.530000000000001 112.116 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -62.52 -37.53 86.42 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 118.821 -0.609 . . . . 74.409999999999997 111.969 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.18 -32.97 72.64 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 124.109 0.964 . . . . 64.439999999999998 110.925 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.5 ttt-85 -67.45 -41.79 84.12 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 121.778 -0.576 . . . . 73.209999999999994 109.683 175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -80.29 -27.63 38.47 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.226 0.329 . . . . 73.239999999999995 111.294 -167.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.64 3.67 6.02 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.506 2.322 . . . . 60.439999999999998 114.501 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -61.28 1.42 0.19 Allowed 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 127.974 2.51 . . . . 75.200000000000003 116.767 -167.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -121.56 145.54 47.87 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.189 -1.411 . . . . 71.409999999999997 107.189 -163.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 m -115.56 115.1 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 105.661 -1.978 . . . . 62.030000000000001 105.661 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -75.0 128.21 35.04 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.181 -1.785 . . . . 63.329999999999998 106.181 168.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.3 m -121.32 121.36 37.5 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 106.534 -1.654 . . . . 60.439999999999998 106.534 -172.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.0 ttp -124.13 165.23 17.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.22 1.408 . . . . 75.409999999999997 107.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 75.31 12.17 3.31 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.028 2.131 . . . . 72.120000000000005 111.862 -174.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.17 167.95 9.31 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.647 -0.658 . . . . 71.409999999999997 109.423 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.47 151.87 45.55 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.604 -0.685 . . . . 55.210000000000001 110.58 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.62 -4.19 25.82 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.155 0.982 . . . . 72.209999999999994 113.008 172.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.76 33.1 2.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.596 1.958 . . . . 74.049999999999997 110.374 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.97 138.58 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 121.049 -1.032 . . . . 74.420000000000002 108.768 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -77.91 153.48 80.36 Favored Pre-proline 0 N--CA 1.466 0.363 0 N-CA-C 108.218 -1.03 . . . . 74.019999999999996 108.218 170.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -69.37 0.9 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.395 2.73 . . . . 75.430000000000007 114.039 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -112.87 -5.25 13.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.941 1.246 . . . . 72.409999999999997 111.892 174.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.47 -30.44 64.55 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.6 -1.313 . . . . 63.439999999999998 108.729 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -74.48 -53.23 9.92 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.174 0.99 . . . . 55.409999999999997 110.195 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -64.54 -40.07 94.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 123.46 0.704 . . . . 61.100000000000001 110.524 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -67.87 -27.37 66.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.156 0.582 . . . . 75.409999999999997 112.067 -176.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -62.26 -50.07 73.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 119.502 -0.285 . . . . 60.210000000000001 110.317 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -72.83 -28.26 62.44 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.88 0.764 . . . . 74.400000000000006 111.974 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.0 t -57.73 -20.36 34.04 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.632 1.973 . . . . 60.219999999999999 113.218 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.9 t -76.74 -15.85 59.65 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.149 -0.969 . . . . 63.299999999999997 111.268 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -136.98 11.54 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.031 0.932 . . . . 73.019999999999996 111.461 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.51 173.55 36.29 Favored Glycine 0 N--CA 1.448 -0.502 0 O-C-N 121.198 -0.939 . . . . 23.350000000000001 111.604 -160.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.76 137.12 29.54 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.532 -1.284 . . . . 64.239999999999995 107.532 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.0 t -114.24 131.8 65.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 125.92 1.688 . . . . 64.319999999999993 109.281 -170.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -94.13 -42.54 8.93 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 118.048 -0.977 . . . . 72.200000000000003 110.879 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -167.41 158.45 11.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.783 2.033 . . . . 72.019999999999996 106.36 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.477 HG12 HG22 ' A' ' 59' ' ' VAL . 29.5 m -133.95 163.85 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 126.26 1.824 . . . . 62.219999999999999 109.684 -173.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 136.79 10.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.181 -0.95 . . . . 73.439999999999998 109.235 -177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.4 ptp -136.11 135.55 39.39 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.273 0.942 . . . . 75.030000000000001 110.18 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.39 98.24 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 116.07 -0.514 . . . . 71.329999999999998 112.352 -150.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 44.3 m -89.95 4.83 48.85 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.846 1.258 . . . . 62.439999999999998 114.384 178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.58 24.85 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 129.031 2.932 . . . . 73.019999999999996 115.566 -170.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.66 -73.07 0.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.591 1.956 . . . . 62.439999999999998 109.454 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 p30 47.27 18.73 0.1 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.885 2.074 . . . . 75.439999999999998 113.991 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 44.55 28.26 0.3 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 129.803 3.241 . . . . 72.340000000000003 114.167 -169.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.03 -39.18 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.875 1.67 . . . . 74.329999999999998 108.026 -175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 64.43 -173.51 0.17 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.104 1.761 . . . . 75.109999999999999 107.965 175.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.3 p -73.15 63.87 0.72 Allowed 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.25 -0.906 . . . . 54.210000000000001 109.238 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -12.76 61.68 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.348 1.059 . . . . 61.340000000000003 112.274 165.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.1 62.58 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 124.733 1.159 . . . . 73.319999999999993 110.389 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 pt -146.38 131.54 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.205 1.802 . . . . 75.319999999999993 109.903 -175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.15 165.6 35.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.737 1.615 . . . . 61.32 108.55 173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -124.07 146.12 48.8 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.425 -1.694 . . . . 72.400000000000006 106.425 165.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 42' ' ' VAL . 25.6 t -130.71 113.84 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 106.563 -1.643 . . . . 75.140000000000001 106.563 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -72.1 128.34 35.37 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.097 -1.446 . . . . 74.230000000000004 107.097 170.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -83.18 155.44 23.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.574 0.702 . . . . 64.109999999999999 110.631 169.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 45.5 t -73.18 -26.99 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 117.996 -1.002 . . . . 72.329999999999998 110.187 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -129.13 150.43 50.52 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 120.191 1.36 . . . . 60.130000000000003 111.979 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.3 p -70.78 -34.54 56.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 117.986 -1.006 . . . . 75.140000000000001 111.806 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -69.99 -20.74 63.28 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 121.383 1.902 . . . . 74.340000000000003 112.411 -170.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -89.94 -4.34 57.54 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.829 0.852 . . . . 75.129999999999995 112.443 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.5 t -58.29 -60.84 8.92 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 119.693 1.133 . . . . 71.299999999999997 109.787 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.11 -15.4 46.41 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 CA-C-N 120.92 1.364 . . . . 52.539999999999999 113.381 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.2 tp -60.76 -55.22 35.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 120.547 -1.345 . . . . 74.439999999999998 110.145 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.82 -41.6 78.12 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 123.712 0.633 . . . . 71.310000000000002 111.253 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.01 -39.0 70.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.948 0.899 . . . . 72.310000000000002 110.36 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.58 -36.04 63.52 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.448 1.023 . . . . 74.310000000000002 112.905 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.6 12.75 1.5 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.574 1.15 . . . . 72.120000000000005 113.354 -171.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.567 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -50.38 -28.23 7.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.298 1.439 . . . . 71.129999999999995 113.572 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -105.66 14.73 45.96 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.293 1.425 . . . . 75.219999999999999 112.914 -174.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -93.71 170.4 9.6 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.261 1.03 . . . . 73.439999999999998 108.258 161.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.3 ptt-85 -145.17 87.13 1.8 Allowed 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.635 -0.666 . . . . 73.140000000000001 109.978 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.94 110.23 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.708 -0.849 . . . . 61.25 108.708 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.1 mt 46.97 31.12 1.41 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.353 1.861 . . . . 62.450000000000003 112.979 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.42 19.43 27.8 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.781 0.705 . . . . 62.039999999999999 113.61 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.4 t -118.63 86.43 29.37 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.995 1.718 . . . . 60.450000000000003 109.165 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.23 173.79 8.04 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.456 2.104 . . . . 60.020000000000003 111.914 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.567 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.1 tt -140.17 143.33 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 124.466 1.107 . . . . 71.129999999999995 109.453 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.9 mm -86.14 144.34 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 123.715 0.806 . . . . 72.329999999999998 109.442 172.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.15 10.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 129.298 3.039 . . . . 51.219999999999999 115.471 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.54 -25.66 64.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 114.782 1.401 . . . . 71.040000000000006 114.782 -154.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.83 164.03 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.692 2.797 . . . . 61.219999999999999 111.766 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.82 93.11 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.135 -1.802 . . . . 55.240000000000002 106.135 167.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -105.02 148.44 26.75 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.882 -1.155 . . . . 75.019999999999996 107.882 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 48.8 -178.56 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.588 1.955 . . . . 61.210000000000001 112.693 -162.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -126.36 18.96 7.54 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.852 1.661 . . . . 75.219999999999999 109.611 -172.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -95.15 -153.42 0.39 Allowed 'General case' 0 C--O 1.232 0.153 0 O-C-N 119.744 -1.847 . . . . 63.340000000000003 110.214 -165.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 m120 43.98 75.77 0.09 Allowed 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.376 2.271 . . . . 63.420000000000002 113.594 171.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.001 0 N-CA-C 107.297 -1.371 . . . . 75.299999999999997 107.297 166.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.695 0 N-CA-C 108.969 -1.652 . . . . 52.32 108.969 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -133.03 10.75 4.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.69 1.196 . . . . 65.439999999999998 112.361 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -53.83 120.21 5.99 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.912 1.685 . . . . 70.230000000000004 110.586 -177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -120.5 14.66 11.96 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.469 0.914 . . . . 72.549999999999997 113.469 -171.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -79.08 105.29 10.31 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.251 1.82 . . . . 74.140000000000001 110.275 -169.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 7' ' ' PRO . 14.8 p -83.89 166.06 35.88 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 123.558 0.743 . . . . 72.219999999999999 109.989 -174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 55.7 Cg_endo -63.04 -40.88 31.38 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.59 1.246 . . . . 72.239999999999995 110.543 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -72.95 -29.2 62.91 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 118.955 0.798 . . . . 72.439999999999998 112.182 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -56.99 -47.33 81.06 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.78 -0.822 . . . . 52.130000000000003 108.78 166.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -73.76 -13.22 60.92 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 113.161 0.8 . . . . 70.109999999999999 113.161 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.87 -14.05 22.09 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.177 0.991 . . . . 62.5 111.659 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.71 -75.34 0.26 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.55 1.54 . . . . 73.519999999999996 110.944 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 58.68 -15.97 0.02 OUTLIER 'General case' 0 C--O 1.234 0.242 0 C-N-CA 131.15 3.78 . . . . 73.409999999999997 116.943 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 95.6 m -77.75 155.93 30.89 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.814 0.846 . . . . 64.329999999999998 111.47 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.09 179.29 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 125.499 1.52 . . . . 63.140000000000001 108.54 167.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -140.94 127.05 19.52 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.631 1.173 . . . . 70.200000000000003 110.048 -169.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.3 m -107.77 115.4 30.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.363 1.465 . . . . 72.5 107.451 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 tmm? -128.87 32.59 4.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.623 1.569 . . . . 74.219999999999999 110.141 -174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -147.28 27.36 1.03 Allowed 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.381 -1.449 . . . . 73.299999999999997 110.445 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.517 ' HA ' HG13 ' A' ' 81' ' ' VAL . 59.4 mt -68.03 155.19 40.04 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.949 1.3 . . . . 72.209999999999994 113.654 -172.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.13 -174.87 1.06 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.812 1.645 . . . . 44.100000000000001 110.085 163.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.92 19.57 10.9 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.139 1.376 . . . . 73.0 111.879 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -140.26 8.82 2.26 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.648 1.179 . . . . 73.239999999999995 111.366 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.9 tt -76.0 148.82 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.317 1.447 . . . . 74.030000000000001 108.82 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.26 152.23 88.04 Favored Pre-proline 0 N--CA 1.47 0.537 0 O-C-N 121.033 -1.042 . . . . 62.100000000000001 109.083 170.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -56.06 -48.94 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.687 1.591 . . . . 73.299999999999997 111.198 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttp85 -64.13 -21.27 66.48 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 118.124 -0.941 . . . . 74.329999999999998 112.767 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.19 -33.3 72.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 120.576 1.535 . . . . 62.409999999999997 110.492 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.28 -23.25 54.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.094 -0.955 . . . . 65.409999999999997 111.86 -176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' HB2' HG11 ' A' ' 39' ' ' VAL . 2.9 pt-20 -91.37 -33.48 15.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.19 0.904 . . . . 74.340000000000003 108.628 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -59.42 -36.56 76.11 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 126.272 1.829 . . . . 74.140000000000001 111.107 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -49.9 -62.45 1.56 Allowed 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.126 0.97 . . . . 63.509999999999998 110.471 170.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -67.81 -17.61 64.57 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.543 0.337 . . . . 65.510000000000005 111.833 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.73 -2.33 6.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.727 1.01 . . . . 70.129999999999995 113.727 172.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -69.69 -34.58 74.13 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.416 1.462 . . . . 64.239999999999995 110.159 161.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -8.96 11.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 120.005 1.275 . . . . 64.510000000000005 113.806 -159.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.99 178.48 48.5 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 111.415 -0.674 . . . . 45.039999999999999 111.415 -160.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -119.64 135.75 54.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.892 1.346 . . . . 62.32 112.005 -177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 HG12 ' A' ' 59' ' ' VAL . 9.9 p -123.21 153.29 28.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 125.59 1.556 . . . . 51.32 109.614 -175.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpm_? -97.35 -52.84 3.66 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.323 -1.762 . . . . 64.310000000000002 107.219 -166.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.13 -177.88 3.48 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.164 0.585 . . . . 72.219999999999999 110.267 179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.6 p -148.05 149.52 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.199 1.0 . . . . 72.310000000000002 110.259 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 mtt85 -124.91 159.58 30.84 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.096 1.358 . . . . 70.430000000000007 109.735 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 3.1 ptp -138.6 132.0 30.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.771 1.228 . . . . 54.299999999999997 107.88 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.592 ' HB ' HD13 ' A' ' 56' ' ' ILE . 3.6 mp -84.04 80.88 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 107.256 -1.387 . . . . 54.399999999999999 107.256 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 66.3 m -80.29 96.59 6.68 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.959 1.704 . . . . 73.0 108.911 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.5 -171.11 2.57 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 126.396 1.878 . . . . 55.130000000000003 110.262 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -127.05 -68.72 0.79 Allowed 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.535 1.134 . . . . 73.0 110.699 -174.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -129.43 74.12 1.56 Allowed 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.894 1.33 . . . . 53.399999999999999 107.62 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.38 -68.0 0.32 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 112.691 -2.05 . . . . 63.039999999999999 109.786 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -158.25 42.38 0.28 Allowed 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.487 -0.758 . . . . 62.210000000000001 109.667 -163.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -57.88 -32.33 67.59 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 118.735 -0.65 . . . . 74.129999999999995 109.951 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.3 m 45.27 35.87 1.99 Allowed 'General case' 0 C--N 1.34 0.154 0 C-N-CA 127.787 2.435 . . . . 72.010000000000005 112.706 169.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.36 0.0 OUTLIER 44.7 38.12 2.61 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.049 1.74 . . . . 73.400000000000006 113.581 -175.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.65 111.32 2.75 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.452 -1.459 . . . . 71.299999999999997 109.452 170.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD13 ' HB ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -142.96 141.15 27.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 C-N-CA 124.926 1.29 . . . . 61.399999999999999 109.182 -169.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.82 152.43 28.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.41 1.084 . . . . 70.230000000000004 108.927 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -124.95 146.1 49.53 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.553 1.541 . . . . 72.439999999999998 107.339 173.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 39' ' ' VAL . 1.8 t -130.8 115.27 30.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.869 -1.16 . . . . 73.519999999999996 107.869 -161.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -85.9 96.57 9.84 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.884 0.873 . . . . 74.430000000000007 109.61 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.1 OUTLIER -59.69 157.22 12.3 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 120.029 -1.67 . . . . 74.510000000000005 113.45 166.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.99 -29.19 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 N-CA-C 109.702 -0.481 . . . . 74.319999999999993 109.702 174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -137.44 144.83 42.52 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.97 1.308 . . . . 62.109999999999999 110.001 -171.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 p -72.91 -21.9 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.443 0.697 . . . . 73.230000000000004 112.527 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -59.26 -22.64 61.46 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 120.621 -1.3 . . . . 73.109999999999999 113.755 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m -93.27 -2.08 55.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.801 0.84 . . . . 72.230000000000004 113.094 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.42 -58.35 19.2 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 120.211 -1.556 . . . . 65.5 110.135 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.01 -14.63 44.52 Favored 'Trans proline' 0 C--N 1.349 0.594 0 CA-C-N 121.383 1.53 . . . . 74.329999999999998 112.683 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -41.34 94.59 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.336 -0.853 . . . . 74.510000000000005 108.762 174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.79 -28.54 66.06 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 123.868 0.867 . . . . 62.409999999999997 112.966 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.5 mt -63.49 -40.18 88.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 118.966 0.803 . . . . 70.510000000000005 109.076 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.39 -14.3 59.59 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 121.549 -0.72 . . . . 30.449999999999999 113.794 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.3 mt -98.89 -0.79 41.62 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.508 1.154 . . . . 73.420000000000002 112.287 -175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.5 t -45.54 -45.62 13.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.872 1.269 . . . . 74.420000000000002 111.524 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.67 4.94 79.74 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 123.809 0.718 . . . . 71.209999999999994 114.245 -168.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -78.91 -171.14 2.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 118.505 1.152 . . . . 73.299999999999997 108.929 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.43 121.03 4.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.985 -1.487 . . . . 73.099999999999994 106.985 176.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 97.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.287 -1.375 . . . . 72.420000000000002 107.287 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.8 mt 53.08 16.23 0.72 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.719 1.607 . . . . 70.420000000000002 113.439 -170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.99 7.29 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.132 0.872 . . . . 53.32 113.137 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 20' ' ' LEU . 82.4 t -107.26 86.61 2.68 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 126.724 2.01 . . . . 61.299999999999997 111.222 -174.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -61.76 175.84 1.58 Allowed 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.157 1.904 . . . . 51.340000000000003 111.557 171.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.6 tt -127.19 163.96 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 O-C-N 121.53 -0.731 . . . . 62.409999999999997 110.278 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 86' ' ' GLN . 49.2 mm -99.87 140.25 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.743 -1.577 . . . . 62.229999999999997 106.743 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -44.92 -24.97 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.085 2.154 . . . . 74.209999999999994 114.83 170.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.516 ' H ' HG22 ' A' ' 84' ' ' ILE . 13.1 mt-30 -44.1 -51.7 7.79 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 126.123 1.769 . . . . 73.420000000000002 113.331 -162.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.33 48.75 18.5 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.798 1.239 . . . . 74.200000000000003 112.376 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.5 t 54.15 -152.98 0.3 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.271 -1.011 . . . . 73.140000000000001 108.271 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 50.67 76.98 0.13 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.49 1.516 . . . . 52.200000000000003 113.325 162.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' HB1' ' H ' ' A' ' 92' ' ' LYS . . . -154.16 169.46 23.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.789 -1.194 . . . . 72.510000000000005 112.407 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.08 8.91 42.63 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.844 1.658 . . . . 73.540000000000006 110.73 158.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' H ' ' HB1' ' A' ' 90' ' ' ALA . 23.1 mmtp -67.4 156.55 36.25 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.685 1.194 . . . . 64.540000000000006 109.742 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.36 147.87 28.12 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.226 -1.027 . . . . 71.420000000000002 108.226 159.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.77 2.028 . . . . 75.200000000000003 109.952 162.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.669 0 N-CA-C 111.729 -0.548 . . . . 65.150000000000006 111.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -136.53 169.07 18.3 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.586 1.955 . . . . 73.109999999999999 107.774 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.6 ttm -140.87 49.49 1.68 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.095 -1.076 . . . . 72.129999999999995 108.095 177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.57 150.17 29.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.689 1.196 . . . . 65.430000000000007 107.899 173.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.56 136.76 46.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.146 2.178 . . . . 73.219999999999999 106.793 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.428 ' HB ' ' HD2' ' A' ' 7' ' ' PRO . 30.7 p -76.08 165.52 52.44 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 118.874 0.761 . . . . 61.240000000000002 111.415 -174.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 6' ' ' THR . 23.1 Cg_endo -60.37 -40.97 53.6 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.709 1.606 . . . . 74.540000000000006 110.073 172.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -58.14 -50.04 74.88 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.811 1.245 . . . . 75.150000000000006 110.188 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -52.03 -47.73 64.89 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.169 0.588 . . . . 75.150000000000006 110.422 176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -70.81 -28.54 64.7 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.93 0.892 . . . . 71.25 112.726 -175.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.46 -44.14 52.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.672 1.589 . . . . 73.430000000000007 109.652 176.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.98 -66.02 0.6 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 126.802 2.041 . . . . 54.420000000000002 111.838 -162.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 44.47 59.71 3.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.082 2.153 . . . . 73.239999999999995 114.562 175.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.02 165.58 27.39 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.036 -1.468 . . . . 72.510000000000005 107.036 172.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.76 -178.5 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 123.936 0.895 . . . . 71.430000000000007 109.536 163.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -145.73 102.17 3.64 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.404 1.097 . . . . 75.430000000000007 110.573 176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.5 m -87.66 94.94 9.88 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.384 1.874 . . . . 70.510000000000005 109.117 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.4 ttp -108.17 44.85 1.06 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.769 1.227 . . . . 63.520000000000003 110.207 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -164.8 68.3 0.15 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.187 0.995 . . . . 72.200000000000003 110.36 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.1 mt -101.39 166.1 10.92 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.364 -0.835 . . . . 74.340000000000003 111.367 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -100.9 171.55 7.58 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.627 1.171 . . . . 45.200000000000003 110.654 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.85 -30.94 65.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 113.266 0.839 . . . . 74.400000000000006 113.266 -172.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.63 51.5 1.92 Allowed 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 124.365 1.066 . . . . 62.439999999999998 108.959 -170.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 tt -80.47 154.13 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.772 -0.825 . . . . 71.200000000000003 108.772 170.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 50.9 mtm-85 -111.76 160.59 29.1 Favored Pre-proline 0 N--CA 1.466 0.351 0 N-CA-C 107.802 -1.184 . . . . 72.540000000000006 107.802 167.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -59.96 -21.43 64.69 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.031 1.821 . . . . 73.319999999999993 112.436 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.21 -34.5 73.0 Favored 'General case' 0 C--O 1.222 -0.36 0 O-C-N 120.963 -1.086 . . . . 71.109999999999999 112.297 173.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.1 -34.31 74.74 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.874 1.216 . . . . 63.310000000000002 111.747 -170.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' HG11 ' A' ' 59' ' ' VAL . 2.2 mm? -64.5 -41.8 96.23 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.558 0.743 . . . . 74.409999999999997 110.124 -174.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -81.77 -35.12 29.94 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.221 -0.895 . . . . 62.439999999999998 109.99 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -63.92 -24.31 67.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.597 1.089 . . . . 72.129999999999995 111.253 177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -65.46 -67.6 0.43 Allowed 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 121.874 -0.516 . . . . 73.510000000000005 110.388 168.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -71.4 -19.7 62.23 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 113.552 0.945 . . . . 65.299999999999997 113.552 -167.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.4 t -51.72 -28.64 15.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.96 1.304 . . . . 74.510000000000005 110.798 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.418 HG23 HG13 ' A' ' 36' ' ' VAL . 1.3 t -77.02 -14.94 59.77 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.146 -0.971 . . . . 62.109999999999999 110.987 -172.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG13 HG23 ' A' ' 35' ' ' THR . 31.2 m -131.36 -4.19 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.261 1.024 . . . . 72.230000000000004 113.358 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.15 -156.83 12.79 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.662 -1.375 . . . . 72.209999999999994 109.662 -174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -145.3 139.33 27.0 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.421 1.111 . . . . 73.519999999999996 110.985 166.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.5 t -71.17 143.29 14.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 125.925 1.69 . . . . 73.439999999999998 108.778 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -82.44 -50.6 8.69 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 121.013 -1.054 . . . . 54.119999999999997 109.606 163.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.58 124.06 11.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.275 0.488 . . . . 63.219999999999999 110.817 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.6 t -73.7 108.17 4.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 O-C-N 121.404 -0.81 . . . . 62.409999999999997 109.343 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -104.91 82.58 1.89 Allowed 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.863 1.265 . . . . 71.200000000000003 108.129 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.34 153.57 23.4 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.613 0.765 . . . . 74.200000000000003 109.003 167.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.39 161.73 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.155 -1.054 . . . . 63.439999999999998 108.155 -176.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.3 t 57.76 35.94 26.02 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.907 1.337 . . . . 64.319999999999993 111.025 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.98 4.25 10.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.719 2.007 . . . . 74.219999999999999 110.985 164.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.31 156.74 46.33 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 120.266 -1.522 . . . . 75.510000000000005 108.403 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.82 -24.96 64.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 118.708 -0.663 . . . . 72.120000000000005 112.579 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.8 t -74.88 41.51 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.125 1.784 . . . . 35.329999999999998 112.689 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -159.69 -49.74 0.05 Allowed 'General case' 0 C--N 1.344 0.348 0 O-C-N 120.137 -1.602 . . . . 63.420000000000002 112.062 157.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? 48.12 62.73 2.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 122.048 0.928 . . . . 75.329999999999998 110.268 -164.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.5 m -68.19 27.17 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 O-C-N 119.854 -1.778 . . . . 73.420000000000002 111.911 162.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 61.12 5.94 1.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 115.438 1.644 . . . . 75.209999999999994 115.438 173.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.07 106.42 2.67 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 109.606 -1.398 . . . . 62.219999999999999 109.606 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 pt -145.56 137.36 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.1 1.36 . . . . 74.120000000000005 110.152 -177.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -141.61 135.19 29.76 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.601 -1.259 . . . . 64.400000000000006 107.601 163.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -122.11 70.77 0.98 Allowed 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.625 -1.25 . . . . 75.200000000000003 107.625 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 29' ' ' LEU . 3.1 m -67.35 135.64 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 CA-C-O 121.539 0.685 . . . . 61.100000000000001 109.772 -177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -80.61 145.06 31.89 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.809 -1.182 . . . . 73.340000000000003 107.809 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.18 151.33 24.9 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 113.319 0.859 . . . . 73.439999999999998 113.319 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.2 t -69.34 -43.6 80.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 115.31 -0.859 . . . . 70.299999999999997 109.104 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.38 142.64 46.59 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.518 1.127 . . . . 73.519999999999996 109.71 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.97 -36.66 64.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 111.827 0.306 . . . . 50.299999999999997 111.827 176.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -62.6 -23.51 67.08 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.148 -0.97 . . . . 74.099999999999994 113.065 -166.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -77.07 -13.12 60.0 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.945 0.898 . . . . 54.140000000000001 113.07 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.0 t -53.98 -56.48 25.22 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 120.866 1.666 . . . . 62.310000000000002 111.723 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -65.63 -12.41 34.98 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 121.997 1.798 . . . . 64.230000000000004 113.635 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.26 -47.93 66.43 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.009 -1.057 . . . . 52.439999999999998 109.231 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.28 -30.57 69.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.372 0.669 . . . . 62.329999999999998 112.395 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.424 HG23 HG13 ' A' ' 85' ' ' VAL . 65.9 mt -57.32 -41.4 78.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.754 0.822 . . . . 73.510000000000005 109.362 176.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.85 -18.46 56.92 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.56 -0.578 . . . . 74.540000000000006 112.865 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -101.34 9.44 41.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.708 1.203 . . . . 71.319999999999993 111.554 -171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.0 t -51.64 -30.02 19.96 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.69 1.132 . . . . 61.100000000000001 113.383 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.91 5.41 27.39 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.161 1.362 . . . . 63.100000000000001 112.796 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -74.95 174.95 8.59 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.779 1.29 . . . . 62.409999999999997 108.275 155.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 130.15 10.3 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.83 1.252 . . . . 73.340000000000003 108.642 169.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.19 115.52 17.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 105.819 -1.919 . . . . 65.200000000000003 105.819 162.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.7 mt 57.65 3.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.737 2.125 . . . . 63.520000000000003 116.737 170.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.16 -2.72 7.27 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.736 1.153 . . . . 42.240000000000002 113.923 -171.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.39 86.99 2.97 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 128.323 2.649 . . . . 72.219999999999999 109.675 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -65.77 -176.67 0.61 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.791 2.327 . . . . 74.409999999999997 111.549 167.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.5 tt -136.77 167.5 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 121.19 -0.944 . . . . 71.239999999999995 109.715 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 86' ' ' GLN . 39.8 mm -111.95 144.72 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 106.671 -1.603 . . . . 72.109999999999999 106.671 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.424 HG13 HG23 ' A' ' 71' ' ' ILE . 28.2 t -57.34 -13.39 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.508 1.923 . . . . 73.099999999999994 112.832 171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.491 ' H ' HG22 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -52.42 -26.68 13.28 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.001 2.52 . . . . 75.5 115.419 -171.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 43.32 89.92 0.01 OUTLIER 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.352 1.461 . . . . 54.039999999999999 112.132 155.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.4 t -48.06 118.23 2.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.723 -1.214 . . . . 62.509999999999998 107.723 173.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -146.48 139.57 25.59 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.031 2.932 . . . . 73.5 105.856 -176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 59.19 161.72 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.457 2.303 . . . . 55.399999999999999 114.606 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.41 52.33 2.33 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.643 1.977 . . . . 72.530000000000001 108.425 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -143.36 149.81 38.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.583 2.353 . . . . 75.519999999999996 106.46 -170.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -154.21 104.62 2.63 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.073 -1.084 . . . . 75.439999999999998 108.073 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.095 0 C-N-CA 123.593 0.757 . . . . 75.230000000000004 111.691 -168.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.559 0 N-CA-C 110.191 -1.163 . . . . 62.329999999999998 110.191 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 t60 -99.89 144.06 29.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.09 0.956 . . . . 75.349999999999994 109.029 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mtm -166.41 167.18 16.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 127.4 2.28 . . . . 71.25 108.006 175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -66.68 129.79 41.01 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 118.306 -0.854 . . . . 73.120000000000005 110.075 171.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.8 mt 50.01 -173.55 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.53 1.932 . . . . 74.230000000000004 113.055 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.1 p -88.39 165.95 25.8 Favored Pre-proline 0 C--O 1.239 0.549 0 N-CA-C 107.383 -1.34 . . . . 73.329999999999998 107.383 158.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -23.97 51.77 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.143 1.087 . . . . 55.020000000000003 111.246 167.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.28 4.0 pt-20 -91.99 -33.63 14.77 Favored 'General case' 0 C--O 1.225 -0.234 0 C-N-CA 124.188 0.995 . . . . 62.509999999999998 113.21 -165.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -51.76 -44.26 63.28 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.429 1.013 . . . . 63.310000000000002 111.288 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -63.0 -24.56 67.98 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.607 0.763 . . . . 60.409999999999997 112.556 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -109.57 -18.43 13.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.876 0.846 . . . . 55.450000000000003 111.028 -169.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.49 -72.5 0.41 Allowed 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 127.393 2.277 . . . . 43.149999999999999 109.957 172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.27 73.2 0.16 Allowed 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.655 1.582 . . . . 73.549999999999997 111.164 -164.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.63 150.67 49.7 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.909 -1.119 . . . . 74.349999999999994 109.664 -177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' A' ' 61' ' ' PHE . 28.1 m -133.71 171.7 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 125.357 1.463 . . . . 72.519999999999996 107.557 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.92 142.16 30.63 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.258 1.423 . . . . 75.209999999999994 108.238 -166.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.7 m -130.21 103.28 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.148 1.379 . . . . 64.519999999999996 109.858 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.1 ttm -92.83 -0.34 57.27 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.797 1.036 . . . . 72.120000000000005 113.797 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -128.18 29.08 5.42 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.278 1.214 . . . . 52.32 114.278 -163.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.401 ' HA ' HG13 ' A' ' 81' ' ' VAL . 87.0 mt -73.34 151.53 41.23 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.355 1.062 . . . . 74.099999999999994 113.632 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.21 165.72 17.14 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.549 1.14 . . . . 72.099999999999994 112.95 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.05 -34.1 65.6 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.084 1.354 . . . . 74.140000000000001 113.542 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.98 47.09 1.96 Allowed 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.26 1.024 . . . . 74.109999999999999 110.755 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -60.51 154.49 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 120.995 -1.065 . . . . 74.219999999999999 109.05 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -114.98 157.87 42.23 Favored Pre-proline 0 C--N 1.33 -0.242 0 C-N-CA 127.439 2.296 . . . . 72.310000000000002 107.738 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.21 -19.89 69.58 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.805 1.67 . . . . 74.420000000000002 112.182 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 1.5 ptp180 -76.71 -29.95 56.46 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.363 -0.827 . . . . 73.340000000000003 112.259 175.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -61.89 -25.19 67.4 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.491 1.041 . . . . 75.129999999999995 111.061 -170.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.446 HD22 ' H ' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -78.11 -54.24 6.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.915 0.886 . . . . 75.340000000000003 109.07 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -69.57 -33.29 72.53 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 117.693 -1.146 . . . . 73.420000000000002 111.347 -173.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -66.85 -47.69 71.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 119.02 0.827 . . . . 74.5 109.53 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.423 ' CG ' HG21 ' A' ' 78' ' ' VAL . 9.0 t80 -52.79 -48.21 67.03 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 122.684 0.394 . . . . 61.140000000000001 110.718 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -80.04 -14.46 58.52 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.199 -1.0 . . . . 75.5 112.103 -178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.4 t -64.97 -17.25 64.25 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.362 1.437 . . . . 55.009999999999998 110.848 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.0 p -73.16 -21.77 60.64 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.779 1.172 . . . . 71.430000000000007 111.037 -175.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -142.43 -7.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.641 1.576 . . . . 71.420000000000002 112.736 -166.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -159.7 -166.37 18.46 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.114 1.34 . . . . 22.420000000000002 111.003 -164.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -147.87 134.41 19.78 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.68 1.192 . . . . 73.420000000000002 110.573 -168.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 37.0 t -105.5 144.47 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 126.293 1.837 . . . . 71.299999999999997 108.395 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -101.71 -54.93 2.63 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.275 1.43 . . . . 72.430000000000007 108.378 172.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -138.56 165.04 27.91 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 124.162 0.914 . . . . 64.109999999999999 110.982 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.01 110.26 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.946 2.098 . . . . 71.209999999999994 106.502 -160.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -143.71 81.34 1.69 Allowed 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.041 0.837 . . . . 64.140000000000001 110.047 -160.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.1 mtp -88.41 160.77 17.41 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 122.671 1.224 . . . . 64.329999999999998 110.429 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 46' ' ' SER . 5.7 mm -88.14 -175.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 124.823 1.249 . . . . 60.119999999999997 107.917 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.738 ' H ' HG22 ' A' ' 45' ' ' ILE . 8.4 t 56.73 4.14 0.15 Allowed 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 127.331 2.252 . . . . 40.149999999999999 114.585 -169.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -72.15 -21.88 61.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 122.113 0.959 . . . . 72.230000000000004 111.114 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.5 mmt85 -107.68 4.54 25.89 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.209 1.804 . . . . 72.420000000000002 112.703 173.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 42.84 61.26 2.16 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.562 1.945 . . . . 75.209999999999994 113.209 167.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.9 p -150.62 -51.0 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 113.476 0.917 . . . . 62.310000000000002 113.476 174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.8 ttt85 -124.36 104.04 8.55 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 106.856 -1.535 . . . . 53.039999999999999 106.856 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.5 155.09 42.88 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.942 1.297 . . . . 74.120000000000005 109.299 -175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.0 m -84.06 10.66 9.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 117.734 -1.126 . . . . 55.210000000000001 112.138 171.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.367 0.0 OUTLIER 44.95 68.27 0.58 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.643 1.577 . . . . 75.430000000000007 111.617 -163.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.63 77.26 0.28 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 124.766 1.174 . . . . 74.310000000000002 110.416 163.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 pt -145.65 153.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 118.288 1.044 . . . . 73.519999999999996 110.732 171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.8 40.78 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 124.976 1.31 . . . . 63.329999999999998 109.144 168.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -122.28 154.83 37.05 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.783 -1.562 . . . . 75.25 106.783 164.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 t -134.67 134.46 54.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.184 -2.154 . . . . 75.25 105.184 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -90.55 109.09 20.24 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 105.625 -1.991 . . . . 72.209999999999994 105.625 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' A' ' 15' ' ' VAL . 3.5 m-30 -73.18 168.97 18.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 123.522 0.729 . . . . 71.530000000000001 109.296 173.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.43 -38.67 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 120.538 -0.465 . . . . 62.329999999999998 109.85 169.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -99.11 128.15 45.2 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 118.651 0.659 . . . . 71.219999999999999 110.447 -175.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.82 -37.76 68.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 115.213 -0.903 . . . . 72.349999999999994 111.474 171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -5.5 54.27 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 120.685 -1.259 . . . . 63.420000000000002 112.336 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.9 m -90.88 -12.06 37.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 121.232 -0.918 . . . . 74.340000000000003 111.824 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.5 t -54.58 -57.63 17.99 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-N 119.369 0.986 . . . . 75.219999999999999 110.089 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.86 -22.61 68.88 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.228 1.952 . . . . 73.530000000000001 113.872 177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.21 -52.26 59.73 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 108.771 -0.826 . . . . 72.239999999999995 108.771 173.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.51 -38.86 78.57 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 123.217 0.607 . . . . 74.5 111.328 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.3 mt -56.87 -44.51 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.563 0.745 . . . . 75.109999999999999 109.385 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.92 -10.64 27.05 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.764 0.697 . . . . 40.299999999999997 114.285 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -95.41 5.84 50.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.555 1.178 . . . . 72.129999999999995 111.932 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.679 ' HA ' HG23 ' A' ' 83' ' ' ILE . 8.9 t -44.46 -45.75 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.996 1.718 . . . . 74.120000000000005 112.876 -175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.86 2.93 84.67 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.738 -1.034 . . . . 62.109999999999999 113.703 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -73.06 -176.59 2.16 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.508 1.654 . . . . 74.129999999999995 109.317 171.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -157.45 81.69 0.9 Allowed 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 123.829 0.851 . . . . 71.219999999999999 109.502 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' A' ' 32' ' ' PHE . 60.7 t -58.47 102.01 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 124.487 1.115 . . . . 51.310000000000002 108.541 -174.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.3 mt 56.51 25.03 9.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.53 0.332 . . . . 71.109999999999999 111.677 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 112.73 -6.41 25.99 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.237 -1.313 . . . . 54.130000000000003 113.706 -176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 20' ' ' LEU . 59.1 t -104.7 86.7 1.52 Allowed Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.546 1.938 . . . . 64.299999999999997 111.915 -168.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.08 -179.58 2.27 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.76 2.307 . . . . 71.439999999999998 111.635 169.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.679 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -141.83 168.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.424 0.689 . . . . 53.020000000000003 109.278 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.8 mm -112.45 137.66 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.606 1.562 . . . . 63.439999999999998 106.968 175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -55.31 -2.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 129.731 3.212 . . . . 74.230000000000004 117.058 177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -62.03 -33.2 73.92 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 115.999 1.851 . . . . 72.120000000000005 115.999 -166.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 50.65 -172.91 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 123.515 1.626 . . . . 51.030000000000001 110.709 -162.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.57 -164.59 1.19 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.067 -1.424 . . . . 71.409999999999997 107.616 156.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.77 53.75 10.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 127.306 2.242 . . . . 75.329999999999998 112.824 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -114.28 -161.74 0.78 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 123.125 0.57 . . . . 62.130000000000003 110.043 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.43 16.37 22.35 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.777 2.031 . . . . 74.450000000000003 110.709 173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.8 mtmt -121.73 151.3 40.67 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.296 -0.877 . . . . 73.430000000000007 111.015 -166.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.88 -7.29 0.07 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.267 1.427 . . . . 73.409999999999997 114.22 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--O 1.245 0.863 0 C-N-CA 125.491 1.517 . . . . 75.530000000000001 107.554 -177.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.032 0 N-CA-C 111.31 -0.716 . . . . 72.400000000000006 111.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.2 m80 55.13 27.64 9.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.038 1.735 . . . . 72.209999999999994 112.204 -172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.418 ' HG2' ' H ' ' A' ' 4' ' ' ASN . 31.3 ttm -140.76 167.18 22.79 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.803 2.441 . . . . 72.219999999999999 107.058 -178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.418 ' H ' ' HG2' ' A' ' 3' ' ' MET . 39.2 t-20 62.53 111.08 0.02 OUTLIER 'General case' 0 C--O 1.235 0.336 0 C-N-CA 128.114 2.566 . . . . 73.400000000000006 110.778 -171.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.9 tp -124.96 134.5 52.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.356 1.863 . . . . 72.409999999999997 106.887 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.0 p -66.88 165.99 22.32 Favored Pre-proline 0 C--O 1.24 0.556 0 CA-C-N 118.147 0.43 . . . . 75.310000000000002 111.46 -175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -54.02 -11.65 2.81 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.991 2.461 . . . . 74.319999999999993 114.432 163.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -118.7 -41.37 2.8 Favored 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 125.571 1.548 . . . . 71.319999999999993 110.663 -162.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -57.05 -36.3 70.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.945 1.248 . . . . 64.319999999999993 111.21 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -60.45 -28.98 68.73 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.724 0.81 . . . . 72.239999999999995 112.385 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -88.67 -43.43 11.32 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.608 1.563 . . . . 61.119999999999997 109.511 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.8 0.68 1.08 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.891 2.076 . . . . 75.5 114.199 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -63.44 -17.47 62.72 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.922 1.289 . . . . 61.340000000000003 112.116 163.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -66.7 126.98 30.68 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 107.857 -1.164 . . . . 64.310000000000002 107.857 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 m -98.91 174.2 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 108.528 -0.916 . . . . 73.239999999999995 108.528 174.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.7 98.39 3.18 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.624 1.202 . . . . 74.230000000000004 110.707 -174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' HB3' HD21 ' A' ' 20' ' ' LEU . 62.0 m -80.93 88.14 5.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.559 1.543 . . . . 52.030000000000001 108.541 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.2 ttp -90.94 13.12 17.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.988 0.915 . . . . 55.210000000000001 112.397 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 20' ' ' LEU . 6.0 mt-30 -133.38 94.86 3.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 120.493 -1.38 . . . . 53.030000000000001 107.872 172.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD22 HD11 ' A' ' 29' ' ' LEU . 12.1 mt -118.28 157.51 26.92 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.578 0.351 . . . . 55.25 111.577 175.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.43 160.56 32.13 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 122.011 0.91 . . . . 72.319999999999993 110.055 165.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.64 5.29 13.61 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.948 1.699 . . . . 71.140000000000001 114.103 175.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.71 64.12 1.0 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 120.012 1.278 . . . . 75.120000000000005 108.21 173.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 4.4 tt -109.83 136.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.712 1.205 . . . . 73.439999999999998 109.532 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mtm180 -77.2 149.07 78.93 Favored Pre-proline 0 N--CA 1.465 0.305 0 N-CA-C 107.63 -1.248 . . . . 73.049999999999997 107.63 165.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -60.85 -32.82 93.13 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.238 1.292 . . . . 72.319999999999993 111.158 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.2 ttp85 -66.73 -20.8 66.04 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 118.074 -0.965 . . . . 63.329999999999998 112.507 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.5 -29.0 70.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 120.737 1.608 . . . . 73.129999999999995 109.679 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.647 HD11 HD22 ' A' ' 20' ' ' LEU . 2.4 mm? -77.67 -48.58 16.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.936 0.895 . . . . 75.129999999999995 109.754 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.14 -37.29 80.91 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.896 0.316 . . . . 74.319999999999993 110.996 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.56 -40.25 92.61 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.823 0.849 . . . . 72.019999999999996 111.314 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -57.27 -46.13 83.38 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.498 0.59 . . . . 55.240000000000002 110.311 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -68.23 -26.62 65.79 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.612 -0.68 . . . . 73.140000000000001 112.667 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.35 -15.33 34.99 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.655 1.182 . . . . 72.230000000000004 112.804 -173.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.0 t -61.81 -18.6 60.55 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.425 -0.797 . . . . 62.43 111.679 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.0 m -141.81 24.76 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.2 1.0 . . . . 62.200000000000003 110.401 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -179.3 -161.77 27.36 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 120.201 1.364 . . . . 72.040000000000006 115.371 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.57 146.37 28.24 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.34 1.856 . . . . 75.319999999999993 108.644 175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.1 t -102.21 150.55 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 127.175 2.19 . . . . 73.030000000000001 107.963 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.6 ttt85 -82.04 -56.69 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.608 1.563 . . . . 73.319999999999993 109.282 172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -159.43 134.64 8.25 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.132 -0.692 . . . . 72.230000000000004 109.132 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -66.43 162.27 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 126.397 1.879 . . . . 72.010000000000005 111.205 164.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.78 112.1 1.03 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.335 2.254 . . . . 75.030000000000001 107.81 -175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.0 ptp -116.76 147.8 41.72 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 119.874 1.216 . . . . 75.430000000000007 110.556 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 45' ' ' ILE . 2.3 mp -90.88 78.45 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.886 -1.154 . . . . 52.009999999999998 107.886 -166.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.8 m -94.24 9.68 37.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.039 1.126 . . . . 73.409999999999997 114.039 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -82.07 6.71 15.44 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.945 1.298 . . . . 71.140000000000001 112.767 176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 58.54 -164.51 0.19 Allowed 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.037 -1.039 . . . . 74.239999999999995 109.277 -151.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.8 p30 175.16 -1.73 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.642 1.977 . . . . 72.230000000000004 112.954 -165.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.65 16.16 9.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.043 1.337 . . . . 64.140000000000001 114.516 176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 -57.35 0.88 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 120.369 -1.457 . . . . 73.340000000000003 108.417 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 60.33 72.77 0.51 Allowed 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 127.922 2.489 . . . . 75.310000000000002 110.809 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.0 m -55.76 -2.56 0.06 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.945 2.098 . . . . 75.209999999999994 113.387 161.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm 54.99 30.86 14.88 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.542 1.537 . . . . 74.120000000000005 113.459 177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.75 90.16 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 108.372 -1.891 . . . . 75.25 108.372 175.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.44 135.02 30.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 124.047 0.939 . . . . 74.310000000000002 108.941 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.78 147.78 21.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.329 1.852 . . . . 55.210000000000001 108.174 169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -122.27 123.2 40.88 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 106.116 -1.809 . . . . 75.439999999999998 106.116 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 m -104.73 140.55 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-N 121.986 2.175 . . . . 75.140000000000001 108.057 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.05 115.57 12.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.9 -1.889 . . . . 71.319999999999993 105.9 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.21 160.57 22.98 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 119.307 0.958 . . . . 75.219999999999999 110.35 169.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.64 -27.94 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 118.629 -0.7 . . . . 74.209999999999994 110.759 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -114.73 174.55 5.91 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.888 1.222 . . . . 63.140000000000001 110.217 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 p -102.68 -28.02 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.857 1.263 . . . . 71.230000000000004 110.587 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.3 p -68.99 -17.31 63.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.861 1.21 . . . . 73.109999999999999 110.56 -175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -70.47 -23.55 62.71 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 125.604 1.562 . . . . 72.510000000000005 113.923 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 85.0 t -59.07 -56.29 37.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.422 -0.799 . . . . 44.43 110.11 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -66.17 -13.26 39.05 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.611 1.541 . . . . 74.200000000000003 113.2 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.11 -48.01 69.43 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.798 1.181 . . . . 60.140000000000001 109.839 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.29 -36.56 78.15 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.454 0.57 . . . . 44.200000000000003 111.446 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.77 -39.47 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.967 0.907 . . . . 64.140000000000001 110.016 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.92 -0.09 40.52 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.603 -1.109 . . . . 60.109999999999999 114.025 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -110.12 2.63 19.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.805 1.802 . . . . 74.439999999999998 111.794 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.554 ' HA ' HG23 ' A' ' 83' ' ' ILE . 15.1 t -50.45 -33.03 19.57 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.64 1.176 . . . . 74.129999999999995 113.54 -171.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.78 21.9 26.92 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.725 1.155 . . . . 64.510000000000005 113.848 -177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.93 174.22 8.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.213 1.507 . . . . 73.340000000000003 108.176 153.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -159.87 85.74 0.76 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 119.384 0.993 . . . . 74.510000000000005 112.717 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.0 m -60.37 117.59 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.734 -0.469 . . . . 71.200000000000003 109.734 -175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.3 mt 51.31 31.03 6.52 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.589 1.156 . . . . 63.140000000000001 112.534 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.51 27.67 29.3 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.226 -0.763 . . . . 54.25 113.044 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.9 t -121.15 84.79 40.57 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 118.931 1.365 . . . . 75.230000000000004 109.619 176.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.32 177.54 5.17 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.285 2.657 . . . . 75.310000000000002 112.018 171.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 74' ' ' THR . 16.1 tt -132.69 144.4 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 O-C-N 121.477 -0.764 . . . . 75.439999999999998 109.695 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.464 HG22 ' H ' ' A' ' 86' ' ' GLN . 41.3 mm -86.52 142.54 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.507 -0.923 . . . . 71.329999999999998 108.507 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.53 -3.91 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 114.691 1.367 . . . . 72.209999999999994 114.691 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.464 ' H ' HG22 ' A' ' 84' ' ' ILE . 2.1 mm100 -46.45 -51.41 15.22 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.192 1.797 . . . . 72.409999999999997 113.887 -168.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.01 174.34 0.07 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.282 1.433 . . . . 73.510000000000005 110.281 -169.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.36 156.2 20.3 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.753 -1.573 . . . . 72.510000000000005 106.753 153.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 168.57 19.64 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 126.485 1.914 . . . . 64.409999999999997 107.043 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.93 158.68 35.13 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.495 0.589 . . . . 71.120000000000005 110.551 176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.97 11.62 35.23 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.294 1.438 . . . . 72.310000000000002 110.487 164.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -81.48 158.2 24.6 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.489 1.916 . . . . 63.350000000000001 110.638 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -153.43 19.31 0.55 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.762 1.225 . . . . 71.209999999999994 110.899 168.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 . . . . . 0 C--O 1.238 0.456 0 O-C-N 120.328 -1.482 . . . . 72.230000000000004 109.472 177.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 CA-C-O 119.24 -0.756 . . . . 65.319999999999993 111.519 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 58.66 71.01 0.61 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.256 2.222 . . . . 71.140000000000001 114.362 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.6 tpp -78.51 145.28 35.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.69 1.196 . . . . 63.539999999999999 110.661 167.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 55.74 -161.34 0.18 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.083 1.753 . . . . 74.030000000000001 113.489 163.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.49 156.71 44.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.06 1.744 . . . . 62.210000000000001 106.936 172.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 42.3 p -113.62 166.58 10.99 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 126.43 1.892 . . . . 73.450000000000003 109.514 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -59.8 -9.11 8.79 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 CA-C-N 121.533 1.583 . . . . 71.239999999999995 113.142 168.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -114.03 -25.56 8.49 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.311 -1.493 . . . . 72.150000000000006 114.174 -169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -64.35 -21.47 66.63 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 120.284 1.402 . . . . 63.240000000000002 112.842 -173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -23.93 62.3 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.558 1.072 . . . . 70.219999999999999 112.015 171.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -90.1 -36.09 15.06 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.355 1.062 . . . . 72.209999999999994 110.097 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.19 -21.28 59.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.723 1.209 . . . . 71.019999999999996 112.221 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -53.84 -33.46 56.3 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.035 0.934 . . . . 73.030000000000001 112.562 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.0 m -70.84 149.17 47.09 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.878 0.847 . . . . 53.409999999999997 110.279 -170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.7 m -120.0 114.76 45.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 122.279 1.038 . . . . 65.010000000000005 108.45 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -83.93 104.75 14.27 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.471 -1.24 . . . . 73.209999999999994 108.829 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -92.27 121.11 33.46 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.151 -1.426 . . . . 51.130000000000003 107.151 175.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 ttm -125.53 18.79 8.1 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.267 1.027 . . . . 72.120000000000005 111.474 -171.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.11 22.03 3.79 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.617 -1.302 . . . . 74.349999999999994 111.725 -169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.777 ' HA ' HG13 ' A' ' 81' ' ' VAL . 14.7 mt -77.44 164.51 25.4 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.546 0.573 . . . . 64.409999999999997 112.546 -168.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.48 146.4 26.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.735 1.214 . . . . 71.430000000000007 110.709 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 14.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.143 2.177 . . . . 73.030000000000001 114.929 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.91 16.69 2.12 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.95 1.25 . . . . 63.399999999999999 114.153 170.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.8 tt -61.98 145.0 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 O-C-N 120.639 -1.288 . . . . 73.120000000000005 110.965 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -83.61 156.74 65.04 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-O 118.129 -0.939 . . . . 70.129999999999995 109.489 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -61.41 -37.12 74.13 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.138 1.892 . . . . 74.340000000000003 111.582 170.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 ttt180 -66.14 -28.48 68.82 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 117.684 -1.151 . . . . 65.129999999999995 111.982 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -33.47 69.72 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.866 1.666 . . . . 71.439999999999998 111.024 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -67.2 -29.75 69.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.458 1.103 . . . . 71.030000000000001 110.712 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.487 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.6 pt-20 -92.42 -30.87 15.53 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.937 0.895 . . . . 73.120000000000005 110.526 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.16 -44.68 92.14 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.486 1.514 . . . . 64.209999999999994 110.864 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.33 -63.75 1.04 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.487 1.515 . . . . 63.200000000000003 109.777 178.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -72.02 -22.5 61.4 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 112.266 0.469 . . . . 74.5 112.266 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -19.27 64.65 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.614 1.097 . . . . 74.310000000000002 111.443 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 79.8 p -61.24 -35.31 76.89 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.332 0.969 . . . . 61.140000000000001 111.077 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 m -121.0 8.42 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 127.934 2.494 . . . . 70.219999999999999 109.94 -167.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.19 -140.73 6.18 Favored Glycine 0 N--CA 1.442 -0.914 0 O-C-N 120.635 -1.29 . . . . 63.439999999999998 110.772 -162.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -152.83 -173.43 4.57 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.53 1.932 . . . . 73.109999999999999 106.808 -173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 30' ' ' GLU . 24.3 t -143.99 149.35 17.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 129.712 3.205 . . . . 71.019999999999996 106.169 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -62.89 1.54 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.724 -1.213 . . . . 65.420000000000002 107.724 167.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -158.99 162.25 36.76 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.876 -0.787 . . . . 63.0 108.876 -171.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.78 128.67 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 125.952 1.701 . . . . 74.030000000000001 106.457 -177.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -123.35 74.26 1.23 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.417 1.087 . . . . 73.329999999999998 109.002 170.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.44 130.87 35.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.639 2.376 . . . . 51.32 109.665 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.1 mp -92.71 74.65 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.31 -1.737 . . . . 71.420000000000002 106.31 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.5 m -71.74 91.35 1.13 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.529 -0.915 . . . . 73.010000000000005 108.529 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 50.57 174.92 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 130.005 3.322 . . . . 65.319999999999993 113.645 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 172.81 6.21 Favored 'General case' 0 CA--C 1.52 -0.175 0 O-C-N 120.974 -1.079 . . . . 63.049999999999997 109.031 -168.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -44.85 1.33 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.673 1 C-N-CA 132.683 4.393 . . . . 70.340000000000003 120.593 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -142.58 -61.9 0.43 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 125.203 1.401 . . . . 72.340000000000003 109.321 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 174.36 -38.5 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 128.508 2.723 . . . . 65.25 109.867 176.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? 58.08 -164.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.903 1.281 . . . . 70.140000000000001 109.174 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.82 -14.31 58.81 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.386 -1.292 . . . . 54.140000000000001 113.261 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.317 0.0 OUTLIER 50.39 10.74 0.06 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 117.633 2.457 . . . . 70.510000000000005 117.633 -176.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -146.22 63.43 0.45 Allowed Glycine 0 CA--C 1.523 0.534 0 CA-C-N 118.934 0.788 . . . . 71.450000000000003 111.413 172.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 pt -135.09 130.32 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.084 1.354 . . . . 74.140000000000001 111.177 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.56 151.4 25.99 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.747 1.219 . . . . 65.010000000000005 111.175 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -127.5 80.99 1.99 Allowed 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 124.627 1.171 . . . . 72.129999999999995 109.748 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.395 1.5 p -81.8 121.68 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 120.452 -1.405 . . . . 72.409999999999997 110.585 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -84.66 137.58 33.17 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.637 1.575 . . . . 73.109999999999999 109.989 -173.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -97.46 160.79 14.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.965 0.888 . . . . 71.219999999999999 111.836 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.53 -16.24 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 126.531 1.933 . . . . 70.409999999999997 111.209 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -128.56 170.22 13.46 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.028 1.731 . . . . 71.209999999999994 108.806 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 t -100.99 -28.35 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.542 1.537 . . . . 72.040000000000006 111.032 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 t -77.89 -14.57 59.51 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.459 -1.401 . . . . 72.420000000000002 112.122 -167.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -89.08 -0.49 57.47 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.139 0.975 . . . . 74.299999999999997 112.613 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.86 -56.73 27.09 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 120.83 1.65 . . . . 44.130000000000003 109.425 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.15 -14.81 46.0 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.953 1.769 . . . . 73.239999999999995 114.166 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.7 tp -61.57 -59.61 4.95 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.218 1.372 . . . . 70.510000000000005 108.488 170.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.95 59.46 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.379 1.072 . . . . 71.5 112.241 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.521 HG23 HG13 ' A' ' 85' ' ' VAL . 56.7 mt -57.41 -54.61 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 C-N-CA 123.964 0.906 . . . . 70.530000000000001 108.622 172.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -67.52 -0.4 11.82 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.916 -0.936 . . . . 70.439999999999998 113.818 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -100.61 1.79 41.09 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 120.119 1.959 . . . . 73.239999999999995 111.295 174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.438 ' HA ' HG23 ' A' ' 83' ' ' ILE . 12.9 t -49.45 -30.6 8.36 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.12 1.327 . . . . 73.299999999999997 114.344 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.38 2.43 56.24 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.405 1.002 . . . . 63.119999999999997 114.181 -175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -75.96 175.57 8.71 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.234 1.517 . . . . 72.310000000000002 108.517 164.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -152.63 131.76 12.7 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.278 -0.889 . . . . 74.5 110.057 173.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.2 t -83.61 90.9 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.425 -1.695 . . . . 62.399999999999999 106.425 170.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mt 59.81 37.34 21.94 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.869 0.842 . . . . 73.129999999999995 110.406 168.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 97.72 3.32 58.32 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.997 1.284 . . . . 74.209999999999994 114.581 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.777 HG13 ' HA ' ' A' ' 20' ' ' LEU . 96.8 t -108.49 85.96 3.21 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.8 1.64 . . . . 74.340000000000003 109.801 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.07 -178.31 1.04 Allowed 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.353 2.702 . . . . 73.129999999999995 112.608 168.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.438 HG23 ' HA ' ' A' ' 74' ' ' THR . 20.4 tt -134.33 148.75 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.063 0.945 . . . . 70.400000000000006 110.233 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 86' ' ' GLN . 46.0 mm -91.27 140.57 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 107.516 -1.29 . . . . 73.420000000000002 107.516 177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.521 HG13 HG23 ' A' ' 71' ' ' ILE . 24.8 t -51.19 -18.75 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.917 2.087 . . . . 70.310000000000002 114.795 171.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' H ' HG22 ' A' ' 84' ' ' ILE . 7.6 mm100 -44.31 -47.41 9.52 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 125.662 1.585 . . . . 70.109999999999999 113.276 -169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.05 49.86 16.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.707 0.803 . . . . 63.439999999999998 112.118 173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.307 24.2 p 60.66 -154.97 0.36 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.26 1.424 . . . . 65.540000000000006 110.568 -170.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 44.95 -164.0 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.62 2.768 . . . . 74.310000000000002 115.544 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -156.6 19.21 0.33 Allowed 'General case' 0 C--N 1.345 0.374 0 N-CA-C 114.226 1.195 . . . . 70.540000000000006 114.226 178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.94 44.54 30.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.49 0.716 . . . . 74.319999999999993 111.837 -162.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -141.87 -63.65 0.44 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.796 1.238 . . . . 70.140000000000001 110.574 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 44.7 62.9 1.88 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 128.203 2.601 . . . . 74.140000000000001 111.785 -166.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 ttm180 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 106.39 -1.707 . . . . 73.519999999999996 106.39 177.933 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.923 0 N-CA-C 109.903 -1.279 . . . . 73.239999999999995 109.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 44.06 45.1 6.6 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.86 1.664 . . . . 63.409999999999997 112.795 159.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.3 mtm -80.32 86.2 5.72 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.077 0.941 . . . . 73.319999999999993 110.771 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 63.01 61.81 1.08 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 127.089 2.156 . . . . 70.109999999999999 110.206 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.91 106.66 0.09 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.779 2.032 . . . . 73.219999999999999 111.294 -172.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.712 HG23 ' HB2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.0 151.68 73.77 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.352 1.861 . . . . 71.439999999999998 113.246 174.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.11 -16.42 31.98 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.919 2.413 . . . . 74.349999999999994 112.659 172.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.21 -49.75 10.41 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 119.252 0.933 . . . . 74.409999999999997 109.625 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.712 ' HB2' HG23 ' A' ' 6' ' ' THR . 9.4 tt0 -59.78 -43.11 94.53 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.842 0.857 . . . . 74.219999999999999 110.497 -175.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -56.12 -27.46 54.06 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.625 0.77 . . . . 73.040000000000006 112.444 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.11 -16.23 14.32 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.337 1.455 . . . . 64.329999999999998 110.437 -167.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.35 -50.5 6.87 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.833 2.453 . . . . 74.230000000000004 111.403 177.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 61.1 6.12 1.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 72.349999999999994 116.224 167.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.1 m -107.54 157.08 18.32 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 119.961 -1.712 . . . . 54.439999999999998 109.495 -161.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.78 174.83 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.475 -0.766 . . . . 45.149999999999999 109.52 170.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -138.73 133.83 32.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.686 1.594 . . . . 72.439999999999998 107.36 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.6 m -127.31 121.99 32.57 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.32 -2.104 . . . . 65.549999999999997 105.32 -171.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 38.3 ttp -125.32 14.31 8.3 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.11 0.964 . . . . 65.140000000000001 111.635 -170.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -139.75 33.77 2.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.045 1.338 . . . . 63.140000000000001 109.982 -171.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 mt -64.95 145.04 56.86 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 121.751 -0.593 . . . . 62.210000000000001 110.771 -174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' H ' HG23 ' A' ' 81' ' ' VAL . . . -66.6 162.63 20.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.071 0.939 . . . . 64.510000000000005 109.496 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.34 -8.17 59.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.446 -1.252 . . . . 70.140000000000001 114.31 -166.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -145.87 65.35 1.22 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.489 1.04 . . . . 73.239999999999995 108.762 167.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.573 ' CD1' HG11 ' A' ' 81' ' ' VAL . 5.9 tt -96.97 163.57 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 122.818 0.447 . . . . 73.319999999999993 110.387 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -108.52 155.48 40.4 Favored Pre-proline 0 N--CA 1.466 0.361 0 C-N-CA 125.779 1.632 . . . . 72.549999999999997 108.72 168.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 -36.51 93.07 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.396 2.064 . . . . 74.120000000000005 111.979 173.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -60.99 -32.95 72.5 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 117.962 -1.018 . . . . 61.409999999999997 111.612 179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -72.52 -11.73 60.78 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.232 1.378 . . . . 74.129999999999995 112.865 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.26 -44.99 9.86 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.666 -0.865 . . . . 55.43 108.666 169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 39' ' ' VAL . 3.8 pt-20 -65.71 -38.22 88.59 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.508 0.594 . . . . 73.530000000000001 111.518 -177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.5 -25.8 63.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.112 1.365 . . . . 75.530000000000001 112.651 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -62.28 -64.13 1.02 Allowed 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.689 -1.226 . . . . 73.510000000000005 107.689 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -63.35 -27.68 69.48 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 113.78 1.029 . . . . 75.209999999999994 113.78 -168.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.5 p -67.27 -3.22 7.36 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.991 1.269 . . . . 63.219999999999999 113.523 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 t -55.14 -27.88 48.66 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.754 1.161 . . . . 73.430000000000007 111.005 165.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.4 m -139.83 43.59 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.383 1.073 . . . . 72.209999999999994 110.861 -175.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.03 -141.5 8.86 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.014 -1.234 . . . . 72.540000000000006 110.014 173.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -148.0 157.55 43.58 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.164 -1.05 . . . . 64.420000000000002 108.164 174.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG21 ' HA ' ' A' ' 30' ' ' GLU . 67.0 t -91.98 163.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.518 -0.739 . . . . 53.009999999999998 109.194 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.3 ttt85 -122.31 -31.16 3.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 117.037 -1.459 . . . . 72.319999999999993 111.582 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -164.18 172.51 13.57 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 120.841 1.655 . . . . 54.25 109.196 159.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.55 126.0 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.515 1.926 . . . . 70.239999999999995 108.014 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.13 175.48 5.51 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.28 1.432 . . . . 74.530000000000001 109.929 169.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 19.3 ptp -166.29 154.93 10.88 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.898 1.679 . . . . 73.329999999999998 109.407 161.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.14 95.48 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.504 0.669 . . . . 64.209999999999994 109.923 -172.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.59 61.46 6.28 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 123.336 1.541 . . . . 63.439999999999998 108.768 171.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 44.92 178.61 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 131.757 4.023 . . . . 71.510000000000005 112.897 -162.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -143.96 -37.75 0.32 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.637 1.175 . . . . 74.329999999999998 111.305 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -151.91 0.49 0.34 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.196 1.398 . . . . 70.230000000000004 111.457 -164.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -133.99 -171.59 2.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.793 2.437 . . . . 63.530000000000001 108.42 -172.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.5 ttt85 -133.18 83.57 2.07 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.047 -1.464 . . . . 70.120000000000005 107.047 161.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -136.14 -59.45 0.74 Allowed 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.085 1.354 . . . . 73.420000000000002 107.779 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 p 43.88 42.79 4.79 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.548 1.939 . . . . 65.329999999999998 113.674 173.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -66.35 24.96 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 116.642 2.09 . . . . 61.439999999999998 116.642 -166.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.17 70.68 1.29 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 108.786 -1.726 . . . . 33.530000000000001 108.786 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.71 122.73 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 C-N-CA 125.363 1.465 . . . . 54.420000000000002 109.795 -168.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.89 150.87 37.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.258 1.023 . . . . 70.140000000000001 109.825 171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -107.57 154.83 20.84 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.404 -2.073 . . . . 70.519999999999996 105.404 161.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -141.21 118.03 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 104.962 -2.236 . . . . 70.510000000000005 104.962 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -82.76 122.75 28.58 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.869 1.267 . . . . 72.439999999999998 108.638 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -96.42 176.22 6.12 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.801 0.81 . . . . 72.530000000000001 111.279 178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.536 HG21 ' HG3' ' A' ' 38' ' ' LYS . 19.5 m -86.03 -24.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 126.358 1.863 . . . . 72.430000000000007 112.808 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -133.39 177.37 7.74 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.966 1.706 . . . . 51.439999999999998 111.4 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -101.46 -27.01 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.713 1.205 . . . . 72.209999999999994 111.59 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -67.73 -21.78 65.27 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.011 -1.055 . . . . 73.329999999999998 112.488 -166.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m -87.56 -9.58 54.0 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.523 -1.227 . . . . 71.439999999999998 113.146 172.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 70.1 t -50.7 -58.93 8.46 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 122.784 2.538 . . . . 74.340000000000003 109.895 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.03 -6.13 18.0 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.492 2.128 . . . . 73.219999999999999 114.783 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -70.59 -43.47 69.3 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.684 1.129 . . . . 72.010000000000005 109.395 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -25.61 47.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.999 0.92 . . . . 32.140000000000001 112.756 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.3 mt -61.51 -46.03 97.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.976 0.911 . . . . 63.439999999999998 109.379 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.36 -1.52 43.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.205 -0.775 . . . . 61.049999999999997 113.985 175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.26 4.2 33.51 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.934 1.367 . . . . 73.329999999999998 110.867 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.2 t -55.09 -20.3 9.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.944 1.298 . . . . 70.230000000000004 113.733 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.43 9.86 42.1 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.873 -0.959 . . . . 74.040000000000006 113.411 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -81.4 -179.98 7.6 Favored 'General case' 0 C--O 1.226 -0.169 0 CA-C-N 118.754 1.277 . . . . 74.420000000000002 110.38 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -159.2 88.61 0.89 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.693 -0.629 . . . . 64.310000000000002 109.997 173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.728 ' O ' HG12 ' A' ' 81' ' ' VAL . 57.3 t -68.28 110.13 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.098 -1.445 . . . . 73.530000000000001 107.098 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.7 mt 55.02 21.5 3.81 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.649 -0.657 . . . . 44.219999999999999 112.0 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 111.98 1.22 27.0 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 117.398 -1.779 . . . . 70.420000000000002 115.047 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.728 HG12 ' O ' ' A' ' 78' ' ' VAL . 7.1 p -108.15 85.95 2.97 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 120.723 2.261 . . . . 74.409999999999997 111.563 -172.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.42 162.63 29.83 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.343 2.028 . . . . 52.109999999999999 112.007 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -117.04 159.74 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.428 1.091 . . . . 74.540000000000006 110.288 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.6 mm -102.99 144.25 14.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 107.085 -1.45 . . . . 74.25 107.085 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.7 m -60.21 -0.35 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 128.063 2.545 . . . . 74.409999999999997 115.887 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -61.97 -36.74 82.37 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 114.911 1.448 . . . . 70.230000000000004 114.911 -166.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 55.09 177.96 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 120.482 1.492 . . . . 71.420000000000002 111.227 -169.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p -113.86 139.55 49.08 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.365 -0.834 . . . . 53.210000000000001 108.891 174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 49.88 -171.83 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 128.616 2.766 . . . . 73.120000000000005 112.616 -164.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 52.43 -172.3 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.111 2.164 . . . . 70.0 112.585 -167.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.8 76.74 1.7 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.406 -1.702 . . . . 74.0 106.406 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -130.53 150.62 51.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.524 -0.735 . . . . 70.349999999999994 109.537 177.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 176.51 63.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.014 -1.847 . . . . 74.200000000000003 106.014 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.8 ptt85 . . . . . 0 C--O 1.247 0.926 0 N-CA-C 108.004 -1.11 . . . . 74.010000000000005 108.004 175.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.83 0 N-CA-C 109.216 -1.554 . . . . 72.239999999999995 109.216 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -134.79 53.51 1.99 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.238 1.415 . . . . 63.240000000000002 107.582 169.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttm -108.8 80.61 1.35 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 124.212 1.005 . . . . 73.219999999999999 110.06 -161.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -67.4 156.28 36.93 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.888 1.675 . . . . 71.340000000000003 111.719 -163.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.47 146.89 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 129.354 3.062 . . . . 75.230000000000004 109.965 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.9 p -85.66 163.61 43.4 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.042 -1.661 . . . . 75.319999999999993 111.051 -178.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.92 -55.09 1.48 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.012 2.475 . . . . 73.329999999999998 112.41 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -53.78 -39.9 65.82 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.132 0.573 . . . . 75.109999999999999 112.423 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.22 -47.96 69.29 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 121.704 -0.623 . . . . 63.509999999999998 109.813 175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -62.45 -25.48 68.0 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.481 1.037 . . . . 62.450000000000003 111.644 -176.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -67.24 -60.23 2.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.178 0.899 . . . . 55.409999999999997 109.154 166.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.44 -0.6 0.92 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.76 2.024 . . . . 53.310000000000002 116.138 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HE ' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -57.83 -20.6 37.13 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.395 1.078 . . . . 74.340000000000003 111.407 161.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 77.7 m -50.84 138.61 18.45 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.276 1.83 . . . . 55.25 109.889 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 59' ' ' VAL . 7.1 m -120.49 118.33 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.19 1.396 . . . . 55.149999999999999 109.43 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -68.83 155.67 39.78 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.894 1.278 . . . . 73.209999999999994 109.69 173.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 57' ' ' ALA . 1.8 p -131.11 158.47 40.33 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.764 1.626 . . . . 61.520000000000003 107.947 162.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 tmm? -143.29 11.14 1.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.502 0.927 . . . . 33.100000000000001 113.502 -174.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -140.45 25.31 2.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.477 1.035 . . . . 64.540000000000006 112.391 -163.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.18 165.31 16.29 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.871 -0.518 . . . . 55.039999999999999 111.402 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.4 169.64 8.57 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.592 1.157 . . . . 72.530000000000001 109.857 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.28 -11.47 60.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.531 1.308 . . . . 23.5 114.531 -171.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.8 20.29 10.13 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 120.289 1.404 . . . . 75.540000000000006 113.489 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.9 tp -64.48 163.58 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.885 0 C-N-CA 124.258 1.023 . . . . 60.340000000000003 110.001 177.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -121.59 157.73 55.88 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 126.672 1.989 . . . . 74.010000000000005 107.528 162.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.84 -41.93 64.31 Favored 'Trans proline' 0 CA--C 1.532 0.425 0 CA-C-N 121.374 1.526 . . . . 51.25 109.838 172.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -60.65 -26.09 66.8 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 113.769 1.025 . . . . 73.299999999999997 113.769 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -59.47 -28.19 66.78 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 120.22 1.373 . . . . 61.240000000000002 110.443 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.82 -40.26 16.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.187 1.395 . . . . 63.299999999999997 110.615 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -69.49 -35.63 75.75 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.589 0.632 . . . . 63.130000000000003 110.394 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -58.47 -51.96 67.65 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 125.574 1.549 . . . . 54.100000000000001 108.242 175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -51.45 -57.21 9.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.339 1.056 . . . . 75.329999999999998 110.533 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -72.14 -19.57 61.75 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 113.274 0.842 . . . . 72.129999999999995 113.274 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.0 p -66.05 -18.13 65.14 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.761 0.824 . . . . 43.299999999999997 111.37 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.0 p -66.24 -14.57 62.16 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.001 0.371 . . . . 71.310000000000002 112.001 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.55 5.41 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.974 0.909 . . . . 61.100000000000001 112.121 -167.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.77 -160.22 25.82 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 109.269 -1.532 . . . . 72.239999999999995 109.269 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.31 131.9 21.1 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.716 1.246 . . . . 75.040000000000006 113.201 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.0 154.46 6.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 125.727 1.611 . . . . 34.229999999999997 110.303 165.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -96.2 -58.47 2.07 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.741 1.616 . . . . 74.030000000000001 107.963 164.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -158.83 155.02 27.07 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.633 1.106 . . . . 52.140000000000001 110.091 -174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.64 140.63 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 124.307 1.043 . . . . 63.32 109.03 -169.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.7 mtt-85 -142.26 71.63 1.35 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.544 1.138 . . . . 63.340000000000003 109.876 -172.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.9 ptp -66.13 158.28 29.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.661 -0.816 . . . . 60.520000000000003 108.97 163.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.66 137.04 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.022 -1.473 . . . . 62.130000000000003 107.022 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.2 m -71.44 87.29 0.87 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.434 -1.321 . . . . 73.040000000000006 107.434 168.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -70.62 156.27 39.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.31 1.444 . . . . 75.109999999999999 111.929 -173.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.51 156.74 18.85 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.254 1.022 . . . . 75.439999999999998 113.111 177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -44.51 -30.16 0.83 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 130.767 3.627 . . . . 64.430000000000007 114.156 172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.7 t -55.77 -6.55 0.22 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.626 1.57 . . . . 70.219999999999999 113.607 170.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -156.73 -36.68 0.08 Allowed 'General case' 0 C--N 1.344 0.327 0 O-C-N 119.98 -1.7 . . . . 51.140000000000001 111.028 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 45.12 66.55 0.87 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.519 1.527 . . . . 73.209999999999994 107.96 -165.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.7 m -68.92 23.94 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.991 0.737 . . . . 71.340000000000003 112.991 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.404 18.3 ptpt 46.42 24.55 0.31 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.295 2.638 . . . . 75.540000000000006 117.314 175.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.33 92.58 0.58 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 120.246 1.384 . . . . 60.530000000000001 111.54 173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -132.19 153.98 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 126.203 1.801 . . . . 73.230000000000004 111.102 -168.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . . . -151.75 166.0 32.7 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 126.466 1.907 . . . . 42.140000000000001 109.273 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -124.08 152.37 42.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 104.868 -2.271 . . . . 75.409999999999997 104.868 155.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 15' ' ' VAL 0.356 1.5 p -144.86 115.04 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 120.667 -1.27 . . . . 55.140000000000001 108.963 175.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 -63.24 131.93 50.01 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.416 1.886 . . . . 74.109999999999999 106.651 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.68 156.22 20.53 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.542 0.687 . . . . 73.230000000000004 111.004 170.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.0 t -82.98 -24.74 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.746 -0.661 . . . . 63.310000000000002 109.46 177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.13 131.88 44.42 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 120.976 -1.078 . . . . 73.129999999999995 110.355 -163.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.403 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 3.3 p -63.92 -31.72 54.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.922 1.689 . . . . 60.350000000000001 110.571 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.3 -41.67 98.71 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.385 1.474 . . . . 63.539999999999999 110.913 -169.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.9 m -78.89 -5.47 53.71 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.394 0.886 . . . . 60.329999999999998 113.394 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.3 t -59.97 -56.43 35.7 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 120.809 1.64 . . . . 73.239999999999995 109.563 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.57 -15.5 45.04 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 CA-C-N 120.58 1.243 . . . . 52.43 112.717 172.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.6 tp -64.89 -43.93 91.27 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 121.031 1.741 . . . . 64.540000000000006 109.757 168.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.47 -35.82 76.79 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 120.378 1.444 . . . . 62.509999999999998 111.565 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -58.83 -45.6 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.631 -0.668 . . . . 72.129999999999995 109.288 171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.28 -8.1 22.56 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.177 1.37 . . . . 73.519999999999996 114.109 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.2 mt -113.97 4.31 15.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.426 1.613 . . . . 71.299999999999997 112.358 -172.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.7 t -52.62 -23.54 6.69 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.268 1.027 . . . . 61.509999999999998 113.645 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 19.26 35.29 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 124.86 1.219 . . . . 62.520000000000003 112.281 -174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -101.54 178.85 4.52 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.856 1.328 . . . . 64.530000000000001 109.428 167.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -152.48 95.31 2.01 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 124.426 1.091 . . . . 74.430000000000007 111.718 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.9 t -62.21 110.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.789 -1.189 . . . . 75.540000000000006 107.789 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt 50.85 35.22 11.77 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.746 1.218 . . . . 74.400000000000006 111.868 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.07 35.03 25.21 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.967 -0.907 . . . . 71.530000000000001 113.397 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.64 86.14 56.45 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 125.831 1.652 . . . . 75.239999999999995 108.008 175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -68.83 171.91 12.62 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.505 2.136 . . . . 63.219999999999999 111.575 175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.8 tt -134.64 160.43 41.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 O-C-N 121.584 -0.698 . . . . 53.039999999999999 110.224 -175.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.4 mm -98.72 165.72 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 107.383 -1.34 . . . . 44.420000000000002 107.383 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.67 -21.21 24.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 117.829 -1.082 . . . . 72.340000000000003 113.16 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -44.38 -42.94 7.26 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.585 1.698 . . . . 55.039999999999999 115.585 -150.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 52.05 41.53 29.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 61.450000000000003 112.334 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.286 0.0 OUTLIER 47.18 -161.21 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.085 2.154 . . . . 63.439999999999998 111.828 -173.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -111.4 -164.78 0.94 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 106.473 -1.676 . . . . 71.209999999999994 106.473 168.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 157.57 44.8 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.682 0.674 . . . . 74.430000000000007 109.917 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.72 38.55 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 129.124 2.97 . . . . 62.020000000000003 111.463 -176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 15.2 mtmm -129.77 142.43 50.7 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.295 1.438 . . . . 64.420000000000002 108.593 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -159.27 139.38 11.98 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.903 1.228 . . . . 74.530000000000001 109.003 172.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.247 0.965 0 C-N-CA 128.708 2.803 . . . . 74.519999999999996 114.994 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.766 0 N-CA-C 110.139 -1.184 . . . . 65.209999999999994 110.139 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -66.43 145.79 55.28 Favored 'General case' 0 C--O 1.23 0.069 0 CA-C-N 118.864 1.332 . . . . 74.200000000000003 107.917 157.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.1 ptm -145.73 -1.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.654 0.613 . . . . 73.439999999999998 112.654 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -97.85 172.54 7.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 129.969 3.308 . . . . 64.310000000000002 109.529 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tp -159.36 156.93 29.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.722 1.209 . . . . 74.219999999999999 108.513 175.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.53 HG23 ' H ' ' A' ' 9' ' ' GLU . 1.7 t -80.53 158.5 71.19 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.174 1.352 . . . . 63.219999999999999 109.98 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -56.44 -37.28 97.48 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.208 2.605 . . . . 44.299999999999997 113.12 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -76.0 -31.37 58.91 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.739 1.154 . . . . 72.310000000000002 111.074 -167.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.53 ' H ' HG23 ' A' ' 6' ' ' THR . 19.7 tp10 -63.95 -41.02 97.7 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.292 1.437 . . . . 61.439999999999998 109.828 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -69.72 -19.99 63.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.431 -0.795 . . . . 74.140000000000001 112.237 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -37.46 16.54 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.377 1.071 . . . . 65.099999999999994 110.763 178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.66 -58.76 6.7 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.526 1.53 . . . . 74.329999999999998 111.373 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 44.62 63.3 1.73 Allowed 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 127.256 2.222 . . . . 72.0 110.244 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.28 148.85 49.66 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 120.859 -1.15 . . . . 74.340000000000003 109.278 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.4 114.62 39.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 122.067 0.937 . . . . 63.100000000000001 111.436 172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -84.08 93.31 8.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.414 1.086 . . . . 73.340000000000003 109.821 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -79.17 92.13 5.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.45 -1.25 . . . . 72.329999999999998 108.137 178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 36.2 ttp -93.48 14.62 18.13 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.146 0.795 . . . . 71.409999999999997 113.146 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -137.79 36.14 2.41 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.308 -1.495 . . . . 74.120000000000005 112.19 -165.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.7 mt -78.22 145.4 35.54 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.029 0.932 . . . . 74.310000000000002 112.613 -171.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' H ' HG22 ' A' ' 81' ' ' VAL . . . -72.08 147.85 46.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.377 1.871 . . . . 71.129999999999995 109.84 164.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.79 -0.97 6.06 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 116.321 1.971 . . . . 64.150000000000006 116.321 -169.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -122.37 -0.38 9.32 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 120.56 1.527 . . . . 73.239999999999995 114.248 -166.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.4 150.26 6.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 114.237 1.199 . . . . 54.219999999999999 114.237 -159.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 mtm-85 -90.35 161.99 35.68 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 125.397 1.479 . . . . 71.25 109.901 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.79 -53.04 3.59 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.33 2.02 . . . . 73.230000000000004 111.795 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -66.15 -18.95 65.67 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 112.966 0.728 . . . . 71.109999999999999 112.966 -173.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -59.39 -32.99 70.66 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.324 -0.86 . . . . 72.439999999999998 110.715 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.67 -52.65 16.8 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 119.01 -0.519 . . . . 74.430000000000007 109.872 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.69 -23.99 64.45 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.056 0.847 . . . . 70.420000000000002 110.916 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.76 -26.73 63.49 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.107 0.78 . . . . 71.209999999999994 113.107 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -61.34 -36.01 78.99 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.362 -0.535 . . . . 70.319999999999993 110.757 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -91.21 -25.74 19.38 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.513 0.931 . . . . 73.409999999999997 113.513 -174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.1 p -61.13 -20.71 62.99 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.417 1.887 . . . . 73.0 114.013 -169.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 t -58.08 -40.56 81.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.004 1.322 . . . . 71.219999999999999 108.969 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -148.31 54.29 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.18 0.992 . . . . 63.100000000000001 109.964 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 172.01 163.36 25.79 Favored Glycine 0 CA--C 1.521 0.448 0 O-C-N 120.673 -1.267 . . . . 71.030000000000001 112.032 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.5 ttmt -116.46 124.64 50.46 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.026 0.93 . . . . 72.209999999999994 109.18 173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 99.5 t -91.43 148.1 4.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 107.5 -1.296 . . . . 52.210000000000001 107.5 175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -101.31 -46.79 4.91 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.029 1.731 . . . . 73.310000000000002 109.396 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -157.85 -176.99 6.24 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.012 0.824 . . . . 74.310000000000002 111.088 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -152.98 97.92 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.628 1.571 . . . . 73.439999999999998 108.411 -159.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -119.16 131.07 55.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.718 1.145 . . . . 73.420000000000002 110.161 -167.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.0 ptm -136.45 164.59 27.81 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.261 1.578 . . . . 70.019999999999996 115.261 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.87 73.3 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.666 -1.235 . . . . 74.049999999999997 107.666 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.5 m -75.54 84.48 2.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.276 1.03 . . . . 62.009999999999998 108.738 168.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.24 -177.05 3.24 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.1 -1.815 . . . . 63.020000000000003 106.1 156.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.0 mtp85 -58.71 -65.75 0.61 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.082 0.953 . . . . 71.430000000000007 109.268 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -178.78 -44.54 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 125.14 1.376 . . . . 73.140000000000001 109.376 -165.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.5 t 52.31 -85.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.896 1.678 . . . . 74.230000000000004 110.819 -169.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -158.39 19.64 0.23 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.173 1.351 . . . . 70.420000000000002 110.834 159.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.57 -171.5 2.19 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.8 1.24 . . . . 74.439999999999998 113.514 -168.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -53.73 -12.02 0.46 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.488 1.915 . . . . 72.439999999999998 114.106 166.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt 55.79 20.93 4.36 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.981 1.713 . . . . 64.409999999999997 114.216 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.89 91.27 0.09 OUTLIER Glycine 0 C--N 1.336 0.548 0 O-C-N 120.356 -1.465 . . . . 71.239999999999995 113.482 -177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.9 134.0 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.503 1.121 . . . . 62.409999999999997 110.094 -171.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.57 157.37 43.41 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.682 1.193 . . . . 74.010000000000005 111.819 174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -120.98 108.6 14.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 126.229 1.812 . . . . 74.230000000000004 106.27 171.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.6 t -96.91 121.73 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.326 -1.361 . . . . 70.219999999999999 107.326 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -86.58 116.98 25.05 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.495 1.518 . . . . 74.019999999999996 109.072 -173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.71 162.47 18.74 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.485 1.514 . . . . 61.140000000000001 112.961 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 29.2 t -83.87 -20.34 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 125.046 1.339 . . . . 73.120000000000005 112.525 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -142.0 156.12 45.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 107.909 -1.145 . . . . 65.400000000000006 107.909 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.13 -26.27 36.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 O-C-N 123.456 0.473 . . . . 72.239999999999995 110.576 172.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.5 m -61.81 -36.86 82.38 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.045 -1.034 . . . . 65.040000000000006 113.626 -164.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.0 m -82.16 -5.45 58.48 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.617 1.099 . . . . 73.030000000000001 113.696 -175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.6 t -55.83 -57.97 18.63 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 119.997 1.272 . . . . 72.310000000000002 110.846 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -65.15 -15.86 52.26 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 121.966 1.778 . . . . 53.439999999999998 113.206 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.86 -45.54 81.75 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 119.351 0.978 . . . . 72.030000000000001 109.318 173.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -37.91 71.24 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.412 0.685 . . . . 45.299999999999997 111.14 176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 38.8 mt -62.51 -32.1 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.589 -0.694 . . . . 62.219999999999999 109.882 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.96 0.35 7.62 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.53 1.538 . . . . 71.099999999999994 114.23 173.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.82 11.74 3.67 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.038 1.735 . . . . 72.200000000000003 112.209 -171.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -50.35 -29.55 10.21 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 121.123 1.783 . . . . 70.329999999999998 114.133 -177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.51 -16.02 55.89 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.826 -0.986 . . . . 71.109999999999999 112.894 -174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -70.7 170.88 11.43 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 118.646 1.223 . . . . 65.439999999999998 109.866 173.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -157.43 128.32 6.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.509 0.724 . . . . 64.420000000000002 109.219 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.3 t -84.71 94.95 3.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.262 -2.125 . . . . 65.409999999999997 105.262 171.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.1 mt 65.93 23.23 11.28 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.372 1.069 . . . . 64.329999999999998 112.93 170.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 105.07 11.8 29.01 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.82 -0.55 . . . . 63.049999999999997 113.16 -174.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 21' ' ' ALA . 57.5 t -113.05 83.59 6.27 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 126.078 1.751 . . . . 72.239999999999995 108.853 174.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.64 176.29 8.36 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.225 2.617 . . . . 64.099999999999994 111.796 166.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.3 tt -120.97 177.33 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.724 1.21 . . . . 72.230000000000004 108.926 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.646 HG22 ' H ' ' A' ' 86' ' ' GLN . 34.1 mm -123.75 139.12 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.558 1.143 . . . . 71.040000000000006 108.908 174.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 t -44.73 -18.63 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 130.476 3.51 . . . . 72.319999999999993 115.968 171.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.646 ' H ' HG22 ' A' ' 84' ' ' ILE . 1.3 mt-30 -53.22 -58.34 7.39 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.716 1.143 . . . . 72.319999999999993 110.937 174.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.06 50.15 18.52 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 125.264 1.603 . . . . 65.329999999999998 110.491 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER 52.46 -154.16 0.21 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.294 1.438 . . . . 62.439999999999998 111.138 -174.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -55.44 131.05 45.01 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 107.989 -1.115 . . . . 72.299999999999997 107.989 159.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.96 24.6 1.47 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.871 1.669 . . . . 44.310000000000002 109.218 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 73.5 24.68 2.24 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 72.409999999999997 112.186 175.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.28 -176.07 3.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.73 1.212 . . . . 74.109999999999999 110.924 -166.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 36.5 p-10 -137.07 61.91 1.61 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.607 1.963 . . . . 65.400000000000006 109.657 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.28 -1.343 . . . . 74.140000000000001 108.376 -171.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 108.922 -1.671 . . . . 65.219999999999999 108.922 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 44.12 66.02 0.92 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.249 1.82 . . . . 72.040000000000006 112.397 168.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttp -148.15 166.63 27.29 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.446 -1.687 . . . . 51.539999999999999 106.446 171.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 57.88 -158.87 0.27 Allowed 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.506 1.122 . . . . 73.040000000000006 109.723 -175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.24 143.22 50.41 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.188 2.195 . . . . 74.049999999999997 105.87 162.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.0 165.95 45.35 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 123.727 0.811 . . . . 54.340000000000003 111.555 -175.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -53.84 -40.28 81.0 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.446 1.431 . . . . 72.030000000000001 110.702 160.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.276 6.2 pt-20 -77.51 -40.96 40.99 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 125.906 1.682 . . . . 73.030000000000001 113.385 -165.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -50.83 -45.91 59.79 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 120.583 1.538 . . . . 70.329999999999998 111.844 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.4 -16.14 61.34 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 120.955 -1.091 . . . . 73.349999999999994 112.974 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -34.72 15.95 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.27 1.428 . . . . 65.239999999999995 110.579 176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.98 2.98 18.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.415 2.686 . . . . 44.020000000000003 112.782 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.12 -7.93 4.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 128.198 2.599 . . . . 63.32 114.708 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -102.08 145.98 28.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.591 1.156 . . . . 73.219999999999999 108.75 -175.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 m -112.26 118.34 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 N-CA-C 108.779 -0.823 . . . . 74.450000000000003 108.779 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -72.82 113.06 9.44 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.335 1.054 . . . . 71.219999999999999 108.721 170.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.9 m -98.95 129.95 45.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.519 1.528 . . . . 53.329999999999998 107.469 172.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.6 ttp -127.44 175.85 7.91 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.09 1.756 . . . . 73.530000000000001 107.615 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 64.1 20.83 12.36 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.808 1.643 . . . . 73.439999999999998 113.525 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -72.6 168.73 18.03 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.744 0.817 . . . . 70.209999999999994 111.227 -176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.52 166.13 11.25 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.079 1.14 . . . . 52.140000000000001 114.079 -167.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.23 2.62 23.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.158 2.183 . . . . 64.319999999999993 112.231 169.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -135.68 76.78 1.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 N-CA-C 106.688 -1.597 . . . . 71.219999999999999 106.688 169.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.2 tp -140.77 165.38 20.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 C-N-CA 124.071 0.948 . . . . 65.430000000000007 108.796 168.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -117.51 157.92 46.38 Favored Pre-proline 0 C--N 1.331 -0.214 0 C-N-CA 126.64 1.976 . . . . 74.519999999999996 107.408 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.45 -55.32 2.56 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.235 1.957 . . . . 75.439999999999998 111.94 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -63.48 -21.74 66.49 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.595 -0.717 . . . . 61.329999999999998 112.274 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.3 -19.02 62.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.948 1.249 . . . . 74.409999999999997 110.35 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.34 -40.92 18.83 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 119.887 1.221 . . . . 73.5 110.781 169.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -69.54 -37.83 77.24 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 109.864 -0.421 . . . . 71.109999999999999 109.864 -174.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 34' ' ' SER . 6.2 mm-40 -65.47 -26.71 68.06 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.307 1.043 . . . . 72.530000000000001 112.339 -176.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.73 -16.49 64.28 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 124.23 1.012 . . . . 62.549999999999997 113.37 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -113.66 -26.45 8.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.475 0.71 . . . . 72.409999999999997 111.22 173.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.445 ' HB3' ' HA ' ' A' ' 31' ' ' GLU . 6.5 t -53.78 -18.64 3.37 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.666 1.987 . . . . 62.140000000000001 111.949 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.4 p -46.31 -41.89 13.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.493 1.517 . . . . 74.420000000000002 111.12 169.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 m -150.77 46.24 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.135 1.774 . . . . 60.109999999999999 108.269 -170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.46 178.03 48.32 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 124.274 0.94 . . . . 63.32 110.865 -171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -137.83 134.1 34.73 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.333 1.453 . . . . 74.109999999999999 107.796 169.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 61' ' ' PHE 0.276 1.8 p -118.28 143.25 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.048 1.339 . . . . 61.43 109.562 -178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.8 ttt-85 -77.29 -50.28 13.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.4 1.88 . . . . 62.439999999999998 108.284 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -168.58 -178.49 3.49 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.096 0.558 . . . . 75.219999999999999 110.938 172.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -129.34 152.48 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.366 1.466 . . . . 75.120000000000005 109.024 174.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -125.93 101.34 6.78 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.513 1.925 . . . . 71.409999999999997 106.803 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.3 mtp -95.21 142.12 28.01 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.116 0.966 . . . . 74.540000000000006 110.819 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -143.29 54.82 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 124.078 0.951 . . . . 72.400000000000006 113.36 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.9 t -94.91 4.8 53.39 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 119.711 -1.868 . . . . 70.129999999999995 111.562 163.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.74 36.88 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 125.798 1.639 . . . . 74.400000000000006 110.122 -170.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -116.39 160.71 20.15 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 120.657 -1.277 . . . . 72.109999999999999 108.368 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -122.83 58.36 1.09 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.636 1.975 . . . . 71.540000000000006 108.343 -171.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -161.32 174.25 13.81 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.741 -1.118 . . . . 54.140000000000001 109.453 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -78.29 17.29 0.65 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.05 1.34 . . . . 65.319999999999993 111.181 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -44.8 -65.14 0.57 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.071 2.948 . . . . 72.200000000000003 109.762 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -169.45 -41.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 113.573 0.953 . . . . 73.319999999999993 113.573 -172.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.1 mtmt 44.56 50.25 8.33 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.753 2.021 . . . . 72.239999999999995 113.941 175.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.28 66.06 0.01 OUTLIER Glycine 0 C--N 1.334 0.444 0 N-CA-C 109.534 -1.427 . . . . 74.129999999999995 109.534 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.0 pt -139.8 146.6 24.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 124.838 1.255 . . . . 73.209999999999994 108.555 -175.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.7 159.38 44.56 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.371 1.068 . . . . 44.039999999999999 108.907 168.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -123.85 127.91 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.661 -1.607 . . . . 70.319999999999993 106.661 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.8 t -113.05 112.18 39.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.8 -1.555 . . . . 50.219999999999999 106.8 -167.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -92.41 91.87 7.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.855 1.262 . . . . 72.129999999999995 108.01 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 0.2 OUTLIER -56.08 177.4 0.06 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.043 1.337 . . . . 73.109999999999999 113.91 175.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.5 t -91.77 -31.12 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 O-C-N 120.448 -1.407 . . . . 72.310000000000002 110.917 168.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -117.18 175.66 5.5 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.475 1.489 . . . . 64.150000000000006 110.443 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -94.64 -27.04 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 118.836 0.744 . . . . 60.329999999999998 111.246 171.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -67.4 -22.18 65.55 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 120.558 -1.339 . . . . 72.319999999999993 112.038 -171.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.27 -5.2 57.53 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.945 1.091 . . . . 74.340000000000003 113.945 177.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.9 t -55.46 -55.53 39.07 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 120.32 1.418 . . . . 62.420000000000002 109.459 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.8 -10.32 28.41 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.074 1.849 . . . . 72.049999999999997 113.925 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.65 -59.38 3.65 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 120.082 1.31 . . . . 74.349999999999994 108.218 166.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.526 ' HA ' HD23 ' A' ' 73' ' ' LEU . . . -59.34 -29.43 67.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.814 0.846 . . . . 71.209999999999994 113.007 -175.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.68 -26.27 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.848 1.259 . . . . 64.329999999999998 110.568 173.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.82 -12.61 80.9 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.559 1.552 . . . . 74.25 114.112 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 70' ' ' ALA . 3.2 mm? -87.66 -4.06 58.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.157 1.479 . . . . 72.109999999999999 114.194 -173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.0 t -50.86 -21.35 1.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 116.364 1.987 . . . . 71.209999999999994 116.364 -160.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.4 -12.79 59.35 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 120.724 -1.235 . . . . 62.140000000000001 113.635 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -77.04 165.13 25.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.673 1.236 . . . . 71.319999999999993 110.451 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -140.76 88.35 2.18 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 126.137 1.775 . . . . 63.32 109.531 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.56 100.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 124.145 0.978 . . . . 74.230000000000004 109.002 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 mt 49.06 33.23 4.55 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.836 0.827 . . . . 73.239999999999995 111.275 -171.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.74 5.94 62.59 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.536 -1.147 . . . . 64.140000000000001 114.157 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.6 t -105.5 86.46 1.75 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 126.702 2.001 . . . . 44.030000000000001 108.882 -178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -69.84 176.9 6.21 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.942 3.095 . . . . 65.430000000000007 112.404 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.7 tt -140.58 151.06 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.496 0.665 . . . . 73.439999999999998 110.214 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.2 mm -106.28 156.13 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 125.295 1.438 . . . . 73.239999999999995 108.368 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 m -74.07 -0.78 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 114.904 1.446 . . . . 73.230000000000004 114.904 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -45.78 -60.33 2.28 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.033 1.123 . . . . 63.310000000000002 114.033 -165.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.79 157.37 0.07 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.999 1.319 . . . . 65.420000000000002 112.086 -169.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -88.46 143.81 26.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.081 -1.452 . . . . 74.510000000000005 107.081 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 44.28 69.01 0.46 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.937 2.095 . . . . 71.420000000000002 112.874 176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -147.81 159.2 44.09 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.564 0.745 . . . . 70.430000000000007 112.045 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -85.62 19.18 2.51 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.736 1.214 . . . . 65.040000000000006 110.748 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.02 -9.6 42.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 119.886 -1.759 . . . . 71.329999999999998 112.669 -173.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -84.19 71.66 10.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.972 1.309 . . . . 72.450000000000003 108.345 -171.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.122 0 C-N-CA 126.135 1.774 . . . . 72.129999999999995 106.739 -171.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 CA-C-O 119.255 -0.747 . . . . 73.409999999999997 111.413 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 51.65 60.89 3.53 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.612 1.165 . . . . 73.140000000000001 109.641 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . 0.275 1.0 OUTLIER 45.07 11.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 130.446 3.499 . . . . 71.109999999999999 117.948 178.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -123.02 140.89 52.56 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.371 1.068 . . . . 70.519999999999996 108.927 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.0 134.97 46.22 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.089 1.356 . . . . 74.519999999999996 108.462 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.58 165.06 20.91 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-O 121.153 0.501 . . . . 63.509999999999998 110.346 171.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.0 -47.77 1.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.408 2.072 . . . . 53.399999999999999 110.315 167.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.17 -49.01 77.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.397 1.079 . . . . 73.420000000000002 111.149 -169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.98 -44.05 63.86 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.912 0.885 . . . . 74.310000000000002 111.378 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -63.99 -37.34 87.07 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.201 -0.937 . . . . 74.310000000000002 111.649 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.51 -16.93 55.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 119.206 -0.426 . . . . 74.209999999999994 111.381 -177.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -98.3 -48.51 5.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.884 2.074 . . . . 52.009999999999998 111.936 -174.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' HE ' ' HA ' ' A' ' 63' ' ' ASP . 11.2 mtt85 54.82 10.02 0.34 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 128.195 2.598 . . . . 74.5 117.336 166.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -110.62 153.73 24.78 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.751 1.16 . . . . 70.239999999999995 110.279 -164.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.66 141.59 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.604 1.562 . . . . 44.200000000000003 109.744 176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -115.49 114.16 24.64 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 128.295 2.638 . . . . 74.010000000000005 110.876 -166.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.3 130.48 34.8 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.471 -0.566 . . . . 74.120000000000005 109.471 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -127.77 48.67 2.22 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.036 0.934 . . . . 75.420000000000002 111.695 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.71 11.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.129 -0.982 . . . . 73.019999999999996 113.128 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.9 mt -66.47 168.6 8.78 Favored 'General case' 0 C--O 1.234 0.262 0 O-C-N 120.809 -1.182 . . . . 73.010000000000005 113.264 -169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -121.87 170.57 9.66 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.226 -1.352 . . . . 70.420000000000002 113.194 -167.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.12 -12.43 61.49 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.634 1.574 . . . . 61.119999999999997 115.178 -161.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -134.47 31.01 3.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 119.369 0.986 . . . . 71.439999999999998 111.286 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.4 tp -63.65 165.09 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.54 -0.541 . . . . 43.450000000000003 109.54 174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -122.63 161.92 41.21 Favored Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 125.704 1.602 . . . . 72.239999999999995 109.038 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -56.86 -54.28 3.93 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.862 1.708 . . . . 74.010000000000005 109.535 165.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -38.73 69.01 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.53 -0.748 . . . . 74.140000000000001 111.985 -175.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.7 -34.14 72.5 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.591 1.087 . . . . 54.539999999999999 111.396 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.79 -10.27 59.76 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.442 0.697 . . . . 53.219999999999999 112.348 -173.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' CB ' HG11 ' A' ' 39' ' ' VAL . 0.3 OUTLIER -109.18 -31.66 7.5 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.407 1.083 . . . . 74.120000000000005 109.777 174.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -70.24 -30.86 68.03 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 125.554 1.542 . . . . 54.549999999999997 112.494 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -62.41 -26.04 68.27 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.079 -1.013 . . . . 71.150000000000006 111.693 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.43 -12.05 16.75 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 118.439 -0.791 . . . . 73.010000000000005 112.641 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 88.5 p -62.8 -19.59 64.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.75 1.614 . . . . 73.230000000000004 112.117 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.0 p -64.81 -23.71 67.32 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.781 1.232 . . . . 72.129999999999995 110.926 -177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 m -146.78 8.95 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.593 1.557 . . . . 73.439999999999998 112.3 -166.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.8 -178.61 45.74 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 120.658 -1.276 . . . . 54.329999999999998 111.708 -174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -130.88 141.96 50.34 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 125.686 1.594 . . . . 52.32 107.856 -177.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.463 HG21 ' CG1' ' A' ' 59' ' ' VAL . 11.3 p -135.97 145.96 30.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.801 1.241 . . . . 71.409999999999997 109.295 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -87.58 -46.82 9.21 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 113.908 -1.496 . . . . 73.219999999999999 111.042 -172.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -169.52 174.78 5.74 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 118.781 0.719 . . . . 73.129999999999995 109.798 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG13 HG22 ' A' ' 59' ' ' VAL . 49.1 t -125.87 145.46 33.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.741 1.216 . . . . 73.150000000000006 109.694 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -117.38 98.1 6.24 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.108 1.763 . . . . 70.310000000000002 107.167 173.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.27 149.55 21.15 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.808 -1.182 . . . . 54.439999999999998 107.808 170.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.94 97.22 5.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 106.604 -1.628 . . . . 71.450000000000003 106.604 -176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 61.0 m -152.26 99.41 2.51 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.706 -1.59 . . . . 53.130000000000003 106.706 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -160.67 12.28 0.1 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.126 1.37 . . . . 75.129999999999995 111.745 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -115.26 -83.18 0.62 Allowed 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.24 -0.912 . . . . 72.239999999999995 108.583 -160.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.34 -5.12 0.23 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.497 1.119 . . . . 72.030000000000001 112.582 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.06 40.93 10.44 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 114.978 1.473 . . . . 73.030000000000001 114.978 166.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -149.63 27.08 0.82 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.45 1.9 . . . . 75.409999999999997 109.671 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.53 -85.15 0.47 Allowed 'General case' 0 CA--C 1.523 -0.096 0 O-C-N 120.591 -1.318 . . . . 63.049999999999997 107.99 -170.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.5 m -148.77 48.32 1.01 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.331 1.452 . . . . 74.019999999999996 109.972 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -7.09 5.13 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.147 1.536 . . . . 73.219999999999999 115.147 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.52 77.24 2.12 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 119.994 1.27 . . . . 60.329999999999998 110.512 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 pt -153.96 136.65 6.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 C-N-CA 125.579 1.552 . . . . 72.010000000000005 109.128 -175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.57 151.19 30.36 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.544 1.137 . . . . 73.019999999999996 110.452 169.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -128.01 138.48 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 106.555 -1.646 . . . . 73.030000000000001 106.555 177.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' CG1' HG21 ' A' ' 39' ' ' VAL . 93.4 t -128.66 112.94 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 125.174 1.39 . . . . 64.030000000000001 108.258 -160.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -85.61 81.54 8.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 122.36 1.076 . . . . 61.299999999999997 109.987 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -52.19 150.17 4.76 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.858 1.263 . . . . 73.420000000000002 113.844 171.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 74.5 t -76.59 -24.04 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 115.756 -0.657 . . . . 61.299999999999997 110.062 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HE ' ' A' ' 13' ' ' ARG . 21.9 t0 -132.26 143.79 50.15 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 120.736 1.607 . . . . 70.329999999999998 113.15 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.2 -30.61 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 125.157 1.383 . . . . 62.299999999999997 111.344 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 m -66.28 -15.77 63.48 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 121.077 -1.014 . . . . 70.510000000000005 111.281 -174.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 m -88.27 -6.67 57.65 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 114.476 1.287 . . . . 74.310000000000002 114.476 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.3 t -53.81 -56.7 22.65 Favored Pre-proline 0 N--CA 1.473 0.708 0 CA-C-N 121.85 2.113 . . . . 71.530000000000001 109.83 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -68.17 -6.44 17.29 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 121.779 1.653 . . . . 63.509999999999998 114.335 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.33 -52.48 39.8 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 120.195 -1.565 . . . . 73.510000000000005 108.299 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.15 -23.65 65.7 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.645 0.778 . . . . 74.129999999999995 112.564 -173.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 57.6 mt -62.01 -45.62 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.921 1.289 . . . . 62.100000000000001 109.595 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.11 -2.6 48.38 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 118.951 -0.916 . . . . 13.25 113.247 177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.5 mt -94.99 2.82 55.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.323 1.562 . . . . 71.420000000000002 111.258 175.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.9 t -56.72 -20.87 24.12 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.541 1.064 . . . . 62.350000000000001 113.326 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.15 23.26 14.34 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.638 2.066 . . . . 51.240000000000002 112.045 -174.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -118.35 175.58 5.64 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 128.699 2.8 . . . . 73.019999999999996 109.795 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.2 ptp85 -152.11 127.29 9.82 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.308 1.843 . . . . 74.150000000000006 108.602 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.5 101.0 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.889 -1.522 . . . . 71.450000000000003 106.889 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.7 mt 64.22 -8.98 0.17 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 128.88 2.872 . . . . 70.329999999999998 116.662 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.24 -3.34 1.92 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.187 -1.006 . . . . 74.129999999999995 113.498 -160.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.12 85.25 12.11 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 126.872 2.069 . . . . 72.319999999999993 106.315 -177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -65.99 178.7 2.23 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.718 2.945 . . . . 73.430000000000007 111.92 175.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.1 tt -137.38 161.47 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 124.27 1.028 . . . . 54.140000000000001 109.944 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.5 mm -101.62 158.08 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.283 -1.377 . . . . 74.049999999999997 107.283 177.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 35.8 m -61.92 -1.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 126.295 1.838 . . . . 75.239999999999995 114.877 170.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.66 -46.1 67.03 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.128 -0.982 . . . . 74.0 113.278 -167.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 48.96 29.79 2.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.618 1.71 . . . . 74.099999999999994 115.618 166.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.82 -168.49 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.787 2.035 . . . . 63.32 112.383 -173.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 47.04 47.51 15.95 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.298 2.239 . . . . 73.099999999999994 113.939 172.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.77 156.59 16.59 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.394 1.078 . . . . 52.039999999999999 110.98 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.84 8.86 2.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 128.639 2.776 . . . . 73.340000000000003 113.859 -169.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -66.18 -18.19 65.19 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 120.451 -1.406 . . . . 61.32 113.297 -170.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -79.0 71.06 5.44 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.727 2.011 . . . . 73.430000000000007 112.344 -169.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 . . . . . 0 C--O 1.246 0.896 0 C-N-CA 124.528 1.131 . . . . 72.200000000000003 109.83 171.497 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.876 0 CA-C-O 118.568 -1.129 . . . . 63.109999999999999 111.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 47.09 80.5 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.243 1.817 . . . . 63.509999999999998 111.587 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.2 mtp -132.51 -59.71 0.9 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.001 0.92 . . . . 64.109999999999999 110.046 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -123.71 152.27 42.27 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.913 0.885 . . . . 71.329999999999998 109.499 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.35 127.64 32.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.402 1.481 . . . . 60.5 109.03 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.55 158.29 76.27 Favored Pre-proline 0 N--CA 1.475 0.791 0 CA-C-N 119.91 1.232 . . . . 73.219999999999999 108.903 170.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -62.76 -30.59 78.21 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.261 1.974 . . . . 74.510000000000005 111.858 167.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -71.09 -36.92 72.39 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.929 0.786 . . . . 73.140000000000001 109.858 -172.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -55.99 -44.97 79.12 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 121.563 -0.71 . . . . 72.510000000000005 110.121 170.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -69.21 -15.02 63.29 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 118.089 -0.958 . . . . 75.129999999999995 112.838 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.57 -51.57 8.6 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.398 0.999 . . . . 74.519999999999996 109.329 160.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.57 40.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.674 2.39 . . . . 54.030000000000001 115.275 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.584 HH11 ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -86.27 3.01 45.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.377 1.871 . . . . 63.140000000000001 113.31 175.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.83 152.73 43.42 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.885 1.274 . . . . 74.299999999999997 110.482 -171.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.26 170.1 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.626 -1.25 . . . . 72.109999999999999 107.626 168.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -138.31 104.26 5.13 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.292 1.437 . . . . 74.329999999999998 109.332 -171.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -88.73 75.29 8.22 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.615 1.966 . . . . 73.340000000000003 110.201 -174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 4.8 ttm -81.38 25.07 0.52 Allowed 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.302 0.853 . . . . 53.200000000000003 113.302 -173.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -148.78 48.46 1.01 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 120.131 -1.606 . . . . 75.299999999999997 112.627 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.6 mt -79.15 166.75 21.89 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.558 0.947 . . . . 74.0 113.558 -174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -103.76 -160.72 0.79 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.554 2.342 . . . . 43.420000000000002 110.859 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.45 -20.99 11.09 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 115.938 1.829 . . . . 74.200000000000003 115.938 -164.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -129.62 44.3 2.99 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 123.478 1.608 . . . . 74.340000000000003 108.33 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.7 tt -69.38 140.71 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-N 114.251 -1.341 . . . . 55.229999999999997 107.914 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.81 161.8 32.79 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 124.251 1.02 . . . . 72.129999999999995 108.549 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -59.41 -37.48 89.66 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.055 1.17 . . . . 62.240000000000002 110.1 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.9 ttm-85 -58.29 -31.82 67.85 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 117.56 -1.21 . . . . 75.010000000000005 113.294 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -61.11 -34.95 75.78 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 120.496 1.498 . . . . 72.340000000000003 110.121 -171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -70.14 -32.26 70.17 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.344 1.057 . . . . 72.420000000000002 111.833 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.85 -7.65 23.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 117.998 -1.001 . . . . 64.010000000000005 112.541 -175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.48 -37.27 18.43 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.917 1.235 . . . . 74.0 108.566 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -53.54 -39.05 64.38 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.665 0.786 . . . . 73.099999999999994 112.377 -174.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -106.73 2.2 25.55 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.426 -0.797 . . . . 75.430000000000007 112.278 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.7 p -74.62 -10.66 59.75 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-N 120.422 1.464 . . . . 73.310000000000002 112.076 170.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.5 p -44.93 -52.05 9.1 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.779 2.032 . . . . 71.239999999999995 109.765 165.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 m -153.18 57.01 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 125.676 1.59 . . . . 54.030000000000001 108.299 -171.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 173.58 164.42 28.76 Favored Glycine 0 CA--C 1.527 0.82 0 O-C-N 121.209 -0.932 . . . . 73.420000000000002 113.528 -177.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -123.53 131.19 53.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.798 1.239 . . . . 75.200000000000003 109.456 175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 42.8 t -88.52 138.7 18.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 125.313 1.445 . . . . 73.420000000000002 107.848 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -76.91 -51.78 10.6 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.489 -0.93 . . . . 55.439999999999998 108.489 176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 7.3 t0 -162.47 -172.74 3.27 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.194 1.797 . . . . 55.039999999999999 107.564 172.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 t -132.25 93.98 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-N 119.823 1.192 . . . . 71.140000000000001 110.454 -177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.93 163.14 22.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 122.376 1.084 . . . . 73.409999999999997 110.684 163.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.59 136.19 11.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 127.914 2.486 . . . . 74.329999999999998 105.751 -178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -75.56 99.8 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 105.777 -1.934 . . . . 53.399999999999999 105.777 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 m -72.85 66.37 0.77 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.855 1.662 . . . . 71.400000000000006 111.317 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.251 0.4 OUTLIER 49.34 174.41 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 131.89 4.076 . . . . 73.109999999999999 115.64 -164.761 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.1 ttm-85 -101.58 -75.18 0.6 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 113.742 -1.572 . . . . 72.129999999999995 107.45 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -141.93 -11.3 0.88 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.745 1.218 . . . . 51.329999999999998 112.34 -167.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.4 m -137.62 -86.25 0.29 Allowed 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 108.568 -0.901 . . . . 71.409999999999997 108.568 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -172.98 33.68 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.205 3.002 . . . . 72.409999999999997 107.464 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.74 82.85 1.96 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 127.085 2.154 . . . . 74.439999999999998 110.241 176.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.6 -22.69 56.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.72 -0.657 . . . . 73.109999999999999 111.83 167.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 mtpt 73.78 34.85 0.88 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.404 1.481 . . . . 64.439999999999998 111.846 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.19 65.17 2.53 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 125.846 1.688 . . . . 73.310000000000002 111.871 162.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 pt -141.24 143.6 27.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.163 0.985 . . . . 71.040000000000006 110.099 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.0 156.64 41.57 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 126.7 2.0 . . . . 73.409999999999997 106.462 159.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -116.56 142.57 46.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 104.317 -2.475 . . . . 75.109999999999999 104.317 162.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -126.04 115.91 44.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 105.356 -2.091 . . . . 61.539999999999999 105.356 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 41' ' ' ASP . 2.6 pm0 -73.36 126.36 29.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.668 0.747 . . . . 64.200000000000003 109.507 176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.75 166.67 10.35 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.658 1.183 . . . . 75.329999999999998 110.911 178.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.86 -14.37 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.513 0.725 . . . . 35.340000000000003 111.561 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -138.16 168.64 19.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.517 -1.364 . . . . 64.519999999999996 108.876 -167.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.6 p -76.71 -43.56 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 118.173 -0.918 . . . . 61.399999999999999 108.608 167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 m -64.99 -29.89 70.84 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.623 1.101 . . . . 60.240000000000002 113.681 -152.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.7 m -74.21 -8.14 55.15 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.536 0.939 . . . . 52.009999999999998 113.536 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -62.96 4.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 119.695 -1.878 . . . . 74.400000000000006 108.737 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.58 -10.83 29.34 Favored 'Trans proline' 0 C--N 1.351 0.68 0 CA-C-N 120.948 1.374 . . . . 75.510000000000005 113.134 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.9 -54.32 13.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 119.531 1.06 . . . . 63.340000000000003 109.621 169.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.91 -30.18 63.71 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.942 1.297 . . . . 72.400000000000006 112.415 -178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.04 -49.14 74.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.487 1.115 . . . . 73.409999999999997 108.615 172.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.23 7.83 3.16 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.079 1.323 . . . . 73.409999999999997 114.484 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD2' HE21 ' A' ' 76' ' ' GLN . 70.2 mt -117.05 4.88 12.76 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.799 1.799 . . . . 53.32 111.001 170.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -49.91 -30.41 10.14 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.449 1.477 . . . . 72.0 111.932 175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.57 18.64 54.87 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 125.115 1.34 . . . . 53.5 113.079 -177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.428 HE21 ' CD2' ' A' ' 73' ' ' LEU . 7.2 mt-30 -127.05 165.05 20.21 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.455 1.502 . . . . 72.299999999999997 107.674 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -149.17 130.51 14.68 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 123.29 0.636 . . . . 60.119999999999997 109.59 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.97 104.34 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 106.205 -1.776 . . . . 71.219999999999999 106.205 164.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.3 mt 59.91 19.28 8.27 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 125.625 1.57 . . . . 74.430000000000007 113.566 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.45 1.94 29.36 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 119.545 -0.586 . . . . 74.420000000000002 114.298 -175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.0 t -104.86 86.05 1.38 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.253 1.821 . . . . 55.530000000000001 107.209 171.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.14 179.07 3.07 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.672 2.248 . . . . 61.210000000000001 111.032 163.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 tt -121.34 175.86 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.708 1.203 . . . . 74.400000000000006 108.466 172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.0 mm -123.31 147.32 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 126.131 1.772 . . . . 75.209999999999994 106.848 168.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 25.9 t -55.55 -15.13 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.623 2.769 . . . . 71.200000000000003 115.646 176.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -44.61 -42.52 7.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 115.049 1.499 . . . . 73.099999999999994 115.049 -168.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 58.35 175.53 0.06 Allowed 'General case' 0 N--CA 1.439 -1.009 0 CA-C-O 122.91 1.338 . . . . 63.539999999999999 109.294 -160.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 t -91.09 124.4 35.28 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 104.597 -2.372 . . . . 73.519999999999996 104.597 157.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -122.49 147.28 46.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.805 -1.183 . . . . 62.530000000000001 107.805 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.63 168.5 19.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 124.531 1.144 . . . . 61.539999999999999 111.722 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -76.84 26.64 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.761 2.025 . . . . 64.5 111.848 -171.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -113.9 -3.47 13.4 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.439 1.896 . . . . 73.540000000000006 112.712 -170.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -88.2 -6.35 57.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.065 -0.493 . . . . 64.439999999999998 111.841 177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.268 2.227 . . . . 63.329999999999998 109.875 -164.229 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 111.22 -0.752 . . . . 50.32 111.22 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.9 112.89 4.24 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.738 2.015 . . . . 63.020000000000003 105.703 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.6 mtp -139.51 -85.46 0.23 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.062 0.847 . . . . 54.509999999999998 108.748 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -64.38 148.42 50.47 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.446 -0.576 . . . . 65.430000000000007 109.446 174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.8 tp -79.56 136.55 36.9 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.11 -1.071 . . . . 73.120000000000005 108.11 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.0 p -70.55 159.72 84.01 Favored Pre-proline 0 C--N 1.325 -0.477 0 C-N-CA 123.724 0.81 . . . . 74.030000000000001 110.254 174.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.36 -46.57 5.47 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.565 1.51 . . . . 73.129999999999995 110.179 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.2 -27.82 68.7 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.461 1.504 . . . . 74.030000000000001 112.064 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -73.22 -45.03 58.54 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 121.725 -0.609 . . . . 73.329999999999998 110.092 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -74.24 -33.6 63.38 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.453 0.569 . . . . 64.120000000000005 111.456 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.81 -33.9 77.08 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.497 0.719 . . . . 62.340000000000003 110.575 -177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.94 26.9 2.28 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.766 1.227 . . . . 73.030000000000001 112.698 -170.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.481 ' HE ' ' C ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -71.3 14.01 0.19 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.971 2.108 . . . . 61.229999999999997 115.404 -174.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.38 131.69 55.89 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 120.975 -1.078 . . . . 72.349999999999994 112.011 171.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.61 178.02 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.176 1.79 . . . . 73.120000000000005 109.496 176.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -145.76 117.75 8.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.917 1.287 . . . . 64.349999999999994 110.359 -169.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.0 m -95.96 134.66 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.643 -1.243 . . . . 70.450000000000003 107.643 164.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.6 ttm -131.88 31.51 4.19 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 65.109999999999999 111.047 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -145.18 25.04 1.41 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.582 -1.323 . . . . 74.140000000000001 112.11 -174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 82.0 mt -75.99 166.69 23.13 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.069 -1.02 . . . . 64.109999999999999 113.618 -164.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.96 169.59 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.573 1.149 . . . . 43.25 112.168 168.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.94 -49.13 48.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.948 1.299 . . . . 65.430000000000007 111.925 162.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -92.46 19.83 6.83 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.103 0.961 . . . . 74.450000000000003 112.524 -167.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.548 HD12 HG11 ' A' ' 81' ' ' VAL . 11.6 tt -64.23 163.23 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.441 0.696 . . . . 72.530000000000001 109.78 168.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.0 mtm180 -118.49 160.35 40.22 Favored Pre-proline 0 CA--C 1.519 -0.244 0 C-N-CA 125.11 1.364 . . . . 72.140000000000001 108.965 167.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -57.93 -29.85 87.82 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.605 1.537 . . . . 43.450000000000003 112.352 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -78.55 -18.78 54.17 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 117.662 -1.161 . . . . 74.010000000000005 113.309 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -60.87 -33.61 73.35 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.339 1.427 . . . . 71.420000000000002 110.212 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.44 -44.97 61.64 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.238 1.015 . . . . 74.319999999999993 110.792 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.13 -41.62 85.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.448 -0.901 . . . . 63.240000000000002 108.727 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.02 -39.95 87.6 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.84 0.745 . . . . 73.140000000000001 112.571 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -55.76 -57.44 12.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.626 -0.879 . . . . 73.040000000000006 108.626 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -73.36 -25.14 60.47 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.144 0.794 . . . . 72.25 113.144 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 t -63.03 -11.45 19.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.96 1.304 . . . . 71.409999999999997 112.05 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.1 p -67.33 -21.46 65.65 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 120.846 1.657 . . . . 71.150000000000006 110.943 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.3 -0.57 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.819 0.848 . . . . 71.209999999999994 113.148 -165.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.78 146.08 6.43 Favored Glycine 0 CA--C 1.52 0.385 0 N-CA-C 109.906 -1.278 . . . . 70.319999999999993 109.906 165.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -63.95 148.87 48.53 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.916 0.358 . . . . 72.340000000000003 111.643 -177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.2 145.77 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 126.225 1.81 . . . . 62.210000000000001 108.14 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -84.68 -52.81 5.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 117.862 -1.066 . . . . 71.010000000000005 108.178 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -169.43 170.06 8.58 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.735 1.214 . . . . 54.240000000000002 110.63 171.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -100.52 165.64 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.014 1.726 . . . . 51.539999999999999 111.194 176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -149.87 50.72 0.92 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.139 0.971 . . . . 73.450000000000003 109.859 178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -66.78 120.65 13.88 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.242 2.217 . . . . 70.439999999999998 110.295 -175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 45' ' ' ILE . 3.8 mp -79.69 122.14 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.78 0.832 . . . . 74.030000000000001 109.051 -170.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 t -87.69 4.85 42.49 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.006 0.743 . . . . 73.140000000000001 113.006 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' H ' HG22 ' A' ' 45' ' ' ILE . 7.1 m-20 -89.99 125.65 35.46 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.729 -1.582 . . . . 72.239999999999995 106.729 177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 66.3 mtt85 -130.51 -71.0 0.6 Allowed 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.53 -0.915 . . . . 71.430000000000007 108.53 174.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.3 21.62 0.84 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.072 1.749 . . . . 72.450000000000003 112.289 -171.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.52 4.13 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 128.253 2.621 . . . . 64.109999999999999 115.148 -170.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.8 37.32 0.72 Allowed 'General case' 0 N--CA 1.462 0.143 0 O-C-N 119.889 -1.757 . . . . 73.450000000000003 112.989 -158.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -132.51 -24.93 1.97 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.5 0.72 . . . . 74.329999999999998 112.006 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.4 p -172.92 -58.35 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.873 0.469 . . . . 74.109999999999999 111.445 -159.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt 56.24 81.47 0.13 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 127.208 2.203 . . . . 65.129999999999995 112.746 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.33 59.82 0.71 Allowed Glycine 0 C--N 1.331 0.276 0 N-CA-C 110.711 -0.956 . . . . 45.140000000000001 110.711 161.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 pt -117.08 142.95 28.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 C-N-CA 125.353 1.461 . . . . 72.430000000000007 109.835 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -144.84 150.12 36.57 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.083 1.353 . . . . 62.020000000000003 108.027 160.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.584 ' HD1' HD11 ' A' ' 45' ' ' ILE . 62.0 m-85 -117.74 157.87 25.75 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 105.651 -1.981 . . . . 70.140000000000001 105.651 158.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -162.41 144.54 3.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 126.841 2.056 . . . . 73.349999999999994 106.327 -174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -111.72 119.73 39.64 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.748 1.619 . . . . 74.109999999999999 107.547 -165.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -80.47 173.92 12.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.66 0.743 . . . . 64.219999999999999 111.394 174.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.0 t -85.96 -32.12 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 O-C-N 121.467 -0.771 . . . . 65.010000000000005 108.974 176.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' C ' ' HE ' ' A' ' 13' ' ' ARG . 4.8 m-20 -129.72 120.98 26.0 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.488 1.115 . . . . 73.049999999999997 108.462 -166.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.405 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 7.3 p -45.67 -34.59 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 129.06 2.944 . . . . 74.349999999999994 111.206 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 m -64.65 -18.87 65.34 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 119.929 -1.732 . . . . 74.010000000000005 112.83 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -1.77 24.09 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG23 ' NH2' ' A' ' 13' ' ' ARG . 92.4 t -61.6 -61.34 8.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-N 120.988 1.722 . . . . 74.239999999999995 109.273 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.44 -17.93 60.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.625 . . . . 73.439999999999998 113.703 176.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -59.37 -56.55 20.58 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 119.722 1.146 . . . . 65.319999999999993 110.343 172.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.57 80.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.39 0.676 . . . . 73.040000000000006 111.279 -178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.8 mt -55.98 -47.67 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 124.654 1.182 . . . . 71.329999999999998 109.213 175.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -55.98 -22.25 34.2 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.999 0.809 . . . . 72.349999999999994 114.155 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 38.2 mt -99.12 12.56 35.76 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.296 -1.12 . . . . 72.319999999999993 111.839 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.439 ' HA ' HG23 ' A' ' 83' ' ' ILE . 13.4 t -49.12 -26.39 2.72 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.434 1.094 . . . . 74.239999999999995 113.83 177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -9.02 60.34 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.767 0.699 . . . . 73.439999999999998 114.502 -175.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -76.38 163.49 26.93 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.505 1.153 . . . . 62.43 108.254 172.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -153.33 74.52 1.02 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.881 0.472 . . . . 52.240000000000002 110.633 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 t -53.16 103.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 125.925 1.69 . . . . 73.219999999999999 108.358 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt 54.72 29.57 11.95 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.762 0.825 . . . . 74.150000000000006 112.064 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.73 29.65 34.74 Favored Glycine 0 CA--C 1.533 1.2 0 O-C-N 121.882 -0.511 . . . . 65.109999999999999 112.919 -174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.548 HG11 HD12 ' A' ' 24' ' ' ILE . 38.4 t -125.12 80.08 64.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 125.744 1.618 . . . . 61.32 108.922 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.96 -172.2 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.06 3.174 . . . . 72.420000000000002 112.06 171.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.439 HG23 ' HA ' ' A' ' 74' ' ' THR . 10.5 tt -137.49 146.56 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.72 1.208 . . . . 74.209999999999994 109.592 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.2 mm -87.65 141.58 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 107.084 -1.45 . . . . 71.030000000000001 107.084 171.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.91 0.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 128.697 2.799 . . . . 72.310000000000002 115.737 174.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -55.47 -51.13 67.99 Favored 'General case' 0 CA--C 1.52 -0.21 0 C-N-CA 126.296 1.838 . . . . 74.209999999999994 114.013 -169.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.8 169.95 0.16 Allowed 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.278 1.031 . . . . 73.140000000000001 110.377 -162.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.23 119.24 38.84 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.206 -2.146 . . . . 53.420000000000002 105.206 162.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -106.82 141.74 37.57 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.857 -0.794 . . . . 72.209999999999994 108.857 -172.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 44.42 -153.84 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.875 1.67 . . . . 72.019999999999996 111.136 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -104.63 66.19 0.78 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.196 -1.409 . . . . 71.209999999999994 107.196 163.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -129.44 174.18 9.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.73 0.776 . . . . 71.010000000000005 112.711 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 57.9 t30 59.53 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.366 1 C-N-CA 132.55 4.34 . . . . 64.129999999999995 112.489 -164.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.059 0 C-N-CA 127.513 2.325 . . . . 74.409999999999997 104.879 174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 CA-C-O 117.903 -1.498 . . . . 64.540000000000006 114.119 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -157.65 104.08 1.95 Allowed 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.984 -2.228 . . . . 70.349999999999994 104.984 166.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.6 ttp -141.09 77.44 1.6 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.595 -2.002 . . . . 63.509999999999998 105.595 -174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.32 39.73 0.75 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.651 0.78 . . . . 71.209999999999994 112.805 -171.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.3 tp -54.81 137.66 44.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.372 1.069 . . . . 75.510000000000005 111.772 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.57 157.92 71.77 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 107.702 -1.221 . . . . 71.349999999999994 107.702 170.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -63.52 -27.67 70.12 Favored 'Trans proline' 0 C--N 1.349 0.588 0 CA-C-N 120.535 1.227 . . . . 71.140000000000001 111.114 167.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -57.76 -49.16 77.51 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 124.54 1.136 . . . . 64.439999999999998 109.1 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -50.87 -42.66 59.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.164 1.386 . . . . 71.129999999999995 110.624 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -78.75 -20.85 48.96 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 117.662 -1.161 . . . . 75.349999999999994 113.493 -175.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -87.75 -25.53 23.36 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.514 1.126 . . . . 73.530000000000001 110.582 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 -48.31 18.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.62 1.568 . . . . 63.340000000000003 112.018 -173.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 54.8 4.31 0.07 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 128.983 2.913 . . . . 75.030000000000001 118.764 163.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.1 m -115.0 159.9 20.23 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 119.996 1.271 . . . . 54.140000000000001 109.51 -160.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.4 166.88 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.635 -1.616 . . . . 75.219999999999999 106.635 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -138.34 108.43 6.39 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.419 1.088 . . . . 75.340000000000003 110.721 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.7 m -79.79 125.27 29.47 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 125.726 1.61 . . . . 43.149999999999999 107.97 170.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -137.57 27.73 2.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.447 0.641 . . . . 51.049999999999997 112.542 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -141.99 46.5 1.65 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.644 -1.285 . . . . 70.450000000000003 110.095 -178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.725 ' HA ' HG13 ' A' ' 81' ' ' VAL . 4.0 mp -90.27 -173.88 3.97 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.177 1.391 . . . . 62.310000000000002 112.74 -167.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.67 162.61 18.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.051 2.141 . . . . 61.109999999999999 109.681 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.49 -10.05 59.56 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.379 0.881 . . . . 64.120000000000005 113.379 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.67 56.78 1.83 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.311 1.044 . . . . 75.099999999999994 111.323 -177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.3 tt -112.81 133.13 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.496 1.119 . . . . 75.230000000000004 108.986 174.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 46.6 mtm-85 -81.64 164.88 47.15 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-O 119.04 -0.505 . . . . 64.010000000000005 110.263 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -59.29 -46.21 22.93 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.568 1.512 . . . . 60.32 110.064 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -66.51 -16.82 64.42 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.369 0.878 . . . . 73.299999999999997 113.369 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -63.35 -34.97 78.86 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.801 1.182 . . . . 71.219999999999999 109.551 176.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.55 -43.38 18.8 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.728 -0.653 . . . . 62.310000000000002 110.157 -177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -60.66 -35.13 75.47 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.751 1.16 . . . . 75.030000000000001 110.013 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -76.71 -11.69 59.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.923 1.289 . . . . 72.319999999999993 113.654 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -72.52 -63.71 1.1 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 119.465 1.03 . . . . 74.439999999999998 108.408 170.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -71.21 -15.17 62.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 117.907 -1.044 . . . . 63.020000000000003 112.155 -175.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.6 t -48.51 -25.38 1.66 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.63 1.572 . . . . 54.530000000000001 112.637 164.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 t -68.86 -19.72 64.25 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 120.713 -1.242 . . . . 61.329999999999998 111.094 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.2 m -135.38 -19.55 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 120.157 1.344 . . . . 74.109999999999999 114.525 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.55 -177.54 26.3 Favored Glycine 0 N--CA 1.448 -0.505 0 O-C-N 120.942 -1.099 . . . . 74.040000000000006 111.331 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -123.08 133.11 54.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.489 0.716 . . . . 75.430000000000007 109.373 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.1 t -98.23 133.14 41.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 107.256 -1.387 . . . . 74.439999999999998 107.256 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -74.29 -64.65 0.98 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.764 -1.569 . . . . 72.230000000000004 106.764 174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -156.98 159.85 38.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.554 -1.646 . . . . 71.349999999999994 106.554 -157.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.6 m -134.03 145.36 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 125.176 1.39 . . . . 60.439999999999998 109.374 -176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -132.55 136.4 46.57 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.55 1.94 . . . . 64.409999999999997 108.616 -174.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.78 120.78 15.58 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.15 1.38 . . . . 40.25 109.441 -174.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.14 154.95 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.318 0.963 . . . . 71.409999999999997 110.827 -169.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 50' ' ' SER . 70.2 m -137.74 9.88 2.87 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 116.506 2.039 . . . . 72.239999999999995 116.506 177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.2 t70 71.79 -66.78 0.29 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 129.219 3.007 . . . . 63.420000000000002 107.835 -173.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -158.94 -30.41 0.07 Allowed 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 125.83 1.652 . . . . 75.140000000000001 109.51 157.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -44.82 -31.06 1.1 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 126.8 2.04 . . . . 73.140000000000001 113.743 -168.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.451 ' H ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER 65.43 -11.67 0.17 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.728 1.611 . . . . 75.019999999999996 113.933 172.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ttp-105 -131.44 31.45 4.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.902 2.481 . . . . 55.439999999999998 109.188 -164.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -156.43 -54.01 0.08 Allowed 'General case' 0 C--O 1.226 -0.165 0 C-N-CA 127.046 2.139 . . . . 64.400000000000006 109.871 -172.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . 0.259 19.4 p 44.67 -21.63 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 130.432 3.493 . . . . 55.329999999999998 118.58 -154.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.438 10.4 ptpp? 48.63 22.16 0.48 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 120.926 1.694 . . . . 74.519999999999996 112.939 -148.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' HD13 ' A' ' 20' ' ' LEU . . . 57.69 86.9 0.02 OUTLIER Glycine 0 C--N 1.344 0.979 0 C-N-CA 125.577 1.561 . . . . 74.329999999999998 111.899 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.83 121.85 2.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.622 0.769 . . . . 62.32 110.538 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -140.43 137.89 34.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.887 -0.782 . . . . 55.229999999999997 108.887 169.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -102.65 154.12 19.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.938 -1.875 . . . . 62.340000000000003 105.938 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.92 115.71 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 105.323 -2.102 . . . . 72.409999999999997 105.323 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -81.93 110.04 16.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 105.124 -2.176 . . . . 74.349999999999994 105.124 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.09 163.07 18.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 121.273 -0.892 . . . . 71.439999999999998 110.42 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.88 -15.32 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 122.5 0.32 . . . . 72.329999999999998 111.033 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -145.44 161.83 38.77 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 120.366 -1.459 . . . . 53.310000000000002 111.095 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.6 p -80.12 -22.87 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.089 1.355 . . . . 64.349999999999994 111.669 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -59.37 -27.18 65.73 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.089 -1.007 . . . . 64.329999999999998 111.403 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.9 m -86.06 -4.07 59.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.236 1.199 . . . . 75.329999999999998 114.236 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.05 -58.16 16.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 120.24 1.382 . . . . 72.519999999999996 109.263 174.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.81 -20.39 64.7 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.448 1.432 . . . . 74.310000000000002 113.326 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.09 -52.95 56.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.972 1.26 . . . . 65.540000000000006 110.408 -177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -32.33 73.66 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 123.267 0.355 . . . . 74.129999999999995 111.644 -176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 99.1 mt -59.65 -42.49 88.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 C-N-CA 123.888 0.875 . . . . 74.439999999999998 109.106 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -56.33 -31.14 59.32 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 117.994 0.361 . . . . 41.130000000000003 112.437 176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.31 9.96 16.29 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.334 -1.098 . . . . 74.310000000000002 112.803 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.584 ' HA ' HG23 ' A' ' 83' ' ' ILE . 1.4 t -49.82 -29.85 8.69 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 120.384 1.447 . . . . 71.450000000000003 114.458 -172.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.08 6.46 40.05 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.476 1.036 . . . . 64.109999999999999 113.779 -176.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -81.36 175.05 10.91 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.237 1.019 . . . . 70.230000000000004 108.792 165.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -149.58 135.16 18.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.925 -0.769 . . . . 74.310000000000002 108.925 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.2 p -87.95 119.57 35.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 105.847 -1.909 . . . . 63.020000000000003 105.847 162.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.9 mt 60.3 1.46 0.37 Allowed 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.014 1.857 . . . . 63.399999999999999 116.014 171.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.44 2.21 15.36 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.718 -1.046 . . . . 70.239999999999995 113.902 -172.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 20' ' ' LEU . 68.9 t -104.57 86.39 1.4 Allowed Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 128.906 2.882 . . . . 70.510000000000005 109.151 173.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -65.3 177.49 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.23 1.953 . . . . 45.200000000000003 111.086 161.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.584 HG23 ' HA ' ' A' ' 74' ' ' THR 0.296 8.3 tt -122.19 176.45 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 123.951 0.9 . . . . 71.219999999999999 109.617 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 83' ' ' ILE . 47.8 mm -123.97 145.78 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 126.945 2.098 . . . . 70.239999999999995 106.077 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.0 m -64.52 -4.41 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.533 2.333 . . . . 71.329999999999998 114.819 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -53.85 -49.11 69.2 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.933 1.693 . . . . 72.340000000000003 113.717 -169.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 63.4 179.36 0.15 Allowed 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.575 1.55 . . . . 64.540000000000006 111.498 -170.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.7 t -99.23 112.0 24.25 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.594 1.558 . . . . 74.310000000000002 106.963 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 63.41 -172.23 0.17 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.255 1.422 . . . . 64.25 111.733 -176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -154.25 174.2 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.885 1.674 . . . . 73.310000000000002 108.857 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -74.45 14.9 0.4 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.846 1.259 . . . . 71.510000000000005 113.568 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -115.46 -73.77 0.64 Allowed 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 121.455 -0.778 . . . . 72.209999999999994 110.507 -160.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 50.02 64.05 1.94 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.75 2.02 . . . . 74.540000000000006 111.668 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 . . . . . 0 C--O 1.252 1.219 0 O-C-N 121.847 -0.533 . . . . 75.540000000000006 111.618 -174.138 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.801 0 N-CA-C 110.146 -1.181 . . . . 74.530000000000001 110.146 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -69.53 68.87 0.25 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.246 1.418 . . . . 70.540000000000006 111.975 -175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.0 tpp -170.44 -46.75 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.413 1.885 . . . . 74.450000000000003 109.638 162.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -106.05 167.39 9.84 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.707 0.803 . . . . 75.510000000000005 111.018 -162.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.9 tp -78.93 130.33 35.48 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.618 0.767 . . . . 61.350000000000001 109.039 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.66 HG23 ' H ' ' A' ' 9' ' ' GLU . 3.0 t -65.54 147.61 98.57 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 108.757 -0.831 . . . . 73.409999999999997 108.757 172.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 -11.01 27.05 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.472 2.115 . . . . 75.209999999999994 112.971 169.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -79.91 -49.91 11.22 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.876 1.27 . . . . 75.310000000000002 110.723 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.66 ' H ' HG23 ' A' ' 6' ' ' THR . 75.7 tt0 -58.02 -47.27 83.58 Favored 'General case' 0 C--N 1.334 -0.088 0 C-N-CA 125.475 1.51 . . . . 74.530000000000001 110.861 -177.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -62.99 -32.13 73.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.578 0.585 . . . . 61.140000000000001 112.578 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -32.72 72.68 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.884 1.274 . . . . 74.129999999999995 108.314 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.88 27.2 1.86 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.596 2.759 . . . . 72.420000000000002 112.219 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 -22.9 62.75 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.336 1.236 . . . . 75.340000000000003 114.336 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.5 m -92.51 145.72 24.23 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.282 -1.006 . . . . 74.049999999999997 108.282 -167.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 m -108.41 125.62 65.19 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 N-CA-C 107.855 -1.165 . . . . 53.509999999999998 107.855 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.637 ' H ' ' HA ' ' A' ' 87' ' ' ALA . 7.3 t80 -89.55 124.29 34.41 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.869 1.668 . . . . 75.230000000000004 109.151 -176.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -111.94 86.13 2.28 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.715 1.606 . . . . 71.219999999999999 108.941 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.0 ttp -92.03 27.54 2.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.711 0.804 . . . . 73.25 112.364 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -150.28 37.09 0.68 Allowed 'General case' 0 CA--C 1.546 0.795 0 O-C-N 119.863 -1.773 . . . . 70.230000000000004 113.712 -173.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.67 153.27 42.17 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.476 -0.765 . . . . 72.319999999999993 112.916 -169.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.79 158.06 29.7 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.323 0.582 . . . . 72.230000000000004 111.154 172.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.88 -15.59 43.72 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.193 1.183 . . . . 61.119999999999997 114.193 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.69 30.65 5.48 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.101 1.318 . . . . 64.150000000000006 111.301 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.429 ' CD1' HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -60.89 144.12 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 120.886 -1.134 . . . . 55.549999999999997 109.866 170.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -97.45 158.21 33.52 Favored Pre-proline 0 N--CA 1.464 0.27 0 C-N-CA 123.907 0.883 . . . . 72.340000000000003 109.724 160.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -57.85 -34.87 98.85 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 121.988 1.792 . . . . 62.340000000000003 112.364 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -67.44 -25.89 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 O-C-N 121.917 -0.489 . . . . 72.329999999999998 112.247 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.74 -32.8 74.0 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 120.01 1.277 . . . . 64.340000000000003 111.552 -174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -68.33 -41.37 80.9 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 123.092 0.557 . . . . 62.409999999999997 110.586 -175.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -76.54 -40.23 50.49 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 110.249 -0.278 . . . . 74.439999999999998 110.249 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.6 -44.08 76.64 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.84 1.256 . . . . 62.020000000000003 111.918 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -54.38 -42.43 70.36 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.098 -0.376 . . . . 72.150000000000006 111.232 177.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -88.08 -11.87 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.491 0.716 . . . . 73.409999999999997 112.529 -176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 t -65.66 -12.87 57.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.246 1.818 . . . . 74.450000000000003 111.783 -175.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -59.08 -31.28 68.74 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.153 -0.967 . . . . 71.420000000000002 110.702 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.09 17.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.039 -1.038 . . . . 70.150000000000006 113.03 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -162.37 174.38 38.77 Favored Glycine 0 C--N 1.335 0.486 0 O-C-N 120.764 -1.21 . . . . 70.329999999999998 113.595 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.761 ' HG3' HG21 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -127.26 51.81 1.86 Allowed 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.959 1.304 . . . . 71.530000000000001 111.673 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG21 HG12 ' A' ' 59' ' ' VAL . 2.2 p -43.73 126.42 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 127.904 2.482 . . . . 63.25 110.279 -177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.68 -51.09 29.99 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 113.79 -1.55 . . . . 63.409999999999997 108.664 -158.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -163.54 179.12 7.46 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 125.193 1.558 . . . . 74.319999999999993 109.491 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.636 HG22 HG13 ' A' ' 59' ' ' VAL . 20.6 t -136.92 147.88 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.185 0.994 . . . . 64.129999999999995 109.221 -174.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.58 102.53 11.59 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.56 2.344 . . . . 74.120000000000005 106.822 174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.34 115.85 30.87 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.225 1.81 . . . . 74.340000000000003 107.07 177.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mp -89.81 75.97 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.799 1.639 . . . . 55.340000000000003 108.677 -164.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.6 m -80.01 64.1 4.74 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 122.499 1.142 . . . . 54.32 111.61 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -77.14 19.01 0.34 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.969 2.108 . . . . 44.109999999999999 112.85 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . 0.268 11.1 ptt180 47.92 -170.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 128.99 2.916 . . . . 53.299999999999997 114.098 -172.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -86.82 84.59 7.33 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.022 -1.473 . . . . 73.219999999999999 107.022 172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.4 t -150.42 -83.45 0.09 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.22 -1.4 . . . . 60.310000000000002 107.22 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -124.25 109.17 13.05 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 105.042 -2.207 . . . . 62.100000000000001 105.042 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -155.41 155.78 34.18 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 119.396 0.998 . . . . 60.140000000000001 112.698 173.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -71.2 2.16 5.03 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.537 1.535 . . . . 62.450000000000003 112.808 166.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? 53.52 -1.95 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 129.446 3.098 . . . . 74.219999999999999 118.614 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -164.39 76.09 0.16 Allowed Glycine 0 CA--C 1.517 0.159 0 CA-C-N 120.91 1.686 . . . . 74.010000000000005 109.892 178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.8 pt -143.6 139.84 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.901 0.88 . . . . 64.349999999999994 111.384 -175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.36 157.27 43.52 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 126.289 1.836 . . . . 75.420000000000002 107.094 156.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.414 ' CE2' ' CD1' ' A' ' 16' ' ' PHE . 58.0 m-85 -124.99 128.38 48.48 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 104.884 -2.265 . . . . 75.049999999999997 104.884 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.636 HG13 HG22 ' A' ' 42' ' ' VAL . 2.7 t -116.04 112.93 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 107.291 -1.374 . . . . 73.409999999999997 107.291 -164.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -89.45 88.08 7.32 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 122.952 1.358 . . . . 73.129999999999995 110.578 -170.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -49.92 156.91 0.67 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 123.402 1.572 . . . . 75.510000000000005 113.375 166.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.761 HG21 ' HG3' ' A' ' 38' ' ' LYS . 3.5 m -79.9 -35.33 16.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 128.276 2.63 . . . . 61.32 113.975 176.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -116.73 165.15 13.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 126.012 1.725 . . . . 73.120000000000005 108.438 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.8 t -88.42 -27.38 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 123.227 0.611 . . . . 54.409999999999997 110.075 174.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 t -60.64 -27.61 67.93 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.325 0.966 . . . . 71.439999999999998 112.066 -173.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 p -76.24 -19.67 58.14 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.829 -1.17 . . . . 61.350000000000001 114.147 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.5 t -52.22 -57.71 14.24 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.499 1.12 . . . . 72.040000000000006 109.668 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.82 -17.51 47.07 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.713 1.608 . . . . 74.319999999999993 113.652 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.61 -51.97 50.41 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.022 1.283 . . . . 73.439999999999998 109.733 172.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.96 -39.86 91.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.491 0.716 . . . . 74.049999999999997 110.576 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.6 mt -58.54 -39.28 74.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 123.609 0.764 . . . . 74.430000000000007 109.393 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.76 -4.99 29.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.595 1.093 . . . . 24.309999999999999 114.492 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.9 mt -109.24 13.39 24.37 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.393 1.597 . . . . 70.040000000000006 111.735 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.476 ' HA ' HG23 ' A' ' 83' ' ' ILE . 3.3 t -54.3 -3.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.348 1.859 . . . . 73.349999999999994 115.22 177.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.61 7.88 24.19 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.13 1.347 . . . . 44.509999999999998 114.435 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -97.69 175.14 6.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.275 1.538 . . . . 72.040000000000006 110.311 173.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -155.57 89.07 1.16 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.265 -0.643 . . . . 72.230000000000004 109.265 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 m -60.31 113.45 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 108.151 -1.055 . . . . 72.209999999999994 108.151 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt 59.6 13.16 3.21 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.102 1.149 . . . . 72.329999999999998 114.102 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.07 13.3 37.04 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-O 118.638 -1.09 . . . . 65.25 113.425 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.429 HG11 ' CD1' ' A' ' 24' ' ' ILE . 46.3 t -105.01 85.02 1.12 Allowed Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 125.481 1.513 . . . . 63.020000000000003 108.352 172.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.8 179.38 3.76 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.256 2.638 . . . . 51.350000000000001 111.164 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG23 ' HA ' ' A' ' 74' ' ' THR . 11.7 tt -129.59 177.1 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 126.724 2.01 . . . . 74.430000000000007 108.37 176.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.8 mm -126.73 147.24 31.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.304 1.841 . . . . 70.310000000000002 107.413 169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.43 -10.25 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 116.39 1.996 . . . . 65.019999999999996 116.39 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -56.34 -41.92 76.88 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.975 1.261 . . . . 74.209999999999994 112.898 -166.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.637 ' HA ' ' H ' ' A' ' 16' ' ' PHE . . . 58.97 174.94 0.07 Allowed 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 122.279 1.038 . . . . 72.409999999999997 110.035 -165.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.0 t -88.57 102.79 15.28 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.494 -2.039 . . . . 75.409999999999997 105.494 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 166.89 12.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.504 1.122 . . . . 73.329999999999998 108.927 -175.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.5 122.69 18.14 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.504 -1.295 . . . . 61.109999999999999 107.504 167.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -85.2 60.13 6.05 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.99 -1.855 . . . . 61.329999999999998 105.99 170.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -143.23 165.8 26.45 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 125.967 1.707 . . . . 71.140000000000001 108.424 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -157.93 139.49 13.73 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 103.427 -2.805 . . . . 55.140000000000001 103.427 162.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 . . . . . 0 C--O 1.258 1.518 0 CA-C-N 120.22 1.373 . . . . 71.219999999999999 107.597 175.833 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 N-CA-C 111.304 -0.718 . . . . 74.349999999999994 111.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.45 107.07 4.81 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.585 -1.635 . . . . 74.310000000000002 106.585 164.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.8 mtm -144.3 -80.2 0.18 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 108.067 -1.086 . . . . 72.409999999999997 108.067 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.24 142.04 30.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 118.013 0.369 . . . . 72.349999999999994 110.701 -170.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.95 111.55 5.74 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.46 1.504 . . . . 72.340000000000003 109.985 -172.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.2 p -78.04 164.93 54.18 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.266 -0.896 . . . . 74.230000000000004 110.678 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.53 -51.54 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.256 1.97 . . . . 72.129999999999995 111.503 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.17 -24.32 63.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.822 0.737 . . . . 60.329999999999998 111.279 -175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -57.16 -56.0 27.48 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.85 0.75 . . . . 62.32 109.06 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -57.42 -30.68 65.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.275 0.488 . . . . 63.119999999999997 111.576 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -84.18 -17.79 38.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.495 1.518 . . . . 72.540000000000006 111.808 -175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.4 -85.57 0.05 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.466 0.706 . . . . 64.439999999999998 109.578 164.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.7 37.78 24.51 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.782 0.833 . . . . 75.549999999999997 111.105 -170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.3 m -102.39 147.6 26.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.135 0.574 . . . . 64.439999999999998 109.628 -169.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.41 129.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 124.462 1.105 . . . . 73.549999999999997 108.468 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -100.51 108.74 20.77 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 125.951 1.7 . . . . 71.209999999999994 109.143 -171.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.441 ' O ' HD11 ' A' ' 20' ' ' LEU . 13.1 m -84.88 122.13 28.73 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.761 1.625 . . . . 53.130000000000003 106.871 175.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.2 ttp -139.04 52.27 1.78 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.029 0.919 . . . . 71.230000000000004 111.385 -176.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.443 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 tt0 -154.97 30.45 0.41 Allowed 'General case' 0 C--N 1.327 -0.411 0 O-C-N 120.729 -1.232 . . . . 64.140000000000001 109.668 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.675 ' H ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -84.26 166.63 17.34 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.802 1.287 . . . . 74.219999999999999 110.923 -167.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -105.15 153.12 21.96 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 112.629 -2.078 . . . . 34.350000000000001 110.202 -171.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.46 13.66 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.76 2.024 . . . . 71.129999999999995 114.598 -173.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.49 25.22 1.09 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 127.067 2.147 . . . . 75.200000000000003 111.035 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 81' ' ' VAL . 10.6 tp -72.34 155.3 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 120.456 -1.403 . . . . 74.099999999999994 109.42 177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.31 161.55 25.56 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.997 1.719 . . . . 71.219999999999999 107.274 171.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.38 -42.02 44.87 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.888 1.725 . . . . 75.510000000000005 112.416 177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -62.09 -30.47 71.03 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 111.904 0.335 . . . . 75.519999999999996 111.904 -174.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -24.5 66.82 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.568 0.622 . . . . 63.509999999999998 110.979 -178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.4 -41.45 12.1 Favored 'General case' 0 C--N 1.339 0.15 0 N-CA-C 109.305 -0.628 . . . . 60.350000000000001 109.305 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -66.83 -35.33 79.8 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.558 0.617 . . . . 63.210000000000001 111.261 -175.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -78.93 -24.91 43.71 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 121.56 -0.712 . . . . 75.129999999999995 112.474 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -57.09 -36.3 70.44 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.126 -0.359 . . . . 65.319999999999993 111.111 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -96.96 -1.9 44.74 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.211 0.819 . . . . 65.120000000000005 113.211 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -60.11 -20.48 58.49 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.297 1.839 . . . . 73.430000000000007 111.026 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -13.41 61.52 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.036 -1.04 . . . . 74.239999999999995 112.902 175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.55 2.53 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 120.493 -1.379 . . . . 72.540000000000006 113.67 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.34 -143.45 7.99 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.453 -1.859 . . . . 51.229999999999997 108.453 175.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.701 ' HG2' HG11 ' A' ' 62' ' ' VAL . 3.7 ptmm? -129.24 161.76 29.44 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.408 -0.96 . . . . 64.439999999999998 108.408 174.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.8 t -88.25 140.01 16.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.847 -0.797 . . . . 72.25 108.847 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -78.11 -59.95 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.09 -1.078 . . . . 72.25 108.09 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -142.78 137.47 29.75 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.222 1.009 . . . . 73.450000000000003 108.629 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -103.44 129.81 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.583 1.553 . . . . 72.420000000000002 107.726 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -153.46 112.25 3.71 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 118.828 0.74 . . . . 75.099999999999994 111.381 -172.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -136.78 157.48 46.66 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.065 -1.022 . . . . 64.120000000000005 112.504 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.18 65.34 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 108.648 -0.871 . . . . 74.420000000000002 108.648 -166.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.0 t -104.34 12.92 32.97 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.851 0.86 . . . . 75.329999999999998 112.123 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.53 124.49 16.23 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.282 1.433 . . . . 71.230000000000004 107.332 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -128.67 -69.33 0.72 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 117.764 -1.112 . . . . 74.439999999999998 110.163 160.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.406 ' H ' ' H ' ' A' ' 50' ' ' SER . 8.5 p30 173.43 -2.9 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.946 2.499 . . . . 62.43 112.301 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 49' ' ' ASN . 0.4 OUTLIER -143.2 -176.1 4.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.977 1.711 . . . . 63.509999999999998 111.981 -158.091 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -107.12 90.24 3.24 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 105.968 -1.864 . . . . 63.030000000000001 105.968 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -135.55 -175.35 3.92 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 106.214 -1.773 . . . . 72.219999999999999 106.214 -164.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 p -66.65 78.46 0.11 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 120.391 -0.523 . . . . 75.099999999999994 109.864 162.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . 0.274 6.7 ptmt -83.02 -12.07 57.55 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.32 1.848 . . . . 75.129999999999995 112.519 165.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 20' ' ' LEU . . . -87.97 72.84 2.38 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 108.461 -1.855 . . . . 50.5 108.461 174.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.0 pt -150.19 138.2 14.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.158 1.783 . . . . 73.530000000000001 109.925 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.29 151.48 33.0 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.198 1.399 . . . . 75.519999999999996 108.454 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -128.36 104.21 7.59 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.578 -2.008 . . . . 74.430000000000007 105.578 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.32 118.09 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 106.495 -1.669 . . . . 64.209999999999994 106.495 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -91.16 121.17 32.7 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.672 -1.603 . . . . 75.129999999999995 106.672 -177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -100.88 165.21 11.46 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 122.445 1.116 . . . . 75.140000000000001 112.181 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.701 HG11 ' HG2' ' A' ' 38' ' ' LYS . 15.6 m -76.56 -34.91 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 125.62 1.568 . . . . 61.409999999999997 112.761 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -134.13 152.4 51.81 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.358 1.063 . . . . 55.32 112.908 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.42 -27.72 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.994 0.918 . . . . 71.140000000000001 112.054 171.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 m -60.02 -25.43 65.29 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.344 1.429 . . . . 65.209999999999994 113.95 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.4 p -77.64 -19.21 55.83 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 120.125 1.33 . . . . 64.140000000000001 114.254 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 62.8 t -56.47 -57.23 24.55 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.65 1.18 . . . . 71.150000000000006 111.404 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -63.59 -23.7 70.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.437 1.425 . . . . 73.150000000000006 111.462 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -50.97 52.47 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.967 0.907 . . . . 62.43 109.863 176.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.51 77.65 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.228 1.011 . . . . 65.140000000000001 111.418 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 78.0 mt -53.66 -43.62 55.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.18 0.992 . . . . 74.209999999999994 109.382 172.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.83 -27.33 64.12 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 119.161 -0.8 . . . . 74.329999999999998 112.833 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.7 mt -98.67 4.26 47.88 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.096 1.358 . . . . 65.129999999999995 111.279 -167.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.294 2.8 m -45.55 -26.79 0.64 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.565 0.95 . . . . 70.030000000000001 113.565 161.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.56 18.06 45.04 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.309 0.884 . . . . 61.149999999999999 115.309 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -125.68 163.17 23.39 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 119.328 1.564 . . . . 73.150000000000006 109.367 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -136.25 115.71 12.75 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 125.398 1.479 . . . . 63.229999999999997 110.335 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.8 t -79.96 98.28 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.868 -1.53 . . . . 74.030000000000001 106.868 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.0 mt 54.87 33.25 19.49 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.139 0.976 . . . . 73.239999999999995 112.082 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.04 11.81 57.17 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.71 -1.05 . . . . 52.329999999999998 113.917 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 20' ' ' LEU . 99.3 t -114.06 85.32 9.96 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 118.891 1.345 . . . . 65.230000000000004 108.176 168.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -64.82 -177.63 0.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.734 2.29 . . . . 51.509999999999998 111.714 162.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.7 tt -124.29 156.84 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.648 -0.871 . . . . 70.219999999999999 108.648 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.92 146.85 8.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 107.423 -1.325 . . . . 65.129999999999995 107.423 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.8 m -74.12 16.32 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 126.688 1.995 . . . . 61.310000000000002 112.736 -175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -70.21 -26.64 63.97 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.441 2.296 . . . . 72.310000000000002 112.889 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 53.46 36.24 22.65 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.288 1.835 . . . . 64.010000000000005 113.802 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 50.71 23.26 1.32 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.227 2.211 . . . . 62.520000000000003 114.918 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -78.73 132.95 37.16 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 121.371 -0.831 . . . . 61.119999999999997 109.651 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.8 142.08 11.94 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.305 1.442 . . . . 73.209999999999994 107.148 164.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -83.29 57.65 4.09 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.912 1.685 . . . . 73.430000000000007 107.736 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -128.97 -172.07 2.63 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 125.168 1.387 . . . . 74.109999999999999 110.758 176.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . 0.306 68.3 m-20 74.61 21.7 2.18 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.708 2.803 . . . . 60.119999999999997 112.252 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? . . . . . 0 C--O 1.255 1.349 0 C-N-CA 130.266 3.426 . . . . 73.099999999999994 111.853 174.43 . . . . . . . . 0 0 . 1 stop_ save_